Citrus Sinensis ID: 004645
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 740 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAV6 | 700 | Serine/threonine-protein | yes | no | 0.798 | 0.844 | 0.600 | 0.0 | |
| Q0D598 | 704 | Probable serine/threonine | yes | no | 0.914 | 0.961 | 0.525 | 0.0 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.914 | 0.961 | 0.524 | 0.0 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.698 | 0.910 | 0.611 | 0.0 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.633 | 0.953 | 0.666 | 0.0 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.568 | 0.677 | 0.581 | 1e-146 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.520 | 0.746 | 0.586 | 1e-141 | |
| Q0D847 | 601 | Probable serine/threonine | no | no | 0.658 | 0.810 | 0.505 | 1e-137 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.594 | 0.776 | 0.521 | 1e-132 | |
| Q9SCU5 | 549 | Probable serine/threonine | no | no | 0.555 | 0.748 | 0.530 | 1e-130 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 748 bits (1930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/674 (60%), Positives = 477/674 (70%), Gaps = 83/674 (12%)
Query: 9 ESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEEL 68
E D SEFVEVDPTGRYGRYNE+LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE+L
Sbjct: 8 EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
Query: 69 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 128
ERLYCEIHLLKTLKH+NIMKFYTSWVDTANRNINFVTE+FTSGTLRQYRL+H+RVNIRA+
Sbjct: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV 188
KHWCRQIL GL YLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CV
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Query: 189 GTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248
GTPEFMAPEVYEE YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV+SGKKP+AL
Sbjct: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247
Query: 249 FKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLR 308
+KV+DPEV+ FIEKCLATVS R+SARELL DPFL+IDD + DLR + + D + PL R
Sbjct: 248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDME---DSVGPLYR 304
Query: 309 QSLY--------------------GIYHSNSSSNN---GCGHYIGYDTENGLDYHPHEFQ 345
Q + G Y SNSSS N G+ ++ +NG Y+P E +
Sbjct: 305 QPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAETE 364
Query: 346 ESE-IDLFTC------QEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 398
E+ I+LF +E++ N DI+IKGKRR+D G+FLRLRIADKEGR+RNIYFPFD
Sbjct: 365 ETHGIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPFD 424
Query: 399 IQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEE------SPHR 452
I+TDTALSVATEMV+ELD+ D VTKIA +ID EI+SLVP W+ G EE + +
Sbjct: 425 IETDTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRPGPEFEECLAAAAAANA 484
Query: 453 SSFCHNCASN----GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQ 508
+S C+NC SN G + D++ ++ GA V+QC ++GC HGRFEEIT
Sbjct: 485 ASICNNCVSNRTSMGSVMDFLRTN-PGA---NVIQCCRNGCGETHGRFEEITI------- 533
Query: 509 CAPEGADQAASPQSAVVHYADIWA---QHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEE 565
+ V ++W Q E + LSS I H + E
Sbjct: 534 ------------RETEVRLRELWKLQQQQESRELSS-----IDSGHNHSEEEEEEEVLYE 576
Query: 566 KIINMDSQSKCHERNCFSMNSAMDYGLLDDY--------ENEIRQELRWLKAKYQIQLRE 617
NM S +E N S + + + + Y EN+++QELRWLKAK QI+LR+
Sbjct: 577 DPENMFSCEAGNEINHISGSGSFSF-MPSKYCDEPSEKTENQVQQELRWLKAKCQIELRD 635
Query: 618 LRDQQLGVKYKSSS 631
++D+QL ++ S
Sbjct: 636 IQDEQLKTRWPESG 649
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/744 (52%), Positives = 487/744 (65%), Gaps = 67/744 (9%)
Query: 10 SDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE 69
D E+ EVDPTGRYGRYN++LGKGASKTVYRAFDEY+G+EVAWNQVKL+DFLQSPE+LE
Sbjct: 12 GDLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLE 71
Query: 70 RLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK 129
RLYCEIHLLKTLKHRNIMKFYTSWVD + RNINF+TEMFTSGTLRQYR KH RVNI AVK
Sbjct: 72 RLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVK 131
Query: 130 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 189
HWCRQILSGLLYLHS DPP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA CVG
Sbjct: 132 HWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVG 191
Query: 190 TPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249
TPEFMAPEVYEEEYNELVDIYSFGMC+LEMVTF+YPYSECTHP QIYKKVISG KPEAL+
Sbjct: 192 TPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALY 251
Query: 250 KVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQ 309
KV+DP VRQF+EKCLAT S RLSARELL DPFLQ+D DL DY ++ L +
Sbjct: 252 KVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD----DLVFCPGDGDYSLMNYLRQP 307
Query: 310 SLYGIYHSNSSSNNGCGHYIGYD--TENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISI 367
L Y + S +NG I D TE+ D + + IDLF EDE L N DI+I
Sbjct: 308 YLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITI 367
Query: 368 KGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAE 427
KG++ ED IFLRLRIAD +G +RNIYFPFDI+ DTALSVATEMV+ELDITD +VT+IAE
Sbjct: 368 KGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAE 427
Query: 428 IIDSEIASLVPEWKRGMAMEESPHRSSFCHNCASN----GCLPDYILSDGSGAKNLQVLQ 483
+ID E+++LVP+W+ G +EES +++CHNC SN G L Y+ S G +
Sbjct: 428 MIDGEVSALVPDWRPGPGIEES-QDTTYCHNCGSNVSSCGSLYAYMSSAARGCQ------ 480
Query: 484 CSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQV--LSS 541
CA +HGRFEEIT+Q +G + + + H D A H +
Sbjct: 481 -----CAELHGRFEEITFQANGEQTDLQDSGGSSDDGGGQTQHVKDQEAVHSNGFVQMGR 535
Query: 542 QGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIR 601
+G RD C SS+ + C R+ YE +
Sbjct: 536 RGPRDQFC--------FSSF----------QEQSCSPRH---------------YEYDTS 562
Query: 602 QELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDD-----KTRASDDKVSPSSVLPEP 656
+ + K+++++ + + +++ ++ +L D+ + ++S +K+ S + +
Sbjct: 563 LQAKGFDMKHEVKMAKYKARKMAHLRRAIHPSLDFDNLNGERRMKSSLNKLQ-SFHIGKN 621
Query: 657 ESNRPP--QRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKS 714
+ R P +R+ R + + + + QR E ++ SP+ M TA+S
Sbjct: 622 HNFRIPTCERSPGARDAEEDPDIFNLAYHSRHPDPGAQRARHCE-VDAQSSPDLMFTARS 680
Query: 715 YYTPL-LPHSLHRATSLPVDSVDV 737
YYT LP +L R S+ +++VD
Sbjct: 681 YYTGAQLPTNLPRTKSVTLNAVDA 704
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 707 bits (1825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/744 (52%), Positives = 486/744 (65%), Gaps = 67/744 (9%)
Query: 10 SDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE 69
D E+ EVDPTGRYGRYN++LGKGASKTVYRAFDEY+G+EVAWNQVKL+DFLQSPE+LE
Sbjct: 12 GDLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLE 71
Query: 70 RLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK 129
RLYCEIHLLKTLKHRNIMKFYTSWVD + RNINF+TEMFTSGTLRQYR KH RVNI AVK
Sbjct: 72 RLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVK 131
Query: 130 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 189
HWCRQILSGLLYLHS DPP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA CVG
Sbjct: 132 HWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVG 191
Query: 190 TPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249
TPEFMAPEVYEEEYNELVDIYSFGMC+LEMVTF+YPYSECTHP QIYKKVISG KPEAL+
Sbjct: 192 TPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALY 251
Query: 250 KVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQ 309
KV+DP VRQF+EKCLAT S RLSARELL DPFLQ+D DL DY ++ L +
Sbjct: 252 KVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD----DLVFCPGDGDYSLMNYLRQP 307
Query: 310 SLYGIYHSNSSSNNGCGHYIGYD--TENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISI 367
L Y + S +NG I D TE+ D + + IDLF EDE L N DI+I
Sbjct: 308 YLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITI 367
Query: 368 KGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAE 427
KG++ ED IFLRLRIAD +G +RNIYFPFDI+ DTALSVATEMV+ELDITD +VT+IAE
Sbjct: 368 KGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAE 427
Query: 428 IIDSEIASLVPEWKRGMAMEESPHRSSFCHNCASN----GCLPDYILSDGSGAKNLQVLQ 483
+ID E+++LVP+W+ G +EES +++CHNC SN G L Y+ S G +
Sbjct: 428 MIDGEVSALVPDWRPGPGIEES-QDTTYCHNCGSNVSSCGSLYAYMSSAARGCQ------ 480
Query: 484 CSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQV--LSS 541
CA +HGRFEEIT+Q +G + + + H D A H +
Sbjct: 481 -----CAELHGRFEEITFQANGEQTDLQDSGGSSDDGGGQTQHVKDQEAVHSNGFVQMGR 535
Query: 542 QGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIR 601
+G D C SS+ + C R+ YE +
Sbjct: 536 RGPPDQFC--------FSSF----------QEQSCSPRH---------------YEYDTS 562
Query: 602 QELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDD-----KTRASDDKVSPSSVLPEP 656
+ + K+++++ + + +++ ++ +L D+ + ++S +K+ S + +
Sbjct: 563 LQAKGFDMKHEVKMAKYKARKMAHLRRAIHPSLDFDNLNGERRMKSSLNKLQ-SFHIGKN 621
Query: 657 ESNRPP--QRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKS 714
+ R P +R+ R + + + + QR E ++ SP+ M TA+S
Sbjct: 622 HNFRIPTCERSPGARDAEEDPDIFNLAYHSRHPDPGAQRARHCE-VDAQSSPDLMFTARS 680
Query: 715 YYTPL-LPHSLHRATSLPVDSVDV 737
YYT LP +L R S+ +++VD
Sbjct: 681 YYTGAQLPTNLPRTKSVTLNAVDA 704
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 662 bits (1707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/558 (61%), Positives = 404/558 (72%), Gaps = 41/558 (7%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MNG S E D S FVE+DP+GRYGRY+EILGKGASKTVYRAFDEYEGIEVAWNQVKL +
Sbjct: 1 MNGEESFVE-DCSVFVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRN 59
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
F ++PEELE+ + EIHLLKTL H+NIMKFYTSWVDT N +INFVTE+FTSGTLRQYRL+H
Sbjct: 60 FTRNPEELEKFFREIHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRH 119
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
RRVNIRAVK WC+QIL GLLYLHSR PP+IHRDLKCDNIF+NGNQGEVKIGDLGLAAILR
Sbjct: 120 RRVNIRAVKQWCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILR 179
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KSHA RCVGTPEFMAPEVY+EEYNELVD+Y+FGMC+LEMVTFDYPYSECTHPAQIYKKV
Sbjct: 180 KSHAVRCVGTPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVT 239
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDS-DLRMIQYQTD 299
SGKKPEA + V+DPEVR+F+EKCLA V+ RL+A ELL DPFLQ D+ D +R I Y
Sbjct: 240 SGKKPEAFYLVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNG 299
Query: 300 YDEISPLLRQSLYG--IYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQED 357
YDE LR L +YH S+ C EIDLF ++
Sbjct: 300 YDETGVFLRHPLIDDPLYHDQFESSQIC----------------------EIDLFANDDE 337
Query: 358 EHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDI 417
+H+ DISIKGKR DDGIFLRLRI+D EGRIRNIYFPF+ DTA SVA EMVSELDI
Sbjct: 338 DHV---DISIKGKRNGDDGIFLRLRISDAEGRIRNIYFPFETAIDTAWSVAVEMVSELDI 394
Query: 418 TDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHR------SSFCHNCASNGCLPDYILS 471
T+QDV KIAE+ID+EIA+LVP+WK ++ + + FC CASNG + + + S
Sbjct: 395 TNQDVAKIAEMIDAEIAALVPDWKNDTESSQNVNNNKNNNTAGFCGECASNGYIQETVSS 454
Query: 472 DGSGAKNLQVLQCSKD-GCAAIHGRFEEI-----TYQVDGAEQCAPEGADQAASPQSAVV 525
N S+D C+++HGRF ++ +Y DG +Q + + S
Sbjct: 455 GEKSHHNHHEFDSSEDKSCSSVHGRFADMWGLRESYSDDGEKQSSRKVRSGRWSENEMRR 514
Query: 526 HYADIWAQHEGQVLSSQG 543
+ A+H+ Q++ +G
Sbjct: 515 ELRWLKARHKIQLMKMRG 532
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/516 (66%), Positives = 398/516 (77%), Gaps = 47/516 (9%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MN +S E SD SE+VEVDPTGRYGRYNE+LGKG+SKTVYR FDEY+GIEVAWNQVKLYD
Sbjct: 2 MNNLSHLE-SDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYD 60
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQSP+ELERLYCEIHLLKTLKH++IMKFY SWVDT NRNINFVTEMFTSGTLRQYRLKH
Sbjct: 61 FLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKH 120
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+RVNIRAVK+WCRQIL GL YLH+ DPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L+
Sbjct: 121 KRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQ 180
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
SHAA CVGTPEFMAPEVY+EEYN+LVDIYSFGMC+LEMVTFDYPYSEC+HPAQIYK+VI
Sbjct: 181 HSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVI 240
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SGKKP+ L KV+DPEVR FIEKCLATVS RLSA ELL D FL ID +SD+R ++ +
Sbjct: 241 SGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCID--ESDMRRVESEKGL 298
Query: 301 -DEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQES-EIDLFTCQE-- 356
DE LR S + ++SN G+Y Y+ +N DY+ E ES EIDL Q
Sbjct: 299 IDEAGTPLRHSYHIPHYSN-------GYYSLYN-QNQWDYNGDETVESHEIDLLEFQNDD 350
Query: 357 -----DEHLTNFDISIKGKRRED-DGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATE 410
D+ + DISIKGKRR++ DG+FLRL+ +KEG +RNIYFPFDI+TDTA+SVA E
Sbjct: 351 DEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVARE 410
Query: 411 MVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSSFC---HNCASNGCLPD 467
MV EL++ D+DVTKIA +ID EIASLVP W S FC N +S G + D
Sbjct: 411 MVEELEMDDRDVTKIANMIDGEIASLVPNW------------SIFCSSESNRSSVGSVMD 458
Query: 468 YILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQV 503
+ +QC +DGC HGRFEEIT+++
Sbjct: 459 F-----------NEMQCGRDGCEEKHGRFEEITFEI 483
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 519 bits (1336), Expect = e-146, Method: Compositional matrix adjust.
Identities = 254/437 (58%), Positives = 328/437 (75%), Gaps = 16/437 (3%)
Query: 14 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC 73
EF EVDPT RYGRY E+LGKGA KTVY+AFD+ EG+EVAWNQ+K+ D L++ ++LERL
Sbjct: 17 EFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRS 76
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
E+ LLKTLKH+NI+KFY SW+D N NINF+TE+FTSGTLRQYR+KH++V++RA+K W R
Sbjct: 77 EVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKWSR 136
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPE 192
QILSGL+YLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA IL + +A +GTPE
Sbjct: 137 QILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGTPE 196
Query: 193 FMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252
FMAPE+Y+EEYNELVDIY+FGMC+LE+VTF+YPY EC++ AQIYKKV G+KP +L K+E
Sbjct: 197 FMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIE 256
Query: 253 DPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLY 312
DPEVR FIEKC+A S RLSA+ELL DPFL+ DD + +Q T + + S+
Sbjct: 257 DPEVRFFIEKCIAKASQRLSAQELLMDPFLR-DDGEKIFYPLQSNTKASDGAGSSNSSMG 315
Query: 313 GIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRR 372
Y ++SS H + E+ D + H + + + I+++ + +
Sbjct: 316 YKYDRDASSMAIREHTGSFAEEHPSDRYIH----------STMDPQAAAGRIITVESQMK 365
Query: 373 EDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSE 432
+ + IFL+LRIAD G +NI+FPFDI+ DT++SVATEMV +LD+TDQDVT IAE+ID+E
Sbjct: 366 DLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAE 425
Query: 433 IASLVPEWKRGMAMEES 449
I + +P+W A+EES
Sbjct: 426 IRAHIPDW----ALEES 438
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1296), Expect = e-141, Method: Compositional matrix adjust.
Identities = 255/435 (58%), Positives = 319/435 (73%), Gaps = 50/435 (11%)
Query: 8 EESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE 67
E + EFVE+DPTGRYGRY E+LGKGA K VYRAFD+ EGIEVAWNQVKL D S E+
Sbjct: 5 ENNSEEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSED 64
Query: 68 LERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA 127
L+RLY E+HLLKTLKH++I+KFYTSW+D + IN +TE+FTSG LRQYR KH+ V++RA
Sbjct: 65 LDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRA 124
Query: 128 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 187
+K W RQIL GL+YLHS DPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL ++ +A
Sbjct: 125 LKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHS 184
Query: 188 V-GTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246
V GTPEFMAPE+YEE+YN LVDIY+FGMC+LE+VTF+YPYSECT+ AQIY+KV SG KP
Sbjct: 185 VIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPA 244
Query: 247 ALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPL 306
AL V DP+VR FIEKC+A VS RLSA+ELL DPFL+ Y+ + + +S
Sbjct: 245 ALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKC-----------YKENTENVS-- 291
Query: 307 LRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDIS 366
S NG Y G NG+ + +SE+ L T
Sbjct: 292 ------------SHKENG---YNG----NGI---VDKLSDSEVGLLT------------- 316
Query: 367 IKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDIT-DQDVTKI 425
++G+R++ + IFL+LRI D +G+IRNI+FPF+I+TDT+ SVA EMV ELD+T DQD++ I
Sbjct: 317 VEGQRKDLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTI 376
Query: 426 AEIIDSEIASLVPEW 440
A++ID+EI S +P+W
Sbjct: 377 AKMIDTEIHSHIPDW 391
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D847|WNK3_ORYSJ Probable serine/threonine-protein kinase WNK3 OS=Oryza sativa subsp. japonica GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 273/540 (50%), Positives = 344/540 (63%), Gaps = 53/540 (9%)
Query: 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCE 74
+ EVDPTGRYGR+NEILGKG+SK VYR FDE+ G+EVAWNQV+L D ++ ELER Y E
Sbjct: 24 YAEVDPTGRYGRFNEILGKGSSKIVYRGFDEWRGVEVAWNQVRLRDVVRGGGELERFYGE 83
Query: 75 IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQ 134
+HLL L+HR I++ + WVD R +NFVTE+F SGTLRQYR +HRRV+ AV+ WC Q
Sbjct: 84 VHLLAALRHRGIVRLHAYWVDAPRRALNFVTELFVSGTLRQYRERHRRVSAAAVRRWCAQ 143
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM 194
IL GL YLH+ PP+IHRDLKCDNIFVNGNQGEVKIGDLGLAA R ARCVGTPEFM
Sbjct: 144 ILDGLAYLHAHSPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAFRRGGGHARCVGTPEFM 203
Query: 195 APEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254
APEVY+E Y+EL D+YSFGMC+LEMVT DYPYSEC++P QIYK+VISG KP AL++V DP
Sbjct: 204 APEVYDESYDELADVYSFGMCVLEMVTLDYPYSECSNPIQIYKRVISGIKPAALYRVSDP 263
Query: 255 EVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTD-------YDEISPLL 307
VRQFIE+CLA + R +ARELL DPFL + D Y+ + L
Sbjct: 264 VVRQFIERCLAPAARRPAARELLDDPFLLPLEDDGFFSGDGGDGHGGFGVGYYNLMYNYL 323
Query: 308 RQ----------SLYGIYHSNSSSNNGCGHYIGYDTENG----LDYHPHEFQESEIDLFT 353
Q S G+ SNS +N + ++G D H F E + D
Sbjct: 324 HQPACIDDHHACSNGGLSPSNSVGDNDVDAAVQRGDDDGDNWLRDIH-MLFDEDDDDAAA 382
Query: 354 CQEDEHLTNFDISIKGKRREDDGIFLRLRIADKE--GRIRNIYFPFDIQTDTALSVATEM 411
+E + DI+IKG+R +D G++L LRIADK GR R I F FD + DTA++VA EM
Sbjct: 383 ADANERVGGVDITIKGRRTDDGGVYLGLRIADKNGTGRGRIICFRFDTEADTAMTVAAEM 442
Query: 412 VSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSSF---------------- 455
V+ELDITD +VT+IA++ID ++A+LVP W+ G A ++
Sbjct: 443 VAELDITDHEVTRIAQLIDGKVAALVPGWRPGPATDDDDDDDLVGGGDDPDAPGGAAAAC 502
Query: 456 CHNCASN-------GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQ 508
C NC G L D++ S + ++ C + CA +HGRFEEIT+Q D E+
Sbjct: 503 CKNCRPAASSSSSCGSLVDFMSSAAAAERH----GCRR--CAELHGRFEEITFQADDDEE 556
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1213), Expect = e-132, Method: Compositional matrix adjust.
Identities = 234/449 (52%), Positives = 311/449 (69%), Gaps = 9/449 (2%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS 64
S+ +E E +EVDPT RY RY E++GKGA KTVY+AFDE +GIEVAWNQV++ D LQS
Sbjct: 8 SALQEPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQS 67
Query: 65 PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVN 124
P LERLY E+ LLK+LKH NI++FY SW+D N+ +N +TE+FTSG+LR YR KHR+VN
Sbjct: 68 PNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVN 127
Query: 125 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
++AVK+W RQIL GL YLH ++PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +++A
Sbjct: 128 MKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANA 187
Query: 185 ARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 244
+GTPEFMAPE+Y+E YNEL DIYSFGMC+LEMVTFDYPY EC + AQIYKKV SG K
Sbjct: 188 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIK 247
Query: 245 PEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEIS 304
P +L +V+DPEV+QFIEKCL S RLSA+ELL DPFLQ++ L M D +
Sbjct: 248 PASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLN----GLTMNNPLPLPDIVM 303
Query: 305 PLLRQSLYG--IYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTN 362
P ++ +G S + D + + F ++ N
Sbjct: 304 P--KEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGSRCIEVRRAKRGN 361
Query: 363 FDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDV 422
F + +KG+ ++ + L LRI D+ GR+RNI+F F + DTA V++EMV +L++TDQ+V
Sbjct: 362 FFV-LKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNV 420
Query: 423 TKIAEIIDSEIASLVPEWKRGMAMEESPH 451
T IAE+ID + +++P WK + ++ H
Sbjct: 421 TFIAELIDILLVNMIPTWKTDVTVDHLIH 449
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCU5|WNK5_ARATH Probable serine/threonine-protein kinase WNK5 OS=Arabidopsis thaliana GN=WNK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 466 bits (1200), Expect = e-130, Method: Compositional matrix adjust.
Identities = 241/454 (53%), Positives = 307/454 (67%), Gaps = 43/454 (9%)
Query: 6 SPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP 65
S DS +VE DP+GRYGR+ E+LGKGA KTVY+AFD+ G+EVAWNQVKL + +SP
Sbjct: 6 SSASDDSIAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSP 65
Query: 66 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 125
E L+RLY E+HLLK L H +I+++ TSW+D R NF+TE+FTSGTLR+YR K+++V+I
Sbjct: 66 EPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDI 125
Query: 126 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185
RA+K W RQIL+GL YLH DPPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S A
Sbjct: 126 RAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNA 185
Query: 186 RCV-GTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 244
V GTPEFMAPE+YEE+YNELVDIYSFGMC+LEM+T +YPYSECT+PAQIYKKV SGK
Sbjct: 186 HSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKL 245
Query: 245 PEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEIS 304
P++ ++ E ++F+ KCL TVS RL A+ELL DPFL TD +++
Sbjct: 246 PDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLA-------------ATDERDLA 292
Query: 305 PLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFD 364
PL R + N ++N ++ T + D
Sbjct: 293 PLFRLP-QQLAIQNLAANGTVVEHLPSTT------------------------DPTRTTD 327
Query: 365 ISIKGK-RREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVT 423
+SI GK ED IFL+++I D +G +RNI FPF+I +DT L VA EMV EL+ITD D
Sbjct: 328 MSITGKMNSEDHTIFLQVQILDGDGHMRNIQFPFNILSDTPLEVALEMVKELEITDWDPL 387
Query: 424 KIAEIIDSEIASLVPEWKRGMAMEESPHRSSFCH 457
+IA +I++EI+ LVP W+ A + S SF H
Sbjct: 388 EIAAMIENEISLLVPNWR---ANDSSIRHESFGH 418
|
Regulates flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 740 | ||||||
| 225432654 | 729 | PREDICTED: serine/threonine-protein kina | 0.968 | 0.983 | 0.730 | 0.0 | |
| 255552205 | 732 | conserved hypothetical protein [Ricinus | 0.979 | 0.990 | 0.688 | 0.0 | |
| 359487822 | 743 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.974 | 0.648 | 0.0 | |
| 449444242 | 740 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.977 | 0.644 | 0.0 | |
| 356575845 | 658 | PREDICTED: serine/threonine-protein kina | 0.874 | 0.983 | 0.628 | 0.0 | |
| 255542364 | 775 | kinase, putative [Ricinus communis] gi|2 | 0.908 | 0.867 | 0.639 | 0.0 | |
| 224125588 | 730 | predicted protein [Populus trichocarpa] | 0.968 | 0.982 | 0.617 | 0.0 | |
| 351723121 | 652 | with no lysine kinase 2 [Glycine max] gi | 0.872 | 0.990 | 0.621 | 0.0 | |
| 356535149 | 708 | PREDICTED: serine/threonine-protein kina | 0.932 | 0.974 | 0.609 | 0.0 | |
| 147815157 | 752 | hypothetical protein VITISV_035622 [Viti | 0.929 | 0.914 | 0.635 | 0.0 |
| >gi|225432654|ref|XP_002278361.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/734 (73%), Positives = 604/734 (82%), Gaps = 17/734 (2%)
Query: 9 ESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEEL 68
E D SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL DFLQSPEEL
Sbjct: 6 EPDYSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLNDFLQSPEEL 65
Query: 69 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 128
ERLYCEIHLLKTLKH NIMKFYTSWVD ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV
Sbjct: 66 ERLYCEIHLLKTLKHNNIMKFYTSWVDPANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 125
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV 188
KHWCRQIL GLLYLH+ PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CV
Sbjct: 126 KHWCRQILRGLLYLHNHKPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 185
Query: 189 GTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248
GTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVISGKKP+AL
Sbjct: 186 GTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVISGKKPDAL 245
Query: 249 FKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLR 308
+KV+DPEVRQF+EKCLATV+ RLSARELL DPFLQ DDY SDLR I+YQ D E+ PL R
Sbjct: 246 YKVKDPEVRQFVEKCLATVTLRLSARELLKDPFLQSDDYGSDLRPIEYQRDLGEVGPLPR 305
Query: 309 QSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIK 368
YGI+HS SS N Y ++ ENGLD HP EF+ +EIDLFT QEDEHL N DISI+
Sbjct: 306 LPHYGIHHSYSSLRNEYSGYPDFEPENGLDCHPVEFERNEIDLFTYQEDEHLENVDISIE 365
Query: 369 GKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEI 428
G++R+D GIFLRLRI+DKEGR+RNIYFPFD++TDTALSVA EMVSELDITDQDVTKIA++
Sbjct: 366 GRKRDDHGIFLRLRISDKEGRVRNIYFPFDMETDTALSVAMEMVSELDITDQDVTKIADM 425
Query: 429 IDSEIASLVPEWKRGMAMEESP---HRSSFCHNCASNGCLPDYILSDGSGAKNLQVLQCS 485
ID EIASLVP WK G+ +EES H +SFCH+CASNG DY+ + G KNLQVLQCS
Sbjct: 426 IDDEIASLVPGWKMGLGIEESQNYGHDASFCHHCASNGSPLDYVSPNNPGTKNLQVLQCS 485
Query: 486 KDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSR 545
+ GCAA+HGRFEEITY+V+G+EQC EGA S QS + YADIWAQ EG LSS+GSR
Sbjct: 486 RQGCAAVHGRFEEITYRVEGSEQCVTEGA-PVVSSQSDGMQYADIWAQREGPELSSEGSR 544
Query: 546 DIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIRQELR 605
+I DEEH++L++S YG +E++IN+D+QS+ + +N F+ LDDYENEIRQELR
Sbjct: 545 EIQSDEEHESLDKSIYGKDERVINIDNQSESNAKNSFAP--------LDDYENEIRQELR 596
Query: 606 WLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTRASDDKVSPSSVLP--EPESNRPPQ 663
WLKAKYQ+QLRELRDQQLG K K SLT +D + D+KVSPSS+ E E N PP
Sbjct: 597 WLKAKYQMQLRELRDQQLGAKPKWLSLTPNSDSMEHSRDNKVSPSSLSTPLEGEDNDPPL 656
Query: 664 RTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYT-PLLPH 722
++ KH S P+ E+ C N+A +R H+ E ++ CSPE MVTAKS++T LLP
Sbjct: 657 KSFPC--GKHFNSFFPVDTERGCANLAYRRPHNREPVSESCSPEDMVTAKSFFTGTLLPQ 714
Query: 723 SLHRATSLPVDSVD 736
SLHRATSLPVD+VD
Sbjct: 715 SLHRATSLPVDAVD 728
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552205|ref|XP_002517147.1| conserved hypothetical protein [Ricinus communis] gi|223543782|gb|EEF45310.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2634), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/744 (68%), Positives = 584/744 (78%), Gaps = 19/744 (2%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MNG+ E DS +FVEVDPTGRYGRYNEILGKGASKTVY+AFDEYEGIEVAWNQVKLYD
Sbjct: 1 MNGLPDLE-PDSCDFVEVDPTGRYGRYNEILGKGASKTVYKAFDEYEGIEVAWNQVKLYD 59
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQ PE+LERLYCEIHLLKTLKH NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH
Sbjct: 60 FLQCPEDLERLYCEIHLLKTLKHENIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 119
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
RRVNIRAVKHWCRQIL GLLYLHS +PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL+
Sbjct: 120 RRVNIRAVKHWCRQILKGLLYLHSHNPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILK 179
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KS+AARCVGTPEFMAPEVYEEEYNELVDIY+FGMC+LEMVT +YPYSEC HPAQIYKKV+
Sbjct: 180 KSYAARCVGTPEFMAPEVYEEEYNELVDIYAFGMCVLEMVTSEYPYSECNHPAQIYKKVV 239
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SGKKPEAL+KVEDPEVRQF+EKCLATVS RLSARELL DPFLQIDDY DLR ++YQ D
Sbjct: 240 SGKKPEALYKVEDPEVRQFVEKCLATVSRRLSARELLDDPFLQIDDYGYDLRSLEYQGDS 299
Query: 301 DEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHL 360
+E+ L+RQ YGI H+N S + HY+GYD EN L YHP F+ SEIDLF+CQEDEHL
Sbjct: 300 NEMGALVRQPFYGINHTNGSLFSSYAHYLGYDLENELPYHPVGFEPSEIDLFSCQEDEHL 359
Query: 361 TNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQ 420
N DI+I+G+R+ +D IFLRLRIAD+EG IRNIYFPFDI+TDTALSVA EMVSEL +TDQ
Sbjct: 360 ENVDITIQGRRKGNDCIFLRLRIADEEGCIRNIYFPFDIETDTALSVAAEMVSELGMTDQ 419
Query: 421 DVTKIAEIIDSEIASLVPEWKRGMAMEESPHRS--SFCHNCASNGCLPDYILSDGSGAKN 478
DV KI ++ID EIASLVPEWKR EESPH + +FC NCA L D++ S+ SG KN
Sbjct: 420 DVLKITDMIDGEIASLVPEWKRRHGKEESPHEANDTFCQNCAPVDYLLDHVSSNNSGVKN 479
Query: 479 LQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQV 538
L VL+CSK GCA IHGRFEEITYQV+G E+CA +S QS + + DIWAQ E
Sbjct: 480 LHVLECSKHGCANIHGRFEEITYQVEGPEKCATMDCVPVSSSQSNGISFTDIWAQREAPD 539
Query: 539 LSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYEN 598
LSSQGS+D+HCDE H +++QS EE+IINM S + RN + + DDYEN
Sbjct: 540 LSSQGSKDVHCDERHNSVDQSVTEKEERIINMVSVCESKRRNSVCSSPSTACAHWDDYEN 599
Query: 599 EIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTR----ASDDKVSPSSVLP 654
EIRQELRWLKAKYQ+QLRELRDQQL TLI D + D+ VS S+LP
Sbjct: 600 EIRQELRWLKAKYQMQLRELRDQQLQ--------TLILDPSSNKLGYKKDNGVSLPSILP 651
Query: 655 EPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKS 714
+ + ++ + K + + +K CGN Q +FE +N CSPEQMVTAK+
Sbjct: 652 KVKRDKYKPILESLPSGKQFNTDISTDADKNCGNSEYQ---NFEAINKGCSPEQMVTAKN 708
Query: 715 YYT-PLLPHSLHRATSLPVDSVDV 737
+YT LLP+ LHRATSLPVD++DV
Sbjct: 709 FYTGALLPYPLHRATSLPVDALDV 732
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487822|ref|XP_003633655.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2382), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/756 (64%), Positives = 564/756 (74%), Gaps = 32/756 (4%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MNGV +PE D SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD
Sbjct: 1 MNGVINPEADDYSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQSPE+LERLYCEIHLLKT+KH NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR KH
Sbjct: 61 FLQSPEDLERLYCEIHLLKTMKHNNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRQKH 120
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR
Sbjct: 121 KRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KSHAA CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVI
Sbjct: 181 KSHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVI 240
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SGKKP+AL+KV+DPEVR+F+EKCLA+VS RLSARELL DPFL+IDD +SDLR I+ + +
Sbjct: 241 SGKKPDALYKVKDPEVREFVEKCLASVSLRLSARELLQDPFLRIDDCESDLRPIECRREP 300
Query: 301 DEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHL 360
D++ PLLRQ +HSN+S +NG + + +D NG Y P E + + I+LF EDEH
Sbjct: 301 DDMVPLLRQPFLEYHHSNNSFSNGYSNAVDFDAHNGWGYQPLEMEPTGIELFEYHEDEHP 360
Query: 361 TNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQ 420
N DISIKGKRREDDGIFLRLRIADKE IRNIYFPFDI+ DTALSVATEMV+ELDITDQ
Sbjct: 361 ANVDISIKGKRREDDGIFLRLRIADKEDHIRNIYFPFDIEMDTALSVATEMVAELDITDQ 420
Query: 421 DVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSS--FCHNCA----SNGCLPDYILSDGS 474
DVTKIA++ID EIASLVPEWK G +EE+P ++ CHNC SNG L D IL++
Sbjct: 421 DVTKIADMIDGEIASLVPEWKPGPGIEETPCFATLNLCHNCVSNHTSNGSLMD-ILANNP 479
Query: 475 GAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQH 534
GAKNLQ+ QCS +GCAA+HGRFEEITYQVDGA+ PEG QS +H +IW +H
Sbjct: 480 GAKNLQIFQCS-NGCAAMHGRFEEITYQVDGADHHIPEG-------QSEELHCTEIWDKH 531
Query: 535 EGQVLSSQGSRDIHCDEEHKTLNQS------SYGAEEKIINMDSQSKCHERNCFSMNSAM 588
E + LSS S + DEE++ +N S G + + S H RN S ++
Sbjct: 532 ESRELSSVSSGESPSDEEYEKINHSIIKDERGSGTGNVVASNVKNSISHLRNPSSSSAIP 591
Query: 589 DY--GLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTRASDDK 646
L DDYENEI+Q LRWLKAK+Q+++R LRD QLG K SSL D++ D++
Sbjct: 592 SMSCALSDDYENEIQQVLRWLKAKHQMEMRGLRDLQLGFASKPSSL----DNRQLKPDNE 647
Query: 647 VSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSP 706
S++ + + + KH TS K ++ + E S
Sbjct: 648 GLFSTLSNTSQGHNNGLFLKSSAYDKHFTSNCATQVNKCSPDLVTHGARNCEANKGSRSA 707
Query: 707 EQM---VTAKSYYTP--LLPHSLHRATSLPVDSVDV 737
E M VTAKS+YT LLP +HR SLPVD+VD+
Sbjct: 708 EDMVHVVTAKSFYTAGSLLPCPIHRTMSLPVDAVDI 743
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444242|ref|XP_004139884.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] gi|449492629|ref|XP_004159053.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 921 bits (2380), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/752 (64%), Positives = 575/752 (76%), Gaps = 29/752 (3%)
Query: 1 MNG--VSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL 58
MNG V++ E ++SE+VEVDPTGRYGRYNE+LGKGASKTVYRAFDEY+GIEVAWNQVKL
Sbjct: 1 MNGATVTNSEPDNNSEYVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYDGIEVAWNQVKL 60
Query: 59 YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL 118
DFLQ+PE+LERLY EIHLLKTLKH NIMKFY+SWVD ANRNINFVTEMFTSGTLRQYRL
Sbjct: 61 SDFLQTPEDLERLYREIHLLKTLKHNNIMKFYSSWVDIANRNINFVTEMFTSGTLRQYRL 120
Query: 119 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178
KH++VNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI
Sbjct: 121 KHKKVNIRAVKHWCRQILKGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 180
Query: 179 LRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
LRKS+ ARCVGTPEFMAPE+YEEEYNELVDIYSFGMCILEMVTF+YPYSECTHPAQIYKK
Sbjct: 181 LRKSYVARCVGTPEFMAPEIYEEEYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKK 240
Query: 239 VISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQT 298
VISGKKP+AL+KV+D EVR F+EKCLATVS+RLSARELL DPFLQID DS LR I Y +
Sbjct: 241 VISGKKPDALYKVKDLEVRCFVEKCLATVSTRLSARELLNDPFLQIDGCDSLLRPIDYYS 300
Query: 299 DYDEI-SPLLRQS-LYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQE 356
+YDE+ + L+R YG H +NG +Y ++ NGLDY P + + SEIDLF+CQE
Sbjct: 301 EYDEVNNSLIRGGPFYGTSH--GPLDNGYANYFSHEAGNGLDYCPIDNEASEIDLFSCQE 358
Query: 357 DEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELD 416
DEHL + DI+IKG+RR+DD IFLRLRI DKEGRIRNIYFPFD++ D+A SVA EMVSELD
Sbjct: 359 DEHLEDVDITIKGRRRDDDDIFLRLRIVDKEGRIRNIYFPFDLENDSASSVANEMVSELD 418
Query: 417 ITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH--RSSFCHNCASNGCLPDYILSDGS 474
ITDQDV KIA++ID EIA+LVPEWK+G ++EE+P+ S+ CHNC+ N L DY+
Sbjct: 419 ITDQDVKKIADMIDGEIATLVPEWKKGKSLEETPNCSDSNVCHNCSLNSSLLDYVSPHNL 478
Query: 475 GAKNLQVLQCSKD-GCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQ 533
KNL +LQCS++ GCA+IHGRFEEITYQV+G+EQ + + S+ +HYADIWAQ
Sbjct: 479 AKKNLHILQCSEEHGCASIHGRFEEITYQVEGSEQFNGDENLHRTTGNSSDIHYADIWAQ 538
Query: 534 HEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHE-RNCFSMNSAMDYGL 592
+G + S S + C+E + Q EE +NMD E + S +S
Sbjct: 539 RDGPDVVSPESLEA-CNEFGAS-EQPKLEKEESNVNMDDNDHQMEFQTRNSSSSNPSESF 596
Query: 593 LDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSL---TLITDDKTRASDDKVSP 649
+DD+ENEIRQELRWLKAKYQ+QLRELRDQQLGVK KS SL + +T+ AS +SP
Sbjct: 597 VDDHENEIRQELRWLKAKYQMQLRELRDQQLGVKTKSLSLHPISNLTETDNGASVSYLSP 656
Query: 650 SSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPC----S 705
+ E N+ Q +++ K++TS P N+ + +F+ N S
Sbjct: 657 N--FNEAAKNKTVQTSLSF--GKNITSHSPY---VAADNILENK--TFQDNNVIVDELSS 707
Query: 706 PEQMVTAKSYYT-PLLPHSLHRATSLPVDSVD 736
PE +VTAKS+YT L PHSL RATSLPVD++D
Sbjct: 708 PELIVTAKSFYTGALFPHSLQRATSLPVDAID 739
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575845|ref|XP_003556047.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/748 (62%), Positives = 540/748 (72%), Gaps = 101/748 (13%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MNG + E ++ EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVK YD
Sbjct: 1 MNGAACVE-AECCEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKFYD 59
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQ+PE+LERLY EIHLLKTLKH+NIMK YTSWVDTANR+INFVTEMFTSGTLRQYRLKH
Sbjct: 60 FLQNPEDLERLYSEIHLLKTLKHKNIMKLYTSWVDTANRHINFVTEMFTSGTLRQYRLKH 119
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
RRVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAILR
Sbjct: 120 RRVNIRAVKHWCRQILEGLLYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILR 179
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KS+AARCVGTPEFMAPEVYEE+YNELVDIYSFGMCILEMVTF+YPYSEC HPAQIYKKV+
Sbjct: 180 KSNAARCVGTPEFMAPEVYEEDYNELVDIYSFGMCILEMVTFEYPYSECNHPAQIYKKVV 239
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SGKKPEAL+KV++PEVRQF+EKCLATVS RLSARELL DPFLQIDDY D +++QYQ D
Sbjct: 240 SGKKPEALYKVDNPEVRQFVEKCLATVSLRLSARELLEDPFLQIDDYGFDSKVLQYQRDC 299
Query: 301 DEISPLLRQSLYGIYHSNSSSNNGCGHYI-GYDTENGLDYHPHEFQESEIDLFTCQEDEH 359
E++PL+RQ + GI N++ +G I GY + LDYH +F+ +EI LF C+ED++
Sbjct: 300 YEVTPLIRQPVNGICIINNNLMSGDTDNIGGYGPVSELDYHQDDFEATEIGLFDCEEDDN 359
Query: 360 LTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITD 419
L D +IKG RREDDGIFLRLRIADKEGRIRNIYFPFDI+TDTALSVA EMV+ELDI D
Sbjct: 360 LAEVDTTIKG-RREDDGIFLRLRIADKEGRIRNIYFPFDIETDTALSVANEMVAELDIND 418
Query: 420 QDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRS--SFCHNCASNGCLPDYILSDGSGAK 477
QDVT +A +ID+EIA LVPEWK G +EE S S C NCA+NG L DY+ S+ K
Sbjct: 419 QDVTNLASMIDNEIARLVPEWKTGPRIEEKSECSSASVCLNCAANGSLFDYVSSNNPCGK 478
Query: 478 NLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQ 537
NLQ L CSK GCAA+HGRFEEITYQV+G+E A E
Sbjct: 479 NLQFLHCSKTGCAAVHGRFEEITYQVEGSENSAREA------------------------ 514
Query: 538 VLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYE 597
H+ N S+ + K +N+D QS + + S N A + L DYE
Sbjct: 515 ---------------HEASNSSNIKEDRKTVNVDEQSDLNTKKS-SSNPAPNCVFL-DYE 557
Query: 598 NEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTL-------ITDDKTRASDDKVSPS 650
NEIRQELRWLKAKYQ+QLRELRDQQLG K K +S++ + D R SD +P+
Sbjct: 558 NEIRQELRWLKAKYQMQLRELRDQQLGRKPKFTSISPDPEKLEHLKDGILRLSD---TPN 614
Query: 651 SVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMV 710
+ ++N+P RTI QM+
Sbjct: 615 LKI---QNNKPLLRTI-----------------------------------------QMI 630
Query: 711 TAKSYYTP-LLPHSLHRATSLPVDSVDV 737
TA+ ++T LLPHSL RATSLPVD+VDV
Sbjct: 631 TARDFFTGVLLPHSLQRATSLPVDAVDV 658
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542364|ref|XP_002512245.1| kinase, putative [Ricinus communis] gi|223548206|gb|EEF49697.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/715 (63%), Positives = 538/715 (75%), Gaps = 43/715 (6%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
M S E D SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD
Sbjct: 1 MMNCPSNLEPDYSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQSPE+LERLYCEIHLLKTLKH+NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH
Sbjct: 61 FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR
Sbjct: 121 KRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KSHAA CVGTPEFMAPEVYEE YNELVD+YSFGMCILEMVTF+YPYSECTHPAQIYKKVI
Sbjct: 181 KSHAAHCVGTPEFMAPEVYEEAYNELVDVYSFGMCILEMVTFEYPYSECTHPAQIYKKVI 240
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SG+KP+AL+KV+DPEVRQF+EKCLATVS RLSARELL DPFLQ+DD +S+++ I Y ++
Sbjct: 241 SGRKPDALYKVKDPEVRQFVEKCLATVSLRLSARELLNDPFLQMDDCESNIKSIDYGEEF 300
Query: 301 DEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHL 360
D + PL+RQ Y + +NG + GY+ +N +Y+P EF++S I+LF +DEH
Sbjct: 301 DGMGPLIRQPYYEFHDDTYPYSNGYSNGYGYEAQNEFEYYPVEFEQSGIELFEHHDDEHS 360
Query: 361 TNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQ 420
N DISIKGKRR+D GIFLRLRIADK+GRIRNIYFPFDI+TDTAL+VATEMV+ELDITDQ
Sbjct: 361 PNLDISIKGKRRDDGGIFLRLRIADKDGRIRNIYFPFDIETDTALTVATEMVAELDITDQ 420
Query: 421 DVTKIAEIIDSEIASLVPEWKRGMAMEESPHRS--SFCHNCA----SNGCLPDYILSDGS 474
DVTKIAE+ID EIASLVPEW+RG +EE+P + + CHNCA SNG L D+I ++
Sbjct: 421 DVTKIAEMIDEEIASLVPEWRRGPGIEETPRFANLTLCHNCASARTSNGSLMDFISNN-- 478
Query: 475 GAKNLQVLQCSKDGCAAIHGRFEEITYQ-VDGAEQCAPEGADQAASPQSAVVHYADIWAQ 533
C ++GCA++HGRFEEIT+Q D +E E A A S S V Y IWAQ
Sbjct: 479 --------PCCRNGCASMHGRFEEITFQAADESEHHLTEVAPNALS-HSDCVDYQRIWAQ 529
Query: 534 HEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERN---------CFSM 584
HE + ++ GS H DEE++ +QS +E + M++ S+ RN F
Sbjct: 530 HESREVTPMGSGRSHSDEEYEKFDQSISTKDENDVKMENGSQSGSRNSIPYLKGSGSFYR 589
Query: 585 NSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTRASD 644
++ L D EN+++QELRWLKAKYQI+L +LRDQQL +SS+ ++ TD K R
Sbjct: 590 LPSVCSDLQDSNENKMQQELRWLKAKYQIELSKLRDQQLDFASRSST-SINTDCKIR--- 645
Query: 645 DKVSPSSVLPEPESNRPPQ--RTIAH----RPTKHLTSCLPIGDEKKCGNVANQR 693
+ VS S+++ + NR ++ AH RP H K C N+ +R
Sbjct: 646 NGVSSSTIMNSFQENRNEDLLKSFAHEKLYRPNLHTDV------NKSCPNLDTRR 694
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125588|ref|XP_002319623.1| predicted protein [Populus trichocarpa] gi|222857999|gb|EEE95546.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/750 (61%), Positives = 556/750 (74%), Gaps = 33/750 (4%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MNG+S E D SEFVEVDPTGRYGRYNEILG+GASK VYRAFDEYEGIEVAWNQVKLYD
Sbjct: 1 MNGLSHLEPPDYSEFVEVDPTGRYGRYNEILGRGASKIVYRAFDEYEGIEVAWNQVKLYD 60
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQSPE+LERLYCEIHLLKTLKH+NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH
Sbjct: 61 FLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR
Sbjct: 121 KRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KSHAA CVGTPEFMAPEVYEE YNELVDIYSFGMCILEMVTF+YPYSECTHP QIYKKVI
Sbjct: 181 KSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPVQIYKKVI 240
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SGKKP+AL+KV+DPEVR F+EKCLATVS RLSARELL DPFLQID +SDLR++ ++ +
Sbjct: 241 SGKKPDALYKVKDPEVRHFVEKCLATVSLRLSARELLNDPFLQIDGCESDLRLLDHRIEV 300
Query: 301 DEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHL 360
D + PL+R + +N+S ++G + Y+ +N +YH E + S I+LF DEH
Sbjct: 301 DGLGPLMRPPYLEHHDNNNSYSSGYLNGYDYEAQNEWEYHQVEVELSGIELFEYH-DEHP 359
Query: 361 TNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQ 420
N DISIKGKR +D GIFLRLRIADKEGRIRNIYFPFDI+ DTALSVATEMV+ELDITDQ
Sbjct: 360 ANVDISIKGKRGDDGGIFLRLRIADKEGRIRNIYFPFDIENDTALSVATEMVAELDITDQ 419
Query: 421 DVTKIAEIIDSEIASLVPEWKRGMAMEESP--HRSSFCHNCASNGCLPDYILSDGSGAKN 478
DVTKIA++ID EIASLVPEW+ G +EE+P + CHNCAS S+GS
Sbjct: 420 DVTKIADMIDGEIASLVPEWRPGPGIEETPCFANQTLCHNCAST------CTSNGSFMDF 473
Query: 479 LQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQV 538
L C GCA++HGRF EI ++VD +E EGA + Q +HY +IW Q E +
Sbjct: 474 LSNNPCCSHGCASMHGRFGEIIFEVDESEHHLTEGAPNILN-QPDYLHYKEIWGQQESRQ 532
Query: 539 LSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDS-----QSKCHERNCFSMN--SAMDYG 591
L+ GS DEE++ +QS + K M++ +S H S++ +++
Sbjct: 533 LTPIGSGKSQLDEEYENFDQSIPEKDTKDTKMENGIPGGKSFQHFTGSGSLSRLTSLYND 592
Query: 592 LLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTRASDDKVSPSS 651
L D ENEI+Q+LRWLKAK+Q++LR+LRD++LG+ K S+ + + + + VS +S
Sbjct: 593 LADSNENEIQQDLRWLKAKHQMELRKLRDERLGLAVKPST----SRNGEEKTSNVVSSTS 648
Query: 652 VLP--EPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVAN-QRVHSFEQMNWPCSPEQ 708
+L + SN +++A + + L + G +++ QR + + MN P +
Sbjct: 649 MLNSFQEGSNGDLLKSLAKQISHSLHT--------HAGALSDTQRPWNHKVMNQPPRAKD 700
Query: 709 MVTAKSYYT-PLLPHSLHRATSLPVDSVDV 737
MV AK+ T P+LPHSLHR TSLPVD+VDV
Sbjct: 701 MVNAKNLCTGPMLPHSLHRTTSLPVDAVDV 730
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723121|ref|NP_001235988.1| with no lysine kinase 2 [Glycine max] gi|225348633|gb|ACN87278.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2246), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/743 (62%), Positives = 534/743 (71%), Gaps = 97/743 (13%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MNG + ++ E+VEVDPTGRYGRY+EILGKGASKTVYRAFDEYEGIEVAWNQVK YD
Sbjct: 1 MNGAAFVV-AECCEYVEVDPTGRYGRYSEILGKGASKTVYRAFDEYEGIEVAWNQVKFYD 59
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQ+PE+LERLY EIHLLKTLKH+NIMKFYTSWVDT NR+INFVTEMFTSGTLRQYRLKH
Sbjct: 60 FLQNPEDLERLYSEIHLLKTLKHKNIMKFYTSWVDTTNRHINFVTEMFTSGTLRQYRLKH 119
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAILR
Sbjct: 120 KRVNIRAVKHWCRQILEGLLYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILR 179
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KS+AARCVGTPEFMAPEVYEE+YNELVDIYSFGMCILEMVTF+YPYSEC HPAQIYKKV+
Sbjct: 180 KSNAARCVGTPEFMAPEVYEEDYNELVDIYSFGMCILEMVTFEYPYSECNHPAQIYKKVV 239
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SGKKPEAL+KV++ EVRQF+EKCLATVS RLSARELL DPFLQI DY D +++QY D
Sbjct: 240 SGKKPEALYKVDNTEVRQFVEKCLATVSLRLSARELLDDPFLQIYDYGFDSKVVQYHRDC 299
Query: 301 DEISPLLRQSLYGIYHSNSSSNNGCGHYI-GYDTENGLDYHPHEFQESEIDLFTCQEDEH 359
E++PL+RQ L GIY N++ +G + GY + LDYH +F+ SEI LF C+ED++
Sbjct: 300 YEVNPLIRQPLNGIYSINNNLMSGDTDNVGGYGPVSKLDYHRDDFEASEIGLFGCEEDDN 359
Query: 360 LTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITD 419
L D +IKG RREDDGIFLRLRIADKEGRIRNIYFPFDI+TDTALSVA EMV+ELDI D
Sbjct: 360 LAEVDTTIKG-RREDDGIFLRLRIADKEGRIRNIYFPFDIETDTALSVANEMVAELDIND 418
Query: 420 QDVTKIAEIIDSEIASLVPEWKRGMAMEESPH--RSSFCHNCASNGCLPDYILSDGSGAK 477
QDVT +A +ID+EIA+LVPEWK G +EE +S C NCA+NG L DY+LS+ K
Sbjct: 419 QDVTNLANMIDNEIATLVPEWKTGPIIEEKSECSSASVCLNCAANGYLFDYVLSNNPCGK 478
Query: 478 NLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQ 537
NLQ L CSK GCAA+HGRFEEITYQV+G++ A E
Sbjct: 479 NLQFLHCSKTGCAAVHGRFEEITYQVEGSKNSAREA------------------------ 514
Query: 538 VLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYE 597
H+ N S+ + K IN+D QS + R S N A + L DYE
Sbjct: 515 ---------------HEASNSSNIKEDGKTINVDEQSDLNTRKP-SSNPAPNCVFL-DYE 557
Query: 598 NEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTRASDD--KVSPSSVLPE 655
NEIRQELRWLKAKYQ+QLRELRDQQLG K K +S++ TD D ++S +S L +
Sbjct: 558 NEIRQELRWLKAKYQMQLRELRDQQLGGKPKFTSISPDTDKLEHLKDGILRLSDASNL-K 616
Query: 656 PESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSY 715
++N+P +TI +
Sbjct: 617 IQNNKPLLKTI-----------------------------------------------DF 629
Query: 716 YTP-LLPHSLHRATSLPVDSVDV 737
+T LLPHSL RATSLPVD+VDV
Sbjct: 630 FTGVLLPHSLQRATSLPVDAVDV 652
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535149|ref|XP_003536111.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2223), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/755 (60%), Positives = 551/755 (72%), Gaps = 65/755 (8%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
MNGV+ E D SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEY+GIEVAWNQVKLYD
Sbjct: 1 MNGVTHLE-PDESEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYQGIEVAWNQVKLYD 59
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
FLQSPE+LERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH
Sbjct: 60 FLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 119
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+RVNIRAVKHWCRQILSGLLYLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR
Sbjct: 120 KRVNIRAVKHWCRQILSGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 179
Query: 181 KSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
KSHAA CVGTPEFMAPEVYEE YNELVDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVI
Sbjct: 180 KSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVI 239
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
SGKKP+AL++V+DPEVRQF+EKCLATVS RLSARELL DPFLQIDDY+ DLR + +
Sbjct: 240 SGKKPDALYRVKDPEVRQFVEKCLATVSLRLSARELLDDPFLQIDDYEYDLRTVD-NGEL 298
Query: 301 DEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHL 360
DE PL+RQ + ++ S S+ +N + GY+ + G HP E + S I+LF ++D+
Sbjct: 299 DEFGPLMRQPFFDLHRSYSNFSNEYTNGFGYEGDWGP--HPAEIEPSGIELFEYRDDDEP 356
Query: 361 T-NFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITD 419
+ + DISIKGKR++D GIFLRLRIADKEGRIRNIYFPFDI+ DTA+SVATEMV+ELD+TD
Sbjct: 357 SEDVDISIKGKRKDDGGIFLRLRIADKEGRIRNIYFPFDIEMDTAISVATEMVAELDMTD 416
Query: 420 QDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSS--FCHNCASN----GCLPDYILSDG 473
QDVT+IA++ID EIASLVPEW+ G ++E+P ++ CHNC SN G D+ LS+
Sbjct: 417 QDVTRIADMIDGEIASLVPEWRPGPGIDETPRFANQGLCHNCVSNHTSSGSFLDF-LSNN 475
Query: 474 SGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQ 533
KNLQ+L C + GCA++HGRF EIT+ QS + Y ++W Q
Sbjct: 476 PDNKNLQLLDCCRHGCASMHGRFGEITF-------------------QSEDLQYQELWNQ 516
Query: 534 HEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEE-KIINMDSQSKCHERNCFSMNSAMDYG- 591
HE + LS S H DE+++ L++ ++ + + D S + +++ + D+
Sbjct: 517 HESRELSPVESDQSHSDEQYEQLDKPILAKDKAQDVWEDKFSPNAANSLRNLSGSHDFST 576
Query: 592 -------LLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTRASD 644
L DDYE EI++ELRWL+AKYQ++LR+ +D+Q G S + + R +
Sbjct: 577 IRSTYCDLEDDYEKEIQKELRWLRAKYQMELRDHKDRQFGQCSHS------CNSEHRTEN 630
Query: 645 DKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPC 704
+SPS E+ + P H +S P D ++ N +
Sbjct: 631 GFLSPSLT----ETLKGGNNGTHSHPHVHESS--PNSDTQRAQNCVAIK----------- 673
Query: 705 SP-EQMVTAKSYYT-PLLPHSLHRATSLPVDSVDV 737
SP E MVTAKS+YT LLPHSLHR SLPVD+VD+
Sbjct: 674 SPGEGMVTAKSFYTGSLLPHSLHRTVSLPVDAVDI 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815157|emb|CAN72330.1| hypothetical protein VITISV_035622 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2204), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/719 (63%), Positives = 530/719 (73%), Gaps = 31/719 (4%)
Query: 37 KTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96
K YRAFDEYEGIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKT+KH NIMKFYTSWVDT
Sbjct: 47 KKSYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTMKHNNIMKFYTSWVDT 106
Query: 97 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 156
ANRNINFVTEMFTSGTLRQYR KH+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKC
Sbjct: 107 ANRNINFVTEMFTSGTLRQYRQKHKRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKC 166
Query: 157 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCI 216
DNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEEEYNELVDIYSFGMCI
Sbjct: 167 DNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCI 226
Query: 217 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSAREL 276
LEMVTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+DPEVR+F+EKCLA+VS RLSAREL
Sbjct: 227 LEMVTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDPEVREFVEKCLASVSLRLSAREL 286
Query: 277 LTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENG 336
L DPFL+IDD +SDLR I+ + + D++ PLLRQ +HSN+S +NG + + +D NG
Sbjct: 287 LQDPFLRIDDCESDLRPIECRREPDDMVPLLRQPFLEYHHSNNSFSNGYSNAVDFDAHNG 346
Query: 337 LDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFP 396
Y P E + + I+LF EDEH N DISIKGKRREDDGIFLRLRIADKE IRNIYFP
Sbjct: 347 WGYQPLEMEPTGIELFEYHEDEHPANVDISIKGKRREDDGIFLRLRIADKEDHIRNIYFP 406
Query: 397 FDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSS-- 454
FDI+ DTALSVATEMV+ELDITDQDVTKIA++ID EIASLVPEWK G +EE+P ++
Sbjct: 407 FDIEMDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWKPGPGIEETPCFATLN 466
Query: 455 FCHNCA----SNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCA 510
CHNC SNG L D IL++ GAKNLQ+ QCS +GCAA+HGRFEEITYQVDGA+
Sbjct: 467 LCHNCVSNHTSNGSLMD-ILANNPGAKNLQIFQCS-NGCAAMHGRFEEITYQVDGADHHI 524
Query: 511 PEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEE----- 565
PEG QS +H +IW +HE + LSS S + DEE++ +N S E
Sbjct: 525 PEG-------QSEELHCTEIWYKHESRELSSVSSGESPSDEEYEKINHSIIKDERGSGTG 577
Query: 566 KIINMDSQSKCHERNCFSMNSAMDY--GLLDDYENEIRQELRWLKAKYQIQLRELRDQQL 623
+ + S H RN S ++ L DDYENEI+Q LRWLKAK+Q+++R LRD QL
Sbjct: 578 NVASNVKNSISHLRNPSSSSAIPSMSCALSDDYENEIQQVLRWLKAKHQMEMRGLRDLQL 637
Query: 624 GVKYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDE 683
G K SSL D++ D++ S++ + + + KH TS
Sbjct: 638 GFASKPSSL----DNRQLKPDNEGLFSTLSNTSQGHNNGLFLKSSAYDKHFTSNCATQVN 693
Query: 684 KKCGNVANQRVHSFEQMNWPCSPEQM---VTAKSYYTP--LLPHSLHRATSLPVDSVDV 737
K ++ + E S E M VTAKS+YT LLP +HR SLPVD+VD+
Sbjct: 694 KCSPDLVTHGARNCEANKGSRSAEDMVHVVTAKSFYTAGSLLPCPIHRTMSLPVDAVDI 752
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 740 | ||||||
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.386 | 0.408 | 0.871 | 4.5e-197 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.570 | 0.857 | 0.713 | 3.1e-161 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.355 | 0.509 | 0.727 | 3.8e-127 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.358 | 0.467 | 0.683 | 2.8e-125 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.358 | 0.475 | 0.675 | 9.5e-120 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.364 | 0.491 | 0.665 | 2.5e-119 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.359 | 0.465 | 0.659 | 2.5e-119 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.358 | 0.470 | 0.679 | 4e-116 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.543 | 0.767 | 0.532 | 7.1e-111 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.364 | 0.859 | 0.626 | 1.7e-89 |
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1353 (481.3 bits), Expect = 4.5e-197, Sum P(3) = 4.5e-197
Identities = 252/289 (87%), Positives = 270/289 (93%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
TGRYGRYNE+LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKT
Sbjct: 20 TGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKT 79
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LKH+NIMKFYTSWVDTANRNINFVTE+FTSGTLRQYRL+H+RVNIRA+KHWCRQIL GL
Sbjct: 80 LKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLH 139
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE 200
YLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYE
Sbjct: 140 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYE 199
Query: 201 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260
E YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV+SGKKP+AL+KV+DPEV+ FI
Sbjct: 200 EAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFI 259
Query: 261 EKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQ 309
EKCLATVS R+SARELL DPFL+IDD + DLR + + D + PL RQ
Sbjct: 260 EKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDME---DSVGPLYRQ 305
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1570 (557.7 bits), Expect = 3.1e-161, P = 3.1e-161
Identities = 317/444 (71%), Positives = 360/444 (81%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
TGRYGRYNE+LGKG+SKTVYR FDEY+GIEVAWNQVKLYDFLQSP+ELERLYCEIHLLKT
Sbjct: 21 TGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKT 80
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LKH++IMKFY SWVDT NRNINFVTEMFTSGTLRQYRLKH+RVNIRAVK+WCRQIL GL
Sbjct: 81 LKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLN 140
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE 200
YLH+ DPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L+ SHAA CVGTPEFMAPEVY+
Sbjct: 141 YLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYK 200
Query: 201 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260
EEYN+LVDIYSFGMC+LEMVTFDYPYSEC+HPAQIYK+VISGKKP+ L KV+DPEVR FI
Sbjct: 201 EEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFI 260
Query: 261 EKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY-DEISPLLRQSLYGIYHXXX 319
EKCLATVS RLSA ELL D FL ID+ SD+R ++ + DE LR S Y I H
Sbjct: 261 EKCLATVSLRLSACELLDDHFLCIDE--SDMRRVESEKGLIDEAGTPLRHS-YHIPHYSN 317
Query: 320 XXXXGCGHYIGYDTENGLDYHPHEFQES-EIDLFTCQ-------EDEHLTNFDISIKGKR 371
G+Y Y+ +N DY+ E ES EIDL Q ED+ + DISIKGKR
Sbjct: 318 ------GYYSLYN-QNQWDYNGDETVESHEIDLLEFQNDDDEEEEDKRFGSVDISIKGKR 370
Query: 372 RED-DGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIID 430
R++ DG+FLRL+ +KEG +RNIYFPFDI+TDTA+SVA EMV EL++ D+DVTKIA +ID
Sbjct: 371 RDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMID 430
Query: 431 SEIASLVPEWKRGMAMEESPHRSS 454
EIASLVP W + E + RSS
Sbjct: 431 GEIASLVPNWSIFCSSESN--RSS 452
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 3.8e-127, Sum P(2) = 3.8e-127
Identities = 192/264 (72%), Positives = 225/264 (85%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
TGRYGRY E+LGKGA K VYRAFD+ EGIEVAWNQVKL D S E+L+RLY E+HLLKT
Sbjct: 18 TGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKT 77
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LKH++I+KFYTSW+D + IN +TE+FTSG LRQYR KH+ V++RA+K W RQIL GL+
Sbjct: 78 LKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLV 137
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVY 199
YLHS DPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL ++ +A V GTPEFMAPE+Y
Sbjct: 138 YLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELY 197
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
EE+YN LVDIY+FGMC+LE+VTF+YPYSECT+ AQIY+KV SG KP AL V DP+VR F
Sbjct: 198 EEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAF 257
Query: 260 IEKCLATVSSRLSARELLTDPFLQ 283
IEKC+A VS RLSA+ELL DPFL+
Sbjct: 258 IEKCIAKVSQRLSAKELLDDPFLK 281
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 2.8e-125, Sum P(3) = 2.8e-125
Identities = 181/265 (68%), Positives = 222/265 (83%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
T RY RY E++GKGA KTVY+AFDE +GIEVAWNQV++ D LQSP LERLY E+ LLK+
Sbjct: 24 TFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKS 83
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LKH NI++FY SW+D N+ +N +TE+FTSG+LR YR KHR+VN++AVK+W RQIL GL
Sbjct: 84 LKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLR 143
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE 200
YLH ++PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+
Sbjct: 144 YLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYD 203
Query: 201 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260
E YNEL DIYSFGMC+LEMVTFDYPY EC + AQIYKKV SG KP +L +V+DPEV+QFI
Sbjct: 204 ENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFI 263
Query: 261 EKCLATVSSRLSARELLTDPFLQID 285
EKCL S RLSA+ELL DPFLQ++
Sbjct: 264 EKCLLPASERLSAKELLLDPFLQLN 288
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
Identities = 179/265 (67%), Positives = 222/265 (83%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
T RY RY E++GKGASKTV++ FDE +GIEVAWNQV++ D LQSP+ LERLY E+ LLK+
Sbjct: 24 TCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKS 83
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LKH+NI++FY SW+D N+ +N +TE+FTSG+LRQYR KHR+VN++AVK W RQIL+GL
Sbjct: 84 LKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLK 143
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE 200
YLHS+DPP+IHRD+KCDNIF+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+
Sbjct: 144 YLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYD 203
Query: 201 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260
E YNEL DIYSFGMC+LEMVTF+YPY EC + AQIYKKV SG KP +L KV+DPEV +FI
Sbjct: 204 ENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFI 263
Query: 261 EKCLATVSSRLSARELLTDPFLQID 285
EKCL S RLSA ELL D FL ++
Sbjct: 264 EKCLLPASERLSAEELLLDSFLNVN 288
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 181/272 (66%), Positives = 222/272 (81%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
+GRYGR+ E+LGKGA KTVY+AFD+ G+EVAWNQVKL + +SPE L+RLY E+HLLK
Sbjct: 21 SGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEVHLLKN 80
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
L H +I+++ TSW+D R NF+TE+FTSGTLR+YR K+++V+IRA+K W RQIL+GL
Sbjct: 81 LNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLA 140
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVY 199
YLH DPPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S A V GTPEFMAPE+Y
Sbjct: 141 YLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELY 200
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
EE+YNELVDIYSFGMC+LEM+T +YPYSECT+PAQIYKKV SGK P++ ++ E ++F
Sbjct: 201 EEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRF 260
Query: 260 IEKCLATVSSRLSARELLTDPFLQIDDYDSDL 291
+ KCL TVS RL A+ELL DPFL D + DL
Sbjct: 261 VGKCLETVSRRLPAKELLADPFLAATD-ERDL 291
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 176/267 (65%), Positives = 219/267 (82%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
TGRYGR+ EILG+GA KTVY+A DE GIEVAW+QVKL + L+S +L+RLY E+HLL T
Sbjct: 15 TGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSEVHLLST 74
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
L H++I++FYTSW+D N +NF+TE+FTSGTLRQY+ K+ R++IRA+K W RQIL GL+
Sbjct: 75 LNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLV 134
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVY 199
YLH DPPVIHRDLKCDNIFVNG+ G+VKIGDLGLA +LR H+A + GTPEFMAPE+Y
Sbjct: 135 YLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELY 194
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
EE YNEL+D+YSFGMC LEM+T ++PYSEC HPAQIYKKV+ GK P A ++V D E ++F
Sbjct: 195 EENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRF 254
Query: 260 IEKCLATVSSRLSARELLTDPFLQIDD 286
I KCL + S R+SA+ELL DPFL D+
Sbjct: 255 IGKCLVSASKRVSAKELLQDPFLASDE 281
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 4.0e-116, Sum P(3) = 4.0e-116
Identities = 180/265 (67%), Positives = 218/265 (82%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
+GRY RY+++LG+GA KTVY+AFDE +GIEVAWN V + D +Q P +LERLY E+HLLK
Sbjct: 25 SGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKA 84
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LKH NI+K + SWVD N+ IN +TE+FTSG+LR YR KHR+V+ +A+K+W RQIL GL
Sbjct: 85 LKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLN 144
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE 200
YLHS++PPVIHRDLKCDNIFVNGN GEVKIGDLGLA +L++ A +GTPEFMAPE+YE
Sbjct: 145 YLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYE 204
Query: 201 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260
EEYNELVDIYSFGMC+LEMVT +YPY+EC + AQIYKKV S KP++L KV+DP+VRQFI
Sbjct: 205 EEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFI 264
Query: 261 EKCLATVSSRLSARELLTDPFLQID 285
EKCL SSR +A EL DPFL D
Sbjct: 265 EKCLLPASSRPTALELSKDPFLARD 289
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 7.1e-111, Sum P(2) = 7.1e-111
Identities = 222/417 (53%), Positives = 280/417 (67%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
TGRY RYN++LG+GA KTVY+AFDE EGIEVAWN + + D LQ P +L+RLY E+HLL +
Sbjct: 12 TGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNS 71
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LKH NI+K + SWVD N++IN +TE+FTSG+L YR KHR+V+ +A+ +W RQIL GL
Sbjct: 72 LKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLH 131
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE 200
YLHS+ PPVIHRDLKCDNIFVNGN G+VKIGDLGLAA++++ A +GTPEFMAPE+YE
Sbjct: 132 YLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYE 191
Query: 201 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260
EEYNELVDIYSFGMC+LEMVT +YPY EC + AQIYKKV SG KP++L KV+DP+V+QFI
Sbjct: 192 EEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFI 251
Query: 261 EKCLATVSSRLSARELLTDPFLQIDDY-DSDLRMIQYQTDYDEISPLLRQSLYGIYHXXX 319
EKCL SR +A ELL D L +D DS L T + P + +
Sbjct: 252 EKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMPPQCEYRPMDVEYKKN 311
Query: 320 XXXXGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFL 379
C E L Q E+ Q T F +S G+RR+D +
Sbjct: 312 TSVSICSSAKS-SQECAL------LQTMEV-----QRVAESTEFKLS--GERRDDVAASM 357
Query: 380 RLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASL 436
LRIA G+ R + F F+++TDTA +V EMV ELD++ +VT IAE+ID I L
Sbjct: 358 ALRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
Identities = 171/273 (62%), Positives = 203/273 (74%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
TGRYGRY E+LG GA K VYRAFD+ EGIEVAWNQVKL F P ERLY E+ LLK
Sbjct: 27 TGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSDDPAMTERLYSEVRLLKN 86
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
LK+ NI+ Y W D N +NF+TE+ TSG LR+YR KHR V++RA+K W +QIL GL
Sbjct: 87 LKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLD 146
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVY 199
YLH+ DP +IHRDL C NIFVNGN G+VKIGDLGLAAI+ K+H A + GTPEFMAPE+Y
Sbjct: 147 YLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELY 206
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
EE Y E+VDIYS+GMC+LE+V+ + PYSEC A+IYK+V G KPEAL KV DPE + F
Sbjct: 207 EENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAF 266
Query: 260 IEKCLATVSSRLSARELLTDPFLQ--IDDYDSD 290
IEKC+A +R SA ELL DPF +DD D D
Sbjct: 267 IEKCIAQPRARPSAAELLCDPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0D598 | WNK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5255 | 0.9148 | 0.9616 | yes | no |
| Q9CAV6 | WNK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6008 | 0.7986 | 0.8442 | yes | no |
| A2YMV6 | WNK1_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.5241 | 0.9148 | 0.9616 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 740 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-64 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-60 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-51 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-35 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-32 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-32 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-32 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-30 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.003 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 6e-64
Identities = 93/259 (35%), Positives = 131/259 (50%), Gaps = 14/259 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG+G+ VY A D+ G VA +K + E + R EI +LK LKH NI++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR---EIKILKKLKHPNIVR 61
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
Y + D + V E G L K R++ + + RQILS L YLHS+
Sbjct: 62 LYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY-EEEYNEL 206
++HRDLK +NI ++ + G VK+ D GLA L VGTPE+MAPEV + Y +
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 207 VDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCL 264
VDI+S G IL E++T P+ +++KK+ K P + + PE + I K L
Sbjct: 177 VDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 265 AT-VSSRLSARELLTDPFL 282
RL+A E L PF
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 3e-60
Identities = 95/260 (36%), Positives = 135/260 (51%), Gaps = 11/260 (4%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E+LG+G+ +VY A D+ G +A V+L S EELE L EI +L +L+H NI++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+Y S D +N E + G+L K ++ ++ + RQIL GL YLHS
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYE-EEY 203
++HRD+K NI V+ + G VK+ D G A L GTP +MAPEV EEY
Sbjct: 122 IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263
DI+S G ++EM T P+SE +P K+ S +P + + E + F+ KC
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 264 LAT-VSSRLSARELLTDPFL 282
L R +A ELL PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 85/263 (32%), Positives = 127/263 (48%), Gaps = 16/263 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G+ TVY+A + G VA +K + ++ + EI +L+ L H NI++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
++ D ++ V E G L Y + ++ K QIL GL YLHS
Sbjct: 63 LIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV--YEEEYN 204
+IHRDLK +NI ++ N G VKI D GLA L KS ++ VGTP +MAPEV Y
Sbjct: 119 IIHRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKV--EDPEVRQFI 260
VD++S G+ + E++T P+S Q+ +++ K E + I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 261 EKCLAT-VSSRLSARELLTDPFL 282
+KCL S R +A E+L P+
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 9e-51
Identities = 84/256 (32%), Positives = 119/256 (46%), Gaps = 47/256 (18%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG+G TVY A D+ G +VA +K D EEL R EI +LK L H NI+K Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR---EIEILKKLNHPNIVKLY 57
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
+ D ++ V E G+L+ + +++ + QIL GL YLHS +
Sbjct: 58 GVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GI 113
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE--EYNE 205
IHRDLK +NI ++ + G+VK+ D GL+ +L KS VGTP +MAPEV Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
DI+S G+ + E+ PE++ I K L
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 266 -TVSSRLSARELLTDP 280
R SA+E+L
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 101/279 (36%), Positives = 141/279 (50%), Gaps = 32/279 (11%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP Y E +G+GAS VY+A D G EVA +++L + E + EI ++
Sbjct: 16 DPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEILIM 69
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQ 134
K KH NI+ +Y S++ + V E G+L Q ++ I V CR+
Sbjct: 70 KDCKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CRE 124
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPE 192
+L GL YLHS+ VIHRD+K DNI ++ G VK+ D G AA L K + R VGTP
Sbjct: 125 VLQGLEYLHSQ--NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPY 181
Query: 193 FMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISG----KKPE 246
+MAPEV + ++Y VDI+S G+ +EM + PY P + ++ G K PE
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-PLRALFLITTKGIPPLKNPE 240
Query: 247 ALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQI 284
PE + F+ KCL R SA ELL PFL+
Sbjct: 241 KW----SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 90/261 (34%), Positives = 139/261 (53%), Gaps = 21/261 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +GKG VY+A + G EVA +KL +S E+ E++ EI +LK KH NI+K
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKL----ESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
+Y S++ + V E + G+L+ + ++ + + + C+++L GL YLHS
Sbjct: 62 YYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE-EEYNE 205
+IHRD+K NI + + GEVK+ D GL+A L + A VGTP +MAPEV + Y+
Sbjct: 119 -IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG----KKPEALFKVEDPEVRQFIE 261
DI+S G+ +E+ PYSE ++K +G + PE E + F++
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW----SDEFKDFLK 232
Query: 262 KCLA-TVSSRLSARELLTDPF 281
KCL R +A +LL PF
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 18/268 (6%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
+Y +I GKG+ VY + +G ++ L S +E E E+ +LK L
Sbjct: 1 KYEIIKQI-GKGSFGKVYLVRRKSDGKLYVLKEIDL--SNMSEKEREDALNEVKILKKLN 57
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI----RAVKHWCRQILSG 138
H NI+K+Y S+ + + V E G L Q K ++ + W Q+
Sbjct: 58 HPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAP 196
L YLHSR ++HRD+K NIF+ N G VK+GD G++ +L + A VGTP +++P
Sbjct: 116 LKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 197 EVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
E+ + + YN DI+S G + E+ T +P+ E + ++ K++ G+ P + E
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKGQYP-PIPSQYSSE 230
Query: 256 VRQFIEKCLATV-SSRLSARELLTDPFL 282
+R + L R S ++L PF+
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 84/258 (32%), Positives = 134/258 (51%), Gaps = 13/258 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+++G+GA VY+ + G VA Q+ L E L+ + EI LLK LKH NI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+ S ++T++ ++ + E +G+LRQ K V + Q+L GL YLH +
Sbjct: 64 YIGS-IETSD-SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNE 205
VIHRD+K NI + G VK+ D G+A L VGTP +MAPEV E +
Sbjct: 120 VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
DI+S G ++E++T + PY + P +++ P L + PE++ F+ +C
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQDDHP-PLPEGISPELKDFLMQCFQ 236
Query: 266 -TVSSRLSARELLTDPFL 282
+ R +A++LL P++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 91/265 (34%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE-LERLYCEIHLLKTLKHR 84
R E+LG G+ +VY + +G A +V L D Q+ +E +++L EI LL L+H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
NI+++ + + N+ E+ G+L + K+ ++ + RQIL GL YLH
Sbjct: 63 NIVQYLGT--EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEVYEEE- 202
R+ +HRD+K NI V+ N G VK+ D G+A ++ S A G+P +MAPEV ++
Sbjct: 121 RN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 203 -YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQ 258
Y DI+S G +LEM T P+S+ A ++K S + P + D E +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP----IPDHLSDEAKD 233
Query: 259 FIEKCL-ATVSSRLSARELLTDPFL 282
FI KCL S R +A ELL PF+
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 78/260 (30%), Positives = 126/260 (48%), Gaps = 15/260 (5%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG+G+S VY+ + G A +K E ++L E+ L++ + ++K Y
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
++ I+ V E G+L K ++ + + RQIL GL YLH +I
Sbjct: 66 GAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHII 122
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYE-EEYNEL 206
HRD+K N+ +N ++GEVKI D G++ +L + +C VGT +M+PE + E Y+
Sbjct: 123 HRDIKPSNLLIN-SKGEVKIADFGISKVLENT-LDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 207 VDIYSFGMCILEMVTFDYPYS--ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264
DI+S G+ +LE +P+ ++ + + G P + PE R FI CL
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 265 -ATVSSRLSARELLTDPFLQ 283
R SA ELL PF++
Sbjct: 241 QKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 80/265 (30%), Positives = 131/265 (49%), Gaps = 16/265 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +GKG+ TV + + +G + W ++ Y + + +E ++L E+++L+ LKH NI++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEID-YGNM-TEKEKQQLVSEVNILRELKHPNIVR 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
+Y +D +N+ + V E G L ++ + + + + + Q+L L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 145 RDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVY 199
R P V+HRDLK NIF++ N VK+GD GLA IL A VGTP +M+PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 200 -EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
Y+E DI+S G I E+ P++ Q+ K+ GK + E+ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIKEGKFRR-IPYRYSSELNE 240
Query: 259 FIEKCLA-TVSSRLSARELLTDPFL 282
I+ L R S ELL P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 17/265 (6%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
+ I GKG+ VY+A D+ VA +K+ D ++ +E+E + EI L +
Sbjct: 2 LFTLLECI-GKGSFGEVYKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
I K+Y S++ + I + E G+ LK +++ + R++L GL YL
Sbjct: 58 SPYITKYYGSFLKGSKLWI--IMEYCGGGSCLDL-LKPGKLDETYIAFILREVLLGLEYL 114
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY- 199
H IHRD+K NI ++ +G+VK+ D G++ L + + R VGTP +MAPEV
Sbjct: 115 HEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQ 258
+ Y+E DI+S G+ +E+ + P S+ HP ++ +I P +L + +
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSD-LHPMRVL-FLIPKNNPPSLEGNKFSKPFKD 229
Query: 259 FIEKCL-ATVSSRLSARELLTDPFL 282
F+ CL R SA+ELL F+
Sbjct: 230 FVSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 101/276 (36%), Positives = 136/276 (49%), Gaps = 27/276 (9%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q +EL + EI ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKEL--IINEILVM 70
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQIL 136
+ KH NI+ + S++ + V E G+L I AV CR+ L
Sbjct: 71 RENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECL 125
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFM 194
L +LHS VIHRD+K DNI + G G VK+ D G A + + R VGTP +M
Sbjct: 126 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 195 APEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK----KPEALF 249
APEV + Y VDI+S G+ +EMV + PY +Y +G PE L
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL- 241
Query: 250 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQI 284
R F+ +CL V R SA+ELL PFL+I
Sbjct: 242 ---SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 82/263 (31%), Positives = 128/263 (48%), Gaps = 23/263 (8%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G G VY+A D G VA +KL ++ E + EI +LK +H NI+ ++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
S++ + V E G+L+ Y++ ++ + + CR+ L GL YLH
Sbjct: 67 GSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--K 122
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE----Y 203
IHRD+K NI + G+VK+ D G++A L + A R +GTP +MAPEV E Y
Sbjct: 123 IHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVE--DPEVRQFI 260
+ DI++ G+ +E+ P + HP + ++ S P L E P FI
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFD-LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240
Query: 261 EKCLATVSSRL--SARELLTDPF 281
+KCL T + +A +LL PF
Sbjct: 241 KKCL-TKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 90/274 (32%), Positives = 145/274 (52%), Gaps = 24/274 (8%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
R+ R N+I G G VY A + G +A ++++ D P+ ++ + E+ +L+ LK
Sbjct: 1 RWQRGNKI-GGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLK 57
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLY 141
H N++K+Y V+ + E + GTL + L+H R+ + ++ + Q+L GL Y
Sbjct: 58 HPNLVKYYG--VEVHREKVYIFMEYCSGGTLEEL-LEHGRILDEHVIRVYTLQLLEGLAY 114
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-------VGTPEFM 194
LHS ++HRD+K NIF++ N G +K+GD G A L K++ GTP +M
Sbjct: 115 LHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYM 170
Query: 195 APEVY----EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250
APEV + + DI+S G +LEM T P+SE + QI V +G KP
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDS 230
Query: 251 VE-DPEVRQFIEKCLATV-SSRLSARELLTDPFL 282
++ PE + F+++CL + R +A ELL PF+
Sbjct: 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 89/263 (33%), Positives = 135/263 (51%), Gaps = 22/263 (8%)
Query: 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
E LG+G+ +VY+A + G VA +K + E+L+ + EI +LK I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVA---IK---VVPVEEDLQEIIKEISILKQCDSPYIV 61
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
K+Y S+ N ++ V E +G++ ++ ++ + + Q L GL YLHS
Sbjct: 62 KYYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-Y 203
IHRD+K NI +N +G+ K+ D G++ L + A R +GTP +MAPEV +E Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPA-QIYKKVISGKKPEALFKVED--PEVRQFI 260
N DI+S G+ +EM PYS+ HP I+ +I K P L E PE F+
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSD-IHPMRAIF--MIPNKPPPTLSDPEKWSPEFNDFV 233
Query: 261 EKCLA-TVSSRLSARELLTDPFL 282
+KCL R SA +LL PF+
Sbjct: 234 KKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 86/273 (31%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E++G GA+ VY A +VA +K D + ++ L E+ + H N++K
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLY 141
+YTS+V + V + G+L +K I V +++L GL Y
Sbjct: 64 YYTSFV--VGDELWLVMPYLSGGSLLDI-MKSSYPRGGLDEAIIATV---LKEVLKGLEY 117
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAAR--CVGTPEFMA 195
LHS IHRD+K NI + G G VKI D G++A L + R VGTP +MA
Sbjct: 118 LHSNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 196 PEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP----EALF 249
PEV E+ Y+ DI+SFG+ +E+ T PYS+ P ++ + P A +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGADY 233
Query: 250 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPF 281
K R+ I CL S R +A ELL F
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-33
Identities = 86/266 (32%), Positives = 132/266 (49%), Gaps = 11/266 (4%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEELERLYCEIHLLKTLKHR 84
R ++LG+GA VY +D G E+A QV+ + ++ +E+ L CEI LLK L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
I+++Y D A + + E G+++ + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVY 199
++HRD+K NI + + G VK+GD G L I R V GTP +M+PEV
Sbjct: 125 N--MIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 200 E-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
E Y D++S G ++EM+T P++E A I+K P+ + + R
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240
Query: 259 FIEKCLATVSSRLSARELLTDPFLQI 284
F+ R SA ELL PF Q+
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 70/249 (28%), Positives = 110/249 (44%), Gaps = 25/249 (10%)
Query: 28 NEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+ LG+GA VY+ + + +EVA +K Q EE R E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLY 141
NI+K V T + V E G L Y K+R + + QI G+ Y
Sbjct: 61 PNIVKLLG--VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE---FMAPEV 198
L S+ IHRDL N V N VKI D GL+ L + G +MAPE
Sbjct: 119 LESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 199 YEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED--P 254
+E ++ D++SFG+ + E+ T + PY + A++ + + G + K + P
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLKKGYRLP---KPPNCPP 231
Query: 255 EVRQFIEKC 263
E+ + + +C
Sbjct: 232 ELYKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 84/265 (31%), Positives = 129/265 (48%), Gaps = 16/265 (6%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEELERLYCEIHLLKTLKHR 84
R ++LG+GA VY +D G E+A QV D ++ +E+ L CEI LLK L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
I+++Y D + ++ E G+++ + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVY 199
++HRD+K NI + G VK+GD G L I + V GTP +M+PEV
Sbjct: 123 NM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 200 E-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVR 257
E Y D++S G ++EM+T P++E A I+K I+ + P+ R
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPQLPSHVSPDAR 237
Query: 258 QFIEKCLA-TVSSRLSARELLTDPF 281
F+ + R SA ELL F
Sbjct: 238 NFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 92/277 (33%), Positives = 138/277 (49%), Gaps = 33/277 (11%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP + +I G+G++ V A D+ G +VA VK D L+ + E L+ E+ ++
Sbjct: 16 DPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVA---VKKMD-LRKQQRRELLFNEVVIM 70
Query: 79 KTLKHRNIMKFYTS-------WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 131
+ +H NI++ Y+S WV V E G L + H R+N +
Sbjct: 71 RDYQHPNIVEMYSSYLVGDELWV---------VMEFLEGGALTDI-VTHTRMNEEQIATV 120
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 189
C +L L +LH++ VIHRD+K D+I + + G VK+ D G A + K R VG
Sbjct: 121 CLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVG 177
Query: 190 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA- 247
TP +MAPEV Y VDI+S G+ ++EMV + PY P Q K++ P+
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLK 236
Query: 248 -LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
L KV P +R F+++ L + R +A ELL PFL
Sbjct: 237 NLHKVS-PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 100/276 (36%), Positives = 139/276 (50%), Gaps = 27/276 (9%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP +Y RY +I G+GAS TV+ A D G EVA Q+ LQ + E + EI ++
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVM 70
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQIL 136
K LK+ NI+ F S++ + V E G+L + I AV CR+ L
Sbjct: 71 KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECL 125
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFM 194
L +LH+ VIHRD+K DN+ + G G VK+ D G A + + R VGTP +M
Sbjct: 126 QALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 195 APEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG----KKPEALF 249
APEV + Y VDI+S G+ +EMV + PY +Y +G + PE L
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL- 241
Query: 250 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQI 284
P R F+ +CL V R SA+ELL PFL++
Sbjct: 242 ---SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 5e-32
Identities = 87/267 (32%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE---ELERLYCEIHLLKTLK 82
R ++LG+GA VY +D G E+A QV+ +SPE E+ L CEI LLK L
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLL 62
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
H I+++Y D R ++ E G+++ + + + + RQIL G+ YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAARCVGTPEFMAPE 197
HS ++HRD+K NI + + G VK+GD G + L+ + GTP +M+PE
Sbjct: 123 HSN--MIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 198 VYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256
V E Y DI+S G ++EM+T P++E A I+K P V D
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HC 238
Query: 257 RQFIEKCLATVSSRLSARELLTDPFLQ 283
R F+++ R SA ELL F+
Sbjct: 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 25/263 (9%)
Query: 28 NEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+ LG+GA VY+ + +EVA +K Q EE R E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYL 142
N++K V T + V E G L Y K+R ++++ + + QI G+ YL
Sbjct: 61 PNVVKLLG--VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE---FMAPEVY 199
S+ IHRDL N V N VKI D GL+ L R G +MAPE
Sbjct: 119 ESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 200 EE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED--PE 255
+E ++ D++SFG+ + E+ T + PY + ++ + + +G + + + PE
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLKNGYRLP---QPPNCPPE 231
Query: 256 VRQFIEKCLAT-VSSRLSARELL 277
+ + +C A R + EL+
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 82/268 (30%), Positives = 123/268 (45%), Gaps = 24/268 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE--LERLYCEIHLLKTLKHRNI 86
+ LG GA + Y+A D G +A QV S +E +E L EI L+ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 87 MKFYTSWVDTANRNINFVTEM---FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
++ + + ++ N+ FV M S L +Y V I + Q+L GL YLH
Sbjct: 66 IRMLGATCEDSHFNL-FVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGLSYLH 120
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS------HAARCVGTPEFMAPE 197
+IHRD+K N+ ++ ++I D G AA L + +GT FMAPE
Sbjct: 121 ENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 198 VYE-EEYNELVDIYSFGMCILEMVTFDYPYSE---CTHPAQIYKKVISGKKPEALFKVED 253
V E+Y D++S G I+EM T P++ H A I+ K+ S ++ +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIASATTAPSIPEHLS 237
Query: 254 PEVRQFIEKCL-ATVSSRLSARELLTDP 280
P +R +CL R +RELL P
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 91/269 (33%), Positives = 126/269 (46%), Gaps = 31/269 (11%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKF 89
+LGKG VY A D + +A ++ D ++ L+ EI L LKHRNI+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 90 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----RVNIRAVKHWCRQILSGLLYLHSR 145
S D+ N E G+L L+ + + N + + + +QIL GL YLH
Sbjct: 71 LGS--DSENGFFKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAARCVGTPEFMAPEVYEE 201
++HRD+K DN+ VN G VKI D G LA I GT ++MAPEV ++
Sbjct: 128 Q--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDK 183
Query: 202 ---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK----PEALFKVEDP 254
Y DI+S G I+EM T P+ E P KV K PE+L
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL----SA 239
Query: 255 EVRQFIEKCLA-TVSSRLSARELLTDPFL 282
E + FI +C R SA +LL DPFL
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 91/270 (33%), Positives = 137/270 (50%), Gaps = 23/270 (8%)
Query: 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE-ELERLYCEIHLLKTLK 82
Y R E++G+GA VYR G VA +K+ + L +P+ ++ + E+ LL L+
Sbjct: 3 YQRL-ELIGRGAYGAVYRGKHVPTGRVVA---LKIIN-LDTPDDDVSDIQREVALLSQLR 57
Query: 83 H---RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
NI K+Y S++ I + E G++R +K + + + R++L L
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWI--IMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVAL 114
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPE 197
Y+H VIHRD+K NI V N G VK+ D G+AA+L ++ + R VGTP +MAPE
Sbjct: 115 KYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
Query: 198 VYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DP 254
V E Y+ DI+S G+ I EM T + PYS+ A +I KP L
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSD--VDAFRAMMLIPKSKPPRLEDNGYSK 229
Query: 255 EVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
+R+F+ CL RLSA ELL +++
Sbjct: 230 LLREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 76/243 (31%), Positives = 126/243 (51%), Gaps = 16/243 (6%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+GKG VY+A +G VA +V++++ + + + EI LLK L H N++K+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFE-MMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSR 145
S+++ N +N V E+ +G L + +KH R + R + + Q+ S L ++HS+
Sbjct: 69 ASFIE--NNELNIVLELADAGDLSRM-IKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARC-VGTPEFMAPE-VYEEE 202
++HRD+K N+F+ G VK+GDLGL K+ AA VGTP +M+PE ++E
Sbjct: 126 R--IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 203 YNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261
YN DI+S G + EM P Y + + + KK+ P E+R +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 262 KCL 264
+C+
Sbjct: 243 RCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 37/287 (12%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DPTG + E++G+G VY+A + G VA +K+ D + +E E + E ++L
Sbjct: 3 DPTGIFELV-EVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNIL 56
Query: 79 KTL-KHRNIMKFYTSWVDTANRN----INFVTEMFTSGTLRQYRLKHRRVNIRAVKHW-- 131
+ H NI FY +++ + V E+ G++ R+ R + W
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 132 --CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--C 187
R+ L GL YLH VIHRD+K NI + N EVK+ D G++A L + R
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 188 VGTPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 241
+GTP +MAPEV + Y+ D++S G+ +E+ P + HP + K+
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPR 232
Query: 242 GKKPEALFKVEDPE-----VRQFIEKCLA-TVSSRLSARELLTDPFL 282
P ++ PE FI +CL R ELL PF+
Sbjct: 233 NPPP----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 69/267 (25%), Positives = 110/267 (41%), Gaps = 24/267 (8%)
Query: 26 RYNEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
+ LG+GA VY+ E +VA VK S EE E E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVA---VKTLKEGASEEEREEFLEEASIMKKL 58
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGL 139
H NI++ V T + VTE G L + L+ + QI G+
Sbjct: 59 SHPNIVRLLG--VCTQGEPLYIVTEYMPGGDLLDF-LRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPE---FMA 195
YL S+ +HRDL N V VKI D GL+ I + + G +MA
Sbjct: 116 EYLESK--NFVHRDLAARNCLV-TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 196 PEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED 253
PE ++ ++ D++SFG+ + E+ T + PY + ++ + + G +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLELLEDGYRLPRPENC-P 230
Query: 254 PEVRQFIEKCLAT-VSSRLSARELLTD 279
E+ + + +C A R + EL+ D
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 87/271 (32%), Positives = 129/271 (47%), Gaps = 35/271 (12%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG GA VY+A + G+ A K+ +S EELE EI +L KH NI+ Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAA---AKIIQI-ESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV----NIRAVKHWCRQILSGLLYLHSRD 146
++ I + E G L L+ R IR V CRQ+L L +LHS
Sbjct: 69 EAYFYENKLWI--LIEFCDGGALDSIMLELERGLTEPQIRYV---CRQMLEALNFLHSHK 123
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-- 202
VIHRDLK NI + G+VK+ D G++A + + R +GTP +MAPEV E
Sbjct: 124 --VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 203 ----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP---- 254
Y+ DI+S G+ ++E+ + P+ E +P ++ K++ + P ++ P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHE-LNPMRVLLKILKSEPP----TLDQPSKWS 235
Query: 255 -EVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
F++ CL R +A ELL PF+
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 96/275 (34%), Positives = 143/275 (52%), Gaps = 25/275 (9%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q P++ E + EI ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+ K+ NI+ + S++ + V E G+L + ++ + CR+ L
Sbjct: 71 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQA 127
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAP 196
L +LHS VIHRD+K DNI + G G VK+ D G A + + R VGTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 197 EVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
EV + Y VDI+S G+ +EMV + PY +P + + + PE +++PE
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPE----LQNPE 239
Query: 256 -----VRQFIEKCLAT-VSSRLSARELLTDPFLQI 284
R F+ +CL V R SA+ELL PFL++
Sbjct: 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 86/270 (31%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE-----LERLYCEIHLLKTLKHR 84
++G G+ +VY + G +A QV+L S ++ L+ L EI LLK L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 85 NIMKFYTSWVDTANRNI--NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
NI+++ S +D + NI +V + L Y + V+++ RQIL GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNYL 122
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--------RKSHAARCVGTPEFM 194
H+R +IHRD+K NI V+ N+G +KI D G++ L G+ +M
Sbjct: 123 HNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 195 APEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253
APEV ++ Y DI+S G ++EM+T +P+ +CT I+K I +
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--IGENASPEIPSNIS 237
Query: 254 PEVRQFIEKCLAT-VSSRLSARELLTDPFL 282
E F+EK + R +A ELL PFL
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 83/263 (31%), Positives = 129/263 (49%), Gaps = 11/263 (4%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEELERLYCEIHLLKTLKHR 84
R ++LG+GA VY +D G E+A QV D ++ +E+ L CEI LLK L+H
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
I+++Y D + ++ E G+++ + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVY 199
++HRD+K NI + + G VK+GD G + I + V GTP +M+PEV
Sbjct: 125 N--MIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 200 E-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
E Y D++S ++EM+T P++E A I+K KP V D R
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 259 FIEKCLATVSSRLSARELLTDPF 281
F+++ R +A LL PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 84/291 (28%), Positives = 122/291 (41%), Gaps = 50/291 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHRNIM 87
E LG+G VY+A D+ G VA +++L E + EI LLK LKH NI+
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKHPNIV 61
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSR 145
K V R + V E + L++Y L R ++ +K Q+L GL Y HS
Sbjct: 62 KLLD--VIHTERKLYLVFE-YCDMDLKKY-LDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM-----APEVY- 199
++HRDLK NI +N + G +K+ D GLA R T E + APE+
Sbjct: 118 R--ILHRDLKPQNILINRD-GVLKLADFGLARAF--GIPLRTY-THEVVTLWYRAPEILL 171
Query: 200 -EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--------------------- 237
+ Y+ VDI+S G EM+T + + Q++K
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 238 -----KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
K E + DPE + K L + R+SA+E L P+
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (300), Expect = 3e-29
Identities = 86/325 (26%), Positives = 136/325 (41%), Gaps = 40/325 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKH-RN 85
LG+G+ VY A D VA +K+ +E+ER EI +L +L H N
Sbjct: 6 RKLGEGSFGEVYLARDR---KLVA---LKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYL 142
I+K Y + D ++ V E G+L + ++ QILS L YL
Sbjct: 60 IVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--------CVGTPEFM 194
HS+ +IHRD+K +NI ++ + VK+ D GLA +L + VGTP +M
Sbjct: 118 HSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 195 APEVY----EEEYNELVDIYSFGMCILEMVTFDYPY---SECTHPAQIYKKVISGKKPEA 247
APEV + DI+S G+ + E++T P+ + +Q K ++ P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 248 LFKV-------EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL-QIDDYDSDLRMIQYQT 298
+ ++K LA +RLS+ L+ L + +SDL +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 299 DYDEISPLLRQSLYGIYHSNSSSNN 323
D + L SL + S +S
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAI 320
|
Length = 384 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 95/275 (34%), Positives = 142/275 (51%), Gaps = 25/275 (9%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q P++ E + EI ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+ K+ NI+ + S++ + V E G+L + ++ + CR+ L
Sbjct: 72 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQA 128
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAP 196
L +LHS VIHRD+K DNI + G G VK+ D G A + + R VGTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 197 EVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
EV + Y VDI+S G+ +EM+ + PY +P + + + PE +++PE
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPE----LQNPE 240
Query: 256 -----VRQFIEKCL-ATVSSRLSARELLTDPFLQI 284
R F+ +CL V R SA+ELL FL+I
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 71/246 (28%), Positives = 112/246 (45%), Gaps = 28/246 (11%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLY-------DFLQSPEELERLYCEIHLLKTLKH 83
LGKG+ V + G KLY + +E+E E ++L + H
Sbjct: 1 LGKGSFGKVLLVRKKDTG--------KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH 52
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
I+K + ++ + V E G L + K R + + + +I+ L YLH
Sbjct: 53 PFIVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYE 200
S +I+RDLK +NI ++ G +K+ D GLA L S +R GTPE++APEV
Sbjct: 111 SLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLL 166
Query: 201 -EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
+ Y + VD +S G+ + EM+T P+ +IY+K++ K P + PE R
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKIL--KDPLRFPEFLSPEARDL 223
Query: 260 IEKCLA 265
I L
Sbjct: 224 ISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 78/258 (30%), Positives = 127/258 (49%), Gaps = 15/258 (5%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LGKG+ +VY+ + A +V L S +E E EI +L ++ H NI+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLG--SMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQY----RLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
+++D + V E G L + + K + + + + Q+L GL LH +
Sbjct: 66 EAFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNE 205
++HRDLK NI + N VKIGDLG++ +L+K+ A +GTP +MAPEV++ Y+
Sbjct: 124 --ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
DI+S G + EM TF P+ E + KV GK P + + +++ FI L
Sbjct: 181 KSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQ 238
Query: 266 T-VSSRLSARELLTDPFL 282
R + ++L P +
Sbjct: 239 VKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 32/255 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGI-----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+ LG+GA VY+ + +G EVA +K S EE + E ++K L H
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGH 55
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK---------HWCRQ 134
N+++ V T + V E G L Y K R V K + Q
Sbjct: 56 PNVVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPE- 192
I G+ YL S+ +HRDL N V + VKI D GL+ + + + G
Sbjct: 114 IAKGMEYLASK--KFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLP 170
Query: 193 --FMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEAL 248
+MAPE ++ + D++SFG+ + E+ T PY + ++ + + G +
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRKGYRLPKP 229
Query: 249 FKVEDPEVRQFIEKC 263
E+ + + C
Sbjct: 230 EYC-PDELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 19/262 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC--EIHLLKTLKHRNI 86
+GKG+ V++ + + A Q+ L ER E +L L I
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDL----SKMNRREREEAIDEARVLAKLDSSYI 61
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW--CRQILSGLLYLHS 144
+++Y S++D NI V E +G L + R + + W QIL GL +LHS
Sbjct: 62 IRYYESFLDKGKLNI--VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE 202
+ ++HRD+K N+F++ VKIGDLG+A +L + A VGTP +++PE+ E++
Sbjct: 120 KK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 203 -YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261
YNE D+++ G+ + E T +P+ A I K+I G P + ++ ++ Q I+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALI-LKIIRGVFP-PVSQMYSQQLAQLID 234
Query: 262 KCLA-TVSSRLSARELLTDPFL 282
+CL R +LL +P L
Sbjct: 235 QCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 21/262 (8%)
Query: 30 ILGKGA--SKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
+LGKGA T+YR ++ V W +V L S +E EI +L L+H NI+
Sbjct: 7 VLGKGAFGEATLYRRTED--DSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNII 62
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHS 144
+Y ++D I E GTL ++ ++ + V + QI+S + Y+H
Sbjct: 63 AYYNHFMDDNTLLIEM--EYANGGTLYD-KIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPEVYE-E 201
++HRD+K NIF+ G +K+GD G++ IL S A VGTP +M+PE+ +
Sbjct: 120 AG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 202 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261
+YN DI++ G + E++T + + T+P + K++ G + V E+ +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNY-TPVVSVYSSELISLVH 234
Query: 262 KCLAT-VSSRLSARELLTDPFL 282
L R +A E+L P L
Sbjct: 235 SLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 77/247 (31%), Positives = 130/247 (52%), Gaps = 14/247 (5%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
R + +G+G VYRA +G+ VA +V+++D + + + + EI LLK L H N
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPN 63
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLY 141
++K+Y S+++ + +N V E+ +G L + ++ + R + + V + Q+ S L +
Sbjct: 64 VIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-V 198
+HSR V+HRD+K N+F+ G VK+GDLGL + + A VGTP +M+PE +
Sbjct: 122 MHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 199 YEEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257
+E YN DI+S G + EM P Y + + + KK+ P E+R
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 258 QFIEKCL 264
Q + C+
Sbjct: 239 QLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 14/260 (5%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG G S V + G +A VK + +++ E+ +L I+ FY
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMA---VKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
++ + N +I+ E G+L + + R+ R + +L GL YLH +
Sbjct: 66 GAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE-KHKI 122
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE-VYEEEYNELVD 208
IHRD+K NI VN ++G++K+ D G++ L S A VGT +MAPE + +Y+ D
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 209 IYSFGMCILEMVTFDYPYSECTHPA----QIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264
I+S G+ ++E+ T +PY P ++ + +++ P P+ + F+ CL
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241
Query: 265 -ATVSSRLSARELLTDPFLQ 283
R S +ELL PF++
Sbjct: 242 IKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 82/273 (30%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKL-------YDFLQSPEELERLYCEIHLLKTL 81
E++GKG VY A + G +A QV+L +D Q + ++ L EI LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQK-DMVKALRSEIETLKDL 65
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
H NI+++ +T ++ E G++ + R + V+ + Q+L GL Y
Sbjct: 66 DHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL----AAILRKSHAARCVGTPEFMAPE 197
LHS+ ++HRDLK DN+ V+ G KI D G+ I G+ +MAPE
Sbjct: 124 LHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 198 V---YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-----PEALF 249
V Y + Y+ VDI+S G +LEM P+S+ A ++K + K+ P +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKRSAPPIPPDVS 238
Query: 250 KVEDPEVRQFI-EKCLATVSSRLSARELLTDPF 281
P F+ +R +ARELL PF
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 83/257 (32%), Positives = 134/257 (52%), Gaps = 16/257 (6%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G+G++ V A +++ G +VA VK+ D L+ + E L+ E+ +++ +H+N+++ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
S++ + + E G L + R+N + C +L L YLHS+ VI
Sbjct: 85 KSYL--VGEELWVLMEFLQGGALTDI-VSQTRLNEEQIATVCESVLQALCYLHSQG--VI 139
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELV 207
HRD+K D+I + + G VK+ D G A + K R VGTP +MAPEV Y V
Sbjct: 140 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL-FKVEDPEVRQFIEKCLA- 265
DI+S G+ ++EMV + PY + P Q K++ P+ P +R F+E+ L
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 266 TVSSRLSARELLTDPFL 282
R +A+ELL PFL
Sbjct: 258 EPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 84/285 (29%), Positives = 128/285 (44%), Gaps = 37/285 (12%)
Query: 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCE 74
F + DP + EI G G+ VY A D VA ++ Y QS E+ + + E
Sbjct: 8 FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKE 65
Query: 75 IHLLKTLKHRNIMKF-------YTSWVDTANRNINFVTEMF---TSGTLRQYRLKHRRVN 124
+ L+ L+H N +++ +T+W+ V E S L ++ + V
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWL---------VMEYCLGSASDILEVHKKPLQEVE 116
Query: 125 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
I A+ C L GL YLHS + IHRD+K NI + G VK+ D G A++ S A
Sbjct: 117 IAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASL--VSPA 168
Query: 185 ARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
VGTP +MAPEV E +Y+ VD++S G+ +E+ P + +Y I
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--I 226
Query: 241 SGKKPEALFKVE-DPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
+ L + R F++ CL + R S+ ELL F+
Sbjct: 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 72/299 (24%), Positives = 118/299 (39%), Gaps = 63/299 (21%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC--------EIHLLKT 80
+G+G VY+A ++ G VA ++++ E EI LL+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM----------ENEKEGFPITAIREIKLLQK 54
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFT---SGTLRQYRLKHRRVNIRAVKHWCRQILS 137
L+H NI++ +I V E +G L +K +K + +Q+L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLE 111
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFM 194
GL YLHS ++HRD+K NI +N N G +K+ D GLA K ++A V T +
Sbjct: 112 GLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 195 APEVY--EEEYNELVDIYSFGMCIL-EMVT-------------FDYPYSECTHPA----- 233
PE+ Y VD++S G CIL E+ + + C P
Sbjct: 169 PPELLLGATRYGPEVDMWSVG-CILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 234 -----QIYKKVISGKKPEALFK-----VEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281
++ + K + + + DP ++K L R+SA + L +
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 48/287 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLK-HRN 85
+I+G+G+ TV A ++ E A +K+ D L ++++ + E +L L H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYA---IKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
I+K Y ++ D N+ FV E +G L QY K+ ++ + + + +IL L YLHS+
Sbjct: 64 IIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----------------------RKSH 183
+IHRDLK +NI ++ + +KI D G A +L +
Sbjct: 122 G--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 184 AARCVGTPEFMAPEVYEEEY-NELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVIS 241
A VGT E+++PE+ E+ + D+++ G CI+ +M+T P+ ++K++
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFRGSNEY-LTFQKILK 236
Query: 242 G--KKPEALFKVEDPEVRQFIEKCLAT-VSSRL----SARELLTDPF 281
P P+ + IEK L RL EL PF
Sbjct: 237 LEYSFPPNFP----PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-25
Identities = 80/266 (30%), Positives = 134/266 (50%), Gaps = 21/266 (7%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG GA VY+A ++ G+ A K+ D +S EELE EI +L + H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA---AKVID-TKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
++ N+ + E G + L+ R + ++ C+Q L L YLH + +
Sbjct: 69 DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--ENKI 124
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY------EE 201
IHRDLK NI + G++K+ D G++A ++ R +GTP +MAPEV +
Sbjct: 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 202 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFKVEDPEVRQFI 260
Y+ D++S G+ ++EM + P+ E +P ++ K+ + P A E + F+
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242
Query: 261 EKCL-ATVSSRLSARELLTDPFLQID 285
+KCL V +R + +LL PF+ ++
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVTVN 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-25
Identities = 82/260 (31%), Positives = 133/260 (51%), Gaps = 18/260 (6%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G+G++ V A +++ G +VA VK D L+ + E L+ E+ +++ H N++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVA---VKKMD-LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
S++ + V E G L + H R+N + C +L L YLH++ VI
Sbjct: 86 NSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEE-EYNELV 207
HRD+K D+I + + G +K+ D G A + K R VGTP +MAPEV Y V
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLA 265
DI+S G+ ++EM+ + PY P Q +++ P + KV +R F++ L
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSV-LRGFLDLMLV 257
Query: 266 -TVSSRLSARELLTDPFLQI 284
S R +A+ELL PFL++
Sbjct: 258 REPSQRATAQELLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 68/205 (33%), Positives = 110/205 (53%), Gaps = 17/205 (8%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC--EIHLLKTLKHRNIMK 88
+G+G VYRA + VA +V++++ + + R C EI LLK L H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA---RQDCVKEIDLLKQLNHPNVIK 66
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQ----YRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
+ S++ + +N V E+ +G L Q ++ + R + R V + Q+ S + ++HS
Sbjct: 67 YLDSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-VYEE 201
R V+HRD+K N+F+ G VK+GDLGL + + A VGTP +M+PE ++E
Sbjct: 125 RR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 202 EYNELVDIYSFGMCILEMVTFDYPY 226
YN DI+S G + EM P+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 72/256 (28%), Positives = 131/256 (51%), Gaps = 13/256 (5%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKF 89
++G+GA V+ + + V Q+ + + +E E +LK L H NI+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEY 64
Query: 90 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDP 147
Y ++++ ++ + V E GTL +Y K ++ + H+ QIL L ++H++
Sbjct: 65 YENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARCVGTPEFMAPEVYE-EEYNE 205
++HRDLK NI ++ ++ VKIGD G++ IL KS A VGTP +++PE+ E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
DI++ G + E+ + + PA + K++SG + P++RQ I L
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSGTFAPISDRYS-PDLRQLILSMLN 238
Query: 266 T-VSSRLSARELLTDP 280
S R +++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 68/274 (24%), Positives = 135/274 (49%), Gaps = 27/274 (9%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG+GA +V + + G+ A +K +P+ +++ E+ + K+ K I+K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFA---LKTITTDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
+Y +++D ++ +I E G+L ++ + + R+ + + +L GL YLHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE-VYEEEY 203
R +IHRD+K NI + +G+VK+ D G++ L S A GT +MAPE + + Y
Sbjct: 124 RK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 204 NELVDIYSFGMCILEMVTFDYPY----SECTHPAQIYKKVISGKKPEALFKVEDPEV--- 256
+ D++S G+ +LE+ +P+ P ++ +++ PE ++P
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL---KDEPGNGIK 237
Query: 257 -----RQFIEKCLA-TVSSRLSARELLTDPFLQI 284
+ FI++CL + R + ++L P+++
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 20/267 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKHRNI 86
E+LGKGA TVY +G +A QV+L + L + +E E+L E+ LLK+LKH NI
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
+++ + +D + I+ E G++ + + + +QIL G+ YLH +
Sbjct: 65 VQYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH--N 120
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-------RKSHAARCV-GTPEFMAPEV 198
V+HRD+K +N+ + N G +K+ D G A L S+ + + GTP +MAPEV
Sbjct: 121 NCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 199 YEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVEDPEV 256
E Y DI+S G + EM T P + A ++ + + + L
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSAAA 238
Query: 257 RQFIEKCLA-TVSSRLSARELLTDPFL 282
F+ CL R SA +LL FL
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 89/290 (30%), Positives = 128/290 (44%), Gaps = 42/290 (14%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY ++ +G GA V A D+ G VA K+ +P +R Y E+ LLK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
NI+ ++ + +I FVTE+ GT L R + + ++++ QIL GL Y+H
Sbjct: 69 ENIISLSDIFI-SPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY--EE 201
S V+HRDLK NI +N N ++KI D GLA I + V T + APE+ +
Sbjct: 126 SAG--VVHRDLKPSNILINEN-CDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIMLTWQ 181
Query: 202 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY----------KKVISG--------- 242
+Y+ VDI+S G EM+ + H Q VI+
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241
Query: 243 --------KKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
P FK DP +EK L R+SA E L P+L
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 10/245 (4%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG G V + + A VK +++ ++ E ++ E +L+ H I+K Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
++ D + I + E G L + + + ++ YLH+R +I
Sbjct: 60 RTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARCVGTPEFMAPEVYEEE-YNELVD 208
+RDLK +N+ ++ + G VK+ D G A L GTPE++APE+ + Y+ VD
Sbjct: 116 YRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 209 IYSFGMCILEMVTFDYPYSEC-THPAQIYKKVISGKKPEALFKVEDPEVRQFIEK-CLAT 266
+S G+ + E++T P+ E P +IY ++ G D + I++
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 267 VSSRL 271
RL
Sbjct: 235 PEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 84/270 (31%), Positives = 132/270 (48%), Gaps = 19/270 (7%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP + +I G+G++ V A + G VA VK D L+ + E L+ E+ ++
Sbjct: 17 DPRTYLDNFIKI-GEGSTGIVCIATVKSSGKLVA---VKKMD-LRKQQRRELLFNEVVIM 71
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+ +H N+++ Y S++ + V E G L + H R+N + C +L
Sbjct: 72 RDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLKA 128
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAP 196
L LH++ VIHRD+K D+I + + G VK+ D G A + K R VGTP +MAP
Sbjct: 129 LSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 197 EVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE--D 253
E+ Y VDI+S G+ ++EMV + PY P K+I P L +
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKAMKMIRDNLPPKLKNLHKVS 243
Query: 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
P ++ F+++ L + R +A ELL PFL
Sbjct: 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 54/172 (31%), Positives = 94/172 (54%), Gaps = 10/172 (5%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
E +L++++H ++ Y S+ D + N+ V E G L + K R + +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 193
Q++ L YLHS D +++RDLK +N+ + + G +KI D G A ++ C GTPE+
Sbjct: 109 QVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRTYTLC-GTPEY 164
Query: 194 MAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGK 243
+APE+ + Y + VD ++ G+ I EM+ P + + +P QIY+K++ GK
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD--NPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 79/252 (31%), Positives = 118/252 (46%), Gaps = 28/252 (11%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA V AFD G +VA KL QS +R Y E+ LLK + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 84 RNI---MKFYTSWVDTANRNIN---FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
N+ + +T ++ + VT L +K ++++ ++ QIL
Sbjct: 74 ENVIGLLDVFTP--ASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQILR 129
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE 197
GL Y+HS +IHRDLK NI VN + E+KI D GLA V T + APE
Sbjct: 130 GLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLARHTDDEMTGY-VATRWYRAPE 185
Query: 198 VYEE--EYNELVDIYSFGMCIL-EMVTFD--YPYSECTHPAQIYK--KVISGKKPEALFK 250
+ YN+ VDI+S G CI+ E++T +P S+ H Q+ + ++ E L K
Sbjct: 186 IMLNWMHYNQTVDIWSVG-CIMAELLTGKTLFPGSD--HIDQLKRIMNLVGTPDEELLQK 242
Query: 251 VEDPEVRQFIEK 262
+ R +I+
Sbjct: 243 ISSESARNYIQS 254
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKH 130
E LL LKH NI+ + SW + ++ F G ++LK ++ + V
Sbjct: 49 EAQLLSQLKHPNIVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCV 188
W QI L YLH + ++HRDLK N+F+ +K+GDLG+A +L A+ +
Sbjct: 107 WFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLI 163
Query: 189 GTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 247
GTP +M+PE++ + YN D+++ G C+ EM T + ++ + +Y ++I GK P
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIEGKLPP- 221
Query: 248 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 282
+ K PE+ + I L+ R S + +L P++
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 1e-22
Identities = 89/312 (28%), Positives = 126/312 (40%), Gaps = 68/312 (21%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY + +G GA V A D+ G +VA K+ + + +R+ EI LL+ L+
Sbjct: 1 RY-ELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 83 HRNIMKFYTSWVDTANRNINF-----VTEMFTSGTLRQYRLKHRRVNIRAVKHWCR---Q 134
H NI+ + +F VTE+ + +++ + H Q
Sbjct: 58 HENIIGLLD--ILRPPSPEDFNDVYIVTELMETDL---HKVIKSPQPL-TDDHIQYFLYQ 111
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM 194
IL GL YLHS + VIHRDLK NI VN N ++KI D GLA + F+
Sbjct: 112 ILRGLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFL 163
Query: 195 ----------APEVY--EEEYNELVDIYSFGMCIL-EMVT----F---DY---------- 224
APE+ Y + +DI+S G CI E++T F DY
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVEV 222
Query: 225 ---PYSE----CTHP-AQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLS 272
P E T A+ Y K + K LF PE +EK L R++
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282
Query: 273 ARELLTDPFLQI 284
A E L P+L
Sbjct: 283 ADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 79/258 (30%), Positives = 131/258 (50%), Gaps = 15/258 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +GKG+ V++ D VA +K+ D ++ +E+E + EI +L + K
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+Y S++ + + + E G+ L+ ++ + R+IL GL YLHS
Sbjct: 67 YYGSYLK--DTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKK- 122
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNE 205
IHRD+K N+ ++ GEVK+ D G+A L + R VGTP +MAPEV ++ Y+
Sbjct: 123 -IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
DI+S G+ +E+ + P+SE HP ++ +I P L +++F+E CL
Sbjct: 181 KADIWSLGITAIELAKGEPPHSE-LHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLN 238
Query: 266 TVSS-RLSARELLTDPFL 282
S R +A+ELL F+
Sbjct: 239 KEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 16/268 (5%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP + + I GKG+ VY+ D VA +K+ D ++ +E+E + EI +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
I ++Y S++ I + E G+ LK + + R+IL G
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWI--IMEYLGGGSALDL-LKPGPLEETYIATILREILKG 113
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAP 196
L YLHS IHRD+K N+ ++ QG+VK+ D G+A L + R VGTP +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 197 EVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
EV ++ Y+ DI+S G+ +E+ + P S+ HP ++ +I P L
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSD-LHPMRVL-FLIPKNSPPTLEGQYSKP 228
Query: 256 VRQFIEKCLATVSS-RLSARELLTDPFL 282
++F+E CL R +A+ELL F+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 21/273 (7%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG GA VY+A ++ G A ++ +S EELE EI +L T H I+K
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
++ I + E G + L+ R + ++ CRQ+L L YLHS +
Sbjct: 76 GAFYWDGKLWI--MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE----- 202
IHRDLK N+ + G++K+ D G++A K+ R +GTP +MAPEV E
Sbjct: 132 IHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 203 -YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFI 260
Y+ DI+S G+ ++EM + P+ E +P ++ K+ + P + E R F+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFL 249
Query: 261 EKCL-ATVSSRLSARELLTDPFLQIDDYDSDLR 292
+ L +R SA +LL PF+ + LR
Sbjct: 250 KTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
E +L+ L H ++ + S+ D N+ V ++ G LR + + + + VK W
Sbjct: 50 ERRILQELNHPFLVNLWYSFQD--EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPE 192
+I+ L YLHS+ +IHRD+K DNI ++ QG V I D +A + GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 193 FMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPY 226
+MAPEV + Y+ VD +S G+ E + PY
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 81/266 (30%), Positives = 127/266 (47%), Gaps = 26/266 (9%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP-EELERLYCEIHLLKTLKHRNIM 87
+ +G+G+ +Y A + + +K D + P +E E E+ LL +KH NI+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV---IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR--AVKHWCRQILSGLLYLHSR 145
F+ S+ + N + V E G L + + R V + W QI GL ++H R
Sbjct: 63 TFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE- 202
++HRD+K NIF++ N K+GD G+A L S A CVGTP +++PE+ +
Sbjct: 121 K--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 203 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP----EVRQ 258
YN DI+S G + E+ T +P+ E + Q+ K+ G F P ++R
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGY-----FAPISPNFSRDLRS 232
Query: 259 FIEKCLATVS--SRLSARELLTDPFL 282
I + L VS R S +L PFL
Sbjct: 233 LISQ-LFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 79/276 (28%), Positives = 131/276 (47%), Gaps = 23/276 (8%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+Y EILG G TVY+A+ +A VK+ + E +++ E+ +L
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR-AVKHWCRQILSGLLYLHS 144
I+ FY ++ NR I+ TE G+L YR V R AV ++ GL YL S
Sbjct: 61 IIGFYGAFF-VENR-ISICTEFMDGGSLDVYRKIPEHVLGRIAVA-----VVKGLTYLWS 113
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE-VYEEEY 203
++HRD+K N+ VN +G+VK+ D G++ L S A VGT +MAPE + E+Y
Sbjct: 114 LK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTH------PAQIYKKVISGKKPEALFKVEDPEVR 257
D++S G+ +E+ +PY + P Q+ + ++ P +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230
Query: 258 QFIEKCLATV-SSRLSARELLTDPFL-QIDDYDSDL 291
FI +C+ R + L+ PF+ Q +D ++++
Sbjct: 231 HFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 25/265 (9%)
Query: 31 LGKGASKTVYRAFD----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI 86
LGKG+ TVY D E ++V ++ + + +P E + E LL L H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGEL--NPNETVQANQEAQLLSKLDHPAI 64
Query: 87 MKFYTSWVDTANRNINFVTEMFTSG-----TLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
+KF+ S+++ +TE + G L + + + ++ V W Q+L G+ Y
Sbjct: 65 VKFHASFLE--RDAFCIITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVY 199
+H R ++HRDLK NIF+ N +KIGD G++ +L S A GTP +M+PE
Sbjct: 122 MHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 200 EEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
+ + Y+ DI+S G + EM + + E + + +++ G P +L + ++
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSRQLNS 235
Query: 259 FIEKCLATVSS-RLSARELLTDPFL 282
++ L S R SA E+L +PF+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 67/237 (28%), Positives = 118/237 (49%), Gaps = 15/237 (6%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G G V+ D A + + + ++ +E + ++ E +LK + H I++ +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSHPFIIRLF 67
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
+ D R + + E G L Y R + + +I+ L YLHS++ ++
Sbjct: 68 WTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDI 209
+RDLK +NI ++ +G +K+ D G A LR C GTPE++APEV + + +N+ VD
Sbjct: 124 YRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTWTLC-GTPEYLAPEVIQSKGHNKAVDW 181
Query: 210 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL 264
++ G+ I EM+ YP +P IY+K+++GK P L D + I+K L
Sbjct: 182 WALGILIYEMLV-GYPPFFDDNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-20
Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 16/268 (5%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP + + I GKG+ V++ D VA +K+ D ++ +E+E + EI +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+ K+Y S++ I + E G+ L+ + + ++IL G
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWI--IMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKG 113
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAP 196
L YLHS IHRD+K N+ ++ QG+VK+ D G+A L + R VGTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 197 EVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
EV ++ Y+ DI+S G+ +E+ + P S+ HP ++ +I P L
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVL-FLIPKNNPPTLTGEFSKP 228
Query: 256 VRQFIEKCLATVSS-RLSARELLTDPFL 282
++FI+ CL S R +A+ELL F+
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELER-LYCEIHLLKTLK 82
RY + LG+G VY+A D+ G VA ++KL + ++ + + EI LL+ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLL 140
H NI+ V NIN V E F L + +K + + + +K + L GL
Sbjct: 61 HPNIIGLLD--VFGHKSNINLVFE-FMETDLEKV-IKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPEV- 198
YLHS ++HRDLK +N+ + + G +K+ D GL AR G+P M +V
Sbjct: 117 YLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGL---------ARSFGSPNRKMTHQVV 164
Query: 199 ---YE--------EEYNELVDIYSFGMCIL 217
Y Y VD++S G CI
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G+G VY+A D+ G VA ++KL +S + EI LLK L H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL--RFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
V ++ V E + + + + R + +K + Q+L GL + HS ++
Sbjct: 65 D--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVY--EEEYNEL 206
HRDLK +N+ +N G +K+ D GLA V T + APE+ ++ Y+
Sbjct: 121 HRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 207 VDIYSFGMCIL-EMVT 221
VDI+S G CI E+++
Sbjct: 180 VDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 82/280 (29%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP G + E++G G VY+ G A +K+ D + +E E + EI++L
Sbjct: 13 DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTE--DEEEEIKLEINML 66
Query: 79 KTLKH-RNIMKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHW 131
K H RNI +Y +++ + + + V E +G++ + ++ + +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 189
CR+IL GL +LH+ VIHRD+K N+ + N EVK+ D G++A L ++ R +G
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIG 183
Query: 190 TPEFMAPEVY------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 243
TP +MAPEV + Y+ DI+S G+ +EM P + HP + +
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNP 242
Query: 244 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
P+ K + FIE CL SR S +LL PF+
Sbjct: 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 73/224 (32%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 23 RYGRYNEILGKGASKTV----YRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIH 76
R+ ++ + LGKG +V Y + G VA + LQ + E L EI
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK------LQHSTAEHLRDFEREIE 57
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQI 135
+LK+L+H NI+K+ RN+ V E G+LR Y KHR R++ R + + QI
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE--- 192
G+ YL S+ +HRDL NI V ++ VKIGD GL +L + V P
Sbjct: 118 CKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 193 --FMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA 233
+ APE + E +++ D++SFG+ + E+ F Y C+ PA
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYEL--FTYSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 6e-19
Identities = 81/281 (28%), Positives = 133/281 (47%), Gaps = 28/281 (9%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP G + E++G G VY+ G A +K+ D + +E E + EI++L
Sbjct: 3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAA---IKVMDV--TGDEEEEIKQEINML 56
Query: 79 KTLKH-RNIMKFYTSWVDT----ANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKH 130
K H RNI +Y +++ + + V E +G++ +K+ + N + +
Sbjct: 57 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAY 115
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CV 188
CR+IL GL +LH VIHRD+K N+ + N EVK+ D G++A L ++ R +
Sbjct: 116 ICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 189 GTPEFMAPEVY------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242
GTP +MAPEV + Y+ D++S G+ +EM P + HP + +
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRN 231
Query: 243 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
P K + + FIE CL S R + +L+ PF+
Sbjct: 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-19
Identities = 80/271 (29%), Positives = 121/271 (44%), Gaps = 31/271 (11%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHR 84
R N I G GA TVY+ G A + + + + R C EI +L+ + H
Sbjct: 78 RVNRI-GSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHP 132
Query: 85 NIMKFYTSWVDTANRN--INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
N++K + D + N I + E G+L + + + RQILSG+ YL
Sbjct: 133 NVVKCH----DMFDHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIAYL 184
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYE 200
H R ++HRD+K N+ +N + VKI D G++ IL ++ VGT +M+PE
Sbjct: 185 HRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241
Query: 201 EEYNELV------DIYSFGMCILE--MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252
+ N DI+S G+ ILE + F + A + + + PEA
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301
Query: 253 DPEVRQFIEKCL-ATVSSRLSARELLTDPFL 282
E R FI CL + R SA +LL PF+
Sbjct: 302 -REFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 87/293 (29%), Positives = 135/293 (46%), Gaps = 48/293 (16%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHL 77
DPT + E +GKG VY+ ++ +G A VK+ D + EE+E E ++
Sbjct: 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVDEEIE---AEYNI 71
Query: 78 LKTL-KHRNIMKFYTS------------WVDTANRNINFVTEMFTSGTLRQYRLKHRRVN 124
L++L H N++KFY W+ N VTE+ G L +R++
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL-VKGLLI----CGQRLD 126
Query: 125 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
+ + L GL +LH+ +IHRD+K +NI + +G VK+ D G++A L +
Sbjct: 127 EAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRL 183
Query: 185 AR--CVGTPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 236
R VGTP +MAPEV Y+ Y+ D++S G+ +E+ D P + HP +
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTL 242
Query: 237 KKVISGKKPEALFKVEDPE-----VRQFIEKCL-ATVSSRLSARELLTDPFLQ 283
K+ P L PE FI +CL +R S LL PF++
Sbjct: 243 FKIPRNPPPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 53/156 (33%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEF 193
I+ L YLHS+ VIHRD+K N+ +N G+VK+ D G++ L S A G +
Sbjct: 112 IVKALEYLHSK-LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 194 MAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248
MAPE E Y+ D++S G+ ++E+ T +PY P Q K+V+ P+
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229
Query: 249 FKVEDPEVRQFIEKCLATVSS-RLSARELLTDPFLQ 283
+ PE + F+ KCL R + ELL PF +
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 87/301 (28%), Positives = 119/301 (39%), Gaps = 64/301 (21%)
Query: 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE-------RLYCEIHLLKT 80
EI G+GA TVY+A D G VA +V++ P E R EI LLK
Sbjct: 5 AEI-GEGAYGTVYKARDLNTGRFVALKKVRV------PLSEEGIPLSTLR---EIALLKQ 54
Query: 81 LK---HRNIMKFYTSWVDTANRN-----INFVTEMFTSGTLRQYRLKHRRVNI--RAVKH 130
L+ H NI++ V R + V E L Y K + + +K
Sbjct: 55 LESFEHPNIVRLLD--VCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKD 111
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CV 188
RQ+L G+ +LHS ++HRDLK NI V + G+VKI D GLA I A V
Sbjct: 112 LMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIY-SFEMALTSVV 167
Query: 189 GTPEFMAPEVY-EEEYNELVDIYSFGMCIL-EMVT----FDYPY---------------S 227
T + APEV + Y VD++S G CI E+ F S
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS 226
Query: 228 ECTHPAQIYKKVIS-----GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281
E P + S + ++ E ++K L R+SA E L P+
Sbjct: 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
Query: 282 L 282
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 81 LKHRNIM---------KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI-----R 126
L R+I+ K Y S+ +N+ V E G L L N+
Sbjct: 41 LTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPGGDL--ASLLE---NVGSLDED 93
Query: 127 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------- 176
+ + +I+ L YLHS +IHRDLK DNI ++ N G +K+ D GL+
Sbjct: 94 VARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQIN 150
Query: 177 AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 235
+ R VGTP+++APEV + +++ VD +S G + E + P+ T P +I
Sbjct: 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEI 209
Query: 236 YKKVISGKKPEALFKVEDPEVRQFIEKCL-ATVSSRL---SARELLTDPFL 282
++ +++GK E I K L RL S E+ PF
Sbjct: 210 FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 25 GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY ++ LG G++ V+ A D VA ++ L P+ ++ EI +++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLD 60
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTL---RQYR-------LKHRRVNIRAVKHWC 132
H NI+K Y + + V + ++ ++Y L+ ++ + +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----RKSHAARC 187
Q+L GL Y+HS + V+HRDLK N+F+N +KIGD GLA I+ K + +
Sbjct: 121 YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 188 VGTPEFMAPEV--YEEEYNELVDIYSFGMCIL-EMVT 221
+ T + +P + Y + +D+++ G CI EM+T
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-18
Identities = 90/322 (27%), Positives = 140/322 (43%), Gaps = 46/322 (14%)
Query: 26 RYNEIL--GKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY ++ G GA TV A D G +VA KLY QS +R Y E+ LLK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 84 RNIMKFYTSWVDTANRNI----NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
N++ V T + ++ +F M GT +KH +++ ++ Q+L GL
Sbjct: 74 ENVIGLLD--VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY 199
Y+H+ +IHRDLK N+ VN E+KI D GLA S V T + APEV
Sbjct: 132 KYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR-QTDSEMTGYVVTRWYRAPEVI 187
Query: 200 EE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKVEDPE 255
Y + VDI+S G + EM+T + H Q+ + KV E + K++ +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 256 VRQFIEK---------------------------CLATVSSRLSARELLTDPFL-QIDDY 287
+ +++K + SR++A E L P+ + D
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 288 DSDLRMIQYQTDYDEISPLLRQ 309
+ + Y +DE+ L +
Sbjct: 308 EDETEAPPYDDSFDEVDQSLEE 329
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G G VY+A + + G A +KL + ++ + EI ++K KH NI+ ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL----EPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
S++ + + E G+L+ ++ + + CR+ L GL YLHS+ +
Sbjct: 73 GSYL--SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE----YN 204
HRD+K NI + N G+VK+ D G+AA + + A R +GTP +MAPEV E YN
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHP 232
+L DI++ G+ +E+ P + HP
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFD-LHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 49/301 (16%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEILGK-GASKTVYRAFDEYEGIEVAWNQVKLYDFLQ 63
S P+ SD+ E +E G YG+ ++L K SK + D I+
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID------------- 58
Query: 64 SPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRN---INFVTEMFTSGTL----RQ 115
EE+E E ++LK L H N++KFY + +N + V E+ G++ +
Sbjct: 59 --EEIE---AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG 113
Query: 116 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175
+ + R+ + + + L GL +LH IHRD+K +NI + +G VK+ D G+
Sbjct: 114 FLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGV 170
Query: 176 AAILRKSHAAR--CVGTPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYS 227
+A L + R VGTP +MAPEV + Y+ D++S G+ +E+ D P +
Sbjct: 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
Query: 228 ECTHPAQIYKKVISGKKPEALFKVEDPEV-----RQFIEKCLAT-VSSRLSARELLTDPF 281
+ HP + K+ P + PE+ FI KCL R + +LL F
Sbjct: 231 D-LHPMRALFKIPRNPPP----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
Query: 282 L 282
+
Sbjct: 286 I 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 59/187 (31%), Positives = 95/187 (50%), Gaps = 11/187 (5%)
Query: 64 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 123
SP+E E E+ +L +KH NI+++ S+ + N I V + G L + R V
Sbjct: 39 SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI--VMDYCEGGDLYKKINAQRGV 96
Query: 124 NI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
+ W QI L ++H R ++HRD+K NIF+ G +K+GD G+A +L
Sbjct: 97 LFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNS 153
Query: 182 SH--AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
+ A C+GTP +++PE+ E YN DI++ G + EM T + + E + + K
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLK 212
Query: 239 VISGKKP 245
+I G P
Sbjct: 213 IIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 68/207 (32%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 27 YNEI--LGKGASKTVYRAFDEYEGIEVAWNQVK--LYDFLQSPEELERLYCEIHLLKTLK 82
Y I LG G +VY A ++ G VA ++K Y S EE L E+ L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY----SWEECMNLR-EVKSLRKLN 55
Query: 83 -HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGL 139
H NI+K + + N + FV E + G L Q K + + ++ QIL GL
Sbjct: 56 EHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPEFMAPEV 198
++H HRDLK +N+ V+G VKI D GLA I + V T + APE+
Sbjct: 113 AHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 199 Y--EEEYNELVDIYSFGMCIL-EMVTF 222
Y+ VDI++ G CI+ E+ T
Sbjct: 170 LLRSTSYSSPVDIWALG-CIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G G VY+A + G A +KL + E+ + EI ++K KH NI+ ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKL----EPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
S++ I E G+L+ ++ + + R+ L GL YLHS+ +
Sbjct: 73 GSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE----YN 204
HRD+K NI + N G VK+ D G++A + + A R +GTP +MAPEV E YN
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALF-KVE-DPEVRQFIE 261
+L DI++ G+ +E+ P + HP + ++ S +P L K++ F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFD-LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246
Query: 262 KCLA-TVSSRLSARELLTDPF 281
L R +A +LL PF
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 56/159 (35%), Positives = 87/159 (54%), Gaps = 12/159 (7%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKH 130
E LL +KH NI+ F S+ A+ ++ V E G L Q ++K +R + +
Sbjct: 48 EAVLLAKMKHPNIVAFKESF--EADGHLYIVMEYCDGGDLMQ-KIKLQRGKLFPEDTILQ 104
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--V 188
W Q+ G+ ++H + V+HRD+K NIF+ N G+VK+GD G A +L A C V
Sbjct: 105 WFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTYV 161
Query: 189 GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPY 226
GTP ++ PE++E YN DI+S G + E+ T +P+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 13/182 (7%)
Query: 66 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVN 124
+ L EI +L+ L H NI+K+ + I + E SG+L++Y +++ ++N
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107
Query: 125 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
++ + QI G+ YL SR +HRDL N+ V ++ +VKIGD GL +
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKE 164
Query: 185 ARCV----GTPEF-MAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
V +P F APE + + ++ D++SFG+ + E++T Y SE + P ++ K
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT--YCDSESS-PMTLFLK 221
Query: 239 VI 240
+I
Sbjct: 222 MI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 52/179 (29%), Positives = 96/179 (53%), Gaps = 8/179 (4%)
Query: 66 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 125
++++ + E +L L H I+ S+ D + F+ E G L + K R
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 126 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185
K + +++ YLHS+D +I+RDLK +N+ ++ N+G VK+ D G A +
Sbjct: 118 DVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTFT 174
Query: 186 RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 243
C GTPE++APEV + + + + VD ++ G+ + E + P+ + T P +IY+K+++G+
Sbjct: 175 LC-GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 87/298 (29%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 7 PEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 66
P+ ++ F + DP + EI G G+ VY A D VA ++ Y QS E
Sbjct: 2 PDVAEL--FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNE 57
Query: 67 ELERLYCEIHLLKTLKHRNIMKF-------YTSWVDTANRNINFVTEM---FTSGTLRQY 116
+ + + E+ L+ L+H N +++ +T+W+ V E S L +
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL---------VMEYCLGSASDLLEVH 108
Query: 117 RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176
+ + V I AV H L GL YLHS + +IHRD+K NI ++ G VK+GD G A
Sbjct: 109 KKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSA 162
Query: 177 AILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYP------Y 226
+I+ + A VGTP +MAPEV E +Y+ VD++S G+ +E+ P
Sbjct: 163 SIM--APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 227 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
S H AQ + F R F++ CL + R ++ LL F+
Sbjct: 221 SALYHIAQNESPALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 19/224 (8%)
Query: 23 RYGRYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
R+ ++ + LG+G V + G +VA + Q + ER EI +L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEIL 60
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILS 137
+TL H NI+K+ R++ + E SG+LR Y +HR ++N++ + + QI
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE----- 192
G+ YL S+ IHRDL NI V ++ VKI D GLA +L + V P
Sbjct: 121 GMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 193 FMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 235
+ APE + +++ D++SFG+ + E+ F Y + PA+
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYEL--FTYGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 62/247 (25%), Positives = 114/247 (46%), Gaps = 29/247 (11%)
Query: 30 ILGKGASKTVY----RAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK-TLKHR 84
+LGKG+ V + +E+ I+ V L D +++E E +L +H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHP 56
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
+ + ++ ++ FV E G L + R + + + +I+ GL +LH
Sbjct: 57 FLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-E 201
+ +I+RDLK DN+ ++ G +KI D G+ + + A+ GTP+++APE+ + +
Sbjct: 115 KG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 202 EYNELVDIYSFGMCILEMVTFDYPYSEC---------THPAQIYKKVISGKKPEALFK-- 250
+YNE VD +SFG+ + EM+ P+ + + + IS + + L K
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLF 231
Query: 251 VEDPEVR 257
DP R
Sbjct: 232 ERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 22/269 (8%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELER-LYCEIHLLKTLKHRNIMKF 89
LG G +V + G +A V + + + + + E+ ++ + I+ F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV----HIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 90 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
Y +++ NI E G+L + K + + + ++ GL YL++ +
Sbjct: 69 YGAFL--NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-I 125
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE-VYEEEYNELVD 208
+HRD+K NI VN +G++K+ D G++ L S A VGT +M+PE + +Y D
Sbjct: 126 MHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 209 IYSFGMCILEMVTFDYPYSE-------CTHPAQIYKKV--ISGKKPEALFKVEDPEV-RQ 258
++S G+ I+E+ +P++ P I + I + P L + PE R
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244
Query: 259 FIEKCL-ATVSSRLSARELL-TDPFLQID 285
F++ CL + R + ++L PF+Q
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPPFIQAL 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 85/297 (28%), Positives = 136/297 (45%), Gaps = 36/297 (12%)
Query: 2 NGVSSPEESDSSE-FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
+ S ++ + +E F + DP + EI G G+ VY A D VA ++ Y
Sbjct: 4 SRAGSLKDPEIAELFFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMS-YS 61
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKF-------YTSWVDTANRNINFVTEM---FTS 110
QS E+ + + E+ L+ +KH N +++ +T+W+ V E S
Sbjct: 62 GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL---------VMEYCLGSAS 112
Query: 111 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170
L ++ + V I A+ H L GL YLHS + +IHRD+K NI + G+VK+
Sbjct: 113 DLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKL 166
Query: 171 GDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYPY 226
D G A+I S A VGTP +MAPEV E +Y+ VD++S G+ +E+ P
Sbjct: 167 ADFGSASIA--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
Query: 227 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFL 282
+ +Y + + P R F++ CL + R ++ ELL F+
Sbjct: 225 FNMNAMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 17/169 (10%)
Query: 131 WCRQ----ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 186
W +Q ++ G+ LH R +IHRD+K +N+ ++ G +K+ D GL+ ++ +
Sbjct: 98 WAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENK--K 152
Query: 187 CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK- 244
VGTP+++APE +++ D +S G I E + F YP P ++ ++S +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRIN 211
Query: 245 -PEALFKVEDPEVRQFIEKCLAT-VSSRLSA---RELLTDPFLQIDDYD 288
PE + + PE I + L + RL A +E+ + PF + ++D
Sbjct: 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 17 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLY--CE 74
+ RY + LG+G V +A+D G VA +VK+ + + +L C
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 75 IH--------LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 126
IH ++ +KH NIM +V+ IN V ++ + L++ + R+
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIM-ASDLKKVVDRKIRLTES 119
Query: 127 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------- 176
VK QIL+GL LH +HRDL NIF+N ++G KI D GLA
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176
Query: 177 -AILRKSHAARCVGTPE-----FMAPEVY--EEEYNELVDIYSFGMCI 216
++ R T + + APE+ E+Y+ VD++S G CI
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 86/297 (28%), Positives = 136/297 (45%), Gaps = 37/297 (12%)
Query: 4 VSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ 63
V PE +D F + DP + +EI G G+ VY A + + VA ++ Y Q
Sbjct: 5 VKDPEIADL--FYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQ 60
Query: 64 SPEELERLYCEIHLLKTLKHRNIMKF-------YTSWVDTANRNINFVTEM---FTSGTL 113
+ E+ + + E+ L+ LKH N +++ +T+W+ V E S L
Sbjct: 61 TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL---------VMEYCLGSASDLL 111
Query: 114 RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173
++ + V I A+ H L GL YLHS + +IHRD+K NI + G+VK+ D
Sbjct: 112 EVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADF 165
Query: 174 GLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYPYSEC 229
G A+ S A VGTP +MAPEV E +Y+ VD++S G+ +E+ P
Sbjct: 166 GSASKS--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
Query: 230 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQID 285
+ +Y + P R F++ CL + R ++ ELL F++ D
Sbjct: 224 NAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 26 RYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
++LG GA TVY+ EG I VA +K+ SP+ + + E +++ ++
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVA---IKVLREETSPKANKEILDEAYVMASV 66
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLL 140
H ++++ + + +T++ G L Y H+ + + + +WC QI G+
Sbjct: 67 DHPHVVRLLGI---CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAP 196
YL + ++HRDL N+ V Q VKI D GLA +L K + A P ++MA
Sbjct: 124 YLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 197 E-VYEEEYNELVDIYSFGMCILEMVTF 222
E + Y D++S+G+ + E++TF
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 34/287 (11%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE--LERLYCEIHLLKTLKHRNIMK 88
LGKG +VY+ G+ +A +++L +E ++ E+ +L I+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-----ELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
FY ++ + E +G+L + + + ++ ++ GL +L
Sbjct: 64 FYGAF--FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KE 120
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--- 202
+ +IHRD+K N+ VNGN G+VK+ D G++ L S A +G +MAPE +
Sbjct: 121 EHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 203 ----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV------ISGKKPEALFKVE 252
Y D++S G+ ILEM YPY P + Y + I P L
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDPPTLPSGY 234
Query: 253 DPEVRQFIEKCLATVSS-RLSARELLTDPFLQIDDYDSDLRMIQYQT 298
+ + F+ KCL + + R + +LL P+L + ++D+ M ++ T
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL-VKYKNADVDMAEWVT 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 75/246 (30%), Positives = 116/246 (47%), Gaps = 18/246 (7%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA +V AFD G+ VA KL QS +R Y E+ LLK +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 84 RNIMKFYTSWVDTAN----RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
N++ + + ++ VT + G +K +++ V+ QIL GL
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY 199
Y+HS D +IHRDLK N+ VN E+KI D GLA V T + APE+
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGY-VATRWYRAPEIM 189
Query: 200 EE--EYNELVDIYSFGMCILEMVTFD--YPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
YN+ VDI+S G + E++T +P ++ ++ +++ E L K+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 256 VRQFIE 261
R +I+
Sbjct: 250 ARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 53/154 (34%), Positives = 86/154 (55%), Gaps = 10/154 (6%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
EI++LKTL H NI+K+ + + + + E G+LR Y KH ++N+ + + +
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQ 114
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG---- 189
QI G+ YLHS+ IHRDL N+ ++ N VKIGD GLA + + H V
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 190 TPEF-MAPEVYEE-EYNELVDIYSFGMCILEMVT 221
+P F A E +E +++ D++SFG+ + E++T
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 20/164 (12%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-----YRLKHRRVNIRAV 128
EI LL+ LKH N++ +++ A++++ + + + L Q + K + V
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN---QGEVKIGDLGLAAILRK---- 181
K QIL+G+ YLHS V+HRDLK NI V G +G VKIGDLGLA +
Sbjct: 111 KSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 182 -SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 221
+ V T + APE+ Y + +DI++ G CI E++T
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 36/210 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG+G TVY+ + G VA ++ L +P R EI L+K LKH NI++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSR 145
+ + T N+ + V E + L++Y H ++ VK + Q+L G+ + H
Sbjct: 63 LHDV-IHTENK-LMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-- 117
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE-----------FM 194
+ V+HRDLK N+ +N +GE+K+ D GL AR G P +
Sbjct: 118 ENRVLHRDLKPQNLLINK-RGELKLADFGL---------ARAFGIPVNTFSNEVVTLWYR 167
Query: 195 APEVY--EEEYNELVDIYSFGMCIL-EMVT 221
AP+V Y+ +DI+S G CI+ EM+T
Sbjct: 168 APDVLLGSRTYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 43/236 (18%)
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
I+ FY ++ + I+ E G+L Q K R+ + +L GL YL R
Sbjct: 61 IVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL--R 116
Query: 146 DP-PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEY 203
+ ++HRD+K NI VN GE+K+ D G++ L S A VGT +M+PE + Y
Sbjct: 117 EKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 204 NELVDIYSFGMCILEMVT----------------FDYPYSECTHPAQIYKKVISG---KK 244
DI+S G+ ++EM F P SE +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 245 PEALFKVED----------------PEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
P A+F++ D E + F++KCL R +EL PF++
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 19/199 (9%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLKHRNIM 87
E +G+G TV++A + VA +V+L D + P R EI LLK LKH+NI+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIV 62
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRD 146
+ Y V +++ + V E + L++Y ++ VK + Q+L GL + HS +
Sbjct: 63 RLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--EE 201
V+HRDLK N+ +N N GE+K+ D GLA I + ++A V T + P+V +
Sbjct: 120 --VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 175
Query: 202 EYNELVDIYSFGMCIL-EM 219
Y+ +D++S G CI E+
Sbjct: 176 LYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC----EIHLLKTLKHR 84
+ LG+G+ TVY+ + G VA +++L E E E LLK LKH
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRL-------EHEEGAPFTAIREASLLKDLKHA 63
Query: 85 NIMKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLY 141
NI+ + D + + V E + L+QY +++ V+ + Q+L GL Y
Sbjct: 64 NIVTLH----DIIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEV 198
H R V+HRDLK N+ ++ +GE+K+ D GLA ++ K+++ V T + P+V
Sbjct: 119 CHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDV 174
Query: 199 Y--EEEYNELVDIYSFGMCILEMVT 221
EY+ +D++ G EM T
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 16/161 (9%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPE 192
QI+ GL +LH R +++RDLK +N+ ++ + G V+I DLGLA + GTP
Sbjct: 103 QIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 193 FMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251
+MAPEV E Y+ VD ++ G + EM+ P+ + ++ K+ + + E +
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ--RKEKVEKEELKRRTLEMAVEY 217
Query: 252 ED---PEVRQFIEKCLAT-VSSRL-----SARELLTDPFLQ 283
D PE + E L RL SA E+ P +
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 69/303 (22%), Positives = 118/303 (38%), Gaps = 52/303 (17%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEEL----ERLYCEIHLLKTLKHRN 85
++G+GA V+ D+ G A ++ D ++ + ER +L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERD-----ILADADSPW 62
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
I+K Y S+ D ++ V E G L ++ + + +++ L +H
Sbjct: 63 IVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--------------------- 184
IHRD+K DNI + G +K+ D GL + K+
Sbjct: 121 G--FIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 185 -------ARC---VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA 233
R VGTP+++APEV Y D +S G+ + EM+ P+ T
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-LQ 236
Query: 234 QIYKKVISGKKPEALFKVED---PEVRQFIEKCLATVSSRL-SARELLTDPFLQIDDYDS 289
+ Y K+I+ K+ F + PE I + L RL S E+ + PF + D+++
Sbjct: 237 ETYNKIINWKE-SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN 295
Query: 290 DLR 292
Sbjct: 296 LRE 298
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLKHRNIM 87
E +G+G VY+A D+ G VA +++L + P R EI LLK L H NI+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
+ V + + V E F L++Y ++ +K + Q+L G+ Y HS
Sbjct: 62 RLLD--VVHSENKLYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI----LRK-SHAARCVGTPEFMAPEVY- 199
V+HRDLK N+ ++ +G +K+ D GLA +R +H V T + APE+
Sbjct: 119 R--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHE---VVTLWYRAPEILL 172
Query: 200 -EEEYNELVDIYSFGMCIL-EMVT 221
+Y+ VDI+S G CI EMV
Sbjct: 173 GSRQYSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 135 ILSGLLYL---HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGT 190
I+ L YL H VIHRD+K NI ++ + G VK+ D G++ L S A R G
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 191 PEFMAPEVYE-----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 245
+MAPE + +Y+ D++S G+ ++E+ T +PY C ++ K++ + P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 246 E-ALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDS 289
+ P+ F++ CL R RELL PF++ Y++
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR--RYET 281
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-15
Identities = 71/241 (29%), Positives = 120/241 (49%), Gaps = 42/241 (17%)
Query: 67 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-----YRLKHR 121
E +L E+++++ LKH+NI+++ +++ AN+ + + E +G L + Y++
Sbjct: 55 EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-FG 113
Query: 122 RVNIRAVKHWCRQILSGLLYLHS-RDPP----VIHRDLKCDNIFV--------------N 162
++ A+ RQ+L L Y H+ +D P V+HRDLK NIF+ N
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 163 GNQGE--VKIGDLGLAA-ILRKSHAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCI 216
G KIGD GL+ I +S A CVGTP + +PE+ E Y++ D+++ G I
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 217 LEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLATVSSRLSAR 274
E+ + P+ H A + ++IS K P+ K + E+ I+ L LSA+
Sbjct: 234 YELCSGKTPF----HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLN-----LSAK 284
Query: 275 E 275
E
Sbjct: 285 E 285
|
Length = 1021 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 30 ILGKGASKTV----YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHR 84
+LGKG+ V + DE ++V V L D +++E E +L KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHP 56
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
+ + + S T +R + FV E G L + + R + + + +I+ GL +LH
Sbjct: 57 FLTQLH-SCFQTKDR-LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVY-EE 201
R +I+RDLK DN+ ++ +G +KI D G+ IL + GTP+++APE+ +
Sbjct: 115 RG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 202 EYNELVDIYSFGMCILEMVTFDYPY 226
Y VD ++ G+ + EM+ P+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 42/96 (43%), Positives = 62/96 (64%), Gaps = 6/96 (6%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTP 191
QI+SGL +LH R +I+RDLK +N+ ++ N G V+I DLGLA L+ +S GTP
Sbjct: 105 QIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 192 EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 226
FMAPE+ + EEY+ VD ++ G+ + EM+ P+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 36/212 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-----EIHLLKTLKH 83
+G+GA V A + G++VA ++ SP E + +C EI +L+ KH
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFE-HQTFCQRTLREIKILRRFKH 62
Query: 84 RNIMKFY----TSWVDTANRNINFVTE-MFTSGTLRQYRL-KHRRVNIRAVKHWCRQILS 137
NI+ ++ N ++ V E M T Y+L K + ++ ++++ QIL
Sbjct: 63 ENIIGILDIIRPPSFESFN-DVYIVQELMETD----LYKLIKTQHLSNDHIQYFLYQILR 117
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-----ARCVGTPE 192
GL Y+HS + V+HRDLK N+ +N N ++KI D GLA I H V T
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 193 FMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 221
+ APE+ + Y + +DI+S G CIL EM++
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 60 DFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY 116
+ + +E+E L CE + +T +H ++ + + T + + FV E G L +
Sbjct: 35 GDIIARDEVESLMCEKRIFETANSERHPFLVNLF-ACFQTEDH-VCFVMEYAAGGDLMMH 92
Query: 117 RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176
RAV + +L GL YLH +++RDLK DN+ ++ +G VKI D GL
Sbjct: 93 IHTDVFSEPRAVFYAACVVL-GLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLC 148
Query: 177 --AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYS 227
+ + GTPEF+APEV E Y VD + G+ I EM+ + P+
Sbjct: 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKL-YDFLQSPEELERLYCEIHLLKTLKHRNIM 87
E +G+G VY+A ++ G VA +++L + P R EI LLK L H NI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYR--LKHRRVNIRAVKHWCRQILSGLLYLHSR 145
K V + V E F L+++ + + +K + Q+L GL + HS
Sbjct: 63 KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--E 200
V+HRDLK N+ +N +G +K+ D GLA + +++ V T + APE+
Sbjct: 120 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 175
Query: 201 EEYNELVDIYSFGMCILEMVT 221
+ Y+ VDI+S G EMVT
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 42/225 (18%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--R 117
DFL E ++K L+H +++ Y V T I VTE+ G+L +Y
Sbjct: 47 DFLA----------EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQG 94
Query: 118 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177
R + + + Q+ SG+ YL +++ IHRDL N+ V G K+ D GLA
Sbjct: 95 GAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLAR 151
Query: 178 ILRKS-HAARCVGTP---EFMAPEVYEEEYNELV---DIYSFGMCILEMVTF-DYPYSEC 229
++++ + AR G ++ APE YN D++SFG+ + E+VT+ PY
Sbjct: 152 VIKEDIYEAR-EGAKFPIKWTAPEA--ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208
Query: 230 THPAQIYKKVISGKK-------PEALFKV------EDPEVRQFIE 261
T+ A++ ++V G + P+ L+ + EDP+ R E
Sbjct: 209 TN-AEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQV-KLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
E +G GA V A D G +VA ++ +D + R E+ +L+ KH NI+
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK---RTLRELKILRHFKHDNII 67
Query: 88 KFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLH 143
+++ V ++ S + + H + ++++ Q+L GL Y+H
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLMESDL---HHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFMAPE 197
S + VIHRDLK N+ VN + E++IGD G+A L S V T + APE
Sbjct: 125 SAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 198 VY--EEEYNELVDIYSFGMCIL-EMV 220
+ EY +D++S G CI EM+
Sbjct: 182 LLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-14
Identities = 93/317 (29%), Positives = 137/317 (43%), Gaps = 52/317 (16%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY ++ G GA +V A D+ G +VA KL QS +R Y E+ LLK ++
Sbjct: 16 RYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 83 HRNIMKF---YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
H N++ +TS V ++ + L++ ++ V++ Q+L GL
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP--LSEDKVQYLVYQMLCGL 130
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPE 197
Y+HS +IHRDLK N+ VN E+KI D GLA R + A V T + APE
Sbjct: 131 KYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLA---RHADAEMTGYVVTRWYRAPE 184
Query: 198 VYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKVED 253
V YN+ VDI+S G + EM+T + + Q+ + KV PE + K+ED
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 254 PEVRQFI--------------------------EKCLA-TVSSRLSARELLTDPFL-QID 285
+ +I EK L V RL+A E L P+
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 286 DYDSDLRMIQYQTDYDE 302
D D + Q YD+
Sbjct: 305 DADEETE----QQPYDD 317
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE------LERLYCEIHLLKTLK 82
E +G+G VY+A D+ G VA + +L + EE L EI LL+ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRL----EMDEEGIPPTALR----EISLLQMLS 58
Query: 83 HRNIMKFYTSWVDTANRN----INFVTEMFTSGTLRQYRLKHRRVNIR-----AVKHWCR 133
+ +N + V E + L+++ + R R +K +
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFE-YLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGT 190
Q+L G+ + H V+HRDLK N+ V+ +G +KI DLGL +I KS+ V T
Sbjct: 118 QLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174
Query: 191 PEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 221
+ APEV Y+ VDI+S G EM
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 63/214 (29%), Positives = 87/214 (40%), Gaps = 29/214 (13%)
Query: 17 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELER------ 70
+ + N I G+G VYRA D G VA +V++ + ER
Sbjct: 2 RCRSVTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRM--------DNERDGIPIS 52
Query: 71 -LYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK 129
L EI LL L+H NI++ V +I V E + VK
Sbjct: 53 SLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK 111
Query: 130 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--- 186
Q+L GL YLH +IHRDLK N+ + G +KI D GLA A+
Sbjct: 112 CLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLAR--TYGLPAKPMT 166
Query: 187 -CVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL 217
V T + APE+ Y +D+++ G CIL
Sbjct: 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQV---KLYDFLQSPEELERLYCEIHLLKT 80
RY + +G+GA V++A D G VA +V +L + P + R EI L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALR---EIKALQA 55
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSG 138
+H ++K V V E S L+ + VK + R +L G
Sbjct: 56 CQHPYVVKLLD--VFPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVKSYMRMLLKG 111
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK------SHAARCVGTPE 192
+ Y+H+ ++HRDLK N+ + G +KI D GLA + + SH V T
Sbjct: 112 VAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQ---VATRW 165
Query: 193 FMAPEVY--EEEYNELVDIYSFGMCIL-EM 219
+ APE+ +Y+ VD+++ G CI E+
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 54/275 (19%)
Query: 56 VKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLR 114
VK + S E+L+ L EI + L+H NI+ + TS++ + + V+ + G+
Sbjct: 30 VKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCE 87
Query: 115 QYRLKHRRVNIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172
H + A+ + +L+ L Y+HS+ IHR +K +I ++G+ G+V +
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSG 144
Query: 173 LGLA-AILRKSHAARCV-GTPEF-------MAPEVYEEE---YNELVDIYSFGMCILEMV 220
L + ++++ R V P+ ++PEV ++ YNE DIYS G+ E+
Sbjct: 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204
Query: 221 TFDYPYSECTHPAQIYKKVISGKKPEALFK-------------------------VEDPE 255
P+ + Q+ + + G P L K V+ P
Sbjct: 205 NGHVPFKD-MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263
Query: 256 VR-------QFIEKCLA-TVSSRLSARELLTDPFL 282
R QF+E CL SR SA +LL F
Sbjct: 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 23/182 (12%)
Query: 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 159
N+ FV E G L + + ++ + +I+ GL +LHS+ +++RDLK DNI
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNI 127
Query: 160 FVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCI 216
++ G +KI D G+ +L + GTP+++APE+ ++YN VD +SFG+ +
Sbjct: 128 LLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLL 186
Query: 217 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALF---KVEDPEVRQFIEKCLATVSSRLSA 273
EM+ P+ G E LF ++++P +++ + + +L
Sbjct: 187 YEMLIGQSPF--------------HGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 274 RE 275
RE
Sbjct: 233 RE 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG+G TV++ + VA +++L +P R E+ LLK LKH NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+ R + V E S L+QY L + +++ VK + Q+L GL Y H R
Sbjct: 70 D--IIHTERCLTLVFEYLDS-DLKQY-LDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--EEEY 203
++HRDLK N+ +N +GE+K+ D GLA ++ K+++ V T + P+V EY
Sbjct: 124 ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 204 NELVDIYSFGMCILEMVT 221
+ +D++ G + EM T
Sbjct: 182 STPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 19/251 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIE-VAWNQVKLY------DFLQSPEELERLYCEIHLLK-T 80
E LG GA VY+ + G +A ++ ++ D + + + + E+ ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCR--QIL 136
L+H NI+++Y ++++ N + V ++ L ++ LK ++ + W Q++
Sbjct: 66 LRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARCVGTPEFMA 195
L YLH ++ ++HRDL +NI + G +V I D GLA +S VGT +
Sbjct: 124 LALRYLH-KEKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 196 PEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254
PE+ + E Y E D+++FG + +M T P+ T+ + K++ +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 255 EVRQFIEKCLA 265
+V I CL
Sbjct: 241 DVTDVITSCLT 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLKHRNIMK 88
+G+G VY+A D+ G VA +V+L + + P R EI +L+ L HRNI+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70
Query: 89 FYTSWVDTAN--------RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
D + V E + + +K + +Q+L GL
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPE 197
Y H ++ +HRD+KC NI +N N+G++K+ D GLA + + V T + PE
Sbjct: 131 YCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187
Query: 198 VY--EEEYNELVDIYSFGMCIL-EMVT 221
+ EE Y +D++S G CIL E+ T
Sbjct: 188 LLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 29 EILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
++LG GA TVY+ EG I VA +K SP+ + + E +++ ++ +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNP 69
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLH 143
++ + + + + +T++ G L Y +H+ + + + +WC QI G+ YL
Sbjct: 70 HVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-V 198
R ++HRDL N+ V Q VKI D GLA +L K + A P ++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 199 YEEEYNELVDIYSFGMCILEMVTFDY-PY 226
Y D++S+G+ + E++TF PY
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 16/188 (8%)
Query: 103 FVTEMFTSGTLRQ--YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 160
V + G L+ Y + R + + V H+ QI G+L+LHS D +++RD+K +N+
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL 127
Query: 161 VNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCIL 217
++ +QG ++ DLGLA L+ K+ R GT +MAPE+ +EE Y+ VD ++ G I
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQR-AGTNGYMAPEILKEEPYSYPVDWFAMGCSIY 185
Query: 218 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE----DPEVRQFIEKCLA-TVSSRLS 272
EMV P+ + H ++ K+ + + E K E E + LA RL
Sbjct: 186 EMVAGRTPFKD--HKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLG 243
Query: 273 ARELLTDP 280
+RE DP
Sbjct: 244 SREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG+G TVY+ + VA +++L +P R E+ LLK LKH NI+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
+ +++ V E + L+QY +N+ VK + Q+L GL Y H R V
Sbjct: 71 D--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--EEEYN 204
+HRDLK N+ +N +GE+K+ D GLA +I K+++ V T + P++ +Y+
Sbjct: 126 LHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183
Query: 205 ELVDIYSFGMCILEMVT 221
+D++ G EM T
Sbjct: 184 TQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 74/246 (30%), Positives = 114/246 (46%), Gaps = 18/246 (7%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA +V A+D +VA KL QS R Y E+ LLK +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL----KHRRVNIRAVKHWCRQILSGL 139
N++ V T +I E++ L L K ++++ V+ Q+L GL
Sbjct: 74 ENVIGLLD--VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY 199
Y+HS +IHRDLK N+ VN E++I D GLA V T + APE+
Sbjct: 132 KYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMTGY-VATRWYRAPEIM 187
Query: 200 EE--EYNELVDIYSFGMCILEMVTFD--YPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
YN+ VDI+S G + E++ +P ++ + +V+ PE L K+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 256 VRQFIE 261
R++I+
Sbjct: 248 ARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 44/219 (20%)
Query: 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE-------RLYCEIH 76
Y + N I +G VYRA D+ G VA ++K+ +E E R EI+
Sbjct: 7 YEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKME------KEKEGFPITSLR---EIN 56
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK------HRRVNIRAVKH 130
+L L+H NI+ V + I V E ++ LK + VK
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSEVKC 110
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAA 185
Q+LSG+ +LH ++HRDLK N+ +N N+G +KI D GLA R+
Sbjct: 111 LMLQLLSGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLA---REYGSPLKPYT 164
Query: 186 RCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 221
+ V T + APE+ +EY+ +D++S G CI E++T
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 29 EILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
++LG GA TVY+ EG I VA +K+ + P+ E ++ ++ H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLH 143
++++ + I VT++ G L Y +H+ + + + +WC QI G++YL
Sbjct: 70 HLVRLLGVCLSPT---IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-V 198
R ++HRDL N+ V + VKI D GLA +L K + A P ++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 199 YEEEYNELVDIYSFGMCILEMVTF 222
+ ++ D++S+G+ I E++TF
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHRNIM 87
E +G+G VY+A D +A +++L Q E + EI LLK ++H NI+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 88 KFYTSWVDTANRNINFVTE---------MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+ V + + + V E M +S + N R +K + QIL G
Sbjct: 65 RLQD--VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK--------NPRLIKTYLYQILRG 114
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMA 195
+ Y HS V+HRDLK N+ ++ +K+ D GLA I ++ V T + A
Sbjct: 115 IAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRA 171
Query: 196 PEVY--EEEYNELVDIYSFGMCILEMVT 221
PE+ Y+ VDI+S G EMV
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 40/127 (31%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
FV E G L + R ++ + +I+ GL +LHS+ +I+RDLK DN+ ++
Sbjct: 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD 130
Query: 163 GNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 219
+ G +KI D G+ + + A+ GTP+++APE+ + +Y VD +SFG+ + EM
Sbjct: 131 RD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
Query: 220 VTFDYPY 226
+ P+
Sbjct: 190 LIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG+G TV++ + VA +++L +P R E+ LLK LKH NI+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDP 147
+ + ++++ V E + L+QY + ++ VK + QIL GL Y H R
Sbjct: 69 LHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--EEE 202
V+HRDLK N+ +N +GE+K+ D GLA ++ K+++ V T + P+V E
Sbjct: 125 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 203 YNELVDIYSFGMCILEMVT 221
Y+ +D++ G EM +
Sbjct: 182 YSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 39/127 (30%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
FV E G L + K RR + + + +I S L++LH + +I+RDLK DN+ ++
Sbjct: 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD 130
Query: 163 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 219
++G K+ D G+ I + GTP+++APE+ +E Y VD ++ G+ + EM
Sbjct: 131 -HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189
Query: 220 VTFDYPY 226
+ P+
Sbjct: 190 LCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 76/251 (30%), Positives = 113/251 (45%), Gaps = 29/251 (11%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY ++ +G GA V AFD GI VA KL Q+ +R Y E+ LLK + H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 84 RNIMKFYTSWVDTAN----RNINFVTEMFTSGTLR--QYRLKHRRVNIRAVKHWCRQILS 137
+NI+ + + +++ V E+ + + L H R++ + Q+L
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQMLC 134
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-----E 192
G+ +LHS +IHRDLK NI V + +KI D GLA ++ + TP
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTACTNFMMTPYVVTRY 187
Query: 193 FMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251
+ APEV Y E VDI+S G + E+V + H Q K + P A F
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 252 E-DPEVRQFIE 261
P VR ++E
Sbjct: 248 RLQPTVRNYVE 258
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 68/211 (32%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE--LERLYCEIHLLKTLKHRNI 86
E +G+G VY+ ++ G VA +++L +S EE EI LLK L+H NI
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRL----ESEEEGVPSTAIREISLLKELQHPNI 61
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYR---LKHRRVNIRAVKHWCRQILSGLLYLH 143
+ V + + E F S L++Y K + ++ VK + QIL G+L+ H
Sbjct: 62 VCLQD--VLMQESRLYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE----------- 192
SR V+HRDLK N+ ++ N+G +K+ D GL AR G P
Sbjct: 119 SRR--VLHRDLKPQNLLID-NKGVIKLADFGL---------ARAFGIPVRVYTHEVVTLW 166
Query: 193 FMAPEVY--EEEYNELVDIYSFGMCILEMVT 221
+ APEV Y+ VDI+S G EM T
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 54/295 (18%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHRNIM 87
++G+GA V + ++ G VA +K + + E++++ E+ +L+ L+H NI+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVA---IKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 88 KFYTSWVDTANRN--INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
+ R + V E L + AV+ + Q+L + Y HS
Sbjct: 64 NL----KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPE--VYE 200
+ +IHRD+K +NI V+ + G +K+ D G A LR A+ V T + APE V +
Sbjct: 120 N--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 201 EEYNELVDIYSFGMCIL-EMVTFD--YPYSECTH--------------PAQIY------- 236
Y + VD+++ G CI+ E++ + +P + P+
Sbjct: 177 TNYGKPVDVWAIG-CIMAELLDGEPLFP-GDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234
Query: 237 ---KKVISGKKPEAL-----FKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 282
+PE+L KV P + F++ CL RL+ ELL P+
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPAL-DFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 33/168 (19%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNI---NFVTEMFTSGTLRQYRLKHRRVNIRAVKH 130
E LL+ + H ++++ + V A + ++ ++++T T R R + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-----RPLPIDQALI 161
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--- 187
+QIL GL YLH++ +IHRD+K +NIF+N + +V IGDLG AA+
Sbjct: 162 IEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLG---------AAQFPVV 209
Query: 188 -------VGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYS 227
GT E APEV ++YN DI+S G+ + EM+ YP +
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPST 255
|
Length = 357 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
++LGKG V ++ G A ++ + + + +E+ E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
++ T +R + FV E G L + + R + + +I+S L YLHSRD
Sbjct: 60 LKYAF-QTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNE 205
V++RD+K +N+ ++ G +KI D GL I + GTPE++APEV E+ +Y
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTH 231
VD + G+ + EM+ P+ H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 73/264 (27%), Positives = 129/264 (48%), Gaps = 18/264 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+++GKG+ V A + E A ++ L+ EE + LLK +KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-VKHWCRQILSGLLYLHSRDP 147
+ S+ TA++ + FV + G L Y L+ R + + + +I S L YLHS +
Sbjct: 61 LHFSF-QTADK-LYFVLDYINGGELF-YHLQRERCFLEPRARFYAAEIASALGYLHSLN- 116
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEV-YEEEYN 204
+++RDLK +NI ++ +QG + + D GL I + GTPE++APEV +++ Y+
Sbjct: 117 -IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264
VD + G + EM+ + P + A++Y +++ KP L R +E L
Sbjct: 175 RTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLL 231
Query: 265 AT-VSSRLSARELLTDPFLQIDDY 287
+ RL A D F++I ++
Sbjct: 232 QKDRTKRLGA----KDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKF 89
LGKGA V++A D VA K++D ++ + +R + EI L+ L H NI+K
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 90 YTSWVDTA--NRNINFVTE-MFT--SGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYL 142
V A +++I V E M T +R L+ H+R + Q+L L Y+
Sbjct: 73 LN--VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM-------YQLLKALKYI 123
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-------VGTPEFMA 195
HS + VIHRDLK NI +N + VK+ D GLA L + V T + A
Sbjct: 124 HSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 196 PEVY--EEEYNELVDIYSFGMCIL-EMVT 221
PE+ Y + VD++S G CIL EM+
Sbjct: 181 PEILLGSTRYTKGVDMWSVG-CILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 82/263 (31%), Positives = 118/263 (44%), Gaps = 53/263 (20%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA V A+D G VA KL Q+ +R Y E+ L+K + H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 84 RNIMKFYTSWVDTANRNIN------FVTEMFTSGTLR--QYRLKHRRVNIRAVKHWCRQI 135
+NI+ V T +++ V E+ + + Q L H R++ + Q+
Sbjct: 75 KNIIGLLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM- 194
L G+ +LHS +IHRDLK NI V + +KI D GL AR GT FM
Sbjct: 128 LCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL---------ARTAGT-SFMM 174
Query: 195 ----------APEV-YEEEYNELVDIYSFGMCIL-EMV--TFDYPYSECTHPAQIYKKVI 240
APEV Y E VDI+S G CI+ EM+ T +P ++ H Q + K+I
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMIRGTVLFPGTD--HIDQ-WNKII 230
Query: 241 S--GKKPEALFKVEDPEVRQFIE 261
G + P VR ++E
Sbjct: 231 EQLGTPSDEFMSRLQPTVRNYVE 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 16/136 (11%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEV-YEEEYNELV 207
IHRDLK +N F+ G +K+ D GL+ I+ +++ VG+P++MAPEV + Y+ V
Sbjct: 123 IHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTYANSV--VGSPDYMAPEVLRGKGYDFTV 179
Query: 208 DIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKK-------PEALFKVEDPEVRQF 259
D +S G C+L E + P+S T P + ++ + K+ + F + D E
Sbjct: 180 DYWSLG-CMLYEFLCGFPPFSGST-PNETWENLKYWKETLQRPVYDDPRFNLSD-EAWDL 236
Query: 260 IEKCLATVSSRLSARE 275
I K + S R + E
Sbjct: 237 ITKLINDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG+G+ TVY+ G VA + + P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHS 144
+ + + FV E + L QY ++H N+R + Q+L GL Y+H
Sbjct: 68 LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRL---FMFQLLRGLAYIHG 121
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY-- 199
+ ++HRDLK N+ ++ GE+K+ D GLA +I +++++ V T + P+V
Sbjct: 122 QH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLG 177
Query: 200 EEEYNELVDIYSFGMCILEMV 220
+Y+ +DI+ G +EM+
Sbjct: 178 ATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 68 LERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSG----TLRQYRLKHRRV 123
++ E ++ +L H N+++ Y + + VTE+ G LR+ L H
Sbjct: 40 MDDFLKEAAIMHSLDHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGH--F 94
Query: 124 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183
I + + QI +G+ YL S+ IHRDL NI + + +VKIGD GL L ++
Sbjct: 95 LISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNE 151
Query: 184 ------AARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQI 235
V + APE + ++ D++ FG+ + EM T+ + P++ + +QI
Sbjct: 152 DHYVMEEHLKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-GSQI 209
Query: 236 YKKVISGKKPEALFKVED--PEVRQFIEKCLA 265
KK+ K+ E L + E ++ + +C A
Sbjct: 210 LKKI--DKEGERLERPEACPQDIYNVMLQCWA 239
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEELERLYCEIHLLKTLKHRNIMK 88
+LG GA+ TV A +G A VK+ D S + R E+ L +I+K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFA---VKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 89 FYTSWVDTANRN------INFVTEMFTSGTLRQYRLKHRRVNIRA-VKHWCR----QILS 137
+ + RN I V + +G LRQ +K R R +H Q+L
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ-EIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL----AAILRKSHAARCVGTPEF 193
+ ++HS+ +IHRD+K NI + N G VK+GD G AA + GTP +
Sbjct: 155 AVHHVHSKH--MIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 194 MAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252
+APE++ + Y++ D++S G+ + E++T P+ + + ++ K ++G+ + L
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRY-DPLPPSI 269
Query: 253 DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI 294
PE+++ + L++ R S+ +LL P ++ + S L I
Sbjct: 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL--FISGLLEI 310
|
Length = 496 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 28 NEILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
+G+G VY+ E E I VA VK SP E+ E ++++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVA---VKTCKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLH 143
+I+K + + V E+ G LR Y ++ +++ ++ + Q+ + L YL
Sbjct: 68 HIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPE-VY 199
S+ +HRD+ N+ V+ VK+GD GL+ L A++ ++MAPE +
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 200 EEEYNELVDIYSFGMCILEMVTF 222
+ D++ FG+C+ E++
Sbjct: 182 FRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 38/225 (16%)
Query: 25 GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTL 81
Y + LG+G VY+A G VA ++ +++ P R EI +LK L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---EIKILKKL 64
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFT---------SGTLRQYRLKHRRVNIRAVKHWC 132
KH N++ V+ +++ ++ SG L +K + +K +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYM 121
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR------------ 180
Q+L G+ YLH ++HRD+K NI ++ NQG +KI D GLA
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 181 -KSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 221
V T + PE+ E Y VDI+ G C+ EM T
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 37 KTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96
K VY E +EVA +K +E R E ++ L H I++
Sbjct: 13 KGVYLMKSGKE-VEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIVRLIGVCKGE 68
Query: 97 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 156
+ V E+ G L +Y K R + + +K Q+ G+ YL S+ +HRDL
Sbjct: 69 P---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAA 123
Query: 157 DNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGT-P-EFMAPE-VYEEEYNELVDIY 210
N+ + N+ + KI D G++ L + A G P ++ APE + +++ D++
Sbjct: 124 RNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVW 182
Query: 211 SFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 244
S+G+ + E ++ PY E ++ + SG++
Sbjct: 183 SYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 136
LLK +KH ++ + S+ TA++ + FV + G L + + R + + +I
Sbjct: 49 LLKNVKHPFLVGLHYSF-QTADK-LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFM 194
S L YLHS + +I+RDLK +NI ++ +QG V + D GL I + GTPE++
Sbjct: 107 SALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 195 APEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253
APEV ++ Y+ VD + G + EM+ + P A++Y +++ KP L
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLRLKPNIS 220
Query: 254 PEVRQFIEKCL-ATVSSRLSARELLTDPFLQIDDY 287
R +E L + RL A+ D FL+I ++
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAK----DDFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE------RLYCEIHL 77
+Y ++ +G+G+ V++ + G VA +K F++S ++ R EI +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVA---IK--KFVESEDDPVIKKIALR---EIRM 53
Query: 78 LKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
LK LKH N++ V R ++ V E L + R V +K Q L
Sbjct: 54 LKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ 111
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--RCVGTPEFMA 195
+ + H + IHRD+K +NI + QG++K+ D G A IL V T + A
Sbjct: 112 AVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRA 168
Query: 196 PE--VYEEEYNELVDIYSFGMCILEMVT 221
PE V + +Y VD+++ G E++T
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 5/153 (3%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
E+ +L I+ FY ++ ++ I+ E G+L Q + +R+ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 110
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 193
+L GL YL + ++HRD+K NI VN ++GE+K+ D G++ L S A VGT +
Sbjct: 111 AVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168
Query: 194 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYP 225
M+PE + Y+ DI+S G+ ++E+ YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG G V++ + G+ +A KL P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 150
++ ++ I+ E G+L Q K R+ + + ++ GL YL + ++
Sbjct: 70 GAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDI 209
HRD+K NI VN ++GE+K+ D G++ L S A VGT +M+PE + Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 210 YSFGMCILEMVTFDYP 225
+S G+ ++EM YP
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 78/296 (26%), Positives = 124/296 (41%), Gaps = 54/296 (18%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
+G GA V+ D +G VA K+ + Q+ +R++ E+ +L KH N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL--- 62
Query: 91 TSWVDTANR-NINFVTEMFTSGTLRQYRL-----KHRRVNIRAVKHWCRQILSGLLYLHS 144
S +D +I+ E++ L Q L + ++ VK + QIL GL YLHS
Sbjct: 63 -SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--LRKS-HAARCVGTPEFMAPEVY-- 199
++HRD+K N+ VN N +KI D GLA + +S H + V T + APE+
Sbjct: 122 AG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 200 EEEYNELVDIYSFGMCI-------------------LEMVTFDY----PYSECTHPAQIY 236
Y VDI+S G CI L+++T D +
Sbjct: 179 SRHYTSAVDIWSVG-CIFAELLGRRILFQAQSPIQQLDLIT-DLLGTPSLEAMRSACEGA 236
Query: 237 KKVI--SGKKPEA---LFKVEDP---EVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
+ I KP + L+ + E + + L R+SA + L P+L
Sbjct: 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
++LGKG V ++ G A +K + + + +E+ E +LK +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
S+ T +R + FV E G L + + R + + + +I+S L YLHS
Sbjct: 60 LKYSF-QTKDR-LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNE 205
+++RDLK +N+ ++ + G +KI D GL I + GTPE++APEV E+ +Y
Sbjct: 116 IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTH 231
VD + G+ + EM+ P+ H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 70/208 (33%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC--EIHLLKT 80
+Y EI G GA TVY+A D + G VA V++ Q+ E+ L E+ LLK
Sbjct: 1 QYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKR 55
Query: 81 LK---HRNIMKFYTSWVDTANRNINFVTEMF--TSGTLRQY--RLKHRRVNIRAVKHWCR 133
L+ H NI++ + VT +F LR Y ++ + +K R
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPE 192
Q L GL +LH+ ++HRDLK +NI V + G+VK+ D GLA I A V T
Sbjct: 116 QFLRGLDFLHAN--CIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLW 172
Query: 193 FMAPEV-YEEEYNELVDIYSFGMCILEM 219
+ APEV + Y VD++S G EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 41/282 (14%)
Query: 29 EILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK-TLKH 83
++LGKG+ V A DE I+V V L D ++++ E +L KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
+ + + T +R + FV E G L + R+ + + + ++ L++LH
Sbjct: 56 PFLTALHCCF-QTKDR-LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE 201
VI+RDLK DNI ++ +G K+ D G+ IL GTP+++APE+ +E
Sbjct: 114 RHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 202 -EYNELVDIYSFGMCILEMVTFDYPYS--------------ECTHPAQIYKKVISGKKPE 246
EY VD ++ G+ + EM+ P+ + +P + K+ +S K
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA- 229
Query: 247 ALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYD 288
F ++P R L V+S+ + PF + D+
Sbjct: 230 --FMTKNPNKR------LGCVASQGGEDAIKQHPFFKEIDWV 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 28/177 (15%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 119
FLQ E ++K L+H +++ Y V + I VTE + G+L + LK
Sbjct: 47 AFLQ----------EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDF-LK 93
Query: 120 H---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176
+++ + + QI G+ YL SR+ IHRDL NI V G KI D GLA
Sbjct: 94 SGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLA 150
Query: 177 AILRKSHAARCVGT--P-EFMAPEVYEEEYNELV---DIYSFGMCILEMVTF-DYPY 226
++ G P ++ APE Y D++SFG+ + E+VT+ PY
Sbjct: 151 RLIEDDEYTAREGAKFPIKWTAPEA--ANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 58/240 (24%), Positives = 94/240 (39%), Gaps = 33/240 (13%)
Query: 31 LGKGASKTVYRAF-----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
LG+G+ VY VA +K + S E E ++K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVA---IKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----RVNIRAVKH------WCRQI 135
+++ V T + V E+ G L+ Y R +I
Sbjct: 71 VVRLL-GVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT---P- 191
G+ YL ++ +HRDL N V + VKIGD G+ + ++ R G P
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 192 EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK---KPE 246
+MAPE + + + D++SFG+ + EM T + PY ++ ++ K VI G PE
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDGGHLDLPE 244
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165
E+FT R++ + V+ + +I+ L +LH +I+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTESE------VRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 166 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY---EEEYNELVDIYSFGMCILEM 219
G V + D GL+ R GT E+MAPEV +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 220 VTFDYPYS---ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL---S 272
+T P++ E ++I ++++ K P K E R FI+K L RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 273 ARELLTDPFLQIDDYD 288
A E+ PF Q D+D
Sbjct: 260 ADEIKNHPFFQGIDWD 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 67/251 (26%), Positives = 117/251 (46%), Gaps = 20/251 (7%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY + E++GKG+ V A D + G +VA K+ D + + R+ EI LL+ L+
Sbjct: 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLR 57
Query: 83 HRNIMKFYTSWVDTANR---NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
H +I++ + + R +I V E+ S L Q + + + + Q+L L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-----VGTPEFM 194
Y+H+ + V HRDLK NI N + ++KI D GLA + V T +
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 195 APEV---YEEEYNELVDIYSFGMCILEMVTFD--YPYSECTHPAQIYKKVISGKKPEALF 249
APE+ + +Y +DI+S G E++T +P H + ++ PE +
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 250 KVEDPEVRQFI 260
+V + + R+++
Sbjct: 234 RVRNEKARRYL 244
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG+G+ TVY+ + G VA ++L + +P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDP 147
+ + + V E + L QY KH ++ VK + Q+L GL Y+H R
Sbjct: 68 LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR-- 122
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHA-ARCVGTPEFMAPEVY--EEEY 203
++HRDLK N+ ++ + GE+K+ D GLA A SH + V T + P+V EY
Sbjct: 123 YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 204 NELVDIYSFGMCILEMV 220
+ +D++ G +EM+
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 80/359 (22%), Positives = 153/359 (42%), Gaps = 64/359 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+++G+GA V + G A ++ D L+ E++ + E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+ S+ D N + + E G + +K + + + + + + +H
Sbjct: 66 MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------------------------- 183
IHRD+K DN+ ++ ++G VK+ D GL L+K+H
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 184 ------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECT 230
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+ T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 231 HPAQIYKKVISGKKPEALFKVEDP---EVRQFIEKCLATVSSRLSA---RELLTDPFLQI 284
P + YKKV++ K+ +F E P + + I + R+ A E+ T+PF +
Sbjct: 241 -PQETYKKVMNWKE-TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG 298
Query: 285 DDYDS----------DLRMIQYQTDYDEI--SPLLRQSLYGIYHSNSSSNNGCGHYIGY 331
D++ +++ I +++DE S +L+ ++ H + N +I Y
Sbjct: 299 VDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINY 357
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 160
++F+ ++ G L + +H + ++ + +I+ GL ++H+R V++RDLK NI
Sbjct: 72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANIL 129
Query: 161 VNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILE 218
++ + G V+I DLGLA K VGT +MAPEV ++ Y+ D +S G + +
Sbjct: 130 LDEH-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
Query: 219 MVTFDYPYSE-CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL----- 271
++ P+ + T ++ E L PE+R +E L V+ RL
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPELRSLLEGLLQRDVNRRLGCLGR 247
Query: 272 SARELLTDPFLQIDDY 287
A+E+ PF + D+
Sbjct: 248 GAQEVKEHPFFRSLDW 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 132
E ++ L H +++ Y V T R I VTE ++G L Y R +R + C
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 191
+ + G+ YL S+ IHRDL N V+ +QG VK+ D GL+ + VG+
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 192 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 244
+ PEV +++ D+++FG+ + E+ + PY + ++ +KV G +
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 9/167 (5%)
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 136
LLK +KH ++ + S+ T + FV + G L + + R + + +I
Sbjct: 49 LLKNVKHPFLVGLHYSFQTT--EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFM 194
S L YLHS + +++RDLK +NI ++ +QG V + D GL I + GTPE++
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 195 APEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
APEV ++ Y+ VD + G + EM+ + P C A++Y ++
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 10/153 (6%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWC 132
E ++ L H N+++ Y V T R I VTE +G L Y + + ++ + C
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 191
+ + YL S IHRDL N V G VK+ D GLA + GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 192 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVT 221
++ PEV++ ++ D++SFG+ + E+ +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 50/168 (29%), Positives = 87/168 (51%), Gaps = 9/168 (5%)
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 136
LLK LKH ++ + S+ TA + + FV + G L + + R + + ++
Sbjct: 49 LLKNLKHPFLVGLHYSF-QTAEK-LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFM 194
S + YLHS + +I+RDLK +NI ++ +QG V + D GL + + + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 195 APEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 241
APEV +E Y+ VD + G + EM+ + P +Q+Y ++
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEML-YGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 12/171 (7%)
Query: 66 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-- 123
+E+ E +L+ +H + S+ T +R + FV E G L + L RV
Sbjct: 37 DEVAHTLTESRVLQNTRHPFLTALKYSF-QTHDR-LCFVMEYANGGELF-FHLSRERVFS 93
Query: 124 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRK 181
RA + + +I+S L YLHS D V++RDLK +N+ ++ + G +KI D GL I
Sbjct: 94 EDRA-RFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDG 149
Query: 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH 231
+ GTPE++APEV E+ +Y VD + G+ + EM+ P+ H
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 74/257 (28%), Positives = 108/257 (42%), Gaps = 41/257 (15%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA V A+D VA KL Q+ +R Y E+ L+K + H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 84 RNIMKFYTSWVDTAN----RNINFVTEMFTSGTLR--QYRLKHRRVNIRAVKHWCRQILS 137
+NI+ + + +++ V E+ + + Q L H R++ + Q+L
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLC 137
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE 197
G+ +LHS +IHRDLK NI V + +KI D GL AR GT M P
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL---------ARTAGTSFMMTPY 185
Query: 198 VYEEE-----------YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK 244
V Y E VDI+S G + EM+ + H Q + KVI G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTP 244
Query: 245 PEALFKVEDPEVRQFIE 261
K P VR ++E
Sbjct: 245 CPEFMKKLQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 71/268 (26%), Positives = 107/268 (39%), Gaps = 42/268 (15%)
Query: 30 ILGKGASKTVYR--AFDEY----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
LG GA VY A D I VA VK + +E + E HL+ H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVA---VKTLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-------VNIRAVKHWCRQIL 136
NI+K + N + E+ G L Y R + ++ + C +
Sbjct: 59 PNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLAAILRKSHAARCVGTP- 191
G +YL IHRDL N V+ + VKIGD GLA + KS R G
Sbjct: 117 KGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 192 ---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE 246
+MAPE + + ++ D++SFG+ + E++T PY PA ++V+
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-----PALNNQEVLQHVTAG 229
Query: 247 ALFKVEDPE-----VRQFIEKCLATVSS 269
+++ PE + Q + C A S
Sbjct: 230 G--RLQKPENCPDKIYQLMTNCWAQDPS 255
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 8/206 (3%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
++LGKG V ++ G A +K + + + +E+ E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
S+ T +R + FV E G L + + R + + + +I+S L YLHS +
Sbjct: 60 LKYSF-QTHDR-LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-EKN 116
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNE 205
V++RDLK +N+ ++ + G +KI D GL I + GTPE++APEV E+ +Y
Sbjct: 117 VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTH 231
VD + G+ + EM+ P+ H
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 17/178 (9%)
Query: 74 EIHLLKTLKHRNIMKF-----YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 128
EI L L H NI+K + + +F F ++ + RA+
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-- 186
+Q+L + Y+H + +IHRD+K +NIF+N + G++ +GD G A K A
Sbjct: 273 M---KQLLCAVEYIHDK--KLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDY 326
Query: 187 -CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-PYSECT-HPAQIYKKVI 240
VGT +PE+ + Y E+ DI+S G+ +L+M++ D+ P + P + K+I
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 70/304 (23%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+++G+GA V + G A ++ D L+ E++ + E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+ S+ D RN+ + E G + +K ++ A + + + + + +H
Sbjct: 66 MFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------------------------- 183
IHRD+K DN+ ++ +G VK+ D GL L+K+H
Sbjct: 122 FIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 184 ------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECT 230
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+ T
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 231 HPAQIYKKVISGKKPEALFKVEDP---EVRQFIEKCLATVSSRL---SARELLTDPFLQI 284
P + Y+KV++ K+ +F E P + + I + +R+ E+ + PF +
Sbjct: 241 -PQETYRKVMNWKE-TLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEG 298
Query: 285 DDYD 288
D+
Sbjct: 299 VDWG 302
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPE----VYEEEY 203
+IHRD+K NI ++ N G +K+ D G++ L S A R G +MAPE + Y
Sbjct: 129 IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---ALFKVEDPEVRQFI 260
+ D++S G+ + E+ T +PY + +V+ G P + + P FI
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 261 EKCL-ATVSSRLSARELLTDPFLQIDDYDS 289
CL S R +ELL PF++ DY+
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIK--DYEE 275
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 56/189 (29%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 183
IHRD+K DN+ ++ +G +K+ D GL L+KSH
Sbjct: 123 IHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 184 --------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--Y 226
A VGTP+++APEV+ + YN+ D +S G+ + EM+ YP
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GYPPFC 240
Query: 227 SECTHPAQIYKKVISGKKPEALFKVED----PEVRQFIEKCLATVSSRL---SARELLTD 279
S+ +P + Y+K+I+ K E L ++ PE + I++ RL E+ +
Sbjct: 241 SD--NPQETYRKIINWK--ETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296
Query: 280 PFLQIDDYD 288
PF + D++
Sbjct: 297 PFFKGVDWE 305
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
VT+ + G L + K R + K + +++ L +LH D +++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 163 GNQGEVKIGDLGLA-AILRKSHAARC-VGTPEFMAPEVYEEE--YNELVDIYSFGMCILE 218
G + + D GL+ A L + GT E++APEV +E Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 219 MVTFDYP-YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-----TVSSR 270
M P Y+E T Q+Y+ + GK P+ + E RQF++ L + +
Sbjct: 190 MCCGWSPFYAEDTQ--QMYRNIAFGKVRFPKNVLSDEG---RQFVKGLLNRNPQHRLGAH 244
Query: 271 LSARELLTDPFLQIDDYD 288
A EL PF D+D
Sbjct: 245 RDAVELKEHPFFADIDWD 262
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 38/128 (29%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
F+ ++ G L + +H + + ++ + +I+ GL ++H+R V++RDLK NI ++
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD 131
Query: 163 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMV 220
G V+I DLGLA K VGT +MAPEV ++ Y+ D +S G + +++
Sbjct: 132 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
Query: 221 TFDYPYSE 228
P+ +
Sbjct: 191 RGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 60/265 (22%), Positives = 99/265 (37%), Gaps = 63/265 (23%)
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
++K Y S+ D N + FV + G + ++ + + ++ + +H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-------------------- 185
IHRD+K DNI ++ G +K+ D GL R +H +
Sbjct: 121 G--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 186 --------------------RC-----VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 219
RC VGTP ++APEV Y +L D +S G+ + EM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 220 VTFDYPYSECTHPAQIYKKVISGKK-----PEALFKVEDPEVRQFIEKCLATVSSRL--- 271
+ P+ T PA+ KVI+ + +A E I + RL
Sbjct: 238 LVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLS---REASDLILRLCCGAEDRLGKN 293
Query: 272 SARELLTDPFLQIDDYDSDLRMIQY 296
A E+ PF + D+ S +R +
Sbjct: 294 GADEIKAHPFFKGIDFASLIRRQKA 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTP 191
+I GL +LHS+ +I+RDLK DN+ ++ +G +KI D G+ I GTP
Sbjct: 109 EIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTP 165
Query: 192 EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPY 226
+++APE + + Y + VD ++FG+ + EM+ P+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 32/250 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +GKG VY+ + EVA + P+ + E +LK H NI+K
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
V + I V E+ G+L + R K R+ ++ + +G+ YL S++
Sbjct: 57 LIG--VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA-----AILRKSHAARCVGTPEFMAPEVYEE- 201
IHRDL N V G +KI D G++ I S + + ++ APE
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPI-KWTAPEALNYG 170
Query: 202 EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV-- 251
Y D++S+G+ + E + D PY ++ Q +++ SG + PE ++++
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIESGYRMPAPQLCPEEIYRLML 229
Query: 252 ----EDPEVR 257
DPE R
Sbjct: 230 QCWAYDPENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNIN---FVTE-MFTSGTLRQYRLKHRRVNIRAVK 129
EI LL+ L H N++ N V E M T L Q + ++ +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD--LHQIIRSSQTLSDDHCQ 111
Query: 130 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 189
++ Q+L GL Y+HS + V+HRDLK N+ +N N ++KI D GLA R +
Sbjct: 112 YFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLA---RTTSE----- 160
Query: 190 TPEFM----------APEVY--EEEYNELVDIYSFGMCIL-EMVTFD--YPYSECTHPAQ 234
+FM APE+ EY +D++S G CI E++ +P + H +
Sbjct: 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLK 219
Query: 235 IYKKVISGKKPEALFKVEDPEVRQFIE 261
+ +++ E L + + + R++I
Sbjct: 220 LITELLGSPSEEDLGFIRNEKARRYIR 246
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-10
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 66/297 (22%)
Query: 25 GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY+ I +GKG VY A+D VA +++ D ++P +R E + L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR-------------AVK 129
H I+ Y+ D + + T + G Y LK ++ +V
Sbjct: 61 HPGIVPVYSICSDG---DPVYYTMPYIEG----YTLKSLLKSVWQKESLSKELAEKTSVG 113
Query: 130 HWCR---QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-- 184
+ +I + + Y+HS+ V+HRDLK DNI + G GEV I D G AAI +K
Sbjct: 114 AFLSIFHKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWG-AAIFKKLEEED 169
Query: 185 -------------------ARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY 224
+ VGTP++MAPE + +E DIY+ G+ + +M+T +
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229
Query: 225 PYSECTHPAQIYKKVISGKKPEALFKVEDP-EVRQFIEKCLATVSSRLSARELLTDP 280
PY KK G+K + P EV + E + S+++ + L DP
Sbjct: 230 PYRR--------KK---GRKISYRDVILSPIEVAPYRE--IPPFLSQIAMKALAVDP 273
|
Length = 932 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 30 ILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+LG GA TVY+ +G I VA +K+ SP+ + + E +++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHS 144
+ + + + + VT++ G L Y +++ R+ + + +WC QI G+ YL
Sbjct: 71 VCRLLGICLTST---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL-- 125
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPE-VY 199
+ ++HRDL N+ V + VKI D GLA +L + HA ++MA E +
Sbjct: 126 EEVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 200 EEEYNELVDIYSFGMCILEMVTFDY-PY 226
+ D++S+G+ + E++TF PY
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 75/248 (30%), Positives = 110/248 (44%), Gaps = 23/248 (9%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA V A+D VA KL Q+ +R Y E+ L+K + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 84 RNIMKFYTSWVDTAN----RNINFVTEMFTSGTLR--QYRLKHRRVNIRAVKHWCRQILS 137
+NI+ + + +++ V E+ + + Q L H R++ + Q+L
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLC 130
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAP 196
G+ +LHS +IHRDLK NI V + +KI D GLA S V T + AP
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 197 EV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPEALFKVED 253
EV Y E VDI+S G + EMV + + Q + KVI G K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQ 246
Query: 254 PEVRQFIE 261
P VR ++E
Sbjct: 247 PTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 45/133 (33%), Positives = 67/133 (50%), Gaps = 14/133 (10%)
Query: 126 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETI 158
Query: 186 RC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 243
R VGT +MAPEV + E Y D + G I EM+ E P + K+ + +
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI-------EGKSPFRQRKEKVKRE 211
Query: 244 KPEALFKVEDPEV 256
+ E K ED E
Sbjct: 212 EVERRVK-EDQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 34/243 (13%)
Query: 2 NGVSSPEESDSSEFVEVD---PTGRYGRYNEILGKGASKTVYRA--FDEYEGIEVAWNQV 56
+ ++ E+ D + ++ D + + I+G G+ VY A D E +V
Sbjct: 42 HNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSE-------KV 94
Query: 57 KLYDFLQSPEELERLYCEIHLLKTLKHRNIM----KFYTSWVDTANRNI--NFVTEMFTS 110
+ LQ P+ R E+ ++K L H NI+ +YT +NI N V E F
Sbjct: 95 AIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME-FIP 150
Query: 111 GTLRQYRLKHRRVNIRA-----VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165
T+ +Y +KH N A VK + Q+ L Y+HS+ + HRDLK N+ ++ N
Sbjct: 151 QTVHKY-MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207
Query: 166 GEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVTF 222
+K+ D G A +L + + + + APE+ Y +D++S G I EM+
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-L 266
Query: 223 DYP 225
YP
Sbjct: 267 GYP 269
|
Length = 440 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 74/251 (29%), Positives = 108/251 (43%), Gaps = 44/251 (17%)
Query: 74 EIHLLKTLK-HRNIMKFY-TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 131
E+ LL+ + H+NI Y V N N ++ E L Q + + + +
Sbjct: 51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF 110
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA------AILRKSHAA 185
QIL GL Y+HS + V+HRDLK N+ VN + E+KI D GLA
Sbjct: 111 IYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMT 167
Query: 186 RCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMV----TF---DY----------- 224
V T + APE+ + Y + +D++S G CIL E++ F DY
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CILAELLGRKPVFKGKDYVDQLNQILQVL 226
Query: 225 --PYSEC-----THPAQIYKK---VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA 273
P E + AQ Y + I K E++F +P +EK LA + R+S
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286
Query: 274 RELLTDPFLQI 284
E L P+L I
Sbjct: 287 EEALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 119
+ + E+++ + E H+ + + + S T +R + FV E G L + +
Sbjct: 31 ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQR 89
Query: 120 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 177
R++ + + +I L YLH R +I+RDLK DN+ ++ ++G +K+ D G+
Sbjct: 90 QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEG 146
Query: 178 ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 226
+ + GTP ++APE+ E+Y VD ++ G+ + EM+ P+
Sbjct: 147 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 30/252 (11%)
Query: 3 GVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL 62
G PE ++ E + V T ++G+ + AF G + V + L
Sbjct: 55 GEEVPESNNPREHMYVLTT--------LVGRNPTTA---AFVATRGSDPKEKVVAKFVML 103
Query: 63 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLK 119
+ E+H L H I+K + + ++ + + E + G L + RLK
Sbjct: 104 NDERQAAYARSELHCLAACDHFGIVKHFDDF--KSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 120 -HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178
H V QI+ L +HSR ++HRDLK NIF+ G +K+GD G +
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQ 218
Query: 179 LRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA 233
S A+ GTP ++APE++E + Y++ D++S G+ + E++T P+ P+
Sbjct: 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK---GPS 275
Query: 234 Q--IYKKVISGK 243
Q I ++V+ GK
Sbjct: 276 QREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 191
+I L +LH + +I+RDLK +NI ++ QG VK+ D GL +I + GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 248
E+MAPE+ + + VD +S G + +M+T P++ I K++ GK P L
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-DKILKGKLNLPPYL 223
Query: 249 FKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 288
PE R ++K L SSRL A E+ + PF + ++D
Sbjct: 224 ----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 68 LERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA 127
+ E+ LK L+H++++ + V + + +TE+ G+L + L+ +
Sbjct: 46 QQDFQKEVQALKRLRHKHLISLFA--VCSVGEPVYIITELMEKGSLLAF-LRSPEGQVLP 102
Query: 128 VKH---WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-H 183
V Q+ G+ YL ++ IHRDL NI V G K+ D GLA ++++ +
Sbjct: 103 VASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVY 159
Query: 184 AARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA----QIYK 237
+ P ++ APE ++ D++SFG+ + EM T Y + +P ++Y
Sbjct: 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT----YGQVPYPGMNNHEVYD 215
Query: 238 KVISG-------KKPEALFKV------EDPEVRQFIEKCLATVSSRLSA 273
++ +G K P+ ++K+ +PE R + L
Sbjct: 216 QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDR----PSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 63/244 (25%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90
LG G VY + + VA +K + E+E E ++K +KH N+++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPP 148
V T +TE T G L Y + R + AV + QI S + YL ++
Sbjct: 69 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYEEEYNE 205
IHRDL N V G VK+ D GL+ ++ G ++ APE YN+
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNK 181
Query: 206 L---VDIYSFGMCILEMVTFD---YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
D+++FG+ + E+ T+ YP + + ++ +K ++PE P+V +
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC----PPKVYEL 237
Query: 260 IEKC 263
+ C
Sbjct: 238 MRAC 241
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 130
E +L+K L+H +++ Y I +TE +G+L + LK ++ I +
Sbjct: 51 EANLMKQLQHPRLVRLYAV---VTQEPIYIITEYMENGSLVDF-LKTPEGIKLTINKLID 106
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 190
QI G+ ++ ++ IHRDL+ NI V+ KI D GLA ++ + G
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 191 P---EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQI------YKKV 239
++ APE + D++SFG+ + E+VT+ PY T+P I Y+
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223
Query: 240 ISGKKPEALFKV------EDPEVRQFIE 261
PE L+++ E PE R E
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 6/127 (4%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
FV E G L + R + +I GL +LHS+ +I+RDLK DN+ ++
Sbjct: 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD 135
Query: 163 GNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 219
++G +KI D G+ + GTP+++APE+ + Y + VD ++FG+ + EM
Sbjct: 136 -SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 220 VTFDYPY 226
+ P+
Sbjct: 195 LAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+GKG V +Y G +VA +K + E ++ TL+H N+++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKH-WCRQILSGLLYLHSRD 146
V + VTE G+L Y R + R V A + + + G+ YL ++
Sbjct: 65 LLG--VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT-P-EFMAPEVYEE-EY 203
+HRDL N+ V+ K+ D GLA + G P ++ APE E ++
Sbjct: 123 --FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKF 176
Query: 204 NELVDIYSFGMCILEMVTFD---YP 225
+ D++SFG+ + E+ +F YP
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
EI +LK L+H N++ V + + V E L ++ V+ +
Sbjct: 50 EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTP 191
QIL G+ + HS + +IHRD+K +NI V+ + G VK+ D G A L V T
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 192 EFMAPE--VYEEEYNELVDIYSFGMCILEMVT 221
+ APE V + +Y VDI++ G + EM+T
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 54/239 (22%), Positives = 115/239 (48%), Gaps = 12/239 (5%)
Query: 8 EESDSSEFVEVDPTGRYGRYNEI--LGKGA-SKTVYRAFDEYEGIEVAWNQVKLYDFLQS 64
++SDS++ + +Y +N I LG G+ + + + + VA + + ++
Sbjct: 13 KDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ 72
Query: 65 PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVN 124
++++ ++ E +L + H + Y S+ D + + V E G + +++R
Sbjct: 73 -KQVDHVFSERKILNYINHPFCVNLYGSFKDESY--LYLVLEFVIGGEFFTFLRRNKRFP 129
Query: 125 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
+ QI+ YL S + +++RDLK +N+ ++ + G +K+ D G A ++
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRTY 186
Query: 185 ARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242
C GTPE++APE+ + + D ++ G+ I E++ P+ P IY+K++ G
Sbjct: 187 TLC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVYEE----- 201
+HRD+K +N+ ++ G +K+ D G AA L + ++ VGTP+++APEV
Sbjct: 124 VHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 202 --EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV--- 256
Y D +S G+ EM+ P+ E T A+ Y +++ + L EDP+V
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQ--RFLKFPEDPKVSSD 239
Query: 257 -RQFIEKCLATVSSRLSARELLTDPFLQIDDYDS 289
I+ L RL L PF D+++
Sbjct: 240 FLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
E H+L+ + H +I++ ++ T N+ + + + L Y R + I + R
Sbjct: 133 EAHILRAINHPSIIQLKGTF--TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIER 189
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGT 190
+L + YLH +IHRD+K +NIF+N + G+V +GD G A +A + GT
Sbjct: 190 SVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 191 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVT 221
APE+ + Y VDI+S G+ + EM T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 36/233 (15%)
Query: 11 DSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELER 70
D EF D +Y + +I G+G V++A + VA +V L + E E
Sbjct: 1 DQYEFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKV-LME-----NEKEG 53
Query: 71 LYC----EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFT---------SGTLRQYR 117
EI +L+ LKH N++ A + + +G L
Sbjct: 54 FPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN 113
Query: 118 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177
+K I+ V + +L+GL Y+H ++HRD+K NI + + G +K+ D GLA
Sbjct: 114 VKFTLSEIKKV---MKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLAR 167
Query: 178 --ILRKSHAARC----VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 221
L K+ V T + PE+ E +Y +D++ G CI+ EM T
Sbjct: 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CV 188
RQ+LS + Y+H +IHRD+K +N+ VNG + ++ +GD G A R S +
Sbjct: 267 RQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIA 323
Query: 189 GTPEFMAPEVYE-EEYNELVDIYSFGMCILE 218
GT + APEV + Y VDI+S G+ I E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 6/127 (4%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
FV E + G L + + R++ + + +I L +LH R +I+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 163 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 219
+G +K+ D G+ I + GTP ++APE+ E+Y VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 220 VTFDYPY 226
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 38/142 (26%), Positives = 72/142 (50%), Gaps = 7/142 (4%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
V G L + + R ++ + + ++L L LH + VI+RDLK +NI ++
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD 127
Query: 163 GNQGEVKIGDLGLAAI-LRKSHAARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 219
QG + + D GL + ++ GTPE++APE+ Y + VD ++ G+ + EM
Sbjct: 128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
Query: 220 VTFDYPYSECTHPAQIYKKVIS 241
+T P+ + ++Y+K++
Sbjct: 187 LTGLPPFYDENVN-EMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 48/232 (20%)
Query: 29 EILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
+ LG+GA V +A E G++ VA VK+ + ++L L E+ ++K +
Sbjct: 18 KPLGEGAFGQVVKA--EAVGLDNPNETSTVA---VKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 82 -KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR------- 133
KH+NI+ V T + V E G LR + R A R
Sbjct: 73 GKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 134 ---------QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----- 179
Q+ G+ +L S+ IHRDL N+ V +KI D GLA +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDY 187
Query: 180 -RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD---YP 225
RK+ R P ++MAPE +++ Y D++SFG+ + E+ T YP
Sbjct: 188 YRKTTNGR---LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 128 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAA 185
VK + ++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ +I + A
Sbjct: 100 VKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAY 156
Query: 186 RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPY 226
GT E+MAPEV + + D +SFG+ + EM+T P+
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 30 ILGKGASKTVY----RAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+LGKG+ V + DE I++ V + D +++E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
+ S T +R + FV E G L + + + + +I GL +LH R
Sbjct: 62 FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV------GTPEFMAPEVY 199
+I+RDLK DN+ ++ ++G +KI D G+ K H V GTP+++APE+
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMC----KEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 200 E-EEYNELVDIYSFGMCILEMVTFDYPY 226
+ Y + VD +++G+ + EM+ P+
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 18 VDPTGRYGRYNEILGK----GASKTVYRAFDEYEGIEVAWNQ------VKLYDFLQSPEE 67
+DP + R +LGK G V RA E GI+ + VK+ + ++
Sbjct: 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKD 60
Query: 68 LERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR---- 122
L L E+ L+K + KH+NI+ V T + + E G LR++ L+ RR
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLG--VCTQEGPLYVIVEYAAKGNLREF-LRARRPPGP 117
Query: 123 -------------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 169
++ + + Q+ G+ YL SR IHRDL N+ V + +K
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMK 174
Query: 170 IGDLGLAA------ILRKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
I D GLA +K+ R ++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 7/170 (4%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 119
+ + E+++ + E H+ + + S T +R + V E G L + +
Sbjct: 31 ELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-LFLVIEYVNGGDLMFHMQR 89
Query: 120 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 177
R++ + + +I L +LH R +I+RDLK DN+ ++ + G +K+ D G+
Sbjct: 90 QRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEG 146
Query: 178 ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 226
+ + GTP ++APE+ EEY VD ++ G+ + EM+ P+
Sbjct: 147 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 39/143 (27%), Positives = 75/143 (52%), Gaps = 11/143 (7%)
Query: 100 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 158
++ VT++ G+L + +HR ++ + + +WC QI G+ YL ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 159 IFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFG 213
I + + V+I D G+A +L K + TP ++MA E + Y D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 214 MCILEMVTFDY-PYSECTHPAQI 235
+ + EM+++ PY+ P ++
Sbjct: 199 VTVWEMMSYGAEPYAG-MRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 26/170 (15%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------R 121
E LL L+H +I+KFY D + V E G L ++ H R
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114
Query: 122 RVN----IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177
+ + + H QI SG++YL S+ +HRDL N V G VKIGD G++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSR 171
Query: 178 ILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
+ + R G +M PE + ++ D++SFG+ + E+ T+
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKH 130
E +L+KTL+H +++ Y V T I +TE G+L + LK +V + +
Sbjct: 51 EANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLID 107
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 190
+ QI G+ Y+ ++ IHRDL+ N+ V+ KI D GLA ++ + G
Sbjct: 108 FSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGA 164
Query: 191 P---EFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPY 226
++ APE + D++SFG+ + E+VT+ PY
Sbjct: 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 31 LGKGASKTVYRAFDEYEGIE-VAWNQVKLYDFLQSPEE-----LERLYCEIHLLKTLKHR 84
+G+GA V++A D G VA +V++ Q+ EE R + L+T +H
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 85 NIMKFYTSWVDTANRNINFVTEMF--TSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLL 140
N+++ + + +T +F L Y ++ V +K Q+L GL
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAARCVGTPEFMAPEV- 198
+LHS V+HRDLK NI V + G++K+ D GLA I + V T + APEV
Sbjct: 125 FLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181
Query: 199 YEEEYNELVDIYSFGMCILEM 219
+ Y VD++S G EM
Sbjct: 182 LQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 57/218 (26%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 29 EILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
LG+GA V+ E + VA VK S + + E LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDARKDFEREAELLTNFQH 67
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--------------RLKHRRVNIRAVK 129
NI+KFY V T V E G L ++ + + +
Sbjct: 68 ENIVKFYG--VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 130 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 189
QI SG++YL S+ +HRDL N V G VKIGD G++ + + R G
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 190 TP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
+M PE + ++ D++SFG+ + E+ T+
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 82 KHRNIMKFYTS-WVDTA------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQ 134
+ R+IM F S WV ++ + V E G L + + V + K + +
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL-MSNYDVPEKWAKFYTAE 150
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTP 191
++ L +HS +IHRD+K DN+ ++ G +K+ D G + ++ RC VGTP
Sbjct: 151 VVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207
Query: 192 EFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246
++++PEV + + Y D +S G+ + EM+ D P+ Y K++ K
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMDHKN-- 264
Query: 247 ALFKVEDPEVRQFIEKCLATVSSRLSAR-------ELLTDPFLQIDDYDSD 290
+L ED E+ + + + + R E+ PF + D ++ D
Sbjct: 265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWD 315
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 82 KHRNIMKFYTS-WVDTA------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQ 134
+ R+IM F S WV +R + V E G L + + V + + + +
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAE 150
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTP 191
++ L +HS IHRD+K DN+ ++ G +K+ D G + K RC VGTP
Sbjct: 151 VVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 192 EFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPY 226
++++PEV + + Y D +S G+ + EM+ D P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRA---- 127
EI LL+ LKH N++ ++ A+R + + + + L HR + N +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 128 ---VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 181
VK QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 107 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 182 -----SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVTFDYPYSEC 229
+ V T + APE+ Y + +DI++ G E++T + P C
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 15/153 (9%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGT--LRQYRLKHRRVNIRAVKHW 131
EI +LKT+ HR I+ A R + V + L Y + + +
Sbjct: 136 EIDILKTISHRAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARC--- 187
R++L L YLH R +IHRD+K +NIF++ +GD G A L +C
Sbjct: 191 QRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 188 VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 219
GT E +PE+ + Y DI+S G+ + EM
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 47/277 (16%)
Query: 8 EESDSSEFVEVDPTG-------RYGRYN----EILGKGA-----SKTVYRAFDEYEGIEV 51
E + +E+V +DPT + R N + LG GA T Y ++V
Sbjct: 9 ESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV 68
Query: 52 AWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTS 110
A VK+ E E L E+ ++ L H NI+ + T I +TE
Sbjct: 69 A---VKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--TIGGPILVITEYCCY 123
Query: 111 GTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 168
G L + R + + + + + Q+ G+ +L S++ IHRDL N+ + G++
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT--HGKI 179
Query: 169 -KIGDLGLAA-ILRKSH-----AARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEM 219
KI D GLA I+ S+ AR P ++MAPE ++ Y D++S+G+ + E+
Sbjct: 180 VKICDFGLARDIMNDSNYVVKGNAR---LPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 220 VTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
+ PY ++ YK + G +++ PE
Sbjct: 237 FSLGSNPYPGMPVDSKFYKLIKEG------YRMAQPE 267
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 61/263 (23%), Positives = 101/263 (38%), Gaps = 63/263 (23%)
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
++K Y S+ D N+ FV + G + ++ + + ++ + +H
Sbjct: 63 VVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-------------------- 185
IHRD+K DNI ++ + G +K+ D GL R +H +
Sbjct: 121 G--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 186 ------------------------RC-----VGTPEFMAPEV-YEEEYNELVDIYSFGMC 215
RC VGTP ++APEV + Y +L D +S G+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 216 ILEMVTFDYPYSECTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLATVSSRL- 271
+ EM+ P+ T P + KVI+ + K+ PE I K + RL
Sbjct: 238 LFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERLG 295
Query: 272 --SARELLTDPFLQIDDYDSDLR 292
A ++ PF D+ SD+R
Sbjct: 296 RNGADDIKAHPFFSEVDFSSDIR 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYEE----- 201
IHRD+K DN+ ++ + G +K+ D G + + RC VGTP++++PEV +
Sbjct: 164 IHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 202 EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEV---- 256
Y D +S G+ + EM+ D P Y++ Y K++ K +L +D E+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHKN--SLTFPDDIEISKQA 278
Query: 257 RQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSD 290
+ I L RL E+ + PF + D + D
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFD 315
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 126 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTI 158
Query: 186 RC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 243
+ VGT +MAPEV + E Y D ++ G + EM+ P+ Q KK I +
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIKRE 211
Query: 244 KPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDP 280
+ E L K E + ++ L L DP
Sbjct: 212 EVERLVKEVQEEYSEKFSPDARSLCKML----LCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 21/192 (10%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 130
E +++KTL+H ++K + I +TE G+L + LK + + +
Sbjct: 51 EANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLID 106
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 190
+ QI G+ ++ R+ IHRDL+ NI V+ + KI D GLA ++ + G
Sbjct: 107 FSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGA 163
Query: 191 P---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQI------YKKV 239
++ APE + + D++SFG+ ++E+VT+ PY ++P I Y+
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 240 ISGKKPEALFKV 251
PE L+ +
Sbjct: 224 RPENCPEELYNI 235
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VG 189
+ +IL GL LH + ++RDLK +NI ++ + G ++I DLGLA + + + R VG
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 190 TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 226
T +MAPEV + Y D + G I EM+ P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 43/205 (20%)
Query: 56 VKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 115
VK+ S EL L E +LLK + H +++K Y + + + + + E G+LR
Sbjct: 35 VKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRS 92
Query: 116 YRLKHRRV------------------------NIRAVKHWCRQILSGLLYLHSRDPPVIH 151
+ + R+V + + + QI G+ YL + ++H
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL--AEMKLVH 150
Query: 152 RDLKCDNIFVNGNQGEVKIGDLGLA-------AILRKSHAARCVGTPEFMAPE-VYEEEY 203
RDL N+ V + ++KI D GL+ + +++S V ++MA E +++ Y
Sbjct: 151 RDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPV---KWMAIESLFDHIY 206
Query: 204 NELVDIYSFGMCILEMVTFD---YP 225
D++SFG+ + E+VT YP
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 64 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS-GTLRQY----RL 118
S ++ L E LL L H+NI+ V + FV + + G L+ + RL
Sbjct: 48 SEIQVTLLLQESCLLYGLSHQNILP--ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL 105
Query: 119 ----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174
+ ++ + + H QI G+ YLH R VIH+D+ N ++ + +VKI D
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNA 162
Query: 175 LAAILRKS--HAARCVGTPE-----FMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYP 225
L+ L H C+G E +MA E +EY+ D++SFG+ + E++T P
Sbjct: 163 LSRDLFPMDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
Query: 226 YSECTHPAQIYKKVISGKK-------PEALFKV 251
Y E P ++ + G + P+ LF V
Sbjct: 220 YVE-IDPFEMAAYLKDGYRLAQPINCPDELFAV 251
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 27/177 (15%)
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--------LRKSHAAR---- 186
L YLH+ ++HRDLK DN+ + + G +K+ D GL+ I L + H +
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 187 -----CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240
GTPE++APEV + Y + VD ++ G+ + E + P+ T P +++ +VI
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVI 229
Query: 241 SG-----KKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLR 292
S + EAL + + + + A E+ F D++ LR
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 16/164 (9%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 132
E ++ L H +++ Y V T I V E G L Y R + + + + C
Sbjct: 49 EAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 191
+ G+ YL S + VIHRDL N V NQ VK+ D G+ + GT
Sbjct: 107 LDVCEGMAYLESSN--VIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 192 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 232
++ +PEV+ +Y+ D++SFG+ + E+ +SE P
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 64 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--- 120
SPE E ++K L+H +++ Y + I VTE + G+L + LK
Sbjct: 44 SPESFLE---EAQIMKKLRHDKLVQLYAV---VSEEPIYIVTEYMSKGSLLDF-LKDGEG 96
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
R + + + Q+ +G+ Y+ + IHRDL+ NI V G+ KI D GLA ++
Sbjct: 97 RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIE 153
Query: 181 KSHAARCVGTP---EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 221
+ G ++ APE + D++SFG+ + E+VT
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRA---- 127
EI LL+ LKH N++ ++ ++R + + + + L HR + N +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFD-YAEHDLWHIIKFHRASKANKKPMQLP 106
Query: 128 ---VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 181
VK QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 107 RSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 182 -----SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVTFDYPYSEC 229
+ V T + APE+ Y + +DI++ G E++T + P C
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 75/293 (25%)
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
+++ Y S+ D N+ FV + G + ++ + + ++ + +H
Sbjct: 63 VVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-------------------- 185
IHRD+K DNI ++ G +K+ D GL R +H +
Sbjct: 121 G--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 186 ------------------------RC-----VGTPEFMAPEV-YEEEYNELVDIYSFGMC 215
RC VGTP ++APEV Y +L D +S G+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 216 ILEMVTFDYPYSECTHPAQIYKKVISGKK-----PEALFKVEDPEVRQFIEKCLATVSSR 270
+ EM+ P+ T P + KVI+ + P+A PE I K R
Sbjct: 238 LYEMLVGQPPFLAQT-PLETQMKVINWQTSLHIPPQAKLS---PEASDLIIKLCRGPEDR 293
Query: 271 L---SARELLTDPFLQIDDYDSDLRM--------IQYQTDYDEISPLLRQSLY 312
L A E+ PF + D+ SDLR I + TD P+ L+
Sbjct: 294 LGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLW 346
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 31 LGKGASKTVYRAFDEYEGI-------EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
LG GA VY Y G +VA VK S ++ E ++ H
Sbjct: 14 LGHGAFGEVYEG--LYRGRDGDAVELQVA---VKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVN--------IRAVKHWCRQI 135
+NI++ + R I + E+ G L+ + L+ R ++ + R +
Sbjct: 69 QNIVRLIGVSFERLPRFI--LLELMAGGDLKSF-LRENRPRPERPSSLTMKDLLFCARDV 125
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAA-ILRKSH---AARCVG 189
G YL IHRD+ N + G KI D G+A I R S+ R +
Sbjct: 126 AKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 190 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-PYSECT 230
++M PE + + + D++SFG+ + E+ + Y PY T
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 17/199 (8%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKF 89
+G+G V +A G A +K +S E++ L EI L+ L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNNLR-EIQALRRLSPHPNILRL 63
Query: 90 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
D + V E+ + + R + + VK + Q+L L ++H +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--I 121
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLG-LAAILRKSHAARCVGTPEFMAPEV-----YEEEY 203
HRD+K +NI + +K+ D G I K + T + APE Y Y
Sbjct: 122 FHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGY---Y 176
Query: 204 NELVDIYSFGMCILEMVTF 222
+DI++ G E+++
Sbjct: 177 GPKMDIWAVGCVFFEILSL 195
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 25/169 (14%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------- 120
E LL L+H++I++FY V T R + V E G L ++ H
Sbjct: 57 EAELLTVLQHQHIVRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114
Query: 121 --RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178
++ + + QI SG++YL S +HRDL N V G VKIGD G++
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRD 171
Query: 179 LRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
+ + R G +M PE + ++ DI+SFG+ + E+ T+
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 18/149 (12%)
Query: 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165
E+FT + R+ R K + V I + +I+ L +LH +I+RD+K +NI ++ N
Sbjct: 91 ELFTHLSQRE-RFKEQEVQI-----YSGEIVLALEHLHKLG--IIYRDIKLENILLDSN- 141
Query: 166 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY---EEEYNELVDIYSFGMCILEM 219
G V + D GL+ + R GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 220 VTFDYPYS---ECTHPAQIYKKVISGKKP 245
+T P++ E A+I ++++ + P
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 48/230 (20%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNI 86
++LGKG V+ + G A +K+ D + +++R+ E +L TL H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFA---LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 87 MKFYTSWVDTANRNINFVTEMFTSG----TLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
Y + V + + G L Q + + ++ + + ++L L YL
Sbjct: 64 PTLY--ASFQTETYLCLVMD-YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYL 119
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-----------AILRKSHAAR----- 186
H +++RDLK +NI ++ + G + + D L+ LRK
Sbjct: 120 HLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 187 ---------------CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMV 220
VGT E++APEV + + VD ++ G+ + EM+
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 25/192 (13%)
Query: 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165
EMFT R + V+ + +I+ L +LH +++RD+K +NI ++ ++
Sbjct: 91 EMFTHLYQRDN------FSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 166 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMV 220
G V + D GL+ R GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 221 TFDYPYS---ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT------VSSRL 271
T P++ E +++ ++++ P PE + + K L +
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILKCDPP--FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259
Query: 272 SARELLTDPFLQ 283
A E+ PF +
Sbjct: 260 GASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 34/200 (17%)
Query: 47 EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVT 105
E + VA VK+ + ++L L E+ ++K + KH+NI+ + T + + +
Sbjct: 46 EAVTVA---VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIV 100
Query: 106 EMFTSGTLRQY----------------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149
E + G LR+Y R+ ++ + + Q+ G+ YL S+
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--C 158
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPE-VYEEE 202
IHRDL N+ V N +KI D GLA + +K+ R ++MAPE +++
Sbjct: 159 IHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRL--PVKWMAPEALFDRV 215
Query: 203 YNELVDIYSFGMCILEMVTF 222
Y D++SFG+ + E+ T
Sbjct: 216 YTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 132
E ++ L H +++ Y V T + + VTE +G L Y R + +++ + C
Sbjct: 49 EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 191
+ + G+ YL IHRDL N V+ + G VK+ D G+ + G
Sbjct: 107 QDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKF 163
Query: 192 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVT 221
++ PEV+ +Y+ D++SFG+ + E+ T
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 73 CEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHW 131
E ++ H NI+ V T ++ + VTE +G+L + KH + + +
Sbjct: 54 SEASIMGQFDHPNIIHL--EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAARC 187
R I SG+ YL D +HRDL NI VN N K+ D GL+ +L ++ R
Sbjct: 112 LRGIASGMKYL--SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 188 VGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTH 231
P + APE + ++ D++S+G+ + E++++ + PY E ++
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 21/172 (12%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---------RLKHRRVN 124
E+ + + L H+N+++ + + + E G L+Q+ +LK ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 125 IRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 182
+ C QI G+ +L +R +HRDL N V+ +Q EVK+ L L+ + S
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSE 171
Query: 183 -HAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECT 230
+ R P ++APE V E++++ D++SFG+ + E+ T + P+ +
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 16/187 (8%)
Query: 67 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 126
+ R E L L H NI+ S + V E TLR+ +
Sbjct: 21 QRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALPAG 79
Query: 127 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHA 184
Q+L L H++ ++HRDLK NI V+ K+ D G+ +L
Sbjct: 80 ETGRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 185 A---------RCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 234
A +GTP + APE + E D+Y++G+ LE +T + A+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT-GQRVVQGASVAE 196
Query: 235 IYKKVIS 241
I + +S
Sbjct: 197 ILYQQLS 203
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE----- 201
+HRD+K DNI ++ N G +++ D G L + ++ VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 202 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKK----PEALFKVEDPE 255
+Y D +S G+C+ EM+ + P Y+E + Y K+++ K+ P + V + +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKERFQFPAQVTDVSE-D 239
Query: 256 VRQFIEKCLATVSSRLSA---RELLTDPFLQIDDYDS 289
+ I + + + RL + PF D+D+
Sbjct: 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+++G G V+R + G + +K + ++ + E ++ H NI++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
V T + +TE +G L +Y R + + R I +G+ YL D
Sbjct: 71 L--EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDM 126
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-----EFMAPE-VYEE 201
+HRDL NI VN + E K+ D GL+ +L + + APE +
Sbjct: 127 NYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 202 EYNELVDIYSFGMCILEMVTF-DYPYSE 228
++ D++SFG+ + E+++F + PY +
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 30/80 (37%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEYNEL 206
+++RDLK +NI ++ ++G ++I DLGLA + + R VGT +MAPEV E+Y
Sbjct: 123 IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 207 VDIYSFGMCILEMVTFDYPY 226
D + G I EM+ P+
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 23/157 (14%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEE----- 201
+HRD+K DN+ ++ N G +++ D G L + VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 202 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEAL-FKVEDPEV-- 256
Y D +S G+C+ EM+ + P Y+E + Y K+++ K E F + +V
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHK--EHFQFPPDVTDVSE 238
Query: 257 --RQFIEKCLATVSSRL---SARELLTDPFLQIDDYD 288
+ I + + + +RL ++ PF + D+D
Sbjct: 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 31 LGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRN 85
LG+G V A D+ + V VK+ + ++L L E+ ++K + KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-----------------VNIRAV 128
I+ + T + + + E + G LR+Y L+ RR ++ + +
Sbjct: 86 IINLLGAC--TQDGPLYVIVEYASKGNLREY-LRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKS 182
Q+ G+ YL S+ IHRDL N+ V + +KI D GLA + +K+
Sbjct: 143 VSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKT 199
Query: 183 HAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
R ++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 200 TNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 39/262 (14%)
Query: 46 YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105
+ G+ A VK +P+E E+ + L H N+++ +++ V
Sbjct: 17 HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP--YLLVL 74
Query: 106 EMFTSGTLRQYRLKHRRVNIRA------VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 159
E G L+ Y L+ R + ++ ++ SGLL+LH D IH DL N
Sbjct: 75 EFCPLGDLKNY-LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNC 131
Query: 160 FVNGNQGEVKIGDLGLAAILRKSH---AARCVGTP-EFMAPEVYEEEYNELV-------- 207
+ + VKIGD GLA C P ++APE+ E +L+
Sbjct: 132 QLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS 190
Query: 208 DIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK-----KPEALFKVEDP--EVRQF 259
+I+S G+ + E+ T D PY + + Q+ K+V+ + KP+ K D EV QF
Sbjct: 191 NIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQF 249
Query: 260 IEKCLATVSSRLSARE---LLT 278
C +R +A E LLT
Sbjct: 250 ---CWLDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 59/249 (23%), Positives = 112/249 (44%), Gaps = 32/249 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
EI+G+G V + EY G +VA +K Q+ E ++ L H+N+++
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVR 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRR-VNIRAVKHWCRQILSGLLYLHSRD 146
+ + + V E+ + G L + R + R V++ + + + G+ YL S+
Sbjct: 64 LLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPEVYEE-EYN 204
++HRDL NI V+ G K+ D GLA + P ++ APE + +++
Sbjct: 121 --LVHRDLAARNILVS-EDGVAKVSDFGLARVGSM--GVDNSKLPVKWTAPEALKHKKFS 175
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264
D++S+G+ + E+ + Y +P K+V + E +++E P E C
Sbjct: 176 SKSDVWSYGVLLWEV----FSYGRAPYPKMSLKEV--KECVEKGYRMEPP------EGCP 223
Query: 265 ATVSSRLSA 273
A V +++
Sbjct: 224 ADVYVLMTS 232
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 13/204 (6%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 131
EI L+ + NI+K Y +D + ++ + E T G LR+ K + ++ +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 132 CRQILSGLLYLHSRD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 189
GL L+ P +++L + V N ++KI GL IL S + V
Sbjct: 128 AIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIICHGLEKIL-SSPPFKNVN 182
Query: 190 TPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246
+ + ++ EY DIYS G+ + E+ T P+ T +IY +I+
Sbjct: 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLIINKNNSL 241
Query: 247 ALFKVEDPEVRQFIEKCLATVSSR 270
L E++ +E C + S +
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIK 265
|
Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 64 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 123
SPE + E ++K L+H +++ Y + I VTE + G+L +
Sbjct: 44 SPEAFLQ---EAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGK 97
Query: 124 NIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
+R + QI SG+ Y+ + +HRDL+ NI V G K+ D GLA ++
Sbjct: 98 YLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIED 154
Query: 182 SHAARCVGTP---EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 221
+ G ++ APE + D++SFG+ + E+ T
Sbjct: 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 23/167 (13%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------- 120
E LL L+H +I+KFY V+ + V E G L ++ H
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+ + H +QI +G++YL S+ +HRDL N V G VKIGD G++ +
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVY 171
Query: 181 KSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
+ R G +M PE + ++ D++S G+ + E+ T+
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 36/157 (22%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE----- 201
+HRD+K DN+ ++ N G +++ D G + + ++ VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 202 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKK----PEALFKVEDPE 255
+Y D +S G+C+ EM+ + P Y+E + Y K+++ ++ P + V + E
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHEERFQFPSHITDVSE-E 239
Query: 256 VRQFIEKCLATVSSRLSAR---ELLTDPFLQIDDYDS 289
+ I++ + + RL + F + D+++
Sbjct: 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 44/137 (32%), Positives = 72/137 (52%), Gaps = 12/137 (8%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAA-ILRKSHAARCVGT- 190
Q+ +G+ +L S++ +HRDL N+ + +G+ VKI D GLA I+R S+ T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 191 -P-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE 246
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 247 ALFKVEDPEVRQFIEKC 263
D E+ + ++KC
Sbjct: 363 KPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E++G G V R + G + +K + ++ E ++ H NI+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
V T +R + +TE +G L + R + + + R I +G+ YL +
Sbjct: 70 L--EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SEM 125
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTP---EFMAPE-VY 199
+HRDL NI VN N K+ D GL+ L + +G + APE +
Sbjct: 126 NYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 200 EEEYNELVDIYSFGMCILEMVTF-DYPY 226
++ D++S+G+ + E++++ + PY
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVA-WNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
R+ E LG+ A +Y+ G++ A +K + +P++ E L+ L H
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHRRVNIRA-----VK------- 129
NI+ V T + + + E G L ++ R H V + VK
Sbjct: 68 NIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 130 --HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 187
H QI +G+ YL S +H+DL NI + G Q VKI DLGL+ + + R
Sbjct: 126 FLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYRV 182
Query: 188 VGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PY 226
+M PE + +++ DI+SFG+ + E+ +F PY
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 66 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----- 120
E E+ +L L NI + V T + + + E +G L Q+ KH
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLG--VCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 121 ------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174
+ ++ + + QI SG+ YL S + +HRDL N V N +KI D G
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFG 175
Query: 175 LAAILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF--DYPYS 227
++ L S R G +MA E V ++ D+++FG+ + E++T + PY
Sbjct: 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 228 ECT 230
T
Sbjct: 236 HLT 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 63/198 (31%)
Query: 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 183
IHRD+K DNI ++ G +K+ D GL+ K H
Sbjct: 123 IHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 184 -----------------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 219
A VGTP+++APE++ ++ Y + D +S G + E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 220 VTFDYPY-SECTHPAQIYKKVISGKKPEALFKVED----PEVRQFIEKCLATVSSRL--- 271
+ P+ SE +H + Y+K+I+ + E L+ +D E I + + +RL
Sbjct: 242 LIGWPPFCSENSH--ETYRKIINWR--ETLYFPDDIHLSVEAEDLIRRLITNAENRLGRG 297
Query: 272 SARELLTDPFLQIDDYDS 289
A E+ + PF + D+D+
Sbjct: 298 GAHEIKSHPFFRGVDWDT 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 47/287 (16%)
Query: 66 EELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-------- 116
++L L E+ ++K + KH+NI+ + T + + + E + G LR+Y
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 117 --------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 168
+L ++ + + Q+ G+ YL S+ IHRDL N+ V +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVM 173
Query: 169 KIGDLGLAAIL------RKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVT 221
KI D GLA + +K+ R ++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 174 KIADFGLARDVHNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
Query: 222 FD---YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELL 277
YP ++ K+ KP E+ + +C V S R + ++L
Sbjct: 232 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVPSQRPTFKQL- 286
Query: 278 TDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNG 324
++D D L + +Y ++S Q G S SS ++G
Sbjct: 287 ------VEDLDRVLTVTS-TDEYLDLSVPFEQYSPGCPDSPSSCSSG 326
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLL 140
H NI++ V T +R + +TE +G+L ++ L+ + R I SG+
Sbjct: 64 HPNIIRLEG--VVTKSRPVMIITEYMENGSLDKF-LRENDGKFTVGQLVGMLRGIASGMK 120
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA---RCVGTP-EFMAP 196
YL + +HRDL NI VN + K+ D GL+ L S A + P + AP
Sbjct: 121 YLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 197 E-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG 242
E + ++ D++SFG+ + E++++ + PY + ++ + K V G
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 130
E ++K L+H ++ Y + I VTE G+L + LK + + + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAV---VSEEPIYIVTEFMGKGSLLDF-LKEGDGKYLKLPQLVD 106
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 190
QI G+ Y+ + IHRDL+ NI V N KI D GLA ++ + G
Sbjct: 107 MAAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGA 163
Query: 191 P---EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 221
++ APE + D++SFG+ + E+VT
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 41/164 (25%), Positives = 62/164 (37%), Gaps = 31/164 (18%)
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV--- 188
C Q L L LH + K NI + + GL L S A +
Sbjct: 23 CLQCLGALRELHRQA--------KSGNILLTWD---------GLLK-LDGSVAFKTPEQS 64
Query: 189 -GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246
P FMAPEV + Y E DIYS G+ + E + ++ PY+E + I + +++G +
Sbjct: 65 RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD 124
Query: 247 A------LFKVED-PEVRQFIEKCLATVSS-RLSARELLTDPFL 282
L V F+ C + + R +A L
Sbjct: 125 DPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 34/223 (15%)
Query: 26 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
R+ E LG+GA VY+ + VA +K + +E + E L+
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMSD 64
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKH--W 131
L+H NI+ V T + + E G L ++ +++ VK
Sbjct: 65 LQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 132 CR-------QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
C QI +G+ YL S +HRDL N V G VKI D GL+ + +
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADY 179
Query: 185 ARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
R +M PE + ++ DI+SFG+ + E+ ++
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 15/113 (13%)
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE 192
+Q+ +G+ YL R +HRDL N V N VKI D GL+ R ++A E
Sbjct: 137 KQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS---RNIYSADYYKASE 190
Query: 193 -------FMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIY 236
+M PE ++ Y D++++G+ + E+ ++ PY H IY
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 34/243 (13%)
Query: 29 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+ILG+G +V D+ ++VA +KL S E+E E +K H N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPN 62
Query: 86 IMKFYTSWVDTANRN---INFVTEMFTS-GTLRQYRLKHR------RVNIRAVKHWCRQI 135
+MK + ++ V F G L + L R ++ ++ + + I
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVG 189
G+ YL +R+ IHRDL N + + V + D GL+ + R+ A+
Sbjct: 123 ALGMEYLSNRN--FIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAK--- 176
Query: 190 TP-EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISG---K 243
P +++A E + Y D+++FG+ + E+ T PY + +IY + G K
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHGNRLK 235
Query: 244 KPE 246
+PE
Sbjct: 236 QPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 62/259 (23%), Positives = 114/259 (44%), Gaps = 30/259 (11%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGI--EVAWNQVKLY-------DFLQSPEELERLYCE-- 74
++ +++G+G V +A + +G+ + A ++K Y DF E L +L
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 75 -IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK---H 130
I+LL +HR + + N ++F+ + T + + + + + + H
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAAR 186
+ + G+ YL + IHRDL NI V G KI D GL+ ++K+
Sbjct: 129 FAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 187 CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 244
V +MA E Y D++S+G+ + E+V+ PY T A++Y+K+ G +
Sbjct: 186 PV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYR 241
Query: 245 PEALFKVEDPEVRQFIEKC 263
E +D EV + +C
Sbjct: 242 LEKPLNCDD-EVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK------SHAARC 187
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA + K AR
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR- 236
Query: 188 VGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD---YP 225
P ++MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 237 --LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 31/77 (40%), Positives = 36/77 (46%), Gaps = 19/77 (24%)
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT-- 190
RQIL L LHS ++HRD+K NI + G KI DLG AA LR VG
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR-------VGINY 312
Query: 191 --------PEFMAPEVY 199
P + APE Y
Sbjct: 313 IPKEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 14/123 (11%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAILRKSHAARCVGTP- 191
Q+ G+ +L S++ +HRDL N+ + QG+ VKI D GLA + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 192 ---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG---K 243
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 244 KPE 246
KP+
Sbjct: 361 KPD 363
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 33/184 (17%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR----------- 122
E+ +L LK NI++ VD + +TE +G L Q+ L
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQF-LSSHHLDDKEENGNDA 125
Query: 123 ---------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173
++ ++ H QI SG+ YL S + +HRDL N V N +KI D
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADF 182
Query: 174 GLAAILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF--DYPY 226
G++ L R G +MA E + ++ D+++FG+ + E++ + PY
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 227 SECT 230
E T
Sbjct: 243 GELT 246
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ +GKG V +Y G +VA +K + + E ++ L+H N+++
Sbjct: 12 QTIGKGEFGDV--MLGDYRGNKVAVKCIK------NDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRV-NIRAVKHWCRQILSGLLYLHSRD 146
V+ + VTE G+L Y R + R V + + + + YL + +
Sbjct: 64 LLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPE-VYEEEYN 204
+HRDL N+ V+ K+ D GL S P ++ APE + E++++
Sbjct: 123 --FVHRDLAARNVLVS-EDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
D++SFG+ + E+ Y + +P K V+ + E +K++ P+
Sbjct: 178 TKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVP--RVEKGYKMDAPD 222
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAR 186
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 187 CVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQIYKKVISGKK 244
+ ++MAPE ++++ Y D++SFG+ + E+ + PY + +++ G +
Sbjct: 239 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 245 PEALFKVEDPEVRQFIEKC 263
A + PE+ + + C
Sbjct: 296 MRAP-ENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 40/180 (22%), Positives = 79/180 (43%), Gaps = 28/180 (15%)
Query: 119 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178
K +++ VK RQ++ L LH + +IH D+K +N+ + + + + D GL
Sbjct: 102 KEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGL--- 156
Query: 179 LRKSHAARCVGTP-------EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPY---- 226
+ +GTP ++ +PE + Y+ D ++ G+ E++T +P+
Sbjct: 157 ------CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 227 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-RELLTDPFLQI 284
E + K+ +K K F++ L ++ RL+ E++ PFL+I
Sbjct: 211 DEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
V E+ G L ++ K++ V + + Q+ G+ YL + +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 163 GNQGEVKIGDLGLAAILRKS---HAARCVGT-P-EFMAPEVYE-EEYNELVDIYSFGMCI 216
Q KI D GL+ L + A+ G P ++ APE +++ D++SFG+ +
Sbjct: 130 -TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 217 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262
E F Y G+KP K EV Q IE
Sbjct: 189 WE--AFSY-----------------GQKPYKGMK--GNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 17/129 (13%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV-KIGDLGLAAILRKSHAARCVGTP- 191
Q+ G+ +L S++ IHRDL NI + G + KI D GLA +R G
Sbjct: 222 QVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 192 ---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE 246
++MAPE ++ Y D++S+G+ + E+ + PY ++ YK + G
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---- 333
Query: 247 ALFKVEDPE 255
+++ PE
Sbjct: 334 --YRMLSPE 340
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAR 186
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 187 CVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
+ ++MAPE +++ Y D++SFG+ + E+ +
Sbjct: 244 PL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 30/201 (14%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKF 89
++G+GA V + + VA + K D ++ E E E+ +L+TLK NI++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 90 YTSW---------VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
++ + +N+ + E +G + + I+A+ HWC
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI-HWC-------- 116
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA---RCVGTPEFMAPE 197
H D ++HRD+K +N+ ++ N +K+ D G A L + A V T + +PE
Sbjct: 117 --HKND--IVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 198 -VYEEEYNELVDIYSFGMCIL 217
+ Y + VD++S G CIL
Sbjct: 172 LLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 12/75 (16%)
Query: 111 GTLRQYRLKHRRV---------NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 161
G L ++ + +++ +I +K RQ+L+GL LH ++HRD+K +N+ V
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV 342
Query: 162 NGNQGEVKIGDLGLA 176
+ G+VKI D G A
Sbjct: 343 TVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 25/182 (13%)
Query: 64 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 123
S +E + E ++L+H N+++ + V E G L+ Y L+ R
Sbjct: 35 SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVMEFCPLGDLKGY-LRSCRK 91
Query: 124 ------NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177
+ ++ +I GLL+LH + IH DL N + + VKIGD GL+
Sbjct: 92 AELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSH 148
Query: 178 ILRKSH----AARCVGTPEFMAPEVYEEEYNELV--------DIYSFGMCILEMVTF-DY 224
K + ++APE+ +E + L+ +++S G+ I E+
Sbjct: 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208
Query: 225 PY 226
PY
Sbjct: 209 PY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 56/254 (22%), Positives = 111/254 (43%), Gaps = 33/254 (12%)
Query: 29 EILGKGASKTVYRA-FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
++GKG VY + +G ++ VK + + EE+E+ E ++K H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHC-AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
+ + + + M G LR + R + ++ + + Q+ G+ YL S+
Sbjct: 60 SLLGICLPSEGSPLVVLPYM-KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------AILRKSHAARCVGTPEFMAPE 197
+HRDL N ++ + VK+ D GLA ++ + A V ++MA E
Sbjct: 119 --FVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALE 172
Query: 198 -VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-------PEALF 249
+ +++ D++SFG+ + E++T P I ++ G++ P+ L+
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY 232
Query: 250 KV------EDPEVR 257
+V PE+R
Sbjct: 233 EVMLSCWHPKPEMR 246
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 14/133 (10%)
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPE 192
G+ YL + IHRDL NI V N KI D GL+ ++K+ V
Sbjct: 123 RGMDYLSQKQ--FIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPV---R 176
Query: 193 FMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFK 250
+MA E Y D++S+G+ + E+V+ PY T A++Y+K+ G + E
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRLEKPLN 235
Query: 251 VEDPEVRQFIEKC 263
+D EV + +C
Sbjct: 236 CDD-EVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 14/133 (10%)
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPE 192
+G+ YL + IHRDL N+ V G KI D GL+ ++K+ V
Sbjct: 130 TGMQYL--SEKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTMGRLPV---R 183
Query: 193 FMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFK 250
+MA E Y D++SFG+ + E+V+ PY T A++Y+K+ G + E
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRMEKPRN 242
Query: 251 VEDPEVRQFIEKC 263
+D EV + + +C
Sbjct: 243 CDD-EVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 31 LGKGASK--TVYRAFDEYEGIEVAWNQVKLYDFLQSPEE-LERLYCEIHLLKTLKHRNIM 87
+G+G +VY A G V V++ D EE L+ L E+ L +H NIM
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVT---VRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHS 144
+T V T + ++ G+ LK ++ + + L GL YLH
Sbjct: 63 TSWT--VFTTGSWLWVISPFMAYGSANSL-LKTYFPEGMSEALIGNILFGALRGLNYLHQ 119
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLG-LAAILRKSHAARCV-GTPEF-------MA 195
IHR++K +I ++G+ G V + L L +++R A+ V P+F ++
Sbjct: 120 NG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 196 PEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSE 228
PE+ ++ YN DIYS G+ E+ T P+ +
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 740 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.32 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.16 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.99 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.87 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 97.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.79 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.65 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.63 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.49 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.47 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.15 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.81 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.55 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.41 | |
| PLN02236 | 344 | choline kinase | 96.36 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.11 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.09 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.83 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.18 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.87 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.8 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 94.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.76 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.69 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.97 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 92.67 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.79 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 90.71 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.08 | |
| PTZ00296 | 442 | choline kinase; Provisional | 89.75 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.56 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-90 Score=767.96 Aligned_cols=484 Identities=58% Similarity=0.900 Sum_probs=400.7
Q ss_pred CCCCCCCCceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc
Q 004645 7 PEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI 86 (740)
Q Consensus 7 ~~~~~~~~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI 86 (740)
.++++.+++++++|+|||.|+.++||+|+|.+||+|+|..+|..|||..+++.+..+++..+++|+.|+++|+.|+||||
T Consensus 24 ~~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NI 103 (632)
T KOG0584|consen 24 ESEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNI 103 (632)
T ss_pred hhccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCce
Confidence 34577899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 87 Vkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
|+||++|++..++++.+|+|+|++|+|+.|++++++++.+.++.|++|||+||.|||++.||||||||||+||||+++.|
T Consensus 104 irfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G 183 (632)
T KOG0584|consen 104 IRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG 183 (632)
T ss_pred eeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEeccchhhhhccCccccccCCCCCCCccccccccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc
Q 004645 167 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~ 246 (740)
.|||+|+|||+.++.+.....+|||+|||||+|.+.|++.+|||||||||+||+|+++||++|.++++||++|++|.+|.
T Consensus 184 ~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 184 EVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred ceeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCChHHHHHHHHHhhCccCCCCHHHHhcCcccCCCCcchhhhhhhccCcccccchHHhhhhhhcccCCCCCCCCCC
Q 004645 247 ALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 326 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~dPskRpSa~ELL~HPff~~~~~~~~l~~~~~~~~~~~i~pll~~~l~~~~~s~~s~~~~~s 326 (740)
.+.++.+|++++||++||...+.|+||.|||+||||+.++... ..+.. .........++-.+...... .....
T Consensus 264 sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~--~~~~e-~d~~~~~~~~~~~~~~~~~~----~~~~~ 336 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIV--ELAPE-DDMSDPALSLSLRDEDGKKN----KRPKA 336 (632)
T ss_pred HhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccc--cccch-hhcccccccccccccchhhc----CCccc
Confidence 9999999999999999999999999999999999999876531 11110 00000000000000000000 00001
Q ss_pred ccccccCCCCCCCCCccccc--ccccccc-ccc------ccccccccccccccccCCC-ceEEEEEEecCCCCccceeee
Q 004645 327 HYIGYDTENGLDYHPHEFQE--SEIDLFT-CQE------DEHLTNFDISIKGKRREDD-GIFLRLRIADKEGRIRNIYFP 396 (740)
Q Consensus 327 ~~~~~d~~~~~~~~~~e~~~--~~~~~~e-~~~------~~~~~~~d~~~~G~~~~~~-~i~L~Lri~d~~g~~r~I~F~ 396 (740)
+.+.+ ++++-.++.+. ..+..++ ..+ ....+..++.++|+++++. .++|.|||+|.+|+.|||+||
T Consensus 337 n~i~~----~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fp 412 (632)
T KOG0584|consen 337 NAIQF----DYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFP 412 (632)
T ss_pred ccccc----eeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCC
Confidence 11111 12222222111 0011111 111 1236678999999999776 999999999999999999999
Q ss_pred eccCCCCHHHHHHHHHhcCCCChhhHHHHHHHHHHHHHhhCCCccCCCCCCCCCC------CcccccccccCCChhhhhh
Q 004645 397 FDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH------RSSFCHNCASNGCLPDYIL 470 (740)
Q Consensus 397 Fd~~~Dta~svA~EMV~~l~i~~~dv~~IA~~Id~~i~~l~p~w~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 470 (740)
|++++|||.+||.|||+++++++++|..||+|||++|.+|+|.|+.....++++. ..+.|.+|.++.....-.+
T Consensus 413 f~~~~dta~~Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~~~~~s~~~~~~~~~~s~~~~~~s~~~~~~~~~ 492 (632)
T KOG0584|consen 413 FDLEGDTAPSVAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKASTPNDESPHEQHTDNSVSIQRSSESATQSQKSFS 492 (632)
T ss_pred CcCCCcchhHHHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCCCccccchhccCcccccccCCCccccccccccc
Confidence 9999999999999999999999999999999999999999999999877766544 2688999998644443333
Q ss_pred cCCCCCCcccccccccC-ccccccccceeeEE
Q 004645 471 SDGSGAKNLQVLQCSKD-GCAAIHGRFEEITY 501 (740)
Q Consensus 471 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 501 (740)
++...+......+|+.+ .|+..|+||...+.
T Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 524 (632)
T KOG0584|consen 493 SADPQQVAPFVQQSMEDPLSSDVESRFSKNEL 524 (632)
T ss_pred ccccccccccccccccCCCccccccccccccc
Confidence 32333344455666666 89999999987655
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=435.69 Aligned_cols=264 Identities=26% Similarity=0.363 Sum_probs=232.3
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH---HHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP---EELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~---~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
...||-+.+.||+|+||.|-+|+.+.||+.||+|++......... .....+.+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 566778999999999999999999999999999999876543322 123346799999999999999999999855
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC--CCcEEEeccch
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGL 175 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~--~g~VKL~DFGl 175 (740)
....|+||||+.||.|.+++..++.+.+..-+-+++||+.||.|||++| |+||||||+|||+..+ +-.+||+|||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 6788999999999999999999999999999999999999999999999 9999999999999743 23689999999
Q ss_pred hhhhcc-CccccccCCCCCCCccccccc----cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc--cc
Q 004645 176 AAILRK-SHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE--AL 248 (740)
Q Consensus 176 A~~l~~-~~~~~~~GTp~YmAPEvl~~~----ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~--~~ 248 (740)
|++... ....+.||||.|.|||++... |..++||||+||+||-+++|.+||++...+..+.++|..|..+. ..
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 998864 355788999999999999742 55689999999999999999999999887777999999999764 35
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcc
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~ 288 (740)
+..++.++++||.+||. +|++|||+.|+|+||||+.....
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 67789999999999999 99999999999999999865533
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=425.15 Aligned_cols=252 Identities=31% Similarity=0.513 Sum_probs=231.0
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
...||+|..|+||++.|+.|++.+|+|+|... ..+...+++.+|+++++..+||+||+||+.|+.... .++|+|||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEY 159 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEY 159 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhh
Confidence 47799999999999999999999999998532 356778899999999999999999999999988544 79999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 186 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~ 186 (740)
|.+|+|..++...+++++..+..+++++++||.|||. ++ ||||||||+||||+. .|.|||||||.+..+......+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNS-KGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeecc-CCCEEeccccccHHhhhhhccc
Confidence 9999999999999999999999999999999999995 88 999999999999995 5899999999999999888899
Q ss_pred ccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCC----CCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 187 CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE----CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 187 ~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~----~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
++||..|||||.+.+ .|+.++||||||+.++||++|++||.. .....+++..|..+..|.......++++++||.
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 999999999999986 699999999999999999999999976 357788899999888776655569999999999
Q ss_pred HHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 262 KCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 262 kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.||+ +|++|+|+.|||.|||++...
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999 999999999999999997544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=440.74 Aligned_cols=262 Identities=33% Similarity=0.490 Sum_probs=235.9
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
-+-.||..++|..++.||+|||++||.+.+..+|..||+|+|.... .......+++.+||++.++|+|||||+||++|.
T Consensus 10 ~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 10 EVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred CeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 3556666688899999999999999999999999999999997544 445677889999999999999999999999995
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
| ..++|||+|+|..++|..++++.+.++|..++.+++||+.||.|||+++ |||||||..|+|++.+ -+|||+|||
T Consensus 89 D--s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDFG 163 (592)
T KOG0575|consen 89 D--SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDFG 163 (592)
T ss_pred c--CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEecccc
Confidence 5 7899999999999999999999999999999999999999999999999 9999999999999966 599999999
Q ss_pred hhhhhccC--ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004645 175 LAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 175 lA~~l~~~--~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~ 251 (740)
||+.+... ...+.||||.|.|||++.+ .++..+||||+||+||.||+|++||.. .+..+.|.+|...... ++..
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~--~P~~ 240 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYS--MPSH 240 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcc--cccc
Confidence 99988743 4567799999999999985 599999999999999999999999986 6788899999877653 3447
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.++++++||.++|+ +|.+|||+.++|.|+||+..
T Consensus 241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 241 LSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred cCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 89999999999999 99999999999999999543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=408.00 Aligned_cols=266 Identities=28% Similarity=0.399 Sum_probs=227.8
Q ss_pred CCceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeE
Q 004645 13 SEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS 92 (740)
Q Consensus 13 ~~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 92 (740)
..-.+..++..-|.+.+.||.|..++||+|+...++..||||++.+.+. ...++.+.+|++.|+.++||||++++.+
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcCCCCcceEEEE
Confidence 3345556666677999999999999999999999999999999998764 3347889999999999999999999999
Q ss_pred eeecCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEE
Q 004645 93 WVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 93 fvd~~~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL 170 (740)
|+. +..+|+||.||.+|++.+.++.. ..+++..|..+++++|+||.|||.+| .||||||+.||||+ .+|.|||
T Consensus 93 Fvv--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkL 167 (516)
T KOG0582|consen 93 FVV--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKL 167 (516)
T ss_pred EEe--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEE
Confidence 987 78999999999999999988775 46999999999999999999999999 99999999999998 5589999
Q ss_pred eccchhhhhccC-----cc-ccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Q 004645 171 GDLGLAAILRKS-----HA-ARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 241 (740)
Q Consensus 171 ~DFGlA~~l~~~-----~~-~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~ 241 (740)
+|||.+..+... .. .+++|||+|||||++.+ .|+.|+|||||||++.||.+|..||.......-+..++ +
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-q 246 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-Q 246 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 999988655332 12 56689999999999653 59999999999999999999999999866555555544 4
Q ss_pred CCCC--------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 242 GKKP--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 242 g~~p--------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
|..| ....+..+..++.||..||. ||.+||||++||+|+||+....
T Consensus 247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 4443 22334567789999999999 9999999999999999986654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=402.40 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=231.5
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+.+.++||+|+||+||+++.+.|++.+|+|++++..... ..+.+....|..+|.+++||.||+++..| ++...+|+|
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLylV 103 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLYLV 103 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEEEE
Confidence 378899999999999999999999999999998766433 35677899999999999999999999999 558899999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--C
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--S 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~ 182 (740)
+||+.||.|...+.+.+.+++..++.++..|+.||.|||++| ||||||||+|||++ .+|+|+|+||||++..-. .
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCC
Confidence 999999999999999999999999999999999999999999 99999999999999 669999999999985433 3
Q ss_pred ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
...++|||++|||||++.+ .|+..+|.||||+++|+|+||.+||.+ .+...+++++..++.+. .+...++++++||+
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~~-~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLPL-PPGYLSEEARDLLK 258 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCCC-CCccCCHHHHHHHH
Confidence 5566799999999999874 699999999999999999999999987 67788999999888432 34557999999999
Q ss_pred HHhh-CccCCC----CHHHHhcCcccCCCCcchh
Q 004645 262 KCLA-TVSSRL----SARELLTDPFLQIDDYDSD 290 (740)
Q Consensus 262 kcL~-dPskRp----Sa~ELL~HPff~~~~~~~~ 290 (740)
++|. +|.+|+ .+.++-+||||+..++...
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 9999 999996 6899999999998888654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=407.22 Aligned_cols=260 Identities=29% Similarity=0.510 Sum_probs=227.3
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC-HHHHHHHHHHHHHHHhCC-CCCcceeeeEeee
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLK-HRNIMKFYTSWVD 95 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~-~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd 95 (740)
....|+| ++++.||+|+||+|++|.+..+|..||+|++........ ....+.+.+|+.++++++ ||||+++++++..
T Consensus 13 ~~~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 3456777 999999999999999999999999999997765421111 134556778999999998 9999999998744
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
...+|+||||+.||+|.+++...+++.+..++.+++||+.|++|||++| |+||||||+|||++.+.+++||+|||+
T Consensus 92 --~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 92 --PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred --CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 5669999999999999999999999999999999999999999999999 999999999999997657999999999
Q ss_pred hhhh--ccCccccccCCCCCCCcccccc-c-c-CcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 176 AAIL--RKSHAARCVGTPEFMAPEVYEE-E-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 176 A~~l--~~~~~~~~~GTp~YmAPEvl~~-~-y-s~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
+... ......+.+|||.|+|||++.+ . | +.++||||+||+||.|++|.+||.+ .+...++.++..|.... +.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~~--p~ 244 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFKI--PS 244 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCccC--CC
Confidence 9988 3456678899999999999985 3 6 4789999999999999999999998 67778888888887643 33
Q ss_pred CC-ChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 251 VE-DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 251 ~~-spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.. +++++.||.+||. +|.+|+|+.+++.||||+..
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 34 9999999999999 99999999999999999873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=415.92 Aligned_cols=263 Identities=35% Similarity=0.563 Sum_probs=234.8
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
.||..+| .-.++||+|+.|.||.|....+++.||+|++.+... ...+-+.+|+.+|+.++|+|||+|++.|+.
T Consensus 269 ~dP~~~y-~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-- 341 (550)
T KOG0578|consen 269 GDPRSKY-TDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLV-- 341 (550)
T ss_pred CChhhhh-cchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcc--
Confidence 7888888 555789999999999999999999999999987642 234568999999999999999999999987
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
.+.+|+||||++||+|.+.+.. -.+++.+++.+++.++.||+|||.+| |||||||.+|||++ .+|.|||+|||++.
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFca 417 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCA 417 (550)
T ss_pred cceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeee
Confidence 4789999999999999997544 55999999999999999999999999 99999999999998 56899999999998
Q ss_pred hhccC--ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 178 ILRKS--HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 178 ~l~~~--~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
.+... ...+.+|||+|||||++. ..|++++||||||++++||+-|++||-.......+|.....|..........++
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP 497 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence 87654 345678999999999998 569999999999999999999999998767777888888889888888888999
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcchhh
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDL 291 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~~l 291 (740)
++++|+.+||. |+.+|++|.|||.||||+.....+.+
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL 535 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSL 535 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHh
Confidence 99999999999 99999999999999999766654443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=399.25 Aligned_cols=255 Identities=33% Similarity=0.515 Sum_probs=218.2
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+..++.||+|+||+||++.+..+|...|+|.+.+.. .. ..+.+.+|+.+|++|+|||||++++.........++++
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeeccc---ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 367899999999999999999999999999998652 22 27789999999999999999999996332222479999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--
Q 004645 105 TEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-- 181 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~-- 181 (740)
|||+++|+|.+++.+++ ++++..++.+.+||++||+|||++| ||||||||+|||++...+.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999987 7999999999999999999999999 999999999999996357999999999987663
Q ss_pred ---CccccccCCCCCCCcccccccc--CcccchhhhhhHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCCCcccccCCChH
Q 004645 182 ---SHAARCVGTPEFMAPEVYEEEY--NELVDIYSFGMCILEMVTFDYPYSE-CTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 182 ---~~~~~~~GTp~YmAPEvl~~~y--s~ksDIWSLGvILyELlTG~~Pf~~-~~~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
.......|||.|||||++...+ ..++|||||||+++||+||..||.+ ....+.++.....+..| .++..++++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~ 251 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDE 251 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHH
Confidence 2234567999999999998432 3499999999999999999999987 34445555555555455 677889999
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
+++||.+|+. +|.+||||.+||+|||++...
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999 999999999999999997544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=395.30 Aligned_cols=260 Identities=28% Similarity=0.484 Sum_probs=227.9
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
+-.|.| .+.+.||+|+||+||+|+++.++..||||.|.+... +....+.+..|+.+|+.|+|||||.+++++.. .
T Consensus 7 ~~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~ 81 (429)
T KOG0595|consen 7 RVVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIED--D 81 (429)
T ss_pred cccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--C
Confidence 345677 777889999999999999999999999999876543 56677889999999999999999999997744 7
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC-C----CcEEEecc
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-Q----GEVKIGDL 173 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~-~----g~VKL~DF 173 (740)
+.+|+|||||.||+|..|+.+++.+++..++.++.||+.||++||+++ ||||||||.|||++.. . -.+||+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 799999999999999999999999999999999999999999999999 9999999999999854 1 35899999
Q ss_pred chhhhhccCc-cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-Cccccc
Q 004645 174 GLAAILRKSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-PEALFK 250 (740)
Q Consensus 174 GlA~~l~~~~-~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~-p~~~~~ 250 (740)
|+|+.+.... ..+.+|+|.|||||++. ++|+.|+|+||+|+|+|+|++|+.||.. .++.++...+..|.. ...+..
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhh
Confidence 9999988654 45678999999999995 7899999999999999999999999987 566777777776653 334455
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
..++..++++-..|. ++..|.+..+-+.|+|+....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 667778899999998 899999999999999997544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=412.10 Aligned_cols=286 Identities=25% Similarity=0.439 Sum_probs=247.6
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
-.|-| ++++.||+|+.|.|-+|++..||+.+|||+|.+.. .........+.+||-+|+.|.||||+++|++| +.+.
T Consensus 10 tiGpw-kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~ 85 (786)
T KOG0588|consen 10 TIGPW-KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQ 85 (786)
T ss_pred cccce-eccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCc
Confidence 34555 99999999999999999999999999999997653 22344567789999999999999999999988 5588
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+|+|.||++||.|++|+.+.+++++..++++++||+.|+.|||..+ |+||||||+|+|++.+ +.|||+|||+|..-
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLE 162 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecc
Confidence 99999999999999999999999999999999999999999999999 9999999999999966 46999999999875
Q ss_pred ccC-ccccccCCCCCCCccccccc-c-CcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004645 180 RKS-HAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256 (740)
Q Consensus 180 ~~~-~~~~~~GTp~YmAPEvl~~~-y-s~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spel 256 (740)
.+. ...+.||+|.|+|||++.|. | +.++||||.|||||.||||++||.+ .|...++.+|..|.+- ++..+++++
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~ea 239 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEA 239 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHH
Confidence 544 55778999999999999864 5 6899999999999999999999996 8899999999999874 457789999
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcCcccCCCCcchhhhh--------hhccCcccccchHHhhhhhhcc
Q 004645 257 RQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRM--------IQYQTDYDEISPLLRQSLYGIY 315 (740)
Q Consensus 257 rdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~~l~~--------~~~~~~~~~i~pll~~~l~~~~ 315 (740)
++||.+||. ||++|+|.+|+++|||+........... +......++|.|.+-+.+.-..
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~iLw 307 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCILW 307 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhhee
Confidence 999999999 9999999999999999987765544321 1222345577777777665444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=379.70 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=229.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||.|+||.|.+++++.+|..+|+|++++.+.. .-...+...+|..+|+.+.||.++++++.|.+ ...+|+||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~lymvm 123 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLYMVM 123 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEEEEE
Confidence 4568999999999999999999999999999866532 34556788999999999999999999999866 78999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~ 185 (740)
||++||.|..|+++.+++++..++.++.||+.||+|||+++ |++|||||+|||+| ..|.+||+|||+|...... ..
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TW 199 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EE
Confidence 99999999999999999999999999999999999999999 99999999999999 5589999999999887766 66
Q ss_pred cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
+.||||.|+|||++. ..|+.++|.|||||++|||+.|.+||.+ .++.++|.+|..|... ++...++++++||.++|
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v~--fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKVK--FPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCccc--CCcccCHHHHHHHHHHH
Confidence 779999999999987 5699999999999999999999999987 6779999999999863 45677999999999999
Q ss_pred h-CccCC-----CCHHHHhcCcccCCCCcch
Q 004645 265 A-TVSSR-----LSARELLTDPFLQIDDYDS 289 (740)
Q Consensus 265 ~-dPskR-----pSa~ELL~HPff~~~~~~~ 289 (740)
+ |-++| .-..++..||||+..++..
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 9 98888 3567999999999877753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=385.42 Aligned_cols=245 Identities=31% Similarity=0.462 Sum_probs=218.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.++||+|+||+||++.+..+|..||+|.+.... -+....+.+..|+.+|++|+|||||++|+.-+..++..++||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~--md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM--MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh--ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 388899999999999999999999999999998433 245677889999999999999999999994444556679999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 105 TEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPP--VIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~--IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
||||.+|+|.+.++. .+.++++.++.++.|++.||..||+.-+. |+||||||.|||++.+ |.|||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHhH
Confidence 999999999987655 36799999999999999999999995444 9999999999999955 8999999999999
Q ss_pred hccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004645 179 LRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 179 l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
+.... ..+.+|||.||+||++.+ .|+.++||||+||++|||..-+.||.+ .+..++-++|.+|..|.-....++..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 87653 456789999999999885 699999999999999999999999998 58899999999998876666788999
Q ss_pred HHHHHHHHhh-CccCCCCH
Q 004645 256 VRQFIEKCLA-TVSSRLSA 273 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa 273 (740)
++.+|..|+. +|..||+.
T Consensus 257 l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHccCCcccCCCc
Confidence 9999999999 99999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=404.03 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=226.2
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
.+++.||.|+|++|++|.++.++..+|||++.+.- ...+....-+..|-.+|.+| .||.|+++|..|.| ...+|+|
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~-Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sLYFv 152 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY-IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESLYFV 152 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHH-HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccceEEE
Confidence 88999999999999999999999999999886443 22333445577899999999 99999999999966 6789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
+||+++|+|.+|+.+.+.|++.-++.++.||+.||+|||++| ||||||||+|||++++ +++||+|||.|..+.+..
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999999 9999999999999955 899999999998875321
Q ss_pred --------------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004645 184 --------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 184 --------------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~ 248 (740)
..+++||..|.+||++.. ..+..+|||+||||+|+|+.|.+||.+ .|...++++|+.-.. .+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~y--~f 306 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALDY--EF 306 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhcc--cC
Confidence 145789999999999985 578899999999999999999999987 778889999886544 34
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcch
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 289 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~ 289 (740)
+...++.+++||+++|. +|++|+|+.+|..||||...++..
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 56678999999999999 999999999999999999888764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=378.02 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=215.2
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+|.+ ..++|+|+||+||+++++.||+.||||++.-. ..++...+-..+||++|++|+|+|+|.++++| ..++.++
T Consensus 3 kYE~-LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklh 77 (396)
T KOG0593|consen 3 KYEK-LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLH 77 (396)
T ss_pred HHhh-hhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeE
Confidence 4644 45699999999999999999999999987633 34566677889999999999999999999988 4478999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+|||+..-|.++-..-..++...++.+++|++.|+.|||+++ +|||||||+||||+. .|.+||||||+|+.+..+
T Consensus 78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~-~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQ-NGVVKLCDFGFARTLSAP 154 (396)
T ss_pred EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEec-CCcEEeccchhhHhhcCC
Confidence 99999988766665444478999999999999999999999999 999999999999994 479999999999988743
Q ss_pred --ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCc-----------
Q 004645 183 --HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE----------- 246 (740)
Q Consensus 183 --~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~p~----------- 246 (740)
..+.++.|.+|+|||++.+ +|+..+||||+||++.||+||++.|++.++.+|+|..... |..+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 2345689999999999986 5999999999999999999999999999999999865432 22210
Q ss_pred ----------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 247 ----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 247 ----------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.-+...+..+.+|+++||. ||.+|++.++||.||||
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 1123456688999999999 99999999999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=392.76 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=225.5
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+..+||+||||.||+|+-+.||..+|+|++++.... ...+.+.+..|-.+|...++|.||++|.+|.+ ..++|+||
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~LYLiM 220 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYLYLIM 220 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCeeEEEE
Confidence 6778999999999999999999999999999877643 34567889999999999999999999999955 78999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc----
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK---- 181 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~---- 181 (740)
||++||++..++.+.+.+++..++.++.+++.|+..||++| +|||||||+|+||| ..|++||+||||++.+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999999 99999999999999 558999999999853210
Q ss_pred --------------------Cc-------------------------cccccCCCCCCCcccccc-ccCcccchhhhhhH
Q 004645 182 --------------------SH-------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMC 215 (740)
Q Consensus 182 --------------------~~-------------------------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvI 215 (740)
.. ....+|||.|||||++.+ .|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00 113479999999999985 59999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHhhCccCCCC---HHHHhcCcccCCCCcch
Q 004645 216 ILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDYDS 289 (740)
Q Consensus 216 LyELlTG~~Pf~~~~~~~~i~k~i~~g~~--p~~~~~~~spelrdLI~kcL~dPskRpS---a~ELL~HPff~~~~~~~ 289 (740)
|||||.|.+||.. .++.+.+++|..... ...-....++++++||.+||.+|.+|+- ++||.+||||+..++..
T Consensus 378 myEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 378 MYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcch
Confidence 9999999999987 788999999987652 2222334679999999999999999985 89999999999888763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=389.18 Aligned_cols=277 Identities=26% Similarity=0.329 Sum_probs=227.7
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
...| ...++||+|+||.||+|++..+|+.||+|.|.+... .+.......+||.+|++|+||||+++.+..++.....
T Consensus 116 ~~~f-eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSF-EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHH-HHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 3445 335789999999999999999999999999987542 3455667889999999999999999999887765689
Q ss_pred EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 101 INFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
+|+|+|||+. +|.-++.. .-+|++.+++.+++||+.||+|||++| |+|||||+.||||| +.|.+||+|||||+++
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeec
Confidence 9999999965 77777555 347999999999999999999999999 99999999999999 6699999999999987
Q ss_pred ccCc---cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC----------
Q 004645 180 RKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK---------- 243 (740)
Q Consensus 180 ~~~~---~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~---------- 243 (740)
.... .+..+-|.+|+|||++.| .|+.++|+||.||||.||++|++.|.+.+..+|+-+.+.- |.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 6543 344578999999999986 4999999999999999999999999998888887654432 11
Q ss_pred CCc---------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcchhhhhhhccCcccccc
Q 004645 244 KPE---------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEIS 304 (740)
Q Consensus 244 ~p~---------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~~l~~~~~~~~~~~i~ 304 (740)
+|. ..++..++.+.+|+.++|. +|.+|.||.++|+++||...........++......++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~ 425 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELD 425 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHH
Confidence 110 1135567899999999999 999999999999999997766655444444333333333
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.39 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=220.4
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||+||+|.+..+|..||+|+++.... ......+.+.+|+.+|++++||||+++++++.+ ...++
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 2 DL-ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred Cc-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEE
Confidence 45 788999999999999999999999999999875432 123345678899999999999999999997754 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||||+.+|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC
Confidence 99999999999999988889999999999999999999999999 99999999999998 4579999999999876543
Q ss_pred ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
.....||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+... ++...++.+++||.
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~ 230 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLE--FPRHLDLYAKDLIK 230 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcC--CCccCCHHHHHHHH
Confidence 234579999999999875 588999999999999999999999987 5667788888777543 34556899999999
Q ss_pred HHhh-CccCCCC-----HHHHhcCcccCCCCc
Q 004645 262 KCLA-TVSSRLS-----ARELLTDPFLQIDDY 287 (740)
Q Consensus 262 kcL~-dPskRpS-----a~ELL~HPff~~~~~ 287 (740)
+||. +|.+|++ +.++++||||+..++
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999 9999995 999999999976544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=375.79 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=222.5
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
..| ++.+.||+|+||+||+|.+..+|..||+|+++.... ......+.+.+|+.+|++++||||++++++|.+ ...+
T Consensus 18 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 18 SDF-EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 445 889999999999999999999999999999875432 223445678999999999999999999998855 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCC
Confidence 999999999999999998889999999999999999999999999 99999999999998 457999999999976644
Q ss_pred CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
.. ....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+ .++..+++.+..+..+ ++...++.+++||
T Consensus 171 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li 246 (329)
T PTZ00263 171 RT-FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK--FPNWFDGRARDLV 246 (329)
T ss_pred Cc-ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC--CCCCCCHHHHHHH
Confidence 32 34579999999999874 588999999999999999999999986 5667788888877643 3455789999999
Q ss_pred HHHhh-CccCCCC-----HHHHhcCcccCCCCcc
Q 004645 261 EKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 288 (740)
Q Consensus 261 ~kcL~-dPskRpS-----a~ELL~HPff~~~~~~ 288 (740)
.+||. +|.+|++ +.+++.||||...++.
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 99999 9999997 7999999999865443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=388.54 Aligned_cols=260 Identities=31% Similarity=0.404 Sum_probs=218.8
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeec
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDT 96 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~ 96 (740)
+.-..|| .+.+.||.|+||.||+|....+|..||||.+|..- ..-++. .=.+|++.|++|+ |||||++++++.+.
T Consensus 6 ~~~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 6 VIFMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF--YSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hhHHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh--ccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 3445678 77899999999999999999999999999887432 122222 2358999999998 99999999998774
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
.. .+|||||||+ .+|.++++.. +.|++..++.|++||++||+|+|.+| +.||||||+|||+.++ ..|||+||||
T Consensus 82 ~~-~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGL 156 (538)
T KOG0661|consen 82 DR-ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGL 156 (538)
T ss_pred Cc-eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEeccccc
Confidence 33 9999999994 5888887654 67999999999999999999999999 9999999999999966 4899999999
Q ss_pred hhhhccC-ccccccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC-------
Q 004645 176 AAILRKS-HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK------- 244 (740)
Q Consensus 176 A~~l~~~-~~~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~------- 244 (740)
|+..... ..+.++.|.+|+|||++. +.|+.++||||+|||++|+.+.++.|.+.+..+||++...- |..
T Consensus 157 ARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 157 AREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 9877654 446678999999999886 46999999999999999999999999999999999985432 111
Q ss_pred ------------C-------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 245 ------------P-------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 245 ------------p-------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
| ..+....++++.++|.+||. ||.+||||.++|+||||+...
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1 12234467899999999999 999999999999999998654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=391.18 Aligned_cols=263 Identities=30% Similarity=0.499 Sum_probs=230.5
Q ss_pred CceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEe
Q 004645 14 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 93 (740)
Q Consensus 14 ~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 93 (740)
....++|...| +..+.||+|+||.||+|.|..+++.||+|++.+.. ...+.+.+.+|+.+|.+++++||.++|+.|
T Consensus 5 ~~~~~~~~~~~-~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsy 80 (467)
T KOG0201|consen 5 DVLKIDPELLY-TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSY 80 (467)
T ss_pred hhhcCCccccc-ccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhhe
Confidence 34456777888 44599999999999999999999999999998765 456678899999999999999999999999
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
+. +..++++||||.||++.+.+.....+++..+..++++++.||.|||+.+ .+|||||+.|||+... |.|||+||
T Consensus 81 l~--g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~Df 155 (467)
T KOG0201|consen 81 LK--GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADF 155 (467)
T ss_pred ee--cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEec
Confidence 87 6789999999999999999888887899999999999999999999999 9999999999999955 89999999
Q ss_pred chhhhhccC--ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 174 GLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 174 GlA~~l~~~--~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
|++..+... ...+++|||.|||||++.+ .|+.++||||||++++||++|++||.+......++ ++....|..+..
T Consensus 156 gVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--lIpk~~PP~L~~ 233 (467)
T KOG0201|consen 156 GVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--LIPKSAPPRLDG 233 (467)
T ss_pred ceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--eccCCCCCcccc
Confidence 999877654 3367899999999999986 69999999999999999999999999866533222 233445666666
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
..++.+++||+.||. +|..||+|.+||+|+|++....
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k 271 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKK 271 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCC
Confidence 889999999999999 9999999999999999987543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=373.48 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=215.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
++||+|+||+||+|.+..+|..||+|+++.... ........+.+|+.+|++++||||+++++.|.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 469999999999999999999999999875332 233456678899999999999999999998754 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Ccccc
Q 004645 109 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAR 186 (740)
Q Consensus 109 ~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~~ 186 (740)
++|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ ..+.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 99999999988889999999999999999999999999 99999999999998 457999999999865322 22334
Q ss_pred ccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh
Q 004645 187 CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265 (740)
Q Consensus 187 ~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~ 265 (740)
.+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.. .+...++..+..+.. .++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 579999999999874 589999999999999999999999976 455666666665543 2345678999999999999
Q ss_pred -CccCCC-----CHHHHhcCcccCCCCcc
Q 004645 266 -TVSSRL-----SARELLTDPFLQIDDYD 288 (740)
Q Consensus 266 -dPskRp-----Sa~ELL~HPff~~~~~~ 288 (740)
+|.+|| ++.++++||||+..++.
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=381.79 Aligned_cols=255 Identities=33% Similarity=0.514 Sum_probs=212.6
Q ss_pred CceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeE-EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeE
Q 004645 14 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIE-VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS 92 (740)
Q Consensus 14 ~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~-VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 92 (740)
...++++..-- +.+.||+|+||+||+|. +.|.. ||+|++...+. .....+.|.+|+.+|.+|+|||||+|+++
T Consensus 34 ~~~~i~~~~l~--~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 34 PEEEIDPDELP--IEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cceecChHHhh--hhhhcccCCceeEEEEE--eCCceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34555555543 45669999999999994 56777 99998875443 22337789999999999999999999998
Q ss_pred eeecCCC-eEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEE
Q 004645 93 WVDTANR-NINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 169 (740)
Q Consensus 93 fvd~~~~-~i~lV~Ey~~gGSL~~~l~~--~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VK 169 (740)
+.. .. ..++||||+++|+|..++.+ .+.++...+..|+.||++||.|||++++ ||||||||+|||++.+.-++|
T Consensus 108 ~~~--~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~K 184 (362)
T KOG0192|consen 108 CTS--PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLK 184 (362)
T ss_pred EcC--CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEE
Confidence 754 33 78999999999999999888 5789999999999999999999999986 999999999999995533999
Q ss_pred EeccchhhhhccC--ccccccCCCCCCCccccccc---cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Q 004645 170 IGDLGLAAILRKS--HAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 244 (740)
Q Consensus 170 L~DFGlA~~l~~~--~~~~~~GTp~YmAPEvl~~~---ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~ 244 (740)
|+|||+++..... ......||+.|||||++.+. |+.++|||||||++|||+||+.||.+... .++...+..+..
T Consensus 185 I~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 185 IADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGL 263 (362)
T ss_pred ECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCC
Confidence 9999999877653 23335799999999999953 99999999999999999999999998766 555555554443
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 245 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 245 p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
...++...++.+..++++||. +|.+||+..+++.
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 334555589999999999999 9999999999874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=371.39 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=217.6
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||.||+|.+..+|..||+|+++.... ........+..|+.+|+.++||||+++++++.. ...+|
T Consensus 2 ~y-~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 2 DF-QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred Cc-EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEE
Confidence 45 889999999999999999999999999999875431 223455678899999999999999999998854 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-
Confidence 99999999999999988889999999999999999999999999 99999999999998 457999999999976544
Q ss_pred ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc------ccCCChH
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL------FKVEDPE 255 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~------~~~~spe 255 (740)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+......... ....+++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 3345579999999999874 589999999999999999999999986 5566666655543221111 1245889
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
+.+||.+||. +|.+||++.++++||||.....
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 9999999999 7999999999999999986443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=375.40 Aligned_cols=255 Identities=25% Similarity=0.462 Sum_probs=216.3
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.++||+|+||+||+|.+..+|..||+|+++..... .......+.+|+.+|+.++||||+++++.|.+ ...+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~ 80 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYLIM 80 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEEEE
Confidence 7889999999999999999999999999999754321 23445678899999999999999999998855 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-- 183 (740)
||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccccc
Confidence 99999999999988889999999999999999999999999 99999999999998 45799999999986543211
Q ss_pred --------------------------------------cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCC
Q 004645 184 --------------------------------------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDY 224 (740)
Q Consensus 184 --------------------------------------~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~ 224 (740)
....+||+.|+|||++. ..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 11246999999999987 458999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCccc--ccCCChHHHHHHHHHhhCccCCCC---HHHHhcCcccCCCCc
Q 004645 225 PYSECTHPAQIYKKVISGKKPEAL--FKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDY 287 (740)
Q Consensus 225 Pf~~~~~~~~i~k~i~~g~~p~~~--~~~~spelrdLI~kcL~dPskRpS---a~ELL~HPff~~~~~ 287 (740)
||.. .+..+.+..+......... ....++++++||.+||.+|.+|++ +.++|.||||+..++
T Consensus 238 Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 238 PFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9987 4456666666654432222 224689999999999999999997 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=374.39 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=215.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||+||+|.+..+|..||+|+++.... ........+..|+.++.+++|+||+++++.|.+ ...+|+||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEEEE
Confidence 788999999999999999999999999999875432 223445678899999999999999999998854 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-- 183 (740)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. .+.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~-~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDS-KGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECC-CCCEEEeeccCcccccccccc
Confidence 99999999999998899999999999999999999999999 999999999999984 5799999999986543210
Q ss_pred -----------------------------------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCC
Q 004645 184 -----------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYS 227 (740)
Q Consensus 184 -----------------------------------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~ 227 (740)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 123479999999999874 58999999999999999999999998
Q ss_pred CCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHhhCc---cCCCCHHHHhcCcccCCCCcc
Q 004645 228 ECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATV---SSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 228 ~~~~~~~i~k~i~~g~~p~~~~--~~~spelrdLI~kcL~dP---skRpSa~ELL~HPff~~~~~~ 288 (740)
. .+...+++.+........++ ...++++++||.+++.+| ..||++.|+++||||+..++.
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 238 S-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred C-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 6 55677777777643222222 236889999999977643 457899999999999877654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=372.16 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=218.3
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||+||+|.+..+|..||+|+++..... .......+..|+.+|..++||||+++++.|.+ ...++
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 2 DF-EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred Cc-eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEE
Confidence 56 8889999999999999999999999999998754321 22445678899999999999999999998854 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCccc
Confidence 99999999999999988889999999999999999999999999 99999999999998 4479999999998765433
Q ss_pred c-------------------------------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCC
Q 004645 183 H-------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT 230 (740)
Q Consensus 183 ~-------------------------------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~ 230 (740)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 233469999999999875 58999999999999999999999998744
Q ss_pred CHHHHHHHHHcC--CCCcccccCCChHHHHHHHHHhhCccCCCC-HHHHhcCcccCCCCc
Q 004645 231 HPAQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLATVSSRLS-ARELLTDPFLQIDDY 287 (740)
Q Consensus 231 ~~~~i~k~i~~g--~~p~~~~~~~spelrdLI~kcL~dPskRpS-a~ELL~HPff~~~~~ 287 (740)
....+..+... ..........++++++||.+||.+|.+|++ +.++|+||||+..++
T Consensus 235 -~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 235 -LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred -HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence 55566666652 222222233689999999999999999999 999999999986554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.85 Aligned_cols=258 Identities=29% Similarity=0.421 Sum_probs=219.5
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee---cCCC
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD---TANR 99 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd---~~~~ 99 (740)
+||...+.||+|+||.|+.|.++.+|..||+|++. +..++....++.++|+++|+.++|+||+.+++.+.. ..-+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 33355689999999999999999999999999765 334567788999999999999999999999998865 2345
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+|+|+|+| +.+|.+.++.++.++...+..+++|||.||+|+|+.+ |+||||||.|+|++.+ ..+||+|||+|+..
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceeec
Confidence 799999999 6789998888888999999999999999999999999 9999999999999966 58999999999988
Q ss_pred c----cCccccccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc------------
Q 004645 180 R----KSHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS------------ 241 (740)
Q Consensus 180 ~----~~~~~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~------------ 241 (740)
. ....+.++-|.+|.|||++. ..|+.++||||+|||+.||++|++-|.+.....|+...+..
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 5 44556778999999999886 46999999999999999999999999886665555322110
Q ss_pred ------------CCCC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 242 ------------GKKP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 242 ------------g~~p----~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
+..| ..+++..+|.+.+|+++||. ||.+|+|++|+|.||||....
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 1111 23456789999999999999 999999999999999997543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=361.84 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=227.1
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
..| .+.+.||+|.|+.||++.+..+|+.+|+|++....+.+. ..+.+.+|+++.+.|+||||+++.+.+ ......
T Consensus 11 d~y-~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~ 85 (355)
T KOG0033|consen 11 DNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSI--QEESFH 85 (355)
T ss_pred hhh-hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhh--ccccee
Confidence 344 678899999999999999999999999999987765443 678899999999999999999999976 446789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC--CcEEEeccchhhhh
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~--g~VKL~DFGlA~~l 179 (740)
|+|+|+++|++|..-+...-.+++..+..+++|||.+|.|||.++ |||||+||+|+|+-.+. .-+||+|||+|..+
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999999999876666677899999999999999999999999 99999999999996432 35899999999887
Q ss_pred ccCc-cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChH
Q 004645 180 RKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPE 255 (740)
Q Consensus 180 ~~~~-~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~--p~~~~~~~spe 255 (740)
.... ....+|||.|||||++.. .|+..+|||+-|||||-|+.|.+||.+ .+...+|+.|..|.. |...+..++++
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 7443 345679999999999984 699999999999999999999999987 567889999999874 56678889999
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
+++||++||. +|++|+|+.|+|+|||++...
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 9999999999 999999999999999997654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=374.73 Aligned_cols=257 Identities=22% Similarity=0.383 Sum_probs=213.9
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+|++++||||++++++|.+ ...+|
T Consensus 2 ~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 2 DF-HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred Cc-eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeE
Confidence 35 788999999999999999999999999999865332 223456788999999999999999999998854 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||||++||+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++ ..+.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence 99999999999999988889999999999999999999999999 99999999999998 4579999999998532110
Q ss_pred -------------------------------------------------ccccccCCCCCCCcccccc-ccCcccchhhh
Q 004645 183 -------------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSF 212 (740)
Q Consensus 183 -------------------------------------------------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSL 212 (740)
.....+||+.|+|||++.+ .|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0012469999999999874 58999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc--ccCCChHHHHHHHHHhhCccC---CCCHHHHhcCcccCCCCc
Q 004645 213 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL--FKVEDPEVRQFIEKCLATVSS---RLSARELLTDPFLQIDDY 287 (740)
Q Consensus 213 GvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~--~~~~spelrdLI~kcL~dPsk---RpSa~ELL~HPff~~~~~ 287 (740)
||++|+|+||..||.. .+....+..+........+ ....++++++||.+||.+|.+ |+++.++|.||||+..++
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999986 4456666666653322222 224688999999999996555 569999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=365.30 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=213.0
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||+|+||+||+|.+..++..||+|+++.... ........+..|+.+|++++||||+++++.|.. ...+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 7999999999999999999999999874332 234456778899999999999999999998754 6789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Ccccccc
Q 004645 111 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAARCV 188 (740)
Q Consensus 111 GSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~~~~ 188 (740)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999988889999999999999999999999999 99999999999998 457999999999875432 2233457
Q ss_pred CCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-C
Q 004645 189 GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 266 (740)
Q Consensus 189 GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-d 266 (740)
||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+.. .++...++++++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL--RFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCCC
Confidence 9999999999875 589999999999999999999999986 456677777766543 3455678999999999999 9
Q ss_pred ccCCC---CHHHHhcCcccCCCC
Q 004645 267 VSSRL---SARELLTDPFLQIDD 286 (740)
Q Consensus 267 PskRp---Sa~ELL~HPff~~~~ 286 (740)
|.+|| ++.++|.||||....
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCC
Confidence 99997 589999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=370.69 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=219.9
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCC-eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg-~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
..| .+.+.||+|+||.||+|.+..++ ..||+|++..... ......+.+.+|+.+|+.++||||++++++|.+ ...
T Consensus 30 ~~y-~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 30 EDF-NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred hhc-EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 345 78899999999999999876655 6899998875432 223445678899999999999999999998855 678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecC
Confidence 9999999999999999999899999999999999999999999999 99999999999998 55799999999997654
Q ss_pred cCccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 181 KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 181 ~~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
.. .....||+.|||||++.+ .++.++|||||||++|+|+||..||.. .++..+++.+..+... ++...++.++++
T Consensus 183 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~l 258 (340)
T PTZ00426 183 TR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGIIY--FPKFLDNNCKHL 258 (340)
T ss_pred CC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHH
Confidence 32 345579999999999875 588999999999999999999999986 5667777888776542 345678999999
Q ss_pred HHHHhh-CccCCC-----CHHHHhcCcccCCCCcc
Q 004645 260 IEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 288 (740)
Q Consensus 260 I~kcL~-dPskRp-----Sa~ELL~HPff~~~~~~ 288 (740)
|.+||+ +|.+|+ +++++++||||+..++.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999 999995 89999999999875543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=373.59 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=214.7
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| .+.++||+|+||+||+|.+..++..||+|++..... ........+.+|+.+|++++||||+++++.|.+ ...+|
T Consensus 2 ~f-~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~ 77 (382)
T cd05625 2 MF-VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLY 77 (382)
T ss_pred Cc-EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEE
Confidence 34 778999999999999999999999999999874432 223456778999999999999999999999865 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccc
Confidence 99999999999999988888999999999999999999999999 99999999999998 4579999999997532100
Q ss_pred -------------------------------------------------ccccccCCCCCCCcccccc-ccCcccchhhh
Q 004645 183 -------------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSF 212 (740)
Q Consensus 183 -------------------------------------------------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSL 212 (740)
.....+||+.|+|||++.+ .|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0123469999999999874 69999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--cccccCCChHHHHHHHHHhhCccCCCC---HHHHhcCcccCCCCc
Q 004645 213 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDY 287 (740)
Q Consensus 213 GvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p--~~~~~~~spelrdLI~kcL~dPskRpS---a~ELL~HPff~~~~~ 287 (740)
||++|+|+||..||... ++.+....+...... .......+++++++|.+++.+|.+|++ +.++++||||+..+.
T Consensus 235 Gvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred hHHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 99999999999999874 444444455443222 122345789999999998889999987 999999999987655
Q ss_pred c
Q 004645 288 D 288 (740)
Q Consensus 288 ~ 288 (740)
.
T Consensus 314 ~ 314 (382)
T cd05625 314 S 314 (382)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=364.65 Aligned_cols=255 Identities=25% Similarity=0.452 Sum_probs=214.1
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.+| ++.+.||+|+||.||+|.+..+|..||+|+++... ......++.+|+++|++++||||+++++++.. ...+
T Consensus 5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (331)
T cd06649 5 DDF-ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEI 78 (331)
T ss_pred ccc-eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 456 78899999999999999999999999999887532 34556789999999999999999999998865 5789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ +|+||||||+|||++ ..+.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCcccccccc
Confidence 999999999999999988888999999999999999999999852 299999999999998 447999999999987665
Q ss_pred CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHH----------------------
Q 004645 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK---------------------- 238 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~---------------------- 238 (740)
.......||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +...+...
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCccccc
Confidence 55556679999999999874 5899999999999999999999999653 22222211
Q ss_pred ------------------------HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 239 ------------------------VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 239 ------------------------i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+.....+.......++++++||.+||. +|.+|||+.+||+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 111112222223467899999999999 99999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=389.36 Aligned_cols=254 Identities=26% Similarity=0.472 Sum_probs=226.8
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~l 103 (740)
+++.++||+|.||+|++|..+.+++.+|||++|+...++ .++.+.++.|.+|+... +||.++++|..| +++.++|+
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~l~f 446 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEHLFF 446 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCeEEE
Confidence 488999999999999999999999999999999877554 46788999999999988 599999999999 66899999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh--cc
Q 004645 104 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RK 181 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l--~~ 181 (740)
||||+.||++.. +...+.+++..++.++..|+.||.|||++| |||||||.+|||+| ..|++||+|||+++.. ..
T Consensus 447 vmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCC
Confidence 999999999544 345578999999999999999999999999 99999999999999 5589999999999753 34
Q ss_pred CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
..+.++||||.|||||++.+ .|+.++|.|||||+|||||+|+.||.+ .+.++++..|...... ++...+.++..++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~~--yP~~ls~ea~~il 599 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEVR--YPRFLSKEAIAIM 599 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCC--CCCcccHHHHHHH
Confidence 56788999999999999985 699999999999999999999999997 7789999999876543 4556789999999
Q ss_pred HHHhh-CccCCCCH-----HHHhcCcccCCCCcc
Q 004645 261 EKCLA-TVSSRLSA-----RELLTDPFLQIDDYD 288 (740)
Q Consensus 261 ~kcL~-dPskRpSa-----~ELL~HPff~~~~~~ 288 (740)
+++|. +|.+|+-+ .++.+||||+.-++.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 99999 99999865 789999999988775
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=373.63 Aligned_cols=258 Identities=25% Similarity=0.353 Sum_probs=212.8
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|.+.+.||+|+||+||+|.+..++..||+|++..... ........+.+|+.+|++++||||++++++|.+ ...+++|
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 3788999999999999999999999999999875432 233456789999999999999999999998865 6789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-- 182 (740)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccc
Confidence 999999999999988889999999999999999999999999 99999999999998 4579999999987532100
Q ss_pred -----------------------------------------------ccccccCCCCCCCcccccc-ccCcccchhhhhh
Q 004645 183 -----------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGM 214 (740)
Q Consensus 183 -----------------------------------------------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGv 214 (740)
.....+||+.|+|||++.+ .|+.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0123479999999999874 5899999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCcccccCCChHHHHHHHHHhh---CccCCCCHHHHhcCcccCCCCcch
Q 004645 215 CILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLA---TVSSRLSARELLTDPFLQIDDYDS 289 (740)
Q Consensus 215 ILyELlTG~~Pf~~~~~~~~i~k~i~~g~--~p~~~~~~~spelrdLI~kcL~---dPskRpSa~ELL~HPff~~~~~~~ 289 (740)
++|||+||..||.... .......+.... .........++++++||.+++. ++..|+++.+++.||||+..++..
T Consensus 237 il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 237 ILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence 9999999999998744 444444444322 2222233578999999999664 455699999999999998765543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=373.83 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=213.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|+||+||+|.+..+|..||+|++..... ........+.+|+.+|++++||||+++++.|.+ +..+++|
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-LMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 3889999999999999999999999999998864332 122345678899999999999999999998855 6789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-- 182 (740)
|||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccccc
Confidence 999999999999988888999999999999999999999999 99999999999998 4579999999997532100
Q ss_pred -------------------------------------------ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHH
Q 004645 183 -------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILE 218 (740)
Q Consensus 183 -------------------------------------------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyE 218 (740)
.....+||+.|||||++.+ .++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0113469999999999875 58999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCCC--cccccCCChHHHHHHHHHhhCccCCC---CHHHHhcCcccCCCCcc
Q 004645 219 MVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYD 288 (740)
Q Consensus 219 LlTG~~Pf~~~~~~~~i~k~i~~g~~p--~~~~~~~spelrdLI~kcL~dPskRp---Sa~ELL~HPff~~~~~~ 288 (740)
|+||..||... ++......+...... .......++++.+||.+|+.+|.+|+ ++.++++||||+..+..
T Consensus 237 ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 237 MLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred hhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 99999999874 444444444433221 12233578999999999888999999 99999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=363.09 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=214.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
++||+|+||+||+|.+..+|..||+|+++.... ........+.+|+.+|+.++||||+++++.|.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCC
Confidence 469999999999999999999999999875322 233456678899999999999999999998854 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--cccc
Q 004645 109 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAR 186 (740)
Q Consensus 109 ~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~--~~~~ 186 (740)
++|+|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ +++.+||+|||++...... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 99999999888889999999999999999999999999 99999999999998 4579999999998753221 2234
Q ss_pred ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh
Q 004645 187 CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265 (740)
Q Consensus 187 ~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~ 265 (740)
..||+.|+|||++. +.++.++|||||||++|+|+||..||.. .+...+++.+..+.. .++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 56999999999987 4689999999999999999999999986 455666666655443 2345678999999999999
Q ss_pred -CccCCC-----CHHHHhcCcccCCCCcc
Q 004645 266 -TVSSRL-----SARELLTDPFLQIDDYD 288 (740)
Q Consensus 266 -dPskRp-----Sa~ELL~HPff~~~~~~ 288 (740)
+|.+|+ ++.++++||||....+.
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999998 89999999999875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=382.10 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=223.1
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| .+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. .+..+++.+.+|+++++.|+|||||.++++| +....+|
T Consensus 3 ~y-hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~ 77 (808)
T KOG0597|consen 3 QY-HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLW 77 (808)
T ss_pred ch-hHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEE
Confidence 45 56688999999999999999999999999886543 4567889999999999999999999999998 5688999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+||+.| +|+.++...+.++++.++.++++++.||.|||+++ |+|||+||.|||+. ..|.+|++|||+|+.+...
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccC
Confidence 99999977 99999999999999999999999999999999999 99999999999998 4489999999999987654
Q ss_pred c--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 183 H--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 183 ~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
. .....|||.|||||++.+ .|+..+|+||||||+|||++|++||.. ....++.+.|..... .++...++.++.|
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~v--~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDPV--KPPSTASSSFVNF 230 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCCC--CCcccccHHHHHH
Confidence 3 345569999999999985 599999999999999999999999986 556777777775443 3344778999999
Q ss_pred HHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 260 IEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
++.+|. ||.+|+|..+|+.|||.+..
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999 99999999999999998754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=365.19 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=213.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
++||+|+||+||+|.+..+|..||+|+++... .........+.+|+.+|+.++||||+++++.|.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 46999999999999999999999999987433 2234456788899999999999999999998754 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Ccccc
Q 004645 109 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAR 186 (740)
Q Consensus 109 ~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~~ 186 (740)
++|+|..++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 99999999888889999999999999999999999999 99999999999998 457999999999875322 22234
Q ss_pred ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh
Q 004645 187 CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265 (740)
Q Consensus 187 ~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~ 265 (740)
.+||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+...+.+.+..+.. .++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--KFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHHcC
Confidence 57999999999987 4689999999999999999999999986 445566666654443 2445678999999999999
Q ss_pred -CccCCC-----CHHHHhcCcccCCCCc
Q 004645 266 -TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 266 -dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
+|.+|+ ++.++++||||...++
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999997 8999999999976554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.24 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=206.9
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC---C
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN---R 99 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~---~ 99 (740)
|| ++.++||+|+||.||+|.+..+|..||+|+++... .......++.+|+.+|++++||||+++++++..... .
T Consensus 1 ry-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred Ce-EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 45 88999999999999999999999999999886322 223345678899999999999999999998765332 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+|+||||+ +++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++...
T Consensus 78 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCcccccc
Confidence 589999999 5789999888888999999999999999999999999 99999999999998 4579999999998754
Q ss_pred ccCc-----cccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHH--------------H
Q 004645 180 RKSH-----AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY--------------K 237 (740)
Q Consensus 180 ~~~~-----~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~--------------k 237 (740)
.... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.....++. .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3221 123469999999999763 58999999999999999999999997643322111 1
Q ss_pred HHHc-----------CCCC---cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 238 KVIS-----------GKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 238 ~i~~-----------g~~p---~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.+.. ...+ .......++.+.+||.+||. +|.+|||+.++|+||||+...
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 1100 0011 11123467889999999999 999999999999999997533
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.40 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=207.0
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||+||+|.+..++..||+|+++.... .....+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 76 (287)
T cd07848 2 KF-EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLY 76 (287)
T ss_pred Cc-eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEE
Confidence 55 889999999999999999999999999999875432 23445678899999999999999999998844 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||||++++++..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccc
Confidence 99999999887766555567999999999999999999999999 99999999999998 4579999999999776432
Q ss_pred c---cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCc-----------
Q 004645 183 H---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI-SGKKPE----------- 246 (740)
Q Consensus 183 ~---~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~-~g~~p~----------- 246 (740)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+..... .+..|.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2 223469999999999874 589999999999999999999999987544333322111 011110
Q ss_pred -----------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 247 -----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 247 -----------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
......++.+++||.+||. +|.+|||++++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1112367889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=349.74 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=216.1
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.|| ...++||+|.||.||+|+|..||+.||||.|++..... .......+||+.|+.++|+||+.+.+.|.. ...+
T Consensus 2 ~rY-~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l 76 (318)
T KOG0659|consen 2 DRY-EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPH--KSNL 76 (318)
T ss_pred chh-hhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccC--CCce
Confidence 366 33578999999999999999999999999999875322 233467899999999999999999999844 7789
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
.+|+||++ .+|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccC
Confidence 99999995 5888876654 57999999999999999999999999 99999999999998 45899999999999887
Q ss_pred cCcc--ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC-Cc--------
Q 004645 181 KSHA--ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK-PE-------- 246 (740)
Q Consensus 181 ~~~~--~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~-p~-------- 246 (740)
.+.. ...+-|.+|+|||++.| .|+..+||||.|||+.||+-|.+-|.+.++.+|+...+.. |.. +.
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 5433 33378999999999875 5999999999999999999999999998888888765543 211 10
Q ss_pred ---------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 247 ---------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 247 ---------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.++...+..+.+|+.++|. +|.+|+||.|+|+|+||+...
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 1234456788999999999 999999999999999997543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=373.27 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=227.7
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCe
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~ 100 (740)
..+|.+++.||+|.||+||+|.++.+|..+|+|.+++.... .......+.+|+.+|++|. |||||.+++.|.+ ...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~-~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR-GKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc-ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 34559999999999999999999999999999999866533 2335678999999999998 9999999999854 679
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC---CcEEEeccchhh
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAA 177 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~---g~VKL~DFGlA~ 177 (740)
+++|||++.||.|.+.+... .+++..+..+++||+.+++|||+.| |+||||||+|+|+.... +.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999998877 5999999999999999999999999 99999999999997542 479999999998
Q ss_pred hhccC-ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCC
Q 004645 178 ILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVED 253 (740)
Q Consensus 178 ~l~~~-~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~--p~~~~~~~s 253 (740)
..... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .+...++..+..|.. +...+..++
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccC
Confidence 87763 455678999999999999 6799999999999999999999999987 455666667888765 556677889
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
..+++||.++|. +|.+|+||.++|+|||++...
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 999999999999 999999999999999998653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=369.13 Aligned_cols=256 Identities=25% Similarity=0.450 Sum_probs=215.9
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||+||+|.+..+|..||+|+++.... ........+..|+.++.+++||||+++++.|.+ ...+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~ 80 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLIM 80 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEE
Confidence 788999999999999999999999999999874432 223456778899999999999999999998854 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-- 183 (740)
||++||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCccccccccc
Confidence 99999999999988889999999999999999999999999 99999999999998 45899999999986442210
Q ss_pred -----------------------------------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCC
Q 004645 184 -----------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYS 227 (740)
Q Consensus 184 -----------------------------------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~ 227 (740)
....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 113469999999999874 58999999999999999999999998
Q ss_pred CCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHhhCccCCC---CHHHHhcCcccCCCCcc
Q 004645 228 ECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYD 288 (740)
Q Consensus 228 ~~~~~~~i~k~i~~g~~p~~~~--~~~spelrdLI~kcL~dPskRp---Sa~ELL~HPff~~~~~~ 288 (740)
. .++..++..+........++ ...++++++||.+++.+|.+|+ ++.++++||||+..++.
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 238 S-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred C-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 6 55666777776543222121 2368899999999888898888 58999999999877654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.96 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=213.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
+.||+|+||+||+|.+..+|..||+|+++.... ........+..|+++++.++||||+++++.|.. ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 469999999999999999999999999875432 233456678899999999999999999998754 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 109 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 109 ~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
++|+|..++...+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999999998888899999999999999999999997 78 99999999999998 457999999999864322 2223
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
...||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHh
Confidence 4569999999999874 689999999999999999999999986 455666666655443 234567899999999999
Q ss_pred h-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 265 A-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
. +|.+|+ ++.++|+||||+...+
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 9 999997 9999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=354.01 Aligned_cols=256 Identities=20% Similarity=0.313 Sum_probs=211.1
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|+||+||+|.+..+|..||+|.+...... .......+.+|+.+|++++|+||+++++.|.+ ...+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 47889999999999999999999999999988754321 22334567899999999999999999998854 6789999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
|||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC
Confidence 9999999998876543 46899999999999999999999999 99999999999998 4579999999998765432
Q ss_pred c-cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCcccccCCChHHH
Q 004645 183 H-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP---AQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 183 ~-~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~---~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
. .....||+.|||||++.+ .|+.++|||||||++|+|++|+.||...... ..+...+..+ +..+....++.+.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~ 233 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAK 233 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHH
Confidence 2 234579999999999874 6899999999999999999999999864321 2233333222 2234456789999
Q ss_pred HHHHHHhh-CccCCCC-----HHHHhcCcccCCCCcc
Q 004645 258 QFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 288 (740)
Q Consensus 258 dLI~kcL~-dPskRpS-----a~ELL~HPff~~~~~~ 288 (740)
+||.+||+ +|.+||+ ++++++||||+..+..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 99999999 9999997 8999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=355.18 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=203.3
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| .+.++||.|+||+||+|.+..++..||+|+++.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 78 (288)
T cd07871 5 ETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCL 78 (288)
T ss_pred ccc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeE
Confidence 345 778999999999999999999999999999875432 1223457789999999999999999998754 6689
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeecc
Confidence 999999975 8998876654 5899999999999999999999999 99999999999998 45799999999986543
Q ss_pred cC--ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCc---------
Q 004645 181 KS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE--------- 246 (740)
Q Consensus 181 ~~--~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~p~--------- 246 (740)
.. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||......+.+...+.. +..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 22 2233468999999998864 5899999999999999999999999875443333221111 11000
Q ss_pred -----------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 247 -----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 247 -----------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
......++++++||.+||. +|.+|||++|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0112457889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=362.46 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=215.7
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|+||+||+|.+..+|..||+|+++.... ......+.+..|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~lv~ 80 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYLVM 80 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEEEE
Confidence 888999999999999999999999999999885432 223456678899999999999999999998754 67899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 106 EMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCCc
Confidence 999999999998876 68999999999999999999999999 99999999999998 45799999999997654332
Q ss_pred --cccccCCCCCCCccccc-------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc--ccCC
Q 004645 184 --AARCVGTPEFMAPEVYE-------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL--FKVE 252 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~-------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~--~~~~ 252 (740)
.....||+.|+|||++. ..++.++|||||||++|+|+||..||... +....+..+......... ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCC
Confidence 12346999999999985 34788999999999999999999999874 445556666654432222 2246
Q ss_pred ChHHHHHHHHHhhCccCCCCHHHHhcCcccCCCCc
Q 004645 253 DPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 253 spelrdLI~kcL~dPskRpSa~ELL~HPff~~~~~ 287 (740)
++.+++||.+||.+|.+|||+.+++.||||+..++
T Consensus 237 ~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 237 SSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred CHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCH
Confidence 88999999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=367.74 Aligned_cols=257 Identities=20% Similarity=0.357 Sum_probs=215.4
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
..| ++.++||+|+||+||+|.+..+|..||+|+++.... ......+.+..|+.+|+.++||||++++++|.+ ...+
T Consensus 43 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 43 EDF-DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 456 888999999999999999999999999999874332 122344567899999999999999999998754 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++||||++||+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccC
Confidence 999999999999998754 46899999999999999999999999 99999999999998 457999999999876543
Q ss_pred C---ccccccCCCCCCCcccccc-----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cC
Q 004645 182 S---HAARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KV 251 (740)
Q Consensus 182 ~---~~~~~~GTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~--~~ 251 (740)
. .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+.....++ ..
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCC
Confidence 2 1234579999999998853 378899999999999999999999987 45566777777654332222 24
Q ss_pred CChHHHHHHHHHhh-CccC--CCCHHHHhcCcccCCCCc
Q 004645 252 EDPEVRQFIEKCLA-TVSS--RLSARELLTDPFLQIDDY 287 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPsk--RpSa~ELL~HPff~~~~~ 287 (740)
.++++++||.+||. +|.+ |+|+.++++||||+...+
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 68999999999999 7876 999999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=361.60 Aligned_cols=250 Identities=23% Similarity=0.412 Sum_probs=213.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.++.++..||+|+++.... ......+.+..|+.++..+ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcC
Confidence 469999999999999999999999999874322 1234456778899999877 79999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cCccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~~~~ 185 (740)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 999999999988889999999999999999999999999 99999999999998 45799999999986532 22233
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
...||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...+++.+..+... ++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHc
Confidence 4579999999999874 589999999999999999999999986 5567777777766543 34457899999999999
Q ss_pred h-CccCCCCH------HHHhcCcccCCCCc
Q 004645 265 A-TVSSRLSA------RELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa------~ELL~HPff~~~~~ 287 (740)
. +|.+|+++ +++++||||+...+
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 9 99999998 99999999976544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=360.27 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=212.9
Q ss_pred EEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~---~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
+.||+|+||+||+|.+. .++..||+|+++.............+..|+.+|+.++||||+++++.|.. +..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 57999999999999863 57899999998754432333445678899999999999999999998855 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~ 183 (740)
||+.+++|.+++.+.+.+.+..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++..... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CCCEEEeeCcCCeecccCCCc
Confidence 99999999999988888999999999999999999999999 999999999999984 57999999999864322 22
Q ss_pred cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 184 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+..+... ++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKLN--LPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 334569999999999874 588999999999999999999999987 4455566666666542 345678999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 263 CLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 263 cL~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
||. +|.+|| ++.+++.||||....+
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999 999999 8999999999986544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=355.46 Aligned_cols=255 Identities=27% Similarity=0.363 Sum_probs=204.7
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.++| ++.+.||+|+||+||+|.+..+|..||+|+++..... .....+.+|+.+++.++||||+++++++.+ ...
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 77 (303)
T cd07869 4 ADSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHT--KET 77 (303)
T ss_pred cccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCe
Confidence 4566 7889999999999999999999999999998754321 223457789999999999999999998854 678
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
+++||||+. ++|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAK 153 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceec
Confidence 999999995 6787776654 57899999999999999999999999 99999999999998 4579999999998654
Q ss_pred ccC--ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC---------
Q 004645 180 RKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK--------- 244 (740)
Q Consensus 180 ~~~--~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g~~--------- 244 (740)
... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..+.....+.+.. +..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 2234568999999999864 4889999999999999999999999876554433332221 100
Q ss_pred ------Cccc-------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 245 ------PEAL-------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 245 ------p~~~-------------~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+... ....++.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000 00134678999999999 99999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=360.14 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=210.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..+|..||+|++...... .......+..|.. +++.++||||+++++.|.. ...+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 4699999999999999999999999998754322 2223345555554 5678999999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ +++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 999999999988889999999999999999999999999 99999999999998 457999999999865322 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+... +....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPLR--LKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 4579999999999874 589999999999999999999999986 5667777777765432 34456899999999999
Q ss_pred h-CccCCCCH----HHHhcCcccCCCCc
Q 004645 265 A-TVSSRLSA----RELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa----~ELL~HPff~~~~~ 287 (740)
+ +|.+||++ .+++.||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 9 99999998 69999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.57 Aligned_cols=257 Identities=27% Similarity=0.370 Sum_probs=222.2
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+++.+.||.|.-|+||+|....++..+|+|++.... ......+.++..|-+||+.++||.++.+|..| +..+.+|++
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~-l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~ 155 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES-LASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLV 155 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH-HhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEE
Confidence 367789999999999999999999999999998654 33466778899999999999999999999998 568899999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--
Q 004645 105 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-- 180 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~-- 180 (740)
||||+||+|..+++++ +.+++..++.++..++.||+|||..| ||+|||||+||||. ++|+|.|+||.|+....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCC
Confidence 9999999999998775 68999999999999999999999999 99999999999998 56899999999973210
Q ss_pred --------------------------------c-C-----------------------ccccccCCCCCCCccccccc-c
Q 004645 181 --------------------------------K-S-----------------------HAARCVGTPEFMAPEVYEEE-Y 203 (740)
Q Consensus 181 --------------------------------~-~-----------------------~~~~~~GTp~YmAPEvl~~~-y 203 (740)
. . ....++||-+|.|||++.|. .
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01244799999999999964 8
Q ss_pred CcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC----HHHHhc
Q 004645 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS----ARELLT 278 (740)
Q Consensus 204 s~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpS----a~ELL~ 278 (740)
+.++|+|+|||++|||+.|..||.+..+.+.+...+.+....... ...+..+++||+++|. ||++|+- |.||.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 999999999999999999999999988877777666544332222 2567899999999999 9999999 999999
Q ss_pred CcccCCCCcc
Q 004645 279 DPFLQIDDYD 288 (740)
Q Consensus 279 HPff~~~~~~ 288 (740)
||||+..+|.
T Consensus 392 HpFF~gVnWa 401 (459)
T KOG0610|consen 392 HPFFEGVNWA 401 (459)
T ss_pred CccccCCChh
Confidence 9999998886
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=359.35 Aligned_cols=256 Identities=21% Similarity=0.357 Sum_probs=213.3
Q ss_pred eEEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCe
Q 004645 25 GRYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~---~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~ 100 (740)
|++.+.||+|+||+||+|.+. .+|..||+|+++...........+.+..|+.+|+.+ +||||+++++.|.. ...
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~ 79 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EAK 79 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CCE
Confidence 378899999999999999763 578999999987543333344566788999999999 59999999988744 678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~-~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDS-EGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECC-CCCEEEeeCcCCcccc
Confidence 9999999999999999988889999999999999999999999999 999999999999984 4799999999987643
Q ss_pred cC---ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCC---CCHHHHHHHHHcCCCCcccccCC
Q 004645 181 KS---HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSEC---THPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 181 ~~---~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~---~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
.. .....+||+.|||||++.+ .++.++|||||||++|+|+||..||... .....+...+..... .+....
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCC
Confidence 22 2234569999999999875 3788999999999999999999999632 234455555554332 234567
Q ss_pred ChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 253 DPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
++.+++||.+||. +|.+|| ++.++++||||+...+
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 8999999999999 999999 8899999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=359.50 Aligned_cols=251 Identities=21% Similarity=0.385 Sum_probs=210.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..++..||+|+++... .........+..|+.+++++ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL-VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeC
Confidence 46999999999999999999999999997543 22344566788999999999 79999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cCccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~~~~ 185 (740)
+++|+|..++.+.+++++..++.++.||+.||.|||++| |+||||||+|||++. .+.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECC-CCCEEECcCccccccccCCCccc
Confidence 999999999888889999999999999999999999999 999999999999984 5799999999986422 22234
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCcccccCCChHH
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQIYKKVISGKKPEALFKVEDPEV 256 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~--------~~~~~i~k~i~~g~~p~~~~~~~spel 256 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+++.+..+.. .++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHH
Confidence 4579999999999875 5899999999999999999999999631 122334555554433 2445678999
Q ss_pred HHHHHHHhh-CccCCCC------HHHHhcCcccCCCCc
Q 004645 257 RQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 287 (740)
Q Consensus 257 rdLI~kcL~-dPskRpS------a~ELL~HPff~~~~~ 287 (740)
.++|.+||+ +|.+|++ +.++++||||...++
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999999 9999987 789999999975443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=377.08 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=206.2
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
..+.++| ++.++||+|+||+||+|.+..++..||+|++.... ....+|+.+|+.++||||++++++|....
T Consensus 62 ~~~~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 62 RSPNKSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTEC 132 (440)
T ss_pred cCcCCeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence 3466677 89999999999999999999999999999875321 12457999999999999999998875421
Q ss_pred ------CCeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCc
Q 004645 98 ------NRNINFVTEMFTSGTLRQYRL----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 167 (740)
Q Consensus 98 ------~~~i~lV~Ey~~gGSL~~~l~----~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~ 167 (740)
...+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.
T Consensus 133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCc
Confidence 2357799999964 6766654 3467999999999999999999999999 9999999999999866668
Q ss_pred EEEeccchhhhhccC-ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC
Q 004645 168 VKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK 243 (740)
Q Consensus 168 VKL~DFGlA~~l~~~-~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~ 243 (740)
+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.....++.+.+.. |.
T Consensus 210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999999866543 2334578999999998764 5899999999999999999999999886665555443321 11
Q ss_pred C-----------------Cc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 244 K-----------------PE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 244 ~-----------------p~--------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
. |. .++...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 0 00 1122457899999999999 9999999999999999964
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.46 Aligned_cols=258 Identities=21% Similarity=0.371 Sum_probs=213.4
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.++| ++.+.||+|+||.||+|.+..++..||+|+++.... ........+..|+.+++.++||||+++++.|.+ ...
T Consensus 42 ~~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 42 AEDY-DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred HHHC-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCE
Confidence 3556 889999999999999999999999999999874332 123345568899999999999999999998854 678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
+|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecc
Confidence 9999999999999998765 46899999999999999999999999 99999999999998 55799999999997664
Q ss_pred cCc---cccccCCCCCCCcccccc-----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccc--c
Q 004645 181 KSH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--K 250 (740)
Q Consensus 181 ~~~---~~~~~GTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~--~ 250 (740)
... ....+||+.|||||++.+ .++.++|||||||++|+|+||..||.. .+....+..+........++ .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcc
Confidence 322 234579999999999863 278899999999999999999999986 45556666666543222222 3
Q ss_pred CCChHHHHHHHHHhhC-cc--CCCCHHHHhcCcccCCCCc
Q 004645 251 VEDPEVRQFIEKCLAT-VS--SRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 251 ~~spelrdLI~kcL~d-Ps--kRpSa~ELL~HPff~~~~~ 287 (740)
..++.++++|.+||.+ +. .|+++.++++||||+...+
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 4688999999999983 33 4899999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=358.21 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=214.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..+|..||+|+++.... ......+.+..|+.++..+ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeC
Confidence 469999999999999999999999999875332 2334566788899999876 89999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECC-CCCEEEeecccceecccCCcccc
Confidence 999999999988889999999999999999999999999 999999999999984 57999999999865322 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
...||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...+++.+..+... .+...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDVL--YPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 4569999999999874 589999999999999999999999986 5567777777766542 23456899999999999
Q ss_pred h-CccCCC-------CHHHHhcCcccCCCCcc
Q 004645 265 A-TVSSRL-------SARELLTDPFLQIDDYD 288 (740)
Q Consensus 265 ~-dPskRp-------Sa~ELL~HPff~~~~~~ 288 (740)
. +|.+|+ ++.++++||||...++.
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 9 999999 99999999999765543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.87 Aligned_cols=255 Identities=25% Similarity=0.457 Sum_probs=213.2
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.++| ++.++||+|+||+||+|.+..+|..+|+|.++... .......+.+|+++|++++||||++++++|.+ ...
T Consensus 4 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (333)
T cd06650 4 DDDF-EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 77 (333)
T ss_pred hhhh-heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCE
Confidence 3556 88899999999999999999999999999887532 34456779999999999999999999999866 678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+. + |+||||||+|||++ ..+.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhh
Confidence 999999999999999998888899999999999999999999974 6 99999999999998 4579999999999776
Q ss_pred ccCccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHH----------------------
Q 004645 180 RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY---------------------- 236 (740)
Q Consensus 180 ~~~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~---------------------- 236 (740)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..++.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCC
Confidence 5554455679999999999875 58899999999999999999999997522 22221
Q ss_pred ----------------------HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 237 ----------------------KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 237 ----------------------k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
..+.....+.......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11122222222223457889999999999 99999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.91 Aligned_cols=259 Identities=25% Similarity=0.287 Sum_probs=218.6
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
...|++|+||.||+|+|+.|+..||+|.++.... .....-.-.+||.+|.+++|||||.+-.+.+...-+.+|+||||
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 4679999999999999999999999999987652 12223346789999999999999999999888778889999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--c
Q 004645 108 FTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--A 184 (740)
Q Consensus 108 ~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~--~ 184 (740)
|+. +|+.++..- .++...+++.++.|+|+||+|||.+. |+|||||++|+|++ +.|.+||+|||+|+.+..+. .
T Consensus 159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCcccC
Confidence 964 888887765 48999999999999999999999999 99999999999998 66999999999999887663 3
Q ss_pred ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCccc-------------
Q 004645 185 ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPEAL------------- 248 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~p~~~------------- 248 (740)
+..+-|.+|+|||++.+ .|+.++|+||+|||+.||+++++.|.+....+|+.+.+.- |.....+
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 44568999999999885 4999999999999999999999999998888888776543 2211111
Q ss_pred -------------ccC--CChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcchhhh
Q 004645 249 -------------FKV--EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLR 292 (740)
Q Consensus 249 -------------~~~--~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~~l~ 292 (740)
+.. .+....+|+..+|. ||.+|.||.+.|+|.||.......+..
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~ 374 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPS 374 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChh
Confidence 111 45788899999999 999999999999999998765544433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.43 Aligned_cols=256 Identities=23% Similarity=0.404 Sum_probs=219.0
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----------HHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----------PEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~----------~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
|++.+.||+|.||.|-+|++..+++.||+|++........ ...+++.++||.+|++|.|||||+++++.-
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 4788899999999999999999999999999976542211 112468999999999999999999999876
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~-lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
+.....+|||+|||..|.+... -..++ +++.+++.+++.++.||+|||.+| ||||||||+|+||+.+ |+|||+||
T Consensus 179 DP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VKIsDF 254 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVKISDF 254 (576)
T ss_pred CcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEEeecc
Confidence 7777899999999999987653 34455 999999999999999999999999 9999999999999955 89999999
Q ss_pred chhhhhccC-------ccccccCCCCCCCcccccc---c--cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Q 004645 174 GLAAILRKS-------HAARCVGTPEFMAPEVYEE---E--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 241 (740)
Q Consensus 174 GlA~~l~~~-------~~~~~~GTp~YmAPEvl~~---~--ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~ 241 (740)
|.+...... .....+|||.|||||.+.+ . -+.+.||||+||+||.|+.|++||.+ .....++.+|..
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn 333 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVN 333 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhc
Confidence 999766322 2234579999999998875 2 35789999999999999999999987 667888999998
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 242 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 242 g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
..........+.+.++++|.++|. ||.+|.+..++..|||...+
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 776555555678999999999999 99999999999999998654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.66 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=211.6
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHH---HhCCCCCcceeeeEeeecCCCeE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL---KTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iL---k~L~HpNIVkl~~~fvd~~~~~i 101 (740)
|++.+.||+|+||+||+|.+..+|..||+|+++.... ......+.+..|++++ +.++||||++++++|.. ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEE
Confidence 4788999999999999999999999999999875432 1233456677777665 46689999999998854 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
|+||||+.+++|..++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~-~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDT-EGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECC-CCcEEeCcccCCccCCC
Confidence 99999999999998764 457999999999999999999999999 999999999999984 57999999999864322
Q ss_pred --CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 182 --SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 182 --~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
......+||+.|||||++.+ .++.++|||||||++|+|++|..||.. .+..++...+..+... .+...++.+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEVR--YPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHH
Confidence 22334579999999999874 589999999999999999999999986 4556666666665432 34557899999
Q ss_pred HHHHHhh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 259 FIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 259 LI~kcL~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
||.+||. +|.+|| ++.++++||||+....
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999999 999999 7999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=355.92 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=215.2
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR-NIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~Hp-NIVkl~~~fvd~~~~~i~lV 104 (740)
++.+.||+|+||.||+|.+..++..||+|+++.... ......+.+..|+.++..+.|+ +|++++++|.. ...+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv 79 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFV 79 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEEE
Confidence 788999999999999999999999999999875432 2234566788999999999765 57888887754 6789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cC
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~ 182 (740)
|||+++|+|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++.... ..
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDA-EGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcC-CCCEEEeecCcceecCCCCC
Confidence 999999999999988889999999999999999999999999 999999999999984 5799999999986432 22
Q ss_pred ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
.....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+..+++..+..+.. .++...+++++++|.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~ 233 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICK 233 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 2334579999999999875 589999999999999999999999986 556677777766543 234567899999999
Q ss_pred HHhh-CccCCCCH-----HHHhcCcccCCCCc
Q 004645 262 KCLA-TVSSRLSA-----RELLTDPFLQIDDY 287 (740)
Q Consensus 262 kcL~-dPskRpSa-----~ELL~HPff~~~~~ 287 (740)
+||. +|.+|+++ .++++||||+..++
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999 99999986 89999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=354.33 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=216.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~l 103 (740)
|++.+.||+|+||+||+|.+..++..||+|+++.... ......+.+..|..++..+ .|++|+++++++.. ...+++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 3788999999999999999999999999999875432 2233455677888888887 68999999988744 678999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--c
Q 004645 104 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--K 181 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~ 181 (740)
||||+++|+|..++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence 9999999999999888889999999999999999999999999 99999999999998 44799999999986532 2
Q ss_pred CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
......+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+... ++...++++++++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 232 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEAVAIC 232 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCcCCHHHHHHH
Confidence 22334579999999999874 589999999999999999999999986 5567777777765542 3456789999999
Q ss_pred HHHhh-CccCCCCH-----HHHhcCcccCCCCcc
Q 004645 261 EKCLA-TVSSRLSA-----RELLTDPFLQIDDYD 288 (740)
Q Consensus 261 ~kcL~-dPskRpSa-----~ELL~HPff~~~~~~ 288 (740)
.+||+ +|.+|+++ .++++||||+..++.
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99999 99999984 899999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.37 Aligned_cols=251 Identities=21% Similarity=0.379 Sum_probs=209.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..++..||+|+++.... ........+..|+.++.++ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeC
Confidence 469999999999999999999999999985432 2344566788999998877 89999999998855 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
+++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECC-CCCEEEeeCCccccccCCCCccc
Confidence 999999999888889999999999999999999999999 999999999999984 47999999999865322 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCcccccCCChHH
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQIYKKVISGKKPEALFKVEDPEV 256 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~--------~~~~~i~k~i~~g~~p~~~~~~~spel 256 (740)
...||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+++.+..+.. .++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHH
Confidence 4579999999999874 5899999999999999999999999521 122334455554433 2455678999
Q ss_pred HHHHHHHhh-CccCCCC------HHHHhcCcccCCCCc
Q 004645 257 RQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 287 (740)
Q Consensus 257 rdLI~kcL~-dPskRpS------a~ELL~HPff~~~~~ 287 (740)
++||.+||+ +|.+|++ +.++++||||+..++
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999999 9999998 579999999976554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=355.49 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=210.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||.||+|.+..+|..||+|+++..... .......+..|..++..+ +||||+++++.|.. ...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECC
Confidence 4699999999999999999999999998753221 123455677888888765 99999999998855 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cCccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~~~~ 185 (740)
+.+|+|..++....++++..+..++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECC-CCCEEeCccCCCeecccCCCcee
Confidence 999999999888889999999999999999999999999 999999999999984 4799999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++.+.+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTP--HYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHc
Confidence 5579999999999874 589999999999999999999999986 456677776665432 234457899999999999
Q ss_pred h-CccCCCCH-HHHhcCcccCCCCc
Q 004645 265 A-TVSSRLSA-RELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa-~ELL~HPff~~~~~ 287 (740)
. +|.+|+++ .++++||||+..++
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCH
Confidence 9 99999997 58999999986554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.92 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=208.4
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHH-HHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEI-HLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei-~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
+.||+|+||+||+|.+..++..||+|++........ .....+..|. .+++.++||||++++++|.. ...+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeC
Confidence 469999999999999999999999999875432212 2233444444 45788999999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 999999999988888999999999999999999999999 99999999999998 457999999999865322 2234
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+++.+..+.. ......++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHHc
Confidence 4579999999999875 589999999999999999999999986 556667777765543 234567899999999999
Q ss_pred h-CccCCCCHH----HHhcCcccCCCCc
Q 004645 265 A-TVSSRLSAR----ELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa~----ELL~HPff~~~~~ 287 (740)
+ +|.+|+++. ++++|+||...++
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 9 999999876 8999999976554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.85 Aligned_cols=250 Identities=23% Similarity=0.394 Sum_probs=213.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
+.||+|+||+||+|.+..++..||+|+++.... ........+..|+.++..+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 469999999999999999999999999875432 2234566788899999988 79999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cCccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~~~~ 185 (740)
+++|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECC-CCcEEecccCCCeecCcCCCccc
Confidence 999999999888889999999999999999999999999 999999999999984 5799999999986432 22233
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+.. .++...++.+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 4569999999999874 589999999999999999999999976 456677776665543 234567899999999999
Q ss_pred h-CccCCCCH-----HHHhcCcccCCCCc
Q 004645 265 A-TVSSRLSA-----RELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa-----~ELL~HPff~~~~~ 287 (740)
. +|.+||++ .+++.||||+..++
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9 99999999 99999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=354.23 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=211.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
+.||+|+||+||+|.+..++..||+|+++.... ........+..|..++..+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeC
Confidence 469999999999999999999999999875421 1123345677788888865 99999999998855 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cCccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~~~~ 185 (740)
+++|+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDT-DGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECC-CCCEEEccCCcceECCCCCCcee
Confidence 999999999888888999999999999999999999999 999999999999984 4799999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+.. .++...+.++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHh
Confidence 4579999999999874 589999999999999999999999986 456667766665442 234457889999999999
Q ss_pred h-CccCCCCHH-HHhcCcccCCCCcc
Q 004645 265 A-TVSSRLSAR-ELLTDPFLQIDDYD 288 (740)
Q Consensus 265 ~-dPskRpSa~-ELL~HPff~~~~~~ 288 (740)
. +|.+|+++. +++.||||+..++.
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHH
Confidence 9 999999996 99999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.57 Aligned_cols=250 Identities=24% Similarity=0.434 Sum_probs=209.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..++..||+|+++.... ......+.+..|..++..+ +||||+++++++.. ...+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 469999999999999999999999999875432 1233455567777777755 89999999998754 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
++||+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 999999999888889999999999999999999999999 99999999999998 457999999999875432 2333
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..... .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence 4579999999999875 589999999999999999999999987 455667766665432 234567899999999999
Q ss_pred h-CccCCCCH-HHHhcCcccCCCCc
Q 004645 265 A-TVSSRLSA-RELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa-~ELL~HPff~~~~~ 287 (740)
. +|.+||++ .+++.||||...++
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCH
Confidence 9 99999986 58999999986554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=360.98 Aligned_cols=257 Identities=21% Similarity=0.355 Sum_probs=214.9
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|+||+||+|.+..++..||+|++..... ......+.+.+|+.+++.++||||+++++.|.+ ...+
T Consensus 43 ~~y-~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~ 118 (371)
T cd05622 43 EDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 118 (371)
T ss_pred hhc-EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 566 889999999999999999999999999999874332 123345568899999999999999999998854 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++||||++||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCc
Confidence 999999999999998755 46899999999999999999999999 99999999999998 457999999999976643
Q ss_pred Cc---cccccCCCCCCCcccccc-----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc--ccccC
Q 004645 182 SH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE--ALFKV 251 (740)
Q Consensus 182 ~~---~~~~~GTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~--~~~~~ 251 (740)
.. ....+||+.|||||++.+ .++.++|||||||++|+|++|..||.. .+....+..+....... .....
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCC
Confidence 22 234579999999999863 278899999999999999999999986 56667777777654322 22345
Q ss_pred CChHHHHHHHHHhhCcc---CCCCHHHHhcCcccCCCCc
Q 004645 252 EDPEVRQFIEKCLATVS---SRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 252 ~spelrdLI~kcL~dPs---kRpSa~ELL~HPff~~~~~ 287 (740)
.++.+++||.+||.+|. .|+++.++++||||+....
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 78999999999999543 3789999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.86 Aligned_cols=251 Identities=25% Similarity=0.474 Sum_probs=225.7
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
-|| .|.+.||+|.||.|-+|++...|+.||||.|+... ..+...+-.+.+||++|..|+||||+.+|.+| +....+
T Consensus 53 HRy-E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk-IkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKI 128 (668)
T KOG0611|consen 53 HRY-EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK-IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKI 128 (668)
T ss_pred hHH-HHHHHhcCCcccceeehhhccCCcEeehhhhhhhh-cccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceE
Confidence 355 78899999999999999999999999999987554 45677788899999999999999999999988 557889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
.|||||..+|.|.+|+...+.+++..++.+++||+.|+.|||.++ ++|||||.+|||+|.| +++||+||||+..+.+
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhcc
Confidence 999999999999999999999999999999999999999999999 9999999999999966 6999999999988765
Q ss_pred C-ccccccCCCCCCCccccccc-c-CcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 182 S-HAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 182 ~-~~~~~~GTp~YmAPEvl~~~-y-s~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
. ...++||+|.|.+||+.+|. | ++.+|.|||||+||.|+.|.+||.+ .+-..+.++|.+|...+. ..+..+.-
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~g 281 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDASG 281 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHHH
Confidence 4 56788999999999999975 4 6889999999999999999999998 455677888988876542 23567889
Q ss_pred HHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 259 FIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
||+.||. +|.+|.|+.++-.|=|..
T Consensus 282 LIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 282 LIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHhcCcccchhHHHHhhhheee
Confidence 9999999 999999999999999985
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=369.09 Aligned_cols=253 Identities=31% Similarity=0.500 Sum_probs=225.8
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe-
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN- 100 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~- 100 (740)
..| .+.+++|+|+||.+++++++..+..++||.+.+... +....+...+|+.++++++|||||.++++|++ +..
T Consensus 4 ~~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~--~~~~ 78 (426)
T KOG0589|consen 4 DNY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE--DGQL 78 (426)
T ss_pred chh-hhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhc--CCce
Confidence 345 677999999999999999999999999999998764 33445578899999999999999999999976 445
Q ss_pred EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
++|||+|++||+|.+.+.+.+ .++++.+..|+.||+.||.|||++. |+|||||+.|||++.+ +.|||+|||+|+.
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKI 155 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-Cceeecchhhhhh
Confidence 999999999999999987764 6999999999999999999999998 9999999999999955 6889999999999
Q ss_pred hccC--ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004645 179 LRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 179 l~~~--~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
+... ...+.+|||.||.||++.+ .|+.++||||||||+|||++-+.+|.+ .+...+..++..+.. ..++..++.+
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~-~Plp~~ys~e 233 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLY-SPLPSMYSSE 233 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccC-CCCCccccHH
Confidence 9876 5667889999999999986 699999999999999999999999987 677777778887773 3456778999
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
++.+|+.||. +|..||+|.+||.+|.++.
T Consensus 234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 234 LRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999 8999999999999998863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=343.49 Aligned_cols=252 Identities=29% Similarity=0.400 Sum_probs=200.0
Q ss_pred ceeEEeEEecccCceEEEEEEEcC-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEeee---
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVD--- 95 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~-tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fvd--- 95 (740)
+| ++.+.||+|+||+||+|.+.. +|..||+|.++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y-~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred Cc-ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 45 888999999999999999854 5788999988754321 12233456677777766 69999999998753
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccc
Confidence 23456899999995 6899987664 45899999999999999999999999 99999999999998 4579999999
Q ss_pred chhhhhccCc-cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC-----
Q 004645 174 GLAAILRKSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-KP----- 245 (740)
Q Consensus 174 GlA~~l~~~~-~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-~p----- 245 (740)
|++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+ ..+.... .|
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhc
Confidence 9997654332 23446899999999986 46899999999999999999999999875544433 3333211 00
Q ss_pred -------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 -------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 -------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
..+....++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 01123467889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=354.61 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=209.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..+|..||+|++...... .......+..|.. +++.++||||+++++.|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcC
Confidence 4699999999999999999999999998754321 2233445566655 5677999999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cCccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~~~~ 185 (740)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ +.|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 999999999888889999999999999999999999999 99999999999998 45799999999986532 22234
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+... .....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPLV--LRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCcc--CCCCCCHHHHHHHHHHh
Confidence 4579999999999874 589999999999999999999999986 5566777777765432 33457889999999999
Q ss_pred h-CccCCCCH----HHHhcCcccCCCCc
Q 004645 265 A-TVSSRLSA----RELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa----~ELL~HPff~~~~~ 287 (740)
. +|.+||++ .++++||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 9 99999977 59999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=352.94 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=208.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHH-HHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..+|..||+|++...... .......+..|.. +++.++||||+++++.|.+ ...+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcC
Confidence 4699999999999999999999999998744321 2223345555654 6788999999999998744 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
+++++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 999999998888888999999999999999999999999 99999999999998 457999999999875322 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPL--QLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 4579999999999874 589999999999999999999999986 556777777776543 344567889999999999
Q ss_pred h-CccCCCCH----HHHhcCcccCCCCc
Q 004645 265 A-TVSSRLSA----RELLTDPFLQIDDY 287 (740)
Q Consensus 265 ~-dPskRpSa----~ELL~HPff~~~~~ 287 (740)
+ +|.+|+++ .++++||||...++
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 9 99999876 49999999975543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.64 Aligned_cols=251 Identities=33% Similarity=0.552 Sum_probs=208.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|+||+||+|.+..++..||+|++..... ..........|+.++++++||||+++++++.+ ...+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--ccccccc
Confidence 5899999999999999999999999999999985532 12223344569999999999999999998866 7789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh--ccC
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l--~~~ 182 (740)
|||+.+++|.+++.+.+.+++..+..++.||+.||.+||+++ |+|+||||+||+++ +.+.++|+|||++... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998899999999999999999999999999 99999999999999 6689999999998753 223
Q ss_pred ccccccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCcccc--cCCChHH
Q 004645 183 HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEALF--KVEDPEV 256 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~k~i~~g~~p~~~~--~~~spel 256 (740)
......+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ....+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 334456899999999987 468999999999999999999999998752 2233333333222221111 1123899
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 257 RQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 257 rdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
+++|.+||. +|.+|||+.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999 99999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.91 Aligned_cols=251 Identities=32% Similarity=0.540 Sum_probs=213.2
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
.+.+.||+|++|.||+|.+..++..||+|.+....... .......+.+|+.++++++||||+++++++.. ...+++|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 82 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETLSIF 82 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeEEEE
Confidence 78899999999999999999999999999987543211 12345678999999999999999999998855 5699999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
+||+++++|.+++...+.+++..++.+++||+.||.|||+.+ |+||||||+||+++ +++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999 99999999999998 557999999999875533211
Q ss_pred -----ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 185 -----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 185 -----~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
....|++.|+|||++.+ .++.++||||||+++|+|++|+.||........+. .+........+....++.+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHHH
Confidence 23458899999999875 48899999999999999999999998754444443 344444444456678899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCccc
Q 004645 259 FIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~HPff 282 (740)
||.+||. +|.+|||+.++|+||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=352.17 Aligned_cols=257 Identities=20% Similarity=0.369 Sum_probs=211.6
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||+||+|.+..++..||+|++..... ......+.+..|+.+++.++|+||+++++.|.. ...+|
T Consensus 2 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 2 DF-EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred Cc-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEE
Confidence 45 889999999999999999999999999999874332 223445678899999999999999999998854 67899
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..+..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCC
Confidence 99999999999999876 467999999999999999999999999 99999999999998 457999999999866543
Q ss_pred Ccc---ccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc---ccc
Q 004645 182 SHA---ARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---ALF 249 (740)
Q Consensus 182 ~~~---~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~---~~~ 249 (740)
... ....||+.|||||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 221 2246999999999986 3478899999999999999999999986 44556666665433211 112
Q ss_pred cCCChHHHHHHHHHhhC---ccCCCCHHHHhcCcccCCCCc
Q 004645 250 KVEDPEVRQFIEKCLAT---VSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 250 ~~~spelrdLI~kcL~d---PskRpSa~ELL~HPff~~~~~ 287 (740)
...++.+++||.+||.. +..|+++.++|+||||...++
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 34688999999999973 334889999999999976554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=354.67 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=212.0
Q ss_pred eeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC---e
Q 004645 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR---N 100 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~---~ 100 (740)
.++-.+++|+|+||.||+|....++..||||++-...... .+|+++|+.++|||||++.-+|...... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 3466789999999999999999999999999886433222 3589999999999999999888765544 5
Q ss_pred EEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 101 INFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
.++||||++ .+|..+++. +.+++.-.++-+..||++||+|||++| |+||||||.|||+|.+.|.+||||||.|
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 678999994 688887664 578999999999999999999999999 9999999999999999999999999999
Q ss_pred hhhccCc-cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC--------
Q 004645 177 AILRKSH-AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK-------- 244 (740)
Q Consensus 177 ~~l~~~~-~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~-------- 244 (740)
+.+.... ..++.-|..|+|||++.| .|+.+.||||.||++.||+-|++-|.+.+...|+...+.- |..
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 9886554 345678999999999885 5999999999999999999999999997777777654421 111
Q ss_pred ---------C----c----ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 245 ---------P----E----ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 245 ---------p----~----~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
| . .+.+..++++.+|+.++|. +|.+|.++.|+|.||||..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 1 0 1345678999999999999 9999999999999999964
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=352.68 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=211.1
Q ss_pred EEecccCceEEEEEEE---cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d---~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
+.||+|+||+||++.+ ..+|..||+|+++.... ......++..|+.+|++++||||+++++.|.. ...+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEE
Confidence 5799999999999976 45889999999875432 22334567889999999999999999998854 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--c
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--H 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~--~ 183 (740)
||+++|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999888888999999999999999999999999 99999999999998 4579999999998765433 2
Q ss_pred cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 184 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
.....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..+... ++...++.+++||.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKLG--MPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 234579999999999874 588999999999999999999999986 4556666666655432 345578999999999
Q ss_pred Hhh-CccCCCC-----HHHHhcCcccCCCCc
Q 004645 263 CLA-TVSSRLS-----ARELLTDPFLQIDDY 287 (740)
Q Consensus 263 cL~-dPskRpS-----a~ELL~HPff~~~~~ 287 (740)
||+ +|.+||+ +.++++||||+...+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 999 9999999 778999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=351.82 Aligned_cols=251 Identities=20% Similarity=0.353 Sum_probs=210.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
++||+|+||+||+|.+..++..||+|+++... .......+.+..|+.++.++ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeC
Confidence 46999999999999999999999999987543 22344567788999999988 79999999998855 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc--cCccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~--~~~~~ 185 (740)
+++|+|..++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 999999999888889999999999999999999999999 99999999999998 44799999999986432 22233
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC------CCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC------THPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~------~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....++..+.... ..++...++.+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCCCHHHHH
Confidence 4579999999999874 6899999999999999999999999532 23344555554433 2355667899999
Q ss_pred HHHHHhh-CccCCCC------HHHHhcCcccCCCCc
Q 004645 259 FIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 287 (740)
Q Consensus 259 LI~kcL~-dPskRpS------a~ELL~HPff~~~~~ 287 (740)
+|.+||. +|.+|++ ..+++.||||+..++
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 9999999 9999998 469999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.02 Aligned_cols=255 Identities=30% Similarity=0.402 Sum_probs=203.4
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC---
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--- 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~--- 97 (740)
.++| ++.+.||+|+||+||+|.+..+|..||+|+++... .......++.+|+.+++.++||||++++++|....
T Consensus 20 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 4677 88899999999999999999999999999886432 23445667889999999999999999999885432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 -NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 -~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
...+|+||||+.+ +|..++. ..+++..+..++.||+.||.|||++| |+||||||+|||++. +|.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~-~~~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS-DCTLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECC-CCCEEEecCCCc
Confidence 2357999999965 5665543 35889999999999999999999999 999999999999984 579999999998
Q ss_pred hhhccC-ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------
Q 004645 177 AILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS------------- 241 (740)
Q Consensus 177 ~~l~~~-~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~------------- 241 (740)
...... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+......+...+..
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 765433 2234578999999999875 5899999999999999999999999865433222111100
Q ss_pred --------C--CCC----------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 242 --------G--KKP----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 242 --------g--~~p----------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
. ..+ .......++.+++||.+||. +|.+|||+.|+|.||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0 000 00112346789999999999 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=361.82 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=199.6
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|+||.||+|.+..++..||+|... ...+.+|+.+|++|+||||++++++|.. +...
T Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 158 (391)
T PHA03212 92 AGF-SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFT 158 (391)
T ss_pred CCc-EEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCee
Confidence 456 88999999999999999999999999999643 2346789999999999999999998855 6788
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++|+|++ +++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCccccccc
Confidence 9999999 5789999888888999999999999999999999999 99999999999998 457999999999865432
Q ss_pred ---CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCC-------CHHHHHHHHH-cCCCCcc--
Q 004645 182 ---SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-------HPAQIYKKVI-SGKKPEA-- 247 (740)
Q Consensus 182 ---~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~-------~~~~i~k~i~-~g~~p~~-- 247 (740)
......+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.... ...++...+. .|..|..
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 22234579999999999874 58999999999999999999998874321 1111111111 0111100
Q ss_pred -----------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 248 -----------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 248 -----------------------------~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.....+.++++||.+||. +|.+||||.|+|+||||+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 001235689999999999 9999999999999999975
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.80 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=214.2
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i~lV 104 (740)
++.+.||+|+||+||+|.++.+|..||+|+++.... ......+.+..|+.++..+. |++|++++++|.. ...+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv 79 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFV 79 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEEE
Confidence 678999999999999999999999999999875332 22344567888999999885 5778888887744 5689999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-- 182 (740)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCc
Confidence 999999999999988889999999999999999999999999 99999999999998 4579999999998754322
Q ss_pred ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
......||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...+++.+..+.. .++...++++++++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 233 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICK 233 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHH
Confidence 2234569999999999874 589999999999999999999999986 556777777776554 234567899999999
Q ss_pred HHhh-CccCCCC-----HHHHhcCcccCCCCc
Q 004645 262 KCLA-TVSSRLS-----ARELLTDPFLQIDDY 287 (740)
Q Consensus 262 kcL~-dPskRpS-----a~ELL~HPff~~~~~ 287 (740)
+||. +|.+|++ ..++++||||+..++
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 9999 9999997 579999999986554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=367.24 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=212.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-C-----CCcceeeeEeeecCCC
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-H-----RNIMKFYTSWVDTANR 99 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-H-----pNIVkl~~~fvd~~~~ 99 (740)
.+.+.||+|+||.|.+|.|..|++.||||++|. ......+...|+.+|..|+ | -|+|++|++|.. .+
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~ 261 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RN 261 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeecc-----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cc
Confidence 668999999999999999999999999999983 4566777889999999996 4 389999999976 78
Q ss_pred eEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe-CCCCcEEEeccchh
Q 004645 100 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLA 176 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld-~~~g~VKL~DFGlA 176 (740)
++|||+|++ +.+|.+|++.+ ..++...++.+++||+.||.+||+.+ |||+||||+||||. .+...|||+|||+|
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999999 78999999887 46899999999999999999999999 99999999999985 33447999999999
Q ss_pred hhhccCccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCc--------
Q 004645 177 AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE-------- 246 (740)
Q Consensus 177 ~~l~~~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~p~-------- 246 (740)
+...+... +++-+..|+|||++.| .|+.+.||||||||+.||+||.+.|.+.+..+|+...+.. |..|.
T Consensus 339 c~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 339 CFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred cccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 98776655 7789999999999886 6999999999999999999999999987777777554321 11110
Q ss_pred ------------------c---------------------------------cccCCChHHHHHHHHHhh-CccCCCCHH
Q 004645 247 ------------------A---------------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSAR 274 (740)
Q Consensus 247 ------------------~---------------------------------~~~~~spelrdLI~kcL~-dPskRpSa~ 274 (740)
. ........+.+||.+||. ||.+|+|+.
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0 001223567899999999 999999999
Q ss_pred HHhcCcccCCC
Q 004645 275 ELLTDPFLQID 285 (740)
Q Consensus 275 ELL~HPff~~~ 285 (740)
++|+||||...
T Consensus 498 qal~Hpfl~~~ 508 (586)
T KOG0667|consen 498 QALNHPFLTGT 508 (586)
T ss_pred HHhcCcccccc
Confidence 99999999743
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.31 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=204.8
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||+|+||+||+|.+..+|..||+|.+..... ......+.+..|+.+|+.++|+||++++++|.. ...+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 7999999999999999999999998874432 122344677899999999999999999988744 6789999999999
Q ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--c
Q 004645 111 GTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--A 184 (740)
Q Consensus 111 GSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~--~ 184 (740)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.++|+|||++..+.... .
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999887643 356899999999999999999999999 99999999999998 45799999999987654332 2
Q ss_pred ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 185 ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+...+..+ +..+....++.+++|+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 33469999999999874 589999999999999999999999975332 22333333322 2234456789999999
Q ss_pred HHHhh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 261 EKCLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 261 ~kcL~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
.+||+ +|.+|| +++++++||||+...+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 99999 999999 8999999999976443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.20 Aligned_cols=255 Identities=29% Similarity=0.490 Sum_probs=211.3
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeec
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 96 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~ 96 (740)
.+|.|+| ++.+.||+|+||+||+|.+..++..||+|.+.... .....+..|+.+++++ +|+||+++++.|...
T Consensus 2 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 2 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred CChhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 3788999 88899999999999999999999999999887432 2235688899999999 799999999998754
Q ss_pred C----CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEE
Q 004645 97 A----NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 97 ~----~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL 170 (740)
. ...++++|||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++. .+.++|
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~-~~~~~l 152 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTE-NAEVKL 152 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECC-CCCEEE
Confidence 3 24689999999999999988764 46899999999999999999999999 999999999999984 479999
Q ss_pred eccchhhhhccC--ccccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 004645 171 GDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242 (740)
Q Consensus 171 ~DFGlA~~l~~~--~~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g 242 (740)
+|||++...... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||....... ....+...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-~~~~~~~~ 231 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPRN 231 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-HHHHHhcC
Confidence 999998765432 223456899999999884 247889999999999999999999997644333 22333333
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 243 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 243 ~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
..+.......+..+++||.+||. +|.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33333344567899999999999 99999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.61 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=204.7
Q ss_pred CCCceeEEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEe
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 93 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d-----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 93 (740)
|.++| ++.++||+|+||+||+|.+ ..++..||+|+++.. ........+.+|+.+|..+ +||||++++++|
T Consensus 5 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45677 8999999999999999974 345678999988632 2334556799999999999 899999999987
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHhc-----------------------------------------------------
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 120 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~----------------------------------------------------- 120 (740)
.. .+..+++||||+++|+|.+++...
T Consensus 81 ~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 81 TK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred cC-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 54 245689999999999999998653
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc----ccc
Q 004645 121 ---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARC 187 (740)
Q Consensus 121 ---------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~----~~~ 187 (740)
.++++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||++........ ...
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCC
Confidence 24778889999999999999999999 999999999999984 47999999999976533211 223
Q ss_pred cCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh
Q 004645 188 VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265 (740)
Q Consensus 188 ~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~ 265 (740)
.+++.|+|||++. ..++.++|||||||++|||++ |..||........+...+..+..+. .+...++.++++|.+||.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYRIMLACWQ 315 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcc
Confidence 4668899999886 458999999999999999997 9999987555555666666555432 345678999999999999
Q ss_pred -CccCCCCHHHHhc
Q 004645 266 -TVSSRLSARELLT 278 (740)
Q Consensus 266 -dPskRpSa~ELL~ 278 (740)
+|.+|||+.++++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.26 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=225.8
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
...|-| .+.+.||+|-|+.|-+|++..||..||+|+|.+.+. .......+++|++-|+.++|||||++|++. ...
T Consensus 15 kIAGLY-DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQ 89 (864)
T KOG4717|consen 15 KIAGLY-DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQ 89 (864)
T ss_pred ceeeee-hhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--ccc
Confidence 345556 888999999999999999999999999999986654 234456799999999999999999999964 456
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
-.+|+|+|+=.+|+|.+|+.++ ..+.+..++.+++||+.|+.|||+.. +|||||||+||.+..+.|.|||.|||++.
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccc
Confidence 7899999999999999999987 57999999999999999999999999 99999999999998899999999999998
Q ss_pred hhccC-ccccccCCCCCCCccccccc-cC-cccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 178 ILRKS-HAARCVGTPEFMAPEVYEEE-YN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 178 ~l~~~-~~~~~~GTp~YmAPEvl~~~-ys-~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
.+.+. ...+.||+..|.|||++.|. |+ +++||||||||||.|++|++||.+.++.+.+- .|...++ ..+...+.
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-mImDCKY--tvPshvS~ 244 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-MIMDCKY--TVPSHVSK 244 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-hhhcccc--cCchhhhH
Confidence 77654 56778999999999999864 65 78999999999999999999999876666553 3444443 34667899
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
++++||..||. +|.+|.+.++|..++|++..+
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999999999 999999999999999998765
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=352.56 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=208.2
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEeeecCCCeEEEEEec
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
||+|+||+||+|.+..+|..||+|++...... .......+..|..++..+ .||||++++..|.. ...+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcC
Confidence 79999999999999999999999998744321 223344566677777765 79999999998754 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 185 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~~~ 185 (740)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999888889999999999999999999999999 99999999999998 457999999999865322 2233
Q ss_pred cccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004645 186 RCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kc 263 (740)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+..... ....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHH
Confidence 4579999999999864 488999999999999999999999986 566777777776654321 234689999999999
Q ss_pred hh-CccCCC----CHHHHhcCcccCCCC
Q 004645 264 LA-TVSSRL----SARELLTDPFLQIDD 286 (740)
Q Consensus 264 L~-dPskRp----Sa~ELL~HPff~~~~ 286 (740)
|. +|.+|| ++.++++||||+...
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 99 999998 799999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=366.99 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=199.9
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC------CcceeeeEee
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR------NIMKFYTSWV 94 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~Hp------NIVkl~~~fv 94 (740)
.++| ++.++||+|+||+||+|.+..++..||+|+++.. ......+..|+.+++.++|. +|++++++|.
T Consensus 128 ~~~y-~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcE-EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 4566 8999999999999999999999999999998632 12234456688888777554 5888888775
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCC-------
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQG------- 166 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g------- 166 (740)
. ....+++||+++ |++|.+++.+++.+++..++.++.||+.||.|||+ .| ||||||||+|||++....
T Consensus 202 ~-~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 N-ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred c-CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 4 345789999988 78999998888899999999999999999999998 58 999999999999974421
Q ss_pred --------cEEEeccchhhhhccCccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHH
Q 004645 167 --------EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 237 (740)
Q Consensus 167 --------~VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k 237 (740)
.+||+|||++..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....+.+.+..
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998754322 2345679999999999875 599999999999999999999999987554433321
Q ss_pred HHH-cCCCCccc--------------------------------------ccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 004645 238 KVI-SGKKPEAL--------------------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 238 ~i~-~g~~p~~~--------------------------------------~~~~spelrdLI~kcL~-dPskRpSa~ELL 277 (740)
... .|..|..+ ....++.+.+||.+||. ||.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 111 12111100 01124668899999999 999999999999
Q ss_pred cCcccCCC
Q 004645 278 TDPFLQID 285 (740)
Q Consensus 278 ~HPff~~~ 285 (740)
+||||+..
T Consensus 437 ~Hp~~~~~ 444 (467)
T PTZ00284 437 THPYVLKY 444 (467)
T ss_pred cCcccccc
Confidence 99999753
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=369.39 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=220.7
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
..+.++| ++.++||+|+||+||+|.+..+|..||+|++..... .......+.+|+.+|..++|+||++++..|....
T Consensus 28 ~~~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 28 KEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 4456777 899999999999999999999999999999875532 4556778899999999999999999988775432
Q ss_pred C------CeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCc
Q 004645 98 N------RNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 167 (740)
Q Consensus 98 ~------~~i~lV~Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~ 167 (740)
. ..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~-~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCS-NGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeC-CCC
Confidence 2 1478999999999999987653 46899999999999999999999999 999999999999985 479
Q ss_pred EEEeccchhhhhccC----ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 004645 168 VKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242 (740)
Q Consensus 168 VKL~DFGlA~~l~~~----~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g 242 (740)
+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~ 260 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAG 260 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC
Confidence 999999998765432 2234579999999999885 589999999999999999999999986 5666777777776
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 243 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 243 ~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
..+. ++...+++++++|.+||. +|.+||++.++|+|||++.
T Consensus 261 ~~~~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 261 RYDP-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 6542 456678999999999999 9999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.10 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=209.7
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.++||+|+||+||++.+..++..||+|++..... ........+.+|+.++++++||||+++++.+.. ...+++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEEE
Confidence 778999999999999999999999999998864332 122334567889999999999999999998744 56899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCC
Confidence 999999999887553 46999999999999999999999999 99999999999998 44799999999987654322
Q ss_pred -cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCcccccCCChHHHH
Q 004645 184 -AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 184 -~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~---~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
....+|++.|+|||++. ..++.++||||||+++|+|++|..||.+..... .+...+..+ +.......++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHH
Confidence 23347999999999987 458899999999999999999999998643221 222222222 22334557899999
Q ss_pred HHHHHhh-CccCCC-----CHHHHhcCcccCCCCcc
Q 004645 259 FIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 288 (740)
Q Consensus 259 LI~kcL~-dPskRp-----Sa~ELL~HPff~~~~~~ 288 (740)
||.+||. +|.+|| ++.++++||||...++.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 9999999 999999 99999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.66 Aligned_cols=253 Identities=30% Similarity=0.382 Sum_probs=200.5
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEeeec---
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDT--- 96 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fvd~--- 96 (740)
+| ++.+.||+|+||+||+|.+..+|..||+|.++..... ......+.+|+.+++.+ +||||++++++|...
T Consensus 1 ~y-~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred Cc-eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 35 7889999999999999999999999999998754321 11123455677777665 799999999987542
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
....+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ +.+.+||+|||
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg 153 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFG 153 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccC
Confidence 2346899999997 5898887664 35899999999999999999999999 99999999999998 45799999999
Q ss_pred hhhhhccCcc-ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC-----CC-
Q 004645 175 LAAILRKSHA-ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK-----KP- 245 (740)
Q Consensus 175 lA~~l~~~~~-~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~-----~p- 245 (740)
++........ ....||+.|+|||++. ..++.++|||||||++|+|++|.+||........+.+.+.. +. .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 9987654322 3446899999999986 45899999999999999999999999775444333322211 00 00
Q ss_pred -----------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 -----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 -----------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.......+..++++|.+||. +|.+|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123457788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=366.51 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=216.1
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCC-CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYE-GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~t-g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
+|...-|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+..|+.+|+.++||||++++++|..
T Consensus 63 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-- 136 (478)
T PTZ00267 63 NPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKS-- 136 (478)
T ss_pred CCcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--
Confidence 34444469999999999999999998887 788998876532 34455678889999999999999999998865
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 98 NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
...+|+||||+++|+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+||
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DF 213 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDF 213 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeC
Confidence 6789999999999999987654 346899999999999999999999999 99999999999998 4579999999
Q ss_pred chhhhhccCc----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004645 174 GLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 174 GlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~ 248 (740)
|++..+.... ....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..+++..+..+..+. .
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~-~ 291 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYDP-F 291 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCC-C
Confidence 9997664432 334569999999999874 589999999999999999999999986 45566777777665542 3
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
+...++.+++||.+||. +|.+||++.++|.|||++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 44578999999999999 9999999999999999964
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.74 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=202.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+|+.++|+||++++++|.. ...+++||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 151 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLL 151 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEE
Confidence 56788999999999999999999999999886332 34456778999999999999999999998844 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-- 183 (740)
||+.+++|... ...++..+..+++||+.||.|||+++ |+||||||+|||++ +++.+||+|||++..+....
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccccccc
Confidence 99999998653 34677888999999999999999999 99999999999998 45799999999997665332
Q ss_pred cccccCCCCCCCcccccc-----c-cCcccchhhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCcccccCCChH
Q 004645 184 AARCVGTPEFMAPEVYEE-----E-YNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~-----~-ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
.....||+.|+|||++.. . ++.++|||||||++|+|++|+.||.... ....+...+..+.. .......+++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 303 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASRE 303 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-CCCCCccCHH
Confidence 234579999999998742 2 3568999999999999999999997422 22233333333322 2334567899
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+++||.+||. +|.+|||+.|+|+||||...
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999 99999999999999999764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=348.44 Aligned_cols=258 Identities=17% Similarity=0.347 Sum_probs=212.2
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||+||++.+..++..||+|+++.... ........+..|+.++..++|+||+++++.|.+ ...+|
T Consensus 2 ~y-~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 2 DF-EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred Cc-eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 35 889999999999999999999999999999874321 123345668889999999999999999998854 67899
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccC
Confidence 99999999999999877 467999999999999999999999999 99999999999998 457999999999876543
Q ss_pred Ccc---ccccCCCCCCCcccccc------ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc---ccc
Q 004645 182 SHA---ARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---ALF 249 (740)
Q Consensus 182 ~~~---~~~~GTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~---~~~ 249 (740)
... ....||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..+.+..+....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 322 23469999999998863 478899999999999999999999986 44556666666543211 122
Q ss_pred cCCChHHHHHHHHHhhC-ccC--CCCHHHHhcCcccCCCCcc
Q 004645 250 KVEDPEVRQFIEKCLAT-VSS--RLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 250 ~~~spelrdLI~kcL~d-Psk--RpSa~ELL~HPff~~~~~~ 288 (740)
...++++++||.+||.. +.+ |++++++++||||+..++.
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 34688999999999983 332 5799999999999875543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=337.47 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=224.4
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+++.||+|-||.||+|+.+.++-.||+|++.+.. .......+++.+|+++-..|+||||+++|++|.+ ...+|+++
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riyLil 101 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIYLIL 101 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeEEEE
Confidence 67899999999999999999999999999987665 2334455779999999999999999999999977 78999999
Q ss_pred eccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRL--KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~--~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||.+.|+|...+. ..+++++...+.+++|++.||.|||.++ ||||||||+|+|++.. |.+||+|||-+.....+.
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCeeccCCCceeecCCCC
Confidence 9999999999988 6678999999999999999999999999 9999999999999844 799999999998877777
Q ss_pred cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 184 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
..+.+||..|.+||+..+ .++..+|+|++|++.||++.|.+||.... ..+.|+++..-... ++..++.+++++|.+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~--~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLK--FPSTISGGAADLISR 255 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcccc--CCcccChhHHHHHHH
Confidence 788899999999999986 59999999999999999999999998744 77888888764432 336789999999999
Q ss_pred Hhh-CccCCCCHHHHhcCcccCC
Q 004645 263 CLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 263 cL~-dPskRpSa~ELL~HPff~~ 284 (740)
||. +|.+|.+..|++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 999 9999999999999999854
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=347.38 Aligned_cols=255 Identities=20% Similarity=0.352 Sum_probs=210.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.++||+|+||+||++.+..++..+|+|++..... ........+..|+.++..++|++|+++++.+.+ ...+++||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 80 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYLVM 80 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEEEE
Confidence 788999999999999999999999999999864321 122334568889999999999999999998754 67899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 106 EMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
||+++|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCc
Confidence 99999999999877 467999999999999999999999999 99999999999998 55799999999986543221
Q ss_pred --cccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc---ccccCC
Q 004645 184 --AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---ALFKVE 252 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~---~~~~~~ 252 (740)
....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+....... ......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccC
Confidence 12346999999999875 3488999999999999999999999986 45566666666543221 122356
Q ss_pred ChHHHHHHHHHhh-C--ccCCCCHHHHhcCcccCCCCc
Q 004645 253 DPEVRQFIEKCLA-T--VSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 253 spelrdLI~kcL~-d--PskRpSa~ELL~HPff~~~~~ 287 (740)
++++++||.+||. + +..|+++.++++||||+..++
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 8999999999997 3 334789999999999986554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.69 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=193.0
Q ss_pred eEEecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 28 NEILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~--~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
+.+||+|+||+||+|.++ .++..||+|+++.... ...+.+|+.+|++++||||+++++.|.......+++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 568999999999999865 4778999998863321 23467899999999999999999998877777899999
Q ss_pred eccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe---CCCCcEEEecc
Q 004645 106 EMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN---GNQGEVKIGDL 173 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~---------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld---~~~g~VKL~DF 173 (740)
||+. ++|.+++... ..+++..++.+++||+.||.|||++| |+||||||+|||+. ...+.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9985 5888876532 25899999999999999999999999 99999999999994 24468999999
Q ss_pred chhhhhccCc-----cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCC---------HHHHHH
Q 004645 174 GLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH---------PAQIYK 237 (740)
Q Consensus 174 GlA~~l~~~~-----~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---------~~~i~k 237 (740)
|++....... .....||+.|+|||++.+ .|+.++|||||||++|+|+||++||..... ..++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 9997654321 234578999999998864 489999999999999999999999964221 111111
Q ss_pred HHHc-CCC-----------Cc-----------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 004645 238 KVIS-GKK-----------PE-----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 238 ~i~~-g~~-----------p~-----------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPf 281 (740)
.+.. |.. +. ......++.+.+||.+||. ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1110 000 00 0011235678999999999 9999999999999999
Q ss_pred c
Q 004645 282 L 282 (740)
Q Consensus 282 f 282 (740)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.98 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=211.7
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
+++..|.+.| ++.+.||+|+||+||+|.+..+|..||+|+++... ......+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~ 76 (267)
T cd06646 2 ILRRNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76 (267)
T ss_pred ccccCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence 5677788888 88999999999999999999999999999887432 223456789999999999999999999886
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
. ...+++||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++ +.+.++|+|||
T Consensus 77 ~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg 151 (267)
T cd06646 77 S--REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFG 151 (267)
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCc
Confidence 5 5789999999999999999888888999999999999999999999999 99999999999998 45789999999
Q ss_pred hhhhhccCc--cccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004645 175 LAAILRKSH--AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 175 lA~~l~~~~--~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~ 248 (740)
++....... .....|++.|+|||.+. ..++.++|||||||++|+|++|..||..................+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 997654322 23346899999999874 347889999999999999999999997543322222211111122111
Q ss_pred --ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 004645 249 --FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 249 --~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPf 281 (740)
....++.+++||.+||. +|.+|||+.++|+|+|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 12457899999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=341.05 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=217.6
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC----CHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ----SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~----~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.++||+|..++|-++.++.+|..+|+|++.+..... .....+.-..|+.+|+++ .||+|+++.++| +.+..++
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~sF~F 99 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESDAFVF 99 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCcchhh
Confidence 578999999999999999999999999998754222 223455677899999998 899999999988 5578899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+|+|+.|.|.+|+...-.++++..+++++|++.|++|||.++ |+||||||+|||++.+ .++||+|||+++.+..+
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEeccceeeccCCc
Confidence 99999999999999999889999999999999999999999999 9999999999999966 59999999999988766
Q ss_pred c-cccccCCCCCCCcccccc-------ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--cccccCC
Q 004645 183 H-AARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVE 252 (740)
Q Consensus 183 ~-~~~~~GTp~YmAPEvl~~-------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p--~~~~~~~ 252 (740)
. ....||||+|+|||.+.. .|+..+|+||+|||||.|+.|.+||.. ....-+.+.|.+|+.. ..-+..+
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhc
Confidence 4 456689999999998752 488899999999999999999999975 2233345677888753 3446778
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
+..+++||.+||+ ||.+|.|++|+|.||||.
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 8999999999999 999999999999999994
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.93 Aligned_cols=258 Identities=31% Similarity=0.539 Sum_probs=218.4
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
++|..+| .+.+.||.|+||+||+|.+..++..||+|+++.. .....+.+..|+.++++++||||+++++.+..
T Consensus 1 ~~~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 73 (280)
T cd06611 1 VNPNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFY-- 73 (280)
T ss_pred CCchhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--
Confidence 4688888 8889999999999999999989999999998743 34556788999999999999999999998865
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
...+++||||+++++|..++... +.+++..++.++.|++.||.|||+.+ |+|+||||+||+++. .+.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~-~~~~~l~d~g~~ 150 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTL-DGDVKLADFGVS 150 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECC-CCCEEEccCccc
Confidence 67899999999999999998764 57999999999999999999999999 999999999999984 579999999988
Q ss_pred hhhccCc--cccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc-c
Q 004645 177 AILRKSH--AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-A 247 (740)
Q Consensus 177 ~~l~~~~--~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~-~ 247 (740)
....... .....|++.|+|||++. ..++.++||||||+++|+|++|..||... ........+..+..+. .
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLD 229 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcC
Confidence 6654322 23346899999999874 23677899999999999999999999864 4455555566554432 2
Q ss_pred cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 248 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 248 ~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.....+.++.+||.+||. +|.+||++.++|+||||....
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 234568899999999999 999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.43 Aligned_cols=262 Identities=33% Similarity=0.507 Sum_probs=219.5
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
....+|..+| ++.+.||+|+||+||+|.+..++..||+|.+..... ...+.+.+|+.+++.+.|+||+++++.|.
T Consensus 13 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~ 87 (296)
T cd06654 13 VSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL 87 (296)
T ss_pred cccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4556888899 778999999999999999999999999998875432 23467889999999999999999999886
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
. ....++||||+++++|.+++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++ .++.++|+|||
T Consensus 88 ~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg 161 (296)
T cd06654 88 V--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG 161 (296)
T ss_pred e--CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccc
Confidence 5 5689999999999999998754 56899999999999999999999999 99999999999998 45799999999
Q ss_pred hhhhhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004645 175 LAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 175 lA~~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~ 251 (740)
++....... .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||........++.....+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 987654332 223468999999998874 48899999999999999999999998654444444444334333333456
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
.++.+.+||.+||. +|.+|||+.+++.||||.....
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 78899999999999 9999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=330.55 Aligned_cols=254 Identities=32% Similarity=0.532 Sum_probs=213.4
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
++.++||+|+||.||+|.+..+|..||+|.+...... ......+.+.+|+.++++++||||++++++|.+.....++++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 7899999999999999999999999999988754322 223456789999999999999999999998866555678999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-- 182 (740)
|||+++++|.+++.+...+++..+..++.||+.||.|||+++ |+|+||||+||+++ ..+.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccccc
Confidence 999999999999888888999999999999999999999999 99999999999998 5579999999998765421
Q ss_pred ---ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 183 ---HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 183 ---~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
......|+..|+|||++.+ .++.++||||||+++|+|++|+.||........+.+ ..........+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHHH
Confidence 1223458999999999864 588999999999999999999999987555554443 33332223344556788999
Q ss_pred HHHHHhhCccCCCCHHHHhcCcccC
Q 004645 259 FIEKCLATVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 259 LI~kcL~dPskRpSa~ELL~HPff~ 283 (740)
+|.+|+.+|.+||+++++++|||+.
T Consensus 241 ~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=370.03 Aligned_cols=268 Identities=27% Similarity=0.458 Sum_probs=226.1
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
|-.++|..-| .|..-||.|+||.||+|.++.++...|-|+|.. .+.++++.+.-||.+|..++||+||++|+.|+
T Consensus 25 ~rdlnP~d~W-eIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy 99 (1187)
T KOG0579|consen 25 YRDLNPRDHW-EIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYY 99 (1187)
T ss_pred hccCCHHHHH-HHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence 3456777766 777779999999999999999999999898873 46788999999999999999999999999886
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
- .+.+||+.|||.||-....+.. .+.+++.++..+++|++.||.|||+++ |||||||..|||++ -+|.|+|+||
T Consensus 100 ~--enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADF 174 (1187)
T KOG0579|consen 100 F--ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADF 174 (1187)
T ss_pred c--cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecc
Confidence 6 5689999999999988876555 578999999999999999999999999 99999999999999 5589999999
Q ss_pred chhhhhcc--CccccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Q 004645 174 GLAAILRK--SHAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 245 (740)
Q Consensus 174 GlA~~l~~--~~~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p 245 (740)
|.+..... ....+++|||+|||||++. ..|+.++||||||++|.||..+++|..+.+....+.+.-.+....
T Consensus 175 GVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT 254 (1187)
T KOG0579|consen 175 GVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 254 (1187)
T ss_pred cccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc
Confidence 99875443 2345789999999999874 359999999999999999999999999855444444433333333
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcchhhh
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLR 292 (740)
Q Consensus 246 ~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~~l~ 292 (740)
...+...+..+++|+.+||. +|..||++.+||+|||++..+....++
T Consensus 255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ir 302 (1187)
T KOG0579|consen 255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIR 302 (1187)
T ss_pred ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHH
Confidence 34456778899999999999 999999999999999999666544433
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.70 Aligned_cols=250 Identities=31% Similarity=0.509 Sum_probs=217.2
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||.|+||+||+|.+..+|..||+|.++.... .....+++..|+.++++++||||+++++.+.......++++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 778999999999999999999999999998875432 345567899999999999999999999988776677899999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 106 EMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLH-----SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLH-----s~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
||+++++|.+++... .++++..+..++.||+.||.||| +.+ |+|+||||+||+++ +.+.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccccc
Confidence 999999999987663 57899999999999999999999 777 99999999999998 4579999999999
Q ss_pred hhhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 177 AILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 177 ~~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
....... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||... +...+.+.+..+..+ .+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 235 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRYS 235 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccccC
Confidence 8765443 334568999999999874 5889999999999999999999999874 466777777766544 3455678
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
+.+.+++.+||. +|.+||++.++|+|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.52 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=210.2
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
.+.++| ++.+.||+|+||.||+|.+..++..||+|+++... ......+.+|+.+++.++||||+++++.+.. .
T Consensus 6 ~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~ 78 (267)
T cd06645 6 NPQEDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--R 78 (267)
T ss_pred CcHHHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--C
Confidence 455667 78899999999999999999999999999987542 2344568899999999999999999998865 6
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
..+++||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+|+||||+||+++ ..+.++|+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQ 155 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeE
Confidence 789999999999999999888889999999999999999999999999 99999999999998 447999999999865
Q ss_pred hccCc--cccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc--cc
Q 004645 179 LRKSH--AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL--FK 250 (740)
Q Consensus 179 l~~~~--~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~--~~ 250 (740)
..... .....|++.|+|||++. +.++.++|||||||++|+|++|..||........+.........+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06645 156 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235 (267)
T ss_pred ccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccC
Confidence 54322 23346999999999873 358889999999999999999999997644434333332222222211 12
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~HPf 281 (740)
..+..+++||.+||. +|.+||++.+++.|||
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 356789999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.83 Aligned_cols=255 Identities=29% Similarity=0.402 Sum_probs=203.6
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC---
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--- 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~--- 97 (740)
.++| ++.+.||+|+||+||+|.+..++..||+|+++... .......++.+|+.+++.++||||++++++|....
T Consensus 16 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 16 LKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4677 88899999999999999999999999999886432 23455677889999999999999999999886432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 -NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 -~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
...+++||||+.+ +|.+++. ..++...+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~ 166 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 166 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCccc
Confidence 2457999999965 6666654 35889999999999999999999999 99999999999998 4579999999999
Q ss_pred hhhccCc-cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-C-----------
Q 004645 177 AILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-G----------- 242 (740)
Q Consensus 177 ~~l~~~~-~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g----------- 242 (740)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+.. +
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 7655432 234579999999999875 5899999999999999999999999864432222111110 0
Q ss_pred --------CC--------C-----------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 243 --------KK--------P-----------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 243 --------~~--------p-----------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.. + .......+..+++||.+||. +|.+|||+.|+|+||||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 0 00112235678999999999 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=331.34 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=211.9
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC--CHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~--~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~l 103 (740)
+..+.||+|+||.||+|.+..++..||+|+++...... .....+.+.+|+.+|++++|+||+++++++.+ ...+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~ 80 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHFNL 80 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeEEE
Confidence 67889999999999999999999999999987543211 12346789999999999999999999998854 678999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 104 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
|+||+.+++|.+++...+++++..+..|+.||+.||.|||++| ++|+||||+||+++.+...++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999988889999999999999999999999999 99999999999998665579999999987654321
Q ss_pred ------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCcccccCCCh
Q 004645 184 ------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 184 ------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
.....|+..|+|||++.+ .++.++||||||+++|+|++|..||..... .......+.........+...++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 123468899999999874 588999999999999999999999964332 22222233333333445556789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
.+++++.+||. +|.+||++.++|+||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=331.28 Aligned_cols=253 Identities=33% Similarity=0.545 Sum_probs=211.9
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
.+.+.||+|+||.||+|.+..+|..||+|+++..... ........+.+|+.++++++||||+++++++.......++++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 6789999999999999999999999999988755321 223456678999999999999999999998876556789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-- 182 (740)
+||+++++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+||+++. .+.++|+|||++..+...
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~-~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECC-CCCEEEccCCCccccccccc
Confidence 999999999999888888999999999999999999999999 999999999999984 478999999998755321
Q ss_pred ---ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 183 ---HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 183 ---~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.+....+. ...++...++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CCCCchhcCHHHHH
Confidence 1122458899999999874 588999999999999999999999987655555554433333 23345567889999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 259 FIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
|| +||. +|.+||+++++++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 5666 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.72 Aligned_cols=261 Identities=31% Similarity=0.493 Sum_probs=217.8
Q ss_pred eeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 17 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 17 e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
..+|.++| ++.+.||.|+||.||+|.+..++..|++|.+... .....+.+..|+.+++.++||||+++++.+..
T Consensus 7 ~~~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (292)
T cd06644 7 DLDPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYW- 80 (292)
T ss_pred ccCcchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-
Confidence 35678888 9999999999999999999999999999988643 45567789999999999999999999998855
Q ss_pred CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
...+++||||+++++|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+||+++. .+.++|+|||+
T Consensus 81 -~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~-~~~~kl~dfg~ 156 (292)
T cd06644 81 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTL-DGDIKLADFGV 156 (292)
T ss_pred -CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcC-CCCEEEccCcc
Confidence 5689999999999999887654 457899999999999999999999999 999999999999984 57999999998
Q ss_pred hhhhccC--ccccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc-
Q 004645 176 AAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE- 246 (740)
Q Consensus 176 A~~l~~~--~~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~- 246 (740)
+...... ......+++.|+|||++. ..++.++|||||||++|+|++|..||.... ....+.++..+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~ 235 (292)
T cd06644 157 SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTL 235 (292)
T ss_pred ceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccC
Confidence 8654322 123446899999999874 236789999999999999999999997643 445555555444332
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcc
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~ 288 (740)
......+.++.+||.+||. +|.+||++.++|+||||......
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 2344567899999999999 99999999999999999765543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.76 Aligned_cols=248 Identities=30% Similarity=0.517 Sum_probs=214.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|++|+||+|.+..+|..|++|.+..... .......+.+|+.++++++||||+++++++.. ...+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 678999999999999999999999999999875432 34556789999999999999999999998865 67899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+++++|.+++... ..++...+..++.||+.||.|||+.+ |+|+||||+||+++. .+.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~-~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeC-CCCEEEcccccceeccCcc
Confidence 999999999998774 57899999999999999999999999 999999999999985 4799999999987654432
Q ss_pred --cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 184 --AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
.....|++.|+|||++.+ .++.++||||||+++++|+||..||.. .+...+...+..+..+. +....++.++++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i 233 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPP-VSQMYSQQLAQLI 233 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHH
Confidence 223468999999999874 588999999999999999999999976 44566667777666544 3336789999999
Q ss_pred HHHhh-CccCCCCHHHHhcCccc
Q 004645 261 EKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+||+ +|.+||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99999 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.44 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=206.3
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC---CCeEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---NRNIN 102 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~---~~~i~ 102 (740)
.+.+.||+|+||+||+|.+..+|..||+|++... .......+++.+|+.+|+.++||||+++++++.... ...+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5778999999999999999999999999987532 223445678899999999999999999999885532 12789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+||+. ++|..++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccC
Confidence 9999995 688888888888999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred c---cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Q 004645 183 H---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS---------------- 241 (740)
Q Consensus 183 ~---~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~---------------- 241 (740)
. .....+|+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.... +....+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhHH
Confidence 2 223468999999999875 4789999999999999999999999864433 22222211
Q ss_pred -------C-CCCc------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 242 -------G-KKPE------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 242 -------g-~~p~------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
. ..+. ......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 1 1111 1223457899999999999 99999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=342.14 Aligned_cols=253 Identities=28% Similarity=0.385 Sum_probs=204.1
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.+| ++.+.||+|+||+||+|.+..++..||+|+++..... .....+.+|+.++++++||||+++++++.. +..+
T Consensus 6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 79 (309)
T cd07872 6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSL 79 (309)
T ss_pred Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeE
Confidence 456 8889999999999999999999999999998754321 223457789999999999999999998855 6789
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINE-RGELKLADFGLARAKS 155 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECC-CCCEEECccccceecC
Confidence 999999965 888877654 45899999999999999999999999 999999999999984 4799999999986543
Q ss_pred cCc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC----------
Q 004645 181 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK---------- 244 (740)
Q Consensus 181 ~~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g~~---------- 244 (740)
... .....+|+.|+|||++.+ .++.++|||||||++|+|+||..||......+. ...+.. +..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcc
Confidence 322 223468999999998864 588999999999999999999999987443322 222211 000
Q ss_pred ---------Cc-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 245 ---------PE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 245 ---------p~-------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+. ......++++++||.+||. +|.+|||+.|+|+||||+.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00 1113467899999999999 99999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.52 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=210.6
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|+||.||+|.+..+|..+|+|.++... .......+.+|++++++++||||+++++.|.. ...+++|
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 388999999999999999999999999999886432 34556678999999999999999999998865 6789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+ .+ ++|+||||+|||++. ++.+||+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEec-CCcEEEccCCCcccccccc
Confidence 9999999999999888899999999999999999999997 57 999999999999984 5799999999987665554
Q ss_pred cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHH----------------------
Q 004645 184 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI---------------------- 240 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~---------------------- 240 (740)
.....|++.|+|||++.+ .++.++||||||+++|+|+||..||.... .......+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 556679999999999874 58899999999999999999999996432 222222111
Q ss_pred --------------cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 241 --------------SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 241 --------------~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
....|.......++++++||.+||. +|.+|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111122367889999999999 99999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=349.96 Aligned_cols=253 Identities=30% Similarity=0.408 Sum_probs=203.8
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec----
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT---- 96 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~---- 96 (740)
.++| ++.+.||+|+||+||+|.+..++..||+|+++... ........+.+|+.+++.++||||++++++|...
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4677 88899999999999999999999999999886432 2344556788999999999999999999987542
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
....+|+||||+.+ +|..++.. .++...++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS-DCTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECC-CCcEEEEeCCCc
Confidence 22468999999964 67776543 5889999999999999999999999 999999999999984 579999999999
Q ss_pred hhhccCc-cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC--------
Q 004645 177 AILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KK-------- 244 (740)
Q Consensus 177 ~~l~~~~-~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g--~~-------- 244 (740)
....... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+..... .+..+... ..
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhh
Confidence 7665432 234579999999999875 58999999999999999999999998744333 33322211 00
Q ss_pred -----------C-------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 245 -----------P-------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 245 -----------p-------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
| .......++.+++||.+||. +|.+|||+.++|+||||.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 0 00011235678999999999 999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=334.38 Aligned_cols=250 Identities=28% Similarity=0.498 Sum_probs=209.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.++||+|+||+||+|.+..++..||+|.+.... .....+.+.+|+.+|++++||||+++++++.. ....++||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICT 78 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEE
Confidence 77899999999999999999999999999886432 34455678999999999999999999998865 67889999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~ 185 (740)
||+++++|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ .++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAK 151 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceeccccccc
Confidence 99999999765 35789999999999999999999999 99999999999998 4579999999999876655555
Q ss_pred cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 186 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH------PAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~------~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
...||+.|+|||++.+ .++.++||||||+++|+|+||..||..... +......+.....+.......++++++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 6689999999999874 589999999999999999999999964221 223333333333333233456889999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 259 FIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
||.+||. +|.+||++.++++||||+..+.
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 9999999 9999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.59 Aligned_cols=254 Identities=29% Similarity=0.393 Sum_probs=211.9
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEeeecC----CCeEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN-IMKFYTSWVDTA----NRNIN 102 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fvd~~----~~~i~ 102 (740)
.++||+|+||+||+|+++.+|+.||+|++.+.... +.......+|+.+|+.|+|+| |+++++++.... ...++
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 35699999999999999999999999999876431 123345788999999999999 999999876532 23899
Q ss_pred EEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 103 FVTEMFTSGTLRQYRLKHR----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k----~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
+|+||+ ..+|..|+.... .++...++.+++||+.||+|||+++ |+||||||.||||+. .|.+||+|||+|+.
T Consensus 94 lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~-~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISS-SGVLKLADFGLARA 169 (323)
T ss_pred EEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECC-CCcEeeeccchHHH
Confidence 999999 569999987765 5888999999999999999999999 999999999999995 68999999999987
Q ss_pred hccC--ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCc-------
Q 004645 179 LRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE------- 246 (740)
Q Consensus 179 l~~~--~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~p~------- 246 (740)
..-+ ...+.++|.+|.|||++.+ .|+..+||||+|||++||++++.-|.+....+++.+.+.. |....
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 6633 2455689999999999886 4999999999999999999999999998888887765542 21110
Q ss_pred -------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 247 -------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 247 -------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
...+..++...+++.+||+ +|.+|.||+.+|.||||.....
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0012234689999999999 9999999999999999986543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=337.17 Aligned_cols=242 Identities=21% Similarity=0.292 Sum_probs=206.7
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee--cCCCeEEEEEe
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD--TANRNINFVTE 106 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd--~~~~~i~lV~E 106 (740)
..||+|+++.||+|.. +|..||+|+++... .......+.+.+|+.+|++++||||+++++++.+ .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccc-cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4699999999999965 79999999987543 2233446788899999999999999999999876 44567899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccc
Q 004645 107 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185 (740)
Q Consensus 107 y~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~ 185 (740)
|+++|+|.+++...+.+++.....++.|++.||.|||+. + ++||||||+|||++. ++.+||+|||++....... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~~-~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSPP-F 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECC-CCcEEEcccchHhhhcccc-c
Confidence 999999999998888899999999999999999999985 7 889999999999984 5799999999998765432 3
Q ss_pred cccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 186 RCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
...||+.|+|||++.+ .|+.++|||||||++|||+||..||.. .+..+++..+..+.....++...++.+++|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999864 689999999999999999999999987 456677777765544444445678999999999
Q ss_pred Hhh-CccCCCCHHHHhc
Q 004645 263 CLA-TVSSRLSARELLT 278 (740)
Q Consensus 263 cL~-dPskRpSa~ELL~ 278 (740)
||+ +|.+|||+.+++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 999 9999999999984
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.23 Aligned_cols=253 Identities=26% Similarity=0.458 Sum_probs=218.1
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|+||.||+|.+..+++.||+|+++.... ........+.+|+++|++++||||+++++++.+ ...+++|
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 79 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYLV 79 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEEE
Confidence 3888999999999999999999999999998874332 223456778999999999999999999998855 6789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+|+||+|.|||++. ++.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~-~~~~kl~dfg~~~~~~~~-~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDS-DGYIKITDFGFAKRVKGR-T 155 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECC-CCCEEEeeCCCccccCCC-C
Confidence 999999999999988889999999999999999999999999 999999999999984 479999999998776544 3
Q ss_pred ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004645 185 ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kc 263 (740)
....|++.|+|||.+. ..++.++||||||+++|+|++|..||... ......+.+..+..+ ++...++.++++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 232 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKVR--FPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCcc--CCccCCHHHHHHHHHH
Confidence 3446899999999886 45788999999999999999999999863 456666666655433 3445689999999999
Q ss_pred hh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 264 LA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 264 L~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
|. +|.+|+ +++++++||||+...+
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 99 999999 9999999999976554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=329.89 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=210.3
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA 97 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~ 97 (740)
+|+++| ++.+.||.|+||+||+|.+..++..+++|++.... ...+.+.+|+.+++++ .|+||++++++|....
T Consensus 3 ~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 3 DPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred Cchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 578899 88999999999999999999999999999887432 2346789999999999 7999999999987633
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEE
Q 004645 98 ----NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 169 (740)
Q Consensus 98 ----~~~i~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VK 169 (740)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++. ++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~-~~~~~ 153 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTK-NAEVK 153 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEcc-CCeEE
Confidence 4568999999999999998765 357999999999999999999999999 999999999999985 47999
Q ss_pred EeccchhhhhccCc--cccccCCCCCCCcccccc------ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Q 004645 170 IGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 241 (740)
Q Consensus 170 L~DFGlA~~l~~~~--~~~~~GTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~ 241 (740)
|+|||++....... .....|++.|+|||++.. .++.++||||||+++|+|+||..||........+ ..+..
T Consensus 154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~ 232 (275)
T cd06608 154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKIPR 232 (275)
T ss_pred ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHhhc
Confidence 99999986554322 233468999999998752 3678899999999999999999999864443333 33444
Q ss_pred CCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 242 GKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 242 g~~p~~~-~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
+..+... ....+..+++||.+||. +|.+|||+.++++|||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 4333222 22357789999999999 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.65 Aligned_cols=263 Identities=27% Similarity=0.444 Sum_probs=228.6
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
|.-.||...|..+ +-||.|+||.||.|+|..+...||||.+.... .++.+.++.+..|+.+|++|+|||+|.+.++|+
T Consensus 19 F~k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 19 FFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HccCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 4567888888554 66999999999999999999999999987554 467788999999999999999999999999997
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
. ..+.|+||||| -|+..+++.-+ +++.+-.|..|+.+.|.||+|||+++ .||||||..|||++ +.|.|||+||
T Consensus 97 r--e~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDF 170 (948)
T KOG0577|consen 97 R--EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADF 170 (948)
T ss_pred c--cchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccc
Confidence 7 56889999999 45777776655 67999999999999999999999999 99999999999998 5589999999
Q ss_pred chhhhhccCccccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccc
Q 004645 174 GLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249 (740)
Q Consensus 174 GlA~~l~~~~~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~ 249 (740)
|.|.+..+ ..+++|||.||||||+. |.|+-++|||||||+..||...++|+.+.+-...+|. |.....|.-..
T Consensus 171 GSAsi~~P--AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesPtLqs 247 (948)
T KOG0577|consen 171 GSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTLQS 247 (948)
T ss_pred cchhhcCc--hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCCCCCC
Confidence 99987654 46789999999999874 6799999999999999999999999988555555654 45555565556
Q ss_pred cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcc
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 250 ~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~ 288 (740)
...+..++.||..||+ -|..|||+++||+|+|.......
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 6778999999999999 69999999999999999766543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.08 Aligned_cols=250 Identities=28% Similarity=0.518 Sum_probs=212.1
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|++|.||+|.+..++..||+|.+..... .....+.+.+|+.++++++|+||+++++.|.. ....++++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEE
Confidence 3889999999999999999999999999999875432 33456678999999999999999999987643 24568999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ +.+.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEeccc
Confidence 9999999999988763 46899999999999999999999999 99999999999998 5579999999998765432
Q ss_pred --ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 183 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 183 --~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
......|++.|+|||++.+ .++.++||||||+++++|++|+.||.. .+.......+..+..+. .....++.+.+|
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 233 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPP-MPKDYSPELGEL 233 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCC-CccccCHHHHHH
Confidence 2234468999999999874 588999999999999999999999986 44455555666666543 345678999999
Q ss_pred HHHHhh-CccCCCCHHHHhcCccc
Q 004645 260 IEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~HPff 282 (740)
|.+||+ +|.+|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=367.40 Aligned_cols=251 Identities=33% Similarity=0.511 Sum_probs=219.5
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
-+||+|.||+||.|+|..|...+|||.|... .....+-+..||.+-++|+|.|||++++++ ..++.+-|.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence 3799999999999999999999999988643 345567799999999999999999999987 4477888999999
Q ss_pred CCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc--Cc
Q 004645 109 TSGTLRQYRLKH-RRV--NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SH 183 (740)
Q Consensus 109 ~gGSL~~~l~~~-k~l--se~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~--~~ 183 (740)
+||+|..++... +++ ++.++..+.+||++||.|||.+. |||||||-+||||+.-.|.+||.|||.++.+.. +.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999999987764 677 89999999999999999999999 999999999999998889999999999987653 45
Q ss_pred cccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 184 AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
+.++.||..|||||++.. .|+.++|||||||++.||.||++||.+..++...+-++-.-+.-..++...+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 667789999999999983 49999999999999999999999998877766655555443444456667789999999
Q ss_pred HHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 261 EKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
.+|+. +|.+||+|.+||.+||++..+.
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCC
Confidence 99999 9999999999999999987643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.37 Aligned_cols=251 Identities=32% Similarity=0.460 Sum_probs=208.9
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeeccc--CCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~--~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~l 103 (740)
++.+.||+|+||+||+|.+. +|..+|+|.++.... .........+.+|+.+|++++|+||+++++++.+ ...+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTISI 79 (265)
T ss_pred cccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEEE
Confidence 77899999999999999864 788999998875432 1123445678999999999999999999998855 578999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-
Q 004645 104 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 182 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~- 182 (740)
++||+++++|.+++.+...+++..+..++.||+.||.|||+.+ |+|+||||+||+++ ..+.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhcc
Confidence 9999999999999988888999999999999999999999999 99999999999998 5579999999998765321
Q ss_pred -------ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 183 -------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 183 -------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||........+.................+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 1123458999999999874 58899999999999999999999998655444443322221222234556789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
++.+||.+||. +|.+||++.++|.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.80 Aligned_cols=255 Identities=30% Similarity=0.508 Sum_probs=212.1
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeec
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 96 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~ 96 (740)
.+|.|+| ++.+.||.|+||+||+|.+..++..+|+|++... ......+..|+.+++++ +|+||++++++|+..
T Consensus 12 ~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 12 RDPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred cChhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3577888 8889999999999999999999999999987643 23445688999999999 799999999998643
Q ss_pred ----CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEE
Q 004645 97 ----ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 97 ----~~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL 170 (740)
....++++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++ +.+.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEE
Confidence 246789999999999999988664 45889999999999999999999999 99999999999998 5579999
Q ss_pred eccchhhhhccC--ccccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 004645 171 GDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242 (740)
Q Consensus 171 ~DFGlA~~l~~~--~~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g 242 (740)
+|||++...... ......|++.|+|||++. ..++.++||||||+++|+|+||..||........+.. +...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~ 241 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRN 241 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-HhhC
Confidence 999998765432 223456899999999874 2478899999999999999999999977554444432 3333
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 243 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 243 ~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
..+.......++++.+||.+||. +|.+||++.+||+||||
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 33333345578999999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.11 Aligned_cols=252 Identities=30% Similarity=0.494 Sum_probs=211.8
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
|..+| .+.+.||.|+||.||+|.+..++..+++|++.... ....+.+.+|+.++++++||||+++++.+.+ ..
T Consensus 1 ~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 73 (262)
T cd06613 1 PQEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RD 73 (262)
T ss_pred Cccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CC
Confidence 56778 88899999999999999999999999999987543 2356789999999999999999999998865 67
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
.++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++ +++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchh
Confidence 899999999999999998776 78999999999999999999999999 99999999999998 557999999999876
Q ss_pred hccCc--cccccCCCCCCCcccccc----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcc--ccc
Q 004645 179 LRKSH--AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA--LFK 250 (740)
Q Consensus 179 l~~~~--~~~~~GTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~--~~~ 250 (740)
..... .....++..|+|||.+.+ .++.++||||||+++|+|+||..||........+......+..+.. ...
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence 55432 234468999999998763 5888999999999999999999999875544444433222222211 122
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~HPf 281 (740)
..++++++||.+||. +|..|||+.+++.|+|
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 346789999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.46 Aligned_cols=253 Identities=30% Similarity=0.447 Sum_probs=204.4
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC----
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~---- 97 (740)
.+| ++.+.||+|+||+||+|.+..++..||+|+++... ........+.+|+.+|++++||||++++++|....
T Consensus 15 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 15 ERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 567 78899999999999999999999999999886432 22334566889999999999999999998875422
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
...++++++++ +++|.+++ ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecC-CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccce
Confidence 24578999988 88998875 4567999999999999999999999999 99999999999998 45799999999997
Q ss_pred hhccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCC--------
Q 004645 178 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKP-------- 245 (740)
Q Consensus 178 ~l~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g~~p-------- 245 (740)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||........+ ..+.. +..+
T Consensus 167 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhcc
Confidence 65443 344579999999999875 4889999999999999999999999764333222 22211 1100
Q ss_pred -------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 246 -------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 246 -------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.......++.+.+||.+||. +|.+|||+.++|.||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 01122356788999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=381.03 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=219.7
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|+||+||+|.+..++..||+|+++.... .......+..|+.+|++|+|||||+++++|++.....+
T Consensus 13 ~~Y-eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 13 NEY-EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 466 899999999999999999999999999999875532 34456789999999999999999999999988777889
Q ss_pred EEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeeeccCCCCceEEeCC--------
Q 004645 102 NFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRD-----PPVIHRDLKCDNIFVNGN-------- 164 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLHs~g-----p~IIHrDLKp~NILld~~-------- 164 (740)
||||||+.+|+|.+++... ..+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999987653 57999999999999999999999854 249999999999999632
Q ss_pred --------CCcEEEeccchhhhhccCc-cccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCH
Q 004645 165 --------QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHP 232 (740)
Q Consensus 165 --------~g~VKL~DFGlA~~l~~~~-~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~ 232 (740)
.+.+||+|||++..+.... ....+||+.|+|||++.+ .++.++||||||||||+|+||..||......
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 2358999999997664332 234579999999999853 4889999999999999999999999877777
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 233 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 233 ~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.++...+..+... .....++++.+||..||. +|.+||++.++|.||||+..
T Consensus 250 ~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 250 SQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 7777766655322 234568899999999999 99999999999999999744
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=330.55 Aligned_cols=251 Identities=28% Similarity=0.488 Sum_probs=215.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+.. ...+++++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICM 78 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEE
Confidence 66788999999999999999999999999887532 23556778999999999999999999998866 57899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+ ++|+||||+||+++. .+.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNS-RGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECC-CCCEEEeecccchhhHHHH
Confidence 999999999998876 789999999999999999999999 88 999999999999985 5799999999987765443
Q ss_pred cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 184 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC----THPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~----~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+..+..+.......++++++
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 334678999999998874 5889999999999999999999999764 23444555555555444333337899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 259 FIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
||.+||. +|.+|||+.+++.||||+.
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999 9999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.25 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=207.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.++||+|+||+||+|.+..+++.||+|.+..... ........+..|+.+|++++|++|+++++.+.+ ...+++||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence 677899999999999999999999999998864432 223334567889999999999999999998754 57899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++. .+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDD-HGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECC-CCCEEEeeccceeecCCCc
Confidence 999999999987554 36899999999999999999999999 999999999999984 4789999999986554322
Q ss_pred c-ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCcccccCCChHHHHH
Q 004645 184 A-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPA--QIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 184 ~-~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~--~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
. ....|++.|+|||++.+ .++.++||||||+++|+|++|..||....... .....+... .+.......++++++|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHH
Confidence 2 23469999999999874 58999999999999999999999997643211 111222111 1223445678999999
Q ss_pred HHHHhh-CccCCCC-----HHHHhcCcccCCCC
Q 004645 260 IEKCLA-TVSSRLS-----ARELLTDPFLQIDD 286 (740)
Q Consensus 260 I~kcL~-dPskRpS-----a~ELL~HPff~~~~ 286 (740)
|.+||+ +|.+||| +.|+++||||+...
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 999999 9999999 99999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.12 Aligned_cols=251 Identities=28% Similarity=0.408 Sum_probs=202.8
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
|| .+.+.||+|+||.||+|.+..+|..||+|.++.... .......+.+|+.++++++||||+++++++.+ ...++
T Consensus 1 ~y-~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~ 75 (284)
T cd07839 1 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLT 75 (284)
T ss_pred Cc-eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceE
Confidence 45 778999999999999999999999999999875432 12233567889999999999999999998855 66899
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++. .+.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcC-CCcEEECccchhhccCC
Confidence 9999996 578877665 467999999999999999999999999 999999999999984 47999999999876543
Q ss_pred Cc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------
Q 004645 182 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-------------- 243 (740)
Q Consensus 182 ~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-------------- 243 (740)
.. .....+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....++.+....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 22 223457899999998864 378999999999999999999988654444443333332110
Q ss_pred -----CC--------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 244 -----KP--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 244 -----~p--------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+ .......++++++||.+||. +|.+|||+.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 01123467899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.97 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=201.9
Q ss_pred EeEEeccc--CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 27 YNEILGKG--ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 27 i~e~LG~G--afGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+.++||+| +|++||++.+..+|..||+|+++.... .......+..|+.+++.++||||++++++|.. +..+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEE
Confidence 46789999 789999999999999999999875432 23455678889999999999999999999865 6789999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
|||+++|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++++||+.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999998664 45899999999999999999999999 99999999999998 4479999999865433211
Q ss_pred ---------ccccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc----
Q 004645 183 ---------HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---- 246 (740)
Q Consensus 183 ---------~~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~---- 246 (740)
......++..|+|||++.+ .|+.++|||||||++|+|++|..||....... .......+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCccccccc
Confidence 1122346788999999864 48899999999999999999999998644333 222222222210
Q ss_pred ----------------------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 247 ----------------------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 247 ----------------------------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
......++.+++||.+||+ +|.+|||+.++|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0112346789999999999 9999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.42 Aligned_cols=253 Identities=30% Similarity=0.528 Sum_probs=210.8
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.++||||++++++|.. ....++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEE
Confidence 47788999999999999999999999999987632 34566788999999999999999999998865 5789999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-
Q 004645 105 TEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~- 182 (740)
+||+.+++|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ..+.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEccccccccccccc
Confidence 999999999988665 467999999999999999999999999 99999999999998 4579999999998654332
Q ss_pred -ccccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-cccccCCCh
Q 004645 183 -HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVEDP 254 (740)
Q Consensus 183 -~~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p-~~~~~~~sp 254 (740)
......|++.|+|||++. ..++.++|||||||++|+|++|..||.... .......+..+..+ ...+...+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCH
Confidence 123346899999999873 247789999999999999999999998744 34444444443332 223445688
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
++++||.+||. +|.+||++.++++||||.....
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 99999999999 9999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.40 Aligned_cols=250 Identities=34% Similarity=0.535 Sum_probs=210.3
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC-----HHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-----PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~-----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.+...||+|+||.||+|.+..++..||+|.+........ ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--ADH 80 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCc
Confidence 678899999999999999999999999998875542221 1234678899999999999999999998865 568
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
.++|+||+++++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ +.+.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCcccc
Confidence 8999999999999999988888999999999999999999999999 99999999999998 45799999999987664
Q ss_pred cCc--------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004645 181 KSH--------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 181 ~~~--------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~ 251 (740)
... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........+. .+..+..+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~~~ 235 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASP-EIPSN 235 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HHhccCCC-cCCcc
Confidence 211 112358899999999874 58889999999999999999999998765544433 33333332 34456
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+..++++|.+||+ +|.+||++.++++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 78999999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.60 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=202.9
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||+|+||+||++.+..+|..||+|.+..... ........+..|+.+|++++||||+++++.|.. ...+++||||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL-KKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh-hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 7999999999999999999999998864332 112223446679999999999999999998744 6789999999999
Q ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc-ccc
Q 004645 111 GTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARC 187 (740)
Q Consensus 111 GSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~-~~~ 187 (740)
++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +.+.++|+|||++........ ...
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 9999887554 35899999999999999999999999 99999999999998 457999999999876654322 234
Q ss_pred cCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004645 188 VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263 (740)
Q Consensus 188 ~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~---~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kc 263 (740)
.|++.|+|||++. +.++.++|||||||++|+|++|..||.... +...+......+..+. .....++++++||.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 6899999999987 458999999999999999999999997543 2234444444433322 2245789999999999
Q ss_pred hh-CccCCCCH----HHHhcCcccCCCC
Q 004645 264 LA-TVSSRLSA----RELLTDPFLQIDD 286 (740)
Q Consensus 264 L~-dPskRpSa----~ELL~HPff~~~~ 286 (740)
|+ +|.+||++ .++++||||+..+
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCC
Confidence 99 99999999 6788999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.26 Aligned_cols=260 Identities=34% Similarity=0.525 Sum_probs=217.2
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
...++.++| ++.+.||.|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.|..
T Consensus 13 ~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred ccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456788888 88899999999999999999999999999887433 2234668899999999999999999998865
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
...+++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.++|+|||+
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~ 161 (297)
T cd06656 88 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 161 (297)
T ss_pred --CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCcc
Confidence 6789999999999999998754 56899999999999999999999999 99999999999998 557999999999
Q ss_pred hhhhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 176 AAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 176 A~~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
+....... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||........++.....+..+...+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 87654332 223468999999998874 588999999999999999999999976444344333333333333344567
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 8899999999999 999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=325.89 Aligned_cols=255 Identities=30% Similarity=0.526 Sum_probs=216.0
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeeccc-CCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.| ++.+.||+|+||.||+|.+..+|..||+|.+..... .........+.+|+.++++++|+||+++++.+.+.....+
T Consensus 3 ~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 3 NW-RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred ce-eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 35 889999999999999999999999999998764321 1234556789999999999999999999998876656778
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++++||+++++|.+++...+.+++..++.++.||+.||.|||+.+ ++|+||||+||+++. .+.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDS-AGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcC-CCCEEECcccccccccc
Confidence 999999999999999888788999999999999999999999999 999999999999984 57899999999976532
Q ss_pred C-----ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004645 182 S-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 182 ~-----~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
. ......|++.|+|||++.+ .++.++|+|||||++|+|++|+.||........+.+ +.....+..++...++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-IATQPTKPMLPDGVSDA 237 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-HHcCCCCCCCCcccCHH
Confidence 1 1123468999999999875 588999999999999999999999987555555543 33333444556678899
Q ss_pred HHHHHHHHhhCccCCCCHHHHhcCccc
Q 004645 256 VRQFIEKCLATVSSRLSARELLTDPFL 282 (740)
Q Consensus 256 lrdLI~kcL~dPskRpSa~ELL~HPff 282 (740)
+.+||.+||.+|.+||++.++|.|||.
T Consensus 238 ~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 999999999988999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.86 Aligned_cols=253 Identities=34% Similarity=0.506 Sum_probs=213.4
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
|| +..+.||+|+||+||+|.+..++..|++|.+...... ...+..+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~-~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RW-RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred Cc-cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeE
Confidence 35 7789999999999999999989999999998765422 234456789999999999999999999998744 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++++||+++++|.+++.+...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++. ++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~-~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDT-NGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEccCccceeccc
Confidence 999999999999999988888999999999999999999999999 999999999999984 57999999999876544
Q ss_pred Cc-cccccCCCCCCCcccccc-c-cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 182 SH-AARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 182 ~~-~~~~~GTp~YmAPEvl~~-~-ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
.. .....|++.|+|||.+.. . ++.++|+||||+++|+|++|..||........+.+....+.. ..++...++.+++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-PPIPDHLSDEAKD 233 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC-CCcCCCcCHHHHH
Confidence 33 234568999999998763 4 889999999999999999999999875544444333322322 3345567899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCccc
Q 004645 259 FIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~HPff 282 (740)
|+.+||. +|.+||++.++|.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.57 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=221.4
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
.|...| .+.++||+|+||.||+|.++.+|..+|||++.+. ..++.+..||.+|++++.|++|++|++|+. +
T Consensus 30 ~PEEVF-Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~ 100 (502)
T KOG0574|consen 30 PPEEVF-DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--H 100 (502)
T ss_pred ChHHHH-HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhcc--C
Confidence 344555 6778999999999999999999999999998754 457789999999999999999999999976 5
Q ss_pred CeEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 99 RNINFVTEMFTSGTLRQYRL-KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~-~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
..+|+|||||..|+..+.++ +++.+++..+..+++..|+||.|||-.. -||||||..|||++ .+|+.||+|||.|.
T Consensus 101 sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAG 177 (502)
T KOG0574|consen 101 SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAG 177 (502)
T ss_pred CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccc
Confidence 67999999999999999754 4688999999999999999999999988 89999999999999 44899999999998
Q ss_pred hhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 178 ILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 178 ~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
.+.+.. ..+.+|||.|||||++.+ .|+.++||||||++..||..|++||.+......|+..-.........+...+.
T Consensus 178 QLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 178 QLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSS 257 (502)
T ss_pred hhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhh
Confidence 887653 356689999999999986 69999999999999999999999999866555554322211111122345678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcchhh
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDL 291 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~~l 291 (740)
++.+||++||. +|.+|.||.+|++|||++......-+
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 99999999999 89999999999999999877654433
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.66 Aligned_cols=257 Identities=35% Similarity=0.556 Sum_probs=214.6
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
.+|..+| ++.+.||.|+||+||+|.+..+|+.|++|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 87 (296)
T cd06655 15 GDPKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLV-- 87 (296)
T ss_pred CCCcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEec--
Confidence 3466677 77899999999999999999999999999887432 2235678899999999999999999998855
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
...+++|+||+++++|..++.. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~ 163 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCA 163 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccch
Confidence 6789999999999999998754 46899999999999999999999999 99999999999998 45799999999987
Q ss_pred hhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 178 ILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 178 ~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
...... .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||........+......+..+...+...++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCH
Confidence 654332 223468999999998874 58899999999999999999999998755444443333333333334456788
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.+++||.+||. +|.+|||+.+++.||||+..
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 99999999999 99999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.09 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=213.7
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||.|+||.||+|.+..++..||+|++..... ......+.+.+|+.++++++||||+++++.+.+ ...+++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 7999999999999999999999999875432 223445779999999999999999999998754 6789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-cccccC
Q 004645 111 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-AARCVG 189 (740)
Q Consensus 111 GSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-~~~~~G 189 (740)
++|.+++.+...++...+..++.||+.||.|||+++ ++|+||||+||+++. ++.++|+|||++....... .....|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcC-CCCEEEeeCCcccccCcccccccccC
Confidence 999999988888999999999999999999999999 999999999999984 5799999999998765442 233468
Q ss_pred CCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-C
Q 004645 190 TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 266 (740)
Q Consensus 190 Tp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~-~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-d 266 (740)
++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... ++..++..+..+......+...++++++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 999999998864 58899999999999999999999997644 35666676665444444445558999999999999 9
Q ss_pred ccCCCC-----HHHHhcCcccCCCC
Q 004645 267 VSSRLS-----ARELLTDPFLQIDD 286 (740)
Q Consensus 267 PskRpS-----a~ELL~HPff~~~~ 286 (740)
|.+||+ +.|+++||||+..+
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCC
Confidence 999999 99999999997543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.91 Aligned_cols=250 Identities=29% Similarity=0.406 Sum_probs=203.9
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|++|+||+|.+..+|..||+|+++.... .......+.+|+.++++++||||+++++++.+ ...+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEE
Confidence 3788999999999999999999999999999875432 22234567889999999999999999998865 6789999
Q ss_pred EeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 105 TEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~---k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.++|+|||++.....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGI 153 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCC
Confidence 99996 6888887553 46899999999999999999999999 99999999999998 557999999999875543
Q ss_pred Cc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Q 004645 182 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------ 245 (740)
Q Consensus 182 ~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p------------ 245 (740)
.. .....+++.|+|||++.+ .++.++||||||+++|+|+||..||.+......+.........+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 22 123357899999998864 47889999999999999999999998755444443322211000
Q ss_pred --------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 --------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 --------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.......++++++||.+||. +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123468899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.79 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=215.8
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++|+||+++++++.+ ...++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 75 (274)
T cd06609 2 LF-TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLW 75 (274)
T ss_pred hh-hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEE
Confidence 55 77889999999999999999999999999987542 23445678899999999999999999998866 57899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+||+++++|.+++... ++++..++.++.||+.||.|||+++ ++|+||+|+||+++. .+.++|+|||++..+...
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSE-EGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECC-CCCEEEcccccceeeccc
Confidence 999999999999987765 8999999999999999999999999 999999999999985 579999999999776543
Q ss_pred --ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 183 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 183 --~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
......|++.|+|||.+.+ .++.++||||||+++|+|+||..||.... +......+..+..+.......++.++++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 2234468999999999874 58999999999999999999999997643 4444455555544433323378899999
Q ss_pred HHHHhh-CccCCCCHHHHhcCcccCCCCcc
Q 004645 260 IEKCLA-TVSSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~HPff~~~~~~ 288 (740)
+.+||. +|.+|||++++++||||+.....
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999999 99999999999999999865543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.36 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=205.0
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|+||.||+|.+..++..||+|.++..... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~ 79 (301)
T cd07873 6 ETY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSL 79 (301)
T ss_pred cce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeE
Confidence 455 8889999999999999999999999999998754321 223457789999999999999999998854 6789
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++ +++.++|+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccC
Confidence 99999996 5898887664 56899999999999999999999999 99999999999998 45799999999987543
Q ss_pred cCc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C-----------
Q 004645 181 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--K----------- 243 (740)
Q Consensus 181 ~~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g--~----------- 243 (740)
... .....+++.|+|||++.+ .++.++||||||+++|+|+||+.||.......++ ..+... .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-HFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCChhhchhhhc
Confidence 322 223457899999998864 4788999999999999999999999875433322 222110 0
Q ss_pred --------CCc-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 244 --------KPE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 244 --------~p~-------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.+. ......++.+++||.+||. +|.+|||+.++|+||||+.-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0113467889999999999 999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=322.53 Aligned_cols=249 Identities=31% Similarity=0.502 Sum_probs=209.0
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||.|+||+||+|.+..++..+|+|++..... ......+.+|+.+|+.++|+||+++++.+.. ...+++|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 3889999999999999999998999999998864332 2256789999999999999999999998865 6789999
Q ss_pred EeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 105 TEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~---k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+|++++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++. .+.++|+|||++..+..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGE-DGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcC-CCCEEEcccchHHHhcc
Confidence 9999999999998764 45899999999999999999999999 999999999999985 47899999999977654
Q ss_pred Ccc------ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc----c
Q 004645 182 SHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL----F 249 (740)
Q Consensus 182 ~~~------~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~----~ 249 (740)
... ....|++.|+|||++.. .++.++|+||||+++|+|++|+.||.+... ...+.....+..+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGADY 233 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCcccc
Confidence 322 23468999999998864 488999999999999999999999987544 3344444443322111 1
Q ss_pred cCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 250 ~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
...++.+++|+.+||. +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 3567899999999999 99999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=327.77 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=207.8
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||.||+|.+..+|..||+|++..... .....+.+.+|+.++++++|+||++++++|.. ...++
T Consensus 2 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 76 (286)
T cd07847 2 KY-EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLH 76 (286)
T ss_pred ce-eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEE
Confidence 45 788999999999999999999999999998874431 12233457899999999999999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||||+++++|..+......+++..++.++.||+.||.|||+.+ |+||||||+||+++ +.+.++|+|||++......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCC
Confidence 99999999999888777778999999999999999999999999 99999999999998 4479999999999766543
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C--------------
Q 004645 183 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG-K-------------- 243 (740)
Q Consensus 183 ~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g-~-------------- 243 (740)
. .....++..|+|||++.+ .++.++||||||+++|+|+||..||.+..+.+.++...... .
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 223458899999998864 47899999999999999999999998766555544322110 0
Q ss_pred -----CCc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 244 -----KPE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 244 -----~p~--------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.|. ......++.+.+||.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0123457889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.55 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=192.1
Q ss_pred EeEEecccCceEEEEEEEcC--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 27 YNEILGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~--tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
-+.+||+|+||+||+|.+.. ++..||+|.++... ....+.+|+.+|++++||||++++++|.......+++|
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 35689999999999998654 66889999876322 12357789999999999999999999887777889999
Q ss_pred EeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe---CCCCcEEEec
Q 004645 105 TEMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN---GNQGEVKIGD 172 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~---------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld---~~~g~VKL~D 172 (740)
+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99985 5787776432 24889999999999999999999999 99999999999994 2446899999
Q ss_pred cchhhhhccCc-----cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCC---------HHHHH
Q 004645 173 LGLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH---------PAQIY 236 (740)
Q Consensus 173 FGlA~~l~~~~-----~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---------~~~i~ 236 (740)
||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||..... ..++.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 99997664332 223468999999999864 488999999999999999999999964221 11111
Q ss_pred HHHHc-CCC--------------C--------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 004645 237 KKVIS-GKK--------------P--------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 280 (740)
Q Consensus 237 k~i~~-g~~--------------p--------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HP 280 (740)
+.+.. |.. + .......+..+++||.+||. +|.+|||+.|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 11100 000 0 00011235678899999999 999999999999999
Q ss_pred cc
Q 004645 281 FL 282 (740)
Q Consensus 281 ff 282 (740)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=325.36 Aligned_cols=247 Identities=34% Similarity=0.489 Sum_probs=204.7
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
...||+|+||+||+|.+..++..||+|.+... .....+.+.+|+.++++++|+||+++++++.. ...+++|+||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEec
Confidence 35799999999999999999999999987633 34456789999999999999999999998754 6789999999
Q ss_pred cCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 108 FTSGTLRQYRLKH-RRV--NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 108 ~~gGSL~~~l~~~-k~l--se~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
+++++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||.||+++...+.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999988764 455 88999999999999999999999 99999999999998656799999999987654321
Q ss_pred -cccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 184 -AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 184 -~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
.....|++.|+|||++.+ .++.++||||||+++|+|++|..||.....................++...++++++|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 223358999999999853 3788999999999999999999999765443333222222122233455678999999
Q ss_pred HHHHhh-CccCCCCHHHHhcCccc
Q 004645 260 IEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~HPff 282 (740)
+.+||. +|.+|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=328.81 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=208.8
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA 97 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~ 97 (740)
++.++| .+.+.||+|+||.||+|.+..++..+|+|++.... .....+..|+.++.++ +||||++++++|....
T Consensus 19 ~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 578888 88899999999999999999999999999886321 2235678899999999 8999999999886532
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEE
Q 004645 98 ---NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 98 ---~~~i~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL 170 (740)
...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEE
Confidence 2468999999999999998753 457899999999999999999999999 99999999999998 4578999
Q ss_pred eccchhhhhccCc--cccccCCCCCCCcccccc------ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 004645 171 GDLGLAAILRKSH--AARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242 (740)
Q Consensus 171 ~DFGlA~~l~~~~--~~~~~GTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g 242 (740)
+|||++....... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||........+. .+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~ 248 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRN 248 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcC
Confidence 9999987654322 233468999999998753 26789999999999999999999998754434443 33333
Q ss_pred CCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 243 KKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 243 ~~p~-~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
..+. .........+.+||.+||. +|.+||++.++|.||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 3221 1223456789999999999 999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=322.72 Aligned_cols=250 Identities=32% Similarity=0.509 Sum_probs=208.9
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
|.++| .+.+.||+|+||.||+|.+..++..+++|.++... ..+.+.+|++++++++||||+++++.+.. ..
T Consensus 1 ~~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 71 (256)
T cd06612 1 PEEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFK--NT 71 (256)
T ss_pred Ccccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CC
Confidence 45677 88899999999999999999899999999886432 26789999999999999999999998865 57
Q ss_pred eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
.+|+++||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++. .+.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNE-EGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECC-CCcEEEcccccchh
Confidence 89999999999999999865 457899999999999999999999999 999999999999984 57999999999987
Q ss_pred hccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CcccccCCCh
Q 004645 179 LRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-PEALFKVEDP 254 (740)
Q Consensus 179 l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~-p~~~~~~~sp 254 (740)
..... .....|+..|+|||++.+ .++.++||||||+++|+|+||..||......... ..+..... ........+.
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTLSDPEKWSP 227 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhhccCCCCCCCchhhcCH
Confidence 65443 223458999999999874 5889999999999999999999999864333222 22222211 1122334678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+.+||.+||+ +|.+|||+.++|.||||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999 99999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=317.77 Aligned_cols=252 Identities=37% Similarity=0.579 Sum_probs=219.4
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.++++++||||+++++.+.......+++++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 778999999999999999999999999999875542 245678899999999999999999999988664337899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-- 183 (740)
||+.+++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. .+.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcC-CCCEEEcccccEEeccccccc
Confidence 99999999999888889999999999999999999999999 999999999999985 5799999999987766543
Q ss_pred --cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 184 --AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
.....++..|+|||.+.+ .++.++||||||+++|+|++|..||....+.......+..+.....++...++.+++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 334568999999999875 48899999999999999999999998766555555555544455556667789999999
Q ss_pred HHHhh-CccCCCCHHHHhcCccc
Q 004645 261 EKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+||. +|.+||++.++|+||||
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHHhhCCCC
Confidence 99999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.42 Aligned_cols=250 Identities=29% Similarity=0.498 Sum_probs=215.6
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
|| ++.+.||.|+||.||.+.+..++..+++|.+..... +......+.+|+.+|++++|+||++++++|.+ ...++
T Consensus 1 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 75 (256)
T cd08221 1 HY-IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLL 75 (256)
T ss_pred Cc-eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEE
Confidence 35 788999999999999999999999999999875542 34556778999999999999999999999866 67899
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 103 FVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. .+.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTK-AGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeC-CCCEEECcCcceEEcc
Confidence 999999999999998765 46899999999999999999999999 999999999999984 5799999999987654
Q ss_pred cCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004645 181 KSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 181 ~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..++...+..+..+. .....+.++.
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELI 230 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHH
Confidence 332 234468999999998875 478899999999999999999999976 45566666677666543 3356788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 258 QFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 258 dLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
++|.+||. +|.+||++.++|+|||+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999999 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=320.11 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=212.2
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+|++++||||+++++.+.. ...+++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 788999999999999999999999999999875432 33456789999999999999999999998754 67899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.+.+.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999998764 35899999999999999999999999 99999999999998666678999999997665432
Q ss_pred -cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 184 -AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 184 -~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+..+..+ .+....++.++++|.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 234 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSGTFA-PISDRYSPDLRQLIL 234 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhcCCC-CCCCCcCHHHHHHHH
Confidence 233468999999999874 47889999999999999999999998744 44455555544433 234457889999999
Q ss_pred HHhh-CccCCCCHHHHhcCccc
Q 004645 262 KCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 262 kcL~-dPskRpSa~ELL~HPff 282 (740)
+||. +|.+|||+.++|.||||
T Consensus 235 ~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 235 SMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHccCChhhCCCHHHHhhCCCC
Confidence 9999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=332.92 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=212.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||+|+||+||+|.+..++..||+|.+..... ......+.+..|+.+|+.++|+||+++++.+.. ...+++|
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 79 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLV 79 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEE
Confidence 3788999999999999999999999999999875432 223456789999999999999999999998754 6789999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
|||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|+||||+|||++. ++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcC-CCCEEEeecchhhccccc
Confidence 9999999999998764 57999999999999999999999999 999999999999984 579999999998654221
Q ss_pred c-------------------------------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCC
Q 004645 183 H-------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT 230 (740)
Q Consensus 183 ~-------------------------------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~ 230 (740)
. ....+||..|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1 112368999999999874 58889999999999999999999998754
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC----HHHHhcCcccCCCCc
Q 004645 231 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS----ARELLTDPFLQIDDY 287 (740)
Q Consensus 231 ~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpS----a~ELL~HPff~~~~~ 287 (740)
.. ..+..+.............++.+++||.+||. +|.+||| +.++|.||||+..++
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 237 RD-ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred hH-HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 44 33444443333222223368999999999999 9999999 999999999986543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.73 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=201.3
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHH---hCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK---TLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk---~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
+||+|+||.||+|.+..+|..+|+|.+........ .....+..|..+++ ...||||+.+++.|.. .+.+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEe
Confidence 48999999999999999999999998864432211 22233444544443 3479999999998754 568999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcccc
Q 004645 107 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 186 (740)
Q Consensus 107 y~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~ 186 (740)
|+++++|.+++..++.+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.++|+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 9999999999988889999999999999999999999999 99999999999998 44799999999987655444444
Q ss_pred ccCCCCCCCccccc-c-ccCcccchhhhhhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 187 CVGTPEFMAPEVYE-E-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 187 ~~GTp~YmAPEvl~-~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
..||+.|+|||.+. + .++.++|||||||++|+|+||..||..... ...+.... ...+..++...++++++||.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--hcCCcCCccccCHHHHHHHHH
Confidence 57999999999885 3 488999999999999999999999975332 22222221 122334455678999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 263 CLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 263 cL~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
||. +|.+|+ |+.++++||||+..++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 999 999999 6999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=328.20 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=207.4
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeec-
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT- 96 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~- 96 (740)
++..+| .+.+.||+|+||+||+|.+..++..+|+|+++... .....+..|+.+++++ +||||+++++.+...
T Consensus 15 ~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred Ccccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 577888 88899999999999999999999999999875321 2235678899999999 799999999987542
Q ss_pred --CCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEE
Q 004645 97 --ANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 97 --~~~~i~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL 170 (740)
....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++. .+.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~-~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTT-EGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECC-CCCEEE
Confidence 34579999999999999988653 356889999999999999999999999 999999999999985 478999
Q ss_pred eccchhhhhccC--ccccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Q 004645 171 GDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242 (740)
Q Consensus 171 ~DFGlA~~l~~~--~~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g 242 (740)
+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+.+ +..+
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~ 244 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRN 244 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-cccc
Confidence 999998765432 223346999999999874 2378899999999999999999999987544343332 2222
Q ss_pred CCC-cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 243 KKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 243 ~~p-~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
..+ .......+..+++||.+||. +|.+|||+.++|+|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222 22334457889999999999 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.12 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=212.8
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| +..+.||.|++|+||+|.+..++..+|+|.+.... ......++.+|++++++++||||++++++|.+.....++
T Consensus 2 ~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KI-VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ce-EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 45 77899999999999999999999999999887442 234567799999999999999999999998776677899
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 103 FVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++. .+.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~-~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTR-KGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEec-CCeEEEeecccccc
Confidence 99999999999987543 346899999999999999999999999 999999999999984 47899999999876
Q ss_pred hccCccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCCCc---ccc-
Q 004645 179 LRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSEC----THPAQIYKKVISGKKPE---ALF- 249 (740)
Q Consensus 179 l~~~~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~----~~~~~i~k~i~~g~~p~---~~~- 249 (740)
..........++..|+|||.+. ..++.++||||||+++|+|++|..||... ....++...+.....+. ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 5544444456889999999887 46899999999999999999999999764 23344444444422221 111
Q ss_pred -cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 250 -KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 250 -~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
...++.+++||.+||. +|.+|||+.|+++||||+....
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 1235789999999999 9999999999999999965443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=325.83 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=206.7
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.++++++||||+++++++.. ...+++|+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 889999999999999999999999999999875432 23345678999999999999999999998865 67899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 106 EMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ |+|+||||+||+++. .+.++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISA-DGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcC-CCcEEEeeeeecccccCCCC
Confidence 999 9999998765 467999999999999999999999999 999999999999985 5799999999987765433
Q ss_pred --cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 004645 184 --AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-------------- 245 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p-------------- 245 (740)
.....|++.|+|||.+.+ .++.++||||||+++|+|+||.+||....+...+...+..-..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 234568999999998763 47899999999999999999988887654443333222111000
Q ss_pred -------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 246 -------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 246 -------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
.......+..+.+||.+||. +|.+|||++++|.||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01123456889999999999 999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.80 Aligned_cols=252 Identities=33% Similarity=0.557 Sum_probs=212.6
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
|| .+.+.||+|+||.||+|.+..++..|++|.++.... .....+.+..|+.++++++|+||+++++++.. ...++
T Consensus 1 ~y-~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~ 75 (264)
T cd06626 1 RW-QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVY 75 (264)
T ss_pred Cc-eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEE
Confidence 45 788999999999999999999999999999876542 24567889999999999999999999997644 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. .+.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEcccccccccCCC
Confidence 99999999999999888778999999999999999999999999 999999999999985 579999999998776433
Q ss_pred cc------ccccCCCCCCCcccccc-c---cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcc-cccC
Q 004645 183 HA------ARCVGTPEFMAPEVYEE-E---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA-LFKV 251 (740)
Q Consensus 183 ~~------~~~~GTp~YmAPEvl~~-~---ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~-~~~~ 251 (740)
.. ....+++.|+|||++.+ . ++.++||||||+++|+|++|..||....+...+...+..+..+.. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccc
Confidence 21 12357899999999874 3 788999999999999999999999875555554444444433221 1223
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.++.+.+||.+||+ +|.+|||+.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 48899999999999 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=329.00 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=209.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
+..+.||+|+||+||+|.+..+|..||+|++..... ........+.+|+.+|+.++|+||+++++.|.. +..+++||
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence 667889999999999999999999999998865432 122334567889999999999999999988754 67899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-
Q 004645 106 EMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 182 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~- 182 (740)
||+.+++|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence 999999999887553 46999999999999999999999999 9999999999999844 79999999998654332
Q ss_pred ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCcccccCCChHHHH
Q 004645 183 HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~---~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
......|++.|+|||++. ..++.++|+||||+++|+|+||..||....... .+...+..+. ..+....++.+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccCCHHHHH
Confidence 223446999999999986 458999999999999999999999998643322 2222222222 2234557889999
Q ss_pred HHHHHhh-CccCCCC-----HHHHhcCcccCCCCcc
Q 004645 259 FIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 288 (740)
Q Consensus 259 LI~kcL~-dPskRpS-----a~ELL~HPff~~~~~~ 288 (740)
|+.+||+ +|.+||+ +.+++.|+||+.....
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 9999999 9999999 8999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=320.55 Aligned_cols=252 Identities=30% Similarity=0.500 Sum_probs=217.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|++|.||+|.+..+|..|++|++..... ......+.+|+.++.+++|+||+++++++.. ....++|+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVL 78 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEE
Confidence 778999999999999999999999999998875432 2456789999999999999999999998865 57899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
||+++++|.+++.....+++..+..++.||+.||.|||+ .+ ++||||+|+||+++. .+.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~-~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINS-KGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECC-CCCEEEccCccceecccCCC
Confidence 999999999999888899999999999999999999999 99 999999999999984 57999999999877654333
Q ss_pred c--cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 185 A--RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 185 ~--~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
. ...++..|+|||.+.. .++.++|+||||+++|+|+||..||.... ...++.+.+..+..+.......+..++++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 2 4468899999998874 58889999999999999999999998764 55666666665554443333378999999
Q ss_pred HHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 260 IEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
|.+||. +|.+||++.++|.||||+..
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999 89999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=323.82 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=212.3
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||.|+||.||+|.+..++..||+|++..... ......+.+.+|++++++++||||+++++.|. ....+++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 79 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLVV 79 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEEE
Confidence 788999999999999999999999999999875432 23345678999999999999999999999874 467899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-cc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HA 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-~~ 184 (740)
||+.|++|..++.....+++..+..|+.||+.||.|||.++ ++|+||+|+||+++ +++.++|+|||++...... ..
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccc
Confidence 99999999999888778999999999999999999999999 99999999999998 4579999999998766543 22
Q ss_pred ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 185 ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~--~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
....|+..|+|||++.. .++.++|+||||+++|+|++|..||..... ...+...... .....+...++.+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 34468899999999874 478999999999999999999999986543 4444433332 223344556799999999
Q ss_pred HHhh-CccCCCCH--HHHhcCccc
Q 004645 262 KCLA-TVSSRLSA--RELLTDPFL 282 (740)
Q Consensus 262 kcL~-dPskRpSa--~ELL~HPff 282 (740)
+||. +|.+||++ .+++.||||
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 9999 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.76 Aligned_cols=251 Identities=27% Similarity=0.497 Sum_probs=211.0
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|+||+||+|.+..+|..||+|.++... .......+.+|+.++++++||||+++++.+.. ...+++||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCM 78 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEE
Confidence 77899999999999999999999999999887431 34456789999999999999999999998755 67899999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 106 EMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~---k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
||+++++|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||+++. .+.+||+|||++..+..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECC-CCCEEEeecCCcccccC
Confidence 999999999987663 379999999999999999999996 57 999999999999985 57999999999977655
Q ss_pred CccccccCCCCCCCcccccc-------ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHH---HHHHcCCCCcccccC
Q 004645 182 SHAARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY---KKVISGKKPEALFKV 251 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~---k~i~~g~~p~~~~~~ 251 (740)
.......|++.|+|||++.+ .++.++|||||||++|+|+||..||.... ....+ ..+..+..+ ..+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~-~~~~~ 233 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDPP-TLPSG 233 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCCC-CCCcc
Confidence 55555678999999998753 25789999999999999999999997533 22232 233334333 34455
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.++++++||.+||. +|.+||++.+++.||||....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 88999999999999 999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=328.26 Aligned_cols=252 Identities=23% Similarity=0.415 Sum_probs=211.0
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++++.. ...+++||
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCM 82 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEE
Confidence 77889999999999999999999999999887432 23456789999999999999999999999865 57899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
||+++++|..++.+.+.+++..+..++.|++.||.|||+ ++ ++||||||+||+++ +.+.++|+|||++........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhcc
Confidence 999999999998888889999999999999999999997 57 99999999999998 557999999999876544444
Q ss_pred ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCH-------H---HHHHHHHcCCCCcccccCCC
Q 004645 185 ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP-------A---QIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~-------~---~i~k~i~~g~~p~~~~~~~s 253 (740)
....|+..|+|||++. +.++.++|||||||++|+|+||..||...... . .+...+.....+.......+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 4557999999999876 56889999999999999999999999753321 1 22333333333322223367
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+.+.+||.+||. +|.+|||+.|+++||||...
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 889999999999 99999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.27 Aligned_cols=250 Identities=26% Similarity=0.499 Sum_probs=213.4
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||+||++.+..+|..||+|.+..... .......+.+|+.++++++||||+++++.+.. ....+
T Consensus 1 ~y-~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 75 (256)
T cd08218 1 KY-VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLY 75 (256)
T ss_pred Cc-eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEE
Confidence 35 889999999999999999999999999999875432 23455678999999999999999999998744 67899
Q ss_pred EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 103 FVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
+|+||+.+++|.+++.... .+++..+..|+.|++.||.|||+++ ++|+||+|+|||++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTK-DGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcC-CCCEEEeeccceeecC
Confidence 9999999999999876643 5899999999999999999999999 999999999999984 4799999999987654
Q ss_pred cCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004645 181 KSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 181 ~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
... .....|++.|+|||++.+ .++.++|+||||+++++|+||..||.. .+...++..+..+..+. .....++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLR 230 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHH
Confidence 322 223468999999999874 578899999999999999999999986 45566666667666543 3445688999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 258 QFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 258 dLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
++|.+||+ +|.+||++.++|+||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.41 Aligned_cols=260 Identities=25% Similarity=0.298 Sum_probs=209.1
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
.+..+| ++.+.||+|+||.||+|.+..+|..||+|+++..... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 4 RSVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 456677 8889999999999999999999999999998755321 1222345679999999999999999999877655
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
..+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++ +.+.+||+|||++.
T Consensus 81 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~ 156 (309)
T cd07845 81 DSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLAR 156 (309)
T ss_pred CeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceee
Confidence 78999999996 5888887653 67999999999999999999999999 99999999999998 45799999999997
Q ss_pred hhccC--ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C--------
Q 004645 178 ILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-K-------- 244 (740)
Q Consensus 178 ~l~~~--~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-~-------- 244 (740)
..... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||..... .+.+..+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchh
Confidence 66543 1222346889999999864 478999999999999999999999987443 43333333210 0
Q ss_pred ------------Ccc-------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 245 ------------PEA-------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 245 ------------p~~-------~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
+.. .....++.+.+||.+||. +|.+|||+.++|.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 000 012357889999999999 999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=356.44 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=217.2
Q ss_pred CCCCCCCceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 004645 8 EESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87 (740)
Q Consensus 8 ~~~~~~~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV 87 (740)
+..++.+++++-+..-- +++.||+|.||+||+|+ +-| .||||++++... +++.++.|++|+.+|++-+|.||+
T Consensus 379 ~~s~s~~~WeIp~~ev~--l~~rIGsGsFGtV~Rg~--whG-dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 379 QASDSLEEWEIPPEEVL--LGERIGSGSFGTVYRGR--WHG-DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred cCCccccccccCHHHhh--ccceeccccccceeecc--ccc-ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhhe
Confidence 33455566777666544 88999999999999994 455 699999987763 567899999999999999999999
Q ss_pred eeeeEeeecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 88 kl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
-|.|++.. ..+.||+-+|+|.+|..++.-. .+|++.+...|++||++|+.|||.++ |||||||..|||+. +++
T Consensus 452 LFMG~~~~---p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~ 525 (678)
T KOG0193|consen 452 LFMGACMN---PPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDL 525 (678)
T ss_pred eeehhhcC---CceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCC
Confidence 99998743 3459999999999999887553 57999999999999999999999999 99999999999998 558
Q ss_pred cEEEeccchhhhhc----cCccccccCCCCCCCcccccc----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 004645 167 EVKIGDLGLAAILR----KSHAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238 (740)
Q Consensus 167 ~VKL~DFGlA~~l~----~~~~~~~~GTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~ 238 (740)
+|||+||||+..-. ........|...|||||+++. .|++.+||||||+++|||+||..||. ..+.++|.-.
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifm 604 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFM 604 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEE
Confidence 99999999996543 223334458889999999872 49999999999999999999999999 6889999888
Q ss_pred HHcCCC---CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 239 VISGKK---PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 239 i~~g~~---p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
+-+|.. +.......+.++++|+..||. ++.+||...+||.
T Consensus 605 VGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 605 VGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 888843 344445566799999999999 9999999999885
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.50 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=197.3
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcC----------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEY----------------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~----------------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H 83 (740)
|.++| ++.++||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.+|.+++|
T Consensus 3 ~~~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 3 PRGHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred chhhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCC
Confidence 56777 899999999999999997532 44579999876432 34456779999999999999
Q ss_pred CCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 004645 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------------------RVNIRAVKHWCRQILSGLLYLHS 144 (740)
Q Consensus 84 pNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k-------------------~lse~~i~~i~~QIL~aL~yLHs 144 (740)
|||+++++++.+ ...+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+
T Consensus 79 ~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 79 PNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999999865 567899999999999999876532 35778899999999999999999
Q ss_pred CCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHH
Q 004645 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 219 (740)
Q Consensus 145 ~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyEL 219 (740)
++ |+||||||+|||++. .+.+||+|||++..+.... .....+++.|||||++. +.++.++||||||+++|+|
T Consensus 157 ~~--ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN--FVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC--ccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99 999999999999984 5799999999987654322 12234678999999876 5699999999999999999
Q ss_pred Hh--cCCCCCCCCCHHHHHHHHHc----C--CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 004645 220 VT--FDYPYSECTHPAQIYKKVIS----G--KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 220 lT--G~~Pf~~~~~~~~i~k~i~~----g--~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL 277 (740)
++ +..||..... .++...+.. . ......+...++.+.+||.+||. +|.+|||+.++.
T Consensus 234 ~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 234 LMLCKEQPYGELTD-EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHccCCCCCCcCCH-HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 87 5688876443 333332221 1 11112234567899999999999 999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=326.08 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=204.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||.|++|+||+|.+..+|..||+|.++.... .......+.+|++++++++||||+++++++.+ ...+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEE
Confidence 3788999999999999999999999999998875432 22334578899999999999999999998754 6789999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
|||+. ++|..++... ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINT-EGAIKLADFGLARAFGVP 153 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECC-CCCEEEeeccchhhcccC
Confidence 99995 6898887653 56899999999999999999999999 999999999999984 479999999998765433
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc------------
Q 004645 183 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE------------ 246 (740)
Q Consensus 183 ~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~------------ 246 (740)
. .....+++.|+|||++.+ .++.++||||||+++|+|+||+.||........+.+.+.....+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 2 223357899999998864 368899999999999999999999987555444444332211110
Q ss_pred --------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 247 --------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 247 --------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
......+++++++|.+||. +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1123467889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.94 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=204.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHH-HHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHL-LKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~i-Lk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
++.+.||+|+||.||+|.+..+|..||+|+++.... .. ....+..|+.+ ++.++||||+++++++.. ...++++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 788999999999999999999999999998875321 22 23345556665 666799999999998854 5679999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 105 TEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
|||++ |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+|||++. .+.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~-~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINR-NGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECC-CCCEEEeeccccccc
Confidence 99996 688777654 24689999999999999999999997 7 999999999999984 479999999998766
Q ss_pred ccCcc-ccccCCCCCCCcccccc-----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 180 RKSHA-ARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 180 ~~~~~-~~~~GTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
..... ....|+..|+|||++.+ .++.++|+||||+++|+|++|+.||.......+....+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 44332 22468999999998753 3688999999999999999999999764444344444445544443344578
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.++++||.+||. +|.+||++.+++.||||+...
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 899999999999 999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.07 Aligned_cols=257 Identities=22% Similarity=0.372 Sum_probs=214.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|+||.||+|.+..++..|++|.++.... ........+..|+.+++.++||||+++++.+.. +..+++||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 80 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMVM 80 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEEE
Confidence 788999999999999999999999999998874431 223445678899999999999999999998744 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC---
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--- 182 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~--- 182 (740)
||++|++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||.||+++ ..+.++|+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccc
Confidence 99999999999988888999999999999999999999999 99999999999998 5579999999987531100
Q ss_pred --------------ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc-
Q 004645 183 --------------HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE- 246 (740)
Q Consensus 183 --------------~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~- 246 (740)
......|++.|+|||.+. ..++.++||||||+++|+|++|..||.+ ....++...+..+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCC
Confidence 011235788999999876 4689999999999999999999999986 45566666666554322
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCC---HHHHhcCcccCCCCcch
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLS---ARELLTDPFLQIDDYDS 289 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~-dPskRpS---a~ELL~HPff~~~~~~~ 289 (740)
......+++++++|.+||+ +|.+||+ +.++|.||||...+...
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 1223568899999999999 9999998 79999999998766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.91 Aligned_cols=252 Identities=31% Similarity=0.472 Sum_probs=208.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC------CHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ------SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~------~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
.+.+.||.|+||.||+|.+..+|..||+|.+++..... .....+.+..|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 81 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--EE 81 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--CC
Confidence 77899999999999999999999999999887532111 11234568899999999999999999998744 67
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+++||||+.+++|.+++.+...++...++.++.||+.||.|||+++ ++||||+|+||+++ ..+.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeeccccccc
Confidence 89999999999999999888888999999999999999999999999 99999999999998 4579999999998765
Q ss_pred ccCc----cccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCcccc
Q 004645 180 RKSH----AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG---KKPEALF 249 (740)
Q Consensus 180 ~~~~----~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g---~~p~~~~ 249 (740)
.... .....|+..|+|||++.. .++.++|+||||+++|+|++|..||........+.+..... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 223358899999998863 37889999999999999999999997655444443322222 2233334
Q ss_pred cCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 250 ~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
...+..+++||.+||. +|.+|||+.++|+||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 4568899999999999 99999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.91 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=210.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||.|+||.||+|.+..+|..+++|++..... ......+.+.+|+.++++++||||+++++.+. ....+|+++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCC
Confidence 6899999999999999999999998864432 22355678999999999999999999998774 46789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--------
Q 004645 111 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-------- 182 (740)
Q Consensus 111 GSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-------- 182 (740)
++|.+++.+.+.+++..+..+++||+.||.|||+.+ ++|+||+|+||+++. ++.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcC-CCCEEEEecccchhcccCcccccccc
Confidence 999999988788999999999999999999999999 999999999999984 579999999998764332
Q ss_pred --ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 183 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 183 --~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
......+++.|+|||.+.+ .++.++||||||+++|+|+||..||.. .....++..+..+..+.......++.+++|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 2223458899999998864 588899999999999999999999976 456666777766554433222348999999
Q ss_pred HHHHhh-CccCCCCH---HHHhcCcccCCC
Q 004645 260 IEKCLA-TVSSRLSA---RELLTDPFLQID 285 (740)
Q Consensus 260 I~kcL~-dPskRpSa---~ELL~HPff~~~ 285 (740)
|.+||+ +|.+|||+ .++|+||||...
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999999 99999999 999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=330.70 Aligned_cols=263 Identities=35% Similarity=0.524 Sum_probs=216.4
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
...++.++| .+.+.||+|+||+||++.+..++..||+|.+.... ....+.+.+|+.++++++||||++++++|..
T Consensus 13 ~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~ 87 (293)
T cd06647 13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLV 87 (293)
T ss_pred eccCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeee
Confidence 446677888 78899999999999999999999999999886432 2335678999999999999999999998866
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
....++|+||+++++|.+++.+ ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||+
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~ 161 (293)
T cd06647 88 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 161 (293)
T ss_pred --CCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcc
Confidence 5688999999999999998765 46889999999999999999999999 99999999999998 457999999998
Q ss_pred hhhhccCc--cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 176 AAILRKSH--AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 176 A~~l~~~~--~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
+....... .....|++.|+|||.+. +.++.++||||||+++|+|++|..||.......++......+..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd06647 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241 (293)
T ss_pred eecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcccc
Confidence 86554322 22346889999999886 4588999999999999999999999986544444333222232222233456
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcch
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 289 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~ 289 (740)
++.+++||.+||. +|.+||++.+++.||||+......
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~ 279 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence 7889999999999 999999999999999998665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=340.61 Aligned_cols=245 Identities=27% Similarity=0.369 Sum_probs=193.7
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||.||+|.+..++..||+|+.... ....|+.+|++++||||++++++|.. ....+
T Consensus 67 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 133 (357)
T PHA03209 67 GY-TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVS--GAITC 133 (357)
T ss_pred Cc-EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEe--CCeeE
Confidence 45 8899999999999999999999999999964321 23569999999999999999998865 56789
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+|+|++. ++|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++.....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIND-VDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECC-CCCEEEecCcccccccc
Confidence 9999995 678887655 467999999999999999999999999 999999999999984 47999999999875432
Q ss_pred C-ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCC-CCCCC---------HHHHHHHHHc-CCCCccc
Q 004645 182 S-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPY-SECTH---------PAQIYKKVIS-GKKPEAL 248 (740)
Q Consensus 182 ~-~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf-~~~~~---------~~~i~k~i~~-g~~p~~~ 248 (740)
. ......||+.|+|||++.+ .|+.++|||||||++|+|+++..|+ ..... ...+.+.+.. +..|..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 2 2234569999999999874 6899999999999999999965554 32111 1122221111 1111111
Q ss_pred c------------------------------cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 249 F------------------------------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 249 ~------------------------------~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
. ...+..+.+||.+||+ +|.+||||.|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1 1345677889999999 9999999999999999974
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.83 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=214.7
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
--.+|..+| ++.+.||+|+||+||+|.+..+|..||+|++.... .......+.+.+|+.+++.++||||++++++|.+
T Consensus 9 ~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 9 SKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred cCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 345677887 78899999999999999999999999999886443 2234556778999999999999999999999865
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
....++|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||+|+||+++. ++.++|+|||
T Consensus 87 --~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~-~~~~kL~dfg 160 (307)
T cd06607 87 --EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTE-PGTVKLADFG 160 (307)
T ss_pred --CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECC-CCCEEEeecC
Confidence 567899999996 577776654 467999999999999999999999999 999999999999984 5799999999
Q ss_pred hhhhhccCccccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 175 LAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 175 lA~~l~~~~~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
++...... ....|++.|+|||++. +.++.++||||||+++|+|+||..||........++ .+..+..+.....
T Consensus 161 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (307)
T cd06607 161 SASLVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSSN 237 (307)
T ss_pred cceecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCch
Confidence 98655432 3456889999999874 458899999999999999999999998644333333 3444444433344
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
..+..++++|.+||. +|.+||++.+++.||||.....
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence 567899999999999 9999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.72 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=201.9
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHH---HHHHhCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEI---HLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei---~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
+||+|+||+||+|.+..+|+.||+|.+........ .....+..|. .+++...||+|+++++.|.. ...+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEe
Confidence 48999999999999999999999998875432211 1112233343 44555689999999988754 678999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcccc
Q 004645 107 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 186 (740)
Q Consensus 107 y~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~ 186 (740)
|+.|++|..++...+.+++..++.|+.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++..........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDE-HGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECC-CCCEEEccCcCccccCccCCcC
Confidence 9999999999888888999999999999999999999999 999999999999984 4799999999987665444445
Q ss_pred ccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 187 CVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 187 ~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
..|++.|+|||++.+ .++.++||||||+++|+|++|..||.... ....+...... .+..++...++.+.++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 679999999999863 48899999999999999999999997642 22333322222 1223444568999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 263 CLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 263 cL~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
||. +|.+|| ++.++++||||+...+
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 999 899999 9999999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.45 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=199.3
Q ss_pred CceeEEeEEecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~--~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
++| ++.+.||+|+||+||+|... .++..||+|.+... ..+.+|+.+|++|+||||+++++.|.. ..
T Consensus 92 ~~y-~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~ 159 (392)
T PHA03207 92 MQY-NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRW--KS 159 (392)
T ss_pred Cce-EEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEee--CC
Confidence 456 88999999999999999753 46778998877522 125679999999999999999998854 67
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+++|||++. ++|.+++.....+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.++|+|||++...
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCcccccc
Confidence 8999999995 689888877788999999999999999999999999 99999999999998 4579999999998765
Q ss_pred ccCc----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHc--CC------
Q 004645 180 RKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVIS--GK------ 243 (740)
Q Consensus 180 ~~~~----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~k~i~~--g~------ 243 (740)
.... .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+... ..++.. +.. +.
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccC
Confidence 4332 224569999999999874 589999999999999999999999965432 112211 111 00
Q ss_pred ------------------CC-ccc-----ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 244 ------------------KP-EAL-----FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 244 ------------------~p-~~~-----~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.+ ... ....+.++++||.+||. +|.+|||+.++|.||||+...
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00 000 01346688999999999 999999999999999997654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.48 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=208.8
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|+||+||+|.+..++..||+|.++.... .......+.+|++++++++|+||++++++|.. ...+
T Consensus 1 ~~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 75 (288)
T cd07833 1 NKY-EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRL 75 (288)
T ss_pred Cce-eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEE
Confidence 356 889999999999999999999999999998864432 23445778999999999999999999999865 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++|+||++++.|..+..+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++. .+.+||+|||++.....
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSE-SGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CCCEEEEeeecccccCC
Confidence 999999998877777666677999999999999999999999999 999999999999984 57999999999877654
Q ss_pred Cc---cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCC----------
Q 004645 182 SH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP---------- 245 (740)
Q Consensus 182 ~~---~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~p---------- 245 (740)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||......+.+...... +..+
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 32 234568899999999863 5789999999999999999999999875554444332110 0000
Q ss_pred ---------c---------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 ---------E---------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 ---------~---------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
. ......++++++||.+||. +|.+|||+.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 1122347889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=351.42 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=199.7
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.++| ++.+.||+|+||.||+|.+..++..||+|.... ..+.+|+++|++|+|+|||++++++.. ...
T Consensus 168 ~~gy-~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~ 234 (461)
T PHA03211 168 GLGF-AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVV--GGL 234 (461)
T ss_pred cCCe-EEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCE
Confidence 3455 899999999999999999999999999995431 235689999999999999999998765 578
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.++|||++ .++|..++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++. .+.+||+|||++...
T Consensus 235 ~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~-~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNG-PEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECC-CCCEEEcccCCceec
Confidence 89999999 46888887664 56999999999999999999999999 999999999999984 478999999999765
Q ss_pred ccCcc----ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC-------CCHHHHHHHHHcCCCCc-
Q 004645 180 RKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-------THPAQIYKKVISGKKPE- 246 (740)
Q Consensus 180 ~~~~~----~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~-------~~~~~i~k~i~~g~~p~- 246 (740)
..... ....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ....++.+.+..+....
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43321 23469999999999875 5899999999999999999987665321 12344555444322110
Q ss_pred -------------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 247 -------------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 247 -------------------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
......++.+++||.+||+ ||.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0011345689999999999 9999999999999999963
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.31 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=204.7
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHH-HhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL-KTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iL-k~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
+.||.|+||.||+|.+..+|..||+|.++..... .......+..|..++ ..++|+||++++++|.. ...+++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEec
Confidence 5699999999999999999999999988644321 122334455565554 45599999999998854 6789999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccccc
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 187 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~~ 187 (740)
+.+++|.+++...+.+++..+..++.||+.||.|||+.+ ++||||+|+|||++. .+.++|+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CCcEEEeecccceeccc--cccC
Confidence 999999999988888999999999999999999999999 999999999999984 57999999998875433 2344
Q ss_pred cCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHh
Q 004645 188 VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 188 ~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~--p~~~~~~~spelrdLI~kcL 264 (740)
.|++.|+|||.+.+ .++.++||||||+++|+|+||..||.. .+..+++..+..+.. +.......++.++++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 68999999999875 478999999999999999999999976 445666666655442 33344467899999999999
Q ss_pred h-CccCCCCH---HHHhcCcccCCCC
Q 004645 265 A-TVSSRLSA---RELLTDPFLQIDD 286 (740)
Q Consensus 265 ~-dPskRpSa---~ELL~HPff~~~~ 286 (740)
. +|.+||++ +|+|.||||+..+
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCC
Confidence 9 99999955 7999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.41 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=210.2
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| .+.+.||+|+||.||+|.+..++..||+|.++.... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (267)
T cd08228 2 ANF-QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNEL 77 (267)
T ss_pred cce-eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeE
Confidence 355 889999999999999999999999999998875432 234556778999999999999999999998865 5688
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 102 NFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
++++||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++. .+.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~-~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcC-CCCEEECccccce
Confidence 999999999999988653 345899999999999999999999999 999999999999984 5789999999987
Q ss_pred hhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCcccccCCC
Q 004645 178 ILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 178 ~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~-~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
...... .....|++.|+|||.+.+ .++.++||||||+++|+|+||..||... .+...+...+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 654322 123468899999998874 5888999999999999999999999643 244566666666665555555677
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..++++|.+||. +|.+||++.++|+
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 899999999999 9999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.97 Aligned_cols=249 Identities=29% Similarity=0.480 Sum_probs=210.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+.. ...+++|+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 788999999999999999999999999999876432 22345678899999999999999999998744 67899999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ ++|+||||+||+++.+...+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999999987654 4799999999999999999999999 99999999999998665567999999987765432
Q ss_pred c--ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 184 A--ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 184 ~--~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
. ....|++.|+|||++. ..++.++|+||||+++++|++|..||... +.......+..+..+. .....+..++++|
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i 234 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP-ISPNFSRDLRSLI 234 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCCC-CCCCCCHHHHHHH
Confidence 2 2345899999999886 45889999999999999999999999764 4444555555544332 3345678999999
Q ss_pred HHHhh-CccCCCCHHHHhcCccc
Q 004645 261 EKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+||. +|.+|||+.++++||||
T Consensus 235 ~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 235 SQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHhccChhhCcCHHHHhhCCCC
Confidence 99999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.10 Aligned_cols=256 Identities=28% Similarity=0.403 Sum_probs=207.8
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
|| .+.+.||+|+||.||+|.+..+|..||+|.++...... .......+..|+.++++++|+||+++++++.+ ...+
T Consensus 1 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RY-EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred Cc-eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEE
Confidence 35 77889999999999999999999999999997654321 12334567789999999999999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++||||+ +++|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+|||++. .+.++|+|||++....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~-~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIAS-DGVLKLADFGLARSFG 153 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcC-CCCEEEccceeeeecc
Confidence 9999999 999999987766 7999999999999999999999999 999999999999984 5799999999997665
Q ss_pred cCc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC----------
Q 004645 181 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-KP---------- 245 (740)
Q Consensus 181 ~~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-~p---------- 245 (740)
... .....+++.|+|||.+.+ .++.++|||||||++|+|++|.+||........+ .++.... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL-GKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH-HHHHHHcCCCchhhhhhccc
Confidence 432 223357889999998753 4789999999999999999998888764443332 2222110 00
Q ss_pred ---------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 246 ---------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 246 ---------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.......+..+++||.+||. +|.+|||+.++|.||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 01123456789999999999 999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.91 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=209.7
Q ss_pred CCCCceeeCCCC------------ceeEEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHH
Q 004645 11 DSSEFVEVDPTG------------RYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYC 73 (740)
Q Consensus 11 ~~~~~~e~dp~g------------RY~ri~e~LG~GafGtVYkA~d-----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~ 73 (740)
+...|+-+||+. +| ++.++||+|+||+||+|.+ ..++..||+|+++... .....+.+.+
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~ 87 (375)
T cd05104 12 NGNNYVYIDPTQLPYDHKWEFPRNRL-SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMS 87 (375)
T ss_pred cCceEEEecCCCCCCccccccchHHe-ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHH
Confidence 344566666552 45 8899999999999999964 4567789999886332 2344567899
Q ss_pred HHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcC-------------------------------
Q 004645 74 EIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------------------- 121 (740)
Q Consensus 74 Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k------------------------------- 121 (740)
|+.+|+.+ +||||++++++|.+ ....++||||+++|+|.+++...+
T Consensus 88 Ei~il~~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (375)
T cd05104 88 ELKVLSYLGNHINIVNLLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSL 165 (375)
T ss_pred HHHHHHHhcCCcceeeeeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhh
Confidence 99999999 89999999998855 667899999999999999876432
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCC
Q 004645 122 --------------------------------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 157 (740)
Q Consensus 122 --------------------------------------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~ 157 (740)
.+++..+..|+.||+.||.|||+++ |+||||||+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 243 (375)
T cd05104 166 NEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAAR 243 (375)
T ss_pred hhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchh
Confidence 4678889999999999999999999 999999999
Q ss_pred ceEEeCCCCcEEEeccchhhhhccCccc----cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCC
Q 004645 158 NIFVNGNQGEVKIGDLGLAAILRKSHAA----RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTH 231 (740)
Q Consensus 158 NILld~~~g~VKL~DFGlA~~l~~~~~~----~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~ 231 (740)
|||++. .+.+||+|||++......... ...+++.|+|||++.+ .++.++|||||||++|+|++ |..||.....
T Consensus 244 Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~ 322 (375)
T cd05104 244 NILLTH-GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322 (375)
T ss_pred hEEEEC-CCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence 999984 578999999998765433221 1234567999999874 68999999999999999998 8999987666
Q ss_pred HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 232 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 232 ~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
...+++.+..+..+. .+...++++++||.+||. +|.+|||+.++++.
T Consensus 323 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 323 DSKFYKMIKEGYRML-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred hHHHHHHHHhCccCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 666777666665432 334567899999999999 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.30 Aligned_cols=255 Identities=27% Similarity=0.346 Sum_probs=203.0
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCC---
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN--- 98 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~--- 98 (740)
+| ++.+.||+|+||+||+|.+..+|..||+|+++.... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 2 ~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AY-EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred Cc-eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 45 788999999999999999999999999998865421 222335688899999999 56999999998765322
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+.+.+||+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeec
Confidence 238999999975 788887653 35799999999999999999999999 9999999999999964689999999
Q ss_pred chhhhhccCc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----
Q 004645 174 GLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP---- 245 (740)
Q Consensus 174 GlA~~l~~~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p---- 245 (740)
|++....... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||.......++.+....-..|
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9987543321 123357899999998763 47899999999999999999999998755555443322210000
Q ss_pred ---------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 246 ---------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 246 ---------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
.......++++.+||.+||. +|.+||++.++|.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01113467889999999999 999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=311.21 Aligned_cols=248 Identities=30% Similarity=0.529 Sum_probs=214.2
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||.||+|.+..++..|++|++..... .......+..|+++++.++|||++++++.+.. ...+++|+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 788999999999999999999999999999875432 34556778999999999999999999998866 47899999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 106 EMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++ +.+.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeeccc
Confidence 999999999988764 67999999999999999999999999 99999999999998 457999999999876654
Q ss_pred Cc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 182 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 182 ~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
.. .....|++.|+|||.+.+ .++.++|+||||+++++|++|..||.. .+...+......+.. ..+....+..+++
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQY-PPIPSQYSSELRN 233 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCCC-CCCCCCCCHHHHH
Confidence 42 233468999999998764 588999999999999999999999976 345666666665543 3344567899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcCccc
Q 004645 259 FIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~HPff 282 (740)
++.+||. +|.+|||+.++|+||||
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=350.02 Aligned_cols=233 Identities=30% Similarity=0.435 Sum_probs=199.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
+-||+|+.|.||+|+ ..+..||||+|+- .-..+|+-|++|+||||+.|.++| +....++||||||
T Consensus 130 eWlGSGaQGAVF~Gr--l~netVAVKKV~e-----------lkETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGR--LHNETVAVKKVRE-----------LKETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeee--ccCceehhHHHhh-----------hhhhhHHHHHhccCcceeeEeeee--cCCceeEEeeecc
Confidence 669999999999995 4589999997761 123478889999999999999988 5578999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-ccccc
Q 004645 109 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARC 187 (740)
Q Consensus 109 ~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-~~~~~ 187 (740)
..|.|...++..+.++...+..|.++|+.|+.|||.+. |||||||.-||||..+ ..|||+|||.+....+. ....+
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999 9999999999999966 48999999999877654 44567
Q ss_pred cCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-
Q 004645 188 VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA- 265 (740)
Q Consensus 188 ~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~- 265 (740)
+||..|||||+++. ..++++|||||||+|||||||+.||.+....+.|+ -|-+..+-...+...+..++-||+.||+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCcccCchHHHHHHHHHHhc
Confidence 89999999999985 58999999999999999999999998755433332 2222233334456678899999999999
Q ss_pred CccCCCCHHHHhcCc
Q 004645 266 TVSSRLSARELLTDP 280 (740)
Q Consensus 266 dPskRpSa~ELL~HP 280 (740)
+|..||++.++|.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 999999999999884
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.96 Aligned_cols=244 Identities=19% Similarity=0.271 Sum_probs=202.1
Q ss_pred eEEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 25 GRYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~---~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
+++.++||+|+||.||+|.+. ..+..||+|.++.. ........+.+|+.+|++++||||+++++++.. +..+
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 81 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM 81 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence 389999999999999999764 45678999988743 233445678999999999999999999998754 6789
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+|||++. ++.++|+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~-~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNS-DLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcC-CCcEEECCCccccccc
Confidence 9999999999999998774 57899999999999999999999999 999999999999984 4799999999875543
Q ss_pred cCcc---ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004645 181 KSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 181 ~~~~---~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
.... ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.. .....+.+.+..+..+. .+...+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRLP-APRNCPNL 236 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCCC-CCCCCCHH
Confidence 2211 1223567899999886 568999999999999999775 9999987 44555666666664432 45567889
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhc
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
+.+++.+||+ +|.+||++.+|++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=321.73 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=206.8
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg-----~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
.| ++.+.||+|+||.||+|.+...+ ..||+|.++.. ........+.+|+.+|.+++||||+++++++..
T Consensus 6 ~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-- 79 (283)
T cd05048 6 AV-RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-- 79 (283)
T ss_pred Hc-chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--
Confidence 44 78899999999999999876555 77999887633 234556779999999999999999999998754
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEE
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 161 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~----------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILl 161 (740)
...++++|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~ 157 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV 157 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE
Confidence 56789999999999999998765 45788999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccchhhhhccC----ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHH
Q 004645 162 NGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQI 235 (740)
Q Consensus 162 d~~~g~VKL~DFGlA~~l~~~----~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i 235 (740)
+ +++.++|+|||++...... ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+ ....++
T Consensus 158 ~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05048 158 G-EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEV 235 (283)
T ss_pred c-CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 4579999999998754322 122335788999999876 568999999999999999998 9999987 455677
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 236 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 236 ~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
+..+..+..+. .....++++.+|+.+||+ +|.+||++.+++++
T Consensus 236 ~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77777766543 345678999999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=322.62 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=200.5
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.++| ++.+.||+|+||.||+|.+..+|..||+|.++.... ......+.+|+.+|+.++|+||+++++++.. ...
T Consensus 4 ~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~ 77 (291)
T cd07870 4 ATSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHT--KET 77 (291)
T ss_pred ccee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCe
Confidence 4556 889999999999999999999999999999875432 1223356789999999999999999998754 678
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++ ..+.++|+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEecccccccc
Confidence 999999995 6777766543 56888999999999999999999999 99999999999998 5579999999998654
Q ss_pred ccC--ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC---------
Q 004645 180 RKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK--------- 244 (740)
Q Consensus 180 ~~~--~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g~~--------- 244 (740)
... ......+++.|+|||++.+ .++.++||||||+++|+|+||..||.......+....+.. |..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 322 1223357899999999864 4788999999999999999999999765544333322211 100
Q ss_pred --------------Cccc---c--cCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 245 --------------PEAL---F--KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 245 --------------p~~~---~--~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
+... . ...++.+.+|+.+||. +|++|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0 1135789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.86 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=210.7
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH----------HHHHHHHHHHHHHHhCCCCCcce
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP----------EELERLYCEIHLLKTLKHRNIMK 88 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~----------~~~~~l~~Ei~iLk~L~HpNIVk 88 (740)
+..+||..+.+.||.|+||+||+|.+..+|..||+|+++........ .....+.+|+.++++++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 56789977889999999999999999999999999998754322110 01124778999999999999999
Q ss_pred eeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcE
Q 004645 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 168 (740)
Q Consensus 89 l~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~V 168 (740)
++++|.. ...+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ |+|+||||+|||++ ..+.+
T Consensus 85 ~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~ 158 (335)
T PTZ00024 85 LVDVYVE--GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGIC 158 (335)
T ss_pred eeEEEec--CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCE
Confidence 9998855 678999999996 689999888888999999999999999999999999 99999999999998 45799
Q ss_pred EEeccchhhhhcc----------------CccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCC
Q 004645 169 KIGDLGLAAILRK----------------SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECT 230 (740)
Q Consensus 169 KL~DFGlA~~l~~----------------~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~ 230 (740)
+|+|||++..... .......+++.|+|||.+.+ .++.++||||||+++|+|+||..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876541 11122346889999998864 37889999999999999999999998754
Q ss_pred CHHHHHHHHHc--CCCCc------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 231 HPAQIYKKVIS--GKKPE------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 231 ~~~~i~k~i~~--g~~p~------------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
....+ ..+.. +..+. ......+..+++||.+||. +|.+|||+.++|.||||+
T Consensus 239 ~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 43333 22221 10000 1123447789999999999 999999999999999998
Q ss_pred CCCc
Q 004645 284 IDDY 287 (740)
Q Consensus 284 ~~~~ 287 (740)
....
T Consensus 318 ~~~~ 321 (335)
T PTZ00024 318 SDPL 321 (335)
T ss_pred CCCC
Confidence 6543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.43 Aligned_cols=256 Identities=30% Similarity=0.518 Sum_probs=209.8
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
|...| .....||.|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++.+.. ..
T Consensus 20 ~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~ 92 (292)
T cd06658 20 PREYL-DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GD 92 (292)
T ss_pred hHHHH-hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CC
Confidence 33344 3357799999999999999999999999988642 23456678999999999999999999998855 67
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
..++||||+++++|.+++. .+.+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.++|+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~ 168 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTS-DGRIKLSDFGFCAQV 168 (292)
T ss_pred eEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcC-CCCEEEccCcchhhc
Confidence 8999999999999999864 457899999999999999999999999 999999999999984 479999999998765
Q ss_pred ccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc-ccccCCChH
Q 004645 180 RKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFKVEDPE 255 (740)
Q Consensus 180 ~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~-~~~~~~spe 255 (740)
.... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||... .....+..+.....+. ......++.
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSV 247 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHH
Confidence 4322 233468999999999874 5889999999999999999999999863 3444444444332221 122346789
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
+++||.+||. +|.+|||+.++|+||||+....
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 9999999999 9999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.48 Aligned_cols=259 Identities=37% Similarity=0.580 Sum_probs=216.1
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
.++...| .+...||.|+||.||+|.+..++..|++|+++.... ....+.+|+.++++++|+||+++++.+..
T Consensus 15 ~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 86 (286)
T cd06614 15 GDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLV-- 86 (286)
T ss_pred CCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--
Confidence 3455555 788999999999999999998999999999875432 45678899999999999999999999876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
....++|+||+++++|.+++.... .++...+..++.||+.||.|||+.| |+|+||+|+||+++ ..+.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchh
Confidence 578999999999999999988876 8999999999999999999999999 99999999999998 4579999999998
Q ss_pred hhhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-cccccCC
Q 004645 177 AILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVE 252 (740)
Q Consensus 177 ~~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p-~~~~~~~ 252 (740)
....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.... +......+..+..+ .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-PLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCcchhhC
Confidence 7654332 223358899999998874 58999999999999999999999998643 33443444333322 2223346
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcc
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~ 288 (740)
+..+++||.+||+ +|.+||++.++|.||||+.....
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence 8899999999999 99999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.64 Aligned_cols=245 Identities=28% Similarity=0.439 Sum_probs=209.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||.|+||.||++.+..++..+|+|.++... .....+.+..|+.+++.++|+||+++++.|.+ ...+++++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 78899999999999999999999999999987543 23456788899999999999999999998855 67899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+++++|.+++... ..+++..+..|+.||+.||.|||+++ |+|+||||+||+++ ..+.++|+|||++.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecccc
Confidence 999999999987653 46899999999999999999999999 99999999999998 45799999999987654322
Q ss_pred --cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 184 --AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
.....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+...+...+..+..+. .+...+..+++||
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 232 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRSLI 232 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHHHH
Confidence 234568999999999874 588999999999999999999999986 45556666666665432 3455788999999
Q ss_pred HHHhh-CccCCCCHHHHhcCc
Q 004645 261 EKCLA-TVSSRLSARELLTDP 280 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~HP 280 (740)
.+||. +|.+|||+.++|.--
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHhCCcccCCCHHHHhhcc
Confidence 99999 999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=321.11 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=205.4
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||+|+||+||+|.+..+|..||+|++..... ........+..|+.+|++++||||+++++.|.. ...+|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 6999999999999999999999998864332 122335567789999999999999999998744 6789999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-cccc
Q 004645 111 GTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-AARC 187 (740)
Q Consensus 111 GSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-~~~~ 187 (740)
++|.+++.+.+ .+++..+..++.||+.||.|||+.+ ++||||+|+||+++ +++.++|+|||++....... ....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999987765 7999999999999999999999999 99999999999998 45799999999987664322 2334
Q ss_pred cCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004645 188 VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263 (740)
Q Consensus 188 ~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~k~i~~g~~p~~~~~~~spelrdLI~kc 263 (740)
.++..|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.+++||.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 58899999999864 588999999999999999999999975432 2333332222 23334556789999999999
Q ss_pred hh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 264 LA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 264 L~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
|+ +|.+|| ++.+++.||||...++
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 99 999999 9999999999975543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=321.60 Aligned_cols=256 Identities=29% Similarity=0.485 Sum_probs=213.6
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
|.+.| ...+.||.|+||.||+|.+..++..||+|+++... .......+.+|+.+++++.||||+++++++.+ ..
T Consensus 2 ~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06640 2 PEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GT 75 (277)
T ss_pred hHHhh-hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CC
Confidence 44556 56688999999999999999999999999887543 34556789999999999999999999998865 67
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+++||||+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceec
Confidence 89999999999999998754 57899999999999999999999999 99999999999998 4579999999998665
Q ss_pred ccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004645 180 RKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256 (740)
Q Consensus 180 ~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spel 256 (740)
.... .....++..|+|||++.+ .++.++|+||||+++|+|+||..||.... +......+..+. +..+....+..+
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPF 229 (277)
T ss_pred cCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHH
Confidence 4322 223458899999999864 58899999999999999999999998744 344433333333 333445567899
Q ss_pred HHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 257 RQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 257 rdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
.+||.+||. +|.+||++.++++||||.....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 999999999 8999999999999999965543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.95 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=199.7
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i~l 103 (740)
|++.+.||+|+||.||+|.+..++..||+|+++.... ... .....+|+.++.++. |+||+++++++.+.....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 3788999999999999999999999999998864321 112 223457899999994 999999999987754578999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 104 VTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
|+||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++. +.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 999996 5777776653 57899999999999999999999999 999999999999985 89999999999766443
Q ss_pred cc-ccccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCC------------
Q 004645 183 HA-ARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKP------------ 245 (740)
Q Consensus 183 ~~-~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g~~p------------ 245 (740)
.. ....+++.|+|||++. +.++.++|||||||++|+|++|..||..... ...+..+.. +..+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 22 3346899999999764 3478899999999999999999999976433 322222211 1100
Q ss_pred ------c-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 ------E-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 ------~-------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
. ......+..+++||.+||. +|.+||++.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0 0123457899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.63 Aligned_cols=247 Identities=35% Similarity=0.562 Sum_probs=208.3
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|.+.+.||+|++|.||+|.+..++..+++|++..... .....+.+|+.++++++|+||+++++++.. ....+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEE
Confidence 4778999999999999999999999999998874332 456789999999999999999999998855 5788999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 105 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
+||+++++|.+++... +.+++..+..++.|++.||.|||.++ ++||||+|+||+++. .+.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTS-DGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEcc-CCeEEEeeccccccccccc
Confidence 9999999999998776 68999999999999999999999999 999999999999984 5799999999987765543
Q ss_pred -cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccc-cCCChHHHHHH
Q 004645 184 -AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF-KVEDPEVRQFI 260 (740)
Q Consensus 184 -~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~-~~~spelrdLI 260 (740)
.....|+..|+|||.+.+ .++.++||||||+++|+|++|..||........+..... ...+.... ...+..+++||
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHH
Confidence 344568999999998874 478899999999999999999999987544444433222 22222222 22378999999
Q ss_pred HHHhh-CccCCCCHHHHhcCcc
Q 004645 261 EKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~HPf 281 (740)
.+||. +|.+|||+.++|+|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 99999 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=320.82 Aligned_cols=251 Identities=28% Similarity=0.394 Sum_probs=199.9
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|++|+||+|.++.++..||+|.+...... .....+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 78 (291)
T cd07844 5 ETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTL 78 (291)
T ss_pred cce-eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeE
Confidence 345 7889999999999999999999999999998754321 112346789999999999999999998754 6789
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++....
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISE-RGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcC-CCCEEECccccccccC
Confidence 99999997 4899987764 46899999999999999999999999 999999999999984 4799999999986543
Q ss_pred cC--ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C-C---------
Q 004645 181 KS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--K-K--------- 244 (740)
Q Consensus 181 ~~--~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g--~-~--------- 244 (740)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+..+.+... . .
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 22 1122357889999998864 47899999999999999999999997655333332222110 0 0
Q ss_pred -------------Cc---ccccCCC--hHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 245 -------------PE---ALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 245 -------------p~---~~~~~~s--pelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
+. ......+ +.+.++|.+||. +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0011233 788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.21 Aligned_cols=256 Identities=32% Similarity=0.552 Sum_probs=212.5
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
++...|.. .+.||+|++|.||+|.+..++..+++|+++... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 16 ~~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~ 88 (285)
T cd06648 16 DPRSYLDN-FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--G 88 (285)
T ss_pred cchHhhhc-ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--C
Confidence 44445533 478999999999999999999999999886432 3345668899999999999999999998865 6
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
...++++||+++++|.+++.. .+++...+..++.||+.||+|||+++ |+||||+|+||+++. ++.++|+|||++..
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~ 164 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTS-DGRVKLSDFGFCAQ 164 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcC-CCcEEEcccccchh
Confidence 788999999999999998776 67999999999999999999999999 999999999999984 57999999998865
Q ss_pred hccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc-ccCCCh
Q 004645 179 LRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL-FKVEDP 254 (740)
Q Consensus 179 l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~-~~~~sp 254 (740)
..... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .++...+..+..+..+... ....++
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSP 243 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCH
Confidence 54322 223468999999999874 588999999999999999999999976 4455556666655332211 223678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.+.+||.+||. +|.+|||+.++|.||||+...
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 99999999999 999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.34 Aligned_cols=250 Identities=30% Similarity=0.515 Sum_probs=210.6
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|+||.||+|.+..+|..||+|.++.... ......+++.+|+.++++++|+||+++++.|.. ....
T Consensus 2 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~ 77 (267)
T cd08224 2 GNF-KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNEL 77 (267)
T ss_pred Cce-eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeE
Confidence 466 889999999999999999999999999999875443 233456789999999999999999999999865 5788
Q ss_pred EEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 102 NFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
++||||+++++|..++... ..+++..++.|+.||+.||.|||+.| |+||||||+||+++. .+.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~-~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECC-CCcEEEeccceee
Confidence 9999999999999987642 45899999999999999999999999 999999999999984 4799999999987
Q ss_pred hhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCcccccCCC
Q 004645 178 ILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 178 ~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~-~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
...... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... .+...+...+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 654332 233468999999998874 5889999999999999999999999643 344456666666665544444678
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..++++|.+||. +|.+|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999999 8999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.00 Aligned_cols=252 Identities=32% Similarity=0.502 Sum_probs=208.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEeeecCCCeE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fvd~~~~~i 101 (740)
|++.+.||+|+||.||+|.+..+|..||+|.++... .......+.+|+.++++++ ||||++++++|.+ ...+
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~ 77 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRL 77 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEE
Confidence 477789999999999999999999999999886432 2345567889999999996 9999999998865 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++||||+++++|.+++.. +.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. .+.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTN-TGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcC-CCCEEEccCCceeecCC
Confidence 999999999999998755 57999999999999999999999999 999999999999985 57999999999876654
Q ss_pred Cc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004645 182 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 182 ~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
.. .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||..... ......+.....+.......++++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccccCCCCCCCcccCCHHHH
Confidence 32 233468999999998863 378899999999999999999999986433 3222222222222222223788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 258 QFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 258 dLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
+|+.+||. +|.+||++.++++||||+...
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999 999999999999999997544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.86 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=200.7
Q ss_pred CceeEEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeee
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 95 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~-----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd 95 (740)
.+| .+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+.+|+.+ +|+||+++++.|..
T Consensus 38 ~~~-~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 38 DNL-QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHc-eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345 789999999999999998644 34579999886432 234567789999999999 89999999998855
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKH------------------------------------------------------- 120 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~------------------------------------------------------- 120 (740)
...+++||||+.+|+|.+++...
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 56899999999999999987542
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccc
Q 004645 121 ---------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185 (740)
Q Consensus 121 ---------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~ 185 (740)
.++++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcce
Confidence 24788899999999999999999999 99999999999998 5579999999998765433221
Q ss_pred ----cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 186 ----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 186 ----~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
...+++.|||||++. +.++.++|||||||++|+|++ |..||........+++.+..+..+ ..+...+++++++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHHHH
Confidence 123556899999886 569999999999999999997 999998755544455555444322 3344568999999
Q ss_pred HHHHhh-CccCCCCHHHHhc
Q 004645 260 IEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~ 278 (740)
|.+||+ +|.+|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=332.31 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=206.0
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC-
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA- 97 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~- 97 (740)
++.+|| ++.+.||.|+||+||+|.+..+|..||+|++..... ...+.+.+|+.+|++++||||+++++.+....
T Consensus 2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 456788 889999999999999999999999999999875442 34567889999999999999999998765432
Q ss_pred -----------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 98 -----------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 98 -----------~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
...+++|+||+. ++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++..++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence 135789999996 58988764 457899999999999999999999999 999999999999986667
Q ss_pred cEEEeccchhhhhccCc-----cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 004645 167 EVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 239 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~-----~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i 239 (740)
.+||+|||++..+.... .....|++.|+|||++.+ .++.++|||||||++|+|++|..||......... ..+
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~ 231 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLI 231 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH
Confidence 89999999987653221 122357889999998753 4888999999999999999999999764433322 222
Q ss_pred HcC------------------------CCC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 240 ISG------------------------KKP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 240 ~~g------------------------~~p----~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
... ..+ .......+.++++||.+||+ +|.+|||+.++|.||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 211 000 01123467889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.77 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=202.3
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||.|++|+||+|.+..+|..||+|++++... ......+.+|+.++++++|+||++++++|.+ ....++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 788999999999999999999999999999876532 1223557789999999999999999999866 56789999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 106 EMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~---k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ +++.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCC
Confidence 99975 888887654 35899999999999999999999999 99999999999998 5579999999999765433
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 004645 183 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------- 245 (740)
Q Consensus 183 ~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p------------- 245 (740)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+...+.+.....|
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2 223457899999998764 47889999999999999999999998755444332222111000
Q ss_pred -------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 -------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 -------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
..+....++.++++|.+||+ +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01123457889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.19 Aligned_cols=252 Identities=26% Similarity=0.332 Sum_probs=204.7
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.| ++.+.||.|+||.||+|.+..++..+|+|.++..... ......+.+|+.++++++||||+++++++.......++
T Consensus 6 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 6 EY-EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hh-hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 45 7778999999999999999999999999999865422 22334577899999999999999999998775558899
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||||+|||++. .+.++|+|||++.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNN-RGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECC-CCcEEEeecCceeeccC
Confidence 9999996 59998877654 5899999999999999999999999 999999999999984 47999999999876654
Q ss_pred C--ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C------------
Q 004645 182 S--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-K------------ 244 (740)
Q Consensus 182 ~--~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-~------------ 244 (740)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+ .++.... .
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchHHHHHhhcc
Confidence 3 2223458899999998864 3688999999999999999999999875443333 2221100 0
Q ss_pred C----------------cccccC-CChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 245 P----------------EALFKV-EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 245 p----------------~~~~~~-~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
+ ..+... .++.+++||.+||+ +|++|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 011111 47889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.96 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=205.3
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|+.++||||++++++|.. ...++
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 76 (286)
T cd07846 2 KY-ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLY 76 (286)
T ss_pred ce-eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEE
Confidence 45 788999999999999999999999999998764332 22345568899999999999999999998844 67899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+||+.+++|..+......+++..++.++.||+.||.|||+.+ |+|+||+|+||+++. ++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECC-CCcEEEEeeeeeeeccCC
Confidence 99999999999888766667999999999999999999999999 999999999999984 579999999998765433
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC--------------
Q 004645 183 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK-------------- 243 (740)
Q Consensus 183 ~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~-------------- 243 (740)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||........+.+.... +.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2 223468899999998864 4788999999999999999999999764443333222110 00
Q ss_pred -----CCc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 244 -----KPE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 244 -----~p~--------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+. ...+..+..+++|+.+||. +|.+||++.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0123457889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.51 Aligned_cols=248 Identities=31% Similarity=0.482 Sum_probs=214.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||.|+||.||++.+..++..+|+|.++.... .......+..|+.++++++|+||+++++++.. ....++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 788999999999999999999999999998875432 23456678899999999999999999998865 57899999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 106 EMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 106 Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
||+++++|..++.+ ...+++..+..++.|++.||.|||+.| ++|+||+|+||+++. .+.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVA-NDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEec-CCcEEEeeccchhhhcc
Confidence 99999999998766 356899999999999999999999999 999999999999985 57999999999987766
Q ss_pred CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
.......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+...+...+..+..+.. ....+.+++++|
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li 233 (256)
T cd08530 156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPPI-PPIYSQDLQNFI 233 (256)
T ss_pred CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCC-chhhCHHHHHHH
Confidence 54445568999999999874 588899999999999999999999986 455566666666655433 346788999999
Q ss_pred HHHhh-CccCCCCHHHHhcCccc
Q 004645 261 EKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~HPff 282 (740)
.+||. +|.+||++.++|+||++
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHcCCCcccCCCHHHHhcCCCC
Confidence 99999 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.41 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=205.6
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|++|+||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.+ ...+
T Consensus 2 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (294)
T PLN00009 2 DQY-EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRL 76 (294)
T ss_pred Cce-EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeE
Confidence 355 788999999999999999999999999998865432 22334568889999999999999999998855 6789
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 102 NFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999995 57887766543 3588999999999999999999999 9999999999999866668999999999754
Q ss_pred ccCc--cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCc--------
Q 004645 180 RKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE-------- 246 (740)
Q Consensus 180 ~~~~--~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~p~-------- 246 (740)
.... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||........+.+.+.. +....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3321 233457899999998864 4788999999999999999999999875544444433211 10000
Q ss_pred -----------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 247 -----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 247 -----------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
......++.+++||.+||. +|.+||++.++|.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0123457889999999999 99999999999999999643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.09 Aligned_cols=267 Identities=28% Similarity=0.460 Sum_probs=227.6
Q ss_pred CCCCceeEE-eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 19 DPTGRYGRY-NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 19 dp~gRY~ri-~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
|-..-|.-+ .++||+|-||+||-|+++.+|+.||+|+|.+..+....+ ..+.+|+.+|+++.||.||.+-..| ++
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe--sqlR~EVaILq~l~HPGiV~le~M~--ET 634 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE--SQLRNEVAILQNLHHPGIVNLECMF--ET 634 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH--HHHHHHHHHHHhcCCCCeeEEEEee--cC
Confidence 334445222 378999999999999999999999999998777644433 6799999999999999999998766 66
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC--CCcEEEecc
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKIGDL 173 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~--~g~VKL~DF 173 (740)
.+.++.|||-+ .|++.+.+... +++++...+.++.|||.||.|||-++ |+|.||||+|||+... ..++|||||
T Consensus 635 ~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 635 PERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred CceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccc
Confidence 88999999999 56777766553 68999999999999999999999999 9999999999999753 347999999
Q ss_pred chhhhhccC-ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCcccc
Q 004645 174 GLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KKPEALF 249 (740)
Q Consensus 174 GlA~~l~~~-~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g--~~p~~~~ 249 (740)
|+|+++.+. ...+.+|||.|+|||++. +.|+..-|+||+|||+|--+.|..||.+. ++|..+|... ..|...+
T Consensus 712 GfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQNAaFMyPp~PW 788 (888)
T KOG4236|consen 712 GFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQNAAFMYPPNPW 788 (888)
T ss_pred cceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc---cchhHHhhccccccCCCch
Confidence 999998765 456678999999999998 56999999999999999999999999763 4566666654 3577778
Q ss_pred cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcchhhhhhh
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQ 295 (740)
Q Consensus 250 ~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~~~l~~~~ 295 (740)
+.+++++.+||..+|+ +-++|.|....|.|||+|....-.+++.+.
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHH
Confidence 8999999999999999 899999999999999999887666666654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=321.27 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=202.0
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeEEEEE
Q 004645 27 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
..+.||+|+||.||++.+..+|..||+|.+..... ......+.+|+.++.++. |+||+++++++.. ....+++|
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~ 82 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM 82 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence 45679999999999999999999999998875432 245667899999999995 9999999998755 56788999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 106 EMFTSGTLRQYRL-----KHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 106 Ey~~gGSL~~~l~-----~~k~lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
||+. ++|.++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++. .+.+||+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDR-NGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEcc-CCcEEEeecchhHHh
Confidence 9985 46554322 246799999999999999999999974 7 999999999999984 479999999999766
Q ss_pred ccCcc-ccccCCCCCCCcccccc----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc---ccC
Q 004645 180 RKSHA-ARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL---FKV 251 (740)
Q Consensus 180 ~~~~~-~~~~GTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~---~~~ 251 (740)
..... ....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.......+....+..+..|... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 54322 33468999999999874 48899999999999999999999998755333333344444333222 234
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.++++.+||.+||. +|.+|||+.++++||||+..
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 68899999999999 99999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.05 Aligned_cols=240 Identities=26% Similarity=0.389 Sum_probs=202.4
Q ss_pred eeEEeEEecccCceEEEEEEEcCCCe-EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 24 YGRYNEILGKGASKTVYRAFDEYEGI-EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~tg~-~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
..++.+.||+|-||.||.|.. .|. .||+|.++... ...+.|.+|+++|++|+|++||++|+++.. .+.+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~--~~~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKW--NGSTKVAVKTIKEGS-----MSPEAFLREAQIMKKLRHEKLVKLYGVCTK--QEPIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEE--cCCCcccceEEeccc-----cChhHHHHHHHHHHhCcccCeEEEEEEEec--CCceE
Confidence 345778999999999999954 444 89999988542 223568899999999999999999998744 55899
Q ss_pred EEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 103 FVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~--~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
|||||++.|+|.+|++. .+.+....+..++.||++|++||++++ +|||||-..||||+ ++..+||+|||||+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccC
Confidence 99999999999999987 467999999999999999999999999 99999999999998 44699999999999655
Q ss_pred cCccccccC---CCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004645 181 KSHAARCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 181 ~~~~~~~~G---Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
+.......| ...|.|||.+. +.++.++|||||||+|+||+| |+.||.+. +..++.+.+.+|..... +...+++
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~ev~~~le~GyRlp~-P~~CP~~ 432 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEEVLELLERGYRLPR-PEGCPDE 432 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-CHHHHHHHHhccCcCCC-CCCCCHH
Confidence 443222222 34799999988 679999999999999999999 89999984 45667788888876433 4568999
Q ss_pred HHHHHHHHhh-CccCCCCHHHHh
Q 004645 256 VRQFIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL 277 (740)
+.+++..||. +|.+|||.+.|.
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999 999999998654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.23 Aligned_cols=267 Identities=24% Similarity=0.439 Sum_probs=223.0
Q ss_pred CCceeeCCCCcee------EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCC
Q 004645 13 SEFVEVDPTGRYG------RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRN 85 (740)
Q Consensus 13 ~~~~e~dp~gRY~------ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpN 85 (740)
+.|++++-..||. .+...||.|+.|+|+++..+.+|...|+|++... .+.++.+++++.+.++... +.|+
T Consensus 76 tg~lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpy 152 (391)
T KOG0983|consen 76 TGYLTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPY 152 (391)
T ss_pred ceeEEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCe
Confidence 4567777655551 1235699999999999999999999999998744 4678889999999987776 5999
Q ss_pred cceeeeEeeecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC
Q 004645 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 164 (740)
Q Consensus 86 IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~ 164 (740)
||++|++|+. +..+++.||.| +.-+..++++ .+++++..+-.+...++.||.||-.+. +|||||+||+|||+| .
T Consensus 153 IV~c~GyFi~--n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e 227 (391)
T KOG0983|consen 153 IVQCFGYFIT--NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-E 227 (391)
T ss_pred eeeeeeEEee--CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-c
Confidence 9999999977 56778899988 4445555444 578999999999999999999998754 499999999999999 6
Q ss_pred CCcEEEeccchhhhhccCccc-cccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 004645 165 QGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 239 (740)
Q Consensus 165 ~g~VKL~DFGlA~~l~~~~~~-~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i 239 (740)
.|.|||||||.+..+-++... ...|.+.|||||.+. ..|+.++||||||+.++||+||++||.+|...-+..-++
T Consensus 228 ~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 228 RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV 307 (391)
T ss_pred CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH
Confidence 689999999999888776553 457999999999986 259999999999999999999999999998888888888
Q ss_pred HcCCCCcccc-cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 240 ISGKKPEALF-KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 240 ~~g~~p~~~~-~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
.....|.-.. ...++.+++|+..||. |+.+||...+||+|||+.....
T Consensus 308 ln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 308 LNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 8754432222 2379999999999999 9999999999999999976554
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.06 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=202.8
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
--.+..++| ++.+.||+|+||+||+|.+..++..||+|.+..... .......+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 6 PFCDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred cccchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 345566778 788999999999999999999999999998875432 12223456789999999999999999998765
Q ss_pred cC------CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcE
Q 004645 96 TA------NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 168 (740)
Q Consensus 96 ~~------~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~V 168 (740)
.. ...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~ 158 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGIL 158 (310)
T ss_pred ccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcE
Confidence 32 246799999995 5788776654 37899999999999999999999999 99999999999998 45799
Q ss_pred EEeccchhhhhccCcc------ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 004645 169 KIGDLGLAAILRKSHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 240 (740)
Q Consensus 169 KL~DFGlA~~l~~~~~------~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~ 240 (740)
||+|||++........ ....+++.|+|||.+.+ .++.++||||||+++|+|+||..||...... .....+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~ 237 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLIS 237 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 9999999976543221 22357889999998764 3788999999999999999999999764332 2211111
Q ss_pred c--CCCCccc----------------------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 241 S--GKKPEAL----------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 241 ~--g~~p~~~----------------------------~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
. |..+... ....++.+++||.+||. +|.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1 1111100 11245778899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.20 Aligned_cols=248 Identities=34% Similarity=0.561 Sum_probs=212.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|++|.||+|.+..++..|++|.+..... .......+.+|++++++++|+|++++++++.. ...+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 788999999999999999999999999999875432 23566789999999999999999999998755 57899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc-
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA- 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~- 184 (740)
||+++++|.+++.....+++..+..++.|++.||.|||++| |+||||||+||+++. .+.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECC-CCCEEEeccccceecCCCccc
Confidence 99999999999988889999999999999999999999999 999999999999985 57999999999987654433
Q ss_pred -ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 185 -ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 185 -~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
....+++.|+|||.+.+ .++.++||||||+++|+|++|..||..........+ ...+..+ .+....++.+++||.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDHP-PLPEGISPELKDFLMQ 233 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccCCC-CCCCCCCHHHHHHHHH
Confidence 33468999999998764 478899999999999999999999986553333333 3333332 3455678999999999
Q ss_pred Hhh-CccCCCCHHHHhcCccc
Q 004645 263 CLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 263 cL~-dPskRpSa~ELL~HPff 282 (740)
||. +|.+|||+.+++.||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 999 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=331.14 Aligned_cols=253 Identities=30% Similarity=0.438 Sum_probs=202.5
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC---
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--- 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~--- 97 (740)
.++| ++.+.||+|+||+||+|.+..+|..||+|+++... ........+.+|+.++++++||||++++++|....
T Consensus 15 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3666 78899999999999999999999999999876332 23445567889999999999999999999875432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 -NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 -~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
....|+||||+. ++|.+++... ++...+..++.||+.||+|||++| |+||||||+|||++. .+.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~-~~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS-DCTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECC-CCCEEEccCccc
Confidence 235799999995 5888876544 899999999999999999999999 999999999999985 479999999999
Q ss_pred hhhccCcc-ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC--------
Q 004645 177 AILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK-------- 244 (740)
Q Consensus 177 ~~l~~~~~-~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g~~-------- 244 (740)
........ ....|++.|+|||++.+ .++.++|||||||++|+|++|+.||........ +..+.. |..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHh
Confidence 76554322 33468999999999874 589999999999999999999999976443222 222211 000
Q ss_pred -----------------------Cccc--------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 245 -----------------------PEAL--------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 245 -----------------------p~~~--------~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
+... ....++.+++||.+||. +|.+|||+.|+|.||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0000 12345678999999999 999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.78 Aligned_cols=253 Identities=31% Similarity=0.522 Sum_probs=209.4
Q ss_pred eeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEE
Q 004645 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~l 103 (740)
++.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~i 95 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWV 95 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEE
Confidence 3355678999999999999999999999999986543 1234568899999999999999999998855 678999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 104 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
|+||+++++|..++. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhccccc
Confidence 999999999998754 467899999999999999999999999 99999999999998 55799999999987654332
Q ss_pred --cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-cccccCCChHHHHH
Q 004645 184 --AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVEDPEVRQF 259 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p-~~~~~~~spelrdL 259 (740)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+.....+ .......++.+.+|
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 233468999999999874 5889999999999999999999999763 344444444433222 22234567899999
Q ss_pred HHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 260 IEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
|.+||. +|.+||++.++++||||.....
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 999999 9999999999999999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=318.62 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=203.5
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||.|++|+||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+ ....++++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEE
Confidence 678899999999999999999999999999875432 12233567889999999999999999998854 67899999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+ +++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+||+++. ++.++|+|||++.......
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPV 153 (283)
T ss_pred ecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcC-CCcEEEeecccccccCCCc
Confidence 999 468999987765 7999999999999999999999999 999999999999985 6799999999986553221
Q ss_pred --cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------
Q 004645 184 --AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--------------- 244 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~--------------- 244 (740)
.....+++.|+|||++.+ .++.++||||||+++|+|+||..||.......++++.+.....
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 123357899999998764 4788999999999999999999999865444433332221100
Q ss_pred -----------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 245 -----------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 245 -----------p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
........++.+.++|.+||+ +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 011124466889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=326.19 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=219.9
Q ss_pred eEEe-EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEE
Q 004645 25 GRYN-EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 25 ~ri~-e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~ 102 (740)
|++. ++||+|+|+.|-.+....+|.++|+|+|.+. ......++.+|++++.+. .|+||+.++++|.+ +..+|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FY 152 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFY 152 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEE
Confidence 3443 6899999999999999999999999998743 345678899999999999 69999999999854 77899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC--CcEEEeccchhhhhc
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAILR 180 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~--g~VKL~DFGlA~~l~ 180 (740)
+|||-|.||+|...+.+++.+++..+.++.+.|+.||.|||.+| |.||||||+|||-...+ .-||||||.|.....
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 99999999999999999999999999999999999999999999 99999999999986332 138999999875443
Q ss_pred ---------cCccccccCCCCCCCccccc---c---ccCcccchhhhhhHHHHHHhcCCCCCCCC--------------C
Q 004645 181 ---------KSHAARCVGTPEFMAPEVYE---E---EYNELVDIYSFGMCILEMVTFDYPYSECT--------------H 231 (740)
Q Consensus 181 ---------~~~~~~~~GTp~YmAPEvl~---~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~--------------~ 231 (740)
.+...+.+|+.+|||||+.. + .|+.++|.||||||+|.||.|.+||.+.- -
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 22344568999999999764 3 48999999999999999999999996421 1
Q ss_pred HHHHHHHHHcCCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 232 PAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 232 ~~~i~k~i~~g~~--p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
...+++.|..|.. |..-+..++.+++++|..+|. ++..|++|.++|+|||++.-..
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 4568899999974 777788899999999999999 9999999999999999976543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.36 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=224.0
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.++||+|.||.|-+++.+.+|+.+|+|++++.- ....++...-..|-++|+..+||.+..+..+| +.+..+|+||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev-iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drlCFVM 247 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV-IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRLCFVM 247 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhh-eeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceEEEEE
Confidence 45689999999999999999999999999987543 34456677788899999999999999888777 5588999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh--ccCc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l--~~~~ 183 (740)
||..||.|.-.+.+.+.+++...+.+-..|+.||.|||+++ ||+||||.+|+|++ .+|++||+||||++.- ....
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccccce
Confidence 99999999988888899999999999999999999999999 99999999999999 6689999999999643 3345
Q ss_pred cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 184 AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
..++||||+|+|||++. ..|+.++|.|.+||+||||++|+.||.+ .+-+.++..|..+.. .++..++++++.|+..
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMEDL--KFPRTLSPEAKTLLSG 401 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhhc--cCCccCCHHHHHHHHH
Confidence 67889999999999998 4699999999999999999999999987 444667776665543 2456789999999999
Q ss_pred Hhh-CccCCC-----CHHHHhcCcccCCCCcchh
Q 004645 263 CLA-TVSSRL-----SARELLTDPFLQIDDYDSD 290 (740)
Q Consensus 263 cL~-dPskRp-----Sa~ELL~HPff~~~~~~~~ 290 (740)
+|. +|.+|+ .|.|+.+|+||...++...
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 999 999997 4889999999998887543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.24 Aligned_cols=252 Identities=29% Similarity=0.468 Sum_probs=208.9
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
...| +..+.||+|+||.||+|.+..++..||+|.++... .....+.+.+|+.++++++||||+++++.|.. +..
T Consensus 3 ~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 76 (277)
T cd06642 3 EELF-TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTK 76 (277)
T ss_pred HHHH-HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCc
Confidence 3444 56678999999999999999999999999886432 23456789999999999999999999998855 678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
+++|+||+++++|.+++.. +.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ +++.++|+|||++..+.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLT 152 (277)
T ss_pred eEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEcccccccccc
Confidence 9999999999999998654 57899999999999999999999999 99999999999998 45799999999987654
Q ss_pred cCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004645 181 KSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 181 ~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
... .....|+..|+|||.+.+ .++.++||||||+++|+|+||..||.... +..+...+..+.. ..+....+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNSP-PTLEGQYSKPFK 230 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhhhcCCC-CCCCcccCHHHH
Confidence 332 123458899999999874 58889999999999999999999997633 3333333333332 233445678899
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 258 QFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 258 dLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
++|.+||. +|.+||++.++|+||||..
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 231 EFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 99999999 9999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.35 Aligned_cols=253 Identities=29% Similarity=0.420 Sum_probs=199.3
Q ss_pred EEeEEecccCceEEEEEEEcC--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~--tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~l 103 (740)
++.+.||+|+||.||+|.+.. ++..||+|.++.... ......+.+.+|+.++++++||||+++++++.+.....+++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 788999999999999999988 899999999875321 12223456788999999999999999999997755578999
Q ss_pred EEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeC---CCCcEEEeccch
Q 004645 104 VTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGL 175 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~-----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~---~~g~VKL~DFGl 175 (740)
||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. ..+.+||+|||+
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 9999964 677665433 26899999999999999999999999 999999999999985 157899999999
Q ss_pred hhhhccCcc-----ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHH--------HHHHHHH
Q 004645 176 AAILRKSHA-----ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPA--------QIYKKVI 240 (740)
Q Consensus 176 A~~l~~~~~-----~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~--------~i~k~i~ 240 (740)
+........ ....+++.|+|||++.+ .++.++||||||+++|+|++|..||....... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 876543321 23468899999998764 47899999999999999999999997533211 0000000
Q ss_pred c----------------------------CCCC-cc------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 241 S----------------------------GKKP-EA------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 241 ~----------------------------g~~p-~~------~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
. ...+ .. .....++.+.++|.+||. +|.+|||+.|++.||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 0000 00 001567789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=355.43 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=207.0
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeee-Eeeec---C-C
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYT-SWVDT---A-N 98 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~-~fvd~---~-~ 98 (740)
.++.+.|.+|||+.||+|.+...|..||+|.+-.. ++..++.+.+||.+|++|+ |+|||.|++ +.... . .
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 37889999999999999999988899999988643 5778899999999999995 999999999 33221 1 2
Q ss_pred CeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 99 RNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~--~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
..+.|.||||.||.|-+++.+ +.+|++..+++|++|+++|+++||...|||||||||-+||||+ .+|+.||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCccccc
Confidence 468899999999999999875 3579999999999999999999999999999999999999998 5579999999998
Q ss_pred hhhccCc-cc----------cccCCCCCCCccccc---c-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Q 004645 177 AILRKSH-AA----------RCVGTPEFMAPEVYE---E-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 241 (740)
Q Consensus 177 ~~l~~~~-~~----------~~~GTp~YmAPEvl~---~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~ 241 (740)
+..-... .. ...-|+.|+|||++. + ..++|+|||||||+||-|+....||.+.-. -.|..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----laIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----LAILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----eeEEe
Confidence 6433222 11 113689999999875 3 489999999999999999999999987422 23566
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 004645 242 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 242 g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPf 281 (740)
|.+....+..++..+++||..||+ +|.+||++.+++.+-|
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 666555556788999999999999 9999999999987544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=315.74 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=211.4
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i 101 (740)
+| .+.+.||+|+||.||+|.+..+|..||+|++..... ........+..|+.+++++. ||||+++++++.. ...+
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~ 77 (280)
T cd05581 2 DF-KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENL 77 (280)
T ss_pred Cc-eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceE
Confidence 35 788999999999999999999999999998875332 23344567889999999998 9999999998744 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++||||+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCC
Confidence 999999999999999998889999999999999999999999999 99999999999998 557999999999876543
Q ss_pred Cc----------------------cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 004645 182 SH----------------------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238 (740)
Q Consensus 182 ~~----------------------~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~ 238 (740)
.. .....|++.|+|||++. ..++.++||||||+++++|++|..||.... ....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHH
Confidence 22 12335789999999876 458889999999999999999999998744 3444455
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH----HHHhcCccc
Q 004645 239 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFL 282 (740)
Q Consensus 239 i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa----~ELL~HPff 282 (740)
+..+.. .++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 234 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 543322 2334568899999999999 99999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=378.39 Aligned_cols=251 Identities=29% Similarity=0.473 Sum_probs=222.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
..+..||.|.||.||.|.+..+|...|+|.+++.+.. ......+.+|+.+|..|+|||+|++|++=++ ....+|.|
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IFM 1313 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIFM 1313 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeec--HHHHHHHH
Confidence 4467899999999999999999999999999876533 3445668899999999999999999995544 67889999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-- 183 (740)
|||.+|+|.+++...+-.++...+.+..|++.||+|||++| ||||||||+|||++.+ |.+|++|||.|..+....
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence 99999999999888788888889999999999999999999 9999999999999955 799999999997766542
Q ss_pred ----cccccCCCCCCCccccccc----cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004645 184 ----AARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 184 ----~~~~~GTp~YmAPEvl~~~----ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spe 255 (740)
.....|||-|||||++.+. ..-++|||||||+++||+||+.||.+..+.-+|+-+|-.|..|..... .+++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHh
Confidence 2344799999999999753 567899999999999999999999999999999999999999865544 8999
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.++||++||. ||++|.++.|||.|-|=+.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999 9999999999999999754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.81 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=226.8
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
.+..-.|.| .+...||+|.|++|.+|++..+|..||+|.+.... .+....+.+.+|+++|+.|+|||||++|.+.
T Consensus 50 ~~~~~vg~y-~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-- 124 (596)
T KOG0586|consen 50 DDSNSVGLY-VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-- 124 (596)
T ss_pred cccccccce-eeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcCCcceeeeeeee--
Confidence 333444555 99999999999999999999999999999887554 3455567799999999999999999999976
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
.....+|+||||+.+|.+++|+.++++..+..++.++.|++.|++|||+++ |+|||||.+|||++.+ -.+||+|||+
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgf 201 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGF 201 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeecccc
Confidence 457899999999999999999999999999999999999999999999999 9999999999999966 4799999999
Q ss_pred hhhhccC-ccccccCCCCCCCccccccc--cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 176 AAILRKS-HAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 176 A~~l~~~-~~~~~~GTp~YmAPEvl~~~--ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
+.++... ...+++|+|.|.|||++.+. -++.+|+||+|+++|.|+.|.+||.+ .+...+-..++.|+.-. +-..
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~rI--p~~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYRI--PFYM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeecc--ccee
Confidence 9988754 45788999999999999863 46899999999999999999999987 55566666777776543 3345
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
+-++.++|.++|. +|++|++.+++++|.|+....
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 7789999999999 999999999999999986543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=368.20 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=224.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.++||+|+||.|.+++++.|++.||.|++++...... .....|..|-.+|.--+.+-|+.++-.|.| ++++|+||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LYlVM 154 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-AETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLYLVM 154 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-hhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceEEEE
Confidence 678999999999999999999999999999887554432 345678889999999999999999888844 88999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-c-
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-H- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-~- 183 (740)
||++||+|..++.++.++++..++.++..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+... .
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcE
Confidence 99999999999999999999999999999999999999999 99999999999999 5589999999999877633 2
Q ss_pred -cccccCCCCCCCccccc------cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cCCCh
Q 004645 184 -AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KVEDP 254 (740)
Q Consensus 184 -~~~~~GTp~YmAPEvl~------~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~--~~~sp 254 (740)
....+|||-|.+||++. +.|++.+|.||+||++|||+.|..||.. .+...-|.+|..-+....++ ..+++
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCH
Confidence 34458999999999984 3599999999999999999999999986 56677788887754322222 34899
Q ss_pred HHHHHHHHHhhCccCCCC---HHHHhcCcccCCCCcc
Q 004645 255 EVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDYD 288 (740)
Q Consensus 255 elrdLI~kcL~dPskRpS---a~ELL~HPff~~~~~~ 288 (740)
++++||.+.|.+|..|+. ++++-.||||...+|.
T Consensus 311 eakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 311 EAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred HHHHHHHHHhcChhhhcccccHHHHHhCccccCCChh
Confidence 999999999999999998 9999999999999983
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.40 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=202.3
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC---
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--- 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~--- 97 (740)
+++| ++.+.||+|+||+||+|.+..+|..||+|+++... ......++.+|+.++++++||||+++++++....
T Consensus 4 ~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 4566 88999999999999999999999999999886322 2334567889999999999999999998765432
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
...+++|+||+. ++|..++ ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECccccee
Confidence 246899999995 5887765 4467999999999999999999999999 99999999999998 55799999999987
Q ss_pred hhccCc-----cccccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHH------------
Q 004645 178 ILRKSH-----AARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK------------ 238 (740)
Q Consensus 178 ~l~~~~-----~~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~------------ 238 (740)
...... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||.+......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 654321 12346899999999865 35889999999999999999999999764322211110
Q ss_pred --HHcCC-------CC-------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 239 --VISGK-------KP-------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 239 --i~~g~-------~p-------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+.... .+ .......++++++||.+||. +|.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000 00 01123457889999999999 99999999999999999743
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.40 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=204.6
Q ss_pred CceeEEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~-----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
++| .+.+.||+|+||.||+|.+. .++..||+|.++... ..+..+.+.+|+++|++++|+||+++++++..
T Consensus 5 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 79 (280)
T cd05049 5 DTI-VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTE- 79 (280)
T ss_pred HHh-hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEec-
Confidence 344 77899999999999999874 346789999876432 23356789999999999999999999998865
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHR--------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k--------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld 162 (740)
....++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~ 156 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG 156 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc
Confidence 578999999999999999987643 4788999999999999999999999 99999999999998
Q ss_pred CCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHH
Q 004645 163 GNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIY 236 (740)
Q Consensus 163 ~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~ 236 (740)
.+ +.+||+|||++....... .....+++.|+|||++. +.++.++||||||+++|+|++ |..||... +...+.
T Consensus 157 ~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~ 234 (280)
T cd05049 157 YD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVI 234 (280)
T ss_pred CC-CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence 44 799999999986543221 12334678999999987 468999999999999999999 99999874 456666
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 237 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 237 k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+..+..+. .....+..+++++.+||. +|.+||++.|+++
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7777666543 334578999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=330.95 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=203.9
Q ss_pred CCCceeEEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEe
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 93 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~-----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 93 (740)
|..|| ++.++||+|+||.||+|.+. .++..||+|+++... .....+.+..|+.+++++ +|+||+++++++
T Consensus 5 ~~~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 45677 99999999999999999643 356789999886322 234556788999999999 899999999987
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHhc-----------------------------------------------------
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 120 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~----------------------------------------------------- 120 (740)
... ...+++++||+++++|.+++...
T Consensus 81 ~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 81 TKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 643 45788999999999999987642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc----ccccc
Q 004645 121 --------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCV 188 (740)
Q Consensus 121 --------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~ 188 (740)
..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.++|+|||++..+.... .....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCC
Confidence 25788999999999999999999999 999999999999985 5799999999998654322 12234
Q ss_pred CCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-
Q 004645 189 GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA- 265 (740)
Q Consensus 189 GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~- 265 (740)
++..|+|||++. ..++.++|||||||++|+|++ |..||......+.+...+..+..+ ......++++.+++.+||+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccC
Confidence 677899999876 469999999999999999998 999998644444454555444433 2345678899999999999
Q ss_pred CccCCCCHHHHhcC
Q 004645 266 TVSSRLSARELLTD 279 (740)
Q Consensus 266 dPskRpSa~ELL~H 279 (740)
+|.+||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.49 Aligned_cols=249 Identities=30% Similarity=0.496 Sum_probs=209.4
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.++++++||||++++++|.. +..+++||
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 67788999999999999999999999999876432 23455678999999999999999999999865 67899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~-- 183 (740)
||+.+++|..++.. ..++...+..++.|++.||.|||+++ ++|+||||+||+++ +.+.++|+|||++.......
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhh
Confidence 99999999998654 56899999999999999999999999 99999999999998 55799999999986554321
Q ss_pred cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 184 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 184 ~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
.....|+..|+|||.+.+ .++.++|+|||||++|+|++|..||... +...+...+..+..+ .+....+.++.++|.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEA 235 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCCCC-CCCcccCHHHHHHHHH
Confidence 223458899999998864 5788999999999999999999999763 344444444444332 3445678899999999
Q ss_pred Hhh-CccCCCCHHHHhcCcccCCC
Q 004645 263 CLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 263 cL~-dPskRpSa~ELL~HPff~~~ 285 (740)
||. +|.+||++.++++||||...
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhh
Confidence 999 99999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.33 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=206.8
Q ss_pred EEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~t---g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
+.||+|+||.||+|.+... +..|++|.++.... ....+.+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4699999999999998866 89999998874432 2256789999999999999999999998865 77899999
Q ss_pred eccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 106 EMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~---------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.+ +.++|+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEcccccc
Confidence 999999999998875 77999999999999999999999999 9999999999999854 79999999999
Q ss_pred hhhccCc----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 177 AILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 177 ~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+..+ ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 7765432 334457899999998874 68999999999999999999 59999874 567777777765443 2345
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
..++++.+++.+||. +|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.32 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=215.4
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
...++...| ...+.||+|+||+||+|.+..+|..|++|++..... ........+.+|+.+++.++|||++++++++.+
T Consensus 15 ~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 15 YKDDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred ccCCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 556677777 556789999999999999999999999998875432 234556778999999999999999999998866
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
....|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++| |+|+||||+||+++ .++.+||+|||
T Consensus 93 --~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg 166 (313)
T cd06633 93 --EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFG 166 (313)
T ss_pred --CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecC
Confidence 578999999995 577776654 457899999999999999999999999 99999999999998 45799999999
Q ss_pred hhhhhccCccccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 175 LAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 175 lA~~l~~~~~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
++.... ......|++.|+|||++. +.++.++||||||+++|+|++|..||........++ .+..+..+.....
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (313)
T cd06633 167 SASKSS--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSN 243 (313)
T ss_pred CCcccC--CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCcc
Confidence 886432 223456899999999874 458889999999999999999999998754444444 3444444444445
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCcc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~~ 288 (740)
..+..+++|+.+||+ +|.+||++.++|.||||+.....
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 567889999999999 99999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.00 Aligned_cols=243 Identities=30% Similarity=0.485 Sum_probs=199.6
Q ss_pred EEeEEecccCceEEEEEEEc----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 26 RYNEILGKGASKTVYRAFDE----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.+.+.||.|+||.||+|... ..+..|++|.++. .......+.+.+|+++|++++||||+++++++.. ...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceeeeecccccccccccccccccccccc--cccc
Confidence 46789999999999999877 4678899998853 2345567889999999999999999999999874 4569
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 102 NFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
++|+||+++|+|.+++... ..++...+..|+.||+.||.|||+++ |+|++|++.|||++.+ +.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-cccccccccccccc
Confidence 9999999999999999887 68999999999999999999999999 9999999999999954 69999999999776
Q ss_pred ccC----ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 180 RKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 180 ~~~----~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
... ......+...|+|||.+.. .++.++||||||+++|||+| |+.||.+. +..++...+..+..+. .....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 321 1122346779999999874 58999999999999999999 78999875 6677777777666543 445678
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+.++|.+||. +|.+|||+.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999999 9999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.15 Aligned_cols=249 Identities=31% Similarity=0.521 Sum_probs=208.7
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||.||+|.+..+|..+|+|.+...+. ........+.+|+.+++.++||||++++++|.. ...++
T Consensus 3 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08229 3 NF-RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 78 (267)
T ss_pred hh-hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEE
Confidence 45 778999999999999999999999999998875442 233455788999999999999999999998865 67899
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 103 FVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
++|||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++. ++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~-~~~~~l~dfg~~~~ 155 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcC-CCCEEECcchhhhc
Confidence 99999999999998764 356899999999999999999999999 999999999999984 57999999999876
Q ss_pred hccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCcccccCCCh
Q 004645 179 LRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 179 l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~-~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ....+.+.+..+..+.......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 64332 223468999999999864 58889999999999999999999996533 334555566655555544556788
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.++++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999 9999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.95 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=192.8
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEeccC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFT 109 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~Ey~~ 109 (740)
||+|+||.||++.++.++..+|+|.+....... .|+.+...+ +||||+++++.|.. ...+++||||++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCC
Confidence 599999999999999999999999887432211 122222222 79999999998865 568999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccccccC
Q 004645 110 SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 189 (740)
Q Consensus 110 gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~~~G 189 (740)
+++|.+++...+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++...... ....|
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 168 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDG 168 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCC
Confidence 9999999988889999999999999999999999999 9999999999999866448999999998765433 23468
Q ss_pred CCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCCcccccCCChHHHHHHHHHhh-C
Q 004645 190 TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPA-QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 266 (740)
Q Consensus 190 Tp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~-~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-d 266 (740)
++.|+|||++.+ .++.++||||||+++|+|++|..||....... .+.........+....+..++.+++||.+||+ +
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 248 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYN 248 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccC
Confidence 999999999874 58899999999999999999999997533211 11111111122334455789999999999999 9
Q ss_pred ccCCCC-HHHHhcCcccC
Q 004645 267 VSSRLS-ARELLTDPFLQ 283 (740)
Q Consensus 267 PskRpS-a~ELL~HPff~ 283 (740)
|.+|++ ++++|+||||+
T Consensus 249 p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 249 INYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hhhCCchHHHHhcCCccc
Confidence 999996 59999999996
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.19 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=199.7
Q ss_pred CCceeEEeEEecccCceEEEEEE----EcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 21 TGRYGRYNEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~----d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
.+||+++.+.||+|+||+||++. ...++..||+|.++... .......+.+|+.+|++++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46898999999999999998764 34578899999886432 233456788999999999999999999988766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
....+++||||+.+++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~-~~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDN-DRLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcC-CCcEEEeecccc
Confidence 566799999999999999997654 5999999999999999999999999 999999999999984 479999999998
Q ss_pred hhhccCcc-----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHH--------------HHH
Q 004645 177 AILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA--------------QIY 236 (740)
Q Consensus 177 ~~l~~~~~-----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~--------------~i~ 236 (740)
........ ....++..|+|||.+. +.++.++||||||+++|+|+||..||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 76643321 1223566799999887 468999999999999999999999986432111 111
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 237 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 237 k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+..+..+ ......++++++++.+||. +|++|||+.+++.
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111111 1234567899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.96 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=205.4
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC---
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--- 98 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~--- 98 (740)
.+| ++.+.||+|+||+||+|.+..+|..||+|.++... ........+.+|+.+|+.++|+||+++++++.....
T Consensus 5 ~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 456 88899999999999999999999999999886432 123334567889999999999999999997754322
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++. .+.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNA-NCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcC-CCCEEECcCccccc
Confidence 35899999995 789999888889999999999999999999999999 999999999999984 47999999999876
Q ss_pred hccC--ccccccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC---------
Q 004645 179 LRKS--HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GK--------- 243 (740)
Q Consensus 179 l~~~--~~~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g~--------- 243 (740)
.... ......++..|+|||++. ..++.++||||||+++|+|++|..||.+... ......+.. |.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhc
Confidence 5433 223446899999999876 3588999999999999999999999975322 111111110 00
Q ss_pred --------------CC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 244 --------------KP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 244 --------------~p----~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.+ .......++.+++||.+||+ +|.+|||+.++|+||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00 11234568899999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.22 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=204.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||+|+||.||+|.+..++..||+|.++.. ......+.+|+.+|++++|+||+++++++.. ...+++||
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIIT 81 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEEE
Confidence 7889999999999999999999999999987632 2335678899999999999999999998754 56889999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++ +++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccce
Confidence 999999999998764 35899999999999999999999999 99999999999998 55799999999987665432
Q ss_pred ccc---ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 184 AAR---CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 184 ~~~---~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
... ..+++.|+|||.+. ..++.++||||||+++|+|+| |..||.. .....++..+..+..+ ......++++.+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVYE 236 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHH
Confidence 221 12456899999887 458899999999999999998 8999986 4566777777665443 344567899999
Q ss_pred HHHHHhh-CccCCCCHHHHhc
Q 004645 259 FIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~ 278 (740)
+|.+||. +|.+|||+.++++
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 9999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.01 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=197.7
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
+.||+|+||+||+|.+..+|..||+|.+... ...+....+.+|+.+|++++||||+++++++.. ...+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeec
Confidence 4699999999999999999999999977522 234556789999999999999999999998754 66899999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccccc
Q 004645 109 TSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 187 (740)
Q Consensus 109 ~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~~ 187 (740)
.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 999999998664 46899999999999999999999999 99999999999998 457899999999876543221111
Q ss_pred ----cCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 188 ----VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 188 ----~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
.++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+..+..+ ......+..+.+|+.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVRL-PCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence 1245799999886 458999999999999999998 88999763 444555555544332 344566889999999
Q ss_pred HHhh-CccCCCCHHHHhc
Q 004645 262 KCLA-TVSSRLSARELLT 278 (740)
Q Consensus 262 kcL~-dPskRpSa~ELL~ 278 (740)
+||. +|.+|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.18 Aligned_cols=246 Identities=20% Similarity=0.324 Sum_probs=202.1
Q ss_pred eEEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 25 GRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~-----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
+.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.++++++|+||+++++++.+ ..
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 82 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL 82 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence 3888999999999999999877 78889999775322 23445678899999999999999999998755 56
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC--CCcEEE
Q 004645 100 NINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKI 170 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k-------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~--~g~VKL 170 (740)
..++||||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+|||++.+ ...+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 7889999999999999987654 4899999999999999999999999 9999999999999743 236899
Q ss_pred eccchhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC
Q 004645 171 GDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKK 244 (740)
Q Consensus 171 ~DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~ 244 (740)
+|||++........ ....+++.|+|||++. ..++.++|||||||++|+|++ |..||... +...+.+.+..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc
Confidence 99999876532211 1223456899999986 469999999999999999997 99999874 44556666655443
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 245 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 245 p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
+ ..+...++.+.+|+.+||+ +|.+|||+.++|+|
T Consensus 240 ~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3 2345668899999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.54 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=204.3
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|.+.+.||.|+||.||+|.+..+|..+|+|.++... ........+.+|+.++++++||||+++++++........++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 367899999999999999999999999999998553 223344668899999999999999999998865434789999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 105 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
+||++ ++|..++... ..+++..++.++.||+.||+|||+.+ ++|+||||.||+++. ++.++|+|||++.......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINN-DGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcC-CCCEEEccccceeeccCCC
Confidence 99996 5898887665 57999999999999999999999999 999999999999984 5799999999997665442
Q ss_pred ---cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC------------
Q 004645 184 ---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-KP------------ 245 (740)
Q Consensus 184 ---~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-~p------------ 245 (740)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||........+ ..+.... .+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchhhccccccch
Confidence 223357889999998764 4789999999999999999999999875543332 3222110 00
Q ss_pred ----------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 ----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 ----------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
..+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111237889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=321.40 Aligned_cols=245 Identities=25% Similarity=0.435 Sum_probs=201.3
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeE----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIE----VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~----VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
.| ++.+.||+|+||+||+|.+..+|.. ||+|+++.. ......+++..|+.+++.++||||+++++++..
T Consensus 8 ~f-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--- 80 (316)
T cd05108 8 EF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 80 (316)
T ss_pred hc-eeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---
Confidence 45 8889999999999999987666554 888877532 234556789999999999999999999998854
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
...++|+||+.+|+|.+++... ..++...+..++.||+.||+|||+++ |+||||||+|||++ +.+.+||+|||++.
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~ 157 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAK 157 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccc
Confidence 3567999999999999998775 46899999999999999999999999 99999999999998 44789999999998
Q ss_pred hhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004645 178 ILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 178 ~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~ 251 (740)
....... ....++..|+|||++. ..++.++||||||+++|+|+| |..||.+ ....++...+..+..+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~ 235 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPI 235 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCCC
Confidence 7653322 1122467899999887 468999999999999999998 9999976 44555655555544332 2345
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.+..+.+++.+||. +|.+||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 67899999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=314.79 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=202.9
Q ss_pred eEEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 25 GRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d-----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
+++.+.||+|+||+||++.+ ..++..+|+|.++.. .......+.+|+.+|++++||||+++++++.. ..
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 48889999999999999975 335667888877632 34556789999999999999999999998855 57
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 100 NINFVTEMFTSGTLRQYRLKHR-------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k-------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
.+++||||+++++|.+++..++ .+++..+..++.||+.||+|||+++ ++||||||+|||++ +.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence 8999999999999999987654 4899999999999999999999999 99999999999998 457
Q ss_pred cEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 004645 167 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 240 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~ 240 (740)
.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|+| |..||... ....+...+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH
Confidence 99999999987553221 12234578899999987 458999999999999999999 89999764 4556667777
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 241 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 241 ~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+..+. .....++++.+|+.+||+ +|.+|||+.+++.
T Consensus 237 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 776543 344578899999999999 9999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.44 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=202.9
Q ss_pred EEeEEecccCceEEEEEEEcCCCe--EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC----CC
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGI--EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----NR 99 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~--~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~----~~ 99 (740)
.++++||+|+||.||+|.+..++. .||+|.++... ......+.+..|+.+|+.++|+||+++++.+.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 467899999999999999877775 68988876432 24556778999999999999999999999765422 23
Q ss_pred eEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 100 NINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
..++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 578999999999999886432 34889999999999999999999999 99999999999998 4579999999
Q ss_pred chhhhhccCcc----ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004645 174 GLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEA 247 (740)
Q Consensus 174 GlA~~l~~~~~----~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~ 247 (740)
|++........ ....+++.|+|||.+.+ .++.++||||||+++|+|++ |+.||.. ....++++.+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 99986643221 12246778999999874 58999999999999999999 7999976 45667777777776543
Q ss_pred cccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 248 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 248 ~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.....+..++++|.+||. +|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 234567889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=314.92 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=210.9
Q ss_pred eEEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCe
Q 004645 25 GRYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~---~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~ 100 (740)
|++.+.||.|+||.||+|.+. .+|..||+|+++...........+.+.+|+.+|+++ +|+||+++++.|.. +..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DTK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CCe
Confidence 378899999999999999874 478999999987543322334456788999999999 69999999988744 678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
+++|+||+++++|.+++.....+++..+..++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDS-NGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECC-CCCEEEeeCccceecc
Confidence 9999999999999999988888999999999999999999999999 999999999999984 5799999999987654
Q ss_pred cCc---cccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCcccccC
Q 004645 181 KSH---AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 181 ~~~---~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~---~~~~i~k~i~~g~~p~~~~~~ 251 (740)
... .....|++.|+|||.+.. .++.++||||||+++|+|+||..||.... ....+.+.+..+..+ .+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCcc
Confidence 322 223468999999998863 47789999999999999999999996422 233444444433322 3455
Q ss_pred CChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccCCCCc
Q 004645 252 EDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRp-----Sa~ELL~HPff~~~~~ 287 (740)
.++.+.+|+.+||. +|.+|+ ++.+++.||||+...+
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 78999999999999 999997 8999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=313.59 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=202.3
Q ss_pred EEeEEecccCceEEEEEEE----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 26 RYNEILGKGASKTVYRAFD----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++.+.||+|+||+||+|.. ..++..||+|.++.. ........+.+|+.++++++||||+++++++.. ....
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 82 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQPV 82 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCce
Confidence 7889999999999999985 345678999988632 234556778999999999999999999998754 5678
Q ss_pred EEEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC
Q 004645 102 NFVTEMFTSGTLRQYRLKH-----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 164 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-----------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~ 164 (740)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~-~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG-E 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-C
Confidence 9999999999999997543 24788899999999999999999999 99999999999998 4
Q ss_pred CCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHH
Q 004645 165 QGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 238 (740)
Q Consensus 165 ~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~ 238 (740)
++.+||+|||++....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||.+ .+...+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 5789999999997653321 22334677899999886 468999999999999999998 9999976 445666666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 239 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 239 i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
+..+..+ ......++.+++++.+||+ +|.+||++.+++++
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6665543 2455678999999999999 99999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.85 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=200.4
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC---
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--- 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~--- 97 (740)
.++| ++.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC--CCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 4677 889999999999999999999999999998875432 1112345678999999999999999999876533
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 98 ---NRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 98 ---~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
...+++|+||+.+ +|..++.. ...+++..++.++.||+.||.|||++| |+|+||||+|||++. .+.++|+||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~-~~~~~l~df 159 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDN-QGILKIADF 159 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC-CCCEEECcC
Confidence 2358999999965 67666554 457999999999999999999999999 999999999999984 579999999
Q ss_pred chhhhhccCcc-------------ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHH
Q 004645 174 GLAAILRKSHA-------------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238 (740)
Q Consensus 174 GlA~~l~~~~~-------------~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~ 238 (740)
|++........ ....|++.|+|||++.+ .++.++||||||+++|+|++|..||.+..... ....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~ 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHL 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 99976543211 12357889999998764 48899999999999999999999998644333 2222
Q ss_pred HHc--CCC-C----------c---------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 239 VIS--GKK-P----------E---------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 239 i~~--g~~-p----------~---------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
+.. +.. + . .......+.+++||.+||. +|.+|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 221 100 0 0 0012344788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.35 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=216.1
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
+...+|...| ...+.||+|+||+||+|.+..+|..||+|.+..... ...+....+.+|+.++++++|||++++++++.
T Consensus 18 ~~~~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 18 FFKEDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hcCCCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 4667777776 778899999999999999999999999998874432 24455678999999999999999999999886
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
+ ....++||||+.| +|.+++.. ..++++..+..++.||+.||.|||+++ |+||||+|+||+++ +++.++|+||
T Consensus 96 ~--~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~df 169 (317)
T cd06635 96 R--EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADF 169 (317)
T ss_pred e--CCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecC
Confidence 5 5678999999965 77776654 467899999999999999999999999 99999999999998 4579999999
Q ss_pred chhhhhccCccccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccc
Q 004645 174 GLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249 (740)
Q Consensus 174 GlA~~l~~~~~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~ 249 (740)
|++..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||........+ ..+..+..+....
T Consensus 170 g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 246 (317)
T cd06635 170 GSASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPTLQS 246 (317)
T ss_pred CCccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHhccCCCCCC
Confidence 98865433 23346899999999863 45889999999999999999999999875433334 4444444444444
Q ss_pred cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 250 ~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
...++.+++||.+||+ +|.+||++.++++|+|+.....
T Consensus 247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 5678899999999999 8999999999999999965443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=308.73 Aligned_cols=239 Identities=22% Similarity=0.337 Sum_probs=200.9
Q ss_pred EecccCceEEEEEEE--cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 30 ILGKGASKTVYRAFD--EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 30 ~LG~GafGtVYkA~d--~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
.||+|+||.||+|.. ..++..+|+|+++... ......+.+..|+.+++.++||||+++++++. ...+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEec
Confidence 589999999999964 5678899999886442 23455678999999999999999999999763 3567899999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc---
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 184 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~--- 184 (740)
+++++|.+++...+.+++..+..++.||+.||.|||++| |+||||||.||+++. .+.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVT-QHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcC-CCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999999 999999999999984 47899999999976543321
Q ss_pred --ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 185 --ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 185 --~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
....+++.|+|||.+. +.++.++||||||+++|||+| |..||.. .+...+...+..+..+. .+...++++.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERME-CPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHHH
Confidence 1223467999999887 458889999999999999998 9999986 45566777777766543 4456789999999
Q ss_pred HHHhh-CccCCCCHHHHhc
Q 004645 261 EKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~ 278 (740)
.+||+ +|.+||++.++.+
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99999 9999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=313.62 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=204.8
Q ss_pred CceeEEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~-----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
++| ++.+.||+|+||.||+|.++. .+..||+|.++.. ........+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 80 (288)
T cd05061 6 EKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES---ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK- 80 (288)
T ss_pred HHc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 466 888999999999999997652 3567999876532 223344568899999999999999999998754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k----------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
....++||||+++|+|.+++...+ ..+...+..++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~-~~ 156 (288)
T cd05061 81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAH-DF 156 (288)
T ss_pred -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcC-CC
Confidence 567899999999999999987532 3456788899999999999999999 999999999999985 47
Q ss_pred cEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 004645 167 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 240 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~ 240 (740)
.++|+|||++....... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. ....++.+.+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999999987543221 11224567899999887 468999999999999999999 7899976 45566766666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc------CcccCCCC
Q 004645 241 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT------DPFLQIDD 286 (740)
Q Consensus 241 ~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~------HPff~~~~ 286 (740)
.+..+. .....++.+++++.+||+ +|.+|||+.++++ ||||...+
T Consensus 236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 655433 234557899999999999 9999999999986 89987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.24 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=207.4
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec--CCC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT--ANR 99 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~--~~~ 99 (740)
.+| .+.+.||.|+||.||+|.+..+|..||+|++.... ........+.+|+.+|++++||||++++++|... ...
T Consensus 5 ~~y-~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hce-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 455 78899999999999999999999999999887432 1223456788899999999999999999876532 245
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceee
Confidence 7899999995 689999887888999999999999999999999999 99999999999998 4579999999998654
Q ss_pred ccCc------cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC-----
Q 004645 180 RKSH------AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI-SGKKP----- 245 (740)
Q Consensus 180 ~~~~------~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~-~g~~p----- 245 (740)
.... .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||.......++..... .|..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 3221 123468999999998753 488999999999999999999999976443322211111 01100
Q ss_pred ----------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 246 ----------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 246 ----------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.......++.+++||.+||+ +|.+|||+.++|.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 01124468899999999999 999999999999999997443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=312.74 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=200.6
Q ss_pred CceeEEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~-----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
++| ++.+.||+|+||+||+|.+. .++..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~-~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~- 80 (277)
T cd05062 6 EKI-TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 80 (277)
T ss_pred HHc-eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 445 88999999999999999764 346789999875322 23445678899999999999999999998743
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k----------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
....++||||+++++|.+++...+ .++...+..++.|++.||.|||+.+ ++||||||+|||++. .+
T Consensus 81 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~-~~ 156 (277)
T cd05062 81 -GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAE-DF 156 (277)
T ss_pred -CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcC-CC
Confidence 668899999999999999986532 2567889999999999999999999 999999999999985 57
Q ss_pred cEEEeccchhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 004645 167 EVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 240 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~ 240 (740)
.++|+|||++........ ....+++.|||||++. +.++.++||||||+++|+|++ |..||.. .+...+.+.+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 999999999865432211 1224578899999987 458999999999999999999 6899976 45566666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 241 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 241 ~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.+..+. .....++.+++++.+||+ +|.+|||+.|++++
T Consensus 236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554432 345567899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=308.64 Aligned_cols=247 Identities=21% Similarity=0.332 Sum_probs=202.4
Q ss_pred EEeEEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC----
Q 004645 26 RYNEILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN---- 98 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~---tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~---- 98 (740)
++.++||+|+||+||+|.+.. ++..||+|.++... ........+.+|+.+|+.++||||+++++.+.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI--HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 678999999999999998765 34789999887533 234556789999999999999999999998755322
Q ss_pred CeEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEec
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~D 172 (740)
...++++||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~-~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRE-DMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECC-CCeEEECC
Confidence 3478999999999999887543 36899999999999999999999999 999999999999984 47999999
Q ss_pred cchhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004645 173 LGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 246 (740)
Q Consensus 173 FGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~ 246 (740)
||++........ ....++..|+|||++. ..++.++||||||+++|||++ |..||.+ ....++++.+..+..+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 999876543221 1123567899999886 458999999999999999999 8999976 44556667776665433
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.+...++.+.+++.+||+ +|.+|||+.+++++
T Consensus 236 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 -QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345678999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.74 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=204.7
Q ss_pred CCCceeEEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEe
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 93 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d-----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 93 (740)
|.+|| ++.+.||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.+|.++ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 56787 9999999999999999974 4578899999886432 234466788999999999 789999999987
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHhc-----------------------------------------------------
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 120 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~----------------------------------------------------- 120 (740)
... ...++++|||+++|+|.+++...
T Consensus 81 ~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 81 TKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred ecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 543 45788999999999999997643
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc--
Q 004645 121 --------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-- 184 (740)
Q Consensus 121 --------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~-- 184 (740)
..++...+..++.||+.||+|||+++ |+||||||.|||++. .+.+||+|||++........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcC-CCcEEEEecccccccccCcchh
Confidence 23677888999999999999999999 999999999999984 47999999999876532211
Q ss_pred --ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 185 --ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 185 --~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
....+++.|+|||++. ..++.++||||||+++|+|++ |..||........+...+..+..+. .+...++.+.+++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 315 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTM 315 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-CCCCCCHHHHHHH
Confidence 1223567899999876 458999999999999999997 9999987655556666666555432 2345688999999
Q ss_pred HHHhh-CccCCCCHHHHhcC
Q 004645 261 EKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~H 279 (740)
.+||. +|.+|||+.++++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.14 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=203.4
Q ss_pred CceeEEeEEecccCceEEEEEEEcCC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYE-----GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~t-----g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
.+| ++.+.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (277)
T cd05032 6 EKI-TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVST- 80 (277)
T ss_pred HHe-eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-
Confidence 455 7889999999999999987654 488999987532 233445678899999999999999999998754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k----------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
....++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~-~~ 156 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAE-DL 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcC-CC
Confidence 578999999999999999986532 3678899999999999999999999 999999999999985 47
Q ss_pred cEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 004645 167 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 240 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~ 240 (740)
.+||+|||++....... .....++..|+|||.+. +.++.++||||||+++|+|+| |..||.. .+...+.+.+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~ 235 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVI 235 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHh
Confidence 99999999987654332 22335678999999886 568999999999999999998 9999986 45666777666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 241 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 241 ~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+..+. .+...++.+.++|.+||. +|.+|||+.+++.
T Consensus 236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 554432 344468999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.35 Aligned_cols=254 Identities=30% Similarity=0.426 Sum_probs=209.5
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC---CC
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---NR 99 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~---~~ 99 (740)
|| ++.+.||.|+||.||+|.+..+|..||+|++.... ......+.+..|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y-~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RY-ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred Cc-eeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 45 88999999999999999999999999999886432 22445677999999999999999999999876532 23
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++| |+||||||.|||++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEee
Confidence 7899999997 589998888789999999999999999999999999 9999999999999855 79999999999876
Q ss_pred ccCc-----cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCc----
Q 004645 180 RKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KKPE---- 246 (740)
Q Consensus 180 ~~~~-----~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g--~~p~---- 246 (740)
.... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... ..+.++.+... ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhh
Confidence 5442 234468999999999874 48889999999999999999999998744 33334433321 1110
Q ss_pred -----------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 247 -----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 247 -----------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
......++.+++||.+||. +|.+|||+.++|.||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0123357889999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.87 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=215.9
Q ss_pred CceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEe
Q 004645 14 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 93 (740)
Q Consensus 14 ~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 93 (740)
.+...+|..+| ...+.||+|+||+||+|.+..++..||+|.+.... ........++.+|+.+++.++|+|++++++++
T Consensus 7 ~~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 84 (308)
T cd06634 7 LFFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84 (308)
T ss_pred hhhcCCcHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc-ccChHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 34556677777 56688999999999999999999999999886432 22344566788999999999999999999988
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEec
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~D 172 (740)
.. ....++|+||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||.|||++. .+.++|+|
T Consensus 85 ~~--~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~-~~~~kl~d 158 (308)
T cd06634 85 LR--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSE-PGLVKLGD 158 (308)
T ss_pred Ec--CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECC-CCcEEECC
Confidence 66 578899999996 577776654 456899999999999999999999999 999999999999984 57999999
Q ss_pred cchhhhhccCccccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004645 173 LGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 173 FGlA~~l~~~~~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~ 248 (740)
||++...... ....|++.|+|||.+. +.++.++|||||||++|+|++|..||........++ .+..+..+...
T Consensus 159 fg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 235 (308)
T cd06634 159 FGSASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQ 235 (308)
T ss_pred cccceeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcC
Confidence 9998765432 3446899999999874 357889999999999999999999997644333333 34445555444
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCCc
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~~ 287 (740)
....+..+++||.+||. +|.+||++.+++.|||+.....
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 55678899999999999 8999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=313.22 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=202.1
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCC----------------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEG----------------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg----------------~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H 83 (740)
+.++| ++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.+|++++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 3 PRQPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSD 78 (296)
T ss_pred chhhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCC
Confidence 34567 89999999999999999876644 557888876432 33556788999999999999
Q ss_pred CCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 004645 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 152 (740)
Q Consensus 84 pNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k-----------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHr 152 (740)
|||++++++|.. ...+++++||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||
T Consensus 79 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~ 154 (296)
T cd05051 79 PNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHR 154 (296)
T ss_pred CCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccc
Confidence 999999998855 578899999999999999987766 7899999999999999999999999 9999
Q ss_pred cCCCCceEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh--cCCC
Q 004645 153 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT--FDYP 225 (740)
Q Consensus 153 DLKp~NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT--G~~P 225 (740)
||||+||+++.+ +.++|+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ +..|
T Consensus 155 dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 155 DLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ccchhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999999844 799999999987654322 223346789999998874 68999999999999999998 7788
Q ss_pred CCCCCCHHHHHHHHHcC------CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 226 YSECTHPAQIYKKVISG------KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 226 f~~~~~~~~i~k~i~~g------~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
|.... ..++...+... ..........++++.+++.+||+ +|.+|||+.++++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 234 YEHLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCcC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 87644 34444444332 11112234467899999999999 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=313.41 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=204.3
Q ss_pred CceeEEeEEecccCceEEEEEEEcCC-----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeee
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYE-----GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 95 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~t-----g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd 95 (740)
++| ++.+.||+|+||.||+|..... ...+|+|.++.. ........+.+|+.+++++ +|+||+++++++..
T Consensus 12 ~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 12 DRL-TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred hHe-EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 456 8889999999999999987643 378999987632 2344556789999999999 89999999998744
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCce
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 159 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~----------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NI 159 (740)
...+++||||+.+|+|..++... +.+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Ni 163 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNV 163 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeE
Confidence 66899999999999999998642 46889999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeccchhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHH
Q 004645 160 FVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPA 233 (740)
Q Consensus 160 Lld~~~g~VKL~DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~ 233 (740)
|++ +++.+||+|||++..+..... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.. ....
T Consensus 164 l~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~ 241 (293)
T cd05053 164 LVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVE 241 (293)
T ss_pred EEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHH
Confidence 998 557999999999976544321 1123467899999876 458999999999999999997 9999986 4556
Q ss_pred HHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 234 QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 234 ~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
++++.+..+..+. .....++.+.+|+.+||. +|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6777777665443 334567899999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=332.76 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=202.0
Q ss_pred CCceeEEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEee
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWV 94 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~-----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv 94 (740)
.++| ++.++||+|+||+||+|.+.. ++..||+|+++... .....+.+.+|+.+|+++. ||||++++++|.
T Consensus 36 ~~~~-~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGL-VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccce-ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3455 778999999999999998643 34579999886432 3344578999999999995 999999999885
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKH------------------------------------------------------ 120 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~------------------------------------------------------ 120 (740)
. ...+++||||+++|+|.+++...
T Consensus 112 ~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 K--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred c--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 4 67899999999999999987543
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCc
Q 004645 121 ------------------------------------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 158 (740)
Q Consensus 121 ------------------------------------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~N 158 (740)
+.+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 23677888999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCH
Q 004645 159 IFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHP 232 (740)
Q Consensus 159 ILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~ 232 (740)
||++. .+.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 268 ill~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 268 VLLAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEEeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99985 4689999999987653321 12234778999999886 458999999999999999997 99999875555
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 233 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 233 ~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..++..+..+..+ ......++.+++++.+||. +|.+|||+.++.+
T Consensus 347 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 5666666666443 2345678899999999999 9999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.90 Aligned_cols=245 Identities=26% Similarity=0.382 Sum_probs=202.0
Q ss_pred CceeEEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~-----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
+.| .+.+.||+|+||.||+|.+. .++..+++|.++. ......+.+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~-~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 78 (291)
T cd05094 5 RDI-VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD- 78 (291)
T ss_pred HHe-EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-
Confidence 344 78899999999999999753 3566788887752 233445678899999999999999999998754
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceE
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 160 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NIL 160 (740)
....++||||+++++|.+++..+. .+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil 155 (291)
T cd05094 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCL 155 (291)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEE
Confidence 667999999999999999987643 3789999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHH
Q 004645 161 VNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQ 234 (740)
Q Consensus 161 ld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~ 234 (740)
++. ++.++|+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|+| |..||.. .+...
T Consensus 156 ~~~-~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~ 233 (291)
T cd05094 156 VGA-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTE 233 (291)
T ss_pred Ecc-CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 984 4799999999987554321 22345788999999887 458899999999999999999 9999976 34455
Q ss_pred HHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 235 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 235 i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
+...+..+..+. .....+..+++++.+||. +|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 VIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 666666665543 345568899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=311.86 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=206.1
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec---C
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT---A 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~---~ 97 (740)
+.|| ||.+.||.|||+-||++.+..++..+|+|.+.+. +.+..+...+|++..++++||||++++++.+.+ .
T Consensus 20 ~~Ry-ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRY-RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceE-EEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 4566 9999999999999999999999999999999854 356778899999999999999999999887653 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
....|+++.|+..|||.+.+... ..+++.++.+|+.+|++||++||+..||++||||||.|||+.+ .+.++|+||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceEEEec
Confidence 45799999999999999987653 3699999999999999999999999999999999999999985 579999999
Q ss_pred chhhhhccCcc-----------ccccCCCCCCCcccccc----ccCcccchhhhhhHHHHHHhcCCCCCCCC-CHHHHHH
Q 004645 174 GLAAILRKSHA-----------ARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYK 237 (740)
Q Consensus 174 GlA~~l~~~~~-----------~~~~GTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~-~~~~i~k 237 (740)
|.++...-... .....|..|+|||++.- ..++++|||||||++|+|+.|..||.... ....+.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99876532111 11236889999999973 36899999999999999999999995310 0001111
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 238 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 238 ~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.+.++.........++..+.+||+.||+ ||.+||++.+|+.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2233333323334478999999999999 99999999999864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.79 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=198.3
Q ss_pred EEeccc--CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 29 EILGKG--ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 29 e~LG~G--afGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
..||+| +||+||+|.+..+|..||+|+++.... .....+.+.+|+.+++.++||||++++++|.. ...+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEe
Confidence 456666 999999999999999999998875432 34556789999999999999999999999865 668899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 107 MFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 107 y~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
|+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999999988764 35899999999999999999999999 99999999999998 45799999998654332111
Q ss_pred c--------ccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C------
Q 004645 184 A--------ARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-P------ 245 (740)
Q Consensus 184 ~--------~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~-p------ 245 (740)
. ....++..|+|||++.+ .++.++|||||||++|+|++|..||........+...+..... |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 0 01124667999999864 3789999999999999999999999875544443332221100 0
Q ss_pred -------------------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 246 -------------------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 246 -------------------------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.......++.+++||.+||. +|.+|||+.++|+||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00112346789999999999 9999999999999999953
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.37 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=203.3
Q ss_pred ceeEEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~t---g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
+| ++.+.||+|+||+||+|....+ ...||+|.++... .......+..|+.++++++||||+++++++.. ..
T Consensus 5 ~~-~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 78 (266)
T cd05033 5 YV-TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SR 78 (266)
T ss_pred Hc-eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CC
Confidence 34 7899999999999999988654 4578998776332 34456678999999999999999999998744 67
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
.+++||||+++++|.+++... ..++...+..++.|++.||.|||+++ |+|+||||+|||++. .+.++|+|||++..
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~-~~~~~l~dfg~~~~ 155 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNS-NLVCKVSDFGLSRR 155 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcC-CCCEEECccchhhc
Confidence 799999999999999998765 47899999999999999999999999 999999999999984 47999999999987
Q ss_pred hccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 179 LRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 179 l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
...... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.... ...+...+..+..+. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~ 233 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRLP-PPMDC 233 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCCC-CCCCC
Confidence 642111 1123567899999887 468999999999999999998 999997744 455666666654332 23457
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
++.+.+++.+||+ +|.+||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=323.42 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=207.3
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCC
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~ 99 (740)
.++| .+.+.||+|+||.||+|.+..+|..+|+|.+... .........+.+|+.+++++ +||||++++++|......
T Consensus 6 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc--cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3455 7789999999999999999999999999987532 12334456688899999999 999999999988665566
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+++||||+. ++|..++... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhcc
Confidence 7899999996 5999987665 7899999999999999999999999 99999999999998 5579999999998765
Q ss_pred ccC-------ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------
Q 004645 180 RKS-------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK------ 244 (740)
Q Consensus 180 ~~~-------~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~------ 244 (740)
... ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||........+.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432 1223468999999998753 4788999999999999999999999765544433222111110
Q ss_pred ----------------------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 245 ----------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 245 ----------------------p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
+....+..+.++++||.+||+ +|.+|||+.++|.||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 112223468899999999999 9999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.74 Aligned_cols=241 Identities=22% Similarity=0.387 Sum_probs=200.0
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+++.++||+|+||+||+|.+. ++..||+|.++.. ....+.+.+|+.++++++|+||+++++.+.+ ....+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYII 79 (261)
T ss_pred eEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEE
Confidence 489999999999999999865 5667999987632 2235678999999999999999999998744 6778999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ ++||||||+||+++ +++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCC
Confidence 9999999999998663 56889999999999999999999999 99999999999998 5579999999999766543
Q ss_pred cc---ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004645 183 HA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 183 ~~---~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
.. ....++..|+|||.+. +.++.++||||||+++|+|+| |..||.. .....+...+..+.... .....+.++.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPDELY 234 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence 21 1223567899999887 458899999999999999998 9999986 44555666666554332 3345788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004645 258 QFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 258 dLI~kcL~-dPskRpSa~ELL~ 278 (740)
+++.+||. +|.+||++.++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.72 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=201.3
Q ss_pred eeEEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 24 YGRYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~tg~----~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
.+++.++||+|+||+||+|.+..+|. .||+|+++... .......+.+|+.+++.+.||||+++++++.. .
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---S 81 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence 34888999999999999998777766 47888876332 34456778999999999999999999998754 4
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
..++++||+++|+|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceee
Confidence 577899999999999998764 56999999999999999999999999 99999999999997 457899999999876
Q ss_pred hccCccc----cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 179 LRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 179 l~~~~~~----~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
....... ...+++.|+|||.+. ..++.++|||||||++|||+| |..||.. .....+...+..+..+. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~ 236 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPIC 236 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCccC
Confidence 6433221 123467899999886 458999999999999999998 8999976 44556666666654433 34557
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
++.+.++|.+||. +|.+||++.+++.
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.00 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=199.1
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+++.+.||+|+||.||+|... .+..+|+|.++... .....+.+|+.+|++++||||+++++++.. ...+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred cEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 377899999999999999765 45679999776322 123568889999999999999999998744 6789999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 105 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcC-CCeEEECCCCCccccCCCc
Confidence 9999999999987654 46899999999999999999999999 999999999999984 4799999999987653322
Q ss_pred cc---cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 184 AA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 184 ~~---~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
.. ...++..|+|||++. ..++.++||||||+++|+|++ |+.||.. .+..++...+..+..+. .+...++.+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 232 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRLY-RPKLASMTVYE 232 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHH
Confidence 11 223556899999987 468899999999999999999 8999976 44566677777765432 23456789999
Q ss_pred HHHHHhh-CccCCCCHHHHhc
Q 004645 259 FIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~ 278 (740)
++.+||. +|.+||++.++++
T Consensus 233 li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 9999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=335.09 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=203.6
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~ 98 (740)
-.||-|.+.+.||+||.+.||++.....+. +|+|.+.... .....+..+.+|+.+|.+| .|.+||++|++-+. +
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d 432 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--D 432 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--C
Confidence 357777888999999999999998765554 5555554332 3567788999999999999 69999999997654 7
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCC-HHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVN-IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~ls-e~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
..+|+||||= ..+|..++++..... .-.++.+.+|||.|+.++|.+| |||.||||.|+|+- .|.+||+|||.|.
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIAN 507 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhc
Confidence 8999999974 679999888765433 3588899999999999999999 99999999999985 3799999999998
Q ss_pred hhccCcc----ccccCCCCCCCcccccc------------ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Q 004645 178 ILRKSHA----ARCVGTPEFMAPEVYEE------------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 241 (740)
Q Consensus 178 ~l~~~~~----~~~~GTp~YmAPEvl~~------------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~ 241 (740)
.+..... .+.+||+.||+||.+.. +.+.++||||||||||+|+.|+.||....+...-+..|+.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 8876543 34589999999998741 1567899999999999999999999875544433344433
Q ss_pred CCCCcccccCCCh-HHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 242 GKKPEALFKVEDP-EVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 242 g~~p~~~~~~~sp-elrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
-.-...++....+ ++.++++.||. ||.+|+|+.+||+|||+++-
T Consensus 588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 2111122222233 38999999999 99999999999999999873
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.03 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=218.8
Q ss_pred CCCCceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCccee
Q 004645 11 DSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKF 89 (740)
Q Consensus 11 ~~~~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl 89 (740)
...++-+-.-+..|.--.++||-|-.|.|-.++++.||+++|+|++. + + ....+|+++--.. .|||||.+
T Consensus 50 ~~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--D---s----~KARrEVeLHw~~s~h~~iV~I 120 (400)
T KOG0604|consen 50 SDMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--D---S----PKARREVELHWMASGHPHIVSI 120 (400)
T ss_pred hhcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--c---C----HHHHhHhhhhhhhcCCCceEEe
Confidence 34455555566777333478999999999999999999999999764 1 1 2356677654443 79999999
Q ss_pred eeEeee--cCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC
Q 004645 90 YTSWVD--TANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165 (740)
Q Consensus 90 ~~~fvd--~~~~~i~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~ 165 (740)
+++|.. ...+.+.+|||.++||.|.+.+..++ .++++.+..|++||..|+.|||+.+ |.||||||+|+|...+.
T Consensus 121 idVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~ 198 (400)
T KOG0604|consen 121 IDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTS 198 (400)
T ss_pred ehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCC
Confidence 998743 23567889999999999999888765 4999999999999999999999999 99999999999997433
Q ss_pred --CcEEEeccchhhhhcc-CccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCC---HHHHHHH
Q 004645 166 --GEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKK 238 (740)
Q Consensus 166 --g~VKL~DFGlA~~l~~-~~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~k~ 238 (740)
..+||+|||+|+.... ....+.+-||.|.|||++. ++|+..+|+||+||+||-|++|.+||..... ...+..+
T Consensus 199 ~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r 278 (400)
T KOG0604|consen 199 PNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR 278 (400)
T ss_pred CCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH
Confidence 3589999999987663 4456678899999999998 6799999999999999999999999965322 3345567
Q ss_pred HHcCC--CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 239 VISGK--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 239 i~~g~--~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
|..|. +|..-+...+..++++|+++|. +|++|+|+.+++.|||+....
T Consensus 279 I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 279 IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 77776 4667778889999999999999 999999999999999997544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.47 Aligned_cols=243 Identities=29% Similarity=0.454 Sum_probs=208.7
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||.|+||.||++.+..++..+|+|+++.... ........+..|+.++++++||||+++++.+. .+..+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCC
Confidence 7999999999999998999999998875432 23345678899999999999999999998774 47789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--cccccc
Q 004645 111 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCV 188 (740)
Q Consensus 111 GSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~--~~~~~~ 188 (740)
++|.+++.....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999988888999999999999999999999999 99999999999998 4579999999998766543 233456
Q ss_pred CCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-C
Q 004645 189 GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 266 (740)
Q Consensus 189 GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-d 266 (740)
++..|+|||...+ .++.++|+||||+++|+|++|..||.. .....+...+..+.. .++...+..+++||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPL--RFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHhcCC
Confidence 8999999998874 478899999999999999999999976 444666666665433 2444558899999999999 9
Q ss_pred ccCCCCH---HHHhcCccc
Q 004645 267 VSSRLSA---RELLTDPFL 282 (740)
Q Consensus 267 PskRpSa---~ELL~HPff 282 (740)
|.+||++ .++++||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.43 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=198.8
Q ss_pred EEecccCceEEEEEEEcCCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg---~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++||+|+||.||+|+...++ ..+|+|.+..... ....+.+..|+.+++++.||||+++++++. ...+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEE
Confidence 46999999999999876655 7899998864432 245567899999999999999999999763 34679999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~ 185 (740)
||+.+++|.+++.....+++..+..|+.||+.||.|||..+ ++|+||||+|||++ ..+.+||+|||++.........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 99999999999988888999999999999999999999999 99999999999998 4579999999998765433211
Q ss_pred -----cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 186 -----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 186 -----~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||... +..++.+.+..+... ......++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGERL-PRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 112346799999887 458999999999999999998 99999874 456666766665433 344567889999
Q ss_pred HHHHHhh-CccCCCCHHHHhc
Q 004645 259 FIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~ 278 (740)
+|.+||. +|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.47 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=200.2
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|++|.||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 6 ~~~-~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (261)
T cd05068 6 TSI-QLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPI 76 (261)
T ss_pred hhe-eeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEec--CCCe
Confidence 445 89999999999999999875 456899998864321 23558889999999999999999998754 6678
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 102 NFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++. .+.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGE-NNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcC-CCCEEECCcceEEEc
Confidence 99999999999999987654 7899999999999999999999999 999999999999984 479999999999776
Q ss_pred ccCccccccC---CCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 180 RKSHAARCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 180 ~~~~~~~~~G---Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
.........| +..|+|||++. ..++.++||||||+++|+|+| |+.||.. .+...+...+..+..+ ......+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPK 231 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCH
Confidence 5332222223 35799999887 458899999999999999999 9999986 4455566666554322 23445688
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+++++.+||+ +|.+||++.++++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.38 Aligned_cols=244 Identities=23% Similarity=0.371 Sum_probs=199.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCe--EEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGI--EVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~--~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~ 102 (740)
++.++||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.. ...++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 888999999999999999887775 4677766522 2334567789999999999 79999999998754 56789
Q ss_pred EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 103 FVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
+++||+++++|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++. ++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~-~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGE-NL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECC-CC
Confidence 9999999999999987643 4788999999999999999999999 999999999999985 47
Q ss_pred cEEEeccchhhhhccCcccc-ccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCC
Q 004645 167 EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGK 243 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~~~~-~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~ 243 (740)
.+||+|||++.......... ...+..|+|||++.+ .++.++|||||||++|+|+| |..||.. .....++..+..+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC
Confidence 99999999986433221111 123457999998874 58999999999999999998 9999986 45566667776654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 244 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 244 ~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.+ ..+...++.+++||.+||. +|.+|||+.++++.
T Consensus 236 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33 2345678999999999999 89999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.95 Aligned_cols=257 Identities=30% Similarity=0.420 Sum_probs=207.3
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC-
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN- 98 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~- 98 (740)
..++| ++.+.||+|+||+||+|.+..+|..||+|+++.. .........+.+|+.+|++++||||+++++.|.....
T Consensus 13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 45677 7889999999999999999999999999988643 2234445678899999999999999999998754321
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 99 ---RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 99 ---~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
..+++||||+ +++|..++. ...+++..++.++.||+.||.|||++| |+||||||+||+++ +.+.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccc
Confidence 2568999998 789988765 467999999999999999999999999 99999999999998 457999999999
Q ss_pred hhhhccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCC-------
Q 004645 176 AAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG-KKP------- 245 (740)
Q Consensus 176 A~~l~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g-~~p------- 245 (740)
+...... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||..........+..... ..+
T Consensus 165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 165 ARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 8765432 233468999999998864 47889999999999999999999998754433322211110 000
Q ss_pred --------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 246 --------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 246 --------------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.......++.++++|.+||. +|.+|||+.+++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 01124567889999999999 99999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.02 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=203.3
Q ss_pred ceeEEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeec
Q 004645 23 RYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 96 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d-----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~ 96 (740)
+| .+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 36 ~~-~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 110 (302)
T cd05055 36 NL-SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTI- 110 (302)
T ss_pred He-EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence 44 7889999999999999975 3456789999876432 244567899999999999 89999999998855
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
...+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+|||++ ..+.++|+|||
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg 186 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFG 186 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCc
Confidence 567999999999999999987643 3899999999999999999999999 99999999999998 45799999999
Q ss_pred hhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004645 175 LAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 175 lA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~ 248 (740)
++........ ....+++.|+|||.+. +.++.++|||||||++|+|+| |..||........+.+.+..+..+ ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CC
Confidence 9876543221 1234678899999876 458999999999999999998 999998766555566666555433 33
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
....++.+++|+.+||. +|.+|||+.++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 45568999999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.52 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred CCceeEEeEEecccCceEEEEEEEcC-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeE
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTS 92 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~-------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~ 92 (740)
.++| .+.+.||+|+||+||+|.+.. ++..+|+|.++.. ........+..|+.+++.+ +||||++++++
T Consensus 17 ~~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred hHHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3566 899999999999999997643 3457998887632 2344567788999999999 89999999998
Q ss_pred eeecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCC
Q 004645 93 WVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 156 (740)
Q Consensus 93 fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp 156 (740)
+.. ...+++||||+.+|+|.+++...+ .++...+..++.||+.||+|||++| ++||||||
T Consensus 93 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 93 CTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred Eec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 854 568999999999999999987643 4788999999999999999999999 99999999
Q ss_pred CceEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCC
Q 004645 157 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECT 230 (740)
Q Consensus 157 ~NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~ 230 (740)
+|||++.+ +.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .
T Consensus 169 ~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~ 246 (307)
T cd05098 169 RNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V 246 (307)
T ss_pred HheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-C
Confidence 99999854 799999999987554221 111224578999998874 58999999999999999998 8899976 5
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 231 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 231 ~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
+..++.+.+..+..+ ..+...++++++||.+||. +|.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 667777777666543 3445678899999999999 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.81 Aligned_cols=244 Identities=24% Similarity=0.377 Sum_probs=198.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEE--EEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEV--AWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~V--AiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.+.+.||+|+||+||+|.+..+|..+ |+|.++ . .........+.+|+.++.++ +||||+++++++.. ...++
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~--~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~ 84 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--E-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 84 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEec--c-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCce
Confidence 78899999999999999998887654 555443 2 22345567889999999999 89999999998744 67899
Q ss_pred EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 103 FVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
+||||+++++|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++. ++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~-~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE-NY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecC-CC
Confidence 9999999999999987543 4789999999999999999999999 999999999999984 47
Q ss_pred cEEEeccchhhhhccCc-cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCC
Q 004645 167 EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGK 243 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~-~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~ 243 (740)
.+||+|||++....... .....++..|+|||++.+ .++.++|||||||++|+|+| |..||.. .+..++++.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~ 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCC
Confidence 99999999986432111 111234678999998874 48899999999999999998 9999976 44556666665543
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 244 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 244 ~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.+. .....++.+.+||.+||+ +|.+||++.++|.+
T Consensus 241 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 322 234467899999999999 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=354.47 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=201.1
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
|+| ++.++||+|+||+||+|.+..+|..||+|+++... .......+++.+|+.++++++||||+++++++.+ +...
T Consensus 2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~l 77 (932)
T PRK13184 2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPV 77 (932)
T ss_pred CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEE
Confidence 677 88999999999999999999999999999986432 2334556789999999999999999999998755 6789
Q ss_pred EEEEeccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEE
Q 004645 102 NFVTEMFTSGTLRQYRLKH-----------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-----------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL 170 (740)
++||||++||+|.+++... ..++...+..++.||+.||.|||++| |+||||||+|||++ ..|.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEE
Confidence 9999999999999987642 23566778899999999999999999 99999999999998 4579999
Q ss_pred eccchhhhhccC--------------------ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC
Q 004645 171 GDLGLAAILRKS--------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC 229 (740)
Q Consensus 171 ~DFGlA~~l~~~--------------------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~ 229 (740)
+|||++...... .....+||+.|||||++.+ .++.++|||||||++|+|+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999765210 0112469999999999874 5899999999999999999999999764
Q ss_pred CCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 230 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 230 ~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
......+................++.+.+++.+||. +|.+|++..+.|.+
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332222222221111111234578899999999999 99999887666543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.20 Aligned_cols=239 Identities=21% Similarity=0.337 Sum_probs=199.7
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+++.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.++++++|+||+++++++.. ....++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv 78 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 78 (256)
T ss_pred CeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEE
Confidence 37889999999999999965 4888999987522 234578899999999999999999997654 34578999
Q ss_pred EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+||+++++|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++ +++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecccc
Confidence 99999999999987654 4889999999999999999999999 99999999999998 5579999999998754432
Q ss_pred ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI 260 (740)
. ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+..++...+..+..+ ......++.++++|
T Consensus 156 ~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (256)
T cd05082 156 Q-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVM 232 (256)
T ss_pred C-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 2 23345678999998874 58899999999999999998 9999976 4566676666665443 34466789999999
Q ss_pred HHHhh-CccCCCCHHHHhc
Q 004645 261 EKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 261 ~kcL~-dPskRpSa~ELL~ 278 (740)
.+||. +|.+|||+.++++
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 233 KQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 99999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=316.87 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=197.1
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 27 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
+++.+|.| +.||.+.+..+|..||+|+++... ........+..|+.+|++++|+||++++++|.. ....+++||
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e 79 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSP 79 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEe
Confidence 44444444 555666667799999999987542 234567789999999999999999999998865 678899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--
Q 004645 107 MFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-- 182 (740)
Q Consensus 107 y~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-- 182 (740)
|+++++|.+++... ..+++..+..+++||+.||.|||+++ |+||||||+|||++ ..+.+||+|||.+......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccc
Confidence 99999999998764 46899999999999999999999999 99999999999998 4579999999988644221
Q ss_pred -------ccccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc------
Q 004645 183 -------HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE------ 246 (740)
Q Consensus 183 -------~~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~------ 246 (740)
......++..|+|||++.. .|+.++|||||||++|+|++|..||........+..++.. ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG-TVPCLLDKST 235 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCccccccCc
Confidence 1122357889999999864 4889999999999999999999999875544444443321 1110
Q ss_pred --------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 247 --------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 247 --------------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
......++++.+|+.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0111234678899999999 99999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.40 Aligned_cols=255 Identities=25% Similarity=0.454 Sum_probs=206.3
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCe
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~ 100 (740)
+.| ++.+.||+|+||+||+|.+..++..||+|+++... .......+..|+.++.++ .||||+++++++.+ ...
T Consensus 15 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~ 88 (296)
T cd06618 15 NDL-ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSD 88 (296)
T ss_pred chh-eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCe
Confidence 445 88899999999999999999999999999987543 233455677788777776 59999999998865 668
Q ss_pred EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 101 INFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
++++|||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||+|+||+++ +++.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchh
Confidence 999999984 577777655 4678999999999999999999997 57 99999999999998 557999999999876
Q ss_pred hccCcc-ccccCCCCCCCcccccc-----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc-ccC
Q 004645 179 LRKSHA-ARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL-FKV 251 (740)
Q Consensus 179 l~~~~~-~~~~GTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~-~~~ 251 (740)
+..... ....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+..+..+... ...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 543322 23357889999998863 37889999999999999999999997654444555555555433221 224
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
.+.++++||.+||. +|.+||++.+++.||||+...
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 68899999999999 999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.80 Aligned_cols=244 Identities=22% Similarity=0.340 Sum_probs=199.8
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
|.++| ++.++||+|+||+||+|.+..++ .||+|.++.... ..+.+.+|+.++++++||||+++++.+. ..
T Consensus 4 ~~~~~-~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~ 73 (262)
T cd05071 4 PRESL-RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EE 73 (262)
T ss_pred ChHHe-eEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC---CC
Confidence 55677 99999999999999999887654 599998864321 1346889999999999999999998763 34
Q ss_pred eEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
..++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ +++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCcee
Confidence 578999999999999998764 45889999999999999999999999 99999999999998 45799999999997
Q ss_pred hhccCccc---cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 178 ILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 178 ~l~~~~~~---~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
........ ...++..|+|||++. +.++.++||||||+++|+|+| |..||... ....++..+..+..+ ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPEC 228 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCcccc
Confidence 65433221 223567899999876 468999999999999999999 88899764 445566666554432 224457
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
++.+.++|.+||+ +|.+||++.+++.
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.85 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=204.5
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
...| ++.++||.|+||+||+|.+.. +..+|+|+++... ......+..|+.+++.++|+||+++++++.+ ...
T Consensus 5 ~~~y-~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 76 (261)
T cd05148 5 REEF-TLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEP 76 (261)
T ss_pred HHHH-HHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCC
Confidence 3445 778999999999999999987 8899999887432 3345678899999999999999999998754 668
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
+++||||+++++|.+++... ..++...+..|+.||+.||.|||+++ |+|+||||+|||++ +++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhh
Confidence 99999999999999998763 46899999999999999999999999 99999999999998 457999999999976
Q ss_pred hccCcc--ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 179 LRKSHA--ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 179 l~~~~~--~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
...... ....+++.|+|||++. +.++.++||||||+++|+|++ |..||.. .+..+++..+..+..+ ......++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQ 231 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCH
Confidence 643321 1223567899999886 468899999999999999998 8999976 4455666666655433 23456789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+.++|.+||+ +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.07 Aligned_cols=241 Identities=24% Similarity=0.395 Sum_probs=199.5
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||+||+|.... +..+|+|.++.... ....+.+|+.++++++||||+++++++.. ...+++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVT 78 (256)
T ss_pred EEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEE
Confidence 788999999999999997653 45699998763321 13468899999999999999999998744 56789999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 106 EMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||.|||++ .++.+||+|||++........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCce
Confidence 999999999998764 46899999999999999999999999 99999999999998 457999999999875543322
Q ss_pred cc---ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 185 AR---CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 185 ~~---~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
.. ..++..|+|||++. ..++.++|||||||++|+|+| |..||... +...+...+..+..+. .....++.++++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 233 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRLY-RPHLASEKVYAI 233 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCCC-CCCCCCHHHHHH
Confidence 22 23456899999987 468999999999999999999 99999863 4556666777665443 334568899999
Q ss_pred HHHHhh-CccCCCCHHHHhcC
Q 004645 260 IEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~H 279 (740)
+.+||. +|.+||++.+++.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHh
Confidence 999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.44 Aligned_cols=247 Identities=30% Similarity=0.517 Sum_probs=204.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
.+||+|+||.||+|.+..+|..||+|++... .......+.+|+.+++.++|+||+++++.|.. ....++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecC
Confidence 5799999999999999999999999987532 23445678999999999999999999998865 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--ccc
Q 004645 109 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AAR 186 (740)
Q Consensus 109 ~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~--~~~ 186 (740)
++++|.+++ ...++++..+..++.||+.||+|||++| ++|+||+|.||+++. ++.++|+|||++....... ...
T Consensus 100 ~~~~L~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECC-CCCEEEcccccceecccccccccc
Confidence 999999975 4557899999999999999999999999 999999999999984 4799999999886554322 223
Q ss_pred ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc-ccccCCChHHHHHHHHHh
Q 004645 187 CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 187 ~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~-~~~~~~spelrdLI~kcL 264 (740)
..|++.|+|||.+. ..++.++|+||||+++|+|++|..||... ........+..+..+. ......++.+.+|+.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 46899999999886 45889999999999999999999999863 3333334343332221 123456889999999999
Q ss_pred h-CccCCCCHHHHhcCcccCCCC
Q 004645 265 A-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 265 ~-dPskRpSa~ELL~HPff~~~~ 286 (740)
. +|.+||++.++|.||||....
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 9 999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.86 Aligned_cols=242 Identities=23% Similarity=0.374 Sum_probs=199.7
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+++.+.||+|+||.||+|.+. ++..+|+|.++.... ....+..|+.++++++||||+++++++.. ...+++|
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 478899999999999999876 466899998753221 12457889999999999999999998744 5688999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 105 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
|||+++++|.+++..+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +.+.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccc
Confidence 9999999999998764 46899999999999999999999999 99999999999998 45799999999987654332
Q ss_pred ccccc---CCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 184 AARCV---GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 184 ~~~~~---GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
..... ++..|+|||.+. ..++.++||||||+++|+|+| |..||... ....+...+..+..+ ..+...++.+.+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEVYT 232 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 22222 345799999887 468999999999999999999 89999763 456666666665433 234567899999
Q ss_pred HHHHHhh-CccCCCCHHHHhcC
Q 004645 259 FIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL~H 279 (740)
++.+||. +|.+|||+.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.64 Aligned_cols=240 Identities=21% Similarity=0.343 Sum_probs=203.3
Q ss_pred eeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEE
Q 004645 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~l 103 (740)
.+++.+.||.|+||.||+|.+. |..||+|.++... ...+++.+|+.++++++|+||+++++++.+ ....++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 3488999999999999999764 8899999887432 256789999999999999999999998755 678899
Q ss_pred EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 104 VTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++ .++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccccccccc
Confidence 999999999999987765 7999999999999999999999999 99999999999998 457999999999977643
Q ss_pred CccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 182 SHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ......++.+.++
T Consensus 155 ~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 231 (256)
T cd05039 155 GQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYKV 231 (256)
T ss_pred ccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHHH
Confidence 322 233566899999876 568899999999999999997 9999986 4566666666655443 2345578999999
Q ss_pred HHHHhh-CccCCCCHHHHhc
Q 004645 260 IEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~ 278 (740)
|.+||. +|.+|||+.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.60 Aligned_cols=240 Identities=25% Similarity=0.377 Sum_probs=198.1
Q ss_pred EEecccCceEEEEEEEcC-CC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDEY-EG--IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~-tg--~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++||+|++|+||+|.+.. .+ ..||+|.++.... ....+.+.+|+.++++++||||+++++.+.+ ..+++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc---HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999998765 33 3689998874432 1567789999999999999999999998765 6889999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc
Q 004645 106 EMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~ 183 (740)
||+++++|.+++.... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.+ +.+||+|||++..+....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEeccccccccccccc
Confidence 9999999999987764 6899999999999999999999999 9999999999999855 799999999987664421
Q ss_pred -----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004645 184 -----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256 (740)
Q Consensus 184 -----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spel 256 (740)
.....++..|+|||.+.. .++.++|||||||++|+|+| |..||... +..++.+.+.............++.+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 112347789999998874 68999999999999999999 99999764 44556555553222222334567899
Q ss_pred HHHHHHHhh-CccCCCCHHHHhc
Q 004645 257 RQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 257 rdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+++.+||. +|.+|||+.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.12 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=204.3
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||.|++|.||+|.+..+|..+++|.++.... .......+..|+.+|++++|+||+++++++.. ...+++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEE
Confidence 567889999999999999999999999998875432 22345678899999999999999999998755 57899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 106 EMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++. .+.++|+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECC-CCcEEEeeeeeeEecCCCcc
Confidence 99965 88777666 468999999999999999999999999 999999999999984 4799999999987665433
Q ss_pred -cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 004645 184 -AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--------------- 245 (740)
Q Consensus 184 -~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p--------------- 245 (740)
.....++..|+|||.+.+ .++.++||||||+++|+|+||+.||......+++.+.......+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 223458889999998864 58899999999999999999999998755545444332221111
Q ss_pred ------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 ------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 ------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.......+.++++||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01122357899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.14 Aligned_cols=249 Identities=29% Similarity=0.408 Sum_probs=203.2
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i~l 103 (740)
|++.+.||.|+||+||+|.+..++..|++|.+..... . .......+|+..+++++ |+||+++++.+.+ +...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEE
Confidence 3788999999999999999999999999998764321 1 22234567999999998 9999999998855 678999
Q ss_pred EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 104 VTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
||||+ +|+|.+++.... .+++..+..++.||+.+|.|||+++ ++|+||+|+||+++. .+.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence 99999 889998877764 7899999999999999999999999 999999999999984 57999999999976654
Q ss_pred Ccc-ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 004645 182 SHA-ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------- 245 (740)
Q Consensus 182 ~~~-~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p------------- 245 (740)
... ....++..|+|||++.+ .++.++|+||||+++++|++|+.||........+++.......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 322 34568999999998853 47899999999999999999999998765555544332211110
Q ss_pred --------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 --------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 --------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.......++.+++||.+||. +|.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01112336889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.88 Aligned_cols=242 Identities=26% Similarity=0.408 Sum_probs=200.1
Q ss_pred EEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 26 RYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d-----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
++.++||+|+||+||+|.. ..++..+|+|.++. ........+.+|+.++++++|+||+++++++.+ ...
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRP 81 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCc
Confidence 7789999999999999964 33577888887763 234556789999999999999999999998855 567
Q ss_pred EEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC
Q 004645 101 INFVTEMFTSGTLRQYRLKHR---------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k---------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~ 165 (740)
.+++|||+++++|.+++..++ .+++..+..++.||+.||+|||+++ |+||||||+|||++ ++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-QG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-CC
Confidence 899999999999999987653 4789999999999999999999999 99999999999998 45
Q ss_pred CcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHH
Q 004645 166 GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 239 (740)
Q Consensus 166 g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i 239 (740)
+.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.... .......+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHHH
Confidence 799999999986543221 12223578899999887 458999999999999999998 899997644 44555556
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 240 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 240 ~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+..+. .....++.+++||.+||. +|.+||++.+++.
T Consensus 238 ~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6655433 345678999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.58 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=203.1
Q ss_pred CCCceeEEeEEecccCceEEEEEEEc-------CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeee
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDE-------YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYT 91 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~-------~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~ 91 (740)
|.++| .+.+.||+|+||.||+|.+. .....+|+|.++.. ........+..|+.+++++ +||||+++++
T Consensus 10 ~~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 10 PRDRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cHHHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 45677 78999999999999999763 23557898887632 2345567789999999999 6999999999
Q ss_pred EeeecCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCC
Q 004645 92 SWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 155 (740)
Q Consensus 92 ~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~----------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLK 155 (740)
++.+ ...++++|||+.+|+|.+++... ..++...+..++.||+.||.|||++| |+|||||
T Consensus 86 ~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlk 161 (314)
T cd05099 86 VCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLA 161 (314)
T ss_pred EEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecccc
Confidence 8754 56799999999999999998764 24788999999999999999999999 9999999
Q ss_pred CCceEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCC
Q 004645 156 CDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSEC 229 (740)
Q Consensus 156 p~NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~ 229 (740)
|+|||++ +++.+||+|||++....... .....+++.|||||++. +.++.++||||||+++|+|++ |..||..
T Consensus 162 p~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~- 239 (314)
T cd05099 162 ARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG- 239 (314)
T ss_pred ceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-
Confidence 9999998 45799999999997654321 11123456899999886 458999999999999999999 8999976
Q ss_pred CCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 230 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 230 ~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+...++..+..+..+. .....+.+++++|.+||. +|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 IPVEELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55667777776665432 334567899999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.04 Aligned_cols=251 Identities=30% Similarity=0.480 Sum_probs=206.3
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL-QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
|| .+.+.||+|+||+||++.+..++..+++|+++..... ........+..|+.+++.++||||+++++++.+ ....
T Consensus 1 ~y-~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (260)
T cd08222 1 RY-ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAF 77 (260)
T ss_pred Cc-eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCce
Confidence 45 7889999999999999999888877777776543211 122334567789999999999999999998855 5678
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 102 NFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
++|+||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++. +.++|+|||++.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~ 153 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSR 153 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCcee
Confidence 999999999999988754 356899999999999999999999999 999999999999973 579999999987
Q ss_pred hhccCc--cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 178 ILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 178 ~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
...... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .....+...+..+..+. .....++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (260)
T cd08222 154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPS-LPETYSR 231 (260)
T ss_pred ecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCCC-CcchhcH
Confidence 654322 223458899999998864 578899999999999999999999976 34445555565555443 3456788
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
++.++|.+||. +|.+||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.37 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=201.8
Q ss_pred CceeEEeEEecccCceEEEEEEE----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFD----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
+|+|++.+.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+|++++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 56778999999999999999973 4578899999876332 3445567999999999999999999999887655
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
...+++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||+++ +++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCccc
Confidence 57789999999999999998665 46899999999999999999999999 99999999999998 4579999999998
Q ss_pred hhhccCcc-----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCC--------------CCHHHHH
Q 004645 177 AILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSEC--------------THPAQIY 236 (740)
Q Consensus 177 ~~l~~~~~-----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~--------------~~~~~i~ 236 (740)
..+..... ....|+..|+|||++. ..++.++||||||+++|+|+|+..|+... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 76543221 2334677899999876 45889999999999999999987765321 1112222
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 237 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 237 k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
+.+..+... ......++.+.+||.+||+ +|.+|||+.++++.
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 223333322 2344578899999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.42 Aligned_cols=256 Identities=30% Similarity=0.445 Sum_probs=206.9
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC--
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN-- 98 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~-- 98 (740)
.++| .+...||+|++|+||+|.+..++..||+|++.... ........+.+|+.++++++||||+++++++.....
T Consensus 14 ~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCce-EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4566 78899999999999999999999999999876432 233445678899999999999999999887654221
Q ss_pred --CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 99 --RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 99 --~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
..+++|+||+ +++|.+++.. .++++..++.++.||+.||.|||+.| |+||||||+||+++. .+.++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~-~~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNE-DCELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CCCEEEcccccc
Confidence 3489999998 7799998654 57999999999999999999999999 999999999999984 579999999999
Q ss_pred hhhccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCc------
Q 004645 177 AILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPE------ 246 (740)
Q Consensus 177 ~~l~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~--~p~------ 246 (740)
...... .....+++.|+|||++.+ .++.++|||||||++|+|+||+.||...... ..+..+.... .+.
T Consensus 166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhc
Confidence 766443 334568999999998764 4788999999999999999999999864433 3333332211 110
Q ss_pred ---------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 247 ---------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 247 ---------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
......++.+.+||.+||. +|.+|||+.++|.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 1123458899999999999 999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.13 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=200.4
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC--------
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA-------- 97 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~-------- 97 (740)
.+.+.||+|+||+||+|.+..+|..||+|+++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 788999999999999999999999999999875432 1223346778999999999999999999876532
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
...+++|+||+++ +|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||.||+++ +.+.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCccccc
Confidence 3479999999976 677766654 47999999999999999999999999 99999999999998 4579999999999
Q ss_pred hhhccCcc---ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCc--
Q 004645 177 AILRKSHA---ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS---GKKPE-- 246 (740)
Q Consensus 177 ~~l~~~~~---~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~---g~~p~-- 246 (740)
........ ....+++.|+|||++.+ .++.++|||||||++|+|++|.+||........+ +.+.. +..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhhc
Confidence 76643321 22246789999998864 4788999999999999999999999764433322 22221 11111
Q ss_pred -----------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 247 -----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 247 -----------------------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
......++.+.++|.+||. +|.+||++.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122457899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.28 Aligned_cols=246 Identities=28% Similarity=0.422 Sum_probs=196.5
Q ss_pred eEEeEEecccCceEEEEEE----EcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 25 GRYNEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~----d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
+++.+.||+|+||+||+|. +..++..||+|.++.. .....+.+.+|+++|++++||||+++++++.......
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4888999999999999997 4567899999987632 3455678999999999999999999999876655667
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
+++|+||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccccc
Confidence 99999999999999998765 46899999999999999999999999 99999999999998 4579999999999866
Q ss_pred ccCccc-----cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCH---------------HHHHHH
Q 004645 180 RKSHAA-----RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP---------------AQIYKK 238 (740)
Q Consensus 180 ~~~~~~-----~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~---------------~~i~k~ 238 (740)
...... ...++..|+|||++.+ .++.++||||||+++|||++|..|+...... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 433221 1123456999999874 5889999999999999999987776432110 011112
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 239 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 239 i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
+..+..+ ......++++.+||.+||. +|.+|||+.++++
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2222221 2234567899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.10 Aligned_cols=242 Identities=22% Similarity=0.301 Sum_probs=189.9
Q ss_pred EEecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 29 EILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~--~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
+.||+|+||.||+|... .++..+|+|.++... .......+.+|+.++++++||||+++++.+.+ ...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEE
Confidence 35899999999999754 456778988776433 23334578889999999999999999998754 567899999
Q ss_pred ccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 107 MFTSGTLRQYRLKHR-----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 107 y~~gGSL~~~l~~~k-----~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
|+++|+|.+++...+ ..+...+..++.|++.||.|||+.+ ++||||||+||+++. .+.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcC-CCcEEECCccccccccC
Confidence 999999999986532 4567788899999999999999999 999999999999985 57999999999865432
Q ss_pred Cc----cccccCCCCCCCcccccc--------ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC--C-
Q 004645 182 SH----AARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKK--P- 245 (740)
Q Consensus 182 ~~----~~~~~GTp~YmAPEvl~~--------~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~--p- 245 (740)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++ |..||............+..... +
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 21 122357889999998853 25789999999999999996 99999875554443333332222 1
Q ss_pred cccccCCChHHHHHHHHHhhCccCCCCHHHHhc
Q 004645 246 EALFKVEDPEVRQFIEKCLATVSSRLSARELLT 278 (740)
Q Consensus 246 ~~~~~~~spelrdLI~kcL~dPskRpSa~ELL~ 278 (740)
..+....++.+++++++|+.+|.+|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 122234678899999999989999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=304.95 Aligned_cols=252 Identities=30% Similarity=0.354 Sum_probs=199.7
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEeeecCC---
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDTAN--- 98 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fvd~~~--- 98 (740)
|++.+.||+|+||.||+|.+..++..||+|.++.... .......+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 3788999999999999999998999999999875432 222234566788877766 59999999999876332
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
..++++|||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcc
Confidence 23899999996 58988877643 5899999999999999999999999 9999999999999955 79999999998
Q ss_pred hhhccCc-cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Q 004645 177 AILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--------- 245 (740)
Q Consensus 177 ~~l~~~~-~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p--------- 245 (740)
....... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||......+.+.+....-..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 7664332 233457899999999874 58899999999999999999999998754443333222110000
Q ss_pred ---------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 246 ---------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 246 ---------------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.......++.+.+||.+||. +|.+||++.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 01112345788999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.28 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=197.2
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCC--------------CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYE--------------GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~t--------------g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN 85 (740)
|..+| ++.+.||+|+||.||+|.+..+ ...||+|.++.. ........+.+|+++|++++|+|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 3 PRQQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred chHhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCC
Confidence 45677 8999999999999999987543 235888887632 23455677999999999999999
Q ss_pred cceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 004645 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 153 (740)
Q Consensus 86 IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrD 153 (740)
|+++++++.. ....++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|||
T Consensus 79 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 79 IIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred cCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 9999998854 678899999999999999876532 3688899999999999999999999 99999
Q ss_pred CCCCceEEeCCCCcEEEeccchhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh--cCCCC
Q 004645 154 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYPY 226 (740)
Q Consensus 154 LKp~NILld~~~g~VKL~DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT--G~~Pf 226 (740)
|||+|||++ +++.+||+|||++........ ....+++.|+|||++. +.++.++||||||+++|+|++ +..||
T Consensus 155 lkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 155 LATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred cChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 999999998 457899999999876533221 1223567899999876 568999999999999999988 67888
Q ss_pred CCCCCHHHHHHHHHc-----CC-CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 227 SECTHPAQIYKKVIS-----GK-KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 227 ~~~~~~~~i~k~i~~-----g~-~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.... ..++...+.. +. .........++.+++||.+||. +|.+|||+.++++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 234 SLLS-DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccC-hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7643 3333333221 11 1122344567899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.67 Aligned_cols=254 Identities=30% Similarity=0.433 Sum_probs=202.7
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC----
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~---- 97 (740)
.+| .+.+.||+|+||.||+|.+..+|..||+|+++... ......+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 17 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred Cce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 566 78899999999999999999999999999886432 22334567889999999999999999999875422
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
...++++++++ +++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++.
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccccc
Confidence 23477888887 789988764 456999999999999999999999999 99999999999998 45799999999987
Q ss_pred hhccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC---------
Q 004645 178 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KK--------- 244 (740)
Q Consensus 178 ~l~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g--~~--------- 244 (740)
..... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+... ..
T Consensus 169 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcc
Confidence 65432 234468999999998764 47889999999999999999999997643322 22222111 00
Q ss_pred --------------C----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 245 --------------P----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 245 --------------p----~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+ .......++++++||.+||. +|.+||++.++|.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0 01112357889999999999 99999999999999999743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=307.17 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=198.7
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeE----EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIE----VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~----VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
+.| ++.+.||+|+||+||+|....+|.. +++|.+.. .........+..|+.++++++||||+++++++.
T Consensus 7 ~~~-~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--- 79 (279)
T cd05111 7 TEL-RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD---RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--- 79 (279)
T ss_pred hhc-eeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc---ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---
Confidence 345 7889999999999999998777764 55555431 222344567888999999999999999999763
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
....++++||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+|||++. ++.+||+|||++
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~-~~~~kl~Dfg~~ 156 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKS-DSIVQIADFGVA 156 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcC-CCcEEEcCCccc
Confidence 34578899999999999998764 57899999999999999999999999 999999999999984 579999999999
Q ss_pred hhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 177 AILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 177 ~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
....... .....++..|+|||.+. +.++.++||||||+++|||+| |..||.+ ..+..+.+.+..+..+. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERLA-QPQ 234 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCC
Confidence 7653321 12234677899999986 569999999999999999998 9999976 34555555565555443 334
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+..+.+++.+||. +|.+|||+.++++
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 567789999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.44 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=197.9
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.++| ++.+.||+|+||+||+|.+..++ .+|+|.+.... ...+.+.+|+.++++++|+||+++++++. ...
T Consensus 5 ~~~~-~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 74 (260)
T cd05069 5 RESL-RLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEP 74 (260)
T ss_pred hHHe-eeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCC
Confidence 4566 88999999999999999876554 58998765322 12356888999999999999999998763 345
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
.+++|||+.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++ +.+.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceE
Confidence 78999999999999998764 34889999999999999999999999 99999999999998 457999999999976
Q ss_pred hccCcc---ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 179 LRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 179 l~~~~~---~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
...... ....++..|+|||... +.++.++||||||+++|+|+| |..||.+. ....+...+..+..+ ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCP 229 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccC
Confidence 543321 1223567899999887 468899999999999999999 89999874 445555556554332 2345678
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+++++.+||. +|.+||++.++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999 9999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.18 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=189.3
Q ss_pred EecccCceEEEEEEEcC--CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 30 ILGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~--tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
.||+|+||+||+|.... ....+++|.+... ........+.+|+.+++.++||||+++++.+.. ...+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEe
Confidence 59999999999996432 4456777765432 234445678899999999999999999998854 5679999999
Q ss_pred cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 108 FTSGTLRQYRLKHR-----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 108 ~~gGSL~~~l~~~k-----~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+++|+|.+++...+ ..++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecC-CCcEEEeccccccccccc
Confidence 99999999987653 2467888999999999999999999 999999999999985 579999999998643221
Q ss_pred c----cccccCCCCCCCcccccc--------ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC---c
Q 004645 183 H----AARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP---E 246 (740)
Q Consensus 183 ~----~~~~~GTp~YmAPEvl~~--------~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p---~ 246 (740)
. .....+++.|+|||++.. .++.++|||||||++|+|++ |..||....+...+...+..+..+ .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1 122246778999998742 36789999999999999999 789998755555444444443321 2
Q ss_pred ccccCCChHHHHHHHHHhhCccCCCCHHHHhc
Q 004645 247 ALFKVEDPEVRQFIEKCLATVSSRLSARELLT 278 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~dPskRpSa~ELL~ 278 (740)
......++.+.+++..|+.+|.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 23445778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.16 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=208.0
Q ss_pred EEeEEecccCceEEEEEEEc---CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeE
Q 004645 26 RYNEILGKGASKTVYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~---~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i 101 (740)
++.+.||+|+||+||+|.+. .++..||+|+++.............+.+|+.++.++ +||||+++++.|.. ...+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~~ 80 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DTKL 80 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CCEE
Confidence 78899999999999999854 467899999987543322334456788999999999 69999999988744 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
++||||+.+++|..++.....+++..++.++.|++.||.|||+.+ ++||||||.||+++. ++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-EGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECC-CCCEEEEECcccccccc
Confidence 999999999999999888788999999999999999999999999 999999999999985 47999999999876543
Q ss_pred Cc---cccccCCCCCCCccccccc---cCcccchhhhhhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCcccccCC
Q 004645 182 SH---AARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 182 ~~---~~~~~GTp~YmAPEvl~~~---ys~ksDIWSLGvILyELlTG~~Pf~~~~---~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
.. .....|++.|+|||.+.+. ++.++||||||+++|+|+||..||.... ....+.+.+.....+ .....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC--CCccc
Confidence 32 1223589999999988642 6789999999999999999999996322 233444444443322 34457
Q ss_pred ChHHHHHHHHHhh-CccCCCC---HHHHhcCcccCCCCc
Q 004645 253 DPEVRQFIEKCLA-TVSSRLS---ARELLTDPFLQIDDY 287 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpS---a~ELL~HPff~~~~~ 287 (740)
++.+++||.+||+ +|++||| +.++|+||||+.-.+
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 8899999999999 9999998 578899999976554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=298.96 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=205.4
Q ss_pred EEeEEecccCceEEEEEEEcCCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg----~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.+.+.||.|+||.||+|.+..++ ..||+|.++... .......+..|+.+++.++|+||+++++++.+ ....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCee
Confidence 46788999999999999998776 899999886432 22356789999999999999999999998865 5789
Q ss_pred EEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 102 NFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~--lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
+++|||+++++|.+++..... +++..+..++.||+.||+|||+.+ ++|+||||+||+++ +++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 999999999999999876554 999999999999999999999999 99999999999998 4579999999998766
Q ss_pred ccCccc---cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 180 RKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 180 ~~~~~~---~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
...... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...++..+..+..+. .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 543111 123678999999886 458999999999999999998 7888876 56677777777766543 3445789
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+.+++.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999 9999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.51 Aligned_cols=248 Identities=20% Similarity=0.321 Sum_probs=204.0
Q ss_pred CceeEEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~-----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
.+| ++.+.||+|+||+||+|+.+. ....|++|.+... ......+.+.+|+++|++++|+||+++++++.+
T Consensus 5 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 79 (275)
T cd05046 5 SNL-QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE- 79 (275)
T ss_pred Hhc-eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-
Confidence 455 788999999999999998754 3456888866532 123356789999999999999999999998744
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCc
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHR---------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 167 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k---------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~ 167 (740)
....++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++. .+.
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~-~~~ 155 (275)
T cd05046 80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSS-QRE 155 (275)
T ss_pred -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeC-CCc
Confidence 567899999999999999987766 6899999999999999999999999 999999999999984 579
Q ss_pred EEEeccchhhhhccCc---cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcC
Q 004645 168 VKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 242 (740)
Q Consensus 168 VKL~DFGlA~~l~~~~---~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g 242 (740)
++|+|||++....... .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||... ....+...+..+
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~ 234 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAG 234 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcC
Confidence 9999999986443221 12234678899999876 458889999999999999999 88999763 445566666666
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 243 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 243 ~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
..+.......++.+.+++.+||. +|.+|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 65544455678999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=308.17 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=199.1
Q ss_pred EEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 26 RYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~-----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
++.+.||+|+||+||+|.+.. ....+++|.++... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 778999999999999998753 33568887765322 33456789999999999999999999998754 567
Q ss_pred EEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCC
Q 004645 101 INFVTEMFTSGTLRQYRLKH------------------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 156 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~------------------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp 156 (740)
.++++||+.+++|.+++... ..++...+..++.|++.||.|||+++ |+||||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp 155 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA 155 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence 89999999999999997653 24788999999999999999999999 99999999
Q ss_pred CceEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCC
Q 004645 157 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECT 230 (740)
Q Consensus 157 ~NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~ 230 (740)
+|||++ +.+.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+ .
T Consensus 156 ~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~ 233 (290)
T cd05045 156 RNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-I 233 (290)
T ss_pred heEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-C
Confidence 999998 45799999999987543221 12224567899999876 458999999999999999999 9999976 5
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 231 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 231 ~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+..+...+..+..+. .....+..+++|+.+||+ +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5677777666654433 345578899999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=302.21 Aligned_cols=238 Identities=21% Similarity=0.343 Sum_probs=195.9
Q ss_pred EecccCceEEEEEEEc--CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 30 ILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~--~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
.||+|+||.||+|... ..+..||+|+++... .....+.+.+|+.++++++||||+++++++. ...+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEe
Confidence 3899999999999765 456679999876332 3445567999999999999999999999763 3568999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc--
Q 004645 108 FTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-- 184 (740)
Q Consensus 108 ~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~-- 184 (740)
+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccce
Confidence 999999999875 457899999999999999999999999 99999999999998 457999999999875543211
Q ss_pred ---ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 185 ---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 185 ---~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
....+++.|+|||.+. +.++.++||||||+++|+|++ |..||... ....+...+..+..+ ..+...++++.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1112357899999887 468899999999999999996 99999874 455666667666544 3445678999999
Q ss_pred HHHHhh-CccCCCCHHHHhc
Q 004645 260 IEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~ 278 (740)
|.+||. +|.+||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=302.68 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=202.0
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGI---EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~---~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
++| ++.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 77 (267)
T cd05066 4 SCI-KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--S 77 (267)
T ss_pred HHe-EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 355 889999999999999998865443 68888776322 23456788999999999999999999998754 5
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
...++||||+++++|.+++.+. ..++...+..++.||+.||.|||+++ ++||||||+|||++. ++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~-~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNS-NLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECC-CCeEEeCCCCccc
Confidence 6889999999999999998765 46899999999999999999999999 999999999999984 4799999999987
Q ss_pred hhccCccc-----cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 178 ILRKSHAA-----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 178 ~l~~~~~~-----~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
........ ...++..|+|||.+. +.++.++|+||||+++|+|++ |..||.+. ...++...+..+..+. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 232 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APM 232 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCC
Confidence 65433211 112356899999987 468999999999999999886 99999864 3455666666654332 334
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..++.+++++.+||+ +|.+||++.++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 568899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.90 Aligned_cols=244 Identities=20% Similarity=0.259 Sum_probs=201.6
Q ss_pred eEEeEEecccCceEEEEEEEcC-----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 25 GRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~-----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
+++.+.||+|+||+||+|.+.. .+..||+|.++... .....+.+..|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~ 81 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQ 81 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CC
Confidence 3778899999999999998754 36789999887332 23445678899999999999999999998754 56
Q ss_pred eEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeC
Q 004645 100 NINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 163 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~----------------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~ 163 (740)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~- 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF- 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-
Confidence 789999999999999997532 34788899999999999999999999 99999999999998
Q ss_pred CCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHH
Q 004645 164 NQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYK 237 (740)
Q Consensus 164 ~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k 237 (740)
+++.+||+|||++....... .....+++.|+|||++. +.++.++||||||+++|||+| |..||.+ ....++..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIE 237 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 45789999999987653322 12234678999999886 568999999999999999998 8889876 45567777
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 238 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 238 ~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+..+..+. .....+..+.+|+.+||+ +|.+||++.+++.
T Consensus 238 ~i~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 238 MIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 777765432 345678899999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.83 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=201.3
Q ss_pred eEEeEEecccCceEEEEEEEcCC--CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeec--CCC
Q 004645 25 GRYNEILGKGASKTVYRAFDEYE--GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT--ANR 99 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~t--g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~--~~~ 99 (740)
|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 38899999999999999999888 9999999876322 1233456788899999999 599999999875432 234
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.++++++|+. ++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++. .+.+||+|||++..+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~-~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcC-CCCEEeCcCCCceec
Confidence 6788899885 689999888889999999999999999999999999 999999999999984 579999999998755
Q ss_pred ccC------ccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc--C-------
Q 004645 180 RKS------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--G------- 242 (740)
Q Consensus 180 ~~~------~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~--g------- 242 (740)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .+...+.. |
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 422 1223468999999998764 5889999999999999999999999763322 22211111 0
Q ss_pred ----------------CCC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 243 ----------------KKP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 243 ----------------~~p----~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
..+ .......++.+++|+.+||+ +|.+|||+.+++.||||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 000 11223457899999999999 999999999999999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=303.98 Aligned_cols=245 Identities=24% Similarity=0.294 Sum_probs=203.6
Q ss_pred eEEeEEecccCceEEEEEEEcC----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 25 GRYNEILGKGASKTVYRAFDEY----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
|++.++||+|+||.||+|.+.. ++..|++|.++. .........+.+|+.+|++++||||+++++++... +..
T Consensus 8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~ 83 (280)
T cd05043 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEP 83 (280)
T ss_pred eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC---CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCC
Confidence 4889999999999999999876 367889887652 23455677899999999999999999999987553 467
Q ss_pred EEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEec
Q 004645 101 INFVTEMFTSGTLRQYRLKH--------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~--------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~D 172 (740)
.+++++|+++++|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++. .+.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~-~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDE-ELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcC-CCcEEECC
Confidence 88999999999999998664 35889999999999999999999999 999999999999984 47999999
Q ss_pred cchhhhhccCcc----ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004645 173 LGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 246 (740)
Q Consensus 173 FGlA~~l~~~~~----~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~ 246 (740)
||+++.+..... ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||.. .++..+...+..+..+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCCC
Confidence 999976533211 12235678999998874 58999999999999999999 9999986 46667777766665433
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.....++++++++.+||. +|++|||+.+++.
T Consensus 240 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 -QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 234568899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.02 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=202.0
Q ss_pred CCceeEEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~-----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
..+| ++.+.||+|+||.||+|.+. .++..||+|+++... .......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNI-EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhc-eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 3455 88899999999999999874 367889999876332 34455678999999999999999999998754
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHR----------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 153 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k----------------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrD 153 (740)
...+++|+||+++++|.+++.... .+++..+..++.||+.||.|||+++ ++|||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~d 155 (288)
T cd05050 80 --GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRD 155 (288)
T ss_pred --CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccc
Confidence 567899999999999999987532 3678889999999999999999999 99999
Q ss_pred CCCCceEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCC
Q 004645 154 LKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYS 227 (740)
Q Consensus 154 LKp~NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~ 227 (740)
|||+|||++ .++.++|+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.
T Consensus 156 l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 156 LATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ccHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999998 45799999999986543221 11223567899999877 568999999999999999998 888997
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 228 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 228 ~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
+ .+..++...+..+..+. .....++++.+||.+||+ +|.+|||+.|+++
T Consensus 235 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 G-MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred C-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6 44566667676665542 234567899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=302.77 Aligned_cols=242 Identities=23% Similarity=0.345 Sum_probs=197.9
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
..+| ++.+.||+|+||+||+|.+. .+..||+|.++.... . .+.+.+|+.++++++|+||+++++++. ...
T Consensus 5 ~~~~-~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~ 74 (260)
T cd05070 5 RESL-QLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVS---EEP 74 (260)
T ss_pred hHHh-hhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEEC---CCC
Confidence 3456 88899999999999999766 566799998864332 1 346889999999999999999998763 345
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
++++|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~-~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGD-GLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeC-CceEEeCCceeeee
Confidence 78999999999999998764 45899999999999999999999999 999999999999984 57999999999976
Q ss_pred hccCccc---cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 179 LRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 179 l~~~~~~---~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
+...... ...++..|+|||++. ..++.++||||||+++|+|++ |..||... +...+...+..+..+ ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCP 229 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCC
Confidence 5433211 223556899999876 458899999999999999999 89999864 445555656554332 3345678
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHh
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL 277 (740)
..+++|+.+||. +|.+|||+.+++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHH
Confidence 899999999999 999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.77 Aligned_cols=253 Identities=30% Similarity=0.415 Sum_probs=201.8
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC----
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~---- 97 (740)
.+| .+.+.||+|+||+||+|.+..+|..||+|+++... ........+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 567 77899999999999999999999999999886432 22333456889999999999999999999875432
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
...+++|+||+. .+|..++ ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~-~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNE-DCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEeeCCCCc
Confidence 235799999995 4777654 346899999999999999999999999 999999999999984 5799999999987
Q ss_pred hhccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C----------
Q 004645 178 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-K---------- 244 (740)
Q Consensus 178 ~l~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-~---------- 244 (740)
..... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ...+..+.... .
T Consensus 166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADAE-MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCC-CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhc
Confidence 54332 233468899999998864 488999999999999999999999986433 33333222210 0
Q ss_pred -----------C-------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 245 -----------P-------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 245 -----------p-------~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
+ .......++.+.+||.+||+ +|.+||++.++|.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0 00123457789999999999 99999999999999999654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=301.75 Aligned_cols=243 Identities=22% Similarity=0.361 Sum_probs=199.6
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
...| ++.++||+|+||.||+|.+. ++..||+|.+.... .....+.+|+.++++++|+||+++++++. ...
T Consensus 5 ~~~~-~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 74 (260)
T cd05067 5 RETL-KLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEP 74 (260)
T ss_pred hHHc-eeeeeeccCccceEEeeecC-CCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCC
Confidence 3455 88999999999999999865 57789999876332 12356889999999999999999998753 356
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 101 INFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
++++|||+.+++|.+++... ..++...+..++.||+.||+|||+.+ ++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceee
Confidence 89999999999999987654 46899999999999999999999999 99999999999998 457999999999876
Q ss_pred hccCcc---ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 179 LRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 179 l~~~~~---~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
...... ....++..|+|||++. +.++.++||||||+++|+|++ |+.||.+. +...+...+..+..+ ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCP 229 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCC
Confidence 552221 1223567899999987 458899999999999999999 99999874 445556666555433 3345567
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+++++|.+||. +|.+||++++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=308.35 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=196.3
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcC----------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEY----------------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~----------------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H 83 (740)
|.++| ++.++||+|+||+||+|.+.. ++..||+|+++... .......+.+|+.+|+.++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 3 PRKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred Chhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence 56777 899999999999999985432 34568888876332 34456788999999999999
Q ss_pred CCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 004645 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 152 (740)
Q Consensus 84 pNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k-----------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHr 152 (740)
+||+++++++.. ...+++||||+.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||
T Consensus 79 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 999999998865 567899999999999999987643 3667889999999999999999999 9999
Q ss_pred cCCCCceEEeCCCCcEEEeccchhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh--cCCC
Q 004645 153 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYP 225 (740)
Q Consensus 153 DLKp~NILld~~~g~VKL~DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT--G~~P 225 (740)
||||+|||++ ..+.++|+|||++..+..... ....+++.|+|||+.. +.++.++|||||||++|+|+| |..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 9999999998 457999999999876543221 1223467899999765 568999999999999999998 7899
Q ss_pred CCCCCCHHHHHHHHHc----C--CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 226 YSECTHPAQIYKKVIS----G--KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 226 f~~~~~~~~i~k~i~~----g--~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
|.... ..++...... . ..........++.+++|+.+||. +|.+||++.++++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQLS-DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccC-hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 97643 3333332211 1 11111234467899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.91 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=189.5
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCC-eEEEEEEEe-------------ecccCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEG-IEVAWNQVK-------------LYDFLQSPEELERLYCEIHLLKTLKHRNIM 87 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg-~~VAiK~vk-------------l~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV 87 (740)
++| ++.+.||+|+||+||+|..+... ..++.|.+. .............+.+|+.+|++|+||||+
T Consensus 148 ~~Y-~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHF-RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hcc-EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 455 89999999999999998754322 222222110 001112233456788999999999999999
Q ss_pred eeeeEeeecCCCeEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe
Q 004645 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162 (740)
Q Consensus 88 kl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~-----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld 162 (740)
++++++.. ....|+|++++ +++|..++... .......++.|+.||+.||.|||++| ||||||||+|||++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 99998855 56789999998 46777775442 23446778899999999999999999 99999999999998
Q ss_pred CCCCcEEEeccchhhhhccCc---cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCC-CCCCC-C-HHHH
Q 004645 163 GNQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP-YSECT-H-PAQI 235 (740)
Q Consensus 163 ~~~g~VKL~DFGlA~~l~~~~---~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~P-f~~~~-~-~~~i 235 (740)
..+.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..| |.... + ..++
T Consensus 302 -~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 -CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred -CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 45799999999997665432 234579999999999874 599999999999999999999764 43221 2 2333
Q ss_pred HHHHHcCC-----CCc-------------------c-----cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 236 YKKVISGK-----KPE-------------------A-----LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 236 ~k~i~~g~-----~p~-------------------~-----~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.+.+.... .|. . .....++.+.++|.+||. ||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 33222110 110 0 011245677888999999 99999999999999999764
Q ss_pred C
Q 004645 286 D 286 (740)
Q Consensus 286 ~ 286 (740)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 4
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=353.35 Aligned_cols=248 Identities=33% Similarity=0.575 Sum_probs=209.0
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec-----------
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT----------- 96 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~----------- 96 (740)
.++||+||||.||+++++-+|..+|||+|.+.. +.....++.+|+.+|.+|+|||||+||..|++.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 368999999999999999999999999987653 455677899999999999999999999999740
Q ss_pred -------------------------------------------C------------------------------------
Q 004645 97 -------------------------------------------A------------------------------------ 97 (740)
Q Consensus 97 -------------------------------------------~------------------------------------ 97 (740)
.
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence 0
Q ss_pred -------------------C--------CeEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCCe
Q 004645 98 -------------------N--------RNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPV 149 (740)
Q Consensus 98 -------------------~--------~~i~lV~Ey~~gGSL~~~l~~~k~l-se~~i~~i~~QIL~aL~yLHs~gp~I 149 (740)
. -.+||=||||+..+|++++..+... ....++++++||+.||+|+|+.| |
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--i 718 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--I 718 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--e
Confidence 0 2467889999988888887776654 57888999999999999999999 9
Q ss_pred eeccCCCCceEEeCCCCcEEEeccchhhhhc--------------------cCccccccCCCCCCCcccccc----ccCc
Q 004645 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--------------------KSHAARCVGTPEFMAPEVYEE----EYNE 205 (740)
Q Consensus 150 IHrDLKp~NILld~~~g~VKL~DFGlA~~l~--------------------~~~~~~~~GTp~YmAPEvl~~----~ys~ 205 (740)
|||||||.|||++ .++.|||+|||+|+... ....+..+||.-|+|||++.+ .|+.
T Consensus 719 IHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999 45799999999997721 112345589999999999873 5999
Q ss_pred ccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcc--cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA--LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 206 ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~--~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
|+|+||||||++||+ +||.-...-..+...+..|..|.. ++...-+.-+.+|..+|+ +|++||||.|||++.||
T Consensus 798 KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 999999999999998 478876666777778888888765 333445677899999999 99999999999999999
Q ss_pred CC
Q 004645 283 QI 284 (740)
Q Consensus 283 ~~ 284 (740)
..
T Consensus 875 pp 876 (1351)
T KOG1035|consen 875 PP 876 (1351)
T ss_pred Cc
Confidence 74
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=299.86 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=200.5
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
+..+| ++.++||+|+||+||+|.+. .+..||+|.+.... ...+.+.+|+.++++++|+||+++++++.. ..
T Consensus 4 ~~~~~-~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 74 (261)
T cd05034 4 PRESL-KLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EE 74 (261)
T ss_pred chhhe-eeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CC
Confidence 34556 88999999999999999876 45779999876332 224568899999999999999999998743 56
Q ss_pred eEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
.+++||||+++++|.+++... ..++...+..|+.||+.||.|||+++ ++|+||||+||+++. ++.++|+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~-~~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGE-NLVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcC-CCCEEECccccce
Confidence 789999999999999998765 36899999999999999999999999 999999999999984 4799999999987
Q ss_pred hhccCcc---ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 178 ILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 178 ~l~~~~~---~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
....... ....++..|+|||.+.+ .++.++||||||+++|+|+| |+.||.+. +.......+..+..+ ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 229 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRM-PRPPNC 229 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCC
Confidence 6543211 12234578999998874 58899999999999999999 99999864 445566666655332 223345
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
++.+++++.+||. +|.+||++.+++.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7899999999999 9999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.66 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=202.4
Q ss_pred CceeEEeEEecccCceEEEEEEEc-------CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEe
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDE-------YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 93 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~-------~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 93 (740)
.+| .+.+.||+|+||.||+|.+. .++..||+|.++.. ........+.+|+.+++.+ +||||+++++++
T Consensus 15 ~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 15 DKL-TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred HHe-eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 344 88999999999999999742 24557898877532 2344567899999999999 899999999988
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCC
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 157 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~ 157 (740)
.. ...+++||||+.+|+|.+++.+.+ .++...+..++.||+.||.|||++| |+||||||+
T Consensus 91 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~ 166 (304)
T cd05101 91 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAAR 166 (304)
T ss_pred ec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccc
Confidence 54 568899999999999999987642 4678889999999999999999999 999999999
Q ss_pred ceEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCC
Q 004645 158 NIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTH 231 (740)
Q Consensus 158 NILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~ 231 (740)
|||++ ..+.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|+| |..||.. .+
T Consensus 167 Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~ 244 (304)
T cd05101 167 NVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IP 244 (304)
T ss_pred eEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CC
Confidence 99998 45799999999987654321 12224567899999886 458999999999999999998 7889976 45
Q ss_pred HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 232 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 232 ~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
...+.+.+..+..+. .....+..+++||.+||. +|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 677777776665432 345678899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.48 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=199.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGI---EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~---~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
...+.||+|+||.||+|.+..++. .+|+|.++.. ......+.+..|+.++++++||||+++++++.. ....+
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 82 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG---YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPAM 82 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCcE
Confidence 678999999999999999876665 6888876532 234456779999999999999999999998754 56789
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceeccc
Confidence 999999999999998764 57899999999999999999999999 99999999999998 457999999999876543
Q ss_pred Ccccc-----ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 182 SHAAR-----CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 182 ~~~~~-----~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
..... ...++.|+|||++. +.++.++||||||+++|+|+| |..||... +...+.+.+..+... ......++
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-PAPMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC-CCCCCCCH
Confidence 22111 12345799999887 468999999999999999998 99999763 445666666655332 22345688
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+.+++.+||. +|.+||++.++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=302.99 Aligned_cols=240 Identities=25% Similarity=0.376 Sum_probs=194.4
Q ss_pred EEecccCceEEEEEEEcCCCeE--EEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDEYEGIE--VAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~--VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++||+|+||.||+|.+..+|.. +++|.++.. ......+.+.+|+.++.++ +||||+++++++.. ...++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEE
Confidence 3699999999999999888764 577766521 2345566889999999999 89999999998854 56789999
Q ss_pred eccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEE
Q 004645 106 EMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 169 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VK 169 (740)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ ++||||||+|||++. ++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~-~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE-NYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcC-CCeEE
Confidence 9999999999987643 4789999999999999999999999 999999999999984 47999
Q ss_pred EeccchhhhhccCcc-ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004645 170 IGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 246 (740)
Q Consensus 170 L~DFGlA~~l~~~~~-~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~ 246 (740)
|+|||++........ .....++.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...++..+..+..+.
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~~ 231 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLE 231 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCCC
Confidence 999999853221111 1122456799999886 458899999999999999997 9999976 44556666666554332
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.....+.++.+++.+||. +|.+|||+.+++.
T Consensus 232 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 -KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 334567899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=342.76 Aligned_cols=149 Identities=24% Similarity=0.346 Sum_probs=133.9
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.++||+|+||+||+|.+..++..||+|+++.... ........+..|+.+++.++||||++++..+.. ...+
T Consensus 4 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 4 EEF-VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEE
Confidence 355 889999999999999999999999999999875442 344556789999999999999999999987754 6789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
|+||||+.|++|.+++...+.+++..++.|+.||+.||.|||+++ ||||||||+||||+ ..+.+||+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999999999988888999999999999999999999999 99999999999998 45799999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.30 Aligned_cols=244 Identities=20% Similarity=0.339 Sum_probs=200.4
Q ss_pred eEEeEEecccCceEEEEEEEcCCCe---EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGI---EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~---~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
+++.+.||+|+||.||+|.++.++. .||+|.++.. ........+..|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence 4899999999999999999887665 5999987643 235566789999999999999999999998744 6678
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++| ++|+||||+||+++. .+.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~-~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNS-NLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcC-CCcEEECCCccccccc
Confidence 9999999999999998764 56899999999999999999999999 999999999999984 4699999999987654
Q ss_pred cCccc----ccc---CCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004645 181 KSHAA----RCV---GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 181 ~~~~~----~~~---GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~ 251 (740)
..... ... .+..|+|||.+. +.++.++||||||+++|||++ |..||.. .....+...+..+.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~-~~~~~~ 235 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYR-LPPPMD 235 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCc-CCCccc
Confidence 32211 111 245799999987 468999999999999999886 9999976 344556666654432 222345
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.++.+.+++.+||. +|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67899999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=299.65 Aligned_cols=233 Identities=21% Similarity=0.345 Sum_probs=188.1
Q ss_pred EEecccCceEEEEEEEcCCC----------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 29 EILGKGASKTVYRAFDEYEG----------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg----------~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
+.||+|+||.||+|.+..++ ..|++|+++... .....+.+|+.+|++++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46999999999999998777 457777655322 125778999999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC-------cEEE
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-------EVKI 170 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g-------~VKL 170 (740)
...++||||+++|+|.+++.... .++...+..+++||+.||.|||+++ |+||||||+|||++.. + .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEe
Confidence 45689999999999999988766 7999999999999999999999999 9999999999999844 4 6999
Q ss_pred eccchhhhhccCccccccCCCCCCCcccccc---ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004645 171 GDLGLAAILRKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 246 (740)
Q Consensus 171 ~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~---~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~ 246 (740)
+|||++..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.... ............
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~--- 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH--- 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC---
Confidence 99999876544 223457788999999874 48899999999999999999 588887644 222222222111
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.........+.++|.+||. +|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1112223789999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.19 Aligned_cols=249 Identities=32% Similarity=0.429 Sum_probs=203.0
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||+|+||.||+|.+..++..||+|+++... ......+.+..|+.++++++|+||+++++++.+ ...+++|+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEe
Confidence 67788999999999999999999999999987543 123334567889999999999999999998755 57899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 106 EMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
||+. ++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||+|+||+++. .+.++|+|||++.......
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcC-CCCEEEecCCcccccCCCcc
Confidence 9997 5899998876 58999999999999999999999999 999999999999985 5799999999987654432
Q ss_pred -cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------------
Q 004645 184 -AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS------------------- 241 (740)
Q Consensus 184 -~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~------------------- 241 (740)
.....++..|+|||.+.+ .++.++|||||||++|+|++|..||........+.+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 223356789999998763 5888999999999999999999999774443332221110
Q ss_pred CCCCc-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 242 GKKPE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 242 g~~p~-------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
...+. ......++.+++||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 1122347789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.40 Aligned_cols=255 Identities=33% Similarity=0.462 Sum_probs=203.8
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
-+++| .+.+.||.|+||.||+|.+..+|..||+|++.... ......+.+..|+.++++++||||++++++|... ..
T Consensus 8 ~~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~ 83 (328)
T cd07856 8 ITNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE 83 (328)
T ss_pred cccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence 35566 88899999999999999999999999999876432 1223456788999999999999999999988643 45
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
..++|+||+ +++|..++. ...+++..+..++.||+.||.|||+++ |+||||||.|||++ ..+.++|+|||++...
T Consensus 84 ~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQ 158 (328)
T ss_pred cEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCcccccccc
Confidence 688999998 678988754 456889999999999999999999999 99999999999998 4579999999998755
Q ss_pred ccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHH---------------cC
Q 004645 180 RKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI---------------SG 242 (740)
Q Consensus 180 ~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~---------------~g 242 (740)
... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||..... ...+..+. .+
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 159 DPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred CCC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhccch
Confidence 432 234468899999998764 588999999999999999999999976332 11111110 00
Q ss_pred -------------CCC-cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 243 -------------KKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 243 -------------~~p-~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
..| .......++.++++|.+||+ +|.+|||+.++|.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 000 11223467899999999999 99999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.04 Aligned_cols=239 Identities=25% Similarity=0.377 Sum_probs=197.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
++||.|+||.||+|.+.. +..||+|.++.... ......+.+|+.++++++|+||+++++++.+ ....++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcC
Confidence 469999999999999887 99999998875432 2456789999999999999999999998755 56789999999
Q ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc---
Q 004645 109 TSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 184 (740)
Q Consensus 109 ~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~--- 184 (740)
.+++|.+++.. ...++...+..++.|++.||.|||+++ ++||||||+|||++ ..+.++|+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 99999999866 356899999999999999999999999 99999999999998 457999999999876542211
Q ss_pred -ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 185 -ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 185 -~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+.. ...+...+.++.+++.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHHHH
Confidence 1112356799999876 468999999999999999999 88999764 34455555554432 2234566889999999
Q ss_pred HHhh-CccCCCCHHHHhc
Q 004645 262 KCLA-TVSSRLSARELLT 278 (740)
Q Consensus 262 kcL~-dPskRpSa~ELL~ 278 (740)
+||. +|.+|||+.++|+
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.74 Aligned_cols=245 Identities=25% Similarity=0.415 Sum_probs=203.3
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~----~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
++| ++.+.||+|+||+||+|.+..+|. .+|+|..+... .......+.+|+.+|++++||||+++++++..
T Consensus 7 ~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (279)
T cd05057 7 TEL-EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-- 80 (279)
T ss_pred HHc-EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 455 888999999999999999877665 57888765332 34556788999999999999999999998764
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
...++|+||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+||+++ ..+.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCccc
Confidence 6789999999999999998774 46999999999999999999999998 99999999999998 4579999999999
Q ss_pred hhhccCccc----cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 177 AILRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 177 ~~l~~~~~~----~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
......... ...++..|+|||.+. ..++.++||||||+++|+|+| |..||.. ....++...+..+... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 234 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERL-PQPP 234 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCC
Confidence 766532211 112356899999886 568999999999999999999 9999987 4566777777766443 2334
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+..+.+++.+||. +|..||++.++++
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 577899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.67 Aligned_cols=241 Identities=21% Similarity=0.332 Sum_probs=194.1
Q ss_pred EEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~---tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
+.||+|+||+||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++... +...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEE
Confidence 468999999999998654 3457888876422 2345567889999999999999999999976543 45678999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 106 EMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
||+.+++|.+++.+. ...+...+..++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcC-CCcEEECCccccccccCCcc
Confidence 999999999998764 45678888999999999999999999 999999999999984 5799999999987543221
Q ss_pred -----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004645 184 -----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256 (740)
Q Consensus 184 -----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG-~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spel 256 (740)
.....+++.|+|||.+. ..++.++||||||+++|+|++| .+||.. .+...+.+.+..+..+. .....++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 11234677899999886 5689999999999999999995 556654 55666666676665443 234567899
Q ss_pred HHHHHHHhh-CccCCCCHHHHhc
Q 004645 257 RQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 257 rdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+++.+||. +|.+||++.++++
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.86 Aligned_cols=242 Identities=24% Similarity=0.415 Sum_probs=198.4
Q ss_pred EEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~t---g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 7889999999999999987544 3468888765322 24556789999999999999999999998743 4578
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+||||+++++|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+|||++. .+.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSS-PDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEec-CCCeEEccCceeeeccc
Confidence 9999999999999987754 5899999999999999999999999 999999999999985 47999999999876543
Q ss_pred Ccc---ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004645 182 SHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256 (740)
Q Consensus 182 ~~~---~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spel 256 (740)
... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..... .+....+..+..+ ..+...++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCCCHHH
Confidence 321 1223456899999886 458899999999999999986 9999987544 4444556655543 2345678999
Q ss_pred HHHHHHHhh-CccCCCCHHHHhc
Q 004645 257 RQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 257 rdLI~kcL~-dPskRpSa~ELL~ 278 (740)
+++|.+|+. +|.+|||+.+++.
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999 9999999999885
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.55 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=199.5
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
+.++| ++.+.||+|+||.||+|.+. .+..+|+|.++.. ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~-~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~ 73 (260)
T cd05073 4 PRESL-KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---E 73 (260)
T ss_pred cccce-eEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---C
Confidence 44566 99999999999999999765 4556998877632 2345678999999999999999999998744 5
Q ss_pred eEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
..+++|||+++++|.+++.+. ..++...+..++.||+.||.|||+.+ ++|+||||+||+++ ..+.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCccee
Confidence 689999999999999998764 46788999999999999999999999 99999999999998 45799999999987
Q ss_pred hhccCcc---ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004645 178 ILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 178 ~l~~~~~---~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~ 252 (740)
....... ....++..|+|||++. +.++.++|+||||+++|+|+| |..||... +...+...+..+... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM-PRPENC 228 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC-CCcccC
Confidence 6543221 1223567899999987 458889999999999999999 89999864 445555555555432 234567
Q ss_pred ChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 253 spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
+.++.+++.+||. +|.+||++.+++.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8899999999999 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.70 Aligned_cols=237 Identities=19% Similarity=0.304 Sum_probs=188.3
Q ss_pred EEecccCceEEEEEEEcCCCeE-------EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 29 EILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~-------VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
+.||+|+||+||+|.+..++.. ||+|.+... .....+.+..|+.+|+.++||||+++++++.. ....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCc
Confidence 4699999999999988665443 777766422 23445678899999999999999999998865 5678
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC-------cEEEecc
Q 004645 102 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-------EVKIGDL 173 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g-------~VKL~DF 173 (740)
++||||+.+|+|..++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.+.. .++++||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 89999999999999987654 5899999999999999999999999 999999999999975432 2799999
Q ss_pred chhhhhccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004645 174 GLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 174 GlA~~l~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG-~~Pf~~~~~~~~i~k~i~~g~~p~~~~~ 250 (740)
|++...... ....+++.|+|||++.+ .++.++||||||+++|+|++| ..||..... ..... +.... ..++.
T Consensus 153 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~--~~~~~ 226 (258)
T cd05078 153 GISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQ-FYEDR--HQLPA 226 (258)
T ss_pred ccccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHH-HHHcc--ccCCC
Confidence 988654332 23468899999999874 478999999999999999999 566665333 22222 22111 12333
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 251 ~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
..++++.++|.+||+ +|.+|||+.++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 456889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.99 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=196.6
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEecc
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
++||+|+||.||+|... ++..+|+|.++.. ........+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED---LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECC
Confidence 46999999999999865 6888999987532 123445578899999999999999999998754 56789999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc---
Q 004645 109 TSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 184 (740)
Q Consensus 109 ~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~--- 184 (740)
++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999999987654 46899999999999999999999999 99999999999998 557999999999865433221
Q ss_pred ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004645 185 ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~k 262 (740)
....+++.|+|||++. +.++.++||||||+++|+|++ |..||... +.......+..+... ......++.+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1123467899999987 458899999999999999998 99999864 445555556555433 2344578999999999
Q ss_pred Hhh-CccCCCCHHHHhcC
Q 004645 263 CLA-TVSSRLSARELLTD 279 (740)
Q Consensus 263 cL~-dPskRpSa~ELL~H 279 (740)
||. +|.+||++.++++.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 230 CWDYKPENRPKFSELQKE 247 (250)
T ss_pred HcccCcccCCCHHHHHHH
Confidence 999 99999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=324.13 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=201.1
Q ss_pred EEeEEecccCceEEEEEEE-----cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCC
Q 004645 26 RYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANR 99 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d-----~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~ 99 (740)
.+.+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+|.++. ||||+++++.|.. ..
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~~ 114 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--GG 114 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--CC
Confidence 5678999999999999985 3456789999987432 2344567899999999997 9999999998855 56
Q ss_pred eEEEEEeccCCCCHHHHHHhcC----------------------------------------------------------
Q 004645 100 NINFVTEMFTSGTLRQYRLKHR---------------------------------------------------------- 121 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k---------------------------------------------------------- 121 (740)
.+++||||+.+|+|.+++.+.+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 8999999999999999986532
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEE
Q 004645 122 ----------------------------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 161 (740)
Q Consensus 122 ----------------------------------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILl 161 (740)
.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 3566778889999999999999998 9999999999999
Q ss_pred eCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHH
Q 004645 162 NGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQI 235 (740)
Q Consensus 162 d~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i 235 (740)
+. .+.+||+|||++....... .....+++.|||||++. ..++.++||||||+++|||++ |..||......+.+
T Consensus 273 ~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 84 5799999999987543221 12235788999999887 458899999999999999998 89999876666666
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 236 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 236 ~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
...+..+..+. .+...++++.+|+.+||. +|.+||++.+|++.
T Consensus 352 ~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66666664432 345578999999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.97 Aligned_cols=240 Identities=20% Similarity=0.298 Sum_probs=186.5
Q ss_pred EecccCceEEEEEEEcCCC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 30 ILGKGASKTVYRAFDEYEG--IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg--~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
.||+|+||+||+|.....+ ..+++|.++. .......+.+.+|+.+++.++||||+++++.+.. ...+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKA---NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecC---CCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEec
Confidence 5999999999999754322 2344554442 2234456789999999999999999999998865 5678999999
Q ss_pred cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-
Q 004645 108 FTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 182 (740)
Q Consensus 108 ~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~- 182 (740)
+++|+|.+++.+. ...+...++.++.||+.||.|||+++ |+||||||+|||++. .+.++|+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcC-CccEEecccccccccCcch
Confidence 9999999998764 34677788999999999999999999 999999999999984 479999999987542211
Q ss_pred ---ccccccCCCCCCCcccccc--------ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC----Cc
Q 004645 183 ---HAARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKK----PE 246 (740)
Q Consensus 183 ---~~~~~~GTp~YmAPEvl~~--------~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~----p~ 246 (740)
......|++.|+|||++.. .++.++||||||+++|+|++ |..||..... ..++..+..+.. ..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCCC
Confidence 1223468899999998742 35778999999999999997 5778876444 444444433322 12
Q ss_pred ccccCCChHHHHHHHHHhhCccCCCCHHHHhc
Q 004645 247 ALFKVEDPEVRQFIEKCLATVSSRLSARELLT 278 (740)
Q Consensus 247 ~~~~~~spelrdLI~kcL~dPskRpSa~ELL~ 278 (740)
.+....++.+++++..|+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 23345688899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.14 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=201.2
Q ss_pred eeEEeEEecccCceEEEEEEEcC-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeee
Q 004645 24 YGRYNEILGKGASKTVYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 95 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~-------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd 95 (740)
.|++.+.||+|+||.||+|.+.. .+..||+|.++.. ......+.+.+|+.+++++ +||||+++++.+..
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34899999999999999997643 2346898877632 2345567899999999999 89999999998854
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCce
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 159 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NI 159 (740)
...+++++||+++|+|.+++.+.+ .++...+..++.||+.||.|||++| |+||||||+||
T Consensus 90 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni 165 (334)
T cd05100 90 --DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNV 165 (334)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceE
Confidence 567999999999999999987532 4778889999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHH
Q 004645 160 FVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPA 233 (740)
Q Consensus 160 Lld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~ 233 (740)
|++. .+.+||+|||++....... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.. .+..
T Consensus 166 ll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~ 243 (334)
T cd05100 166 LVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVE 243 (334)
T ss_pred EEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHH
Confidence 9984 4799999999987654321 111234568999999874 58999999999999999998 8899976 4566
Q ss_pred HHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 234 QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 234 ~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.++..+..+..+. .....+.++.++|.+||. +|.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7777776655433 334567899999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=309.70 Aligned_cols=258 Identities=28% Similarity=0.398 Sum_probs=204.1
Q ss_pred eEEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~----~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
|.+...||+|.||.||+|..+.++. .+|||.++-.+.. .......-+|+.+++.|+||||+.+..+|+.. ++.
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 4777889999999999997666544 6899988754321 12234567899999999999999999988765 789
Q ss_pred EEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC---CCcEEEec
Q 004645 101 INFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN---QGEVKIGD 172 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~-----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~---~g~VKL~D 172 (740)
+++++||.+. +|.+.+.-+ +.++...++.++.||+.|+.|||++. |+||||||.||||.++ .|.|||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999965 788776544 46999999999999999999999999 9999999999999854 47999999
Q ss_pred cchhhhhccCcc-----ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCC------CCH---HHHH
Q 004645 173 LGLAAILRKSHA-----ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSEC------THP---AQIY 236 (740)
Q Consensus 173 FGlA~~l~~~~~-----~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~------~~~---~~i~ 236 (740)
||+++.+..+.. ...+-|.+|+|||++.| .|+++.||||+|||+.||+|.++.|.+. .+| .|+-
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999999876532 23467999999999986 4999999999999999999999888532 111 1221
Q ss_pred HHHH-cCC-----------CCcc----------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 004645 237 KKVI-SGK-----------KPEA----------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 237 k~i~-~g~-----------~p~~----------------------~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPf 281 (740)
+.+. -|. .|+- ..+..++...+|+.++|. ||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 1111 011 1110 123456778999999999 9999999999999999
Q ss_pred cCCCCcc
Q 004645 282 LQIDDYD 288 (740)
Q Consensus 282 f~~~~~~ 288 (740)
|..+...
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9987644
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.28 Aligned_cols=239 Identities=22% Similarity=0.387 Sum_probs=198.3
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
+.| ++.+.||+|+||.||++. .++..||+|.++.. ...+.+.+|+.++++++||||+++++.+.. ...
T Consensus 6 ~~~-~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~ 73 (254)
T cd05083 6 QKL-TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGL 73 (254)
T ss_pred HHc-eeeeeeccCCCCceEecc--cCCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCc
Confidence 345 889999999999999984 57889999987632 224578899999999999999999998754 347
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 102 NFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
++||||+.+++|.+++.... .+++..+..++.||+.||.|||++| ++||||||+||+++. ++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSE-DGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcC-CCcEEECCCccceec
Confidence 89999999999999987653 5899999999999999999999999 999999999999984 479999999998654
Q ss_pred ccCccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004645 180 RKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 180 ~~~~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
... ......+..|+|||.+. +.++.++|+||||+++|+|++ |..||.. .+...+...+..+..+. .....++.++
T Consensus 151 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (254)
T cd05083 151 SMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVY 227 (254)
T ss_pred ccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHH
Confidence 332 12233467899999886 568899999999999999998 9999986 44556666666665443 3456788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004645 258 QFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 258 dLI~kcL~-dPskRpSa~ELL~ 278 (740)
+++.+||+ +|.+||++.+++.
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 99999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=298.71 Aligned_cols=227 Identities=19% Similarity=0.239 Sum_probs=188.0
Q ss_pred cCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCH
Q 004645 34 GASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL 113 (740)
Q Consensus 34 GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL 113 (740)
|.+|.||+|.+..+|+.||+|+++... ....|...+....||||+++++++.. ...+++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCH
Confidence 899999999999999999999987432 12345555666789999999998854 6789999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccccccCCCCC
Q 004645 114 RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 193 (740)
Q Consensus 114 ~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~Y 193 (740)
.+++.+...+++..+..++.||+.||.|||+++ |+||||||+||+++. .+.++|+|||++....... ....++..|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDSC-DGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcC-CCCEEEecccchhcccccc-ccCCcCccc
Confidence 999888888999999999999999999999999 999999999999985 4789999999886654432 234567889
Q ss_pred CCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCC
Q 004645 194 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL 271 (740)
Q Consensus 194 mAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRp 271 (740)
+|||.+. +.++.++||||+|+++|+|++|..|+...... + .......++...++.+++||.+||+ +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999887 45889999999999999999999888642211 1 1111112345578899999999999 999999
Q ss_pred CH-----HHHhcCccc
Q 004645 272 SA-----RELLTDPFL 282 (740)
Q Consensus 272 Sa-----~ELL~HPff 282 (740)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 96 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.45 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=187.4
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHH-------HHHHHHHHHHHHhCCCCCcce
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEE-------LERLYCEIHLLKTLKHRNIMK 88 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~t---g~~VAiK~vkl~~~~~~~~~-------~~~l~~Ei~iLk~L~HpNIVk 88 (740)
+..+..|++.++||+|+||+||+|.+..+ +..+|+|+..........+. ......++..+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34444449999999999999999998777 66777775443321110010 011223444566779999999
Q ss_pred eeeEeeecCC--CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 89 FYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 89 l~~~fvd~~~--~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
+++.+..... ...+++++++ ..++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~-~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG-NN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC-CC
Confidence 9987644322 2346788877 4467777666666789999999999999999999999 999999999999984 47
Q ss_pred cEEEeccchhhhhccC---------ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHH-
Q 004645 167 EVKIGDLGLAAILRKS---------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI- 235 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~---------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i- 235 (740)
.++|+|||++..+... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999765321 1123369999999999875 5899999999999999999999999875333222
Q ss_pred -------HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 236 -------YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 236 -------~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+.+..+.. .....++.+.+++..|+. +|.+||+..++++
T Consensus 244 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 233333322 234457899999999999 9999999999875
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.32 Aligned_cols=241 Identities=22% Similarity=0.378 Sum_probs=198.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++.+.||.|+||.||+|.+. .+..+|+|.++.... ....+..|+.++++++||||+++++++.. ...+++|+
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLVF 78 (256)
T ss_pred EEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEEE
Confidence 78899999999999999875 477899998763321 13458889999999999999999998744 56789999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 106 EMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++ ..+.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCcc
Confidence 999999999998764 46899999999999999999999999 99999999999998 457999999999875543222
Q ss_pred c---cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004645 185 A---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 185 ~---~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdL 259 (740)
. ...++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+. .....+..+.+|
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 233 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY-KPRLASQSVYEL 233 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCHHHHHH
Confidence 1 123457899999887 568899999999999999998 9999976 44566666666554332 234568899999
Q ss_pred HHHHhh-CccCCCCHHHHhcC
Q 004645 260 IEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 260 I~kcL~-dPskRpSa~ELL~H 279 (740)
+.+||. +|.+|||+.++++.
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHcccChhhCCCHHHHHHh
Confidence 999999 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=326.31 Aligned_cols=245 Identities=22% Similarity=0.364 Sum_probs=206.5
Q ss_pred EeEEecccCceEEEEEEEcCCCe---E-EEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 27 YNEILGKGASKTVYRAFDEYEGI---E-VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~tg~---~-VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+.++||+|+||.||+|..+..+. . ||+|..+... ....+.+..+.+|+++|++|+|||||++||+.++ ...++
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl~ 237 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EEPLM 237 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCccE
Confidence 45899999999999998766432 3 8999887532 2356788899999999999999999999998765 67899
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 103 FVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+|||+|.||+|.+|+++.+ .++......++.+.+.||+|||+++ +|||||=..|+|++.+ +.+||+||||+..-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCccccccCCcc
Confidence 9999999999999999987 4999999999999999999999999 9999999999999844 5789999999876542
Q ss_pred Ccccc-c-cCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004645 182 SHAAR-C-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 182 ~~~~~-~-~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelr 257 (740)
..... . --...|+|||.+. +.|+.++|||||||++||+++ |..||.+ ....++..+|.....+...+...++.+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 21111 1 1346899999998 569999999999999999998 8889998 5567788888665555556667788999
Q ss_pred HHHHHHhh-CccCCCCHHHHhc
Q 004645 258 QFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 258 dLI~kcL~-dPskRpSa~ELL~ 278 (740)
.++.+|+. +|..|||+.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999999 9999999998864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.25 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=200.6
Q ss_pred CceeEEeEEecccCceEEEEEEEc----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDE----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
.+++++.+.||+|+||+||+|... .++..||+|+++.... ....+.+.+|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 455688899999999999999854 3588999998874432 135678999999999999999999999886655
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
....+++|||+++++|.+++.... .++...+..++.||+.||+|||+++ ++|+||||+|||++.+ +.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccccc
Confidence 678999999999999999987764 6999999999999999999999999 9999999999999854 79999999999
Q ss_pred hhhccCccc-----cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCH--------------HHHH
Q 004645 177 AILRKSHAA-----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP--------------AQIY 236 (740)
Q Consensus 177 ~~l~~~~~~-----~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~--------------~~i~ 236 (740)
......... ...++..|+|||.+. ..++.++||||||+++|+|+||..|+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 876532211 123456799999876 46888999999999999999999998643211 1122
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 237 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 237 k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+..+... ......+.++.+++.+||. +|.+|||+.+++.
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222222221 2234456889999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=296.53 Aligned_cols=248 Identities=23% Similarity=0.401 Sum_probs=204.2
Q ss_pred eEEeEEecccCceEEEEEEEcC-CCeEEEEEEEeeccc------CCCHHHHHHHHHHHHHHHh-CCCCCcceeeeEeeec
Q 004645 25 GRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDF------LQSPEELERLYCEIHLLKT-LKHRNIMKFYTSWVDT 96 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~-tg~~VAiK~vkl~~~------~~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~fvd~ 96 (740)
|.+.+.||+|+||.||+|.+.. ++..+|+|.+..... ........++..|+.++.+ ++||||+++++++..
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~- 80 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE- 80 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-
Confidence 3678899999999999999987 788999998875431 1234456678889998875 699999999998855
Q ss_pred CCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCCcEEEe
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIG 171 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~----~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g~VKL~ 171 (740)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||||+|||++ .++.++|+
T Consensus 81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~ 156 (269)
T cd08528 81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTIT 156 (269)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEe
Confidence 6789999999999999988643 3468999999999999999999996 66 99999999999998 45799999
Q ss_pred ccchhhhhccC-ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccc
Q 004645 172 DLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249 (740)
Q Consensus 172 DFGlA~~l~~~-~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~ 249 (740)
|||++...... ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||.. .+...+...+..+..+....
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCc
Confidence 99998765544 2234468999999999874 588999999999999999999999976 44555555666555443334
Q ss_pred cCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 250 ~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
...++.+++||.+||. +|.+||++.|+..
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 4578999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.94 Aligned_cols=244 Identities=24% Similarity=0.383 Sum_probs=188.2
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
..+||+|+||+||+|.... |..||+|.+..... . . ...|.+|+.+|.+++|||+|+++|+|.+... ..++|+||
T Consensus 80 ~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~--~-~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEy 153 (361)
T KOG1187|consen 80 SNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSG--Q-G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEY 153 (361)
T ss_pred hcceecCCCeEEEEEEECC-CCEEEEEEecCCCC--c-c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEc
Confidence 4689999999999998664 48999996653321 1 1 3449999999999999999999999987432 68999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc-Cc
Q 004645 108 FTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SH 183 (740)
Q Consensus 108 ~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~-~~ 183 (740)
+++|+|.+++.... .+++....+|+.++++||+|||.. .|+|||||||+.|||+|.+ ...||+|||+|..... ..
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCcccc
Confidence 99999999887765 899999999999999999999994 4589999999999999955 6999999999966543 22
Q ss_pred c-ccc-cCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCC--CHHHH----HHHHHcCCCCccc----c-
Q 004645 184 A-ARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQI----YKKVISGKKPEAL----F- 249 (740)
Q Consensus 184 ~-~~~-~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~--~~~~i----~k~i~~g~~p~~~----~- 249 (740)
. ... .||.+|+|||.+. +..+.++|||||||+|+||+||+.|..... ....+ ...+..+.....+ .
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE 312 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence 2 222 7999999999886 689999999999999999999998876422 11111 1233333222111 1
Q ss_pred cCCC--hH---HHHHHHHHhh-CccCCCCHHHHhc
Q 004645 250 KVED--PE---VRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 250 ~~~s--pe---lrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
...+ .+ +..+..+|++ +|.+||++.++++
T Consensus 313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1222 23 4456667888 8999999998643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.56 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=215.1
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC---HHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS---PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~---~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
.|| -+..+||+|||+.||+|+|....+.||+|+-.+.+.... ....+...+|.++-+.|+||-||++|++|-. +.
T Consensus 463 ~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-Dt 540 (775)
T KOG1151|consen 463 DRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DT 540 (775)
T ss_pred HHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-cc
Confidence 566 567899999999999999999999999998766542222 2334567799999999999999999999854 35
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeC--CCCcEEEeccchh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLA 176 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~--~~g~VKL~DFGlA 176 (740)
..+|-|+|||+|.+|.-|++.++.++++.++.|+.||+.||.||....|||||-||||.|||+-. ..|.+||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 78999999999999999999999999999999999999999999999999999999999999842 2367999999999
Q ss_pred hhhccCc---------cccccCCCCCCCccccc-c----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHH--HH
Q 004645 177 AILRKSH---------AARCVGTPEFMAPEVYE-E----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK--VI 240 (740)
Q Consensus 177 ~~l~~~~---------~~~~~GTp~YmAPEvl~-~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~--i~ 240 (740)
.++.... +....||.+|++||.+. + +.+.++||||+|||+|..+.|+.||........|... |+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9987542 22346999999999875 3 3678999999999999999999999875444444322 22
Q ss_pred cCC-CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 241 SGK-KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 241 ~g~-~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
... ......+..+++++.||++||+ ....|....+|-.||+|.
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 111 1122345689999999999999 788999999999999995
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=326.04 Aligned_cols=255 Identities=21% Similarity=0.364 Sum_probs=228.8
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 27 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
....||-|+||.|-++.-......+|+|++++.... .....+.++.|-++|..++.|.||++|..|-+ .+.+|++||
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmLmE 500 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYVYMLME 500 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhhhhhHH
Confidence 346799999999999976655556899988866543 33556789999999999999999999999955 789999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-ccc
Q 004645 107 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAA 185 (740)
Q Consensus 107 y~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-~~~ 185 (740)
-|-||.|+..+...+.++....+.++..+++|++|||++| ||+|||||+|.+++ +.|-+||.|||+|+.+... .+.
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCcee
Confidence 9999999999999999999999999999999999999999 99999999999998 6689999999999988765 567
Q ss_pred cccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHh
Q 004645 186 RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL 264 (740)
+++|||+|.|||++. ...+.++|.||||+++|||+||.+||++ .++...|..|..|.....+++.++..+.+||+++.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 899999999999865 5689999999999999999999999997 78899999999999888888999999999999988
Q ss_pred h-CccCCCC-----HHHHhcCcccCCCCcc
Q 004645 265 A-TVSSRLS-----ARELLTDPFLQIDDYD 288 (740)
Q Consensus 265 ~-dPskRpS-----a~ELL~HPff~~~~~~ 288 (740)
. .|.+|+- +.++-+|.||..-++.
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 8 8999986 7899999999887775
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.53 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=215.2
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
..+++.-++||+|+||.||-+.-+.||+-+|.|.+.+... ..........+|-.+|.++..+.||.+-..| ++...+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi-Kkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~L 260 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI-KKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDAL 260 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH-HHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCce
Confidence 3455777899999999999999999999999987654331 1222334567899999999999999987666 668899
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 102 NFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
++|+.+|.||+|.-.+...+ .+++..+..++.+|+.||++||..+ ||+|||||+|||+| +.|+|+|+|+|||..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEec
Confidence 99999999999987666655 8999999999999999999999999 99999999999999 6699999999999888
Q ss_pred ccCcccc-ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCcccccCCCh
Q 004645 180 RKSHAAR-CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 180 ~~~~~~~-~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
....... .+||.+|||||++. +.|+...|.|||||++|||+.|+.||..... -+++-+.+.+ .+..++...++
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~ 415 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSE 415 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCH
Confidence 7665443 48999999999997 5699999999999999999999999964321 2233333332 34455677899
Q ss_pred HHHHHHHHHhh-CccCCC-----CHHHHhcCcccCCCCcc
Q 004645 255 EVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 288 (740)
Q Consensus 255 elrdLI~kcL~-dPskRp-----Sa~ELL~HPff~~~~~~ 288 (740)
+++++.+.+|. +|++|+ .+.++.+||||+..++.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 99999999999 999986 56799999999987664
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.52 Aligned_cols=239 Identities=26% Similarity=0.406 Sum_probs=194.5
Q ss_pred EecccCceEEEEEEEcCCC------eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEE
Q 004645 30 ILGKGASKTVYRAFDEYEG------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg------~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~l 103 (740)
.||+|+||.||+|.+.... ..+|+|.+.... .......+.+|+.+|+.++||||+++++++.+ ....++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEE
Confidence 6999999999999876544 789998775322 23445678899999999999999999998855 567899
Q ss_pred EEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC-----cEEEe
Q 004645 104 VTEMFTSGTLRQYRLKH-------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-----EVKIG 171 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~-------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g-----~VKL~ 171 (740)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ + .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEEC
Confidence 99999999999998653 34788999999999999999999999 9999999999999854 4 79999
Q ss_pred ccchhhhhccCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004645 172 DLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 245 (740)
Q Consensus 172 DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p 245 (740)
|||++........ ....++..|+|||++. +.++.++||||||+++|+|+| |..||... +..++...+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc
Confidence 9999876543211 1224578899999887 468999999999999999998 99999864 445555555554433
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 246 ~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
. .....++.+.+||.+||. +|.+||++.++++
T Consensus 233 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 Q-KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred C-CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 334568899999999999 9999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.42 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=199.8
Q ss_pred eEEeEEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC--
Q 004645 25 GRYNEILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR-- 99 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~---tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~-- 99 (740)
|++.++||+|+||+||+|.+.. ++..||+|+++... ......+.+.+|+.+|++++||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 3678899999999999998643 67899999886432 2345567889999999999999999999987653322
Q ss_pred --eEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEe
Q 004645 100 --NINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 171 (740)
Q Consensus 100 --~i~lV~Ey~~gGSL~~~l~~~------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~ 171 (740)
..+++++|+.+|+|..++... ..++...+..++.||+.||+|||+++ |+||||||+||+++. .+.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~-~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNE-NMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcC-CCCEEEC
Confidence 347889999999999886532 24788999999999999999999999 999999999999984 5789999
Q ss_pred ccchhhhhccCc----cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004645 172 DLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 245 (740)
Q Consensus 172 DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p 245 (740)
|||++....... .....+++.|++||.+.+ .++.++||||||+++|+|++ |..||.. .+...++..+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999987654321 122345678999998874 58889999999999999999 8899976 4556677766665433
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 246 ~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
. .....++.+.+++.+||+ +|.+|||+.+++.
T Consensus 235 ~-~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 235 K-QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 234567899999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.63 Aligned_cols=236 Identities=21% Similarity=0.369 Sum_probs=185.8
Q ss_pred EEecccCceEEEEEEEcC------------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 29 EILGKGASKTVYRAFDEY------------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~------------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
+.||+|+||+||+|+... ....|++|++... .......+..|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 468999999999997432 2345777765422 23445678899999999999999999998865
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC-------cE
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-------EV 168 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g-------~V 168 (740)
+...++||||+++++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ + .+
T Consensus 76 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~~~~~~~~ 151 (262)
T cd05077 76 -DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLARE-GIDGECGPFI 151 (262)
T ss_pred -CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecC-CccCCCCcee
Confidence 56778999999999999987654 56899999999999999999999999 9999999999999743 3 28
Q ss_pred EEeccchhhhhccCccccccCCCCCCCccccc--cccCcccchhhhhhHHHHHH-hcCCCCCCCCCHHHHHHHHHcCCCC
Q 004645 169 KIGDLGLAAILRKSHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMV-TFDYPYSECTHPAQIYKKVISGKKP 245 (740)
Q Consensus 169 KL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELl-TG~~Pf~~~~~~~~i~k~i~~g~~p 245 (740)
+++|||++...... ....++..|+|||++. ..++.++|||||||++|+|+ +|..||.... ..+.. ....+..+
T Consensus 152 ~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~-~~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEKE-RFYEGQCM 227 (262)
T ss_pred EeCCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHHH-HHHhcCcc
Confidence 99999988654322 2346889999999886 45889999999999999997 5888887633 22222 22222222
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 246 ~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.....++++++||.+||. +|.+||++.+||++
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122345789999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=283.76 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=205.3
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
-++||+|.||+||+|++..++..||+|.+++.+.. +.......+||-+|+.|+|.|||++++.. ..++.+-+|+||
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrldddd--egvpssalreicllkelkhknivrl~dvl--hsdkkltlvfe~ 82 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLVFEF 82 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCC--CCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeEEeHHH
Confidence 37899999999999999999999999999987632 23345678999999999999999999954 557889999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc--
Q 004645 108 FTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-- 184 (740)
Q Consensus 108 ~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~-- 184 (740)
| ..+|..|... ++.++.+.++.++.|+++||.|+|+++ +.||||||.|+||+.+ |.+||+|||+++.+.-+..
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCCceEee
Confidence 9 5688888665 578999999999999999999999999 9999999999999965 8999999999988765532
Q ss_pred ccccCCCCCCCccccccc--cCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHc-CCCCcc-------------
Q 004645 185 ARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVIS-GKKPEA------------- 247 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~~~--ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~-g~~p~~------------- 247 (740)
...+-|.+|.+|.++.+. |+...|+||.|||+.|+.. |.+.|++..-.+|+.+.+.. |...+.
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 233579999999999864 9999999999999999976 67778886666666554432 221110
Q ss_pred ------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 248 ------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 248 ------------~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
+-+.....-|+++.++|. +|.+|++|+++|+||||.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 011233567899999999 899999999999999995
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.48 Aligned_cols=243 Identities=26% Similarity=0.445 Sum_probs=197.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCe----EEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~----~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
+..+.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 777899999999999999887776 4677766422 223444568899999999999999999998754 346
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++++||+++|+|.+++..+. .+++..+..++.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEcccccccccc
Confidence 78999999999999987754 6899999999999999999999999 99999999999997 45789999999997654
Q ss_pred cCcc----ccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 181 KSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 181 ~~~~----~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
.... ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+. ....+...+..+..+. .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 238 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLP-QPPICTI 238 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCCC-CCCCCCH
Confidence 3221 1223577899999887 458999999999999999997 89999763 3455555555444332 3345678
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.+++++.+||. +|.+||++.++++.
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.74 Aligned_cols=236 Identities=21% Similarity=0.277 Sum_probs=185.1
Q ss_pred EecccCceEEEEEEEcCC------------------------CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC
Q 004645 30 ILGKGASKTVYRAFDEYE------------------------GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~t------------------------g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN 85 (740)
.||+|+||.||+|....+ ...|++|++... .......+..|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 599999999999974322 245777776522 2334567889999999999999
Q ss_pred cceeeeEeeecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC
Q 004645 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 164 (740)
Q Consensus 86 IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~ 164 (740)
|+++++++.. ....++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 9999998865 5678999999999999998866 467899999999999999999999999 9999999999999742
Q ss_pred ------CCcEEEeccchhhhhccCccccccCCCCCCCcccccc--ccCcccchhhhhhHHHHH-HhcCCCCCCCCCHHHH
Q 004645 165 ------QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEM-VTFDYPYSECTHPAQI 235 (740)
Q Consensus 165 ------~g~VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyEL-lTG~~Pf~~~~~~~~i 235 (740)
.+.+||+|||++...... ....+++.|+|||.+.+ .++.++||||||+++|+| ++|..||..... .+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHH
Confidence 124899999987543222 22357889999998864 488999999999999998 479999976433 333
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 236 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 236 ~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
...+.... ..+....+.+.++|.+||. +|.+|||+.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222111 1222346789999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=329.80 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=216.2
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeec
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 96 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~ 96 (740)
-||++.+ .|.++||.|.+|.||+++++.+|+.+|+|+..... +.-+.+..|+.+|+.+ .|||++.+|++|.-.
T Consensus 15 pdp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 15 PDPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3678888 88999999999999999999999999999775432 2224467789999988 799999999998753
Q ss_pred ---CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEe
Q 004645 97 ---ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 171 (740)
Q Consensus 97 ---~~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~ 171 (740)
..+.+|||||||.|||.-++++.. .++.+..+..|++.++.||.+||.+. +||||||-.|||++.+ |.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEe
Confidence 356899999999999999987664 67999999999999999999999999 9999999999999955 799999
Q ss_pred ccchhhhhccC--ccccccCCCCCCCcccccc------ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Q 004645 172 DLGLAAILRKS--HAARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 243 (740)
Q Consensus 172 DFGlA~~l~~~--~~~~~~GTp~YmAPEvl~~------~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~ 243 (740)
|||++..+... ...+++|||.|||||++.. .|+..+|+||||++..||.-|.+|+.+......++. |-...
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-IpRNP 244 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNP 244 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-CCCCC
Confidence 99999887654 4467789999999999862 377899999999999999999999988555444443 33333
Q ss_pred CCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 244 KPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 244 ~p~~~-~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
.|... ++..+.++.+||..||. +-.+||+..++|+|||++
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 33222 45667899999999999 899999999999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=326.85 Aligned_cols=239 Identities=25% Similarity=0.373 Sum_probs=207.8
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
.+...+|.|+|+.|-.+.+..+++..++|++.... ....+|+.++... +||||+++++.+. ....+|+|
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v 394 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLV 394 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceec--CCceeeee
Confidence 67788999999999999999999999999987542 1234567666655 8999999999874 48899999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
||++.|+-|.+-+...+.+. ..+..|+++|+.|+.|||++| ||||||||+|||++++.|+++|+|||.+...+.. .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-h
Confidence 99999999888766655555 778889999999999999999 9999999999999657789999999999887766 3
Q ss_pred ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004645 185 ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kc 263 (740)
.+.+-|..|.|||++.. .|++++||||||++||+||+|..||....+..+++.++..|... ..+|.++++||.+|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKDLLQQL 546 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHHHHHHh
Confidence 34456889999999984 69999999999999999999999998877777888888777654 66799999999999
Q ss_pred hh-CccCCCCHHHHhcCccc
Q 004645 264 LA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 264 L~-dPskRpSa~ELL~HPff 282 (740)
|+ +|.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99 99999999999999999
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.18 Aligned_cols=254 Identities=23% Similarity=0.395 Sum_probs=221.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
.+..+||+|+||.|.+|..+-+...+|||+++..-.. ..+..+.-..|-++|... +-|.+++++..| ++-+.+|+|
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVii-QdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLyFV 428 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLYFV 428 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceee-ecCcccceehhhhheecCCCCchHHHHHHHh--hhhhheeeE
Confidence 5678999999999999999999999999998755433 345566777888888877 567888888776 446789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh--hccC
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--LRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~--l~~~ 182 (740)
|||+.||+|.-.++..+++.+..+..++..|+-||-|||++| ||+||||.+||+++.+ |+|||+|||++.. ....
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCc
Confidence 999999999988999999999999999999999999999999 9999999999999955 8999999999863 4455
Q ss_pred ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004645 183 HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~ 261 (740)
.+.+++|||.|+|||++. +.|+..+|.||+||+||||+.|++||.+ .+.++++..|..... .+++..+.++..++.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehnv--syPKslSkEAv~ick 582 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHNV--SYPKSLSKEAVAICK 582 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHccC--cCcccccHHHHHHHH
Confidence 677889999999999987 6799999999999999999999999987 677888888876543 456778999999999
Q ss_pred HHhh-CccCCCCH-----HHHhcCcccCCCCcc
Q 004645 262 KCLA-TVSSRLSA-----RELLTDPFLQIDDYD 288 (740)
Q Consensus 262 kcL~-dPskRpSa-----~ELL~HPff~~~~~~ 288 (740)
..|. .|.+|+.+ .++-.||||+..++.
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 9999 89999764 588999999887775
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=316.73 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=213.5
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
.+.||-|+||.|.++.-.+|...+|.|.+.+.+.+ .......++.|-.||...+.+-||++|-+|.| +.++||||+|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYFVMdY 710 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFVMDY 710 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEEEEec
Confidence 47799999999999998889999999988766643 23456678889999999999999999999955 7899999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-----
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----- 182 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~----- 182 (740)
++||++..++.+-+-|.+..++.++..+..|+++.|..| +|||||||+||||| .+|+|||+||||++-++..
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceecccccc
Confidence 999999999999999999999999999999999999999 99999999999999 5589999999999654210
Q ss_pred ---------------------------------------ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhc
Q 004645 183 ---------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTF 222 (740)
Q Consensus 183 ---------------------------------------~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG 222 (740)
.....+||+.|+|||++.. .|+..+|.||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0113369999999999874 699999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCC-CCcccccCCChHHHHHHHHHhhCccCCCC---HHHHhcCcccCCCCcch
Q 004645 223 DYPYSECTHPAQIYKKVISGK-KPEALFKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDYDS 289 (740)
Q Consensus 223 ~~Pf~~~~~~~~i~k~i~~g~-~p~~~~~~~spelrdLI~kcL~dPskRpS---a~ELL~HPff~~~~~~~ 289 (740)
+.||...+..+.-++.+-... +-......+++++.++|.++...+..|+- ++++..||||+..++.+
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 999987554444333222211 11223456799999999999888777764 77899999999888764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.53 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=206.8
Q ss_pred ceeeCC-CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CC----cc
Q 004645 15 FVEVDP-TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RN----IM 87 (740)
Q Consensus 15 ~~e~dp-~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H--pN----IV 87 (740)
|...|- .+|| .+..+||+|.||.|-.+.|..++..||+|+++-. ....+...-|+++|.++.+ |+ +|
T Consensus 81 ~~~gD~l~~Ry-~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 81 YQVGDILTNRY-EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEeccccccce-ehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 556666 6777 8889999999999999999999999999998732 3345567789999999932 32 45
Q ss_pred eeeeEeeecCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC-
Q 004645 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN- 164 (740)
Q Consensus 88 kl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~- 164 (740)
.+.++| .-.+++++|+|.+ |-|+.+++..+ .+++...++.+++||+.+++|||+.+ ++|.||||+|||+...
T Consensus 155 ~m~~wF--dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 155 QMRDWF--DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSE 229 (415)
T ss_pred eeehhh--hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccc
Confidence 555555 3367899999999 77999998875 47999999999999999999999999 9999999999998321
Q ss_pred ------------------CCcEEEeccchhhhhccCccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCC
Q 004645 165 ------------------QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP 225 (740)
Q Consensus 165 ------------------~g~VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~P 225 (740)
...|+|+|||.|+...+.. ...+.|..|.|||++.+ .++.++||||+||||+||.||...
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 1258999999998766655 56679999999999987 699999999999999999999999
Q ss_pred CCCCCCHHHH--HHHHHcCCCCccc---------------------------------------ccC---CChHHHHHHH
Q 004645 226 YSECTHPAQI--YKKVISGKKPEAL---------------------------------------FKV---EDPEVRQFIE 261 (740)
Q Consensus 226 f~~~~~~~~i--~k~i~~g~~p~~~---------------------------------------~~~---~spelrdLI~ 261 (740)
|....+.+++ ++.|. |..|... ... ...++.+||+
T Consensus 309 FqtHen~EHLaMMerIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 9877766654 33332 3333211 001 1235788999
Q ss_pred HHhh-CccCCCCHHHHhcCcccCC
Q 004645 262 KCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 262 kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
+||. ||++|+|+.|+|.||||+.
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhc
Confidence 9999 9999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=278.05 Aligned_cols=240 Identities=36% Similarity=0.550 Sum_probs=206.2
Q ss_pred CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCHH
Q 004645 35 ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLR 114 (740)
Q Consensus 35 afGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~ 114 (740)
+||.||+|.+..+|..+|+|++...... ...+.+.+|++++++++|+||+++++++.. ....++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHH
Confidence 6899999999989999999988744321 115789999999999999999999998865 57899999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-ccccccCCCCC
Q 004645 115 QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARCVGTPEF 193 (740)
Q Consensus 115 ~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~-~~~~~~GTp~Y 193 (740)
.++.....++...+..++.+++.+|.|||+.+ ++|+||+|.||+++.+ +.++|+|||++...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCC
Confidence 99887777999999999999999999999999 9999999999999855 79999999999776554 33445689999
Q ss_pred CCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccC-CChHHHHHHHHHhh-CccCC
Q 004645 194 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV-EDPEVRQFIEKCLA-TVSSR 270 (740)
Q Consensus 194 mAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~-~spelrdLI~kcL~-dPskR 270 (740)
+|||.+. ..++.++||||||+++++|++|..||....+...+.+.+..+..+...... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999887 568889999999999999999999998766777777777666554333222 77899999999999 99999
Q ss_pred CCHHHHhcCccc
Q 004645 271 LSARELLTDPFL 282 (740)
Q Consensus 271 pSa~ELL~HPff 282 (740)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=327.94 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=205.0
Q ss_pred EEeEEecccCceEEEEEEEc-----CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 26 RYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~-----~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
++.+.||+|+||.||+|... .....||||.+|-. ......+.|.+|+.+|..|+|||||+++|.+.. ++.
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~---a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~~P 563 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK---AENQARQDFRREAELLAELQHPNIVRLLGVCRE--GDP 563 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc---ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--CCe
Confidence 56789999999999999642 35567999988733 244577899999999999999999999998855 788
Q ss_pred EEEEEeccCCCCHHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCC
Q 004645 101 INFVTEMFTSGTLRQYRLKHR----------R----VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k----------~----lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g 166 (740)
+++|+|||..|+|.+|++.+. . ++..+...|+.||+.|+.||-++. +|||||-..|+||..+ -
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~-l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGEN-L 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccc-e
Confidence 999999999999999987653 2 788999999999999999999999 9999999999999855 5
Q ss_pred cEEEeccchhhhhccCcccc----ccCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHH
Q 004645 167 EVKIGDLGLAAILRKSHAAR----CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 240 (740)
Q Consensus 167 ~VKL~DFGlA~~l~~~~~~~----~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~ 240 (740)
.|||+||||++..-...-.. ..-..+|||||.+. ++|+.++|||||||+|||+++ |..||.+..| ++..+.+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHHHHH
Confidence 89999999997654322111 12346999999776 789999999999999999988 8999998666 55667788
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 004645 241 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 241 ~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL 277 (740)
.|.. ..-+...++++..|+..||+ .|++||++.||=
T Consensus 720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 8887 45567889999999999999 899999999873
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=332.98 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=202.1
Q ss_pred EEeEEecccCceEEEEEEEcCCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCe
Q 004645 26 RYNEILGKGASKTVYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg-----~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
.+.+.||+|+||.||.|.-.... ..||+|.++. ..+......|.+|..+|+.++|||||++++++++ ...
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~---~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~ 769 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR---LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGP 769 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccc---cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCC
Confidence 57789999999999999764432 3478777653 3356778899999999999999999999999987 667
Q ss_pred EEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEecc
Q 004645 101 INFVTEMFTSGTLRQYRLKH-------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~-------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DF 173 (740)
.+|++|||+||+|..|++.. ..++...+..++.||++|+.||++++ +|||||-+.|+|++.. ..|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEccc
Confidence 88999999999999998876 35899999999999999999999999 9999999999999966 69999999
Q ss_pred chhhhhccCccccc--c--CCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004645 174 GLAAILRKSHAARC--V--GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEA 247 (740)
Q Consensus 174 GlA~~l~~~~~~~~--~--GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~ 247 (740)
|+|+.+-....... . -...|||||.+. +.|+.++|||||||++||++| |..||.+..+.+.+......|++ .
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL--~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL--D 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc--C
Confidence 99984433211111 1 225899999987 679999999999999999999 79999985554444334445543 3
Q ss_pred cccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 248 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 248 ~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+...+..+.+++..||+ +|.+||+...|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 456778888999999999 9999999999998
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=298.15 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=209.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHh-CCCCCcceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT-LKHRNIMKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~fvd~~~~~i~lV~Ey 107 (740)
..||.|+||+|++..++.+|+..|+|++.... ...+.++|..|.++..+ -+.||||+||+..+. ....|+.||+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeeeHHH
Confidence 46999999999999999999999999987543 35667889999886554 489999999998766 4578999999
Q ss_pred cCCCCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 108 FTSGTLRQYR-----LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 108 ~~gGSL~~~l-----~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
| ..||..+- .+...+++..+-.+...++.||.||-..- .|||||+||+|||++ ..|.|||||||.+..+.++
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHHH
Confidence 9 56776542 23467999999999999999999997632 399999999999999 4589999999999888777
Q ss_pred cccc-ccCCCCCCCccccc--c-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccccc----CCCh
Q 004645 183 HAAR-CVGTPEFMAPEVYE--E-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK----VEDP 254 (740)
Q Consensus 183 ~~~~-~~GTp~YmAPEvl~--~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~----~~sp 254 (740)
...+ ..|...|||||.+. + .|+.++||||||++|||+.||.+||.+..+.-+-...+..|..|.-... ..+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 5544 47999999999986 2 4999999999999999999999999987766555667777877754432 3688
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.++.||..||. +.+.||...+|+++||++..
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 99999999999 89999999999999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=322.41 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=177.8
Q ss_pred CceeEEeEEecccCceEEEEEEEcCC----CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeee--
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYE----GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD-- 95 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~t----g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd-- 95 (740)
+.| .+.++||+|+||+||+|.+..+ +..||+|+++... . .+....+ .+....+.++..++..|..
T Consensus 132 ~~y-~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 132 DDF-VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----A--VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CCe-EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----h--hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 455 8899999999999999999988 9999999875321 1 1111111 1222223333333222211
Q ss_pred --cCCCeEEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 004645 96 --TANRNINFVTEMFTSGTLRQYRLKHRR--------------------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 153 (740)
Q Consensus 96 --~~~~~i~lV~Ey~~gGSL~~~l~~~k~--------------------lse~~i~~i~~QIL~aL~yLHs~gp~IIHrD 153 (740)
.....+++|+||+.+++|.+++..... .....+..++.||+.||.|||+++ |+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 345679999999999999998765321 123456789999999999999999 99999
Q ss_pred CCCCceEEeCCCCcEEEeccchhhhhccC---ccccccCCCCCCCcccccc-----------------------ccCccc
Q 004645 154 LKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE-----------------------EYNELV 207 (740)
Q Consensus 154 LKp~NILld~~~g~VKL~DFGlA~~l~~~---~~~~~~GTp~YmAPEvl~~-----------------------~ys~ks 207 (740)
|||+|||++.+.+.+||+|||++..+... .....+||+.|||||.+.. .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999999866679999999999765432 2345679999999996531 134456
Q ss_pred chhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------c------ccccCCChHHHHHHHHHhh-Cc
Q 004645 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-------------E------ALFKVEDPEVRQFIEKCLA-TV 267 (740)
Q Consensus 208 DIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p-------------~------~~~~~~spelrdLI~kcL~-dP 267 (740)
|||||||++|||+++..|+.. ...++.+.+...... . ......+....+||.+||+ +|
T Consensus 361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999997776542 233333332221110 0 0111123345689999999 99
Q ss_pred cCCCCHHHHhcCcccCCCCc
Q 004645 268 SSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 268 skRpSa~ELL~HPff~~~~~ 287 (740)
.+|||+.++|+||||+....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999986554
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.28 Aligned_cols=199 Identities=32% Similarity=0.453 Sum_probs=170.4
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC----CCeE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----NRNI 101 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~----~~~i 101 (740)
-..+.||+||||.||+++++.+|..||+|.++... .....++.-+|+++|++|+|+|||+++++=-... .+.-
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 44688999999999999999999999999988654 2344667889999999999999999998532222 3356
Q ss_pred EEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe-CCCC--cEEEeccch
Q 004645 102 NFVTEMFTSGTLRQYRLK---HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQG--EVKIGDLGL 175 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~---~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld-~~~g--~VKL~DFGl 175 (740)
.+|||||.||+|+.++.+ +..+++.++..++..+..||.|||.+| |+||||||.||++- +.+| .-||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 799999999999998765 467999999999999999999999999 99999999999874 2324 369999999
Q ss_pred hhhhccCc-cccccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCCCCC
Q 004645 176 AAILRKSH-AARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSEC 229 (740)
Q Consensus 176 A~~l~~~~-~~~~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf~~~ 229 (740)
|+-+.+.. ..+.+||+.|.+||++. +.|+..+|.|||||++|+++||..||--.
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99887654 45668999999999998 56899999999999999999999999543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.12 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=210.4
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC------CCcceeeeEeee
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH------RNIMKFYTSWVD 95 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H------pNIVkl~~~fvd 95 (740)
+|| .+....|+|-|++|.+|.|...|..||||+|. .++...+.-+.|+++|++|+. -|+++++..|..
T Consensus 432 ~RY-~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR-----nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 432 SRY-EVQGYTGKGVFSTVVRARDQARGQEVAIKIIR-----NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred cee-EEEeccccceeeeeeeccccCCCCeeEEEEee-----cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 455 55677899999999999999999999999997 244455667889999999953 378999998854
Q ss_pred cCCCeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEec
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k---~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~D 172 (740)
..++|+|+|.+ ..+|++.+++.+ .+...+++.++.|++.||..|-..| |+|.||||+||||+.....+||||
T Consensus 506 --knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 506 --KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred --cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 78999999988 779999998875 5889999999999999999999999 999999999999998878899999
Q ss_pred cchhhhhccCccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHH--HcCCCCcccc
Q 004645 173 LGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV--ISGKKPEALF 249 (740)
Q Consensus 173 FGlA~~l~~~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i--~~g~~p~~~~ 249 (740)
||.|........+.+.-+..|.|||++.| .|+...|+||+||+||||.||+..|++.+|.. +.+.. ..|++|..+.
T Consensus 581 fGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 581 FGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-MLRLFMELKGKFPNKML 659 (752)
T ss_pred CccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH-HHHHHHHhcCCCcHHHh
Confidence 99999988888777778889999999987 59999999999999999999999999866543 32221 2344432110
Q ss_pred ---------------------------------cC----------------CC-------hHHHHHHHHHhh-CccCCCC
Q 004645 250 ---------------------------------KV----------------ED-------PEVRQFIEKCLA-TVSSRLS 272 (740)
Q Consensus 250 ---------------------------------~~----------------~s-------pelrdLI~kcL~-dPskRpS 272 (740)
.. ++ ..+++|+.+||. ||.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 00 11 368899999999 9999999
Q ss_pred HHHHhcCcccCC
Q 004645 273 ARELLTDPFLQI 284 (740)
Q Consensus 273 a~ELL~HPff~~ 284 (740)
..++|+||||+.
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=288.79 Aligned_cols=256 Identities=20% Similarity=0.361 Sum_probs=215.9
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~l 103 (740)
+++.++||+|+|++|.++..+.|.+.+|+|++|+.- ....+.+.-+..|-.+..+. +||.+|-++..| .+...+++
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel-~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrlff 328 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRLFF 328 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHh-cCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceEEE
Confidence 488999999999999999999999999999998654 34556677888899998887 899999998877 44778999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh--cc
Q 004645 104 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RK 181 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l--~~ 181 (740)
|.||++||+|.-..+++++++++.++.+...|..||.|||++| ||+||||.+|+|++.. |++||+|+|+++.- ..
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCCCCC
Confidence 9999999999877788899999999999999999999999999 9999999999999955 89999999998642 23
Q ss_pred CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCC-------CCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYS-------ECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~-------~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
..+.+++|||.|.|||++++ .|+..+|.|+|||+|+||+.|+.||. +.++.+-++..|..... .++...+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprsls 483 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLS 483 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceee
Confidence 45677899999999999996 59999999999999999999999994 22334456666655433 2344456
Q ss_pred hHHHHHHHHHhh-CccCCCC------HHHHhcCcccCCCCcc
Q 004645 254 PEVRQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDYD 288 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpS------a~ELL~HPff~~~~~~ 288 (740)
-.+..+++.-|+ ||.+|+. ..++-.|+||+..++.
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 667788888898 8999864 5689999999876664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.63 Aligned_cols=272 Identities=24% Similarity=0.345 Sum_probs=213.9
Q ss_pred CCCCCceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCccee
Q 004645 10 SDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKF 89 (740)
Q Consensus 10 ~~~~~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl 89 (740)
-++..+.-++-.+.|.++ .+||+|.||.||+|..+.+|+.||+|++-+.. ..........+|+++|..|+|+|++.+
T Consensus 5 ~~s~~~P~~~~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eKeGfpitalreikiL~~lkHenv~nl 81 (376)
T KOG0669|consen 5 KDSMYEPFCDEVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNL 81 (376)
T ss_pred hhcccCCceecchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHH
Confidence 456777788888999664 67999999999999999999999998765432 112233457889999999999999988
Q ss_pred eeEeee------cCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe
Q 004645 90 YTSWVD------TANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162 (740)
Q Consensus 90 ~~~fvd------~~~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld 162 (740)
++.|-. .....+|+|+.+|+. +|.-++... .+++...++.++++++.||.|+|.+. |+|||+|+.|+||+
T Consensus 82 iEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 82 IEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT 158 (376)
T ss_pred HHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc
Confidence 776532 123469999999964 777766554 58999999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccchhhhhccCcc------ccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHH
Q 004645 163 GNQGEVKIGDLGLAAILRKSHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 234 (740)
Q Consensus 163 ~~~g~VKL~DFGlA~~l~~~~~------~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~ 234 (740)
.+|.+||+|||+++.+..+.. +..+-|.+|++||.+.| .|+++.|||+.|||+.||.|+.+-+.+.++..+
T Consensus 159 -~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq 237 (376)
T KOG0669|consen 159 -KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ 237 (376)
T ss_pred -CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH
Confidence 458999999999976643322 22245999999999875 599999999999999999999999987555444
Q ss_pred HHH-----------------------HHHcCCCCccc---------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 004645 235 IYK-----------------------KVISGKKPEAL---------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281 (740)
Q Consensus 235 i~k-----------------------~i~~g~~p~~~---------~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPf 281 (740)
+.- .+.....|... +-..++++.+|++++|. ||.+|+.+.++|.|.|
T Consensus 238 l~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 238 LHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 421 11111111100 12336789999999999 9999999999999999
Q ss_pred cCCCCcc
Q 004645 282 LQIDDYD 288 (740)
Q Consensus 282 f~~~~~~ 288 (740)
|..+...
T Consensus 318 F~kdp~p 324 (376)
T KOG0669|consen 318 FWKDPMP 324 (376)
T ss_pred hhcCCcc
Confidence 9877654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=278.19 Aligned_cols=256 Identities=20% Similarity=0.359 Sum_probs=214.8
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEee
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWV 94 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv 94 (740)
++......| .+.+++|+|.++.||.|++..++.+++||++| +...+.+.+|+.+|..|. ||||+++++...
T Consensus 32 i~wg~~ddY-eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 32 IDWGNQDDY-EIVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred eeccccchH-HHHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 555566677 77899999999999999999999999999987 455678999999999995 999999999988
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
+...+...+|+||+.+.+.+.+ ...++...++.++.+++.||.|||+.| |+|||+||.|++|+.....++|+|+|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred CccccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecc
Confidence 8878889999999988765544 456888999999999999999999999 99999999999999877789999999
Q ss_pred hhhhhccCcccc-ccCCCCCCCccccc--cccCcccchhhhhhHHHHHHhcCCCC-CCCCCHHHHHHHHHc-CC------
Q 004645 175 LAAILRKSHAAR-CVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPY-SECTHPAQIYKKVIS-GK------ 243 (740)
Q Consensus 175 lA~~l~~~~~~~-~~GTp~YmAPEvl~--~~ys~ksDIWSLGvILyELlTG~~Pf-~~~~~~~~i~k~i~~-g~------ 243 (740)
||.+..+..... .+.+..|--||++. ..|+..-|+|||||++..|+..+-|| .+.+|.+|+.+...- |.
T Consensus 179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 999987665433 35678899999987 46999999999999999999998887 456788887653210 10
Q ss_pred -------C--------------------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 244 -------K--------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 244 -------~--------------------p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
. +.......+|++.+|+.++|. |-.+|+||.|++.||||..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 0 011123357999999999999 9999999999999999963
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=299.25 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=206.7
Q ss_pred CCCceeEEe-------EEecccCceEEEEEEEcC----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcce
Q 004645 20 PTGRYGRYN-------EILGKGASKTVYRAFDEY----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88 (740)
Q Consensus 20 p~gRY~ri~-------e~LG~GafGtVYkA~d~~----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk 88 (740)
|++|-|++. ++||.|-||.||+|.-.. ....||+|..|.. ..++..+.|..|.-+|++++|||||+
T Consensus 379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d---~t~d~tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD---CTPDDTEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC---CChhhHHHHHHHHHHHHhCCCcchhh
Confidence 777777774 579999999999996432 3445788877643 24566889999999999999999999
Q ss_pred eeeEeeecCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCc
Q 004645 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 167 (740)
Q Consensus 89 l~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k-~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~ 167 (740)
++|++.+ ..+|||||+++-|.|+.|++.++ .++...+.-++.||+.||+|||+.. +|||||-..||||...+ -
T Consensus 456 LIGv~~e---~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~-C 529 (974)
T KOG4257|consen 456 LIGVCVE---QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQ-C 529 (974)
T ss_pred eeeeeec---cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcc-e
Confidence 9998865 57999999999999999998874 6999999999999999999999999 99999999999998664 8
Q ss_pred EEEeccchhhhhccCccccc-c--CCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcC
Q 004645 168 VKIGDLGLAAILRKSHAARC-V--GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 242 (740)
Q Consensus 168 VKL~DFGlA~~l~~~~~~~~-~--GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g 242 (740)
|||+||||++.+........ . -..-|||||.++ ..++.++|||-|||||||++. |..||.+-.|.+.| -.+..|
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnG 608 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENG 608 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCC
Confidence 99999999998876532211 2 245899999988 789999999999999999866 89999987665544 345566
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 243 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 243 ~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
..+. .+...+|.+..++.+||. +|++||...+|..
T Consensus 609 eRlP-~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 609 ERLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 5543 456789999999999999 9999999988753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=298.82 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=186.6
Q ss_pred CCceeEEeEEecccCceEEEEEEEc----------------CCCeEEEEEEEeecccCCCHH----------HHHHHHHH
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDE----------------YEGIEVAWNQVKLYDFLQSPE----------ELERLYCE 74 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~----------------~tg~~VAiK~vkl~~~~~~~~----------~~~~l~~E 74 (740)
...| ++.++||+|+||+||+|.+. ..+..||+|.++........+ ..+....|
T Consensus 144 ~d~F-~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDF-QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCc-eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4456 88999999999999999752 345679999987532110000 11223457
Q ss_pred HHHHHhCCCCCc-----ceeeeEeeec------CCCeEEEEEeccCCCCHHHHHHhc-----------------------
Q 004645 75 IHLLKTLKHRNI-----MKFYTSWVDT------ANRNINFVTEMFTSGTLRQYRLKH----------------------- 120 (740)
Q Consensus 75 i~iLk~L~HpNI-----Vkl~~~fvd~------~~~~i~lV~Ey~~gGSL~~~l~~~----------------------- 120 (740)
+.++.+++|.++ ++++++|... .....++|+||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 5666666431 235689999999999999887532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc-c--cccCCCCCCCc
Q 004645 121 -RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-A--RCVGTPEFMAP 196 (740)
Q Consensus 121 -k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~-~--~~~GTp~YmAP 196 (740)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++........ . ...+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999999 9999999999999854 7999999999865543221 1 12358999999
Q ss_pred cccccc---------------------cC--cccchhhhhhHHHHHHhcCC-CCCCCC----------CHHHHHHHHHcC
Q 004645 197 EVYEEE---------------------YN--ELVDIYSFGMCILEMVTFDY-PYSECT----------HPAQIYKKVISG 242 (740)
Q Consensus 197 Evl~~~---------------------ys--~ksDIWSLGvILyELlTG~~-Pf~~~~----------~~~~i~k~i~~g 242 (740)
|++... |+ .+.||||+||++|+|++|.. ||.... +....++.+..+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 987421 22 24799999999999999986 775321 111122223333
Q ss_pred CCCcccccCCChHHHHHHHHHhh-Cc---cCCCCHHHHhcCcccCC
Q 004645 243 KKPEALFKVEDPEVRQFIEKCLA-TV---SSRLSARELLTDPFLQI 284 (740)
Q Consensus 243 ~~p~~~~~~~spelrdLI~kcL~-dP---skRpSa~ELL~HPff~~ 284 (740)
..........++..++|+.++|. +| .+|+|+.|+|.||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33333455678999999999998 44 68999999999999953
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=309.36 Aligned_cols=261 Identities=28% Similarity=0.478 Sum_probs=226.8
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
+.-.+|...| .+..++|.|+||.||+|+|+.++...|+|+||++. .+...-+..|+-+++..+|||||.+++.|.
T Consensus 8 isrrnP~ddy-ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 8 ISRRNPQDDY-ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred hhhcCCccch-hheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhh
Confidence 3444899999 66789999999999999999999999999999764 344566888999999999999999999997
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccc
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFG 174 (740)
. ...+|+.||||.||+|.+.-.-.+++++.++...++..++||+|||+.| =+|||||-.|||++ +.|.||++|||
T Consensus 83 r--~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfg 157 (829)
T KOG0576|consen 83 R--RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFG 157 (829)
T ss_pred h--hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccC
Confidence 6 6789999999999999987666789999999999999999999999999 99999999999998 55899999999
Q ss_pred hhhhhccC--ccccccCCCCCCCccccc----cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004645 175 LAAILRKS--HAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 175 lA~~l~~~--~~~~~~GTp~YmAPEvl~----~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~ 248 (740)
.+..+... ....++|||.|||||+-. +.|+..+|||++|+...|+.--+.|-........++-.-.+|..|..+
T Consensus 158 vsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 158 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL 237 (829)
T ss_pred chhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc
Confidence 99877654 345678999999999853 579999999999999999999999987756666666666777766544
Q ss_pred c--cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 249 F--KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 249 ~--~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
. ...++.+-+|++.+|. +|++|||++.+|.|||....
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 2 3457889999999999 89999999999999998654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=284.45 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=198.0
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-----C---CCcceeee
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-----H---RNIMKFYT 91 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-----H---pNIVkl~~ 91 (740)
..||| -+.++||-|-|+|||+|.|..+.+.||+|++|- .....+....||++|++++ | .+||++++
T Consensus 76 ~~gRY-~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 76 NGGRY-HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cCceE-EEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 34788 788999999999999999999999999999983 2345567889999999983 3 36999999
Q ss_pred EeeecC--CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC--
Q 004645 92 SWVDTA--NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-- 165 (740)
Q Consensus 92 ~fvd~~--~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~-- 165 (740)
.|.... ..++++|+|++ |-+|..++++. +.++...++.|++|||.||.|||.. .+|||.||||+|||+....
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~~e~~ 227 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCSTEID 227 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeeccccc
Confidence 997654 45899999999 78888888774 7899999999999999999999985 3599999999999991100
Q ss_pred --------------------------------------------------------------------------------
Q 004645 166 -------------------------------------------------------------------------------- 165 (740)
Q Consensus 166 -------------------------------------------------------------------------------- 165 (740)
T Consensus 228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~ 307 (590)
T KOG1290|consen 228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP 307 (590)
T ss_pred hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 004645 166 -------------------------------------------------------------------------------- 165 (740)
Q Consensus 166 -------------------------------------------------------------------------------- 165 (740)
T Consensus 308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~ 387 (590)
T KOG1290|consen 308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP 387 (590)
T ss_pred CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence
Q ss_pred ---CcEEEeccchhhhhccCccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCC-----C-CCH---
Q 004645 166 ---GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE-----C-THP--- 232 (740)
Q Consensus 166 ---g~VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~-----~-~~~--- 232 (740)
-.|||+|||-|+......+ ..+.|..|+||||+.+ .|+..+||||++|++|||+||.+.|.- + .+.
T Consensus 388 ~~di~vKIaDlGNACW~~khFT-~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 388 ECDIRVKIADLGNACWVHKHFT-EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred ccceeEEEeeccchhhhhhhhc-hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 0256777777766544332 3357899999999986 599999999999999999999999841 1 122
Q ss_pred HHHHHH--------HHcCCCCcc------------------cc----------cCCChHHHHHHHHHhh-CccCCCCHHH
Q 004645 233 AQIYKK--------VISGKKPEA------------------LF----------KVEDPEVRQFIEKCLA-TVSSRLSARE 275 (740)
Q Consensus 233 ~~i~k~--------i~~g~~p~~------------------~~----------~~~spelrdLI~kcL~-dPskRpSa~E 275 (740)
+.|++. ...|+.... +. .....++.+|+.-||. +|.+|+||.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 233321 122222111 10 1112467889999999 9999999999
Q ss_pred HhcCcccCC
Q 004645 276 LLTDPFLQI 284 (740)
Q Consensus 276 LL~HPff~~ 284 (740)
+|+||||..
T Consensus 547 cl~hPwLn~ 555 (590)
T KOG1290|consen 547 CLKHPWLNP 555 (590)
T ss_pred HhcCccccC
Confidence 999999963
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=292.43 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=202.1
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
-|..+. ++.++||+|-||.|.++.-. .+..||+|.++-.. +......|..||++|.+|+||||++++++|+. +
T Consensus 535 fPRs~L-~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--D 607 (807)
T KOG1094|consen 535 FPRSRL-RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--D 607 (807)
T ss_pred cchhhe-ehhhhhcCcccceeEEEEec-CceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--C
Confidence 366666 88999999999999999643 36999999877332 44556889999999999999999999999966 6
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
+.+++|+||++.|+|.+|+.++. ........+++.||+.||+||.+.+ +|||||-+.|+|++++ .++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccc
Confidence 78999999999999999999984 3355666779999999999999999 9999999999999977 59999999999
Q ss_pred hhhccCcccc----ccCCCCCCCcccc-ccccCcccchhhhhhHHHHHHh--cCCCCCCCCCHHHHHHHHH---cCCCC-
Q 004645 177 AILRKSHAAR----CVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVI---SGKKP- 245 (740)
Q Consensus 177 ~~l~~~~~~~----~~GTp~YmAPEvl-~~~ys~ksDIWSLGvILyELlT--G~~Pf~~~~~~~~i~k~i~---~g~~p- 245 (740)
+.+-...... .+-..+|||+|.+ .++++.++|+|+||+++||+++ .+.||+..++ +++.+... .+.-+
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcc
Confidence 8654433222 2345799999965 4899999999999999999865 5899987544 55544322 22211
Q ss_pred --cccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 246 --EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 246 --~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
...+...+..+.+++.+|+. +-.+|||.++|-.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 12355678889999999999 8999999999854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=289.74 Aligned_cols=284 Identities=24% Similarity=0.338 Sum_probs=225.8
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
-+|++.+.-- +..+||-|-||.||.|..+.-.-.||+|.+|- .....+.|+.|..+|+.++|||+|+++++|
T Consensus 261 kWEmeRtdIt--MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVC- 332 (1157)
T KOG4278|consen 261 KWEMERTDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 332 (1157)
T ss_pred hhhccchhee--eeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhh-
Confidence 3455444333 56789999999999999999999999998872 345678899999999999999999999988
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEec
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~D 172 (740)
+....+|||+|||..|+|.+|++... .++.-.+..++.||..|+.||..++ +|||||-..|.||..+ ..||++|
T Consensus 333 -T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvAD 408 (1157)
T KOG4278|consen 333 -THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVAD 408 (1157)
T ss_pred -ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeec
Confidence 44678999999999999999998864 4777888899999999999999999 9999999999999855 5899999
Q ss_pred cchhhhhccCccccccC---CCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004645 173 LGLAAILRKSHAARCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEA 247 (740)
Q Consensus 173 FGlA~~l~~~~~~~~~G---Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~ 247 (740)
|||++++.....+.-.| ..-|.|||.+. ..++.++|||+|||+|||+.| |-.||.+ -+..++|..+..|..-.
T Consensus 409 FGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~- 486 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD- 486 (1157)
T ss_pred cchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-
Confidence 99999988765443344 34799999887 679999999999999999988 7889998 56788888887776543
Q ss_pred cccCCChHHHHHHHHHhh-CccCCCCHHHHhc---CcccCCCCcchhhhhhhccCcccccchHHhhhhh
Q 004645 248 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT---DPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLY 312 (740)
Q Consensus 248 ~~~~~spelrdLI~kcL~-dPskRpSa~ELL~---HPff~~~~~~~~l~~~~~~~~~~~i~pll~~~l~ 312 (740)
-+..++|.+.+|+..||+ .|+.||+..|+-+ .-|-...-.....+.+........+.++++-++.
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk~~~~~sv~~l~~lp~l 555 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGKNNDKKSVVPLPRLPIL 555 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhhcccccccccccccccC
Confidence 346789999999999999 9999999998733 2222111112223333334445555565555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=278.76 Aligned_cols=252 Identities=30% Similarity=0.426 Sum_probs=206.9
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC----
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~---- 97 (740)
.||.. ...+|.|+- .|..|+|..+++.||+|.+... .++....++.++|..++..++|+||++++.+|....
T Consensus 17 ~Ry~n-L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 17 KRYVN-LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeee-ecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 45633 367999999 8999999999999999987655 344566788999999999999999999999985422
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
-..+|+||||+ ..+|.+.+. -.++-+.++.++.|++.|++|||+.| |+||||||+||++.. +..+||.|||+|.
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~-~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNS-DCTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecc-hhheeeccchhhc
Confidence 23589999999 568888766 56888999999999999999999999 999999999999984 4799999999998
Q ss_pred hhccC-ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC----------
Q 004645 178 ILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK---------- 244 (740)
Q Consensus 178 ~l~~~-~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~-g~~---------- 244 (740)
..... ..+.++.|..|.|||++-+ .|.+.+||||+||++.||++|...|.+....++..+.+.. |..
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 77666 4566789999999999875 4999999999999999999999999876665555443322 110
Q ss_pred ---------------------Cccc-------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 245 ---------------------PEAL-------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 245 ---------------------p~~~-------~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
|... .+.....+++++.+||. +|.+|.+++++|+|||++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111 12234578999999999 999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=299.34 Aligned_cols=251 Identities=22% Similarity=0.400 Sum_probs=212.2
Q ss_pred eeeCCCCceeEEeEEecccCceEEEEEEEcCCC---eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeE
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS 92 (740)
Q Consensus 16 ~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg---~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 92 (740)
-|+||. |.+|.++||.|.||.||+|..+..| ..||||.+|.-. .+.....|+.|+.||-+++||||+++-++
T Consensus 624 kEId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 624 KEIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 355665 5568999999999999999987766 569999988543 56677889999999999999999999995
Q ss_pred eeecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEe
Q 004645 93 WVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 171 (740)
Q Consensus 93 fvd~~~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~ 171 (740)
.+..+.++||+|||++|+|..|++.+ +.|+.-++..+++.|+.|++||-.++ +|||||-..||||+.+- ..|++
T Consensus 699 --VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnL-vCKVs 773 (996)
T KOG0196|consen 699 --VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNL-VCKVS 773 (996)
T ss_pred --EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccce-EEEec
Confidence 46688999999999999999998876 67999999999999999999999999 99999999999999664 78999
Q ss_pred ccchhhhhccCcccc--ccC---CCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC
Q 004645 172 DLGLAAILRKSHAAR--CVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKK 244 (740)
Q Consensus 172 DFGlA~~l~~~~~~~--~~G---Tp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~ 244 (740)
||||++++.+..... ..| ..+|.|||.+. .+++.++|||||||+|||.++ |+.||.+.+| .+.++.|..|..
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyR 852 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYR 852 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccC
Confidence 999999886554221 122 36899999887 789999999999999999655 9999998665 556677777764
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 245 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 245 p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
... +-..+..+.+|+..||+ +-..||...+|+.
T Consensus 853 LPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 853 LPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 332 34578899999999999 8999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=301.13 Aligned_cols=240 Identities=29% Similarity=0.413 Sum_probs=189.4
Q ss_pred EeEEecccCceE-EEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEE
Q 004645 27 YNEILGKGASKT-VYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 27 i~e~LG~GafGt-VYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
-.+++|.|+.|+ ||+|. ..|+.||+|.+- .+......+||..|+.- +|||||++|+ .+.+...+||.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIa 581 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIA 581 (903)
T ss_pred cHHHcccCCCCcEEEEEe--eCCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEE
Confidence 357899999987 89994 568899998764 23445678999999998 7999999988 56778899999
Q ss_pred EeccCCCCHHHHHHhc-CCC---CHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC----CCcEEEeccchh
Q 004645 105 TEMFTSGTLRQYRLKH-RRV---NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN----QGEVKIGDLGLA 176 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~-k~l---se~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~----~g~VKL~DFGlA 176 (740)
.|+| ..+|.+|+... ..+ ..-....++.|++.||++||+.+ ||||||||.||||... ...++|+|||++
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 9999 56999998774 111 11335778999999999999999 9999999999999863 136899999999
Q ss_pred hhhccCc-----cccccCCCCCCCccccccc-cCcccchhhhhhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCCCCc-cc
Q 004645 177 AILRKSH-----AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE-AL 248 (740)
Q Consensus 177 ~~l~~~~-----~~~~~GTp~YmAPEvl~~~-ys~ksDIWSLGvILyELlTG-~~Pf~~~~~~~~i~k~i~~g~~p~-~~ 248 (740)
+.+.... .....||-+|+|||++.+. -+.++|||||||++|+.++| ..||.+.. + --..|..|.... .+
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~-R~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--E-RQANILTGNYTLVHL 735 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--H-hhhhhhcCccceeee
Confidence 8876543 2344699999999999854 56789999999999999997 99997622 1 112344554422 22
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
....+.++++||.+||. +|..||+|.++|.||||=
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 22223389999999999 999999999999999993
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=315.31 Aligned_cols=237 Identities=21% Similarity=0.335 Sum_probs=178.0
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
+...+||+|+||.||+|.+..+|..||+|.++.... ....|+++|++++|||||++++++.+ ....++||
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 445689999999999999999999999998763221 12346889999999999999999865 56789999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~-gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
||+++|+|.+++. .+++..+..++.||+.||+|||.. .++|+||||||+||+++.+ +..++. ||....... .
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~--~ 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT--D 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc--C
Confidence 9999999999975 488999999999999999999943 2349999999999999854 466664 555433222 1
Q ss_pred ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCC----CHHHHHHHHHcCCC-----Cccc------
Q 004645 185 ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT----HPAQIYKKVISGKK-----PEAL------ 248 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~----~~~~i~k~i~~g~~-----p~~~------ 248 (740)
....||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ......+....... ...+
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 23368999999999874 59999999999999999999999985321 11111111111100 0000
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
......++.+++.+||+ +|.+|||+.|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112356788999999 99999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=293.85 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=211.6
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcC-------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCc
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNI 86 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~-------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNI 86 (740)
.+|++..+. .+.+.||+|+||+|++|.-.. ....||+|..+... ...+.+.+..|+.+|+.+ +|+||
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcch
Confidence 678877776 467799999999999996321 25678988776433 336778899999999999 79999
Q ss_pred ceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCee
Q 004645 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 150 (740)
Q Consensus 87 Vkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k----------------~lse~~i~~i~~QIL~aL~yLHs~gp~II 150 (740)
+.+.+.+.. ...+++|+||+..|+|..|++..+ .++...+..++.||+.|++||++.. +|
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v 440 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV 440 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence 999998754 778999999999999999987766 3889999999999999999999998 99
Q ss_pred eccCCCCceEEeCCCCcEEEeccchhhhhccCcccc---ccC--CCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cC
Q 004645 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVG--TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FD 223 (740)
Q Consensus 151 HrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~---~~G--Tp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~ 223 (740)
||||-..|||+..+ ..+||+|||+|+......... ..| ...|||||.+.. .|+.++|||||||+|||++| |.
T Consensus 441 HRDLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 441 HRDLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred chhhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 99999999999855 589999999998544332221 122 235999999885 69999999999999999998 79
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 224 YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 224 ~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.||.+......+++.+..|..... +...++++.+++..||. +|.+||+..++..
T Consensus 520 ~PYp~~~~~~~l~~~l~~G~r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 520 TPYPGIPPTEELLEFLKEGNRMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999986667788888888887654 34569999999999999 9999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=256.60 Aligned_cols=211 Identities=27% Similarity=0.442 Sum_probs=182.0
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCeEEEEEe
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
+..||+|++|.|-+.++..+|...|+|.+...- +....+++.+|+.+..+. ..|.+|+||+.+.+ ...+|+.||
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIcME 125 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWICME 125 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEEeHH
Confidence 466999999999999999999999999887543 356677889999987766 89999999998866 567999999
Q ss_pred ccCCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC
Q 004645 107 MFTSGTLRQY----RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 107 y~~gGSL~~~----l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
.| ..||..| +.+.+.+++..+-+++..++.||.|||++= .|||||+||+|||++ ..|+|||||||.+..+.++
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhh
Confidence 99 5677665 445678999999999999999999999862 599999999999999 5589999999999988888
Q ss_pred cccc-ccCCCCCCCcccccc-----ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCc
Q 004645 183 HAAR-CVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246 (740)
Q Consensus 183 ~~~~-~~GTp~YmAPEvl~~-----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~ 246 (740)
...+ ..|...|||||.+.. .|+.++||||||+.++||.++++||....++-+..+.+.....|.
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 7666 579999999998862 589999999999999999999999999888888888888765553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=276.05 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=194.7
Q ss_pred CCCCCceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC--CCCCcc
Q 004645 10 SDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL--KHRNIM 87 (740)
Q Consensus 10 ~~~~~~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIV 87 (740)
+.++..++.+|. .+.++||+|.||.||+| ..+++.||+|++. ....+.+.+|-.+.+.. +|+||+
T Consensus 201 ~~sspl~~l~pl----~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp-------~~~kqs~~~Ek~Iy~lp~m~h~nIl 267 (534)
T KOG3653|consen 201 APSSPLLELDPL----QLLELIGRGRFGCVWKA--QLDNRLVAVKIFP-------EQEKQSFQNEKNIYSLPGMKHENIL 267 (534)
T ss_pred CCCcccccCCch----hhHHHhhcCccceeehh--hccCceeEEEecC-------HHHHHHHHhHHHHHhccCccchhHH
Confidence 335556777777 56689999999999999 4567999999886 45567788898888764 899999
Q ss_pred eeeeEeeecC--CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeeeccCCCCc
Q 004645 88 KFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-------DPPVIHRDLKCDN 158 (740)
Q Consensus 88 kl~~~fvd~~--~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~-------gp~IIHrDLKp~N 158 (740)
+|++.=-..+ ...+++|++|.+.|+|.+|++.+ -+++....+++.-|++||+|||.- .|+|+|||||..|
T Consensus 268 ~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkN 346 (534)
T KOG3653|consen 268 QFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKN 346 (534)
T ss_pred HhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccc
Confidence 9988422111 34799999999999999997664 689999999999999999999974 3689999999999
Q ss_pred eEEeCCCCcEEEeccchhhhhccCc----cccccCCCCCCCccccccccC-------cccchhhhhhHHHHHHhcC----
Q 004645 159 IFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEEEYN-------ELVDIYSFGMCILEMVTFD---- 223 (740)
Q Consensus 159 ILld~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~~ys-------~ksDIWSLGvILyELlTG~---- 223 (740)
|||. ++++..|+|||||..+.... ....+||.+|||||++.+..+ .+.||||+|.+||||++..
T Consensus 347 VLvK-~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 347 VLVK-NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred eEEc-cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 9997 66899999999998776432 234589999999999987533 2589999999999999843
Q ss_pred --------CCCC----CCCCHHHHHHHHHcCCC----CcccccC-CChHHHHHHHHHhh-CccCCCCHHHH
Q 004645 224 --------YPYS----ECTHPAQIYKKVISGKK----PEALFKV-EDPEVRQFIEKCLA-TVSSRLSAREL 276 (740)
Q Consensus 224 --------~Pf~----~~~~~~~i~k~i~~g~~----p~~~~~~-~spelrdLI~kcL~-dPskRpSa~EL 276 (740)
.||. .....+++...+...+. |..+.+. .-..+++.++.||. |+..|+||.=+
T Consensus 426 ~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 426 PGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2332 12334555555554432 2222222 23568899999999 99999998644
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=287.29 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=210.5
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEee
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~t---g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
+-|.+.. ++.++||+|.||.|++|..+.- -..||+|.++..... ..+..|.+|+.+|.+|+|+|++++|++..
T Consensus 106 lIpee~i-~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 106 LIPEEQI-KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred eccHHHH-HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 3455555 6779999999999999976542 345888887744432 26788999999999999999999999865
Q ss_pred ecCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEec
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~D 172 (740)
+ ..+.+|||+++.|+|.+.+.+. ..|....+..++.||+.||.||.+++ +|||||-..|||+-.. ..|||+|
T Consensus 182 ~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp-rtVKI~D 255 (1039)
T KOG0199|consen 182 D---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP-RTVKICD 255 (1039)
T ss_pred c---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc-ceeeeec
Confidence 4 5688999999999999988773 46888999999999999999999999 9999999999999754 5899999
Q ss_pred cchhhhhccCcccccc-----CCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004645 173 LGLAAILRKSHAARCV-----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 245 (740)
Q Consensus 173 FGlA~~l~~~~~~~~~-----GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p 245 (740)
|||.+-+......... -...|+|||.++ ..++.++|||+|||++|||+| |+.||.++ +..+|.+.|-.|...
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erL 334 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERL 334 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccC
Confidence 9999887655332211 235799999987 789999999999999999998 69999984 568888888766543
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 246 ~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
. -++..+..+.+++..||. +|.+|||...|..+-+++.
T Consensus 335 p-RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 335 P-RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred C-CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 2 346678999999999999 8999999999976666543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=276.35 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=200.0
Q ss_pred CceeEEeEEecccCceEEEEEEEcC---CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEY---EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~---tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~ 97 (740)
..+|+..++||.|.|++||+|++.. ....||+|.+.... ...++.+|+++|..+ .+.||+++.+.+ ..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~--rn 106 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF--RN 106 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh--cc
Confidence 4566889999999999999999887 78899999887543 245799999999999 689999999977 44
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
++...+|+||++..+-.++.. .++...++.+++.++.||+++|.+| ||||||||.|+|.+...+.-.|+|||||.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 788999999999998888754 3778999999999999999999999 99999999999999888899999999996
Q ss_pred hhc-----------------c----------------C-------------ccccccCCCCCCCcccccc--ccCcccch
Q 004645 178 ILR-----------------K----------------S-------------HAARCVGTPEFMAPEVYEE--EYNELVDI 209 (740)
Q Consensus 178 ~l~-----------------~----------------~-------------~~~~~~GTp~YmAPEvl~~--~ys~ksDI 209 (740)
... . + ......|||+|.|||++.+ .-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210 0 0 0001259999999999874 57889999
Q ss_pred hhhhhHHHHHHhcCCCCCCCCCH----HHHHH--------H--HHcCC--CC----------------------------
Q 004645 210 YSFGMCILEMVTFDYPYSECTHP----AQIYK--------K--VISGK--KP---------------------------- 245 (740)
Q Consensus 210 WSLGvILyELlTG~~Pf~~~~~~----~~i~k--------~--i~~g~--~p---------------------------- 245 (740)
||.|+|++-++++.+||....+. .+|.- + ..-|. ..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999654332 12210 0 00122 00
Q ss_pred -----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 246 -----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 246 -----~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.......+..+.+|+.+||. +|.+|.||+++|+||||..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 01122345588999999999 9999999999999999973
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-31 Score=269.20 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=200.2
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCC---CeEEEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN---RNINFV 104 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~---~~i~lV 104 (740)
.+.||-|+||.||.+.|..+|+.||+|++. ...++-..-+++.+|+++|..++|.|++..++......- ..+|.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 367999999999999999999999999654 445566677899999999999999999988775322111 247889
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc-
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 183 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~- 183 (740)
+|++ ..+|...+..-..++...++-+++||++||+|||+.+ |.||||||.|+|++.| -.+||||||+++......
T Consensus 136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhh
Confidence 9998 4578887777789999999999999999999999999 9999999999999976 489999999998765432
Q ss_pred --cccccCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHH--------------------
Q 004645 184 --AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV-------------------- 239 (740)
Q Consensus 184 --~~~~~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i-------------------- 239 (740)
.+..+-|.+|.|||++.| .|+.++||||+|||+.||+..+..|......+++-..+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 233467899999999986 49999999999999999999999998755444432111
Q ss_pred --H-cCCCCccc---cc-----CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 240 --I-SGKKPEAL---FK-----VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 240 --~-~g~~p~~~---~~-----~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
. .+.++..+ +. ....+...++.++|. +|.+|.+..+.+.|+++...
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 1 11222221 12 223467778888888 99999999999999998644
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=236.53 Aligned_cols=209 Identities=39% Similarity=0.604 Sum_probs=183.2
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCC
Q 004645 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 110 (740)
Q Consensus 31 LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~g 110 (740)
||+|++|.||++.+..+|..+++|++...... ...+.+.+|+..++.++|++|+++++++.. ....++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCC
Confidence 68999999999999888999999988744321 145679999999999999999999998754 5789999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCc--cccc
Q 004645 111 GTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARC 187 (740)
Q Consensus 111 GSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~--~~~~ 187 (740)
++|.+++... ..++...+..++.+++.+|.+||+.+ ++|+||+|.||+++...+.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999998776 57999999999999999999999999 99999999999998525799999999998766543 3445
Q ss_pred cCCCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh
Q 004645 188 VGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265 (740)
Q Consensus 188 ~GTp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~ 265 (740)
.+...|++||.+.. .++.++|+|+||+++++| +.+.+++.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 68899999999875 688899999999999998 567899999999
Q ss_pred -CccCCCCHHHHhcCc
Q 004645 266 -TVSSRLSARELLTDP 280 (740)
Q Consensus 266 -dPskRpSa~ELL~HP 280 (740)
+|.+||++.++++++
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=269.54 Aligned_cols=246 Identities=30% Similarity=0.476 Sum_probs=187.1
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC--CCCCcceeeeEeeecC--
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL--KHRNIMKFYTSWVDTA-- 97 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~~~fvd~~-- 97 (740)
.|...+.+.||+|.||.||+| .+.|..||+|++.-. +.+.+.+|.++.+.. +|+||+.|++.=....
T Consensus 210 arqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeec--cccCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 455688999999999999999 677999999998622 235588898888864 9999999987421111
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeccCCCCceEEeCCCCcEEEe
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR------DPPVIHRDLKCDNIFVNGNQGEVKIG 171 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~------gp~IIHrDLKp~NILld~~~g~VKL~ 171 (740)
--.+|+|++|.+.|||.+|+.+ ..++.+...+++.-++.||++||.. .|.|.|||||..||||..+ |...|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IA 358 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 358 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEe
Confidence 1258999999999999999888 6799999999999999999999963 3789999999999999844 899999
Q ss_pred ccchhhhhccC------ccccccCCCCCCCccccccccC-------cccchhhhhhHHHHHHh----------cCCCCCC
Q 004645 172 DLGLAAILRKS------HAARCVGTPEFMAPEVYEEEYN-------ELVDIYSFGMCILEMVT----------FDYPYSE 228 (740)
Q Consensus 172 DFGlA~~l~~~------~~~~~~GTp~YmAPEvl~~~ys-------~ksDIWSLGvILyELlT----------G~~Pf~~ 228 (740)
|+|||...... .....+||.+|||||++.+..+ ..+||||||.++||++. -.+||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999765543 2234579999999999986432 35899999999999876 2578854
Q ss_pred C----CCHHHHHHHHHcCCC-CcccccC-CCh---HHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 229 C----THPAQIYKKVISGKK-PEALFKV-EDP---EVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 229 ~----~~~~~i~k~i~~g~~-p~~~~~~-~sp---elrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
. .+.+++.+.+-..+. |...... .+| .+-.+++.||. +|+-|.||--+-+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3 344455444432222 2211111 133 34567889999 9999999876643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=281.04 Aligned_cols=199 Identities=29% Similarity=0.424 Sum_probs=176.0
Q ss_pred eeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC----CHHHHHHHHHHHHHHHhCC---CCCcceeeeEeeec
Q 004645 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ----SPEELERLYCEIHLLKTLK---HRNIMKFYTSWVDT 96 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~----~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fvd~ 96 (740)
| ...+.||.|+||.|++|.++.....|++|.+++.+.+. ....+-.+-.||++|..|+ |+||++++++| +
T Consensus 563 y-ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--E 639 (772)
T KOG1152|consen 563 Y-TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--E 639 (772)
T ss_pred c-eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--e
Confidence 5 55688999999999999999999999999987654221 1122334678999999997 99999999999 4
Q ss_pred CCCeEEEEEeccC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 97 ANRNINFVTEMFT-SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 97 ~~~~i~lV~Ey~~-gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
+++++|++||-.. |.+|.+|+..+.++++..++-|++|++.|+++||+.| |||||||-+|++++++ |-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccc
Confidence 4889999999864 4489999999999999999999999999999999999 9999999999999966 7999999999
Q ss_pred hhhhccCccccccCCCCCCCccccccc-c-CcccchhhhhhHHHHHHhcCCCCCC
Q 004645 176 AAILRKSHAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSE 228 (740)
Q Consensus 176 A~~l~~~~~~~~~GTp~YmAPEvl~~~-y-s~ksDIWSLGvILyELlTG~~Pf~~ 228 (740)
|.....+....++||..|.|||++.|. | +..-|||+||++||.++..+.||.+
T Consensus 717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999988888899999999999999964 4 6789999999999999999999964
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=282.39 Aligned_cols=242 Identities=28% Similarity=0.450 Sum_probs=201.5
Q ss_pred EEeEEecccCceEEEEEEEcCCC----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg----~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
|..++||+|+||+||+|.....| .+||+|++.- .........+..|+-+|.+|+|||++++++++.. ..+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~---~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE---FTSPKASIELLDEALRMASLDHPNLLRLLGVCML---STL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeec---cCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chH
Confidence 33578999999999999764444 4677776542 2345566789999999999999999999998865 348
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
.||++|+++|+|.+|++.+ .++..+.+..|..||++||.|||.+. ++||||-..||||... .+|||.|||++..+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccC
Confidence 8999999999999998876 47999999999999999999999999 9999999999999844 699999999998876
Q ss_pred cCccccc----cCCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004645 181 KSHAARC----VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 254 (740)
Q Consensus 181 ~~~~~~~----~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~sp 254 (740)
....... .-.+-|||-|.+. ..|+.++|||||||.+||++| |..||.+ ...++|-+.+..|.. ...+...+-
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCti 927 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTI 927 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccH
Confidence 5432211 1245788888776 579999999999999999998 7899987 566788787777776 445677888
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 255 elrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
.+..++.+||. |+..||+++++-.
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999 9999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=238.55 Aligned_cols=212 Identities=34% Similarity=0.477 Sum_probs=182.5
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
|++.+.||.|++|+||+|.+..++..+++|.+...... ...+.+.+|+..+++++|+|++++++++.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEE
Confidence 36789999999999999999988999999988744321 256789999999999999999999998755 5678999
Q ss_pred EeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC-
Q 004645 105 TEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~-lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~- 182 (740)
+|++.+++|.+++..... +++..+..++.+++.+|.+||+++ ++|+||+|.||+++.+ +.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcc
Confidence 999999999999888776 899999999999999999999998 9999999999999855 79999999998776544
Q ss_pred --ccccccCCCCCCCcccc-c-cccCcccchhhhhhHHHHHHhcCCCCCC-CCCHHHHHHHHHcCCC
Q 004645 183 --HAARCVGTPEFMAPEVY-E-EEYNELVDIYSFGMCILEMVTFDYPYSE-CTHPAQIYKKVISGKK 244 (740)
Q Consensus 183 --~~~~~~GTp~YmAPEvl-~-~~ys~ksDIWSLGvILyELlTG~~Pf~~-~~~~~~i~k~i~~g~~ 244 (740)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ..+...+++.+..|..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 22345688899999998 3 3477799999999999999999999976 5666678888777763
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=282.12 Aligned_cols=199 Identities=19% Similarity=0.207 Sum_probs=148.5
Q ss_pred HhCCC-CCcceeeeEeee----c-CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 004645 79 KTLKH-RNIMKFYTSWVD----T-ANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 151 (740)
Q Consensus 79 k~L~H-pNIVkl~~~fvd----~-~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIH 151 (740)
+.++| .||++++++|.. . ....+++++|++ +++|.+++.. ...+++..++.+++||+.||.|||++| |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 45555 577777777611 1 134678889987 6799999865 356999999999999999999999999 999
Q ss_pred ccCCCCceEEeC------------------CCCcEEEeccchhhhhccC------------------ccccccCCCCCCC
Q 004645 152 RDLKCDNIFVNG------------------NQGEVKIGDLGLAAILRKS------------------HAARCVGTPEFMA 195 (740)
Q Consensus 152 rDLKp~NILld~------------------~~g~VKL~DFGlA~~l~~~------------------~~~~~~GTp~YmA 195 (740)
|||||+||||+. ..+.+||+|||++...... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 2345677777777532110 0012358999999
Q ss_pred ccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH
Q 004645 196 PEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA 273 (740)
Q Consensus 196 PEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa 273 (740)
||++. ..|+.++|||||||+||||++|..|+... ...+..+.....|... ....+....++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence 99987 46999999999999999999998887542 2222333333333222 1235667899999999 99999999
Q ss_pred HHHhcCcccCC
Q 004645 274 RELLTDPFLQI 284 (740)
Q Consensus 274 ~ELL~HPff~~ 284 (740)
.|+|+||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=221.87 Aligned_cols=159 Identities=26% Similarity=0.385 Sum_probs=128.8
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccccccC
Q 004645 111 GTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 189 (740)
Q Consensus 111 GSL~~~l~~~-k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~~~G 189 (740)
|+|.+++..+ +++++..++.|++||+.||.|||+++ ||+|||++ .++.+|+ ||++....... ..|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~~---~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPEQ---SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeecccc---CCC
Confidence 6899998874 56999999999999999999999986 99999998 4478898 99987654432 368
Q ss_pred CCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcc-----cccCCCh--HHHHHHH
Q 004645 190 TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA-----LFKVEDP--EVRQFIE 261 (740)
Q Consensus 190 Tp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~-----~~~~~sp--elrdLI~ 261 (740)
|+.|||||++.+ .|+.++|||||||++|||+||+.||............+..+..+.. .....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999874 6899999999999999999999999765554555555554433221 1112222 6999999
Q ss_pred HHhh-CccCCCCHHHHhcCcccC
Q 004645 262 KCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 262 kcL~-dPskRpSa~ELL~HPff~ 283 (740)
+||. +|.+||++.++++|+|+.
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHH
Confidence 9999 999999999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=236.89 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=198.9
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEe
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 93 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 93 (740)
.-.++-...| .+.+.||+|.||.+-+|.++.+...+++|.+... ....+.|.+|.+.--.| .|.||+.-|+.-
T Consensus 17 l~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 17 LKKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred ccccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence 3344455666 8889999999999999999999999999988633 34567899999876667 699999988865
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe-CCCCcEEEec
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGD 172 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld-~~~g~VKL~D 172 (740)
+.+ .+.+++++||++.|+|..-+.. ..+.+...+.++.|++.||.|+|+++ +||||||.+||||- .+...|||||
T Consensus 91 Fqt-~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 91 FQT-SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred hhc-CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeee
Confidence 544 4588899999999999876443 56889999999999999999999999 99999999999984 4556899999
Q ss_pred cchhhhhccCccccccCCCCCCCccccc----cc--cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHH---HHHHHcCC
Q 004645 173 LGLAAILRKSHAARCVGTPEFMAPEVYE----EE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQI---YKKVISGK 243 (740)
Q Consensus 173 FGlA~~l~~~~~~~~~GTp~YmAPEvl~----~~--ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i---~k~i~~g~ 243 (740)
||+....+... ...--+..|.+||+.. +. .++.+|||.||+++|.++||..||.......+- +.+-..+.
T Consensus 167 FG~t~k~g~tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 167 FGLTRKVGTTV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred cccccccCcee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 99886543221 1112456789999765 22 578899999999999999999999754333322 23333343
Q ss_pred CC--cccccCCChHHHHHHHHHhh-CccCC---CCHHHHhcCccc
Q 004645 244 KP--EALFKVEDPEVRQFIEKCLA-TVSSR---LSARELLTDPFL 282 (740)
Q Consensus 244 ~p--~~~~~~~spelrdLI~kcL~-dPskR---pSa~ELL~HPff 282 (740)
.+ ...++..++.+..+.++-|. ++.+| -+++...+..|.
T Consensus 246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 33 34556778899999999998 78888 566666666665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-23 Score=212.81 Aligned_cols=253 Identities=31% Similarity=0.405 Sum_probs=205.0
Q ss_pred eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC-CcceeeeEeeecCCCeEEE
Q 004645 25 GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR-NIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 25 ~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~Hp-NIVkl~~~fvd~~~~~i~l 103 (740)
|++.+.||.|+||.||++.+. ..+++|.+...... .......+.+|+.++..+.|+ +|+++++.+. .....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEE
Confidence 478899999999999999887 78888888754422 223567899999999999988 7999999883 3556899
Q ss_pred EEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 104 VTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k---~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
+++++.+++|.+++.... .+....+..++.|++.+|.|+|+.+ ++||||||+||+++.....++++|||++....
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999997766664 7999999999999999999999999 99999999999998654379999999987554
Q ss_pred cCc--------cccccCCCCCCCcccccc----ccCcccchhhhhhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC
Q 004645 181 KSH--------AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKP 245 (740)
Q Consensus 181 ~~~--------~~~~~GTp~YmAPEvl~~----~ys~ksDIWSLGvILyELlTG~~Pf~~~~~---~~~i~k~i~~g~~p 245 (740)
... .....||+.|+|||.+.+ .+....|+||+|++++++++|..||..... ..+....+.....+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 432 345579999999999875 578899999999999999999999876553 45666655554433
Q ss_pred -cc--cccCC----ChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 246 -EA--LFKVE----DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 246 -~~--~~~~~----spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.. ..... ...+.+++.+++. +|..|.+..+...++|....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 11 11111 1578999999999 89999999999998766543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-25 Score=254.55 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=200.5
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeec--ccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~--~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
..|.+...++|.|++|.|+.+........+++|.+.+. ...........+..|+-+-..|.|||++.....+.+ ..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--ID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cc
Confidence 55777789999999999999888777777777766532 111122222236778888888999999876665433 34
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+.-+||||++ +|..++....++....+-.+++|++.||.|||..| |.|||||++|+++..+ |.+||+|||.+..+
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVF 470 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceee
Confidence 44445999999 99999888889999999999999999999999999 9999999999999944 79999999999876
Q ss_pred ccCc------cccccCCCCCCCcccccc-ccCc-ccchhhhhhHHHHHHhcCCCCCCCCCHHHHH-HHHHcCC-----CC
Q 004645 180 RKSH------AARCVGTPEFMAPEVYEE-EYNE-LVDIYSFGMCILEMVTFDYPYSECTHPAQIY-KKVISGK-----KP 245 (740)
Q Consensus 180 ~~~~------~~~~~GTp~YmAPEvl~~-~ys~-ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~-k~i~~g~-----~p 245 (740)
.-.. ....+|+..|+|||++.+ .|++ .+||||.|+++..|++|+.||......++.+ .....+. -|
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 5432 234579999999999985 5775 5999999999999999999997544333221 1111111 13
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 246 ~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
..+...++...+.+|.++|+ +|.+|.|+.+||+++||+.-
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 34455677889999999999 99999999999999999753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-22 Score=213.95 Aligned_cols=245 Identities=22% Similarity=0.229 Sum_probs=179.3
Q ss_pred ceeEEeEEecccCceEEEEEEEcCCC-eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC----CCcceeeeEeeecC
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH----RNIMKFYTSWVDTA 97 (740)
Q Consensus 23 RY~ri~e~LG~GafGtVYkA~d~~tg-~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H----pNIVkl~~~fvd~~ 97 (740)
+| ++.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.+|..+.. +++..+++... ..
T Consensus 19 ~~-~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~ 92 (322)
T KOG1164|consen 19 RY-KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-ST 92 (322)
T ss_pred ce-EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CC
Confidence 56 99999999999999999988775 6788887765432111 158889999999963 58888888653 24
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC----CcEEEe
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ----GEVKIG 171 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~----g~VKL~ 171 (740)
...-++||+++ |-+|.+++... +.++...+..++.|++.+|++||+.| ++||||||+|+++.... ..+.|.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence 56788999988 88999987654 58999999999999999999999999 99999999999997442 469999
Q ss_pred ccchhhhhc---c-------C-c-cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHH--H
Q 004645 172 DLGLAAILR---K-------S-H-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI--Y 236 (740)
Q Consensus 172 DFGlA~~l~---~-------~-~-~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i--~ 236 (740)
|||+++... . . . ...+.||..|+++.+..+ ..+.+.|+||+++++.+|+.|..||......... +
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998221 1 1 1 223459999999998875 5899999999999999999999999765433222 2
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHH
Q 004645 237 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAREL 276 (740)
Q Consensus 237 k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~EL 276 (740)
+...............+.++..+...+-. +...+|....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~ 290 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKL 290 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHH
Confidence 22221111111222234455555555444 44555544433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=217.17 Aligned_cols=246 Identities=23% Similarity=0.295 Sum_probs=198.3
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCC-----eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg-----~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
.|. |+..++-+|.||.||+|+.++.. +.|-+|.++- ..++-....+..|--+|..+.|||+..+.++.+..
T Consensus 284 ~Rv-~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 284 CRV-RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhe-echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 444 77888999999999999654432 2344454441 22445567889999999999999999999987764
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcE
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKH--------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 168 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~--------k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~V 168 (740)
...-+.++.++.-|+|..|+... +.++..++..++.|+..|++|||+++ |||.||-..|.+|+ +.-+|
T Consensus 360 -~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqV 435 (563)
T KOG1024|consen 360 -YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQV 435 (563)
T ss_pred -cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeE
Confidence 45667788999899999998843 24677788889999999999999999 99999999999998 44689
Q ss_pred EEeccchhhhhccCcccccc-----CCCCCCCccccc-cccCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHc
Q 004645 169 KIGDLGLAAILRKSHAARCV-----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVIS 241 (740)
Q Consensus 169 KL~DFGlA~~l~~~~~~~~~-----GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~ 241 (740)
||+|=.+++.+-+.. ..+. ....||+||.+. ..|+.++|+||||++||||+| |+.||.+ -+|.+++..+..
T Consensus 436 kltDsaLSRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkd 513 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKD 513 (563)
T ss_pred EeccchhccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhc
Confidence 999999887654332 1122 245899999887 569999999999999999988 7999987 678899988988
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 004645 242 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 242 g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~ 278 (740)
|..... +-..+.++..++.-||. .|.+||+.+++..
T Consensus 514 GyRlaQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GYRLAQ-PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cceecC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 887543 44678999999999999 9999999998863
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=221.17 Aligned_cols=172 Identities=20% Similarity=0.194 Sum_probs=131.2
Q ss_pred CceeEEeEEecccCceEEEEEEEcC-CCeEEEEEEEeeccc-CCCHHHHHHHHHHHHHHHhCCCCCcce-eeeEeeecCC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMK-FYTSWVDTAN 98 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~-tg~~VAiK~vkl~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVk-l~~~fvd~~~ 98 (740)
++| ++.++||+|+||+||+|.+.. ++..||+|++..... .......+.+.+|+++|++|+|+||+. ++. +
T Consensus 18 ~~Y-~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~----- 90 (365)
T PRK09188 18 ARF-VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T----- 90 (365)
T ss_pred CCc-eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c-----
Confidence 445 999999999999999998876 778889987642210 112344567999999999999999985 443 1
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC-CCCceEEeCCCCcEEEeccchhh
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDL-Kp~NILld~~~g~VKL~DFGlA~ 177 (740)
...|+||||++|++|... . ... ...++.|++.||.|||++| |+|||| ||+|||++ ..+.+||+|||+|.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccce
Confidence 357999999999999632 1 111 2578899999999999999 999999 99999997 44789999999998
Q ss_pred hhccCc----------cccccCCCCCCCccccccc-------cCcccchh
Q 004645 178 ILRKSH----------AARCVGTPEFMAPEVYEEE-------YNELVDIY 210 (740)
Q Consensus 178 ~l~~~~----------~~~~~GTp~YmAPEvl~~~-------ys~ksDIW 210 (740)
.+.... .....+++.|+|||.+... .+...|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 654321 1234588999999998632 34457777
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=201.66 Aligned_cols=239 Identities=23% Similarity=0.294 Sum_probs=189.7
Q ss_pred ceeeCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC-CCcceeeeEe
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSW 93 (740)
Q Consensus 15 ~~e~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~f 93 (740)
..+.--.|.| ++.++||+|+||.+|+|.....|..||||+-+.. .....+..|.++.+.|++ ..|..++.++
T Consensus 8 ~~~~iv~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~------a~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 8 LEELIVGGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK------AKHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred hhhheeccce-EEEEeecCCchhheeeeeeccCCceEEEEeeccc------CCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 3344456777 9999999999999999999999999999975422 122347889999999965 5666665544
Q ss_pred eecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe--CCCCcEEE
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKI 170 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld--~~~g~VKL 170 (740)
+....-.+||+++ |-||.++..- .++++.+++.-++-|++.-++|+|.++ +|||||||+|+|.. .....+.|
T Consensus 81 --~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 81 --TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred --cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEE
Confidence 4456778999998 8899988665 478999999999999999999999999 99999999999984 23347999
Q ss_pred eccchhhhhccCcc---------ccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC--CCHHHHHHH
Q 004645 171 GDLGLAAILRKSHA---------ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--THPAQIYKK 238 (740)
Q Consensus 171 ~DFGlA~~l~~~~~---------~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~--~~~~~i~k~ 238 (740)
+|||+|+...+... ....||.+|.+-...-+ ..+...|+-|+|.+|.++.-|..||.+. .+..|-|++
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 99999987754322 23359999999877664 4678899999999999999999999864 355677888
Q ss_pred HHcCCC---CcccccCCChHHHHHHHHHhh
Q 004645 239 VISGKK---PEALFKVEDPEVRQFIEKCLA 265 (740)
Q Consensus 239 i~~g~~---p~~~~~~~spelrdLI~kcL~ 265 (740)
|...+. +..+.+..+.++.-.+.-|-.
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhh
Confidence 776543 345567788888888888876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=200.57 Aligned_cols=212 Identities=21% Similarity=0.301 Sum_probs=173.9
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCe
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~ 100 (740)
|--||++++||+|+||..+.|.+..+++.||||.-... .+.-+|..|.+..+.| ..++|...|-+ ..+..+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~ 98 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKY 98 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeee--ccccch
Confidence 33469999999999999999999999999999854322 2234588899999998 57899888753 455666
Q ss_pred EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeC----CCCcEEEeccch
Q 004645 101 INFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG----NQGEVKIGDLGL 175 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~----~~g~VKL~DFGl 175 (740)
-.+|+|++ |-+|.++..- .++|+.+.+..++.|++.-++|+|+++ +|+|||||+|+||.. +...|.|+|||+
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 77899998 8899987655 468999999999999999999999999 999999999999952 334689999999
Q ss_pred hhhhccCccc---------cccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCC--CCHHHHHHHHHcCC
Q 004645 176 AAILRKSHAA---------RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--THPAQIYKKVISGK 243 (740)
Q Consensus 176 A~~l~~~~~~---------~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~--~~~~~i~k~i~~g~ 243 (740)
|+...++.+. ...||.+||+-....+ +-+.+.|+-|||-+++++|-|.+||.+. .+..+-|++|-..+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 9988765432 2359999999987664 5888999999999999999999999753 46667777776544
Q ss_pred C
Q 004645 244 K 244 (740)
Q Consensus 244 ~ 244 (740)
.
T Consensus 256 r 256 (449)
T KOG1165|consen 256 R 256 (449)
T ss_pred c
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=227.10 Aligned_cols=242 Identities=21% Similarity=0.307 Sum_probs=200.9
Q ss_pred EecccCceEEEEEE---EcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeEEEEE
Q 004645 30 ILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 30 ~LG~GafGtVYkA~---d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
++|.|+||.|+++. ..+.|..+|.|+.+.....+.... ....|-.++...+ ||.++++...| ......++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeee--ccccchhHhh
Confidence 47999999999873 355678889888876553333222 5667888899886 99999998877 4467889999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~ 185 (740)
++..||.|...+.....+++...+.+...++.+++++|+.+ |+|||+|++||+++.+ |++++.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc
Confidence 99999999988788888999999999999999999999999 9999999999999955 89999999999876555444
Q ss_pred cccCCCCCCCccccccccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh
Q 004645 186 RCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265 (740)
Q Consensus 186 ~~~GTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~ 265 (740)
+||..|||||+.+ ....++|.||||+++++|+||..||.. ++.+.|..-..+ .+...++.+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~--~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE--MPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC--CchhhhHHHHHHHHHHHh
Confidence 8999999999998 677899999999999999999999986 455555543332 345568899999999998
Q ss_pred -CccCCCCH-----HHHhcCcccCCCCcc
Q 004645 266 -TVSSRLSA-----RELLTDPFLQIDDYD 288 (740)
Q Consensus 266 -dPskRpSa-----~ELL~HPff~~~~~~ 288 (740)
+|.+|.-+ .|+++|+||+.-++.
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHh
Confidence 89988754 799999999877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-21 Score=222.81 Aligned_cols=228 Identities=28% Similarity=0.426 Sum_probs=171.9
Q ss_pred eCCCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecC
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
..|...=+..+++|..|+||.||++.|+.+.+.+|+| +... + .||+ ||..+-+
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq----~-----------lilR-----nilt~a~------ 130 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ----N-----------LILR-----NILTFAG------ 130 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhhc-cccc----c-----------hhhh-----ccccccC------
Confidence 3444444467799999999999999999999999984 3211 1 1121 1332211
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
+.+.| |+-...++.-+.++... +.+++|||+.+ |+|||+||+|.+|+ .-|++|++|||++.
T Consensus 131 --npfvv------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 131 --NPFVV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSK 191 (1205)
T ss_pred --Cccee------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhh
Confidence 12222 55555555545555443 77999999999 99999999999998 55899999999986
Q ss_pred hhc-----------------cCccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHH
Q 004645 178 ILR-----------------KSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 239 (740)
Q Consensus 178 ~l~-----------------~~~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i 239 (740)
..- +-.....+|||+|.|||++. +.|+..+|+|++|+|+|+.+.|..||.+ .++++++..+
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~v 270 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQV 270 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhh
Confidence 431 11123447999999999876 6699999999999999999999999998 7788998888
Q ss_pred HcCC--CCcccccCCChHHHHHHHHHhh-CccCCC---CHHHHhcCcccCCCCcchhhhh
Q 004645 240 ISGK--KPEALFKVEDPEVRQFIEKCLA-TVSSRL---SARELLTDPFLQIDDYDSDLRM 293 (740)
Q Consensus 240 ~~g~--~p~~~~~~~spelrdLI~kcL~-dPskRp---Sa~ELL~HPff~~~~~~~~l~~ 293 (740)
+... .|+. .....++++++|.++|. .|..|. .+.++.+|+||+.-++...++.
T Consensus 271 isd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRq 329 (1205)
T KOG0606|consen 271 ISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQ 329 (1205)
T ss_pred hhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhh
Confidence 7643 3444 45578999999999999 888774 5788999999999998865543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=192.59 Aligned_cols=176 Identities=12% Similarity=0.068 Sum_probs=135.1
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHH------HHHHHHHHHhCCCCCcceeeeEe
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELER------LYCEIHLLKTLKHRNIMKFYTSW 93 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~------l~~Ei~iLk~L~HpNIVkl~~~f 93 (740)
-.++| |..++||.|+||.||++.+ ++..+|+|++.-. ....+....+ +.+|++.+.+|.|++|.....++
T Consensus 29 l~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~-~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 29 LSYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPK-VKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred hhCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechh-cCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 46888 9999999999999999744 4778999988632 2233444444 57999999999999999999887
Q ss_pred eecC------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCc
Q 004645 94 VDTA------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 167 (740)
Q Consensus 94 vd~~------~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~ 167 (740)
.+.. ....+++|||++|.+|.++. .+++ ..+.+|+.+|..||..| ++|||+||+||+++. +|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~-~g- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSK-NG- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeC-CC-
Confidence 7543 23578999999999998873 2333 34669999999999999 999999999999984 46
Q ss_pred EEEeccchhhhhccCccccccCCCCCCCccccccccCcccchhhhhhHHHHHH
Q 004645 168 VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMV 220 (740)
Q Consensus 168 VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~~ys~ksDIWSLGvILyELl 220 (740)
++|+|||............. =++...|+.++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 99999998765432221110 022346888999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=186.43 Aligned_cols=145 Identities=19% Similarity=0.168 Sum_probs=112.9
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHH----------------------HHHHHHHHHHHHHhCCCCC
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE----------------------ELERLYCEIHLLKTLKHRN 85 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~----------------------~~~~l~~Ei~iLk~L~HpN 85 (740)
...||+|+||+||+|.+. +|..||+|+++......... .......|+..|.+|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 89999999997542110000 0123345999999998887
Q ss_pred cceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeccCCCCceEEeCC
Q 004645 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL-HSRDPPVIHRDLKCDNIFVNGN 164 (740)
Q Consensus 86 IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yL-Hs~gp~IIHrDLKp~NILld~~ 164 (740)
+...+.... ...++||||++|++|...+.....++...+..++.||+.+|.|| |+.| |+||||||+|||++ +
T Consensus 81 v~~p~~~~~----~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL----KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe----cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 744333211 12379999999988876655667899999999999999999999 7999 99999999999998 3
Q ss_pred CCcEEEeccchhhhhcc
Q 004645 165 QGEVKIGDLGLAAILRK 181 (740)
Q Consensus 165 ~g~VKL~DFGlA~~l~~ 181 (740)
+.++|+|||+|.....
T Consensus 154 -~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 -GKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CcEEEEEccccccCCC
Confidence 6899999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=181.13 Aligned_cols=145 Identities=21% Similarity=0.200 Sum_probs=114.0
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccC--------------------CCH--HHHHHHHHHHHHHHhCCCCC
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL--------------------QSP--EELERLYCEIHLLKTLKHRN 85 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~--------------------~~~--~~~~~l~~Ei~iLk~L~HpN 85 (740)
...||+|+||+||+|.+. +|..||+|+++..... .+. .....+..|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999998754210 000 01234568999999999998
Q ss_pred cceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCC
Q 004645 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGN 164 (740)
Q Consensus 86 IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~ 164 (740)
|.....++.. ..++||||++|+++........+++...+..++.|++.+|.+||+ .| |+||||||+|||++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 7544433322 237999999988665443455678899999999999999999999 99 99999999999998
Q ss_pred CCcEEEeccchhhhhcc
Q 004645 165 QGEVKIGDLGLAAILRK 181 (740)
Q Consensus 165 ~g~VKL~DFGlA~~l~~ 181 (740)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 47899999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=190.76 Aligned_cols=240 Identities=18% Similarity=0.163 Sum_probs=151.7
Q ss_pred eCCCCce--eEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC----------CC
Q 004645 18 VDPTGRY--GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH----------RN 85 (740)
Q Consensus 18 ~dp~gRY--~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H----------pN 85 (740)
..+.+++ .+.++.||.|+++.||.+.|..||+.+|+|++.... ......++.+.+|.-....+.+ -.
T Consensus 5 S~~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 5 SELGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp ESSS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred ccCCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 3444444 244578999999999999999999999999998776 3445567788888765555433 11
Q ss_pred cceeeeEee--------e-cCCC------eEEEEEeccCCCCHHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHH
Q 004645 86 IMKFYTSWV--------D-TANR------NINFVTEMFTSGTLRQYRL---KHRR----VNIRAVKHWCRQILSGLLYLH 143 (740)
Q Consensus 86 IVkl~~~fv--------d-~~~~------~i~lV~Ey~~gGSL~~~l~---~~k~----lse~~i~~i~~QIL~aL~yLH 143 (740)
++-.++... . ..+. +.+++|+-+ .++|.+++. .... +....-..+..|+++.+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 111111111 1 1111 346677777 668877643 2222 223333455689999999999
Q ss_pred hCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccccccCCCCCCCcccccc---------ccCcccchhhhhh
Q 004645 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE---------EYNELVDIYSFGM 214 (740)
Q Consensus 144 s~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~---------~ys~ksDIWSLGv 214 (740)
++| |+|+||||+|+|++. +|.++|+||+.....+..... ...+..|.+||+... .++.+.|.|+||+
T Consensus 163 ~~G--lVHgdi~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 163 SYG--LVHGDIKPENFLLDQ-DGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp HTT--EEEST-SGGGEEE-T-TS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred hcc--eEecccceeeEEEcC-CCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999 999999999999995 589999999877655443332 345678999997642 3788999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCC
Q 004645 215 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSR 270 (740)
Q Consensus 215 ILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskR 270 (740)
++|.|.+|..||..... ...... .-......+..++.||..+|+ +|.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~-~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSP-EADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGG-GSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCc-cccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999975321 110000 111123567889999999999 88877
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-21 Score=200.78 Aligned_cols=271 Identities=35% Similarity=0.604 Sum_probs=195.7
Q ss_pred CCCCCceeeCCCCceeEEeEEeccc---CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc
Q 004645 10 SDSSEFVEVDPTGRYGRYNEILGKG---ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI 86 (740)
Q Consensus 10 ~~~~~~~e~dp~gRY~ri~e~LG~G---afGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI 86 (740)
.++.++.+.+|.+|+.+-.+..|+- +.-.||++.++..|.+|.|..+.......-.........=.+-|-+|-|.||
T Consensus 50 ~~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnl 129 (458)
T KOG1266|consen 50 EDESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNL 129 (458)
T ss_pred cchhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHH
Confidence 4567789999999998888888863 2446999999999999999877543321111111122223345667789999
Q ss_pred ceeeeEeeecC---CCeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCce
Q 004645 87 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 159 (740)
Q Consensus 87 Vkl~~~fvd~~---~~~i~lV~Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NI 159 (740)
|+++.+|-+.. .....|++||+..|+|..++++. +.+....+++|+.||+.||.|||+..|||+|+.|.++-|
T Consensus 130 vkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ti 209 (458)
T KOG1266|consen 130 VKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTI 209 (458)
T ss_pred HHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhhe
Confidence 99999997642 34688999999999999998764 468999999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEeccchhhhh------ccCccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCH
Q 004645 160 FVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 232 (740)
Q Consensus 160 Lld~~~g~VKL~DFGlA~~l------~~~~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~ 232 (740)
++. ..|-|||+--...... .........|-++|.|||.=. ...+-++|||+||++.++|..++.--.+....
T Consensus 210 fiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~ 288 (458)
T KOG1266|consen 210 FIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESK 288 (458)
T ss_pred eec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcce
Confidence 998 4478888643222111 111122234678999999754 34667899999999999999987664432221
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 233 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 233 ~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
......+. ..+.....+.-+.+|.+||. .|..||++.++|.||.+-...
T Consensus 289 ~~~ee~ia-----~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 289 VEVEENIA-----NVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred eehhhhhh-----hheeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 11111111 11122234455889999999 899999999999999985433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-20 Score=215.01 Aligned_cols=241 Identities=23% Similarity=0.250 Sum_probs=177.1
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.+.||++.|=+|.+|++. .|. |++|++-+.+...+-....+...|++ ...+++||.+.|--. ....+..|+|-
T Consensus 26 ~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~--~~t~kAAylvR 100 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV--LVTDKAAYLVR 100 (1431)
T ss_pred eeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH--HHhhHHHHHHH
Confidence 67899999999999999765 354 88998876664444444455555666 666799999987653 34467788888
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhh--ccCc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSH 183 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l--~~~~ 183 (740)
+|+. -+|.+.+.....+..-+.++|+.||+.||..+|..| |+|||||.+||||+. .+.+.|+||..-+.. ....
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTS-WNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITS-WNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEee-echhhhhcccccCCccCCCCC
Confidence 8885 478887777677888888999999999999999999 999999999999994 468999999765321 1111
Q ss_pred c---cccc----CCCCCCCcccccc-----------c-cCcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCC
Q 004645 184 A---ARCV----GTPEFMAPEVYEE-----------E-YNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGK 243 (740)
Q Consensus 184 ~---~~~~----GTp~YmAPEvl~~-----------~-ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~~g~ 243 (740)
. .-+. .-.+|.|||.+.. . .+++.||||+||+++||++ |.+||. ..|+..--..+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCc
Confidence 1 1111 2358999998742 1 3568899999999999988 578874 233332211111
Q ss_pred -CCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 244 -KPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 244 -~p~-~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
.++ -+.+..++.+|.+|..|++ +|++|++|++.|+.
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 1223457789999999999 99999999999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=175.54 Aligned_cols=184 Identities=16% Similarity=0.064 Sum_probs=139.1
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeEEEEE
Q 004645 27 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
....|++|+||+||.+.. .+.+++.+.+.........-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 457899999999998844 677888776654433222223346889999999994 5889999874 2468999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccC-CCCceEEeCCCCcEEEeccchhhhhccCcc
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDL-Kp~NILld~~~g~VKL~DFGlA~~l~~~~~ 184 (740)
||+.|.+|...... . ...++.|++.+|.+||++| |+|||| ||+|||++ .+|.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999998654211 1 2457889999999999999 999999 79999998 457999999999975443221
Q ss_pred -----c----------cccCCCCCCCccccc--cccC-cccchhhhhhHHHHHHhcCCCCCC
Q 004645 185 -----A----------RCVGTPEFMAPEVYE--EEYN-ELVDIYSFGMCILEMVTFDYPYSE 228 (740)
Q Consensus 185 -----~----------~~~GTp~YmAPEvl~--~~ys-~ksDIWSLGvILyELlTG~~Pf~~ 228 (740)
. ....++.|++|+... ...+ ...+.++.|.-+|.++|+..|+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 012688899998543 3344 567888999999999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=174.31 Aligned_cols=137 Identities=18% Similarity=0.181 Sum_probs=106.7
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-----CCCCcceeeeEeeecCC-Ce-
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-----KHRNIMKFYTSWVDTAN-RN- 100 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-----~HpNIVkl~~~fvd~~~-~~- 100 (740)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.| .||||+++|+++..... ..
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 36899999999995 7777766 588876532 12346789999999999 57999999998865321 23
Q ss_pred EEEEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeeeccCCCCceEEeCC---CCcEEEeccc
Q 004645 101 INFVTEM--FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL-LYLHSRDPPVIHRDLKCDNIFVNGN---QGEVKIGDLG 174 (740)
Q Consensus 101 i~lV~Ey--~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL-~yLHs~gp~IIHrDLKp~NILld~~---~g~VKL~DFG 174 (740)
+.+|+|| +.+++|.+++.+. .+++. ..+++|++.++ +|||+++ |+||||||+|||++.. .+.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3478999 5579999998664 56666 46788888888 8999999 9999999999999742 2379999954
Q ss_pred hh
Q 004645 175 LA 176 (740)
Q Consensus 175 lA 176 (740)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=175.64 Aligned_cols=153 Identities=22% Similarity=0.180 Sum_probs=119.6
Q ss_pred CCCceeEEeEEecccCceEEEEEE-EcCCCeEEEEEEEeecccCC------------------CHH--HHHHHHHHHHHH
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAF-DEYEGIEVAWNQVKLYDFLQ------------------SPE--ELERLYCEIHLL 78 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~-d~~tg~~VAiK~vkl~~~~~------------------~~~--~~~~l~~Ei~iL 78 (740)
..|+.|++.+.||+|+||.||+|. +..+|..||+|+++...... ... ....+..|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 357777999999999999999998 77899999999987542100 000 123467899999
Q ss_pred HhCCCC--CcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCC
Q 004645 79 KTLKHR--NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 156 (740)
Q Consensus 79 k~L~Hp--NIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp 156 (740)
+++.+. .+.+++.. ...++||||+.|++|..+......+....+..++.||+.+|.+||.+| .|+||||||
T Consensus 105 ~~L~~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp 177 (237)
T smart00090 105 QRLYEAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSE 177 (237)
T ss_pred HHHHhcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCCh
Confidence 999753 34455442 134799999999888776555556777778899999999999999986 599999999
Q ss_pred CceEEeCCCCcEEEeccchhhhhcc
Q 004645 157 DNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 157 ~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
+||+++ .+.++|+|||++.....
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhccCC
Confidence 999998 46899999999875443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-18 Score=177.31 Aligned_cols=238 Identities=15% Similarity=0.283 Sum_probs=186.4
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 27 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
+..+|...-.|..|+| ++.|..++.|++++.+. +....+.|..|.-.|+-+.||||+.+++.+ ....++.+|..
T Consensus 194 l~tkl~e~hsgelwrg--rwqgndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~isq 267 (448)
T KOG0195|consen 194 LITKLAESHSGELWRG--RWQGNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVIISQ 267 (448)
T ss_pred hhhhhccCCCcccccc--cccCcchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceEeee
Confidence 3456778889999999 56778888888887653 334456788899999999999999999987 44688999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEE--eccchhhhhccC
Q 004645 107 MFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI--GDLGLAAILRKS 182 (740)
Q Consensus 107 y~~gGSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL--~DFGlA~~l~~~ 182 (740)
|++.|+|...+.... .++..++.+++..|++|++|||+..|-|.---|....++|+.+ -+.+| +|--++..
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kfsfq---- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKFSFQ---- 342 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccceeeee----
Confidence 999999999887654 3778899999999999999999998655555788889999844 34443 44322211
Q ss_pred ccccccCCCCCCCccccccc----cCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004645 183 HAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~~----ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrd 258 (740)
.......|.||+||.+... --.++|+|||+++++||.|.+.||.+..+.+--++....|..+. +++.+++.+..
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~-ippgis~hm~k 420 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH-IPPGISRHMNK 420 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc-CCCCccHHHHH
Confidence 1111347899999998743 23579999999999999999999999777776677777776654 56778899999
Q ss_pred HHHHHhh-CccCCCCHHHHh
Q 004645 259 FIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 259 LI~kcL~-dPskRpSa~ELL 277 (740)
|+.-|++ ||.+||....++
T Consensus 421 lm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHhcCCCCcCCCcceeh
Confidence 9999999 999999766543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=176.86 Aligned_cols=187 Identities=25% Similarity=0.358 Sum_probs=139.5
Q ss_pred CCCCcceeeeEeee-------------------------cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 004645 82 KHRNIMKFYTSWVD-------------------------TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 136 (740)
Q Consensus 82 ~HpNIVkl~~~fvd-------------------------~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL 136 (740)
+|||||+++++|.+ ..++++|+||... ..||+.|+-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999999876 2456899999988 46899986554 456777788999999
Q ss_pred HHHHHHHhCCCCeeeccCCCCceEEeCCC-C--cEEEeccchhhhhcc-----Cccccc---cCCCCCCCcccccccc--
Q 004645 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-G--EVKIGDLGLAAILRK-----SHAARC---VGTPEFMAPEVYEEEY-- 203 (740)
Q Consensus 137 ~aL~yLHs~gp~IIHrDLKp~NILld~~~-g--~VKL~DFGlA~~l~~-----~~~~~~---~GTp~YmAPEvl~~~y-- 203 (740)
+|+.|||.+| |.|||||.+|||+.-++ + .+.|+|||.+---.. +..... -|.-.-||||+.....
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 99999999999985332 2 578999996532111 111111 2777899999987322
Q ss_pred -----CcccchhhhhhHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHH
Q 004645 204 -----NELVDIYSFGMCILEMVTFDYPYSECTHPAQIY-KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAR 274 (740)
Q Consensus 204 -----s~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~-k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ 274 (740)
..++|.|+.|.+.||+++...||.+. ....+- +.......| .++...+|.+++++-.+|+ +|++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~Yqe~qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRTYQESQLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhhhhhhhCC-CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 35799999999999999999999761 111111 111222233 4566789999999999999 999999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-18 Score=190.54 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=170.1
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeee----
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT---- 91 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~~t---g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~---- 91 (740)
.+.+.+ ++.+..+..+++.++...-... ...++-+..+ ..+-.......+++-.+....|.+..-+.+
T Consensus 241 ~~~~s~-~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~----~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s 315 (516)
T KOG1033|consen 241 EESGSS-SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD----VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPS 315 (516)
T ss_pred cccccc-cccccccccccCCchhhhhcccchhhhhccchhhh----ccchhhhhhhhhhhhheeccccCCcccccCCCCc
Confidence 344444 5566677777777766643322 1112211111 112122333445555555554433322222
Q ss_pred ---EeeecC---CCeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEe
Q 004645 92 ---SWVDTA---NRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162 (740)
Q Consensus 92 ---~fvd~~---~~~i~lV~Ey~~gGSL~~~l~~~k---~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld 162 (740)
.+.... ..++||.|++|...+|.+|+.+.+ ..+...++.|+.|+..|+.| ++ .+|+|+||.||++.
T Consensus 316 ~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~ 390 (516)
T KOG1033|consen 316 LFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS 390 (516)
T ss_pred hhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc
Confidence 111111 235899999999999999987543 46778889999999999999 77 99999999999997
Q ss_pred CCCCcEEEeccchhhhhccCc--------cccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHh-cCCCCCCCCCH
Q 004645 163 GNQGEVKIGDLGLAAILRKSH--------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHP 232 (740)
Q Consensus 163 ~~~g~VKL~DFGlA~~l~~~~--------~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlT-G~~Pf~~~~~~ 232 (740)
.+..+||+|||+........ .+..+||+.||+||.+.+ .|+.++||||||+||+||++ ...+|..
T Consensus 391 -~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---- 465 (516)
T KOG1033|consen 391 -DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---- 465 (516)
T ss_pred -cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----
Confidence 44689999999987655433 234579999999999985 69999999999999999998 3444432
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccC
Q 004645 233 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 233 ~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~ 283 (740)
...+..+..|..|..... ..|+-..|+.++|. .|.+||++.+.-.|+|++
T Consensus 466 ~~t~~d~r~g~ip~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred HHhhhhhhcCCCChHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 233455667777754433 35667799999999 899999888887787753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-17 Score=195.60 Aligned_cols=193 Identities=21% Similarity=0.236 Sum_probs=151.4
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEeeecC
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTA 97 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fvd~~ 97 (740)
.|.-+.|.+.||+|+||+||+|.+.. |+.||+|+-+-.... .|+--.+++.+|+ -+.|++++..++-
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~-- 765 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAHVF-- 765 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHHcc--
Confidence 34455789999999999999999887 999999976633211 1334445566665 2344555444333
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeC------CCCcEEEe
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG------NQGEVKIG 171 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~------~~g~VKL~ 171 (740)
.+.-++|+||.+.|||.++++..+.+++..+..++.|++..++.||..+ |||+||||+|+||.. +.--++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEE
Confidence 3455789999999999999998899999999999999999999999999 999999999999952 11248999
Q ss_pred ccchhhhhc---cC-ccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCC
Q 004645 172 DLGLAAILR---KS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP 225 (740)
Q Consensus 172 DFGlA~~l~---~~-~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~P 225 (740)
|||-+.-+. +. .....++|-.|--+|+..| .++..+|.|.|+-+++-||.|++-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999986543 22 2234468999999999986 499999999999999999998643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=158.40 Aligned_cols=138 Identities=21% Similarity=0.248 Sum_probs=110.7
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEE
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV 104 (740)
+.||+|++|.||+|.. .|..|++|+......... .....++.+|+.++..+.|++|+....++.+ ....+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5799999999999976 788899997543221111 1123568899999999999988766555544 4567899
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
|||++|++|.+++..... ....++.+|+.+|.+||+.+ ++|+|++|.|||++ .+.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999998765432 77899999999999999999 99999999999998 46899999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.8e-18 Score=197.92 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=204.2
Q ss_pred CCCceeEEeEEecccCceEEEEEEEcC-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecC
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTA 97 (740)
Q Consensus 20 p~gRY~ri~e~LG~GafGtVYkA~d~~-tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~ 97 (740)
|...| ++.+.||+|+|+.|-.+.... ....+|.|.+.... .......+...|..+-+.+. |+|++++++.. ..
T Consensus 18 ~~~~~-~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~ 92 (601)
T KOG0590|consen 18 PNSQY-KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SS 92 (601)
T ss_pred ccccc-cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCcc--CC
Confidence 66667 888899999999999887633 44456656554432 34455566777888888886 99999999976 44
Q ss_pred CCeEEEEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeccCCCCceEEeCCCC-cEEEecc
Q 004645 98 NRNINFVTEMFTSGTLRQYR-LKHR-RVNIRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQG-EVKIGDL 173 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l-~~~k-~lse~~i~~i~~QIL~aL~yLH-s~gp~IIHrDLKp~NILld~~~g-~VKL~DF 173 (740)
....+++++|..|+++..-+ .... ..+...+..++.|+..+|.|+| ..+ +.||||||+|.+++.. + .+++.||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCc
Confidence 77889999999999998877 5554 6788888999999999999999 888 9999999999999855 5 8999999
Q ss_pred chhhhhcc-Cc----cccccC-CCCCCCcccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--
Q 004645 174 GLAAILRK-SH----AARCVG-TPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-- 243 (740)
Q Consensus 174 GlA~~l~~-~~----~~~~~G-Tp~YmAPEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~-- 243 (740)
|+|+.+.. .. ....+| ++.|+|||.+.+ ...+..|+||.|+++..|++|..||........-+.......
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR 249 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence 99987765 22 123368 999999999886 357889999999999999999999976444333333222222
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 244 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 244 ~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
.-...+...+....+++.++|. +|..|.+.+++-.+||+..
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1234566778899999999997 9999999999999999976
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=155.45 Aligned_cols=134 Identities=22% Similarity=0.262 Sum_probs=104.7
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCC----HHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEE
Q 004645 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS----PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.||+|+||+||+|. .+|..|++|+......... .....++.+|+.++..+.|+++.....++.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 48999999999996 5788999997543221111 1224678899999999988765444333333 44568999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
||++|++|.+++..... .++.|++.+|.+||+.+ ++|+|++|.||+++ .+.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999988654321 88999999999999999 99999999999998 47899999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-16 Score=156.22 Aligned_cols=145 Identities=21% Similarity=0.175 Sum_probs=110.8
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCC------------------HHHHHHHHHHHHHHHhCC
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS------------------PEELERLYCEIHLLKTLK 82 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~------------------~~~~~~l~~Ei~iLk~L~ 82 (740)
.|+.|.+.+.||+|+||.||+|... +|..||+|++........ .........|+.++..+.
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 4555688899999999999999875 799999998765321000 011124678999999997
Q ss_pred CCC--cceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceE
Q 004645 83 HRN--IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 160 (740)
Q Consensus 83 HpN--IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NIL 160 (740)
|++ ++..++ ....++||||++|++|..+.. ......++.+|+.++.++|+.| |+||||||+||+
T Consensus 92 ~~~i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nil 157 (198)
T cd05144 92 EEGFPVPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNIL 157 (198)
T ss_pred HcCCCCCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEE
Confidence 774 444443 234589999999999976532 1446788999999999999999 999999999999
Q ss_pred EeCCCCcEEEeccchhhhhcc
Q 004645 161 VNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 161 ld~~~g~VKL~DFGlA~~l~~ 181 (740)
++. ++.++|+|||++.....
T Consensus 158 l~~-~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDD-DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcC-CCcEEEEECCccccCCC
Confidence 985 57999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.8e-16 Score=177.07 Aligned_cols=139 Identities=19% Similarity=0.208 Sum_probs=108.3
Q ss_pred eeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccC----CCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC
Q 004645 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL----QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 24 Y~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~----~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
++...+.||+|+||+||+|... +..+++|+....... ......+++.+|+.+++.++|++|+..+.++.+ ..
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~ 409 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PE 409 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CC
Confidence 3356789999999999999654 444444433211111 111234678999999999999999887665554 44
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
..++||||++|++|.+++. ....++.||+.+|.|||+.+ |+||||||+|||++ .+.++|+|||++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 5689999999999999865 35778999999999999999 99999999999994 36899999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.9e-16 Score=173.34 Aligned_cols=195 Identities=25% Similarity=0.410 Sum_probs=153.7
Q ss_pred HHhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-eeccCC
Q 004645 78 LKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPV-IHRDLK 155 (740)
Q Consensus 78 Lk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~-~k~lse~~i~~i~~QIL~aL~yLHs~gp~I-IHrDLK 155 (740)
|+.+.|.|+.+|++.+++. ..++.|.+||..|+|.+.+.. ...++..-...+++.|+.||.|||... | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999998874 789999999999999998777 457888888899999999999999975 4 999999
Q ss_pred CCceEEeCCCCcEEEeccchhhhhccC----ccccccCCCCCCCccccccc--------cCcccchhhhhhHHHHHHhcC
Q 004645 156 CDNIFVNGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEEE--------YNELVDIYSFGMCILEMVTFD 223 (740)
Q Consensus 156 p~NILld~~~g~VKL~DFGlA~~l~~~----~~~~~~GTp~YmAPEvl~~~--------ys~ksDIWSLGvILyELlTG~ 223 (740)
..|.+++... .+||.|||+....... ......-..-|.|||++.+. .+.+.|||||||+++|+++..
T Consensus 77 s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999664 8999999998776431 01111134578999998752 456799999999999999999
Q ss_pred CCCCCC---CCHHHHHHHHHc-CCC---Cccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 004645 224 YPYSEC---THPAQIYKKVIS-GKK---PEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 224 ~Pf~~~---~~~~~i~k~i~~-g~~---p~~~-~~~~spelrdLI~kcL~-dPskRpSa~ELL 277 (740)
-||... ..+.++...+.. +.. |.-. .....+++..++..||. +|.+||+++.+-
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999753 233556666666 332 2211 11345579999999999 899999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.1e-15 Score=145.80 Aligned_cols=142 Identities=25% Similarity=0.210 Sum_probs=99.7
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHH--------------------HHHHHHHHHHHHhCCCC--C
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEE--------------------LERLYCEIHLLKTLKHR--N 85 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~--------------------~~~l~~Ei~iLk~L~Hp--N 85 (740)
.+.||+|+||+||+|.+. +|..||+|+++.......... ......|...+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999887 899999998874321110000 00124567777777443 3
Q ss_pred cceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCC
Q 004645 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGN 164 (740)
Q Consensus 86 IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~ 164 (740)
+.+.+.. ...++||||++++++........... ..+..++.+++.++.++|. .+ |+||||||+||+++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-- 149 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-- 149 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE--
Confidence 4555542 23589999999954321111111111 6678999999999999999 88 99999999999998
Q ss_pred CCcEEEeccchhhhhcc
Q 004645 165 QGEVKIGDLGLAAILRK 181 (740)
Q Consensus 165 ~g~VKL~DFGlA~~l~~ 181 (740)
++.++|+|||++.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 57999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.8e-14 Score=145.08 Aligned_cols=141 Identities=16% Similarity=0.208 Sum_probs=105.4
Q ss_pred eEEec-ccCceEEEEEEEcCCCeEEEEEEEeeccc---------CCCHHHHHHHHHHHHHHHhCCCCCc--ceeeeEeee
Q 004645 28 NEILG-KGASKTVYRAFDEYEGIEVAWNQVKLYDF---------LQSPEELERLYCEIHLLKTLKHRNI--MKFYTSWVD 95 (740)
Q Consensus 28 ~e~LG-~GafGtVYkA~d~~tg~~VAiK~vkl~~~---------~~~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~~fvd 95 (740)
+.+|| .|+.|+||++... +..+++|.+..... .-......++.+|+.++..|.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8889999998653 78899998853221 0112334678899999999998875 666665433
Q ss_pred cCCC--eEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEec
Q 004645 96 TANR--NINFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 96 ~~~~--~i~lV~Ey~~g-GSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~D 172 (740)
.... ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++.+ +.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEE
Confidence 2221 23599999997 689888654 4555543 578999999999999 9999999999999854 6899999
Q ss_pred cchhhh
Q 004645 173 LGLAAI 178 (740)
Q Consensus 173 FGlA~~ 178 (740)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=127.54 Aligned_cols=133 Identities=19% Similarity=0.116 Sum_probs=107.4
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCcceeeeEeeecCCCeEEEEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTANRNINFVT 105 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~fvd~~~~~i~lV~ 105 (740)
.+.||.|.++.||++.+. +..+++|.+..... ...+..|+.+++.+++ .++++++.++.. ....++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEec--CCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEE
Confidence 467999999999999864 36788887753221 4568899999999976 588888876533 46789999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD-PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~g-p~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
||+.|+.+..+ +......++.+++.+|++||... .+++|+||+|.||+++. .+.++++|||++..
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 99999887654 55667888999999999999852 23999999999999985 57999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.6e-14 Score=160.35 Aligned_cols=250 Identities=21% Similarity=0.242 Sum_probs=197.9
Q ss_pred EEeEEecc--cCceEEEEEEE--cCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeecCCCe
Q 004645 26 RYNEILGK--GASKTVYRAFD--EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 26 ri~e~LG~--GafGtVYkA~d--~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~~~ 100 (740)
-+...+|. |.+|.||.+.. ..++..+|+|.-+..- ..+....+=++|+.....+ .|+|.++.+..|.. ...
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~ 192 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGI 192 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCccccc--CCc
Confidence 34577999 99999999998 8899999988754332 2222333445677766777 69999998888744 678
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH----HHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccch
Q 004645 101 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILS----GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~----aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGl 175 (740)
.++-+|++ +.+|..|...- ..++...++..+.+... ||.++|+.+ ++|-|+||+||++..+....+++|||+
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcce
Confidence 88899998 57888886654 45899999999999999 999999999 999999999999986656899999999
Q ss_pred hhhhccCccc-------cccCCCCCCCccccccccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004645 176 AAILRKSHAA-------RCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 176 A~~l~~~~~~-------~~~GTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~ 248 (740)
...+...... ...|...|++||+.++-++...|||++|.++++..++..++....+. -+..+..+.+|..+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLEF 347 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchhh
Confidence 9877654321 11477899999999999999999999999999999987666433111 12233445566667
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCC
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 249 ~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~ 284 (740)
....+..++..+..++. ++..|++++.++.|+++..
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 77777888888899998 8999999999999999973
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.2e-13 Score=160.87 Aligned_cols=255 Identities=21% Similarity=0.332 Sum_probs=198.9
Q ss_pred EeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEe
Q 004645 27 YNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 27 i~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
+.+-+-+|+++.++.+.-..+|...++++.++...... ...+....+-.++-.-.+|-++..+..| ......+++++
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGH 884 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCC--CCCCCcchhhH
Confidence 45678899999999998777887777776665443222 1123333344444444567777665554 34667899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhc------
Q 004645 107 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR------ 180 (740)
Q Consensus 107 y~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~------ 180 (740)
|+.+++|...+......+....+..+..+..+++|||+.. +.|+|++|.|+|+. ..|+.++.|||+.....
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcC
Confidence 9999999998888888898999999999999999999987 99999999999997 45799999998432110
Q ss_pred ------------------------c---CccccccCCCCCCCcccccc-ccCcccchhhhhhHHHHHHhcCCCCCCCCCH
Q 004645 181 ------------------------K---SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP 232 (740)
Q Consensus 181 ------------------------~---~~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~ 232 (740)
. .......||+.|.+||...+ .....+|+|++|+++++.++|..||.. ..+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cch
Confidence 0 00112358999999998875 578899999999999999999999986 778
Q ss_pred HHHHHHHHcCCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHH---HHhcCcccCCCCcc
Q 004645 233 AQIYKKVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSAR---ELLTDPFLQIDDYD 288 (740)
Q Consensus 233 ~~i~k~i~~g~~p~~~-~~~~spelrdLI~kcL~-dPskRpSa~---ELL~HPff~~~~~~ 288 (740)
.++++.+..+..|... ....++++++++.+.|. ++.+|..+. ++-.||||+..++.
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 8999888888776443 34568899999999999 899999988 99999999987765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=117.83 Aligned_cols=143 Identities=19% Similarity=0.184 Sum_probs=104.0
Q ss_pred eEEecccCceEEEEEEEcC------CCeEEEEEEEeecc--------cC-CC---------HHHHHHHH----HHHHHHH
Q 004645 28 NEILGKGASKTVYRAFDEY------EGIEVAWNQVKLYD--------FL-QS---------PEELERLY----CEIHLLK 79 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~------tg~~VAiK~vkl~~--------~~-~~---------~~~~~~l~----~Ei~iLk 79 (740)
...||.|--+.||.|.... .+..+|+|+.+... +. +. ..-...+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998654 35799999887531 00 00 11122333 8999999
Q ss_pred hCC--CCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeccCCC
Q 004645 80 TLK--HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL-HSRDPPVIHRDLKC 156 (740)
Q Consensus 80 ~L~--HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yL-Hs~gp~IIHrDLKp 156 (740)
+|. .-++.+.+.+ ..-++||||+.+..+..-..+...++...+..++.+++.+|..| |..| |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 994 3566777653 24578999997754433223334566677788899999999999 8999 99999999
Q ss_pred CceEEeCCCCcEEEeccchhhhhc
Q 004645 157 DNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 157 ~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
.|||+. + +.+.|+|||.+....
T Consensus 154 ~NIL~~-~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-D-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-C-CcEEEEECCCceeCC
Confidence 999997 3 589999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.4e-11 Score=133.04 Aligned_cols=144 Identities=20% Similarity=0.116 Sum_probs=94.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH--------------------------H----HHH------HHH
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP--------------------------E----ELE------RLY 72 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~--------------------------~----~~~------~l~ 72 (740)
+.||.|++|.||+|... +|+.||+|+.+..-...-. . ... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46999999999999865 7999999987532100000 0 000 244
Q ss_pred HHHHHHHhC----CCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 004645 73 CEIHLLKTL----KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILS-GLLYLHSRD 146 (740)
Q Consensus 73 ~Ei~iLk~L----~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~-k~lse~~i~~i~~QIL~-aL~yLHs~g 146 (740)
+|.+.+.++ ++.+-+.+-..+.+- ....++||||++|++|.++.... ...+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555554 222222222222221 23458999999999998875432 1222 2445556655 478889999
Q ss_pred CCeeeccCCCCceEEeCCCCcEEEeccchhhhhc
Q 004645 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 147 p~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~ 180 (740)
++|+|+||.||+++ .+|.++|+|||++..+.
T Consensus 278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 99999999999997 45799999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.6e-11 Score=114.69 Aligned_cols=128 Identities=20% Similarity=0.078 Sum_probs=93.9
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEeeecCCCeEEEEEec
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRNINFVTEM 107 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fvd~~~~~i~lV~Ey 107 (740)
+.|+.|.++.||++... |..|++|+..... .....+..|+.+++.+.+.++ .+++.+. . ...++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT-----ELLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCc-----ccccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEe
Confidence 57899999999999754 7889998764221 112246789999999865554 4555432 2 234789999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 108 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP---PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 108 ~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp---~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
++|.++... . .....++.+++.+|+.||+.+. .++|+|++|.||+++ + +.++++|||.+.
T Consensus 73 i~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 999988653 0 1123467899999999999872 259999999999998 3 579999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.7e-11 Score=137.56 Aligned_cols=142 Identities=19% Similarity=0.151 Sum_probs=91.0
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecc--------------------------cCCCH----HHHHHHHHHHHH-
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--------------------------FLQSP----EELERLYCEIHL- 77 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~--------------------------~~~~~----~~~~~l~~Ei~i- 77 (740)
+.||+|++|+||+|....+|+.||+|+++..- ..... +..+.+.+|+.+
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 57999999999999998889999999986321 00000 112233344443
Q ss_pred -----HHhC----CCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHH
Q 004645 78 -----LKTL----KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHR----RVNIRAVKHWCRQILSGLLYL 142 (740)
Q Consensus 78 -----Lk~L----~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~--l~~~k----~lse~~i~~i~~QIL~aL~yL 142 (740)
+.++ .+.+.+.+-.+|.+- ....++||||+.|+.+.++ +...+ .+.+..+..++.||+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 3333 133323322222221 2345699999999999875 22222 244455555666665
Q ss_pred HhCCCCeeeccCCCCceEEeCCC---CcEEEeccchhhhhc
Q 004645 143 HSRDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAAILR 180 (740)
Q Consensus 143 Hs~gp~IIHrDLKp~NILld~~~---g~VKL~DFGlA~~l~ 180 (740)
..| ++|+|+||.||+++.+. +.++++|||++..+.
T Consensus 278 -~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 477 99999999999998442 289999999986654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.8e-10 Score=127.36 Aligned_cols=168 Identities=24% Similarity=0.255 Sum_probs=123.3
Q ss_pred EEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhc
Q 004645 41 RAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120 (740)
Q Consensus 41 kA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~ 120 (740)
.|..+.++.+|.+.+.+... ........+-++.|+.|+||||++|++.+.. ...+|+|+|-+. .|..++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHh
Confidence 46667789999988887442 2334557778899999999999999998854 669999999886 466666553
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCcc--ccccCCCCCCCccc
Q 004645 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEV 198 (740)
Q Consensus 121 k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~--~~~~GTp~YmAPEv 198 (740)
....+..-+.||+.||.|||..+ .++|++|.-+.|+|+ ..|..||++|.++........ ....---.|..|+.
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 36777788999999999998542 399999999999999 558999999988754332221 11111123444544
Q ss_pred cccccCcccchhhhhhHHHHHHhc
Q 004645 199 YEEEYNELVDIYSFGMCILEMVTF 222 (740)
Q Consensus 199 l~~~ys~ksDIWSLGvILyELlTG 222 (740)
+... .-..|.|-||+++++++.|
T Consensus 177 ~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc-ccchhhhhHHHHHHHHhCc
Confidence 3211 1346999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.2e-11 Score=135.01 Aligned_cols=250 Identities=18% Similarity=0.146 Sum_probs=178.9
Q ss_pred CCCCceeEEeEEecccCceEEEEEEEc-CCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEeeec
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDE-YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 96 (740)
Q Consensus 19 dp~gRY~ri~e~LG~GafGtVYkA~d~-~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~ 96 (740)
.+.+.+ -+...||.|.|+.|+...-. .++..+++|.++.. ......-..-..|+.+...| .|.+++.++..|..
T Consensus 262 ~~~~df-~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~- 337 (524)
T KOG0601|consen 262 CKLTDF-GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ- 337 (524)
T ss_pred eecCCc-ceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-
Confidence 355666 45678999999999987543 67888888876532 12222223345677777766 68999999998854
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
.+..|+=.|||.++++...+..-..+++...+++..|++.++.++|+.. ++|+|+||+||++..+++.-+++|||..
T Consensus 338 -~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 338 -LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred -cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccc
Confidence 6677788999999998877666677899999999999999999999999 9999999999999854467899999988
Q ss_pred hhhccCccccccCCCCCC-Ccccccc--ccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004645 177 AILRKSHAARCVGTPEFM-APEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 177 ~~l~~~~~~~~~GTp~Ym-APEvl~~--~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~s 253 (740)
+.+.-.. ....++-+++ .+|++.+ .+..++|++|||.-+.+.+++..--..... ...+.+|..|.. ....
T Consensus 415 t~~~~~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~--~~~~ 487 (524)
T KOG0601|consen 415 TRLAFSS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNL--PGLK 487 (524)
T ss_pred cccceec-ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCC--CchH
Confidence 6432211 1122344555 3555553 477899999999999999987543322122 223444544432 2223
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 254 pelrdLI~kcL~-dPskRpSa~ELL~HPff 282 (740)
.++..+.+.++. ++..|+.+.++..|.-|
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 566677777777 88999999999888765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.7e-09 Score=104.79 Aligned_cols=134 Identities=21% Similarity=0.298 Sum_probs=98.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHH-----HHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEE
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE-----ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~-----~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~l 103 (740)
..+++|+-+.+|.+ ..-|..+++|. .+.+....++ ...+..+|+++|.+++--.|.--+-++++ .....|
T Consensus 2 ~~i~~GAEa~i~~~--~~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLT--DFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLI 76 (204)
T ss_pred chhhCCcceeEEee--eccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEE
Confidence 35789999999999 33565665553 4444333333 24567899999999865444332223355 445668
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 104 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 104 V~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
+|||++|-.|++++... ...+++.+=.-+.-||..| |+|+||.++||++.+. .+.++||||+.+
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccc
Confidence 99999999999988775 2556777777888999999 9999999999999743 599999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.4e-09 Score=103.58 Aligned_cols=145 Identities=21% Similarity=0.296 Sum_probs=106.8
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH-----HHHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP-----EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~-----~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
..+|-+|+-+.|+++ ...|+...||.= ..+....+ -..++..+|+++|.++.--.|.----+|+|. ..-.
T Consensus 12 l~likQGAEArv~~~--~~~Ge~~iIK~R-f~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 12 LELIKQGAEARVPRG--SFSGEAAIIKER-FSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred ceeeeccceeeEeee--ccCCceeEEeec-ccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 578899999999999 556888777743 22212222 2356889999999998655553333344664 3446
Q ss_pred EEEeccCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcE--EEeccchhh
Q 004645 103 FVTEMFTS-GTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV--KIGDLGLAA 177 (740)
Q Consensus 103 lV~Ey~~g-GSL~~~l~~~k--~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~V--KL~DFGlA~ 177 (740)
++|||++| .++.+|+...- .........++++|-..+.-||..+ |||+||..+||++..+.+.+ .|+|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 79999977 47888887752 3344444789999999999999999 99999999999998665554 899999986
Q ss_pred hh
Q 004645 178 IL 179 (740)
Q Consensus 178 ~l 179 (740)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.9e-09 Score=106.13 Aligned_cols=145 Identities=21% Similarity=0.241 Sum_probs=105.2
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--CcceeeeEeeecC-CCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR--NIMKFYTSWVDTA-NRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~fvd~~-~~~i~lV~ 105 (740)
+.||.|.++.||++.... |..+++|........ .....+..|+.+++.+.+. .+.+++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999997643 678998876533211 1245688999999999653 4566666542211 13568999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 004645 106 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD--------------------------------------- 146 (740)
Q Consensus 106 Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~g--------------------------------------- 146 (740)
||++|.++...+.. ..++......++.+++.+|..||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988765322 45777778888888888888888531
Q ss_pred ---------------CCeeeccCCCCceEEeCC-CCcEEEeccchhhh
Q 004645 147 ---------------PPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAI 178 (740)
Q Consensus 147 ---------------p~IIHrDLKp~NILld~~-~g~VKL~DFGlA~~ 178 (740)
..++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 237999999999999863 45689999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.8e-08 Score=107.97 Aligned_cols=236 Identities=17% Similarity=0.227 Sum_probs=154.2
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhC-CCCCcce--------eeeE
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMK--------FYTS 92 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk--------l~~~ 92 (740)
|--.-.+..||+|+-+.+|-. ..-+..|| |++.... +.... ..+..|... .||-+-. +|+
T Consensus 10 ge~i~~gr~LgqGgea~ly~l--~e~~d~VA-KIYh~Pp----pa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G- 78 (637)
T COG4248 10 GEPIPPGRPLGQGGEADLYTL--GEVRDQVA-KIYHAPP----PAAQA---QKVAELAATPDAPLLNYRVAWPQATLHG- 78 (637)
T ss_pred CcccCCCccccCCccceeeec--chhhchhh-eeecCCC----chHHH---HHHHHhccCCCCcchhhhhcccHHHhhC-
Confidence 333345567999999999976 33344444 5444222 11111 122334443 5664432 222
Q ss_pred eeecCCCeEEEEEeccCCCCH-HHH------HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCC
Q 004645 93 WVDTANRNINFVTEMFTSGTL-RQY------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165 (740)
Q Consensus 93 fvd~~~~~i~lV~Ey~~gGSL-~~~------l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~ 165 (740)
....+.+.++|..+.|..- ..+ ++......+.-+.+.++.|+.+.+.||.+| .+-+|+.++|+|+. ++
T Consensus 79 --~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~ 153 (637)
T COG4248 79 --GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DD 153 (637)
T ss_pred --CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cC
Confidence 1123448899998877521 111 222345778889999999999999999999 99999999999998 66
Q ss_pred CcEEEeccchhhhhccCcc-ccccCCCCCCCccccc-c-----ccCcccchhhhhhHHHHHHhc-CCCCCCCC------C
Q 004645 166 GEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-E-----EYNELVDIYSFGMCILEMVTF-DYPYSECT------H 231 (740)
Q Consensus 166 g~VKL~DFGlA~~l~~~~~-~~~~GTp~YmAPEvl~-~-----~ys~ksDIWSLGvILyELlTG-~~Pf~~~~------~ 231 (740)
+.|.|.|=..-.+...... .-.+|.++|.+||..+ + .-+...|.|.||+++|+|+.| +.||++.. +
T Consensus 154 ~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~ 233 (637)
T COG4248 154 SKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN 233 (637)
T ss_pred ceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence 8999998654433333222 2336999999999865 3 245679999999999999887 99997532 1
Q ss_pred HHHHHHHHHc-----------CCCCc---ccccCCChHHHHHHHHHhhC---ccCCCCHHH
Q 004645 232 PAQIYKKVIS-----------GKKPE---ALFKVEDPEVRQFIEKCLAT---VSSRLSARE 275 (740)
Q Consensus 232 ~~~i~k~i~~-----------g~~p~---~~~~~~spelrdLI~kcL~d---PskRpSa~E 275 (740)
+-+ ..|.. |.+|. ..+...+|.+..+..+|+.+ +.-|||++.
T Consensus 234 p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 234 PLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111 12222 22222 22456789999999999984 558999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.2e-08 Score=109.97 Aligned_cols=214 Identities=17% Similarity=0.254 Sum_probs=153.2
Q ss_pred CceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcceeeeEeeec--CCCeEEEEEeccCC-C
Q 004645 35 ASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT--ANRNINFVTEMFTS-G 111 (740)
Q Consensus 35 afGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~--~~~~i~lV~Ey~~g-G 111 (740)
--.+.|+|+...+|..|++|.+...+ .+.. .....-+++++++.|+|||+|.++|... .+..+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDR-DQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccc-ccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 45689999999999999999884322 1221 1233457889999999999999888622 24579999999886 4
Q ss_pred CHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 112 TLRQYRLK---------------HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 112 SL~~~l~~---------------~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
+|.++... +.+.++..+|.++.||..||.++|+.| +.-+-|.|.+||++++. +++|...|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccce
Confidence 77765321 235788999999999999999999999 99999999999999774 7888888876
Q ss_pred hhhccCccccccCCCCCCCccccccccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCcccccCCChH
Q 004645 177 AILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI-YKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 177 ~~l~~~~~~~~~GTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i-~k~i~~g~~p~~~~~~~spe 255 (740)
.++...... .+. --.+-|.=.||.+++.|.||..--.......+. .+. +...++.+
T Consensus 441 Dvl~~d~~~------------~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D 497 (655)
T KOG3741|consen 441 DVLQEDPTE------------PLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTD 497 (655)
T ss_pred eeecCCCCc------------chh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHH
Confidence 655443311 111 123568889999999999985432111222222 111 23456788
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 256 lrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
++++|.-+.. .+.. .++.++|.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 8999998888 5555 788888874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.9e-07 Score=96.26 Aligned_cols=107 Identities=16% Similarity=0.141 Sum_probs=80.2
Q ss_pred HHHHHHHHHHhCCCCCc--ceeeeEeeecC---CCeEEEEEeccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q 004645 70 RLYCEIHLLKTLKHRNI--MKFYTSWVDTA---NRNINFVTEMFTSG-TLRQYRLK--HRRVNIRAVKHWCRQILSGLLY 141 (740)
Q Consensus 70 ~l~~Ei~iLk~L~HpNI--Vkl~~~fvd~~---~~~i~lV~Ey~~gG-SL~~~l~~--~k~lse~~i~~i~~QIL~aL~y 141 (740)
.+.+|+..+.+|..-+| +....+..... ...-++|||++++. +|.+++.. ....+......++++++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 37788888888743333 23333332221 23578999999886 89998754 3456677778999999999999
Q ss_pred HHhCCCCeeeccCCCCceEEeC------CCCcEEEeccchhhh
Q 004645 142 LHSRDPPVIHRDLKCDNIFVNG------NQGEVKIGDLGLAAI 178 (740)
Q Consensus 142 LHs~gp~IIHrDLKp~NILld~------~~g~VKL~DFGlA~~ 178 (740)
||..| |+|+||++.|||++. +...+.|+||+.+..
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999 999999999999974 245799999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.7e-07 Score=94.64 Aligned_cols=130 Identities=26% Similarity=0.245 Sum_probs=83.4
Q ss_pred EEEEEEEcCCCeEEEEEEEeecc-------------c---------CCCHHHHHHHHHHHHHHHhCCCC--CcceeeeEe
Q 004645 38 TVYRAFDEYEGIEVAWNQVKLYD-------------F---------LQSPEELERLYCEIHLLKTLKHR--NIMKFYTSW 93 (740)
Q Consensus 38 tVYkA~d~~tg~~VAiK~vkl~~-------------~---------~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~f 93 (740)
.||.|... .|..+|+|+.+... . ...........+|++.|.++... ++.+.+.+
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 48999764 67899999887631 0 00111235678999999999655 56777653
Q ss_pred eecCCCeEEEEEeccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeeeccCCCCceEEeCCCCcEEE
Q 004645 94 VDTANRNINFVTEMFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY-LHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~--gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~y-LHs~gp~IIHrDLKp~NILld~~~g~VKL 170 (740)
. .-.+||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||.+.|||++.+ .+.|
T Consensus 79 -~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~i 147 (188)
T PF01163_consen 79 -N----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYI 147 (188)
T ss_dssp -E----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE
T ss_pred -e----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEE
Confidence 2 2368999998 6555543222 12245567788888886555 57998 9999999999999843 8999
Q ss_pred eccchhhhhc
Q 004645 171 GDLGLAAILR 180 (740)
Q Consensus 171 ~DFGlA~~l~ 180 (740)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-06 Score=88.34 Aligned_cols=109 Identities=17% Similarity=0.163 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHHhCCCCC--cceeeeEeeecC--CCeEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 004645 68 LERLYCEIHLLKTLKHRN--IMKFYTSWVDTA--NRNINFVTEMFTSG-TLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142 (740)
Q Consensus 68 ~~~l~~Ei~iLk~L~HpN--IVkl~~~fvd~~--~~~i~lV~Ey~~gG-SL~~~l~~~k~lse~~i~~i~~QIL~aL~yL 142 (740)
..+..+|...+..|..-+ +++.+.+..... ....++|||++++. +|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346788888888774333 334444333211 23568999999884 8999988755577888899999999999999
Q ss_pred HhCCCCeeeccCCCCceEEeCCC--CcEEEeccchhhh
Q 004645 143 HSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAI 178 (740)
Q Consensus 143 Hs~gp~IIHrDLKp~NILld~~~--g~VKL~DFGlA~~ 178 (740)
|..| |+|+||++.|||++.+. ..+.|+||+.+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999998553 2689999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1e-07 Score=110.26 Aligned_cols=147 Identities=20% Similarity=0.245 Sum_probs=106.7
Q ss_pred HHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhccCccc-----------cccCCCCCCCcccccc-cc
Q 004645 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----------RCVGTPEFMAPEVYEE-EY 203 (740)
Q Consensus 136 L~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~-----------~~~GTp~YmAPEvl~~-~y 203 (740)
..||.|+|.. +.+||+.|.|++|.++.+ |.+||+.|+++.....+... -..-...|.|||.+.. ..
T Consensus 109 ~dgl~flh~s-Ak~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRS-AKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cchhhhhccC-cceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 3899999987 469999999999999955 79999999988665442111 1124568999999875 46
Q ss_pred CcccchhhhhhHHHHHHh-cCCCCCCCCCHHHHHHHHH-cCCC-CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 004645 204 NELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI-SGKK-PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 204 s~ksDIWSLGvILyELlT-G~~Pf~~~~~~~~i~k~i~-~g~~-p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~H 279 (740)
+.++|+||||+++|.+.. |+.-+.. .+....+.... .+.. .......+++++++=+.++|. ++..||++.+++.-
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 789999999999999984 4444433 22122222111 1111 122335678999999999999 99999999999999
Q ss_pred cccCCC
Q 004645 280 PFLQID 285 (740)
Q Consensus 280 Pff~~~ 285 (740)
|||...
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.6e-07 Score=95.45 Aligned_cols=141 Identities=23% Similarity=0.226 Sum_probs=102.2
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecc-----------c----C-CC--HHHHHHHHHHHHHHHhCCC
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-----------F----L-QS--PEELERLYCEIHLLKTLKH 83 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~-----------~----~-~~--~~~~~~l~~Ei~iLk~L~H 83 (740)
|....++..||-|.-+.||.|.+. .|.++|+|.=+.-. . . .+ ........+|.++|.+|.-
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 455678999999999999999876 68899998544321 0 0 00 1123446789999999954
Q ss_pred C--CcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEE
Q 004645 84 R--NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 161 (740)
Q Consensus 84 p--NIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILl 161 (740)
. .|.+.++ .+...+||||++|-.|.... ++.+.+..++..|+.-+.-+-..| |||+||++-|||+
T Consensus 169 ~G~~VP~P~~------~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV 235 (304)
T COG0478 169 EGVKVPKPIA------WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV 235 (304)
T ss_pred cCCCCCCccc------cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE
Confidence 4 6777665 34567899999998776542 234555666666776666666777 9999999999999
Q ss_pred eCCCCcEEEeccchhh
Q 004645 162 NGNQGEVKIGDLGLAA 177 (740)
Q Consensus 162 d~~~g~VKL~DFGlA~ 177 (740)
+ ++|.+.++||--+.
T Consensus 236 ~-~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 T-EDGDIVVIDWPQAV 250 (304)
T ss_pred e-cCCCEEEEeCcccc
Confidence 9 45799999996543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.4e-08 Score=112.07 Aligned_cols=240 Identities=20% Similarity=0.215 Sum_probs=166.4
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEeeecCCCe
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN-IMKFYTSWVDTANRN 100 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fvd~~~~~ 100 (740)
.+++.+..-+++|+++.+++.+...+...+ .+.+... .....++++|.+++||| .+..++.+ +....
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~ 308 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDY 308 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccc
Confidence 445466677999999999999877666555 5554421 23456888999999999 66666544 44667
Q ss_pred EEEEEeccCCC-CHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 101 INFVTEMFTSG-TLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gG-SL~~-~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
.++.++++.++ +-.. .-...-.+..-+...+.+.-+++|++||+.. =+|+| ||+.. + +..+..||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s-~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS-E-EEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc-c-cccccccccCCcc
Confidence 89999999887 2211 1111123444556667778899999999975 58998 88876 3 5899999999877
Q ss_pred hccC-ccccccCCCCCCCccccc-cccCcccchhhhhhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcc--c---ccC
Q 004645 179 LRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA--L---FKV 251 (740)
Q Consensus 179 l~~~-~~~~~~GTp~YmAPEvl~-~~ys~ksDIWSLGvILyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~--~---~~~ 251 (740)
+... ...+..+|+.++|||+.. +.+..+.|+|++|+-..+|.-|.+|-.. .+... ...|.-|.. + ...
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~---~~~g~~p~s~~L~~~~aw 455 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVL---PMIGNGPNSPMLTDKSAW 455 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Ccccc---CCCCCCCCccccchhhhc
Confidence 7654 345567999999999766 5699999999999988888888888654 11111 111211100 0 011
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 252 ~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
....-+++...|+. .|..|+++..++.|.+|..-.
T Consensus 456 ~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 456 SPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 11222358889999 899999999999999986543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.3e-05 Score=80.56 Aligned_cols=141 Identities=14% Similarity=0.150 Sum_probs=96.7
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEEe--ecccCCCHHHHHHHHHHHHHHHhCCCCC--cceee--eEeeecCCCeEEEEE
Q 004645 32 GKGASKTVYRAFDEYEGIEVAWNQVK--LYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFY--TSWVDTANRNINFVT 105 (740)
Q Consensus 32 G~GafGtVYkA~d~~tg~~VAiK~vk--l~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~--~~fvd~~~~~i~lV~ 105 (740)
|+||.+-|++.. ..|..+-+|+-. +.....-+-....|.+|+..|.+|..-+ +.+.. +.--.......+||+
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 567888888863 345567777553 1111111224567999999999984322 33333 111112234578999
Q ss_pred eccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCc--EEEeccchhh
Q 004645 106 EMFTS-GTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAA 177 (740)
Q Consensus 106 Ey~~g-GSL~~~l~~~--k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~--VKL~DFGlA~ 177 (740)
|-+.| .+|.+++... .+.+...-..++.+|...|.-||..| +.|+|+-+.|||++.. |. |+++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 97754 5888886553 34577777899999999999999999 9999999999999844 45 9999997553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.8e-05 Score=76.57 Aligned_cols=141 Identities=22% Similarity=0.255 Sum_probs=81.2
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC--CcceeeeEeeec-CCCeEEEEE
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR--NIMKFYTSWVDT-ANRNINFVT 105 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~fvd~-~~~~i~lV~ 105 (740)
+.|+.|..+.||++.... ..+++|... .......+..|..+++.|... .+.+++...... .....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~------~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYR------PPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEES------SHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeC------CCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 679999999999997654 478888754 224556788899999888433 355666533222 234579999
Q ss_pred eccCCCCHHH----------------HHH---hc----CCCCH------HHHHH---H------------HHHHHH-HHH
Q 004645 106 EMFTSGTLRQ----------------YRL---KH----RRVNI------RAVKH---W------------CRQILS-GLL 140 (740)
Q Consensus 106 Ey~~gGSL~~----------------~l~---~~----k~lse------~~i~~---i------------~~QIL~-aL~ 140 (740)
++++|.++.. .+. .. ..+.. ..... + ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 00000 00000 0 011222 233
Q ss_pred HHHh-----CCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 141 YLHS-----RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 141 yLHs-----~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
.++. ....++|+|+.|.|||++..++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 223499999999999999455667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.9e-06 Score=101.01 Aligned_cols=205 Identities=23% Similarity=0.346 Sum_probs=145.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeeEeeecCCC--eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 004645 67 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144 (740)
Q Consensus 67 ~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~--~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs 144 (740)
.+.....|+..+..+.|+|++.++.+-+..... .+.+..+++.+-++...+..-..++...++.+..++++||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 445566677788888999999998876553222 233456889999999988888999999999999999999999999
Q ss_pred CCCCeeeccCCCC---ceEEeCCCCcEEEe--ccchhhhhccCcc-ccccCCCCCCCccccccc---cCcccchhhhhhH
Q 004645 145 RDPPVIHRDLKCD---NIFVNGNQGEVKIG--DLGLAAILRKSHA-ARCVGTPEFMAPEVYEEE---YNELVDIYSFGMC 215 (740)
Q Consensus 145 ~gp~IIHrDLKp~---NILld~~~g~VKL~--DFGlA~~l~~~~~-~~~~GTp~YmAPEvl~~~---ys~ksDIWSLGvI 215 (740)
.. ..|.-|... +.-+++. +.+.++ ||+.+..+..... ....-+..+.+||..... .....|+|.+|..
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 86 666655555 3333333 456666 8887766554322 233456678888877643 3344799999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCCC
Q 004645 216 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 216 LyELlTG~~Pf~~~~~~~~i~k~i~~g~~p~~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~~ 286 (740)
+..+..|..+-.....+..+. .........+++.+|+. ++++|+++.++|.|||++...
T Consensus 382 ~~~~~~~~~i~~~~~~~~~~l------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVPVSLL------------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HhhhhhcCcccccccchhhhh------------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 999998765543322111111 11112267899999998 899999999999999997544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3e-05 Score=81.17 Aligned_cols=146 Identities=20% Similarity=0.157 Sum_probs=99.0
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCC------------------CHHH--HHHHHHHHHHHHhCC--C
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ------------------SPEE--LERLYCEIHLLKTLK--H 83 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~------------------~~~~--~~~l~~Ei~iLk~L~--H 83 (740)
.+...|..|--+.||+|.. ..+..+|+|+++.....- +... ..-...|+.-|+++. +
T Consensus 51 ~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 51 ELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 3456788888999999964 468899999987542100 0011 112456778888873 4
Q ss_pred CCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEe
Q 004645 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVN 162 (740)
Q Consensus 84 pNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld 162 (740)
-.+.+-+.++ .-.+||||+...-+.-=..+.-.+....+..+..++++.+.-|-. .+ +||+||+.-|||+.
T Consensus 130 VrvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~ 201 (268)
T COG1718 130 VRVPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH 201 (268)
T ss_pred CCCCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE
Confidence 4455555543 236899999654211111122234444678888999999998887 67 99999999999997
Q ss_pred CCCCcEEEeccchhhhhccC
Q 004645 163 GNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 163 ~~~g~VKL~DFGlA~~l~~~ 182 (740)
.+.+.|+|||-|.....+
T Consensus 202 --~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 --DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --CCeEEEEECccccccCCC
Confidence 468999999988766544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.5e-05 Score=78.54 Aligned_cols=135 Identities=11% Similarity=0.129 Sum_probs=78.8
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeeEeeecCCCeEEEEEe
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~fvd~~~~~i~lV~E 106 (740)
..||.|..+.||+. .|..+++|..... . ....+.+|.++++.+..-. +.+.+.+. +.....++|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~---~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG---F---DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC---C---CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence 57899999999984 2556677765421 1 2345688999999985433 35555543 33556788999
Q ss_pred ccCCCC-HHH-----------H-------HH-hcC----CCCHHH-HHHHHHH----------HHHH-HHHH--HhCCCC
Q 004645 107 MFTSGT-LRQ-----------Y-------RL-KHR----RVNIRA-VKHWCRQ----------ILSG-LLYL--HSRDPP 148 (740)
Q Consensus 107 y~~gGS-L~~-----------~-------l~-~~k----~lse~~-i~~i~~Q----------IL~a-L~yL--Hs~gp~ 148 (740)
+++|.+ +.. + +. -|. ..+... ...+..+ +... ..+| +...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999864 111 0 00 011 111111 1111111 1111 1222 222335
Q ss_pred eeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 149 IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
++|+|+.|.||+++. .+ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~-~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSG-KG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcC-CC-cEEEechhcC
Confidence 889999999999984 45 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00012 Score=75.88 Aligned_cols=78 Identities=17% Similarity=0.087 Sum_probs=49.7
Q ss_pred EEeEEecccCc-eEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEeeecCCCeEEE
Q 004645 26 RYNEILGKGAS-KTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 26 ri~e~LG~Gaf-GtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i~l 103 (740)
|+.. |-.|.+ ..||+.... +..+.+|...-.. ...+..|+++++.|. +--+.+++.+... ....++
T Consensus 2 ~~~~-~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 69 (244)
T cd05150 2 RWER-VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWL 69 (244)
T ss_pred ccee-cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEE
Confidence 4433 444554 889999543 4567766543111 234678999998883 4445567765432 356789
Q ss_pred EEeccCCCCHHH
Q 004645 104 VTEMFTSGTLRQ 115 (740)
Q Consensus 104 V~Ey~~gGSL~~ 115 (740)
|||+++|.+|..
T Consensus 70 v~e~i~G~~l~~ 81 (244)
T cd05150 70 LTSAVPGVPAAA 81 (244)
T ss_pred EEEeeCCccHhH
Confidence 999999987764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=97.85 E-value=2e-05 Score=58.39 Aligned_cols=32 Identities=47% Similarity=0.593 Sum_probs=26.9
Q ss_pred eEEEEEEecCCC------CccceeeeeccCCCCHHHHH
Q 004645 377 IFLRLRIADKEG------RIRNIYFPFDIQTDTALSVA 408 (740)
Q Consensus 377 i~L~Lri~d~~g------~~r~I~F~Fd~~~Dta~svA 408 (740)
|.|+||+.|+.+ ...+|.|.|+++.|+|..||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999987 77899999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00023 Score=73.68 Aligned_cols=141 Identities=13% Similarity=0.142 Sum_probs=84.2
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHH------HHHHHHHHHhC---CCCCcceeee
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELER------LYCEIHLLKTL---KHRNIMKFYT 91 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~------l~~Ei~iLk~L---~HpNIVkl~~ 91 (740)
.+.| ++.+++-......|.+. ...|..+++|..+-.. ......... ..+++..+.++ .--.+..+|-
T Consensus 30 ~~~~-~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 30 DNNY-KIIKVFKNTKRNYVALI--EIDGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred hCCc-eEEEeecCCCccEEEEE--EECCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4555 66677766666556555 5567888888654221 111111111 12233333333 2223333332
Q ss_pred EeeecC---CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcE
Q 004645 92 SWVDTA---NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 168 (740)
Q Consensus 92 ~fvd~~---~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~V 168 (740)
...... ....+++|||++|..|.++.. +++ .+...|..+|.-||..| +.|+|..|.|++++ + +.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGI 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcE
Confidence 211111 134668999999998877521 222 24456778899999999 99999999999998 4 369
Q ss_pred EEeccchhh
Q 004645 169 KIGDLGLAA 177 (740)
Q Consensus 169 KL~DFGlA~ 177 (740)
+++||+...
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=9.1e-05 Score=85.63 Aligned_cols=148 Identities=18% Similarity=0.205 Sum_probs=90.1
Q ss_pred eeEEe-EEecccCceEEEEEEEcCCCeEEEEEEEeeccc--------------------------CCCHH----HHHH--
Q 004645 24 YGRYN-EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--------------------------LQSPE----ELER-- 70 (740)
Q Consensus 24 Y~ri~-e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~--------------------------~~~~~----~~~~-- 70 (740)
|-.+. +.|+.++-|.||+|... +|+.||+|+..-.-. ..-.. ..+.
T Consensus 125 F~eF~~~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEPEPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCCCchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 33344 67999999999999876 499999997652100 00000 0111
Q ss_pred ----HHHHHHHHHhCC-----CCC--cceeeeEeeecCCCeEEEEEeccCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHH
Q 004645 71 ----LYCEIHLLKTLK-----HRN--IMKFYTSWVDTANRNINFVTEMFTSGTLRQYR-LKHRRVNIRAVKHWCRQILSG 138 (740)
Q Consensus 71 ----l~~Ei~iLk~L~-----HpN--IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l-~~~k~lse~~i~~i~~QIL~a 138 (740)
+.+|..-+.+++ .++ |.++|.-+ ...-.++|||+.|..+.+.. .+...++.+.+.....++..
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~- 278 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL- 278 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhc----cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH-
Confidence 233333333331 222 23333211 23446899999999888773 22255665555544443332
Q ss_pred HHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhhhhcc
Q 004645 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 139 L~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~ 181 (740)
..+-..| ++|.|..|.||+++.+ |.+.+.|||+...+.+
T Consensus 279 -~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 -RQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred -HHHHhcC--ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 2222356 9999999999999955 8999999999866543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00021 Score=71.56 Aligned_cols=132 Identities=23% Similarity=0.289 Sum_probs=92.6
Q ss_pred EEeEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCcc-eeeeEeeecCCCeEEEE
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM-KFYTSWVDTANRNINFV 104 (740)
Q Consensus 26 ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV-kl~~~fvd~~~~~i~lV 104 (740)
+..+.||+|.++.||++ .+.|..+|+|+-+ .+.....+..|+++|..+.-.++. ++|.+ + ..++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~--~~~~~~~a~Kvrr------~ds~r~~l~kEakiLeil~g~~~~p~vy~y--g----~~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLG--EWRGGEVALKVRR------RDSPRRNLEKEAKILEILAGEGVTPEVYFY--G----EDFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEe--eccCceEEEEEec------CCcchhhHHHHHHHHHHhhhcCCCceEEEe--c----hhhhh
Confidence 34577999999999999 5678899988654 223456699999999999877774 44442 2 33566
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCC--CceEEeCCCCcEEEeccchhhhhccC
Q 004645 105 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC--DNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 105 ~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp--~NILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
|||+.|-.|....... +.+ -+..+++.---|-..| |-|+.|.- .||++. ++.+.|+||..|++...+
T Consensus 91 me~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hhhhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhccCC
Confidence 9999998887763321 222 2344555555566677 88988864 467775 348999999999855443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00055 Score=83.85 Aligned_cols=148 Identities=19% Similarity=0.306 Sum_probs=89.9
Q ss_pred eEEecccCceEEEEEEEcCCC--eEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC-CCCc--ceeeeEeeecC-CCeE
Q 004645 28 NEILGKGASKTVYRAFDEYEG--IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNI--MKFYTSWVDTA-NRNI 101 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg--~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~-HpNI--Vkl~~~fvd~~-~~~i 101 (740)
.+.|+.|.+..+|+......+ ..+++|+....... .....+.+|+++|+.|. |.+| .+++.++.+.. ....
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 467899999999998654332 35666654321111 12346889999999995 6665 67776553321 2357
Q ss_pred EEEEeccCCCCHHH--------------------HHHh-cC----C-----------CCHHHHHHHHHH-----------
Q 004645 102 NFVTEMFTSGTLRQ--------------------YRLK-HR----R-----------VNIRAVKHWCRQ----------- 134 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~--------------------~l~~-~k----~-----------lse~~i~~i~~Q----------- 134 (740)
|+||||++|..+.+ .+.. |. . .-...+..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 1110 10 0 012344444333
Q ss_pred ----HHHHHHHHHhCCC---------CeeeccCCCCceEEeCCCCc-EEEeccchhhh
Q 004645 135 ----ILSGLLYLHSRDP---------PVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 178 (740)
Q Consensus 135 ----IL~aL~yLHs~gp---------~IIHrDLKp~NILld~~~g~-VKL~DFGlA~~ 178 (740)
+...+.+|..+-| .+||+|++++|||++...+. +-|.||.++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2233566754333 39999999999999854334 57999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00089 Score=68.47 Aligned_cols=136 Identities=20% Similarity=0.321 Sum_probs=90.4
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeeccc------------CCCHHHHHHHHHHHHHHHhCC------CCCcceee
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF------------LQSPEELERLYCEIHLLKTLK------HRNIMKFY 90 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~------------~~~~~~~~~l~~Ei~iLk~L~------HpNIVkl~ 90 (740)
..||+|+.-.||.- . ......||++..... ...........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57999999999975 3 344556787764330 000112345666776666665 78899999
Q ss_pred eEeeecCCCeEEEEEeccCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCC
Q 004645 91 TSWVDTANRNINFVTEMFTS------GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 164 (740)
Q Consensus 91 ~~fvd~~~~~i~lV~Ey~~g------GSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~ 164 (740)
|+. +++....+|+|.+.. -||.+|+ +.+.++. .+...+.++ ..||-.++ |+.+||+|.||++...
T Consensus 84 G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFV--ETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEE--ecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEec
Confidence 954 556778889988654 2788887 4455666 444444444 45777777 9999999999999643
Q ss_pred C--C-cEEEec-cchh
Q 004645 165 Q--G-EVKIGD-LGLA 176 (740)
Q Consensus 165 ~--g-~VKL~D-FGlA 176 (740)
. . .+.|+| ||..
T Consensus 155 ~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCceEEEEEeCCCCc
Confidence 2 2 577887 5544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00032 Score=72.63 Aligned_cols=75 Identities=12% Similarity=0.003 Sum_probs=44.0
Q ss_pred EEecccCce-EEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCC---CcceeeeEeeecC-CCeEEE
Q 004645 29 EILGKGASK-TVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR---NIMKFYTSWVDTA-NRNINF 103 (740)
Q Consensus 29 e~LG~GafG-tVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~Hp---NIVkl~~~fvd~~-~~~i~l 103 (740)
+.|+.|+.. .||+. +..+++|..+ . ......+..|+++|..|... -+.+++....... ....++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~---~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPS---A---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCC---c---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 457777776 49986 2345556433 1 11234688999999888532 3444444221111 123478
Q ss_pred EEeccCCCCHH
Q 004645 104 VTEMFTSGTLR 114 (740)
Q Consensus 104 V~Ey~~gGSL~ 114 (740)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0015 Score=66.99 Aligned_cols=129 Identities=21% Similarity=0.299 Sum_probs=90.9
Q ss_pred eEEeEEecccCc-eEEEEEEEcCCCeEEEEEEEeecccCCC----------H-------HHHHHHHHHHHHHHhC---CC
Q 004645 25 GRYNEILGKGAS-KTVYRAFDEYEGIEVAWNQVKLYDFLQS----------P-------EELERLYCEIHLLKTL---KH 83 (740)
Q Consensus 25 ~ri~e~LG~Gaf-GtVYkA~d~~tg~~VAiK~vkl~~~~~~----------~-------~~~~~l~~Ei~iLk~L---~H 83 (740)
.++.+.||.|.- |.||++. -.|..+|+|+++....... . -...-|..|.+...+| .+
T Consensus 39 I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 39 IEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred EeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 377899999999 9999994 4688999999443221111 0 1234588898887777 45
Q ss_pred CCc--ceeeeEeeecC----------------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 004645 84 RNI--MKFYTSWVDTA----------------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145 (740)
Q Consensus 84 pNI--Vkl~~~fvd~~----------------~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~ 145 (740)
.++ |++|+++.-.. .....||.||.+... .+.... +.+|++-|..+|..
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILHKL 183 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHHHC
Confidence 566 99999875431 123467788776543 223333 46788888999999
Q ss_pred CCCeeeccCCCCceEEeCCCCcEEEeccchh
Q 004645 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 146 gp~IIHrDLKp~NILld~~~g~VKL~DFGlA 176 (740)
| |+-+|+++.|.. + -||+|||.+
T Consensus 184 g--I~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 184 G--IVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred C--eeeccCcccccc---C---CEEEecccC
Confidence 9 999999999987 2 299999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0014 Score=70.81 Aligned_cols=78 Identities=9% Similarity=0.028 Sum_probs=52.9
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC---CCcceeeeEeeec-CCCeEEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH---RNIMKFYTSWVDT-ANRNINF 103 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H---pNIVkl~~~fvd~-~~~~i~l 103 (740)
.+.||.|..+.||+..+. +..+.+|..+.. .....+..|...|+.|.- -.+.++++.+.+. ....-++
T Consensus 19 ~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDS--QGNPMPLMARSF------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcC--CCCEEEEEeccc------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 357999999999998432 234666664310 012458889999998843 3577888765432 2355799
Q ss_pred EEeccCCCCH
Q 004645 104 VTEMFTSGTL 113 (740)
Q Consensus 104 V~Ey~~gGSL 113 (740)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0015 Score=67.06 Aligned_cols=74 Identities=15% Similarity=0.164 Sum_probs=46.6
Q ss_pred EEecccCceEEEEEEEcC-CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEeeecCCCeEEEEEe
Q 004645 29 EILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN-IMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~-tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fvd~~~~~i~lV~E 106 (740)
+.|..|-...+|++.... .+..|++|+..... .......+|+.+++.+...+ .++++..+ . . .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-----ELIIDRERELRIHKLLSKHGLAPKLYATF--Q--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-----cceecHHHHHHHHHHHHhCCCCCeEEEEe--C--C--cEEEE
Confidence 568888899999986443 25678888654211 11122347888999884333 45555432 1 1 37999
Q ss_pred ccCCCCH
Q 004645 107 MFTSGTL 113 (740)
Q Consensus 107 y~~gGSL 113 (740)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0009 Score=77.55 Aligned_cols=144 Identities=19% Similarity=0.129 Sum_probs=90.1
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCC---------------------------CHHHHHHHHHHHHHHH--
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ---------------------------SPEELERLYCEIHLLK-- 79 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~---------------------------~~~~~~~l~~Ei~iLk-- 79 (740)
+.||.-+.|.||+|..+. |+.||+|+-+-.-... -.+..+.+..|+..++
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999998775 9999999654210000 0011223333333322
Q ss_pred --------hCCCCC------cceeeeEeeecCCCeEEEEEeccCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 004645 80 --------TLKHRN------IMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLH 143 (740)
Q Consensus 80 --------~L~HpN------IVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~--l~~~k~lse~~i~~i~~QIL~aL~yLH 143 (740)
.+.|-+ |.++|..+ ...-.++|||+.|..+.+. +.+ ..++...+..-+.++..-+- -
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qI--f 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQI--F 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHH--H
Confidence 233444 55555433 2356799999999877553 333 34555555544444433222 2
Q ss_pred hCCCCeeeccCCCCceEEeC---CCCcEEEeccchhhhhccC
Q 004645 144 SRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 144 s~gp~IIHrDLKp~NILld~---~~g~VKL~DFGlA~~l~~~ 182 (740)
..| ++|.|=.|.||+++. .++.+.+-|||+...+...
T Consensus 319 ~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 345 999999999999984 3568999999998766544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.30 E-value=5e-05 Score=94.11 Aligned_cols=160 Identities=15% Similarity=0.070 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 004645 67 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYL 142 (740)
Q Consensus 67 ~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~----k~lse~~i~~i~~QIL~aL~yL 142 (740)
..+.+..|...++.+.|+++...+.-.........|..++|+.+|.+.+.+.+. ..++...+....++.+.+..-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 345566677777778999999888766666667788999999999999988765 2455555555556657777777
Q ss_pred HhCC---CCeeeccCCCCceEEeCCCCcEEEeccchhhhhccC--ccccccCCCCCCCcccccc-ccCcccchhhhhhHH
Q 004645 143 HSRD---PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCI 216 (740)
Q Consensus 143 Hs~g---p~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~--~~~~~~GTp~YmAPEvl~~-~ys~ksDIWSLGvIL 216 (740)
|+.. -..+|++||+-|.+|..+. .+|++++|+.++..+. .....+++|.|++|++.+. .++.++|+|..|+.+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 7642 2478999999999999885 8999999999854433 2234468899999999885 588889999999999
Q ss_pred HHHHhcCCCCC
Q 004645 217 LEMVTFDYPYS 227 (740)
Q Consensus 217 yELlTG~~Pf~ 227 (740)
|++--|..+|-
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99988887774
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00092 Score=67.66 Aligned_cols=101 Identities=23% Similarity=0.139 Sum_probs=78.4
Q ss_pred HHHHHHHHhCCC-CCcceeeeEeeecCCCeEEEEEeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 004645 72 YCEIHLLKTLKH-RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147 (740)
Q Consensus 72 ~~Ei~iLk~L~H-pNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~---l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp 147 (740)
..|.-+|+.|++ +++++++|+| + .++++||...+++... +.....-++.....++.+++..+.+|+..-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----C--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358889999966 6999999987 2 2569999987765421 1222346889999999999999999987321
Q ss_pred -CeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 148 -PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 148 -~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
.+.-.|++++|+-++ ++|++|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence 388899999999998 5579999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0089 Score=67.42 Aligned_cols=80 Identities=26% Similarity=0.260 Sum_probs=55.3
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccC--CC-HHHHHHHHHHHHHHHhCC---CCCcceeeeEeeecCCCeEE
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL--QS-PEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~--~~-~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fvd~~~~~i~ 102 (740)
+.||.|.+..||++.+...++.|++|+-.-.... .. +-..++...|.+.|+.+. -.+++++|.+ + ....+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CCCCE
Confidence 6799999999999998654468999975311110 11 224567888999998872 2467778774 3 34567
Q ss_pred EEEeccCCCC
Q 004645 103 FVTEMFTSGT 112 (740)
Q Consensus 103 lV~Ey~~gGS 112 (740)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0051 Score=67.94 Aligned_cols=154 Identities=19% Similarity=0.196 Sum_probs=105.2
Q ss_pred CCceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecc--------------------cCCCHHHHH--HHHHHHHHH
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--------------------FLQSPEELE--RLYCEIHLL 78 (740)
Q Consensus 21 ~gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~--------------------~~~~~~~~~--~l~~Ei~iL 78 (740)
.|....|...|..|--+.||.|.. ..|..+|||++|-.- ...++..+- -...|++-|
T Consensus 142 RG~i~~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL 220 (520)
T KOG2270|consen 142 RGVIVEINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL 220 (520)
T ss_pred cCeeeecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence 356667778899999999999974 478889999887421 011222222 245788888
Q ss_pred HhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCc
Q 004645 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 158 (740)
Q Consensus 79 k~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~N 158 (740)
++|....|.----..+ +...|||+++....-..-+.+.-.++...+..+..|++.-+.-|... +.+||.||+=-|
T Consensus 221 kRl~~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN 295 (520)
T KOG2270|consen 221 KRLNNAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFN 295 (520)
T ss_pred HHHHhcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhh
Confidence 8887666542222111 34578999995433222234445677788888888998888888654 249999999999
Q ss_pred eEEeCCCCcEEEeccchhhhhccC
Q 004645 159 IFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 159 ILld~~~g~VKL~DFGlA~~l~~~ 182 (740)
+|+. +|.+.|+|.+-+.....+
T Consensus 296 ~Lyh--dG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 296 LLYH--DGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred heEE--CCEEEEEEccccccCCCh
Confidence 9996 379999999877544433
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0035 Score=65.65 Aligned_cols=135 Identities=19% Similarity=0.202 Sum_probs=75.5
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEeeecCCCeEEEEEecc
Q 004645 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fvd~~~~~i~lV~Ey~ 108 (740)
.+..|-...+|+.. ..|..+++|...... ....-....|..+++.+....+ .+++.. +. -++|+||+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i 70 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC----KALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWL 70 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc----ccccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEec
Confidence 35668888999885 456678877543211 1100124679999999854333 344442 22 26899999
Q ss_pred CCCCHHH--------------HHHh-cC------CCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCeee
Q 004645 109 TSGTLRQ--------------YRLK-HR------RVNI-RAVKHWCRQI---------LSGLLYLHSR------DPPVIH 151 (740)
Q Consensus 109 ~gGSL~~--------------~l~~-~k------~lse-~~i~~i~~QI---------L~aL~yLHs~------gp~IIH 151 (740)
+|.++.. .+.+ |. +++. ..+..+..++ ...+..+-.. .+.++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 9876531 1111 10 1121 1222322222 1112222211 124899
Q ss_pred ccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 152 RDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 152 rDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
+|+.|.||+++++ + +.|+||..+..
T Consensus 151 ~Dl~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 151 MDVHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred CCCCcCcEEEeCC-C-CEEEeccccCc
Confidence 9999999999854 3 79999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0058 Score=65.50 Aligned_cols=75 Identities=23% Similarity=0.183 Sum_probs=47.1
Q ss_pred EEecccCceEEEEEEEcC------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEeeecCCCeE
Q 004645 29 EILGKGASKTVYRAFDEY------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN-IMKFYTSWVDTANRNI 101 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fvd~~~~~i 101 (740)
+.|..|-...||++.... .+..+++|+..... .......+|+.+++.+...+ ..+++.++ ..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 456777788999986433 25788888754221 12234677888888884333 34555543 21
Q ss_pred EEEEeccCCCCHH
Q 004645 102 NFVTEMFTSGTLR 114 (740)
Q Consensus 102 ~lV~Ey~~gGSL~ 114 (740)
.+|+||++|.++.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 3589999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0044 Score=70.79 Aligned_cols=163 Identities=18% Similarity=0.181 Sum_probs=104.1
Q ss_pred HHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 004645 70 RLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149 (740)
Q Consensus 70 ~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~I 149 (740)
.+.....+++.+.|+|...++++- .....+..+|+|++ +.+|.+++..+. +-..... .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccc--c
Confidence 466678899999999999988753 33345688899999 678999866654 2211111 222 3
Q ss_pred eeccCCCCceEEeCCCCcEEEeccchhhhhccCccccccCCCCCCCccccccccCcccchhhhhhHHHHHHhcCCCCCCC
Q 004645 150 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSEC 229 (740)
Q Consensus 150 IHrDLKp~NILld~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~~ys~ksDIWSLGvILyELlTG~~Pf~~~ 229 (740)
.|- +.++++| -++ ... ....| +++|||++|.++.++.-|...+...
T Consensus 89 ~~~-------------~~~~~td-~~~---t~~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LHL-------------NIIYITD-HFL---TKY--PSPIG---------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cee-------------hhhhccc-ccc---ccC--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 332 2344444 111 100 11111 4999999999999999988777654
Q ss_pred CCHHHHHHHHHcCCCCc---------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccCCC
Q 004645 230 THPAQIYKKVISGKKPE---------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 230 ~~~~~i~k~i~~g~~p~---------~~~~~~spelrdLI~kcL~-dPskRpSa~ELL~HPff~~~ 285 (740)
.+.+.+.....-+..+. .+....+..+.++.++|+. .|+.||...++.+++-|...
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 44444332222222222 1223456778889999999 89999999999999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.014 Score=62.21 Aligned_cols=139 Identities=18% Similarity=0.168 Sum_probs=78.5
Q ss_pred EEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeeE----eeecCCCeEE
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTS----WVDTANRNIN 102 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~----fvd~~~~~i~ 102 (740)
+.|..|....+|+... .+..+++|+... .. ...+..|+.++..|...+ +.+++.. ++....+..+
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 5677888889999843 344677786542 11 345777888888884322 4444432 1112234568
Q ss_pred EEEeccCCCCHHH-----H------HHh-c---CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 004645 103 FVTEMFTSGTLRQ-----Y------RLK-H---RRVNI--------RAVK------------HWCRQILSGLLYLHS--- 144 (740)
Q Consensus 103 lV~Ey~~gGSL~~-----~------l~~-~---k~lse--------~~i~------------~i~~QIL~aL~yLHs--- 144 (740)
+|+++++|..+.. + +.+ | ..+.. .... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 1 000 0 00000 0000 011112334444443
Q ss_pred --CCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 145 --RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 145 --~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
....++|+|+.|.|||++. ++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 1124999999999999984 3456899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0024 Score=69.48 Aligned_cols=139 Identities=20% Similarity=0.225 Sum_probs=91.7
Q ss_pred CceeEEeEEecccCceEEEEEEEcCCCeEEEEEEEeecc-----cCCCH-----------HHH--HHHHHHHHHHHhCC-
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-----FLQSP-----------EEL--ERLYCEIHLLKTLK- 82 (740)
Q Consensus 22 gRY~ri~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~-----~~~~~-----------~~~--~~l~~Ei~iLk~L~- 82 (740)
|..+-++..||-|.-+.||.+-+. .|.+.++|.-.+-. ...+. -.+ -...+|+..|+.|.
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred chhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 434466888999999999999765 57777777433321 00000 001 12467889999983
Q ss_pred CC-CcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEE
Q 004645 83 HR-NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 161 (740)
Q Consensus 83 Hp-NIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILl 161 (740)
|- -+.+.++ ....++|||++.|..|.... ...+..+ +...+..-+.-|-.+| +||+|+.--||+|
T Consensus 170 ~gfpVPkpiD------~~RH~Vvmelv~g~Pl~~v~---~v~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv 235 (465)
T KOG2268|consen 170 RGFPVPKPID------HNRHCVVMELVDGYPLRQVR---HVEDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMV 235 (465)
T ss_pred cCCCCCCccc------ccceeeHHHhhcccceeeee---ecCChHH---HHHHHHHHHHHHHHcC--ceecccchheeEE
Confidence 32 3444443 34678899999998886642 2233333 4445555566777888 9999999999999
Q ss_pred eCCCCcEEEeccchh
Q 004645 162 NGNQGEVKIGDLGLA 176 (740)
Q Consensus 162 d~~~g~VKL~DFGlA 176 (740)
. +++.++++||--.
T Consensus 236 ~-dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 K-DDDKIVVIDFPQM 249 (465)
T ss_pred e-cCCCEEEeechHh
Confidence 8 4578999999643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.026 Score=62.32 Aligned_cols=138 Identities=15% Similarity=0.154 Sum_probs=78.8
Q ss_pred EEecccCceEEEEEEEcC----CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEeeecCCCeEEE
Q 004645 29 EILGKGASKTVYRAFDEY----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRNINF 103 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~----tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fvd~~~~~i~l 103 (740)
..|-.|-.-.+|++.... .+..|++|+.... ...... -.+|+.+++.+..-++ .++++.+ .. ..
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~----t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~--~~----g~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG----VELFFD-RDDEIRTFECMSRHGQGPRLLGRF--PN----GR 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC----CCeeec-hHHHHHHHHHHHHcCCCCceEEEE--CC----ce
Confidence 345558888999985322 3467887765421 122222 3679999998854444 4566654 21 14
Q ss_pred EEeccCCCCHHHH--------------HHh-cC--------CCCHHHHHHHHHHHH-----------------HHHHH--
Q 004645 104 VTEMFTSGTLRQY--------------RLK-HR--------RVNIRAVKHWCRQIL-----------------SGLLY-- 141 (740)
Q Consensus 104 V~Ey~~gGSL~~~--------------l~~-~k--------~lse~~i~~i~~QIL-----------------~aL~y-- 141 (740)
|++|+++.+|..- +.+ |. ......+..|+.++. ..+..
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 8999987765321 111 10 011233444443221 11111
Q ss_pred --HHh--CCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 142 --LHS--RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 142 --LHs--~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
+.. ....++|+||++.|||++..++.+.|+||..+.
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 221 112489999999999998555689999998774
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.092 Score=56.72 Aligned_cols=29 Identities=34% Similarity=0.415 Sum_probs=23.9
Q ss_pred CeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 148 ~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
++||+|+.|+|||++++ ...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 49999999999999843 345799999774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.034 Score=59.59 Aligned_cols=31 Identities=19% Similarity=0.298 Sum_probs=24.7
Q ss_pred CeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 148 ~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
.++|+|++|.|||++.+....-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999985322356999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.036 Score=59.78 Aligned_cols=141 Identities=20% Similarity=0.176 Sum_probs=76.8
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeeE----eeecCCCeE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTS----WVDTANRNI 101 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~----fvd~~~~~i 101 (740)
.+.++.|....+|++.. .+| .+++|+.... ... ..+..|+.++..|...+ +.+++.. ++....+..
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~---~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKR---VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCC---CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 35678888889999853 334 5777865421 112 23556777777773222 3444331 111123567
Q ss_pred EEEEeccCCCCHH-----HH------HHh-c---CCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 004645 102 NFVTEMFTSGTLR-----QY------RLK-H---RRV--------NIRAVK---------------HWCRQILSGLLYLH 143 (740)
Q Consensus 102 ~lV~Ey~~gGSL~-----~~------l~~-~---k~l--------se~~i~---------------~i~~QIL~aL~yLH 143 (740)
+++++|++|..+. .+ +.+ | ..+ ...... .....+...+.++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885431 11 000 0 111 011000 00112333455553
Q ss_pred h-----CCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 144 S-----RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 144 s-----~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
. ....++|+|+.+.||+++.+ +.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 2 12349999999999999854 456899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.064 Score=59.74 Aligned_cols=87 Identities=17% Similarity=0.156 Sum_probs=55.9
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccC---CCHHHHHHHHHHHHHHHhCC--CC-CcceeeeEeeecCCCeEEE
Q 004645 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL---QSPEELERLYCEIHLLKTLK--HR-NIMKFYTSWVDTANRNINF 103 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~---~~~~~~~~l~~Ei~iLk~L~--Hp-NIVkl~~~fvd~~~~~i~l 103 (740)
.||.|....||++.+...+..|+||+-.-.-.. .-+-...|...|...|+.+. -| .++++|. .+ .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D--~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FD--TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ec--ccccee
Confidence 479999999999997644468999975422111 11334567778888888772 23 5666766 33 455668
Q ss_pred EEeccCCC-CHHHHHHhc
Q 004645 104 VTEMFTSG-TLRQYRLKH 120 (740)
Q Consensus 104 V~Ey~~gG-SL~~~l~~~ 120 (740)
|||+++.. .|+..+..+
T Consensus 78 vMEdL~~~~ilR~~Li~g 95 (370)
T TIGR01767 78 VMEDLSHHKIARKGLIEG 95 (370)
T ss_pred hHhhCccchHHHHHHHcC
Confidence 99999654 344544443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.089 Score=57.73 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=78.7
Q ss_pred cCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCC--CCcceeeeEeeecCCCeEEEEEeccCCC
Q 004645 34 GASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTANRNINFVTEMFTSG 111 (740)
Q Consensus 34 GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~fvd~~~~~i~lV~Ey~~gG 111 (740)
|..-.+|+..+. ++.+++. . ..............+|+.+|+.+.- .-+...++.+.+..-...|+||+|++|.
T Consensus 36 G~sn~t~~~~~~--~~~~vlR-~--P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 36 GWSNDTFRLGDT--GQKYVLR-K--PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred CcccceEEEecC--CceEEEe-c--CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 333344554333 7777766 2 1112233455677889999998843 2233445544332224668999999984
Q ss_pred CH---------H-HHHH--------h-cC-------------CCCHHHHHHHHHHH--------------HHHHHHHHhC
Q 004645 112 TL---------R-QYRL--------K-HR-------------RVNIRAVKHWCRQI--------------LSGLLYLHSR 145 (740)
Q Consensus 112 SL---------~-~~l~--------~-~k-------------~lse~~i~~i~~QI--------------L~aL~yLHs~ 145 (740)
.+ . .+.. . |+ .....++..|..+. ..-..||+.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 22 1 2211 0 00 01122233333222 2334566555
Q ss_pred CC------CeeeccCCCCceEEeCCCCcEEEeccchhhhh
Q 004645 146 DP------PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 146 gp------~IIHrDLKp~NILld~~~g~VKL~DFGlA~~l 179 (740)
-| .++|+|+.+.||+++... -+-+.||+++..-
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG 229 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLG 229 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence 43 599999999999999554 5899999998653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.17 Score=57.31 Aligned_cols=77 Identities=16% Similarity=0.080 Sum_probs=51.1
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCH---HHHHHHHHHHHHHHhCC---CCCcceeeeEeeecCCCeE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP---EELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~---~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fvd~~~~~i 101 (740)
.+.||.|....||+..+. +..+++|+-...-..... -...+-..|+..|+.+. -..++++|.+. ....
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d----ed~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD----RTMA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC----CCCC
Confidence 467899999999998763 456888865422111111 13556667788887763 24788888754 2456
Q ss_pred EEEEeccCC
Q 004645 102 NFVTEMFTS 110 (740)
Q Consensus 102 ~lV~Ey~~g 110 (740)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.13 Score=56.50 Aligned_cols=139 Identities=15% Similarity=0.187 Sum_probs=76.9
Q ss_pred EEecccCceEEEEEEEcCC---CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEeeecCCCeEEEE
Q 004645 29 EILGKGASKTVYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRNINFV 104 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~t---g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fvd~~~~~i~lV 104 (740)
+.|..|-.-.+|+...... +..|++|+.... .. ..-.-.+|..+++.+..-++ .++++++ . +. +|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~----t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~--~-~G---~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPN----TD-YVIDRERELQAIKYLSAAGFGAKLLGVF--G-NG---MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCC----cC-eEechHHHHHHHHHHHhcCCCCceeEEe--C-Cc---Ee
Confidence 4455577788888854322 236777765421 11 11223578888888855444 4555544 2 11 48
Q ss_pred EeccCCCCHHH--------H------HHh-cC-C------C-CHHHHHHHHHHH-------------------------H
Q 004645 105 TEMFTSGTLRQ--------Y------RLK-HR-R------V-NIRAVKHWCRQI-------------------------L 136 (740)
Q Consensus 105 ~Ey~~gGSL~~--------~------l~~-~k-~------l-se~~i~~i~~QI-------------------------L 136 (740)
.+|++|.+|.. . +.+ |. . . -...+..|+.++ +
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 99998776521 0 111 11 1 1 112233333222 1
Q ss_pred HHHHHHH-hCC--CCeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 137 SGLLYLH-SRD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 137 ~aL~yLH-s~g--p~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
..+..+. ..+ ..++|.||.+.|||++.+.+.++++||..|..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1122222 112 23799999999999985556899999998743
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.056 Score=54.98 Aligned_cols=31 Identities=39% Similarity=0.560 Sum_probs=20.6
Q ss_pred CeeeccCCCCceEEeCCCCcEEEeccchhhh
Q 004645 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 148 ~IIHrDLKp~NILld~~~g~VKL~DFGlA~~ 178 (740)
.++|+||.+.|||++..++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 4899999999999944667999999988743
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.18 Score=56.89 Aligned_cols=90 Identities=22% Similarity=0.235 Sum_probs=58.8
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccC--CCHHHHHHHHHHHHHHHhCC--CC-CcceeeeEeeecCCCeEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL--QSPEELERLYCEIHLLKTLK--HR-NIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~--~~~~~~~~l~~Ei~iLk~L~--Hp-NIVkl~~~fvd~~~~~i~ 102 (740)
.+.||.|.-..||++.+...+..|+||+-.-.-.. .=+-...|...|...|+.+. -| .++++|. .+ .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D--~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FD--SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--EC--cHHhh
Confidence 36789999999999988544567898875321111 11334677888999898872 24 5667766 33 45667
Q ss_pred EEEeccCCC-CHHHHHHhcC
Q 004645 103 FVTEMFTSG-TLRQYRLKHR 121 (740)
Q Consensus 103 lV~Ey~~gG-SL~~~l~~~k 121 (740)
+|||+++.. .|+..+..++
T Consensus 110 ~vMEdL~~~~ilR~~Li~G~ 129 (409)
T PRK12396 110 CVMEDLSDHTILRTALINHE 129 (409)
T ss_pred HHHHhCcccHHHHHHHHcCC
Confidence 899999653 3555554443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.018 Score=66.81 Aligned_cols=67 Identities=25% Similarity=0.409 Sum_probs=56.3
Q ss_pred ceEEEEEEecCCC----CccceeeeeccCCCCHHHHHHHHHhcCCCChhhHHHHHHHHHHHHHhhCCCccC
Q 004645 376 GIFLRLRIADKEG----RIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKR 442 (740)
Q Consensus 376 ~i~L~Lri~d~~g----~~r~I~F~Fd~~~Dta~svA~EMV~~l~i~~~dv~~IA~~Id~~i~~l~p~w~~ 442 (740)
++.|.+|..|..+ ..+.|.|.|+++.|++.+||+|||++..+++.|-..+|+.+.+.+.+|--.-..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~ 388 (632)
T KOG0584|consen 318 ALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRND 388 (632)
T ss_pred cccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhc
Confidence 4456677777652 335899999999999999999999999999999999999999999998655443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.16 Score=55.03 Aligned_cols=73 Identities=16% Similarity=0.059 Sum_probs=43.0
Q ss_pred eEEecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEeeecCCCeEEEE
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRNINFV 104 (740)
Q Consensus 28 ~e~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fvd~~~~~i~lV 104 (740)
.+.|+.|....+|+.. .++..+.+|+-. . .....+..|..-|+.|. --.+++.+.+... ...-++|
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS-E------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE-G------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEE
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC-h------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEE
Confidence 4678889999999985 677788888655 1 12245788888888883 3346677765432 3345899
Q ss_pred EeccCCC
Q 004645 105 TEMFTSG 111 (740)
Q Consensus 105 ~Ey~~gG 111 (740)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.79 Score=49.59 Aligned_cols=29 Identities=10% Similarity=0.126 Sum_probs=25.1
Q ss_pred CeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 148 ~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
.++|+|+.++|||++++ +.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhcc
Confidence 49999999999999854 589999998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.5 Score=53.21 Aligned_cols=80 Identities=14% Similarity=0.033 Sum_probs=44.3
Q ss_pred EEecccCceEEEEEEEcCC-CeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEeeecCCCeEEEEEe
Q 004645 29 EILGKGASKTVYRAFDEYE-GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~t-g~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fvd~~~~~i~lV~E 106 (740)
+.|..|-...+|++..... +..+.+|.|-+..........-.-.+|+++++.|...++ .++++.|. -++|.|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------DFTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------CEEEEE
Confidence 4566688889999864322 122222221111101111111223568999999955444 56676552 268999
Q ss_pred ccCCCCHH
Q 004645 107 MFTSGTLR 114 (740)
Q Consensus 107 y~~gGSL~ 114 (740)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987653
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.47 Score=53.96 Aligned_cols=30 Identities=27% Similarity=0.318 Sum_probs=22.7
Q ss_pred CCeeeccCCCCceEEeCCCC----cEEEeccchh
Q 004645 147 PPVIHRDLKCDNIFVNGNQG----EVKIGDLGLA 176 (740)
Q Consensus 147 p~IIHrDLKp~NILld~~~g----~VKL~DFGlA 176 (740)
+-++|+||...|||.+.+.+ ...|+||-.+
T Consensus 268 ~VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~v 301 (414)
T PF07914_consen 268 PVLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCV 301 (414)
T ss_pred cceecCCccHHheeeecCCchhHHHHHHHHHHHh
Confidence 45999999999999986443 3467787654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.79 E-value=0.62 Score=48.86 Aligned_cols=85 Identities=16% Similarity=0.251 Sum_probs=60.4
Q ss_pred HHHHHHHHHHhCCCCCcceeeeEeeecCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 004645 70 RLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 149 (740)
Q Consensus 70 ~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~I 149 (740)
-++++.+++.++. .|+++.. .....+.+|.|+|-.... .. ..++..=+.+|.-.|+.++..
T Consensus 104 ~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------~~----~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------NF----SNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------ch----hHHHHHhHHHHHHhhccCCCe
Confidence 4678888888874 5777764 345678899999843211 00 112222256788889776789
Q ss_pred eeccCCCCceEEeCCCCcEEEeccc
Q 004645 150 IHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 150 IHrDLKp~NILld~~~g~VKL~DFG 174 (740)
+|+|-.|+||+-+ ..|.+||.|-+
T Consensus 165 lHGD~np~NiM~D-~~G~lKlVDP~ 188 (308)
T PF07387_consen 165 LHGDCNPDNIMCD-KFGYLKLVDPV 188 (308)
T ss_pred ecCCCChhheeec-CCCCEEecChh
Confidence 9999999999998 55899999965
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.71 E-value=0.76 Score=52.02 Aligned_cols=63 Identities=17% Similarity=0.209 Sum_probs=44.4
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeccCCCCceEEeCCCC
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQG 166 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs-~gp~IIHrDLKp~NILld~~~g 166 (740)
..++-+|..|.++..++ +.+..+++..+.++.-...||-.+-- -+ ++|.||.|.||++..+.+
T Consensus 320 ~vl~E~~~~Gl~v~~~v-~~~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFV-KWKSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhh-hcccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecCC
Confidence 44666788888888874 44556666667777666666554433 34 999999999999975544
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.08 E-value=1.9 Score=45.59 Aligned_cols=74 Identities=18% Similarity=0.154 Sum_probs=46.0
Q ss_pred EecccCceEEEEEEEcCCCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEeeecCCCeEEEEEe
Q 004645 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 30 ~LG~GafGtVYkA~d~~tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
.+.-|..-..|... .....+-+|. +.......+..|+.-|..|. .-.+.+.+. +.....+.|+|+|
T Consensus 23 ~v~gG~inea~~v~--dg~~~~FvK~-------n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVle 91 (286)
T COG3001 23 EVSGGDINEAWRLR--DGTDPFFVKC-------NQREQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVLE 91 (286)
T ss_pred ccCCccccceeEee--cCCcceEEEe-------cchhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEEe
Confidence 34445444445442 2234455442 23445667888888777773 345667766 4566889999999
Q ss_pred ccCCCCHH
Q 004645 107 MFTSGTLR 114 (740)
Q Consensus 107 y~~gGSL~ 114 (740)
|++-+.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99886553
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.75 E-value=2 Score=49.40 Aligned_cols=74 Identities=14% Similarity=0.119 Sum_probs=44.3
Q ss_pred EEecccCceEEEEEEEcC--------CCeEEEEEEEeecccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEeeecCCC
Q 004645 29 EILGKGASKTVYRAFDEY--------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANR 99 (740)
Q Consensus 29 e~LG~GafGtVYkA~d~~--------tg~~VAiK~vkl~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fvd~~~~ 99 (740)
+.|..|-.-.+|++.... .+..|.+++.-.. .. ..-.-..|..+++.+...+| .++++.| .
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~----te-~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~--- 180 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD----VD-ELYNPISEFEVYKTMSKYRIAPQLLNTF--S--- 180 (442)
T ss_pred EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC----cc-ceeCHHHHHHHHHHHHHCCCCCceEEEe--C---
Confidence 557777778888886432 1456776655321 11 12234568888888855455 3566654 1
Q ss_pred eEEEEEeccCCCCH
Q 004645 100 NINFVTEMFTSGTL 113 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL 113 (740)
-+.|.+|++|-+|
T Consensus 181 -gg~I~efi~g~~l 193 (442)
T PTZ00296 181 -GGRIEEWLYGDPL 193 (442)
T ss_pred -CCEEEEeeCCccC
Confidence 1457899988744
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.56 E-value=1.2 Score=49.70 Aligned_cols=73 Identities=19% Similarity=0.243 Sum_probs=55.5
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeccCCCCceEEeCCCCcEEEeccchhh
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~lse~~i~~i~~QIL~aL~yLHs~gp~IIHrDLKp~NILld~~~g~VKL~DFGlA~ 177 (740)
..+.|++|++. |+.|.- .+....+++..++.+.+..|.-+..+ -+.-||+|..+||||+ + |+|.|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~-GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-E-GNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-c-CceEEEEeeeee
Confidence 45677788876 555532 23345677888888888777777665 4799999999999998 4 899999999987
Q ss_pred h
Q 004645 178 I 178 (740)
Q Consensus 178 ~ 178 (740)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 740 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-69 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-25 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 437 bits (1126), Expect = e-150
Identities = 132/284 (46%), Positives = 185/284 (65%), Gaps = 5/284 (1%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS 64
E ++ V + GR+ +++ +G+G+ KTVY+ D +EVAW +++ +
Sbjct: 8 QDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LT 65
Query: 65 PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHRR 122
E +R E +LK L+H NI++FY SW T + I VTE+ TSGTL+ Y + +
Sbjct: 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV 125
Query: 123 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182
+ I+ ++ WCRQIL GL +LH+R PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 183 HAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242
A +GTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T +YPYSEC + AQIY++V SG
Sbjct: 186 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245
Query: 243 KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 285
KP + KV PEV++ IE C+ R S ++LL F Q +
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-61
Identities = 86/292 (29%), Positives = 130/292 (44%), Gaps = 25/292 (8%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS 64
S+ E S+ +E D +LGKG VY D + +A ++ +
Sbjct: 4 STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE----RD 59
Query: 65 PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRV 123
+ L+ EI L K LKH+NI+++ S+ + I E G+L R K +
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI--FMEQVPGGSLSALLRSKWGPL 117
Query: 124 NIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
+ + +QIL GL YLH ++HRD+K DN+ +N G +KI D G + L
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 182 SHAAR--CVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 236
+ GT ++MAPE+ ++ Y + DI+S G I+EM T P+ E P
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 237 KKVISGKK----PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
KV K PE++ E + FI KC R A +LL D FL+
Sbjct: 236 FKVGMFKVHPEIPESM----SAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 18/267 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+G G+ + + +G + W ++ + E + L E++LL+ LKH NI++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR----AVKHWCRQILSGLLYLHS 144
+Y +D N + V E G L K + V Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 145 RDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPEVY 199
R V+HRDLK N+F++G VK+GD GLA IL S A VGTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 200 EEE-YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257
YNE DI+S G C+L E+ P++ + ++ K+ G K + E+
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQK-ELAGKIREG-KFRRIPYRYSDELN 245
Query: 258 QFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ I + L R S E+L +P +
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 8e-57
Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 17/294 (5%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKL 58
M G P+ + + +G+G VYRA +G+ VA +V++
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 59 YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-- 116
+D L + EI LLK L H N++K+Y S+++ + +N V E+ +G L +
Sbjct: 68 FD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIK 124
Query: 117 RLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174
K ++ I R V + Q+ S L ++HSR V+HRD+K N+F+ G VK+GDLG
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLG 181
Query: 175 LAAILR--KSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPY-SECT 230
L + A VGTP +M+PE E YN DI+S G + EM P+ +
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241
Query: 231 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
+ + KK+ P E+RQ + C+ R +
Sbjct: 242 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 21/287 (7%)
Query: 5 SSPEESDSSEFVEVDPTGRYG-RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDF 61
+ E S + P + + + LG G+ V++ + +G A +
Sbjct: 36 EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF- 94
Query: 62 LQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
+ P++ R E+ + + +H ++ +W + + TE +L Q +
Sbjct: 95 -RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYLQTE-LCGPSL-QQHCEA 149
Query: 121 RRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178
++ V + R L L +LHS+ ++H D+K NIF+ G K+GD GL
Sbjct: 150 WGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVE 206
Query: 179 LRKSHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 237
L + A G P +MAPE+ + Y D++S G+ ILE+ Q+ +
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
Query: 238 KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ + L E+R + L R +A LL P L+
Sbjct: 267 GYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-56
Identities = 63/261 (24%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ +G+G+ +G + ++ + S +E E E+ +L +KH NI++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQ 87
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRD 146
+ S+ + N ++ V + G L + + V + W QI L ++H R
Sbjct: 88 YRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEEE-Y 203
++HRD+K NIF+ + G V++GD G+A +L A C+GTP +++PE+ E + Y
Sbjct: 146 --ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263
N DI++ G + E+ T + + E + K+ISG + ++R + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260
Query: 264 LATV-SSRLSARELLTDPFLQ 283
R S +L F+
Sbjct: 261 FKRNPRDRPSVNSILEKGFIA 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 8e-55
Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 37/274 (13%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E++G G V++A +G +VK E+ E+ L L H NI+
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALAKLDHVNIVH 68
Query: 89 FYTSWVD--------------TANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWC 132
+ W + + + E GTL Q+ + + +++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAARCVGTP 191
QI G+ Y+HS+ +I+RDLK NIF+ +VKIGD GL L+ R GT
Sbjct: 129 EQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250
+M+PE + Y + VD+Y+ G+ + E++ E ++ + + G +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIF-- 240
Query: 251 VEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
D + + ++K L+ R + E+L +
Sbjct: 241 --DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-54
Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 44/297 (14%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+LG+GA V +A + + A +++ + E+L + E+ LL +L H+ +++
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 89 FYTSWVDTANRNIN-----------FVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQIL 136
+Y +W++ N E +GTL ++ RQIL
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---------- 186
L Y+HS+ +IHRDLK NIF++ + VKIGD GLA + +S
Sbjct: 127 EALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 187 ------CVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
+GT ++A EV + YNE +D+YS G+ EM+ YP+S I KK
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKK 240
Query: 239 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 292
+ S P + ++ I + + R AR LL +L + D ++
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-54
Identities = 65/295 (22%), Positives = 119/295 (40%), Gaps = 44/295 (14%)
Query: 22 GRY-GRYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
GRY + I LG+G V+ A ++ + A +++L + E++ E+ L
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKAL 57
Query: 79 KTLKHRNIMKFYTSWVDTANRNINF----------VTEMFTSGTLRQYRLKHRRVN---- 124
L+H I++++ +W++ ++ L+ + + R
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW-MNGRCTIEERE 116
Query: 125 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
H QI + +LHS+ ++HRDLK NIF + VK+GD GL + +
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEE 173
Query: 185 A--------------RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSEC 229
VGT +M+PE Y+ VDI+S G+ + E++ YP+S
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQ 230
Query: 230 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
+ V + K P LF + P ++ L+ R A ++ + +
Sbjct: 231 MERVRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 66/295 (22%), Positives = 114/295 (38%), Gaps = 27/295 (9%)
Query: 3 GVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL 62
GV E+ ++ + +G+G+ V+R D+ G + A +V+L F
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQ-PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR 97
Query: 63 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 122
E+ L I+ Y + + NI E+ G+L Q +
Sbjct: 98 VE---------ELVACAGLSSPRIVPLYGAVREGPWVNI--FMELLEGGSLGQLIKQMGC 146
Query: 123 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182
+ ++ Q L GL YLH+R ++H D+K DN+ ++ + + D G A L+
Sbjct: 147 LPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 183 HAARC-------VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 234
+ GT MAPEV + + VDI+S +L M+ +P+++
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264
Query: 235 IYKKVISGKKPEALFKVED--PEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 286
K I+ + P P Q I++ L R SA EL + +
Sbjct: 265 CLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-51
Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 36/278 (12%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEI-----LGKGASKTVYRAFDEYEGIEVAWNQVKLY 59
+ + + +++ + ++ +G G+ TV+RA E+ G +VA VK+
Sbjct: 21 LYFQGAMDGDDMDIP-------WCDLNIKEKIGAGSFGTVHRA--EWHGSDVA---VKIL 68
Query: 60 DFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-- 116
E + E+ ++K L+H NI+ F + N +I VTE + G+L +
Sbjct: 69 MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLH 126
Query: 117 -RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175
+++ R + G+ YLH+R+PP++HR+LK N+ V+ VK+ D GL
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGL 185
Query: 176 AAILRKSHAAR--CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 232
+ + + + GTPE+MAPEV E NE D+YSFG+ + E+ T P+ +P
Sbjct: 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NP 244
Query: 233 AQIYKKVISGKK----PEALFKVEDPEVRQFIEKCLAT 266
AQ+ V K P L +P+V IE C
Sbjct: 245 AQVVAAVGFKCKRLEIPRNL----NPQVAAIIEGCWTN 278
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-50
Identities = 69/241 (28%), Positives = 113/241 (46%), Gaps = 20/241 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E++G+GA V +A ++ +VA +K ++S E + E+ L + H NI+K
Sbjct: 14 EVVGRGAFGVVCKA--KWRAKDVA---IKQ---IESESERKAFIVELRQLSRVNHPNIVK 65
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSR 145
Y + ++ + V E G+L WC Q G+ YLHS
Sbjct: 66 LYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 146 DP-PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEY 203
P +IHRDLK N+ + +KI D G A + ++H G+ +MAPEV+E Y
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-QTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVEDPEVRQFIEK 262
+E D++S+G+ + E++T P+ E PA I V +G +P L K + + +
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIKNLPKPIESLMTR 239
Query: 263 C 263
C
Sbjct: 240 C 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-50
Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 22/290 (7%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD 60
M + ++ DP + + +I GKG+ V++ D VA +K+ D
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIID 56
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
++ +E+E + EI +L + K+Y S++ + + + E G+ L+
Sbjct: 57 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDL-LEP 113
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
++ + R+IL GL YLHS IHRD+K N+ ++ GEVK+ D G+A L
Sbjct: 114 GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLT 170
Query: 181 KSHAARC--VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 237
+ R VGTP +MAPEV ++ Y+ DI+S G+ +E+ + P+SE HP
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPM---- 225
Query: 238 KV---ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
KV I P L +++F+E CL S R +A+ELL F+
Sbjct: 226 KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-49
Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 15/244 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
EI+G G VYRA + G EVA + + +E + E L LKH NI+
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP- 147
+ N + V E G L + L +R+ + +W QI G+ YLH
Sbjct: 71 LRGVCLKEPNLCL--VMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 148 PVIHRDLKCDNIFVNGNQGE-------VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE 200
P+IHRDLK NI + +KI D GLA ++ G +MAPEV
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187
Query: 201 -EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
+++ D++S+G+ + E++T + P+ A Y ++ +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC-PEPFAKL 246
Query: 260 IEKC 263
+E C
Sbjct: 247 MEDC 250
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-49
Identities = 63/304 (20%), Positives = 120/304 (39%), Gaps = 33/304 (10%)
Query: 3 GVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL 62
G +++ SS + GR + +G G S V++ +E + A V L +
Sbjct: 36 GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA- 93
Query: 63 QSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
+ L+ EI L L+ I++ Y + ++ I V E + L + K
Sbjct: 94 -DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKK 149
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAIL 179
+ ++ K + + +L + +H ++H DLK N V+G +K+ D G+A +
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGM---LKLIDFGIANQM 204
Query: 180 R----KSHAARCVGTPEFMAPEVYEEE------------YNELVDIYSFGMCIL-EMVTF 222
+ VG +M PE ++ + D++S G CIL M
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYG 263
Query: 223 DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPF 281
P+ + + +I + + +++ ++ CL R+S ELL P+
Sbjct: 264 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 282 LQID 285
+QI
Sbjct: 324 VQIQ 327
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 8e-49
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 33/280 (11%)
Query: 3 GVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLY--- 59
G E S + Y + +GKG V++ + VA +K
Sbjct: 1 GAMGGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVA---IKSLILG 55
Query: 60 ---DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY 116
+ E+ + E+ ++ L H NI+K Y + V E G L
Sbjct: 56 DSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL----MHNPPRMVMEFVPCGDLYHR 111
Query: 117 -RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE----VKIG 171
K + I G+ Y+ +++PP++HRDL+ NIF+ K+
Sbjct: 112 LLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 172 DLGLAAILRKSHAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSE 228
D GL+ S + +G ++MAPE E Y E D YSF M + ++T + P+ E
Sbjct: 172 DFGLSQQSVHS-VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 229 CTH-PAQIYKKVISGKK----PEALFKVEDPEVRQFIEKC 263
++ + + PE P +R IE C
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDC----PPRLRNVIELC 266
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 95/281 (33%), Positives = 135/281 (48%), Gaps = 39/281 (13%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP +Y R+ +I G+GAS TVY A D G EVA ++ + LQ + E + EI ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVA---IRQMN-LQQQPKKELIINEILVM 71
Query: 79 KTLKHRNIMKFYTS-------WVDTANRNINFVTEMFTSGTLRQYRLKHRRVN---IRAV 128
+ K+ NI+ + S WV V E G+L + ++ I AV
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWV---------VMEYLAGGSLTDV-VTETCMDEGQIAAV 121
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC- 187
CR+ L L +LHS VIHRD+K DNI + G VK+ D G A + + R
Sbjct: 122 ---CRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 175
Query: 188 -VGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 245
VGTP +MAPEV + Y VDI+S G+ +EM+ + PY +P + I+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYL-IATNGT 233
Query: 246 EALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
L E R F+ +CL V R SA+ELL FL+
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 56/277 (20%), Positives = 110/277 (39%), Gaps = 31/277 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNI 86
+ +G G S V++ +E + A V L + + L+ EI L L+ I
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
++ Y + ++ I V E + L + K + ++ K + + +L + +H
Sbjct: 72 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 147 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILR----KSHAARCVGTPEFMAPEV--- 198
++H DLK N V+G +K+ D G+A ++ VGT +M PE
Sbjct: 129 --IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 199 ---------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249
+ + + D++S G + M P+ + + +I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 250 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 285
+ + +++ ++ CL R+S ELL P++QI
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 56/307 (18%), Positives = 117/307 (38%), Gaps = 49/307 (15%)
Query: 3 GVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL 62
G + ++EF E+ E +G G +V++ +G A + K L
Sbjct: 1 GAMGMKSRYTTEFHEL----------EKIGSGEFGSVFKCVKRLDGCIYAIKRSKK--PL 48
Query: 63 QSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 121
+ + E++ L +H ++++++++W + + ++ E G+L ++
Sbjct: 49 AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENY 106
Query: 122 RVNIR----AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN------------- 164
R+ +K Q+ GL Y+HS ++H D+K NIF++
Sbjct: 107 RIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDED 164
Query: 165 -----QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCIL 217
+ KIGDLG + G F+A EV +E + DI++ + ++
Sbjct: 165 DWASNKVMFKIGDLGHVTRISSPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVV 222
Query: 218 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSAREL 276
+ + ++ G+ P + +V E + ++ + R SA L
Sbjct: 223 CAAGAEPLPRN----GDQWHEIRQGRLPR-IPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
Query: 277 LTDPFLQ 283
+ L
Sbjct: 278 VKHSVLL 284
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 61/308 (19%), Positives = 121/308 (39%), Gaps = 36/308 (11%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKL 58
+ S + + + + Y+ + +G G S V++ +E + A V L
Sbjct: 5 HHHSSGVDLGTENLYFQSMSVKGR-IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL 62
Query: 59 YDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTSWVDTANRNINFVTEMFTSGTLRQY 116
+ + L+ EI L L+ + I++ Y + ++ I V E + L +
Sbjct: 63 EEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVME-CGNIDLNSW 117
Query: 117 RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGL 175
K + ++ K + + +L + +H ++H DLK N V+G +K+ D G+
Sbjct: 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGM---LKLIDFGI 172
Query: 176 AAILRK----SHAARCVGTPEFMAPEVYEEE------------YNELVDIYSFGMCIL-E 218
A ++ VGT +M PE ++ + D++S G CIL
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYY 231
Query: 219 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 277
M P+ + + +I + + +++ ++ CL R+S ELL
Sbjct: 232 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
Query: 278 TDPFLQID 285
P++QI
Sbjct: 292 AHPYVQIQ 299
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-48
Identities = 91/281 (32%), Positives = 135/281 (48%), Gaps = 39/281 (13%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP Y +I G+G++ V A +++ G +VA VK+ D L+ + E L+ E+ ++
Sbjct: 42 DPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIM 96
Query: 79 KTLKHRNIMKFYTS-------WVDTANRNINFVTEMFTSGTLRQYRLKHRRVN---IRAV 128
+ +H N+++ Y S WV + E G L + R+N I V
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWV---------LMEFLQGGALTDI-VSQVRLNEEQIATV 146
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC- 187
C +L L YLH++ VIHRD+K D+I + G VK+ D G A + K R
Sbjct: 147 ---CEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS 200
Query: 188 -VGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 245
VGTP +MAPEV Y VDI+S G+ ++EMV + PY P Q K+ + P
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKR-LRDSPP 258
Query: 246 EALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
L P +R F+E+ L R +A+ELL PFL
Sbjct: 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 37/242 (15%), Positives = 94/242 (38%), Gaps = 17/242 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHRNIM 87
L + S +++ ++G ++ VK+ R + E L+ H N++
Sbjct: 16 TKLNENHSGELWKG--RWQGNDIV---VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
+ + +T G+L + V+ + + G+ +LH+
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--- 202
+P + L ++ ++ + +I + + + P ++APE +++
Sbjct: 131 EPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSPGR---MYAPAWVAPEALQKKPED 186
Query: 203 -YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261
D++SF + + E+VT + P+++ ++ K + G +P + P V + ++
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT-IPPGISPHVSKLMK 245
Query: 262 KC 263
C
Sbjct: 246 IC 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-47
Identities = 84/285 (29%), Positives = 137/285 (48%), Gaps = 32/285 (11%)
Query: 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCE 74
++DP + E+ G GA VY+A ++ G A K+ + +S EELE E
Sbjct: 12 RRDLDPNEVWEIVGEL-GDGAFGKVYKAKNKETGALAA---AKVIE-TKSEEELEDYIVE 66
Query: 75 IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV----NIRAVKH 130
I +L T H I+K ++ + + + E G + L+ R I+ V
Sbjct: 67 IEILATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV-- 122
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--V 188
CRQ+L L +LHS+ +IHRDLK N+ + +G++++ D G++A K+ R +
Sbjct: 123 -CRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 189 GTPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVIS 241
GTP +MAPEV + Y+ DI+S G+ ++EM + P+ E +P + + K I+
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLK--IA 235
Query: 242 GKKPEALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
P L E R F++ L +R SA +LL PF+
Sbjct: 236 KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-47
Identities = 57/257 (22%), Positives = 112/257 (43%), Gaps = 32/257 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIM 87
E++GKG VY + G EVA ++L D + + ++L+ E+ + +H N++
Sbjct: 39 ELIGKGRFGQVYHGR--WHG-EVA---IRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
F + + + I +T + TL R +++ + ++I+ G+ YLH++
Sbjct: 93 LFMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK- 149
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-------CVGTPEFMAPEV- 198
++H+DLK N+F + G+V I D GL +I A R G +APE+
Sbjct: 150 -GILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 199 ---------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249
+ +++ D+++ G E+ ++P+ I ++ +G KP
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQ 265
Query: 250 KVEDPEVRQFIEKCLAT 266
E+ + C A
Sbjct: 266 IGMGKEISDILLFCWAF 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 84/306 (27%), Positives = 122/306 (39%), Gaps = 46/306 (15%)
Query: 9 ESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEEL 68
DSS Y I G GA+ V A+ + +VA +K + + +
Sbjct: 2 SEDSSALPWSINRDDYELQEVI-GSGATAVVQAAYCAPKKEKVA---IKRINLEKCQTSM 57
Query: 69 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 128
+ L EI + H NI+ +YTS+V + V ++ + G++ +KH
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWLVMKLLSGGSVLDI-IKHIVAKGEHK 114
Query: 129 KHW---------CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179
R++L GL YLH IHRD+K NI + G V+I D G++A L
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFL 171
Query: 180 RKSHAARC-------VGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECT 230
VGTP +MAPEV E+ Y+ DI+SFG+ +E+ T PY +
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-Y 230
Query: 231 HPAQIYKKV---ISGKKPEALFKVED---------PEVRQFIEKCLA-TVSSRLSARELL 277
P KV P +L R+ I CL R +A ELL
Sbjct: 231 PPM----KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 278 TDPFLQ 283
F Q
Sbjct: 287 RHKFFQ 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
P + ++ G+G+ +VY+A + G VA +K +E+ + EI ++
Sbjct: 26 QPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVA---IKQVPVESDLQEIIK---EISIM 78
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVN---IRAVKHWCRQ 134
+ +++K+Y S+ N ++ V E +G++ RL+++ + I + +
Sbjct: 79 QQCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI---LQS 133
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPE 192
L GL YLH IHRD+K NI +N +G K+ D G+A L + A R +GTP
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 193 FMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFK 250
+MAPEV E YN + DI+S G+ +EM PY++ HP + I+ I P K
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFM--IPTNPPPTFRK 247
Query: 251 VED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
E F+++CL + R +A +LL PF++
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 78/298 (26%), Positives = 130/298 (43%), Gaps = 25/298 (8%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS 64
S + + F + DP + EI G G+ VY A D VA ++ QS
Sbjct: 37 SLKDPDVAELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQS 94
Query: 65 PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVN 124
E+ + + E+ L+ L+H N +++ ++ V E + + +
Sbjct: 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQ 152
Query: 125 ---IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
I AV L GL YLHS + +IHRD+K NI ++ G VK+GD G A+I+
Sbjct: 153 EVEIAAV---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 206
Query: 182 SHAARCVGTPEFMAPEV----YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IY 236
+++ VGTP +MAPEV E +Y+ VD++S G+ +E+ P + +Y
Sbjct: 207 ANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALY 263
Query: 237 KKVISGKKPEALFKVE-DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLR 292
I+ + AL R F++ CL R ++ LL F+ + + +
Sbjct: 264 H--IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 319
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 69/248 (27%), Positives = 122/248 (49%), Gaps = 25/248 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIM 87
+ +G G+ TVY+ ++ G +VA VK+ + +P++L+ E+ +L+ +H NI+
Sbjct: 30 QRIGSGSFGTVYKG--KWHG-DVA---VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
F + I VT+ +L + + ++ + RQ G+ YLH++
Sbjct: 84 LFM-GYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYEEE 202
+IHRDLK +NIF++ + VKIGD GLA + + G+ +MAPEV +
Sbjct: 140 -SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 203 ----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE---DPE 255
Y+ D+Y+FG+ + E++T PYS + QI + V G L KV
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 256 VRQFIEKC 263
+++ + +C
Sbjct: 258 MKRLMAEC 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 50/290 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ +GKG V+ ++ G +VA VK+ F + E EI+ ++H NI+
Sbjct: 43 KQIGKGRYGEVWMG--KWRGEKVA---VKV--FFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 89 FYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
F + + +T+ +G+L Y LK ++ +++ +SGL +LH+
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDY-LKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 147 ------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFM 194
P + HRDLK NI V N G I DLGLA VGT +M
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 195 APEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECTHP----A 233
PEV +E + + D+YSFG+ + E+ + PY +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 234 QIYKKVISGKK----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 277
+ + V K P E ++ + + +C A +SRL+A +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-45
Identities = 81/306 (26%), Positives = 134/306 (43%), Gaps = 39/306 (12%)
Query: 1 MNGVSSPEESDSSEFVEV-DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLY 59
M S D + + DP G + + G G VY+ G A + +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELV-GNGTYGQVYKGRHVKTGQLAAIKVMDV- 59
Query: 60 DFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNIN----FVTEMFTSGTLR 114
+ +E E + EI++LK HRNI +Y +++ ++ V E +G++
Sbjct: 60 ----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 115 --QYRLKHRRVN---IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 169
K + I + CR+IL GL +LH VIHRD+K N+ + EVK
Sbjct: 116 DLIKNTKGNTLKEEWIAYI---CREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVK 169
Query: 170 IGDLGLAAILRKSHAAR--CVGTPEFMAPEV------YEEEYNELVDIYSFGMCILEMVT 221
+ D G++A L ++ R +GTP +MAPEV + Y+ D++S G+ +EM
Sbjct: 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 222 FDYPYSECTHPAQ-IYKKVISGKKPEALFKVED--PEVRQFIEKCLA-TVSSRLSARELL 277
P + HP + ++ I L K + + + FIE CL S R + +L+
Sbjct: 230 GAPPLCD-MHPMRALFL--IPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285
Query: 278 TDPFLQ 283
PF++
Sbjct: 286 KHPFIR 291
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-44
Identities = 74/290 (25%), Positives = 110/290 (37%), Gaps = 50/290 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +GKG V+R ++ G EVA VK+ F E EI+ L+H NI+
Sbjct: 48 ESIGKGRFGEVWRG--KWRGEEVA---VKI--FSSREERSWFREAEIYQTVMLRHENILG 100
Query: 89 FYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
F + V++ G+L Y L V + + SGL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 147 ------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFM 194
P + HRDLK NI V N G I DLGLA + VGT +M
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 195 APEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECTHP----A 233
APEV ++ E + DIY+ G+ E+ + PY +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 234 QIYKKVISGKK----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 277
++ K V K P E + + + +C ++RL+A +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 50/290 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +GKG V+R ++G VA VK+ F E+ E++ L+H NI+
Sbjct: 14 ECVGKGRYGEVWRG--SWQGENVA---VKI--FSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 89 FYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR- 145
F S + + + + +T G+L Y L+ ++ + I SGL +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 146 -----DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFM 194
P + HRDLK NI V N G+ I DLGLA + +S VGT +M
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 195 APEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECT--HPA-- 233
APEV +E + + VDI++FG+ + E+ + P+ + P+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 234 QIYKKVISGKK----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 277
+ K V ++ P F + + +++C S+RL+A +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 18/266 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIM 87
LG+GA V + G +A VK + +E +RL ++ ++T+ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 88 KFYTSWVDTANRNINFVTE-MFTSGT--LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
FY + ++ E M TS +Q K + + + I+ L +LHS
Sbjct: 70 TFYGALFR--EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEV----- 198
+ VIHRD+K N+ +N G+VK+ D G++ L A G +MAPE
Sbjct: 128 KLS-VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 199 YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
++ Y+ DI+S G+ ++E+ +PY P Q K+V+ P+ E
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245
Query: 259 FIEKCLA-TVSSRLSARELLTDPFLQ 283
F +CL R + EL+ PF
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 49/276 (17%), Positives = 88/276 (31%), Gaps = 33/276 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ LG+G V ++G A ++ ++ E E + + H NI++
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRI----LCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 89 FYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-----VKHWCRQILSGLLY 141
+ A + F GTL ++ + + I GL
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNE-IERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-----------HAARCVGT 190
+H+ HRDLK NI + G+ + DLG A T
Sbjct: 150 IHA--KGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 191 PEFMAPEVYEEE----YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKP 245
+ APE++ + +E D++S G C+L M+ + PY + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 246 EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 280
+ Q + + R LL+
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 58/286 (20%), Positives = 103/286 (36%), Gaps = 28/286 (9%)
Query: 17 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH 76
EV + + A + E E+ L SP ++ +I
Sbjct: 54 EVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIR 113
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCR 133
+ +N + I ++ L+ + R H
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYLYI--QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-------------- 179
QI + +LHS+ ++HRDLK NIF + VK+GD GL +
Sbjct: 172 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 180 RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
+ VGT +M+PE Y+ VDI+S G+ + E++ Y +S +I
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITD 285
Query: 239 VISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
V + K P LF + P+ ++ L+ + R A +++ + +
Sbjct: 286 VRNLKFPL-LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 58/265 (21%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIM 87
+G G V++ G +A VK + EE +R+ ++ +LK+ I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIA---VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
+ + +++ N ++ E+ + + + + R + I+ L YL +
Sbjct: 88 QCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEV------YE 200
VIHRD+K NI ++ +G++K+ D G++ L A G +MAPE +
Sbjct: 146 -VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 201 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQF 259
+Y+ D++S G+ ++E+ T +PY C ++ KV+ + P + + + F
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 260 IEKCLA-TVSSRLSARELLTDPFLQ 283
++ CL R +LL F++
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIK 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 30/288 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ILG+GA+ V+R + G A +K+++ + ++ E +LK L H+NI+K
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSR 145
+ +T R+ + E G+L + R ++ G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 146 DPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE- 200
++HR++K NI + K+ D G A L GT E++ P++YE
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 201 --------EEYNELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYKKVISGKKPEA 247
++Y VD++S G T F P+ ++ K+I+GK A
Sbjct: 190 AVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGA 247
Query: 248 LFKVEDPEVRQFIEKCLATVSSRLS--ARELLTDPFLQIDDYDSDLRM 293
+ V+ E VS LS + LLT I + D +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 66/345 (19%), Positives = 118/345 (34%), Gaps = 82/345 (23%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEILGKGASK--TVYRAFDEYEGIEVAWNQVKLYDF- 61
+ S F+ G Y I GKG TV A + G V V+ +
Sbjct: 10 ENLYFQGMSSFL--PEGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVT---VRRINLE 63
Query: 62 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 121
S E + L E+H+ K H NI+ + +++ A+ + VT G+ + +
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVTSFMAYGSAKDL-ICTH 120
Query: 122 RVN------IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175
++ I + + +L L Y+H +HR +K +I ++ + G+V + L
Sbjct: 121 FMDGMNELAIAYI---LQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRS 174
Query: 176 AAILRKSHAAR---------CVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFD 223
+ + V +++PEV ++ Y+ DIYS G+ E+
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
Query: 224 YPYSECTHPAQIYKKVISGKKPEALFKVED------------------------------ 253
P+ + Q+ + ++G P L
Sbjct: 235 VPFKD-MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS 293
Query: 254 --------------PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
P F+E+CL +R SA LL F +
Sbjct: 294 NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 63/283 (22%), Positives = 117/283 (41%), Gaps = 23/283 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIM 87
+G+GA +V + + G +A VK +E ++L ++ ++++ I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 88 KFYTSWVDTANRNINFVTE-MFTS---GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
+FY + + E M TS Y + + + + L +L
Sbjct: 85 QFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV---- 198
+ +IHRD+K NI ++ G +K+ D G++ L S A G +MAPE
Sbjct: 143 E-NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 199 -YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---P 254
+ Y+ D++S G+ + E+ T +PY + +V+ G P+ E P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260
Query: 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQY 296
F+ CL S R +ELL PF+ + + + + + Y
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILMYE-ERAVEVACY 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-40
Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 30/288 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ILG+GA+ V+R + G A +K+++ + ++ E +LK L H+NI+K
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSR 145
+ +T R+ + E G+L + R ++ G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 146 DPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE- 200
++HR++K NI + K+ D G A L GT E++ P++YE
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 201 --------EEYNELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYKKVISGKKPEA 247
++Y VD++S G T F P+ ++ K+I+GK A
Sbjct: 190 AVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGA 247
Query: 248 LFKVEDPEVRQFIEKCLATVSSRLS--ARELLTDPFLQIDDYDSDLRM 293
+ V+ E VS LS + LLT I + D +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 32/294 (10%)
Query: 5 SSPEESDSSEFVEVDPTGRY--GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-- 60
+ P + V+ RY GR LGKG + D A K+
Sbjct: 24 APPAKEIPEVLVDPRSRRRYVRGR---FLGKGGFAKCFEISDADTKEVFA---GKIVPKS 77
Query: 61 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
L P + E++ EI + ++L H++++ F+ + D N + V E+ +L + +
Sbjct: 78 LLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRR 135
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+ + +++ RQI+ G YLH VIHRDLK N+F+N + EVKIGD GLA +
Sbjct: 136 KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVE 192
Query: 181 KSHAAR---CVGTPEFMAPEVYEEE-YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQI 235
+ C GTP ++APEV ++ ++ VD++S G CI+ ++ P+
Sbjct: 193 YDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKE-T 249
Query: 236 YKKVISGKKPEALFKVED---PEVRQFIEKCLATV-SSRLSARELLTDPFLQID 285
Y ++ + + + P I+K L T ++R + ELL D F
Sbjct: 250 YLRIKKNE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 29/278 (10%)
Query: 21 TGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIH 76
RY LGKG + D A K+ L P + E++ EI
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEIS 67
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 136
+ ++L H++++ F+ + D N + V E+ +L + + + + +++ RQI+
Sbjct: 68 IHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEF 193
G YLH VIHRDLK N+F+N + EVKIGD GLA + + C GTP +
Sbjct: 126 LGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLC-GTPNY 181
Query: 194 MAPEVYEEE-YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251
+APEV ++ ++ VD++S G CI+ ++ P+ Y ++ + + +
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKE-TYLRIKKNE-----YSI 234
Query: 252 ED---PEVRQFIEKCLATV-SSRLSARELLTDPFLQID 285
P I+K L T ++R + ELL D F
Sbjct: 235 PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 50/298 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G V++ + G+ +A KL P ++ E+ +L I+
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
FY ++ + I+ E G+L Q K R+ + + ++ GL YL +
Sbjct: 96 FYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 152
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELV 207
++HRD+K NI VN ++GE+K+ D G++ L S A VGT +M+PE + Y+
Sbjct: 153 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK------------------------ 243
DI+S G+ ++EM YP +
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 244 -KPEALFKVED----------------PEVRQFIEKCLATVSS-RLSARELLTDPFLQ 283
P A+F++ D E + F+ KCL + R ++L+ F++
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 57/282 (20%), Positives = 103/282 (36%), Gaps = 40/282 (14%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIM 87
+L +G VY A D G E A ++ E+ + E+ +K L H NI+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 88 KFYTSWVDTANRNIN-----FVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGL 139
+F ++ + + G L ++ K ++ V Q +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--------------HAA 185
++H + PP+IHRDLK +N+ ++ G +K+ D G A +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 186 RCVGTPEFMAPEVYE----EEYNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVI 240
TP + PE+ + E DI++ G CIL + +P+ + +++
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-----GAKLRIV 262
Query: 241 SGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPF 281
+GK + I L RLS E++
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-37
Identities = 90/394 (22%), Positives = 138/394 (35%), Gaps = 25/394 (6%)
Query: 20 PTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHL 77
PT G + E LG G V R + G +VA +K SP+ ER EI +
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQI 65
Query: 78 LKTLKHRNIMKFY----TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKH 130
+K L H N++ N E G LR+Y + ++
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNI--FVNGNQGEVKIGDLGLAAILRKSHAAR-C 187
I S L YLH +IHRDLK +NI + KI DLG A L +
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 188 VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246
VGT +++APE+ E ++Y VD +SFG E +T P+ P Q + K + K E
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNE 242
Query: 247 ALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQID-DYDSDLRMIQYQTDYDEI-S 304
+ +D L T + + +LQ + R Q
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
Query: 305 PLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFD 364
L + + + Y + EN + Q++ I E++ L
Sbjct: 303 ALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPE----EEQELLQAS 358
Query: 365 ISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 398
+ + + D ++ F FD
Sbjct: 359 GLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFD 392
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHRNIM 87
E+LGKG + + + + + ++ EE +R + E+ +++ L+H N++
Sbjct: 16 EVLGKGCFGQAIKV--THRETGEV---MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
KF V ++ +NF+TE GTLR + + + + I SG+ YLHS +
Sbjct: 71 KFIG--VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----------------CVGT 190
+IHRDL N V N V + D GLA ++ VG
Sbjct: 129 --IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 191 PEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK----- 244
P +MAPE+ Y+E VD++SFG+ + E++ + + + G
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 245 ---PEALFKV------EDPEVR---QFIEKCLATVSSRLSARELLTDPFLQID 285
P + F + DPE R +E L T+ L+ L Q+D
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 31/275 (11%)
Query: 22 GRY--GRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHL 77
+ G +LGKG+ VYRA + G+EVA +K+ D + ++R+ E+ +
Sbjct: 11 EDFKVGN---LLGKGSFAGVYRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 78 LKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQIL 136
LKH +I++ Y + D + + V EM +G + +Y + + + + +H+ QI+
Sbjct: 65 HCQLKHPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEF 193
+G+LYLHS ++HRDL N+ + N +KI D GLA L+ H C GTP +
Sbjct: 123 TGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC-GTPNY 178
Query: 194 MAPEVYE-EEYNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISG--KKPEALF 249
++PE+ + D++S G C+ ++ P+ T KV+ + P L
Sbjct: 179 ISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFDTDTVKN-TLNKVVLADYEMPSFL- 235
Query: 250 KVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
E + I + L + RLS +L PF+
Sbjct: 236 ---SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-37
Identities = 80/327 (24%), Positives = 129/327 (39%), Gaps = 39/327 (11%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVK- 57
M S E+ D E V G+ + ++LG GA T+ ++ +VA VK
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKI-SFCPKDVLGHGAEGTIVYR-GMFDNRDVA---VKR 55
Query: 58 -LYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 115
L + +R E+ LL+ +H N+++++ + D + E + TL++
Sbjct: 56 ILPECF---SFADR---EVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIE-LCAATLQE 106
Query: 116 Y-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE----VKI 170
Y K +Q SGL +LHS + ++HRDLK NI ++ I
Sbjct: 107 YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMI 164
Query: 171 GDLGLAAILRK-----SHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVT 221
D GL L S + GT ++APE+ E+ VDI+S G +++
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
Query: 222 FDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTD 279
P+ + K ED R+ IEK +A R SA+ +L
Sbjct: 225 EGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284
Query: 280 PFLQIDDYDSDLRMIQYQTDYDEISPL 306
PF + L+ Q +D E L
Sbjct: 285 PFFW--SLEKQLQFFQDVSDRIEKESL 309
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 29/230 (12%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+ E+ +G V++A + VA VK++ +Q + + Y E++ L +KH N
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVA---VKIFP-IQDKQSWQNEY-EVYSLPGMKHEN 79
Query: 86 IMKFYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
I++F + + +++ +T G+L + LK V+ + H + GL YLH
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF-LKANVVSWNELCHIAETMARGLAYLH 138
Query: 144 S--------RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTP 191
P + HRD+K N+ + N I D GLA +A VGT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 192 EFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 235
+MAPEV ++ + +D+Y+ G+ + E+ + +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 49/320 (15%), Positives = 93/320 (29%), Gaps = 51/320 (15%)
Query: 7 PEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQS 64
P+ ++++ + R + E L G V+ D + A +K++ S
Sbjct: 46 PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA---LKVFTMGAENS 102
Query: 65 PEELERLYCEIHLLKTLKHRN------------------------IMKFYTSWVDTANRN 100
ELERL+ L + + D A N
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 101 INFVTEMFTS------GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 154
+ + TL + I A+ Q++ L S+ ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHF 220
Query: 155 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIY 210
DN+F+ + G + +GD+ + P AP + + ++ +
Sbjct: 221 TPDNLFIMPD-GRLMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAW 277
Query: 211 SFGMCILEMVTFDYPYSECT-HPAQIYKKVISG--KKPEALFKVED---PEVRQFIEKCL 264
G+ I + P+ T +K+ F V+ I + L
Sbjct: 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337
Query: 265 AT-VSSRLSARELLTDPFLQ 283
RL E + P
Sbjct: 338 NFDRRRRLLPLEAMETPEFL 357
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 46/325 (14%), Positives = 87/325 (26%), Gaps = 65/325 (20%)
Query: 7 PEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 66
E+ R +LG+ A D+ G V + F + P
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVPYFTERPP 113
Query: 67 ---------------------------ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99
R L+K + + +++ D
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 100 NINFVTEMFTS------GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 153
+ F+ S L + H+ + A Q++ L LH ++H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTY 231
Query: 154 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE----------- 202
L+ +I ++ G V + +R + F PE+
Sbjct: 232 LRPVDIVLDQR-GGVFLTGFEHL--VRDGARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 203 -YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQF 259
D ++ G+ I + D P ++ + + K P VR
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWIFRSCKNIP--------QPVRAL 339
Query: 260 IEKCLA-TVSSRLSARELLTDPFLQ 283
+E L RL + + P +
Sbjct: 340 LEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-36
Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 12/268 (4%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+LGKG+ V D+ G E A + ++ + E L E+ LLK L H NIMK
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
Y + D V E++T G L + +R + RQ+LSG+ Y+H
Sbjct: 91 LYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 149 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNE 205
++HRDLK +N+ + ++ ++I D GL+ S + +GT ++APEV Y+E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKC 263
D++S G+ + +++ P++ I KKV GK +K + I K
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 265
Query: 264 LAT-VSSRLSARELLTDPFLQIDDYDSD 290
L S R+SAR+ L ++Q +
Sbjct: 266 LTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 41/294 (13%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVK-------LYDFLQSPEELERLYCEIHLLKTL 81
+ LG GA V AF+ +VA ++ + + + EI +LK L
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVA---IRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
H I+K + + V E+ G L + ++R+ K + Q+L + Y
Sbjct: 198 NHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 142 LHSRDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV 198
LH +IHRDLK +N+ + +KI D G + IL ++ R GTP ++APEV
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 199 YEEE----YNELVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGK---K 244
YN VD +S G IL + P+SE + ++ SGK
Sbjct: 313 LVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365
Query: 245 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 297
PE +V + + ++K L +R + E L P+LQ +D + + +
Sbjct: 366 PEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 41/294 (13%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVK-------LYDFLQSPEELERLYCEIHLLKTL 81
+ LG GA V AF+ +VA +K + + + EI +LK L
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
H I+K + + V E+ G L + ++R+ K + Q+L + Y
Sbjct: 73 NHPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV 198
LH +IHRDLK +N+ ++ + + +KI D G + IL ++ R GTP ++APEV
Sbjct: 130 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 199 YEEE----YNELVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGK---K 244
YN VD +S G IL + P+SE + ++ SGK
Sbjct: 188 LVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 245 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 297
PE +V + + ++K L +R + E L P+LQ +D + + +
Sbjct: 241 PEVWAEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-35
Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 13/261 (4%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ LG GA V D+ +E A ++ S +L E+ +LK L H NIMK
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
Y + D RN V E + G L + + N +Q+LSG+ YLH +
Sbjct: 101 LYDFFED--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 149 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNE 205
++HRDLK +N+ + + +KI D GL+A+ + +GT ++APEV ++Y+E
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE 216
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKC 263
D++S G+ + ++ P+ T +I +KV GK +K + I++
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275
Query: 264 LAT-VSSRLSARELLTDPFLQ 283
L R+SA++ L P+++
Sbjct: 276 LQFDSQRRISAQQALEHPWIK 296
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 19/259 (7%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNIMK 88
LGKG VY A ++ +A +K+ L+ +L E+ + L+H NI++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA---LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
Y + D + + E GT+ + K + + + + ++ + L Y HS+
Sbjct: 74 LYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELV 207
VIHRD+K +N+ + G+ GE+KI D G + S GT +++ PE+ E ++E V
Sbjct: 130 VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLA 265
D++S G+ E + P E + YK++ P+ + R I + L
Sbjct: 189 DLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVEFTFPDFV----TEGARDLISRLLK 243
Query: 266 T-VSSRLSARELLTDPFLQ 283
S R RE+L P++
Sbjct: 244 HNPSQRPMLREVLEHPWIT 262
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 25/277 (9%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAW---NQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+G+G+ V A + I A + + E+++R EI ++K+L H N
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-------EDVDRFKQEIEIMKSLDHPN 67
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
I++ Y ++ D N +I V E+ T G L + + R + +LS + Y H
Sbjct: 68 IIRLYETFED--NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 146 DPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE 202
+ V HRDLK +N F+ + +K+ D GLAA + R VGTP +++P+V E
Sbjct: 126 N--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 203 YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQ 258
Y D +S G ++ ++ YP + +++ K+ G PE + P+
Sbjct: 184 YGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSPQAES 240
Query: 259 FIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI 294
I + L R+++ + L + + S ++
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E++G+G VY+ + VA VK++ F + + I+ + ++H NI +
Sbjct: 19 ELIGRGRYGAVYKG--SLDERPVA---VKVFSF-ANRQNFINE-KNIYRVPLMEHDNIAR 71
Query: 89 FYTSWV-DTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS- 144
F TA+ + + V E + +G+L +Y L + + + GL YLH+
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKY-LSLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 145 ------RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----------V 188
P + HRDL N+ V + G I D GL+ L + R V
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 189 GTPEFMAPEVYE--------EEYNELVDIYSFGMCILEMVT 221
GT +MAPEV E E + VD+Y+ G+ E+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 47/319 (14%), Positives = 89/319 (27%), Gaps = 58/319 (18%)
Query: 10 SDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP-- 65
+ VE + R +LG+ A D+ G V + F + P
Sbjct: 63 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVPYFTERPPS 119
Query: 66 EELERLYCEIHLLKTL----------------------KHRNIMKFYTSWVDTANRNIN- 102
++++ E+ L+ L K K +D + +
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179
Query: 103 -FVTEMFTSG-------TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 154
F L + H+ + A Q++ L LH ++H L
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYL 237
Query: 155 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY------EEEYNE 205
+ +I ++ G V + S + PE A +
Sbjct: 238 RPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
D ++ G+ I + D P ++ + + K VR +E L
Sbjct: 297 AFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLR 349
Query: 266 -TVSSRLSARELLTDPFLQ 283
RL + + P +
Sbjct: 350 YPKEDRLLPLQAMETPEYE 368
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 24/272 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVA---------WNQVKLYDFLQSPEELERLYCEIHLLK 79
LG GA V ++ E A D + E +Y EI LLK
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
+L H NI+K + + D + VTE + G L + + + + + +QILSG+
Sbjct: 102 SLDHPNIIKLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 140 LYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAP 196
YLH + ++HRD+K +NI N N +KI D GL++ K + R +GT ++AP
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 197 EVYEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGK--KPEALFKVE 252
EV +++YNE D++S G I+ ++ YP + + I KKV GK +K
Sbjct: 218 EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQ--NDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 253 DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
E ++ I+ L + R +A E L +++
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 62/292 (21%), Positives = 125/292 (42%), Gaps = 36/292 (12%)
Query: 23 RYGRYN--EILGKGASKTVYRAFDEYEGIEVA----------------------WNQVKL 58
+ +Y + +GKG+ V A++E + A +
Sbjct: 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 59 YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL 118
+Q +E++Y EI +LK L H N++K D ++ V E+ G + +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-P 129
Query: 119 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178
+ ++ + + + ++ G+ YLH + +IHRD+K N+ V + G +KI D G++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNE 186
Query: 179 LRKSHA--ARCVGTPEFMAPEV---YEEEYN-ELVDIYSFGMCILEMVTFDYPYSECTHP 232
+ S A + VGTP FMAPE + ++ + +D+++ G+ + V P+ +
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 233 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
++ K+ S +++ I + L SR+ E+ P++
Sbjct: 247 C-LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 69/261 (26%), Positives = 125/261 (47%), Gaps = 13/261 (4%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+LGKG+ V + D E A + ++ + E+ LLK L H NIMK
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+ D + + V E++T G L +K +R + +Q+ SG+ Y+H +
Sbjct: 86 LFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 149 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNE 205
++HRDLK +NI + + ++KI D GL+ +++ + +GT ++APEV Y+E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKC 263
D++S G+ + +++ P+ I K+V +GK ++ + + I K
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260
Query: 264 LAT-VSSRLSARELLTDPFLQ 283
L S R++A + L P++Q
Sbjct: 261 LTFHPSLRITATQCLEHPWIQ 281
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 68/311 (21%), Positives = 122/311 (39%), Gaps = 39/311 (12%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKL 58
+ G +P + + D Y +LGKG TV+ + ++VA +K+
Sbjct: 7 LQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA---IKV 63
Query: 59 YD-----FLQSPEELERLYCEIHLLKTL----KHRNIMKFYTSWVDTANRNINFVTEMFT 109
+ E+ LL + H +++ W +T V E
Sbjct: 64 IPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD-WFET-QEGFMLVLERPL 121
Query: 110 SGT-LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 168
L Y + + + + Q+++ + + HSR V+HRD+K +NI ++ +G
Sbjct: 122 PAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCA 179
Query: 169 KIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCIL-EMVTFDYP 225
K+ D G A+L GT + PE +Y+ ++S G+ +L +MV D P
Sbjct: 180 KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI-LLYDMVCGDIP 238
Query: 226 YSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLAT-VSSRLSARELLTDPF 281
+ ++++ + P+ I +CLA SSR S E+L DP+
Sbjct: 239 FER-------DQEILEAE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286
Query: 282 LQIDDYDSDLR 292
+Q D L
Sbjct: 287 MQTPAEDVPLN 297
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 64/268 (23%), Positives = 119/268 (44%), Gaps = 25/268 (9%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG GA V+ + G+E +K + +S +E++ EI +LK+L H NI+K
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 89 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
+ + D N+ V E G L + + + ++ V +Q+++ L Y HS
Sbjct: 85 IFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 145 RDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEE 201
+ V+H+DLK +NI F + + +KI D GLA + + + GT +MAPEV++
Sbjct: 143 QH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200
Query: 202 EYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGK---KPEALFKVEDPEV 256
+ DI+S G ++ + ++ +K + E + P+
Sbjct: 201 DVTFKCDIWSAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVE--CRPLTPQA 255
Query: 257 RQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+++ L R SA ++L + +
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 75/269 (27%), Positives = 130/269 (48%), Gaps = 29/269 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEELERLYCEIHLLKTLKHRNIM 87
+LGKG+ V + D E A VK+ + ++ + E+ LLK L H NIM
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
K + D + + V E++T G L +K +R + +Q+ SG+ Y+H +
Sbjct: 85 KLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 148 PVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYN 204
++HRDLK +NI + + + +KI D GL+ +++ + +GT ++APEV Y+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD 200
Query: 205 ELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKKPEALFKVEDP-------E 255
E D++S G IL ++ P Y + + I K+V +GK + + P +
Sbjct: 201 EKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGK-----YAFDLPQWRTISDD 252
Query: 256 VRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ I K L S R++A + L P++Q
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 17/270 (6%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
++ + LG+GA V A + VA VK+ D ++ + E + EI + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
H N++KFY N E + G L + + + Q+++G++YL
Sbjct: 64 HENVVKFYGHR-REGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CVGTPEFMAPEV 198
H + HRD+K +N+ ++ +KI D GLA + R ++ R GT ++APE+
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 199 YE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256
+ E++ E VD++S G+ + M+ + P+ + + Q Y K +K D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 257 RQFIEKCLAT-VSSRLSARELLTDPFLQID 285
+ K L S+R++ ++ D +
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 65/259 (25%), Positives = 118/259 (45%), Gaps = 19/259 (7%)
Query: 31 LGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNIMK 88
LGKG VY A ++ +A +K+ L+ +L EI + L+H NI++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMA---LKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
Y + D + I + E G L + KH R + + + ++ L Y H R
Sbjct: 79 MYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELV 207
VIHRD+K +N+ + G +GE+KI D G + GT +++ PE+ E + ++E V
Sbjct: 135 VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKV 193
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLA 265
D++ G+ E + P+ +H ++++++ K P L + I K L
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNVDLKFPPFL----SDGSKDLISKLLR 248
Query: 266 T-VSSRLSARELLTDPFLQ 283
RL + ++ P+++
Sbjct: 249 YHPPQRLPLKGVMEHPWVK 267
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 70/297 (23%), Positives = 139/297 (46%), Gaps = 26/297 (8%)
Query: 3 GVSSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL 62
G S +D + G Y R + +GKG V A G EVA +K+ D
Sbjct: 1 GNSIASCADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKT 51
Query: 63 Q-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 121
Q +P L++L+ E+ ++K L H NI+K + V + + + E + G + Y + H
Sbjct: 52 QLNPTSLQKLFREVRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHG 109
Query: 122 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
R+ + + RQI+S + Y H + ++HRDLK +N+ ++ + +KI D G +
Sbjct: 110 RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTV 166
Query: 182 SHAAR-CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
G P + APE+++ ++Y+ VD++S G+ + +V+ P+ ++ ++
Sbjct: 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-ELRER 225
Query: 239 VISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 292
V+ GK P + + +++ L R + +++ D ++ + +L+
Sbjct: 226 VLRGKYRIPFYM----STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEELERLYCEIHLLKTLKHRNIM 87
E LGKGA V R + G+E A K+ + S + ++L E + + L+H NI+
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
+ + S + V ++ T G L + + + H +QIL + Y HS
Sbjct: 69 RLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG- 125
Query: 148 PVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-Y 203
++HR+LK +N+ + +G VK+ D GLA + S A GTP +++PEV +++ Y
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 204 NELVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGKK--PEALFKVEDP 254
++ VDI++ G IL Y P+ + ++Y ++ +G P + P
Sbjct: 185 SKPVDIWACG-VIL------YILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTP 236
Query: 255 EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 286
E + I+ L R++A + L P++ +
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 72/328 (21%), Positives = 134/328 (40%), Gaps = 21/328 (6%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
++ + LG+GA V A + VA VK+ D ++ + E + EI + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
H N++KFY N E + G L + + + Q+++G++YL
Sbjct: 64 HENVVKFYGHR-REGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CVGTPEFMAPEV 198
H + HRD+K +N+ ++ +KI D GLA + R ++ R GT ++APE+
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 199 YE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256
+ E++ E VD++S G+ + M+ + P+ + + Q Y K +K D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 257 RQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIY 315
+ K L S+R++ ++ D + R E + +
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298
Query: 316 HSNSSSNNGCGHYIGYDTENGLDYHPHE 343
+ ++ G+ E +H H
Sbjct: 299 DFSPVNSASRTPGSGWSKE----HHHHH 322
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 76/303 (25%), Positives = 136/303 (44%), Gaps = 32/303 (10%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-F 61
+ SEF+ T Y+ E LGKGA V R + G+E A K+ +
Sbjct: 9 GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA---AKIINTK 65
Query: 62 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 121
S + ++L E + + L+H NI++ + S + V ++ T G L + +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVARE 123
Query: 122 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAIL 179
+ H +QIL + Y HS ++HR+LK +N+ + +G VK+ D GLA +
Sbjct: 124 FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 180 RKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-------PYSECT 230
S A GTP +++PEV +++ Y++ VDI++ G IL Y P+ +
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VIL------YILLVGYPPFWDED 234
Query: 231 HPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDY 287
++Y ++ +G P + PE + I+ L R++A + L P++ +
Sbjct: 235 QH-RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
Query: 288 DSD 290
+
Sbjct: 294 VAS 296
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 23 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLL 78
+ G Y + LG G V + G +VA VK+ + ++S + + ++ EI L
Sbjct: 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNL 65
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
K +H +I+K Y V + + V E + G L Y KH RV + +QILS
Sbjct: 66 KLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAP 196
+ Y H V+HRDLK +N+ ++ + KI D GL+ ++ R C G+P + AP
Sbjct: 124 VDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAP 179
Query: 197 EVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVE 252
EV Y VDI+S G+ + ++ P+ + P ++KK+ G PE L
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGVFYIPEYL---- 234
Query: 253 DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 285
+ V + L R + +++ + + D
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 58/295 (19%), Positives = 114/295 (38%), Gaps = 35/295 (11%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-- 60
+ + + +Y +LG G +VY + + VA +K +
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA---IKHVEKD 79
Query: 61 ---FLQSPEELERLYCEIHLLKTLKHR--NIMKFYTSWVDTANRNINFVTEMFT-SGTLR 114
R+ E+ LLK + +++ W + + + E L
Sbjct: 80 RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFER-PDSFVLILERPEPVQDLF 137
Query: 115 QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174
+ + + + + Q+L + + H+ V+HRD+K +NI ++ N+GE+K+ D G
Sbjct: 138 DFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195
Query: 175 LAAILRKSHAARCVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHP 232
A+L+ + GT + PE Y+ ++S G+ + +MV D P+
Sbjct: 196 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---- 251
Query: 233 AQIYKKVISGKKPEALFKVED---PEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+++I G+ E + I CLA S R + E+ P++Q
Sbjct: 252 ---DEEIIRGQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 67/316 (21%), Positives = 111/316 (35%), Gaps = 53/316 (16%)
Query: 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNI 86
+ILG G+S TV ++G VA VK + + EI LL H N+
Sbjct: 20 EKILGYGSSGTVVFQ-GSFQGRPVA---VKRML----IDFCDIALMEIKLLTESDDHPNV 71
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTL-------RQYRLKHRRVNIRAVKHWCRQILSGL 139
+++Y S +R + E + L + RQI SG+
Sbjct: 72 IRYYCSETT--DRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 140 LYLHSRDPPVIHRDLKCDNIFVN------------GNQGEVKIGDLGLAAILR------K 181
+LHS +IHRDLK NI V+ + I D GL L +
Sbjct: 129 AHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 182 SHAARCVGTPEFMAPEV--------YEEEYNELVDIYSFGMCILEMVTFDYP--YSECTH 231
++ GT + APE+ + +DI+S G +++ + +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 232 PAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDS 289
+ I + + S + + L E I + + R +A ++L P
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW--PKSK 304
Query: 290 DLRMIQYQTDYDEISP 305
L + +D EI
Sbjct: 305 KLEFLLKVSDRLEIEN 320
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 71/345 (20%), Positives = 121/345 (35%), Gaps = 72/345 (20%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGR-YGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVK 57
M+ + + + +Y+ +G+G+ V A + A +K
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRA---IK 57
Query: 58 LYD----FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL 113
+ + +P+++ER+ E+ L+K L H NI + Y + D + I V E+ G L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYICLVMELCHGGHL 115
Query: 114 RQYRLKHRRVNI----------------------------------------RAVKHWCR 133
+ + + + R
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAARC----- 187
QI S L YLH++ + HRD+K +N F E+K+ D GL+ K +
Sbjct: 176 QIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 188 -VGTPEFMAPEV---YEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVIS 241
GTP F+APEV E Y D +S G +L ++ + A +V++
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFPGV--NDADTISQVLN 290
Query: 242 GKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
K + V P R + L V R A L P++
Sbjct: 291 KKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 46/298 (15%), Positives = 103/298 (34%), Gaps = 44/298 (14%)
Query: 31 LGKGASKTVYRA-----------FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK 79
L +G + +++ + D + + + E+ ++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV--------KHW 131
+K+ + + + + E + ++ ++ ++ K
Sbjct: 99 DIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP 191
+ +L+ Y+H+ + HRD+K NI ++ N G VK+ D G + + GT
Sbjct: 157 IKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSRGTY 214
Query: 192 EFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK----- 243
EFM PE + E VDI+S G+C+ M P+S +++ + +
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 244 ------------KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYD 288
K E F++ L + R+++ + L +L + +
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 22/275 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG GA V+R ++ G K + P + + EI ++ L H ++
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFV---AKFIN-TPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRD 146
+ ++ D + + E + G L R+ + V ++ RQ GL ++H
Sbjct: 113 LHDAFED--KYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 147 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-Y 203
++H D+K +NI VKI D GLA L + T EF APE+ + E
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 204 NELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQF 259
D+++ G + ++ E + + V E F PE + F
Sbjct: 228 GFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 260 IEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRM 293
I+ L RL+ + L P+L+ D + R+
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 23/277 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP-EELERLYCEIHLLKTLKHRNIM 87
E++GKG V R + G + A V + F SP E L E + LKH +I+
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI----RAVKHWCRQILSGLLYLH 143
+ ++ + + V E L +K H+ RQIL L Y H
Sbjct: 90 ELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 144 SRDPPVIHRDLKCDNI-FVN-GNQGEVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVY 199
+ +IHRD+K + + N VK+G G+A L +S VGTP FMAPEV
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 200 EEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDP 254
+ E Y + VD++ G IL ++ Y ++++ +I GK +
Sbjct: 206 KREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISE 261
Query: 255 EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
+ + + L + R++ E L P+L+ D +
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 62/280 (22%), Positives = 118/280 (42%), Gaps = 29/280 (10%)
Query: 23 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD---FLQSPEELERLYCEIHL 77
G+Y ++LG+G+ V D A VK+ + P + EI L
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQL 59
Query: 78 LKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQIL 136
L+ L+H+N+++ + + + V E G + +R + + Q++
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTP 191
GL YLHS+ ++H+D+K N+ + G +KI LG+A L A G+P
Sbjct: 120 DGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ-GSP 175
Query: 192 EFMAPEVY--EEEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPE 246
F PE+ + ++ VDI+S G+ + + T YP+ E + ++++ + G P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPG 234
Query: 247 ALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 285
P + ++ L + R S R++ + +
Sbjct: 235 DC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 63/306 (20%), Positives = 125/306 (40%), Gaps = 23/306 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG+G V+R + K + + EI +L +HRNI+
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYM---AKFVK--VKGTDQVLVKKEISILNIARHRNILH 65
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRD 146
+ S+ + + E + + + R+ + R + + Q+ L +LHS +
Sbjct: 66 LHESFES--MEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 147 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYEEE-Y 203
+ H D++ +NI + +KI + G A L+ R PE+ APEV++ +
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 204 NELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQF 259
+ D++S G ++ ++ +E QI + +++ + E FK E F
Sbjct: 181 STATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 260 IEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSN 318
+++ L SR++A E L P+L+ ++I+ L+++ L + +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAA 297
Query: 319 SSSNNG 324
S G
Sbjct: 298 RISCGG 303
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 76/356 (21%), Positives = 140/356 (39%), Gaps = 38/356 (10%)
Query: 3 GVSSPEESDSSEFVEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVK--- 57
+ P ++ E + +Y+ LG GA V+ A D+ + EV VK
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVV---VKFIK 58
Query: 58 ----LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGT- 112
L D +L ++ EI +L ++H NI+K + V E SG
Sbjct: 59 KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLD 116
Query: 113 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172
L + +H R++ + RQ++S + YL +D +IHRD+K +NI + + +K+ D
Sbjct: 117 LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLID 173
Query: 173 LGLAAILRKSHA-ARCVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSEC 229
G AA L + GT E+ APEV Y ++++S G+ + +V + P+ E
Sbjct: 174 FGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE- 232
Query: 230 THPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 286
++ + P + E+ + L R + +L+TDP++
Sbjct: 233 ------LEETVEAAIHPPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ-P 281
Query: 287 YDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPH 342
+ + ++ + + + S S+ G +H H
Sbjct: 282 VNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSD--VAQAQELCGGEGHHHHHH 335
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 26/274 (9%)
Query: 23 RYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLL 78
G Y E LG+G+ V A +VA +K L+ + R+ EI L
Sbjct: 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYL 63
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
K L+H +I+K Y T +I V E + G L Y ++ +R+ + + +QI+
Sbjct: 64 KLLRHPHIIKLYDVI-TT-PTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAP 196
+ Y H ++HRDLK +N+ ++ N VKI D GL+ I+ + + C G+P + AP
Sbjct: 121 IEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAP 176
Query: 197 EVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVE 252
EV + Y VD++S G+ + M+ P+ + P ++KKV S P+ L
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-NLFKKVNSCVYVMPDFL---- 231
Query: 253 DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 285
P + I + + R++ +E+ DP+ ++
Sbjct: 232 SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVA-----WNQVKLYDFLQSPEELERLYCEIHLLKTLK- 82
EILG+G S V R + E A + + E E E+ +L+ +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
H NI++ ++ N V ++ G L Y + ++ + + R +L + L
Sbjct: 83 HPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV--- 198
H + ++HRDLK +NI ++ + +K+ D G + L R GTP ++APE+
Sbjct: 141 HKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 199 ----YEEEYNELVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGKKPEA 247
Y + VD++S G I+ Y P+ + + ++SG
Sbjct: 198 SMNDNHPGYGKEVDMWSTG-VIM------YTLLAGSPPFWHRKQM-LMLRMIMSGN---- 245
Query: 248 LFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
++ P V+ + + L R +A E L PF Q +
Sbjct: 246 -YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 26/303 (8%)
Query: 4 VSSPEESDSSEFVEVDPTGRYGRYN----EILGKGASKTVYRAFDEYEGIEVAWNQVKLY 59
+ +P V Y EILG G V++ + G+++A K+
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLA---AKII 122
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 119
+ ++ E + EI ++ L H N+++ Y ++ +I V E G L R+
Sbjct: 123 K-TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDGGELFD-RII 178
Query: 120 HRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLA 176
N+ + +QI G+ ++H ++H DLK +NI VN + ++KI D GLA
Sbjct: 179 DESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 177 AILRKSHAARC-VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHP 232
+ + GTPEF+APEV + + D++S G+ I M+ + +
Sbjct: 237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--ND 293
Query: 233 AQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDS 289
A+ +++ + + F+ E ++FI K L S R+SA E L P+L S
Sbjct: 294 AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353
Query: 290 DLR 292
L
Sbjct: 354 RLS 356
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 24/305 (7%)
Query: 17 EVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLY 72
+ D + G Y + LG G V E G +VA VK+ + ++S + + ++
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVA---VKILNRQKIRSLDVVGKIR 64
Query: 73 CEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWC 132
EI LK +H +I+K Y V + +I V E + G L Y K+ R++ + +
Sbjct: 65 REIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTP 191
+QILSG+ Y H V+HRDLK +N+ ++ + KI D GL+ ++ R G+P
Sbjct: 123 QQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSP 179
Query: 192 EFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPEA 247
+ APEV Y VDI+S G+ + ++ P+ + P ++KK+ G P+
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGIFYTPQY 238
Query: 248 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPL 306
L +P V ++ L R + +++ + + D L I
Sbjct: 239 L----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ-DLPKYLFPEDPSYSSTMIDDE 293
Query: 307 LRQSL 311
+ +
Sbjct: 294 ALKEV 298
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 71/365 (19%), Positives = 128/365 (35%), Gaps = 43/365 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E LG GA V+R + G A K + E + EI + L+H ++
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFA---AKFVM-TPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRD 146
+ ++ D + + + E + G L + ++ + + RQ+ GL ++H +
Sbjct: 219 LHDAFED--DNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 147 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-Y 203
+H DLK +NI F E+K+ D GL A L + + GT EF APEV E +
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 204 NELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQF 259
D++S G + ++ E + + + V S ++ F + + F
Sbjct: 334 GYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 260 IEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI--------------QYQTDYDEIS 304
I K L ++R++ + L P+L + I +Y + +
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLP 450
Query: 305 PLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFD 364
PL R S Y + + E + F
Sbjct: 451 PLGRISNYSSLRKHRPQEYSI------RDAFWDRSEAQPRFIVKPYGTEVGEGQSAN-FY 503
Query: 365 ISIKG 369
+
Sbjct: 504 CRVIA 508
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 33/270 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNI 86
E+LG GA V+ G A +K LE EI +LK +KH NI
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFA---LKCIKKSPAFRDSSLEN---EIAVLKKIKHENI 68
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
+ ++ + V ++ + G L L+ + +Q+LS + YLH
Sbjct: 69 VTLE-DIYESTT-HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 147 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-Y 203
++HRDLK +N+ ++ + ++ I D GL+ + + + GTP ++APEV ++ Y
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 204 NELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKKPEALFKVEDP------- 254
++ VD +S G I ++ YP Y E +++++K+ G ++ E P
Sbjct: 185 SKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGY-----YEFESPFWDDISE 236
Query: 255 EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ FI L + R + + L+ P++
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 67/303 (22%), Positives = 117/303 (38%), Gaps = 57/303 (18%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKT 80
Y ++LG+GA V + E A VK+ + + R E+ +L
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPGHIRSRVFR---EVEMLYQ 66
Query: 81 LK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
+ HRN+++ + + V E G++ + K R N + + S L
Sbjct: 67 CQGHRNVLELIEFFEE--EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 140 LYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAARC---------V 188
+LH++ + HRDLK +NI + NQ VKI D L + ++ +
Sbjct: 125 DFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 189 GTPEFMAPEV------YEEEYNELVDIYSFG--MCIL------------EMVTFDYPYSE 228
G+ E+MAPEV Y++ D++S G + IL +D +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 229 CTHPAQIYKKVISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDP 280
+++ + GK ++ D + I K L RLSA ++L P
Sbjct: 243 PACQNMLFESIQEGK-----YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297
Query: 281 FLQ 283
++Q
Sbjct: 298 WVQ 300
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 25/278 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-----FLQSPEELERLYCEIHLLKTLKH 83
E LG G V + ++ G+E A K + E + E+ +L+ + H
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYA---AKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
N++ + + + ++ + E+ + G L + + ++ + +QIL G+ YLH
Sbjct: 75 HNVITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 144 SRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY 199
++ + H DLK +NI + N +K+ D GLA + + GTPEF+APE+
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 200 EEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDP 254
E D++S G I ++ + + + S E F
Sbjct: 191 NYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHTSE 247
Query: 255 EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 291
+ FI K L RL+ +E L P++ D +
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 25/278 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAW-----NQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
E LG G V + ++ G+E A Q + EE+ER E+ +L+ + H
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER---EVSILRQVLH 74
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
NI+ + + + ++ + E+ + G L + + ++ + +QIL G+ YLH
Sbjct: 75 PNIITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 144 SRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY 199
++ + H DLK +NI + N +K+ D GLA + + GTPEF+APE+
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 200 EEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDP 254
E D++S G I ++ + + + + E F
Sbjct: 191 NYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQTSE 247
Query: 255 EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 291
+ FI K L RL+ +E L P++ D +
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 38/288 (13%)
Query: 24 YGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK- 82
++ LG+G+ + + A VK+ EI LK +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFA---VKIIS----KRMEANTQKEITALKLCEG 64
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
H NI+K + + D + V E+ G L + K + + + R+++S + ++
Sbjct: 65 HPNIVKLHEVFHD--QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 143 HSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEV 198
H V+HRDLK +N+ F + N E+KI D G A + + T + APE+
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 199 YEEE-YNELVDIYSFGMCILEMVTFDYP--YSE-----CTHPAQIYKKVISGKKPEALFK 250
+ Y+E D++S G IL + S CT +I KK+ G F
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-----FS 234
Query: 251 VEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
E E + I+ L + RL L + +LQ S
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 41/283 (14%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEELERLYCEIHLLKTLKHRNIM 87
E LGKGA V R G E A + + S + ++L E + + LKH NI+
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
+ + S + + + ++ T G L + + + H +QIL +L+ H
Sbjct: 74 RLHDSISE--EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG- 130
Query: 148 PVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVYEEE- 202
V+HR+LK +N+ + +G VK+ D GLA + A GTP +++PEV ++
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 203 YNELVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGKKPEALFKVEDP- 254
Y + VD+++ G IL Y P+ + ++Y+++ +G + P
Sbjct: 190 YGKPVDLWACG-VIL------YILLVGYPPFWDEDQ-HRLYQQIKAGA-----YDFPSPE 236
Query: 255 ------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
E + I K L S R++A E L P++ +
Sbjct: 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 279
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 63/271 (23%), Positives = 110/271 (40%), Gaps = 35/271 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG+GA+ VYR + A +K+ + + EI +L L H NI+K
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYA---LKVLKKTVDKKIVRT---EIGVLLRLSHPNIIK 112
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+ I+ V E+ T G L ++ + R +QIL + YLH
Sbjct: 113 LKEIFET--PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG-- 168
Query: 149 VIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-YN 204
++HRDLK +N+ + +KI D GL+ I+ + GTP + APE+ Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 205 ELVDIYSFG--MCILEMVTFDYP--YSECTHPAQIYKKVISGKKPEALFKVEDP------ 254
VD++S G IL + Y E +++++++ + + P
Sbjct: 229 PEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRILNCE-----YYFISPWWDEVS 279
Query: 255 -EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ + K + RL+ + L P++
Sbjct: 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 61/280 (21%), Positives = 117/280 (41%), Gaps = 20/280 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQV--KLYDFLQSPEELERLYCEIHLLKTLKHRNI 86
E LG G V + ++ G++ A + + + E + E+ +LK ++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
+ + + + ++ + E+ G L + + + + +QIL+G+ YLHS
Sbjct: 77 ITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 147 PPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE 202
+ H DLK +NI + N + +KI D GLA + + + GTPEF+APE+ E
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 203 -YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVR 257
D++S G I ++ + + V + + F +
Sbjct: 193 PLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTSALAK 249
Query: 258 QFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL-RMIQ 295
FI + L R++ ++ L P+++ D L R
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAS 289
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 72/280 (25%), Positives = 114/280 (40%), Gaps = 36/280 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIM 87
E +G G+ R + +E A VK+ +S + EI LL+ +H NI+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQHPNII 79
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
+ D + + VTE+ G L L+ + + R I + YLH++
Sbjct: 80 TLKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG- 136
Query: 148 PVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE 202
V+HRDLK NI +GN ++I D G A LR + T F+APEV E +
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 203 -YNELVDIYSFGMCILEMVTFDYP--YSECT-HPAQIYKKVISGKKPEALFKVEDP---- 254
Y+ DI+S G +L + Y + P +I ++ SGK F +
Sbjct: 196 GYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGK-----FSLSGGYWNS 249
Query: 255 ---EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
+ + K L RL+A +L P++ D
Sbjct: 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 56/288 (19%), Positives = 111/288 (38%), Gaps = 37/288 (12%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL- 81
Y ++LG G + V F G + A +KL L + + E+
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCA---LKL---LYDSPKARQ---EVDHHWQAS 79
Query: 82 KHRNIMKFYTSWVDTANRNINF--VTEMFTSGTL--RQYRLKHRRVNIRAVKHWCRQILS 137
+I+ + + + + E G L R + R R I +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 138 GLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAARCVGTPEFMA 195
+ +LHS + + HRD+K +N+ + + + +K+ D G A ++ TP ++A
Sbjct: 140 AIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 197
Query: 196 PEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTH--PAQIYKKVISGKKPEALFK 250
PEV E Y++ D++S G I+ ++ +P YS + +++ G+ +
Sbjct: 198 PEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-----YG 251
Query: 251 VEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
+P + +Q I L T + RL+ + + P++
Sbjct: 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 63/286 (22%), Positives = 121/286 (42%), Gaps = 52/286 (18%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-------FLQSPEELERLYCEIHLLKTL 81
+++G+G S V R G E A VK+ + Q E E E H+L+ +
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFA---VKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 82 K-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLL 140
H +I+ S+ + + V ++ G L Y + ++ + + R +L +
Sbjct: 157 AGHPHIITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 141 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV- 198
+LH+ + ++HRDLK +NI ++ N ++++ D G + L R GTP ++APE+
Sbjct: 215 FLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 199 ------YEEEYNELVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGKKP 245
Y + VD+++ G IL + P+ + + ++ G+
Sbjct: 272 KCSMDETHPGYGKEVDLWACG-VIL------FTLLAGSPPFWHRRQI-LMLRMIMEGQ-- 321
Query: 246 EALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
++ P V+ I + L +RL+A + L PF +
Sbjct: 322 ---YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 57/289 (19%), Positives = 113/289 (39%), Gaps = 38/289 (13%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL- 81
Y +++LG G + V + F++ + A +K ++ + E+ L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LK------MLQDCPKARREVELHWRAS 112
Query: 82 KHRNIMKFYTSWVDTANRNINF--VTEMFTSGTL--RQYRLKHRRVNIRAVKHWCRQILS 137
+ +I++ + + V E G L R + R + I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 138 GLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFM 194
+ YLHS + + HRD+K +N+ + + +K+ D G A ++ TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 195 APEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQ--IYKKVISGKKPEALF 249
APEV E Y++ D++S G I+ ++ YP YS + ++ G+ +
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----Y 284
Query: 250 KVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
+ +P EV+ I L T + R++ E + P++
Sbjct: 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 61/277 (22%), Positives = 116/277 (41%), Gaps = 25/277 (9%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVA-----WNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
E LG G V + + G E A ++ S EE+ER E+++L+ ++H
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER---EVNILREIRH 67
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
NI+ + + + ++ + E+ + G L + + + + +QIL G+ YLH
Sbjct: 68 PNIITLHDIFEN--KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 144 SRDPPVIHRDLKCDNI-FVNGNQ--GEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY 199
S+ + H DLK +NI ++ N +K+ D G+A + + + GTPEF+APE+
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 200 EEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDP 254
E D++S G I ++ E + + + E F
Sbjct: 184 NYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 255 EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
+ FI + L R++ + L +++ +
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 74/308 (24%), Positives = 134/308 (43%), Gaps = 26/308 (8%)
Query: 17 EVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCE 74
++ RY+ + +G G D+ VA VK + + E + E
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVA---VKYIE--RGAAIDENVQRE 66
Query: 75 IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQ 134
I ++L+H NI++F V ++ + E + G L + R + + + +Q
Sbjct: 67 IINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAAR-CVGTPE 192
+LSG+ Y HS + HRDLK +N ++G+ +KI D G + + VGTP
Sbjct: 125 LLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182
Query: 193 FMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK----VISGK--K 244
++APEV +EY+ ++ D++S G+ + M+ YP+ E + Y+K ++S K
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSI 241
Query: 245 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEI 303
P+ + PE I + ++R+S E+ T + + +DL +
Sbjct: 242 PDDIRI--SPECCHLISRIFVADPATRISIPEIKTHSWFLK-NLPADLMNESNTGSQFQE 298
Query: 304 SPLLRQSL 311
QSL
Sbjct: 299 PEQPMQSL 306
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 48/280 (17%), Positives = 94/280 (33%), Gaps = 43/280 (15%)
Query: 29 EILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+LG+GA VY A D + +K+ +P E + LK
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFV---LKVQK-PANPWEFYIGTQLMERLKPSMQ 126
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-----VKHWCRQILSG 138
MKFY++ + V E+++ GTL ++ + V + ++L
Sbjct: 127 HMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNG----------NQGEVKIGDLGLAAILRKSHA---- 184
+ +H + +IH D+K DN + + + DLG + ++
Sbjct: 185 IEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 185 -ARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242
A+C T F E+ + +N +D + + M+ Y + + +
Sbjct: 243 TAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 243 KKPEALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDPF 281
++ +F L L + +LL
Sbjct: 302 LPHLDMWN-------EFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 72/344 (20%), Positives = 122/344 (35%), Gaps = 86/344 (25%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYG-------RYN--EILGKGASKTVYRAFDEYEGIEV 51
+ + D S+ V T G Y +++G G+ VY+A G V
Sbjct: 23 FGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELV 82
Query: 52 AWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK----FYTSWVDTANRNINFVTEM 107
A +V LQ R E+ +++ L H NI++ FY+S +N V +
Sbjct: 83 AIKKV-----LQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD- 133
Query: 108 FTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 163
+ T+ R Y + + + VK + Q+ L Y+HS + HRD+K N+ ++
Sbjct: 134 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDP 191
Query: 164 NQGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEVY--EEEYNELVDIYS 211
+ +K+ D G A L + E APE+ +Y +D++S
Sbjct: 192 DTAVLKLCDFGSAKQLVRG---------EPNVSYICSRYYRAPELIFGATDYTSSIDVWS 242
Query: 212 FGMCIL-EMVT----FDYPYSECTHPAQIYK----------KVISGKKPEA--------- 247
G C+L E++ F P Q+ + + I P
Sbjct: 243 AG-CVLAELLLGQPIF--PGDSGVD--QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 297
Query: 248 -------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
PE + L T ++RL+ E F
Sbjct: 298 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 75/345 (21%), Positives = 121/345 (35%), Gaps = 77/345 (22%)
Query: 23 RYGRYNEILGKGASKTVYRA--FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
+ +G+G VY+A D + + A Q++ S EI LL+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA---------VKHW 131
LKH N++ ++ A+R + + + + L HR VK
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLA----AILRK-SH 183
QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A + L+ +
Sbjct: 134 LYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 184 AARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT----F-------------- 222
V T + APE+ Y + +DI++ G CI E++T F
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTSEPIFHCRQEDIKTSNPYH 250
Query: 223 --------------------------DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256
++ Y K E D +
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310
Query: 257 RQFIEKCLATV-SSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 300
++K L R+++ + + DP+ D + Q Y
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPY 355
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 43/218 (19%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC----EIHLLKTLKHR 84
E +G+G TV++A + VA +V+L ++ E + EI LLK LKH+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLLKELKHK 61
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYL 142
NI++ + V +++ + V E F L++Y ++ VK + Q+L GL +
Sbjct: 62 NIVRLHD--VLHSDKKLTLVFE-FCDQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-- 194
HSR+ V+HRDLK N+ +N GE+K+ + GL AR G + E +
Sbjct: 118 HSRN--VLHRDLKPQNLLIN-RNGELKLANFGL---------ARAFGIPVRCYSAEVVTL 165
Query: 195 ---APEVY--EEEYNELVDIYSFGMCIL-EMVTFDYPY 226
P+V + Y+ +D++S G CI E+ P
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 60/286 (20%), Positives = 109/286 (38%), Gaps = 25/286 (8%)
Query: 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYD-FLQSPEELERLYCEIHLLKTL 81
Y ++ LG+G V + + G E A K + + + EI +L+
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYA---AKFLKKRRRGQDCRAEILHEIAVLELA 85
Query: 82 KHR-NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILS 137
K ++ + + + I + E G + + V +QIL
Sbjct: 86 KSCPRVINLHEVYEN--TSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILE 142
Query: 138 GLLYLHSRDPPVIHRDLKCDNI-FVNGNQ-GEVKIGDLGLAAILRKSHAAR-CVGTPEFM 194
G+ YLH + ++H DLK NI + G++KI D G++ + + R +GTPE++
Sbjct: 143 GVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200
Query: 195 APEVYE-EEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALF 249
APE+ + D+++ G+ I M+ E + Y + E F
Sbjct: 201 APEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETF 257
Query: 250 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI 294
FI+ L R +A L+ +LQ D+++
Sbjct: 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPE 303
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 28/250 (11%)
Query: 26 RYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLK 79
++ + LGKG +V + G VA VK LQ + E L EI +LK
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VKK---LQHSTEEHLRDFEREIEILK 66
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSG 138
+L+H NI+K+ RN+ + E G+LR Y KH+ R++ + + QI G
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EF---- 193
+ YL ++ IHRDL NI V N+ VKIGD GL +L + V P E
Sbjct: 127 MEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 194 MAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252
APE E +++ D++SFG+ + E+ T Y E + + G + ++
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG--QMI 237
Query: 253 DPEVRQFIEK 262
+ + ++
Sbjct: 238 VFHLIELLKN 247
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 25/271 (9%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEELERLYCEIHLLK 79
RY + + LG G TVY A D I+VA +K + E L+R E+H
Sbjct: 11 ERY-KIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSS 66
Query: 80 TLKHRNIMKFYTSWVDT-ANRNINF-VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
L H+NI+ D + + V E TL +Y H +++ ++ QIL
Sbjct: 67 QLSHQNIVSMI----DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFM 194
G+ + H ++HRD+K NI + + +KI D G+A L ++ +GT ++
Sbjct: 123 GIKHAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 195 APE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253
+PE E +E DIYS G+ + EM+ + P++ T I K I P V
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-AVSIAIKHIQDSVPNVTTDVRK 238
Query: 254 ---PEVRQFIEKCLA-TVSSR-LSARELLTD 279
+ I + ++R + +E+ D
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 31/272 (11%)
Query: 7 PEESDSSEFVEVDPT---GRYGRYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLY 59
+ + S F + DPT R+ ++ + LGKG +V + G VA VK
Sbjct: 22 FQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VKK- 77
Query: 60 DFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR 117
LQ + E L EI +LK+L+H NI+K+ RN+ + E G+LR Y
Sbjct: 78 --LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 118 LKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176
KH+ R++ + + QI G+ YL ++ IHRDL NI V N+ VKIGD GL
Sbjct: 136 QKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLT 192
Query: 177 AILRKSHAARCVGTP-EF----MAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECT 230
+L + V P E APE E +++ D++SFG+ + E+ T Y E +
Sbjct: 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKS 248
Query: 231 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262
+ G + V + + ++
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIVF--HLIELLKN 278
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 75/347 (21%), Positives = 132/347 (38%), Gaps = 88/347 (25%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYG------RYN--EILGKGASKTVYRAFDEYEGIEVA 52
+NGV D ++ ++V + Y +++G G+ V++A EVA
Sbjct: 10 LNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVA 68
Query: 53 WNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK----FYTSWVDTANRNINFVTEMF 108
+V + E+ +++ +KH N++ FY++ +N V E +
Sbjct: 69 IKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE-Y 119
Query: 109 TSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 164
T+ R Y + + + +K + Q+L L Y+HS + HRD+K N+ ++
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPP 177
Query: 165 QGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEVY--EEEYNELVDIYSF 212
G +K+ D G A IL E APE+ Y +DI+S
Sbjct: 178 SGVLKLIDFGSAKILIAG---------EPNVSYICSRYYRAPELIFGATNYTTNIDIWST 228
Query: 213 GMCIL-EMVT----FDYPYSECTHPAQIYK----------KVISGKKP------------ 245
G C++ E++ F P Q+ + + I P
Sbjct: 229 G-CVMAELMQGQPLF--PGESGID--QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRP 283
Query: 246 ---EALFKVE-DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287
+F+ P+ I + L T S+RL+A E L PF D+
Sbjct: 284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF--DEL 328
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 50/264 (18%), Positives = 95/264 (35%), Gaps = 27/264 (10%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEY-EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
G+Y + G +Y A D G V +K E E L
Sbjct: 80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 81 LKHRNIMKFYT--SWVDTANRNINF-VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
+ H +I++ + D + + V E +L++ + +++ + + +IL
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE 197
L YLHS +++ DLK +NI + Q +K+ DLG + R + GTP F APE
Sbjct: 194 ALSYLHSI--GLVYNDLKPENIMLTEEQ--LKLIDLGAVS--RINSFGYLYGTPGFQAPE 247
Query: 198 VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257
+ DIY+ G + + + + + + K
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTY--------DSYG 298
Query: 258 QFIEKCLATVSSR--LSARELLTD 279
+ + + + + +A E+
Sbjct: 299 RLLRRAIDPDPRQRFTTAEEMSAQ 322
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 44/239 (18%)
Query: 5 SSPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS 64
P S RY R ++ G+G VY+A D VA +++L
Sbjct: 17 QGPGSMSVSAAPSATSIDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRL------ 69
Query: 65 PEELERLYC----EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 120
E E + E+ LLK L+HRNI++ + V N ++ + E + L++Y K+
Sbjct: 70 EHEEEGVPGTAIREVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKN 126
Query: 121 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGLA 176
V++R +K + Q+++G+ + HSR +HRDLK N+ ++ +KIGD GL
Sbjct: 127 PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGL- 183
Query: 177 AILRKSHAARCVG------TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 221
AR G T E + PE+ Y+ VDI+S CI EM+
Sbjct: 184 --------ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 26 RYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
+ LG+G V ++ G VA VK P+ EI +L+TL
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTL 90
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
H +I+K+ D ++ V E G+LR Y L + + + + +QI G+ Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY-LPRHSIGLAQLLLFAQQICEGMAY 149
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT----PEF-MAP 196
LH++ IHRDL N+ + N VKIGD GLA + + H V P F AP
Sbjct: 150 LHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 197 E-VYEEEYNELVDIYSFGMCILEMVTF 222
E + E ++ D++SFG+ + E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTH 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 44/213 (20%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC----EIHLLKTLKHR 84
E +G+G VY+A D +G VA +++L E E + EI LLK L H
Sbjct: 27 EKVGEGTYGVVYKAKDS-QGRIVALKRIRL------DAEDEGIPSTAIREISLLKELHHP 79
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYL 142
NI+ V + R + V E F L++ L + ++ +K + Q+L G+ +
Sbjct: 80 NIVSLID--VIHSERCLTLVFE-FMEKDLKKV-LDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-- 194
H ++HRDLK N+ +N + G +K+ D GL AR G T E +
Sbjct: 136 HQHR--ILHRDLKPQNLLIN-SDGALKLADFGL---------ARAFGIPVRSYTHEVVTL 183
Query: 195 ---APEVY--EEEYNELVDIYSFGMCIL-EMVT 221
AP+V ++Y+ VDI+S G CI EM+T
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 71/222 (31%), Positives = 103/222 (46%), Gaps = 57/222 (25%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE--------RLYCEIHLLKT 80
E LG G TVY+ ++ G+ VA +VKL + E R EI L+K
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKL--------DSEEGTPSTAIR---EISLMKE 59
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-------VKHWCR 133
LKH NI++ Y V + V E F L++Y + R V VK++
Sbjct: 60 LKHENIVRLYD--VIHTENKLTLVFE-FMDNDLKKY-MDSRTVGNTPRGLELNLVKYFQW 115
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG---- 189
Q+L GL + H ++HRDLK N+ +N +G++K+GD GL AR G
Sbjct: 116 QLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGL---------ARAFGIPVN 163
Query: 190 --TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 221
+ E + AP+V Y+ +DI+S G CIL EM+T
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 31/251 (12%)
Query: 26 RYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLK 79
+Y LGKG +V + G VA VK LQ P++ EI +LK
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVA---VKQ---LQHSGPDQQRDFQREIQILK 79
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSG 138
L I+K+ +++ V E SG LR + +HR R++ + + QI G
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EF---- 193
+ YL SR +HRDL NI V ++ VKI D GLA +L V P +
Sbjct: 140 MEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 194 MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKV 251
APE + + ++ D++SFG+ + E+ T+ D S P+ + +++ ++
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS----PSAEFLRMMGCERDV----P 248
Query: 252 EDPEVRQFIEK 262
+ + +E+
Sbjct: 249 ALSRLLELLEE 259
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 44/213 (20%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC----EIHLLKTLKHR 84
+ LG+G TVY+ + VA +++L E E C E+ LLK LKH
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRL-------EHEEGAPCTAIREVSLLKDLKHA 60
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYL 142
NI+ + + +++ V E + L+QY L I VK + Q+L GL Y
Sbjct: 61 NIVTLHD--IIHTEKSLTLVFE-YLDKDLKQY-LDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-- 194
H + V+HRDLK N+ +N +GE+K+ D GL AR E +
Sbjct: 117 HRQK--VLHRDLKPQNLLIN-ERGELKLADFGL---------ARAKSIPTKTYDNEVVTL 164
Query: 195 ---APEVY--EEEYNELVDIYSFGMCIL-EMVT 221
P++ +Y+ +D++ G CI EM T
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 44/213 (20%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC----EIHLLKTLKHR 84
E +G+G VY+A + Y A +++L E E + EI +LK LKH
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLEK------EDEGIPSTTIREISILKELKHS 60
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYL 142
NI+K Y V + + V E L++ L + + K + Q+L+G+ Y
Sbjct: 61 NIVKLYD--VIHTKKRLVLVFE-HLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-- 194
H R V+HRDLK N+ +N +GE+KI D GL AR G T E +
Sbjct: 117 HDRR--VLHRDLKPQNLLIN-REGELKIADFGL---------ARAFGIPVRKYTHEIVTL 164
Query: 195 ---APEVY--EEEYNELVDIYSFGMCIL-EMVT 221
AP+V ++Y+ +DI+S G CI EMV
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 80/318 (25%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC----EIHLLKTLKHR 84
+G+G+ V++ + G VA + E+ + EI +LK LKH
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE------SEDDPVIKKIALREIRMLKQLKHP 62
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYL 142
N++ V R ++ V E + T+ L + + VK Q L + +
Sbjct: 63 NLVNLLE--VFRRKRRLHLVFE-YCDHTVLHE-LDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFM------- 194
H + IHRD+K +NI + +K+ D G AR + P ++
Sbjct: 119 HKHN--CIHRDVKPENILIT-KHSVIKLCDFGF---------ARLLTGPSDYYDDEVATR 166
Query: 195 ---APEVY--EEEYNELVDIYSFGMCIL-EMVTFDYPY----SECTHPAQIYK------- 237
+PE+ + +Y VD+++ G C+ E+++ P S+ Q+Y
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSD---VDQLYLIRKTLGD 221
Query: 238 ---------------KVISGKKP------EALFKVEDPEVRQFIEKCLATV-SSRLSARE 275
+ P E F ++ CL + RL+ +
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281
Query: 276 LLTDPFLQIDDYDSDLRM 293
LL P+ + DL
Sbjct: 282 LLHHPYFENIREIEDLAK 299
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 68/282 (24%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 1 MNGVSSPEESDSSEFVEVDPTGRYGRYN-------EILGKGASKTVYRAFDEYEGIEVAW 53
M+G ++ + P + + +ILG+G+ TV A + E A
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYA- 59
Query: 54 NQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSG 111
+K+ + + ++ + E ++ L H +K Y ++ D + + F +G
Sbjct: 60 --IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNG 115
Query: 112 TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 171
L +Y K + + + +I+S L YLH + +IHRDLK +NI +N ++I
Sbjct: 116 ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQIT 172
Query: 172 DLGLAAILRK-SHAARC---VGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYP- 225
D G A +L S AR VGT ++++PE+ E+ + D+++ G I ++V P
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPP 231
Query: 226 -YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL 264
+ + I++K+I + PE P+ R +EK L
Sbjct: 232 FRAG--NEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLL 267
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 81/313 (25%), Positives = 130/313 (41%), Gaps = 69/313 (22%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+ +LG+GA V A + G VA +K + P R EI +LK KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVA---IKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 84 RNIMKFYTSWVDTANRNINF-----VTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQI 135
NI+ + + + NF + E M T + L + +++ Q
Sbjct: 69 ENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQT 121
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE--F 193
L + LH + VIHRDLK N+ +N N ++K+ D GLA I+ +S A T +
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 194 M----------APEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY--------- 224
M APEV +Y+ +D++S G CIL E+ F DY
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 225 ----PYSE------CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSR 270
P+S+ + A+ Y K + E +F +P+ +++ L + R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 271 LSARELLTDPFLQ 283
++A+E L P+LQ
Sbjct: 298 ITAKEALEHPYLQ 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 75/311 (24%), Positives = 123/311 (39%), Gaps = 65/311 (20%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + LG G + V+ A D VA +K P+ ++ EI +++ L H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVA---IKKIVL-TDPQSVKHALREIKIIRRLDH 67
Query: 84 RNIMKFY-------TSWVDTANRNINF-----VTE-MFT--SGTLRQYRLKHRRVNIRAV 128
NI+K + + D V E M T + L Q L
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA----- 122
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC- 187
+ + Q+L GL Y+HS + V+HRDLK N+F+N +KIGD GLA I+ ++ +
Sbjct: 123 RLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 188 ----VGTPEFMAPEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY--------- 224
+ T + +P + Y + +D+++ G CI EM+T F
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 225 ----PYSE----CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLS 272
+ E +Y + + L E F+E+ L + RL+
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299
Query: 273 ARELLTDPFLQ 283
A E L+ P++
Sbjct: 300 AEEALSHPYMS 310
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 40/213 (18%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE----RLYCEIHLLKTLKHR 84
+ LG+G TVY+A D+ VA ++KL ++ + + R EI LL+ L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHP 72
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYL 142
NI+ NI+ V + F L +K + + +K + L GL YL
Sbjct: 73 NIIGLLD--AFGHKSNISLVFD-FMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-- 194
H ++HRDLK +N+ ++ G +K+ D GL A+ G T + +
Sbjct: 129 HQHW--ILHRDLKPNNLLLD-ENGVLKLADFGL---------AKSFGSPNRAYTHQVVTR 176
Query: 195 ---APEVY--EEEYNELVDIYSFGMCIL-EMVT 221
APE+ Y VD+++ G CIL E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 29/249 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +G+G V+ + VA VK P+ + E +LK H NI++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVA---VKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
V T + I V E+ G + R + R+ ++ + +G+ YL S+
Sbjct: 177 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK-- 232
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEVYEE-E 202
IHRDL N V +KI D G++ A G + APE
Sbjct: 233 CCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 203 YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV--- 251
Y+ D++SFG+ + E + PY ++ Q + V G + P+A+F++
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLMEQ 350
Query: 252 ---EDPEVR 257
+P R
Sbjct: 351 CWAYEPGQR 359
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 10 SDSSEFVEVDPT---GRYGRYNEILGKGASKTVYRA----FDEYEGIEVAWNQVKLYDFL 62
S+ EVDPT R+ + LG+G V + G +VA VK
Sbjct: 5 SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---VKSLKPE 61
Query: 63 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR- 121
+ L EI +L+ L H NI+K+ + I + E SG+L++Y K++
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 122 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
++N++ + QI G+ YL SR +HRDL N+ V ++ +VKIGD GL +
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIET 178
Query: 182 SHAARCVGT----PEF-MAPE-VYEEEYNELVDIYSFGMCILEMVTF 222
V P F APE + + ++ D++SFG+ + E++T+
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 68/315 (21%), Positives = 121/315 (38%), Gaps = 78/315 (24%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC----EIHLLKTLKHR 84
++G+G+ V + ++ G VA + ++ + + EI LLK L+H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE------SDDDKMVKKIAMREIKLLKQLRHE 84
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLH 143
N++ V + V E F T+ L ++ + V+ + QI++G+ + H
Sbjct: 85 NLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM--------- 194
S + +IHRD+K +NI V+ G VK+ D G AR + P +
Sbjct: 142 SHN--IIHRDIKPENILVS-QSGVVKLCDFGF---------ARTLAAPGEVYDDEVATRW 189
Query: 195 --APEVY--EEEYNELVDIYSFGMCIL-EMVTFDYPY----SECTHPAQIYK-------- 237
APE+ + +Y + VD+++ G C++ EM + P S+ Q+Y
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSD---IDQLYHIMMCLGNL 244
Query: 238 --------------------KVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSAREL 276
++ + E + V +KCL R EL
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304
Query: 277 LTDPFLQIDDYDSDL 291
L F Q+D +
Sbjct: 305 LHHDFFQMDGFAERF 319
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 91/303 (30%), Positives = 130/303 (42%), Gaps = 62/303 (20%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
Y +G GA +V A D+ G +VA KL QS +R Y E+ LLK ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 84 RNIMKFYTSWVDTANRNIN------FVTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQ 134
N++ V T ++ V M T + + ++ ++ Q
Sbjct: 83 ENVIGLLD--VFTPASSLRNFYDFYLVMPFMQTDLQKIMGL-KFSEEKI-----QYLVYQ 134
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPE 192
+L GL Y+HS V+HRDLK N+ VN + E+KI D GLA R + A V T
Sbjct: 135 MLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLA---RHADAEMTGYVVTRW 188
Query: 193 FMAPEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE- 228
+ APEV YN+ VDI+S G CI+ EM+T F DY P +E
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVG-CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 229 ----CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 280
A+ Y + + LF P+ +EK L V RL+A + LT P
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 281 FLQ 283
F +
Sbjct: 308 FFE 310
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-KHRRVNIRAVKHWC 132
E+ +++ L+H ++ + S+ D ++ V ++ G LR Y L ++ VK +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLR-YHLQQNVHFKEETVKLFI 121
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGT 190
+++ L YL ++ +IHRD+K DNI ++ G V I D +AA+L + GT
Sbjct: 122 CELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMA-GT 177
Query: 191 PEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKK 244
+MAPE++ Y+ VD +S G+ E++ PY + +I +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
Query: 245 --PEALFKVEDPEVRQFIEKCL-ATVSSRL-SARELLTDPFLQ-ID 285
P A E+ ++K L R ++ P++ I+
Sbjct: 238 TYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 77/310 (24%), Positives = 120/310 (38%), Gaps = 71/310 (22%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G+GA V A+D + VA +K + +R EI +L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 84 RNIMKFYTSWVDTANRNINF-----VTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQI 135
NI+ + A V + M T L+ L + + ++ QI
Sbjct: 85 ENIIGIND--IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-----CYFLYQI 137
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM- 194
L GL Y+HS + V+HRDLK N+ +N ++KI D GLA + H F+
Sbjct: 138 LRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH-----DHTGFLT 189
Query: 195 ---------APEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY----------- 224
APE+ + Y + +DI+S G CIL EM++ F Y
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 225 --PYSE-----CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSA 273
P E A+ Y + K LF D + ++K L R+
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 274 RELLTDPFLQ 283
+ L P+L+
Sbjct: 309 EQALAHPYLE 318
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 67/274 (24%), Positives = 110/274 (40%), Gaps = 26/274 (9%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEELERLYCEIHLLK 79
RY EILG G V+ A D + +VA VK+ D + P R E
Sbjct: 12 DRY-ELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAA 67
Query: 80 TLKHRNIMKFY-TSWVDTANRNINF-VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
L H I+ Y T +T + + V E TLR + +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-----HAARCVGTPE 192
L + H +IHRD+K NI + VK+ D G+A + S A +GT +
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 193 FMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI-YKKVISGKKPEALFK 250
+++PE + + D+YS G + E++T + P++ + P + Y+ V + P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHV--REDPIPPSA 241
Query: 251 VED---PEVRQFIEKCLA-TVSSR-LSARELLTD 279
+ ++ + K LA +R +A E+ D
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 61/220 (27%), Positives = 88/220 (40%), Gaps = 47/220 (21%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-------EIHLLKTL 81
+G GA TVY+A D + G VA V++ P E+ LL+ L
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRV------PNGGGGGGGLPISTVREVALLRRL 68
Query: 82 K---HRNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCR 133
+ H N+++ + + V E LR Y + + +K R
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 193
Q L GL +LH+ ++HRDLK +NI V + G VK+ D GL AR
Sbjct: 128 QFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGL---------ARIYSYQMA 175
Query: 194 M----------APEV-YEEEYNELVDIYSFGMCIL-EMVT 221
+ APEV + Y VD++S G CI EM
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 88/302 (29%), Positives = 131/302 (43%), Gaps = 52/302 (17%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
Y R + +G GA V A D G +VA KLY QS +R Y E+ LLK
Sbjct: 24 RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKH 80
Query: 81 LKHRNIMKFYTSWVDTANRNIN------FVTE-MFTSGTLRQYRLKHRRVNIRAVKHWCR 133
++H N++ V T + ++ V M T L + +KH ++ ++
Sbjct: 81 MRHENVIGLLD--VFTPDETLDDFTDFYLVMPFMGTD--LGKL-MKHEKLGEDRIQFLVY 135
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 193
Q+L GL Y+H+ +IHRDLK N+ VN + E+KI D GLA S V T +
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQA-DSEMTGYVVTRWY 191
Query: 194 MAPEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE-- 228
APEV Y + VDI+S G CI+ EM+T F D+ P +E
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVG-CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 229 ---CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 281
+ A+ Y K + + ++ P +EK L R++A E L P+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310
Query: 282 LQ 283
+
Sbjct: 311 FE 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 71/244 (29%), Positives = 100/244 (40%), Gaps = 52/244 (21%)
Query: 6 SPEESDSSEFVEVDPTG-------RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL 58
+ F V+ RY + + +G GA V A+D VA KL
Sbjct: 2 GSRSKRDNNFYSVEIGDSTFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIK--KL 58
Query: 59 YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN------FVTE-MFT-- 109
Q+ +R Y E+ L+K + H+NI+ V T +++ V E M
Sbjct: 59 SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANL 116
Query: 110 SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 169
++ L H R + + Q+L G+ +LHS +IHRDLK NI V + +K
Sbjct: 117 CQVIQM-ELDHER-----MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLK 167
Query: 170 IGDLGLAAILRKSHAARCVGTPEFM----------APEV-YEEEYNELVDIYSFGMCIL- 217
I D GL AR GT M APEV Y E VDI+S G CI+
Sbjct: 168 ILDFGL---------ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMG 217
Query: 218 EMVT 221
EM+
Sbjct: 218 EMIK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 74/316 (23%), Positives = 113/316 (35%), Gaps = 75/316 (23%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVA-------WNQVKLYDFLQSPEELERLYCEIH 76
Y + G+ V D EGI VA + + + L +R+ EI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 77 LLKTLKHRNIMKFY---TSWVDTANRNINFVTE-MFTSGTLRQYRLKHRRVNIRA--VKH 130
LL H NI+ + + A + VTE M T L Q + +R+ I +++
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQV-IHDQRIVISPQHIQY 138
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 190
+ IL GL LH V+HRDL NI + N ++ I D L AR
Sbjct: 139 FMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNL---------AREDTA 186
Query: 191 PEFM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY------ 224
APE+ + + +LVD++S G C++ EM F +
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFYNQLNK 245
Query: 225 -------PYSE-----CTHPAQIYKKVISGKKP----EALFKVEDPEVRQFIEKCLA-TV 267
P E + A+ Y + P A+ DP I K L
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305
Query: 268 SSRLSARELLTDPFLQ 283
R+S + L P+ +
Sbjct: 306 QRRISTEQALRHPYFE 321
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 59/253 (23%), Positives = 110/253 (43%), Gaps = 34/253 (13%)
Query: 29 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
++LG GA TVY+ E I VA +K SP+ + + E +++ ++ +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNP 77
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLH 143
++ + + + + +T++ G L Y +H+ + + + +WC QI G+ YL
Sbjct: 78 HVCRLLG--ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-V 198
R ++HRDL N+ V Q VKI D GLA +L + MA E +
Sbjct: 135 DRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 199 YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFK 250
Y D++S+G+ + E++TF PY ++I + G++ ++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTIDVYM 250
Query: 251 V------EDPEVR 257
+ D + R
Sbjct: 251 IMRKCWMIDADSR 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 90/301 (29%), Positives = 133/301 (44%), Gaps = 57/301 (18%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA +V AFD G+ VA KL QS +R Y E+ LLK +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 84 RNIMKFYTSWVDTANRNIN------FVTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 136
N++ V T R++ VT M L +K +++ V+ QIL
Sbjct: 88 ENVIGLLD--VFTPARSLEEFNDVYLVTHLMGAD--LNNI-VKCQKLTDDHVQFLIYQIL 142
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFM 194
GL Y+HS D +IHRDLK N+ VN + E+KI D GLA R + V T +
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA---RHTADEMTGYVATRWYR 196
Query: 195 APEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE--- 228
APE+ YN+ VDI+S G CI+ E++T F D+ P +E
Sbjct: 197 APEIMLNWMHYNQTVDIWSVG-CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 229 --CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
+ A+ Y + ++ +F +P +EK L R++A + L +
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 283 Q 283
Sbjct: 316 A 316
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 60/221 (27%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 29 EILGKGASKTVYRAFDEYEGIE-VAWNQVKLYDFLQSPEELE-------RLYCEIHLLKT 80
+G+GA V++A D G VA +V++ E R E+ +L+
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV------QTGEEGMPLSTIR---EVAVLRH 67
Query: 81 LK---HRNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWC 132
L+ H N+++ + T + V E L Y ++ V +K
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE 192
Q+L GL +LHS V+HRDLK NI V + G++K+ D GL AR
Sbjct: 127 FQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGL---------ARIYSFQM 174
Query: 193 FM----------APEV-YEEEYNELVDIYSFGMCIL-EMVT 221
+ APEV + Y VD++S G CI EM
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 62/304 (20%), Positives = 115/304 (37%), Gaps = 62/304 (20%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK- 82
Y + LG+G V+ A + +V +K P + +++ EI +L+ L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
NI+ D +R V E + +Q ++ + ++ + +IL L Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYC 146
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPE- 197
HS ++HRD+K N+ ++ ++++ D GLA H + V + F PE
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPEL 201
Query: 198 -VYEEEYNELVDIYSFGMCIL-EMVT---------------------------FDYPYSE 228
V + Y+ +D++S G C+L M+ +DY
Sbjct: 202 LVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 229 CTHPAQIYKKVISGKK--------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279
+ ++ + PE F++K L SRL+ARE +
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 280 PFLQ 283
P+
Sbjct: 321 PYFY 324
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-22
Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 26 RYNEI--LGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY + +G GA V A+D VA KL Q+ +R Y E+ L+K + H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 84 RNIMKFYTSWVDTANRNIN------FVTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 136
+NI+ V T + + V E M + ++ ++ + + Q+L
Sbjct: 121 KNIISLLN--VFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQML 174
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM-- 194
G+ +LHS +IHRDLK NI V + +KI D GL AR GT M
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL---------ARTAGTSFMMTP 222
Query: 195 --------APEV-YEEEYNELVDIYSFGMCIL-EMVT 221
APEV Y E VDI+S G CI+ EMV
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVR 258
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 53/241 (21%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 66 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 125
+ + E ++ +++ + ++ D +R + V E G L + + V
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNL-MSNYDVPE 167
Query: 126 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185
+ + + +++ L +HS IHRD+K DN+ ++ G +K+ D G + K
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224
Query: 186 RC---VGTPEFMAPEV-----YEEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIY 236
RC VGTP++++PEV + Y D +S G+ + EM+ D P Y++ Y
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282
Query: 237 KKVISGKKPEALFKVED--PEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDL 291
K+++ K D E + I L RL E+ F + D + +
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET 342
Query: 292 R 292
Sbjct: 343 L 343
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 56/303 (18%), Positives = 112/303 (36%), Gaps = 55/303 (18%)
Query: 7 PEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 66
P + + Y +++LG G + V + F++ + A +K+ LQ
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LKM---LQDCP 55
Query: 67 ELERLYCEIHLLKTL-KHRNIMKFYTSWVDT--ANRNINFVTEMFTSGTL--RQYRLKHR 121
+ R E+ L + +I++ + + + + V E G L R +
Sbjct: 56 KARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 122 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAIL 179
R + I + YLHS + + HRD+K +N+ + + +K+ D G A
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA--- 167
Query: 180 RKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQ--I 235
E E+Y++ D++S G I+ ++ YP YS +
Sbjct: 168 ----------------KETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGM 210
Query: 236 YKKVISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDY 287
++ G+ ++ +P EV+ I L T + R++ E + P++
Sbjct: 211 KTRIRMGQ-----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
Query: 288 DSD 290
Sbjct: 266 VPQ 268
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 69/316 (21%), Positives = 109/316 (34%), Gaps = 72/316 (22%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
R+ + G+G TV ++ G+ VA +V +Q P R + L L H
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFRNRELQIMQDLAVLHH 78
Query: 84 RNIMKFYTSWVDTANRN-----INFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQ 134
NI++ + + R+ +N V E + TL R Y + +K + Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVME-YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM 194
++ + LH V HRD+K N+ VN G +K+ D G A+ + E
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS---------AKKLSPSEPN 188
Query: 195 ----------APEVY--EEEYNELVDIYSFGMCIL-EMVT----F---DY---------- 224
APE+ + Y VDI+S G CI EM+ F +
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 225 ---PYSE---CTHP--AQIYKKVISGKKPEALFKVE----DPEVRQFIEKCLA-TVSSRL 271
P E +P + G +F E + L R+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 272 SARELLTDPFLQIDDY 287
E L P+ D+
Sbjct: 308 KPYEALCHPYF--DEL 321
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 11 DSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELE- 69
DS E D +Y + +I G+G V++A G +VA +V + E E
Sbjct: 6 DSVECPFCDEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLM------ENEKEG 58
Query: 70 ------RLYCEIHLLKTLKHRNIMKFY------TSWVDTANRNINFVTEMFTSGTLRQYR 117
R EI +L+ LKH N++ S + +I V + F L
Sbjct: 59 FPITALR---EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGL- 113
Query: 118 LKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175
L + V +K + +L+GL Y+H ++HRD+K N+ + G +K+ D GL
Sbjct: 114 LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGL 170
Query: 176 A---AILRKSHAAR---CVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 221
A ++ + S R V T + PE+ E +Y +D++ G CI+ EM T
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 64/311 (20%), Positives = 122/311 (39%), Gaps = 51/311 (16%)
Query: 26 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
+ LG+G+ VY + VA +K + S E E ++K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVA---IKTVNEAASMRERIEFLNEASVMKE 84
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK----------H 130
++++ V + + + E+ T G L+ Y R
Sbjct: 85 FNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 190
+I G+ YL++ +HRDL N V + VKIGD G+ + ++ R G
Sbjct: 143 MAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGK 199
Query: 191 PEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 244
M+PE + + + D++SFG+ + E+ T + PY ++ Q+ + V+ G
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEGGL 258
Query: 245 -------PEALFKV------EDPEVR-QFIEKCLATVSSRLSARELLTDPFLQIDDYDSD 290
P+ LF++ +P++R F+E + S + +E + F ++ Y S+
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-----IISSI--KEEMEPGFREVSFYYSE 311
Query: 291 LRMIQYQTDYD 301
+ + D
Sbjct: 312 ENKLPEPEELD 322
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 41/179 (22%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 190
+++ + +H +HRD+K DNI ++ G +++ D G L + + VGT
Sbjct: 183 EMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 191 PEFMAPEVYEEE------YNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGK 243
P++++PE+ + Y D +S G+C+ EM+ + P Y+E + Y K+++ K
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHK 297
Query: 244 K----PEALFKVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDLRMIQ 295
+ P + V + I + + + RL + PF D+D ++R +
Sbjct: 298 ERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD-NIRNCE 354
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-21
Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 35/251 (13%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G VY + + VA +K + E+E E ++K +KH N+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRD 146
V T +TE T G L Y + R + AV + QI S + YL ++
Sbjct: 281 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----RKSHAARCVGTPEFMAPEVYEE 201
IHR+L N V N VK+ D GL+ ++ A+ ++ APE
Sbjct: 339 --FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAY 393
Query: 202 E-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV- 251
++ D+++FG+ + E+ T+ PY +Q+Y+ + + PE ++++
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRMERPEGCPEKVYELM 452
Query: 252 -----EDPEVR 257
+P R
Sbjct: 453 RACWQWNPSDR 463
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 63/311 (20%), Positives = 119/311 (38%), Gaps = 53/311 (17%)
Query: 29 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
++LG GA TVY+ E I VA +K SP+ + + E +++ ++ +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNP 77
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLH 143
++ + + + + +T++ G L Y +H+ + + + +WC QI G+ YL
Sbjct: 78 HVCRLLG--ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-V 198
R ++HRDL N+ V Q VKI D GLA +L + MA E +
Sbjct: 135 DRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 199 YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFK 250
Y D++S+G+ + E++TF PY ++I + G++ ++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTIDVYM 250
Query: 251 V------EDPEVR-------QFIEKCLA------------TVSSRLSARELLTDPFLQID 285
+ D + R K + + +
Sbjct: 251 IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEE 310
Query: 286 DYDSDLRMIQY 296
D D + +Y
Sbjct: 311 DMDDVVDADEY 321
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 53/275 (19%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK- 82
+Y + LGKGA V+++ D G VA K++D Q+ + +R + EI +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 83 HRNIMKFYTSWVDTANRNINFVTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
H NI+ +R++ V + M T +R L+ ++ Q++ +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK-----QYVVYQLIKVI 122
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-------------AILRKSHAAR 186
YLHS ++HRD+K NI +N VK+ D GL+ + +
Sbjct: 123 KYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 187 CVGTPEFM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT----FDYPYSEC 229
+ APE+ +Y + +D++S G CIL E++ F P S
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKPIF--PGSST 236
Query: 230 THPAQIYK--KVISGKKPEALFKVEDPEVRQFIEK 262
+ Q+ + VI E + ++ P + IE
Sbjct: 237 MN--QLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 45/231 (19%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
Y ++G+G+ VY A+D+ VA K+ + + +R+ EI +L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKS 84
Query: 84 RNIMKFYTSWVDTANRNINF-----VTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
I++ Y + + + F V E + L++ + +K +L
Sbjct: 85 DYIIRLYD--LIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--------------AILRKSH 183
G ++H +IHRDLK N +N + VK+ D GLA +
Sbjct: 141 GENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 184 AARCVGTPEFM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT 221
+ + APE+ +E Y + +DI+S G CI E++
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 67 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 126
++E E +L+ + ++K S+ D N N+ V E G + + + R +
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 127 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 186
+ + QI+ YLHS D +I+RDLK +N+ ++ QG +++ D G A ++
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTWTL 198
Query: 187 CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGK 243
C GTPE +APE+ + YN+ VD ++ G+ I EM YP +++ P QIY+K++SGK
Sbjct: 199 C-GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFAD--QPIQIYEKIVSGK 254
Query: 244 K--PEALFKVEDPEVRQFIEKCL-ATVSSRL 271
P +++ + L ++ R
Sbjct: 255 VRFPSHF----SSDLKDLLRNLLQVDLTKRF 281
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-21
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 190
+I+ + +H +HRD+K DNI ++ G +++ D G LR R VGT
Sbjct: 170 EIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 191 PEFMAPEV--------YEEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVIS 241
P++++PE+ Y D ++ G+ EM P Y++ A+ Y K++
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVH 284
Query: 242 GKKPEALFKVED---PEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDLRMIQ 295
K+ +L V++ E R FI++ L +RL A + T PF D+D LR
Sbjct: 285 YKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWD-GLRDSV 343
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 58/252 (23%), Positives = 102/252 (40%), Gaps = 39/252 (15%)
Query: 29 EILGKGASKTVYRAFDEYEG-IEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHRNI 86
+ +G G V+ + +VA +K + + S E+ E ++ L H +
Sbjct: 14 QEIGSGQFGLVHLG--YWLNKDKVA---IKTIREGAMSEEDFIE---EAEVMMKLSHPKL 65
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHS 144
++ Y V I VTE G L Y L+ +R A C + G+ YL
Sbjct: 66 VQLYG--VCLEQAPICLVTEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-Y 199
VIHRDL N V G +K+ D G+ + GT +F +PEV
Sbjct: 123 AC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFS 178
Query: 200 EEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV 251
Y+ D++SFG+ + E+ + PY ++ +++ + + +G + ++++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFRLYKPRLASTHVYQI 237
Query: 252 ------EDPEVR 257
E PE R
Sbjct: 238 MNHCWRERPEDR 249
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 23/193 (11%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
F+ ++ G L + +H + ++ + +I+ GL ++H+R V++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 163 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV--YEEEYNELVDIYSFGMCILEMV 220
G V+I DLGLA K VGT +MAPEV Y+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 221 T----FDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-- 271
F ++ H +I + ++ P++ PE+R +E L V+ RL
Sbjct: 386 RGHSPFRQHKTKDKH--EIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGC 439
Query: 272 ---SARELLTDPF 281
A+E+ PF
Sbjct: 440 LGRGAQEVKESPF 452
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 43/255 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G VY + + VA +K + E+E E ++K +KH N+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRD 146
V T +TE T G L Y + R + AV + QI S + YL ++
Sbjct: 74 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----RKSHAARCVGTPEF----MAPE 197
IHRDL N V N VK+ D GL+ ++ A+ F APE
Sbjct: 132 --FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPE 182
Query: 198 V-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEAL 248
+++ D+++FG+ + E+ T+ PY +Q+Y+ + + PE +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRMERPEGCPEKV 241
Query: 249 FKV------EDPEVR 257
+++ +P R
Sbjct: 242 YELMRACWQWNPSDR 256
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 50/253 (19%), Positives = 107/253 (42%), Gaps = 34/253 (13%)
Query: 29 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
++LG G TV++ E I V +K+ + + + + + + +L H
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLH 143
+I++ + + + VT+ G+L + +HR + + + +W QI G+ YL
Sbjct: 76 HIVRLLG--LCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV- 198
++HR+L N+ + +V++ D G+A +L + MA E
Sbjct: 133 EHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 199 YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFK 250
+ +Y D++S+G+ + E++TF PY+ A++ + G++ ++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTIDVYM 248
Query: 251 V------EDPEVR 257
V D +R
Sbjct: 249 VMVKCWMIDENIR 261
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 45/311 (14%)
Query: 6 SPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAF---DEYEGIEVAWNQVK-LYDF 61
S E + E V + + +LGKG +V A ++ ++VA VK L
Sbjct: 8 SDELKEKLEDVLIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVA---VKMLKAD 62
Query: 62 LQSPEELERLYCEIHLLKTLKHRNIMKFY----TSWVDTANRNINFVTEMFTSGTLRQYR 117
+ + ++E E +K H ++ K S + G L +
Sbjct: 63 IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 118 LKHR------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 171
L R + ++ + + I G+ YL SR+ IHRDL N + + V +
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVA 179
Query: 172 DLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYP 225
D GL+ + R + +A E + + Y D+++FG+ + E++T P
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 226 YSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR---QFIEKCLATVSS 269
Y+ + A+IY +I G + E ++ + DP+ R + L +
Sbjct: 240 YAGIEN-AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298
Query: 270 RLSARELLTDP 280
LS DP
Sbjct: 299 HLSVLSTSQDP 309
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 35/250 (14%)
Query: 29 EILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
+ LG G V +++G +VA +K + + + E + L H ++
Sbjct: 14 KELGSGQFGVVKLG--KWKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
KFY V + I VTE ++G L Y R + + + C + G+ +L S
Sbjct: 67 KFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEE 201
IHRDL N V+ + VK+ D G+ + VGT +F APEV +
Sbjct: 125 --FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYF 180
Query: 202 EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV-- 251
+Y+ D+++FG+ + E+ + PY T+ +++ KV G + + ++++
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQGHRLYRPHLASDTIYQIMY 239
Query: 252 ----EDPEVR 257
E PE R
Sbjct: 240 SCWHELPEKR 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 58/279 (20%), Positives = 112/279 (40%), Gaps = 37/279 (13%)
Query: 6 SPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFL 62
+PE + + V + P+ +NE++G+G VY ++ + I A VK + +
Sbjct: 8 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRI 64
Query: 63 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHR 121
E+ + E ++K H N++ + + V G LR + +++
Sbjct: 65 TDIGEVSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNF-IRNE 121
Query: 122 RVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179
N + Q+ G+ YL S+ +HRDL N ++ VK+ D GLA +
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDM 178
Query: 180 RKSHAARCVGTPEF------MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTH 231
MA E + +++ D++SFG+ + E++T PY +
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN- 237
Query: 232 PAQIYKKVISGKK-------PEALFKV------EDPEVR 257
I ++ G++ P+ L++V E+R
Sbjct: 238 TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 276
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 50/236 (21%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY ++G G+ V A+D+ E VA K+ + + +R+ EI +L L H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNH 111
Query: 84 RNIMKFYTSWVDTANRNINF-----VTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
+++K + F V E + ++ + +K +L
Sbjct: 112 DHVVKVLD--IVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-------------------AI 178
G+ Y+HS ++HRDLK N VN + VK+ D GLA
Sbjct: 168 GVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 179 LRKSHAARCVGTPEFM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT 221
+ + APE+ +E Y E +D++S G CI E++
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLN 279
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 45/255 (17%)
Query: 29 EILGKGASKTVYRAFDEYEG-IEVAWNQVK-----LYDFLQSPEELERLYCEIHLLKTLK 82
+ LG G V ++ G +VA +K +F++ E ++ L
Sbjct: 30 KELGTGQFGVVKYG--KWRGQYDVAIKMIKEGSMSEDEFIE----------EAKVMMNLS 77
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLY 141
H +++ Y V T R I +TE +G L Y R R + + C+ + + Y
Sbjct: 78 HEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE 197
L S+ +HRDL N VN G VK+ D GL+ + VG+ +F PE
Sbjct: 136 LESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPE 191
Query: 198 V-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEAL 248
V +++ DI++FG+ + E+ + PY T+ ++ + + G + E +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGLRLYRPHLASEKV 250
Query: 249 FKV------EDPEVR 257
+ + E + R
Sbjct: 251 YTIMYSCWHEKADER 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 56/273 (20%), Positives = 92/273 (33%), Gaps = 31/273 (11%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKL--YDFLQSPEELERLYCEIHLLK 79
G Y R ++G+G VY A D VA +KL P R+ E
Sbjct: 34 GPY-RLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAG 89
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL 139
L+ +++ + + + L + + RQI S L
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYV--DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAP 196
H+ HRD+K +NI V+ + + D G+A+ VGT +MAP
Sbjct: 148 DAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204
Query: 197 EVYE-EEYNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKV------ISGKKPEAL 248
E + DIY+ C+L E +T PY + + + S +P
Sbjct: 205 ERFSESHATYRADIYALT-CVLYECLTGSPPYQGDQ-LSVMGAHINQAIPRPSTVRPGI- 261
Query: 249 FKVEDPEVRQFIEKCLA-TVSSR-LSARELLTD 279
I + +A R ++ +L
Sbjct: 262 ----PVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 55/251 (21%), Positives = 104/251 (41%), Gaps = 41/251 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ +GKG V +Y G +VA VK +++ + E ++ L+H N+++
Sbjct: 27 QTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQ 78
Query: 89 FYTSWVDTANR-NINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSR 145
V + + VTE G+L Y R + + + + YL
Sbjct: 79 LLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YE 200
+ +HRDL N+ V+ + K+ D GL +++ + + G + APE E
Sbjct: 137 N--FVHRDLAARNVLVSED-NVAKVSDFGLT---KEASSTQDTG--KLPVKWTAPEALRE 188
Query: 201 EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV- 251
++++ D++SFG+ + E+ +F PY + +V G K P A+++V
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPAVYEVM 247
Query: 252 -----EDPEVR 257
D +R
Sbjct: 248 KNCWHLDAAMR 258
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 55/253 (21%), Positives = 104/253 (41%), Gaps = 33/253 (13%)
Query: 28 NEILGKGASKTVYRAF--DEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHR 84
++ LG G TV + + + VA VK L + P + L E ++++ L +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
I++ + A V EM G L +Y ++R V + + Q+ G+ YL
Sbjct: 79 YIVRMIG--ICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEV- 198
+ +HRDL N+ + Q KI D GL+ A+ + + ++ APE
Sbjct: 136 SN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 199 YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFK 250
+++ D++SFG+ + E ++ PY ++ + G++ P ++
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYD 251
Query: 251 V------EDPEVR 257
+ D E R
Sbjct: 252 LMNLCWTYDVENR 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 49/264 (18%), Positives = 92/264 (34%), Gaps = 48/264 (18%)
Query: 26 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHL 77
+NE LG+G +++ + + EV +K L E + +
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVL---LKVLDK--AHRNYSESFFEAASM 65
Query: 78 LKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQIL 136
+ L H++++ Y V V E G+L Y K++ +NI +Q+
Sbjct: 66 MSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVN-------GNQGEVKIGDLGLAAILRKSHAARCVG 189
+ + +L +IH ++ NI + GN +K+ D G+ + V
Sbjct: 124 AAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI---------SITVL 172
Query: 190 TPEF-------MAPEV--YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKV 239
+ + PE + N D +SFG + E+ + D P S + +
Sbjct: 173 PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFY 231
Query: 240 ISGKKPEALFKVEDPEVRQFIEKC 263
L + E+ I C
Sbjct: 232 EDR---HQLPAPKAAELANLINNC 252
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 67 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 126
++E E +L + H I++ + ++ D + I + + G L K +R
Sbjct: 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNP 106
Query: 127 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 186
K + ++ L YLHS+D +I+RDLK +NI ++ G +KI D G A K
Sbjct: 107 VAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFA----KYVPDV 159
Query: 187 ----CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKV 239
C GTP+++APEV + YN+ +D +SFG+ I EM+ Y Y + + Y+K+
Sbjct: 160 TYTLC-GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDS--NTMKTYEKI 215
Query: 240 ISGKK--PEALFKVEDPEVRQFIEKCL-ATVSSRL 271
++ + P + +V+ + + + +S RL
Sbjct: 216 LNAELRFPPFF----NEDVKDLLSRLITRDLSQRL 246
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL----RQ 115
L+ + + E +L + R I+ ++ +T + V + G +
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-ETKTD-LCLVMTIMNGGDIRYHIYN 278
Query: 116 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175
+ + QI+SGL +LH R+ +I+RDLK +N+ ++ + G V+I DLGL
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGL 335
Query: 176 A--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVT----FDYPYSE 228
A ++ GTP FMAPE+ E Y+ VD ++ G+ + EM+ F E
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF-RARGE 394
Query: 229 CTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDP 280
++ ++V+ P+ P + F E L RL S L T P
Sbjct: 395 KVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
Query: 281 F 281
Sbjct: 451 L 451
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 65/333 (19%), Positives = 109/333 (32%), Gaps = 99/333 (29%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ LG G+ V FD G A +K LQ P R E+ ++K L H NI+K
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFA---LK--KVLQDPRYKNR---ELDIMKVLDHVNIIK 64
Query: 89 ----FYTSWVDTANRN--------------------------------INFVTE-MFT-- 109
FYT+ + +N + E +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 110 SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 169
L+ + R + + + + Q+ + ++HS + HRD+K N+ VN +K
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182
Query: 170 IGDLGLAAILRKSHAARCVGTPEFM----------APEVY--EEEYNELVDIYSFGMCIL 217
+ D G A L S E APE+ EY +D++S G C+
Sbjct: 183 LCDFGSAKKLIPS---------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVF 232
Query: 218 -EMVT----F---DY-------------PYSE-----CTHPAQIYKKVISGKKPEALF-K 250
E++ F P E H ++ + K + +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282
+E+ L R++ E + PF
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 52/259 (20%), Positives = 101/259 (38%), Gaps = 37/259 (14%)
Query: 26 RYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
+ ++GKG VY + I+ A +K + +++E E L++ L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCA---IKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 83 HRNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGL 139
H N++ + + + G L Q+ ++ + N + Q+ G+
Sbjct: 81 HPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQF-IRSPQRNPTVKDLISFGLQVARGM 137
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEF---- 193
YL + +HRDL N ++ + VK+ D GLA + + +
Sbjct: 138 EYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 194 MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK------- 244
A E + + D++SFG+ + E++T PY P + + G++
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQPEYC 253
Query: 245 PEALFKV------EDPEVR 257
P++L++V DP VR
Sbjct: 254 PDSLYQVMQQCWEADPAVR 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 55/251 (21%), Positives = 107/251 (42%), Gaps = 32/251 (12%)
Query: 29 EILGKGASKTVYRA---FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+G+G V++ E + VA +K S E+ E ++ H +
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHS 144
I+K V T N + + E+ T G LR + + +++ ++ + Q+ + L YL S
Sbjct: 78 IVKLIG--VITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT--P-EFMAPEVYEE 201
+ +HRD+ N+ V + VK+GD GL+ + S + P ++MAPE
Sbjct: 135 KR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 202 -EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV- 251
+ D++ FG+C+ E++ P+ + + ++ +G++ P L+ +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTLYSLM 250
Query: 252 -----EDPEVR 257
DP R
Sbjct: 251 TKCWAYDPSRR 261
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 57/251 (22%), Positives = 101/251 (40%), Gaps = 32/251 (12%)
Query: 29 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
ILG+G VY + E I VA VK + + E+ E ++K L H +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVA---VKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHS 144
I+K + + E++ G L Y + + + + QI + YL S
Sbjct: 75 IVKLIG--IIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT--P-EFMAPEVYE- 200
+ +HRD+ NI V + VK+GD GL+ + + T P ++M+PE
Sbjct: 132 IN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 201 EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV- 251
+ D++ F +C+ E+++F P+ + + + G + P L+ +
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLM 247
Query: 252 -----EDPEVR 257
DP R
Sbjct: 248 TRCWDYDPSDR 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 75/333 (22%), Positives = 120/333 (36%), Gaps = 87/333 (26%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLY----DFLQSPEELERLYCEIHLL 78
RY LG G TV+ A D VA +K+ + ++ E+ EI LL
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVA---MKIVRGDKVYTEAAED------EIKLL 69
Query: 79 KTLK-----------HRNIMKFYTSWVDTANRNIN---FVTEMFTSGTLRQY--RLKHRR 122
+ + +I+K + N V E+ L + +HR
Sbjct: 70 QRVNDADNTKEDSMGANHILKLL-DHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRG 127
Query: 123 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV-----NGNQGEVKIGDLGLAA 177
+ + VK +Q+L GL Y+H R +IH D+K +N+ + N ++KI DLG A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 178 ILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVT----FD-----YPYS 227
+ H + T E+ +PEV + DI+S I E++T F+
Sbjct: 187 WYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 228 ECTHPAQI--------------------------YKKVISGKKPEAL-------FKVEDP 254
+ H AQI + IS K L +K
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 255 EVRQF---IEKCLA-TVSSRLSARELLTDPFLQ 283
E ++ + L R A L+ P+L+
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 9e-19
Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 22/236 (9%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ--YR 117
++ + E +L+ + R ++ ++ +T + + V + G L+ Y
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-ETKDA-LCLVLTLMNGGDLKFHIYH 277
Query: 118 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177
+ + +I GL LH +++RDLK +NI ++ + G ++I DLGLA
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAV 334
Query: 178 ILRKSHAAR-CVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVT----FDYPYSECTH 231
+ + + VGT +MAPEV E Y D ++ G + EM+ F +
Sbjct: 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIK 393
Query: 232 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPF 281
++ + V + PE + P+ R + L + RL SARE+ P
Sbjct: 394 REEVERLVK--EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 9e-19
Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 33/249 (13%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG+G V+ VA +K E E ++K L+H +++
Sbjct: 190 VKLGQGCFGEVWMGTWNGT-TRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRD 146
Y V + I VTE + G+L + +R + QI SG+ Y+ +
Sbjct: 244 LYA--VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYEE-E 202
+HRDL+ NI V N K+ D GLA ++ + G ++ APE
Sbjct: 301 --YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 203 YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV--- 251
+ D++SFG+ + E+ T PY + ++ +V G + PE+L +
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMCQ 416
Query: 252 ---EDPEVR 257
++PE R
Sbjct: 417 CWRKEPEER 425
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 23/224 (10%)
Query: 29 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKH 83
E LG G+ V R + + VA VK D L PE ++ E++ + +L H
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYL 142
RN+++ Y V + VTE+ G+L KH+ + + + Q+ G+ YL
Sbjct: 81 RNLIRLYG--VVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPE 197
S+ IHRDL N+ + VKIGD GL A+ + + APE
Sbjct: 138 ESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 198 V-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKV 239
++ D + FG+ + EM T+ P+ +QI K+
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKI 237
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 43/266 (16%)
Query: 26 RYNEILGKGASKTVYRAF-----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
LG GA VY ++ ++VA VK + S ++ E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIISK 89
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------HWCR 133
H+NI++ V + + E+ G L+ + + R + H R
Sbjct: 90 FNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAARCVGT 190
I G YL IHRD+ N + G KIGD G+A + ++ R G
Sbjct: 148 DIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 191 PEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 244
M PE E + D +SFG+ + E+ + PY ++ ++ + V SG +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGR 263
Query: 245 -------PEALFKV------EDPEVR 257
P ++++ PE R
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDR 289
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 35/254 (13%)
Query: 29 EILGKGASKTVYRA---FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+I+G G S V + VA +K + + E ++ H N
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVA---IKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLH 143
I++ V T R VTE +G+L + L+ ++ R + +G+ YL
Sbjct: 112 IIRLEG--VVTRGRLAMIVTEYMENGSLDTF-LRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEV 198
+HRDL N+ V+ N K+ D GL+ + AA + APE
Sbjct: 169 DLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 199 -YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALF 249
++ D++SFG+ + E++ + + PY T+ + V G + P AL
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALH 284
Query: 250 KV------EDPEVR 257
++ +D R
Sbjct: 285 QLMLDCWHKDRAQR 298
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 35/250 (14%)
Query: 29 EILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
LG+G V+ + G VA +K E E ++K L+H ++
Sbjct: 273 VKLGQGCFGEVWMG--TWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSR 145
+ Y V + I VTE + G+L + +R + QI SG+ Y+
Sbjct: 326 QLYA--VVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYEE- 201
+ +HRDL+ NI V N K+ D GLA ++ + G ++ APE
Sbjct: 383 N--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 202 EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV-- 251
+ D++SFG+ + E+ T PY + ++ +V G + PE+L +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMC 498
Query: 252 ----EDPEVR 257
++PE R
Sbjct: 499 QCWRKEPEER 508
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/265 (19%), Positives = 97/265 (36%), Gaps = 41/265 (15%)
Query: 26 RYNEILGKGASKTVYRAF---DEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTL 81
+ILG+G +V ++ ++VA VK + S E+E E +K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVA---VKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 82 KHRNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------HW 131
H N+++ + G L Y L + R+ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY-LLYSRLETGPKHIPLQTLLKF 152
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP 191
I G+ YL +R+ +HRDL N + + V + D GL+ + R
Sbjct: 153 MVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 192 EF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK- 244
+ +A E + + Y D+++FG+ + E+ T PY ++Y ++ G +
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-NHEMYDYLLHGHRL 268
Query: 245 ------PEALFKV------EDPEVR 257
+ L+++ DP R
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDR 293
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 61/314 (19%), Positives = 118/314 (37%), Gaps = 54/314 (17%)
Query: 29 EILGKGASKTVYRA---FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+++G G V + I VA +K + ++ E ++ H N
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVA---IKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHS 144
I++ V T ++ + VTE +G+L + KH + + + R I SG+ YL
Sbjct: 108 IIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEVY 199
+HRDL NI +N N K+ D GL + AA + +PE
Sbjct: 166 MG--YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 200 EE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFK 250
++ D++S+G+ + E++++ + PY E ++ + K V G + P AL++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 251 V--------------------------EDPEVRQFIEKCLATVSSRLSARELLTDPFLQ- 283
+ +P + I A S+ L + + +
Sbjct: 282 LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRT 341
Query: 284 IDDYDSDLRMIQYQ 297
D+ + + +
Sbjct: 342 TGDWLNGVWTAHCK 355
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 57/279 (20%), Positives = 113/279 (40%), Gaps = 37/279 (13%)
Query: 6 SPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFL 62
+PE + + V + P+ +NE++G+G VY ++ + I A VK + +
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRI 128
Query: 63 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHR 121
E+ + E ++K H N++ + + V G LR + +++
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNF-IRNE 185
Query: 122 RVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179
N + Q+ G+ +L S+ +HRDL N ++ VK+ D GLA +
Sbjct: 186 THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDM 242
Query: 180 RKSHAARCVGTPE------FMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTH 231
+MA E + +++ D++SFG+ + E++T PY +
Sbjct: 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN- 301
Query: 232 PAQIYKKVISGKK-------PEALFKV------EDPEVR 257
I ++ G++ P+ L++V E+R
Sbjct: 302 TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 55/251 (21%), Positives = 108/251 (43%), Gaps = 32/251 (12%)
Query: 29 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+G+G V++ E + VA +K S E+ E ++ H +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHS 144
I+K V T N + + E+ T G LR + + +++ ++ + Q+ + L YL S
Sbjct: 453 IVKLIG--VITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT--P-EFMAPE-VYE 200
+ +HRD+ N+ V + VK+GD GL+ + S + P ++MAPE +
Sbjct: 510 KR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 201 EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV- 251
+ D++ FG+C+ E++ P+ + + ++ +G++ P L+ +
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLM 625
Query: 252 -----EDPEVR 257
DP R
Sbjct: 626 TKCWAYDPSRR 636
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 54/274 (19%)
Query: 26 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLK 79
LG+GA V+ A + + VA VK L D + + E LL
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVA---VKALKD--PTLAARKDFQREAELLT 72
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK---------- 129
L+H +I+KFY V + V E G L ++ L+ + +
Sbjct: 73 NLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKF-LRAHGPDAMILVDGQPRQAKGE 129
Query: 130 -------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182
H QI SG++YL S+ +HRDL N V N VKIGD G++ + +
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMSRDVYST 186
Query: 183 HAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIY 236
R G M PE + ++ D++SFG+ + E+ T+ P+ + ++ ++
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVI 245
Query: 237 KKVISGKK-------PEALFKV------EDPEVR 257
+ + G+ P+ ++ V +P+ R
Sbjct: 246 ECITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 23/234 (9%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 119
+ + + +E+ E +L+ +H + ++ T +R + FV E G L + +
Sbjct: 41 EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHDR-LCFVMEYANGGELFFHLSR 98
Query: 120 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AI 178
R + + +I+S L YLHSRD V++RD+K +N+ ++ G +KI D GL
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKEG 155
Query: 179 LRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 235
+ + C GTPE++APEV E+ Y VD + G+ + EM+ P+ H ++
Sbjct: 156 ISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERL 213
Query: 236 YKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPF 281
++ ++ + P L PE + + L RL A+E++ F
Sbjct: 214 FELILMEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 37/251 (14%)
Query: 29 EILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
E LG G V+ Y G +VA +K Q + E +L+K L+H+ ++
Sbjct: 19 ERLGAGQFGEVWMG--YYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSR 145
+ Y V T I +TE +G+L + + + K QI G+ ++ R
Sbjct: 72 RLYA--VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEVYEE 201
+ IHRDL+ NI V+ KI D GLA ++ + G +F APE
Sbjct: 129 N--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINY 184
Query: 202 -EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV- 251
+ D++SFG+ + E+VT PY T+P ++ + + G + PE L+++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 252 -----EDPEVR 257
E PE R
Sbjct: 244 RLCWKERPEDR 254
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 51/272 (18%)
Query: 26 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLK 79
LG+GA V+ A E + + VA VK L + S + E LL
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVA---VKALKE--ASESARQDFQREAELLT 98
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK---------- 129
L+H++I++F+ V T R + V E G L ++ H
Sbjct: 99 MLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 130 -----HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 184
Q+ +G++YL +HRDL N V VKIGD G++ + +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDY 213
Query: 185 ARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKK 238
R G M PE + ++ D++SFG+ + E+ T+ P+ + ++ +
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDC 272
Query: 239 VISGKK-------PEALFKV------EDPEVR 257
+ G++ P ++ + +P+ R
Sbjct: 273 ITQGRELERPRACPPEVYAIMRGCWQREPQQR 304
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 56/259 (21%), Positives = 93/259 (35%), Gaps = 57/259 (22%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVK-------LYDFLQSPEELERLYCEIHLLKTL 81
+ +GKG V +Y G +VA VK FL E ++ L
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVA---VKCIKNDATAQAFLA----------EASVMTQL 243
Query: 82 KHRNIMKFYTSWVDTANR-NINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSG 138
+H N+++ V + + VTE G+L Y R + + +
Sbjct: 244 RHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPEF---- 193
+ YL + +HRDL N+ V+ + K+ D GL +
Sbjct: 302 MEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGK------LPVKW 352
Query: 194 MAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK------- 244
APE E +++ D++SFG+ + E+ +F PY + +V G K
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGC 411
Query: 245 PEALFKV------EDPEVR 257
P A++ V D R
Sbjct: 412 PPAVYDVMKNCWHLDAATR 430
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 37/251 (14%)
Query: 29 EILGKGASKTVYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
+ LG G V+ A Y +VA +K +E E +++KTL+H ++
Sbjct: 194 KKLGAGQFGEVWMA--TYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSR 145
K + V T I +TE G+L + K + QI G+ ++ R
Sbjct: 247 KLHA--VVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEVYEE 201
+ IHRDL+ NI V+ + KI D GLA ++ + G +F APE
Sbjct: 304 N--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINF 359
Query: 202 -EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV- 251
+ D++SFG+ ++E+VT+ PY ++P ++ + + G + PE L+ +
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERGYRMPRPENCPEELYNIM 418
Query: 252 -----EDPEVR 257
PE R
Sbjct: 419 MRCWKNRPEER 429
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 60/295 (20%), Positives = 125/295 (42%), Gaps = 48/295 (16%)
Query: 29 EILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR 84
+++G G VY+ + + VA +K + ++ E ++ H
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYL 142
NI++ V + + + +TE +G L ++ L+ + ++ R I +G+ YL
Sbjct: 107 NIIRLEG--VISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-------RKSHAARCVGTP-EFM 194
+ + +HRDL NI VN N K+ D GL+ +L + + P +
Sbjct: 164 ANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKI---PIRWT 217
Query: 195 APEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------P 245
APE ++ D++SFG+ + E++T+ + PY E ++ ++ K + G + P
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCP 276
Query: 246 EALFKV------EDPEVR-QFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRM 293
A++++ ++ R +F + + S L D + D+D + +
Sbjct: 277 SAIYQLMMQCWQQERARRPKFAD-----IVSILDKLIRAPDSLKTLADFDPRVSI 326
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 43/266 (16%)
Query: 26 RYNEILGKGASKTVYRAF-----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
LG GA VY ++ ++VA VK + S ++ E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIISK 130
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------HWCR 133
H+NI++ V + + E+ G L+ + + R + H R
Sbjct: 131 FNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAARCVGT 190
I G YL IHRD+ N + G KIGD G+A + ++ R G
Sbjct: 189 DIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 191 PEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 244
M PE E + D +SFG+ + E+ + PY ++ ++ + V SG +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGR 304
Query: 245 -------PEALFKV------EDPEVR 257
P ++++ PE R
Sbjct: 305 MDPPKNCPGPVYRIMTQCWQHQPEDR 330
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 20/143 (13%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 190
+I+ L +LH +I+RD+K +NI ++ + G V + D GL+ R GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 191 PEFMAPEVYEEE---YNELVDIYSFGMCILEMVT----FDYPYSECTHPAQIYKKVISGK 243
E+MAP++ +++ VD +S G+ + E++T F E A+I ++++ +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSE 282
Query: 244 K--PEALFKVEDPEVRQFIEKCL 264
P+ + + I++ L
Sbjct: 283 PPYPQEM----SALAKDLIQRLL 301
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 62/257 (24%), Positives = 96/257 (37%), Gaps = 47/257 (18%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEELERLYCEIHLL 78
+ + LG GA V A G+ VA VK+ E E L E+ +L
Sbjct: 26 SFGKTLGAGAFGKVVEA--TAYGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVL 80
Query: 79 KTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------- 129
L H NI+ T +TE G L + L+ +R + K
Sbjct: 81 SYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNF-LRRKRDSFICSKTSPAIMED 137
Query: 130 -----------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178
+ Q+ G+ +L S++ IHRDL NI + + KI D GLA
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGLARD 194
Query: 179 LRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHP 232
++ G MAPE ++ Y D++S+G+ + E+ + PY
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 233 AQIYKKVISGK---KPE 246
++ YK + G PE
Sbjct: 255 SKFYKMIKEGFRMLSPE 271
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 119
+ + + +E+ E +L+ +H + S+ T +R + FV E G L + +
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTHDR-LCFVMEYANGGELFFHLSR 241
Query: 120 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 177
R + + + +I+S L YLHS V++RDLK +N+ ++ G +KI D GL
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDK-DGHIKITDFGLCKEG 299
Query: 178 ILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 236
I + GTPE++APEV E+ Y VD + G+ + EM+ P+ H +++
Sbjct: 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLF 358
Query: 237 KKVISGKK--PEALFKVEDPEVRQFIEKCL 264
+ ++ + P L PE + + L
Sbjct: 359 ELILMEEIRFPRTL----GPEAKSLLSGLL 384
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 3e-17
Identities = 59/269 (21%), Positives = 114/269 (42%), Gaps = 40/269 (14%)
Query: 31 LGKGASKTVYRAF--DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G +V + + I+VA +K+ + E + E ++ L + I++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDP 147
V A + V EM G L ++ + R + + V Q+ G+ YL ++
Sbjct: 401 LIG--VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN- 456
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---ARCVGT-P-EFMAPE-VYEE 201
+HR+L N+ + N+ KI D GL+ L + AR G P ++ APE +
Sbjct: 457 -FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 202 EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV-- 251
+++ D++S+G+ + E +++ PY + P ++ + GK+ P L+ +
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMS 573
Query: 252 ----EDPEVR-------QFIEKCLATVSS 269
E R Q + C +++S
Sbjct: 574 DCWIYKWEDRPDFLTVEQRMRACYYSLAS 602
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 53/256 (20%), Positives = 100/256 (39%), Gaps = 45/256 (17%)
Query: 31 LGKGASKTVYRAF--DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G +V + + I+VA +K+ + E + E ++ L + I++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
V A + V EM G L ++ K + + V Q+ G+ YL ++
Sbjct: 75 LIG--VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-------RKSHAARCVGTPEF----MAP 196
+HRDL N+ + N+ KI D GL+ L A + + AP
Sbjct: 131 -FVHRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGK------WPLKWYAP 182
Query: 197 EVYE-EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEA 247
E +++ D++S+G+ + E +++ PY + ++ + GK+ P
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMECPPECPPE 241
Query: 248 LFKV------EDPEVR 257
L+ + E R
Sbjct: 242 LYALMSDCWIYKWEDR 257
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 13/136 (9%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 191
++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ +I + A GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 248
E+MAPEV + + D +SFG+ + EM+T P+ + ++ K P+ L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKLGMPQFL 249
Query: 249 FKVEDPEVRQFIEKCL 264
PE + +
Sbjct: 250 ----SPEAQSLLRMLF 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 53/245 (21%), Positives = 96/245 (39%), Gaps = 38/245 (15%)
Query: 26 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
R+ E LG+ VY+ + VA +K E E L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVA---IKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK----------- 129
L+H N++ V T ++ ++ + + G L ++ L R +
Sbjct: 69 LQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEF-LVMRSPHSDVGSTDDDRTVKSAL 125
Query: 130 ------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 183
H QI +G+ YL S V+H+DL N+ V VKI DLGL + +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD 182
Query: 184 AARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYK 237
+ +G MAPE + +++ DI+S+G+ + E+ ++ PY ++ + +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVE 241
Query: 238 KVISG 242
+ +
Sbjct: 242 MIRNR 246
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAR--CVGT 190
+I S L YLHS + +++RDLK +NI ++ +QG + + D GL + + C GT
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFC-GT 202
Query: 191 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEA 247
PE++APEV ++ Y+ VD + G + EM+ P+ A++Y +++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPLQLKPN 261
Query: 248 LFKVEDPEVRQFIEKCL 264
+ R +E L
Sbjct: 262 I----TNSARHLLEGLL 274
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 35/273 (12%), Positives = 76/273 (27%), Gaps = 44/273 (16%)
Query: 3 GVSSPEESDSSEFVEVDPTGRY--GRY--NEILGKGASKTVYRAFDEYEGIEVAWNQVKL 58
E S + V++ P R GRY G ++A D +VA +
Sbjct: 7 REPDRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVA---LTF 63
Query: 59 --YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY 116
+ + L+ L + + + V T + V E G+L++
Sbjct: 64 VDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL-DVVHTRAGGL-VVAEWIRGGSLQE- 120
Query: 117 RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176
+ + + + + H V + V+ + G+V +
Sbjct: 121 -VADTSPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPATM 176
Query: 177 AILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 236
P+ DI G + ++ +P E + +
Sbjct: 177 P----------DANPQ--------------DDIRGIGASLYALLVNRWPLPEAGVRSGLA 212
Query: 237 K--KVISGKKPEALFKVED--PEVRQFIEKCLA 265
+ +G+ E D ++ + +
Sbjct: 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQ 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 60/255 (23%), Positives = 99/255 (38%), Gaps = 44/255 (17%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEELERLYCEIHLL 78
+ + LG+GA V A + GI+ VA VK+ + E L E+ +L
Sbjct: 30 KLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKIL 84
Query: 79 KTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------- 129
+ H N++ + + + E G L Y L+ +R K
Sbjct: 85 IHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTY-LRSKRNEFVPYKVAPEDLYK 142
Query: 130 ---------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
+ Q+ G+ +L SR IHRDL NI ++ VKI D GLA +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIY 199
Query: 181 KSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQ 234
K G MAPE +++ Y D++SFG+ + E+ + PY +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 235 IYKKVISG---KKPE 246
+++ G + P+
Sbjct: 260 FCRRLKEGTRMRAPD 274
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 15/137 (10%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAR--CVGT 190
+I L +LH + +I+RDLK +NI +N +QG VK+ D GL + C GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFC-GT 184
Query: 191 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEA 247
E+MAPE+ +N VD +S G + +M+T P++ + K++ K P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILKCKLNLPPY 243
Query: 248 LFKVEDPEVRQFIEKCL 264
L E R ++K L
Sbjct: 244 L----TQEARDLLKKLL 256
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 191
+I+ GL +LHS+ +++RDLK DNI ++ G +KI D G+ +L + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 248
+++APE+ + YN VD +SFG+ + EM+ P+ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDNPFYPRWL 241
Query: 249 FKVEDPEVRQFIEKCLA-TVSSRL-SARELLTDPFLQ-ID 285
+ E + + K RL ++ P + I+
Sbjct: 242 ----EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 63/255 (24%), Positives = 100/255 (39%), Gaps = 44/255 (17%)
Query: 26 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHL 77
+ LG+GA V A E + VA VK L D + ++L L E+ +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDA-TEKDLSDLVSEMEM 93
Query: 78 LKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK------- 129
+K + KH+NI+ T + + + E + G LR+Y R +
Sbjct: 94 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 130 ---------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Q+ G+ YL S+ IHRDL N+ V +KI D GLA +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENNVMKIADFGLARDIN 208
Query: 181 KSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQ 234
+ MAPE +++ Y D++SFG+ + E+ T PY +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EE 267
Query: 235 IYKKVISGK---KPE 246
++K + G KP
Sbjct: 268 LFKLLKEGHRMDKPA 282
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 34/136 (25%), Positives = 69/136 (50%), Gaps = 13/136 (9%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 191
+I+S L++LH + +I+RDLK DN+ ++ +G K+ D G+ I A GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 248
+++APE+ +E Y VD ++ G+ + EM+ P+ +++ +++ + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVVYPTWL 247
Query: 249 FKVEDPEVRQFIEKCL 264
+ ++ +
Sbjct: 248 ----HEDATGILKSFM 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 58/261 (22%), Positives = 105/261 (40%), Gaps = 51/261 (19%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEELERLYCEIHLL 78
+ LG+G V +A ++ VA VK+ SP EL L E ++L
Sbjct: 26 VLGKTLGEGEFGKVVKA--TAFHLKGRAGYTTVA---VKMLKENASPSELRDLLSEFNVL 80
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--------- 129
K + H +++K Y + + + + E G+LR + + R+V +
Sbjct: 81 KQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 130 ---------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174
+ QI G+ YL ++HRDL NI V ++KI D G
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEG-RKMKISDFG 195
Query: 175 LAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSE 228
L+ + + + MA E +++ Y D++SFG+ + E+VT PY
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 229 CTHPAQIYKKVISG---KKPE 246
+++ + +G ++P+
Sbjct: 256 IPP-ERLFNLLKTGHRMERPD 275
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 55/250 (22%), Positives = 95/250 (38%), Gaps = 42/250 (16%)
Query: 26 RYNEILGKGASKTVYRAF--DEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTL- 81
++ +++G+G V +A + ++ A +K + ++ S ++ E+ +L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAA---IKRMKEYA-SKDDHRDFAGELEVLCKLG 83
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK------------ 129
H NI+ + E G L + K R +
Sbjct: 84 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 130 ----HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 185
H+ + G+ YL + IHRDL NI V N KI D GL+ R
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLS---RGQEVY 195
Query: 186 RCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKV 239
MA E + Y D++S+G+ + E+V+ PY T A++Y+K+
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKL 254
Query: 240 ISG---KKPE 246
G +KP
Sbjct: 255 PQGYRLEKPL 264
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 191
+I GL +L S+ +I+RDLK DN+ ++ ++G +KI D G+ I GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 248
+++APE+ + Y + VD ++FG+ + EM+ P+ ++++ ++ P+++
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSM 244
Query: 249 FKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPF 281
E + + RL R++ F
Sbjct: 245 ----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 42/222 (18%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAW----NQVKLYDFLQSPEE---LERL-- 71
RY + ++GKG+ V +A+D E VA N+ + Q+ E LE +
Sbjct: 53 MDRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--QAQIEVRLLELMNK 109
Query: 72 ------YCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--- 122
Y +HL + RN ++ V EM S L L++
Sbjct: 110 HDTEMKYYIVHLKRHFMFRN--------------HLCLVFEML-SYNLYDL-LRNTNFRG 153
Query: 123 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRK 181
V++ + + +Q+ + LL+L + + +IH DLK +NI N + +KI D G + L +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 182 SHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCIL-EMVT 221
+ + + +PEV Y+ +D++S G CIL EM T
Sbjct: 214 RIYQ-YIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 191
+I L YLH R +I+RDLK DN+ ++ +G +K+ D G+ + + GTP
Sbjct: 118 EISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTP 174
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
++APE+ E Y VD ++ G+ + EM+ P+ +
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 44/255 (17%)
Query: 26 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHL 77
+ LG+G V A E + VA VK L D + ++L L E+ +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDA-TEKDLSDLVSEMEM 139
Query: 78 LKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK------- 129
+K + KH+NI+ T + + + E + G LR+Y R +
Sbjct: 140 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 130 ---------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180
Q+ G+ YL S+ IHRDL N+ V +KI D GLA +
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENNVMKIADFGLARDIN 254
Query: 181 KSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQ 234
+ MAPE +++ Y D++SFG+ + E+ T PY +
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EE 313
Query: 235 IYKKVISGK---KPE 246
++K + G KP
Sbjct: 314 LFKLLKEGHRMDKPA 328
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 71/338 (21%), Positives = 120/338 (35%), Gaps = 100/338 (29%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAW----NQVKLYDFLQSPEE---LERL---- 71
RY +++GKG+ V +A+D VA N+ + + Q+ EE LE L
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR--QAAEEIRILEHLRKQD 154
Query: 72 ----YCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNI 125
IH+L+ RN +I E+ S L + + K + ++
Sbjct: 155 KDNTMNVIHMLENFTFRN--------------HICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 126 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHA 184
V+ + IL L LH +IH DLK +NI + +K+ D G + +
Sbjct: 200 PLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV- 256
Query: 185 ARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCIL-EMVT--------------------- 221
+ + + APEV Y +D++S G CIL E++T
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLG-CILAELLTGYPLLPGEDEGDQLACMIELL 315
Query: 222 -----------------FD---YPYSECTHPAQIYKKVISGKKP---------------E 246
YP V++G +
Sbjct: 316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN 375
Query: 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283
AL +DP F+++CL + R++ + L P+L+
Sbjct: 376 ALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/259 (20%), Positives = 92/259 (35%), Gaps = 47/259 (18%)
Query: 26 RYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
Y +G+GA V++A VA VK+ S + E L+
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQREAALMAE 106
Query: 81 LKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK----------- 129
+ NI+K V + + + E G L ++ + ++
Sbjct: 107 FDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 130 -------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176
RQ+ +G+ YL R +HRDL N V N VKI D GL+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS 221
Query: 177 AILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECT 230
+ + + G M PE ++ Y D++++G+ + E+ ++ PY
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 231 HPAQIYKKVISG---KKPE 246
H ++ V G PE
Sbjct: 282 H-EEVIYYVRDGNILACPE 299
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 1e-15
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 7/144 (4%)
Query: 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162
FV E G L + + R + +I GL +L S+ +I+RDLK DN+ ++
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD 476
Query: 163 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 219
+G +KI D G+ I GTP+++APE+ + Y + VD ++FG+ + EM
Sbjct: 477 S-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 220 VTFDYPYSECTHPAQIYKKVISGK 243
+ P+ ++++ ++
Sbjct: 536 LAGQAPFEGEDED-ELFQSIMEHN 558
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 67/310 (21%), Positives = 116/310 (37%), Gaps = 55/310 (17%)
Query: 26 RYNEILGKGASKTVYRA-------FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
+ LG+GA V A +VA VK+ + ++L L E+ ++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA---VKMLKSDATEKDLSDLISEMEMM 128
Query: 79 KTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------- 129
K + KH+NI+ T + + + E + G LR+Y R +
Sbjct: 129 KMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 130 --------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
Q+ G+ YL S+ IHRDL N+ V + +KI D GLA +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHH 243
Query: 182 SHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQI 235
+ MAPE +++ Y D++SFG+ + E+ T PY ++
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EEL 302
Query: 236 YKKVISGKK-------PEALFKV------EDPEVR---QFIEKCLATVSSRLSARELLTD 279
+K + G + L+ + P R + + + L + + S +E+
Sbjct: 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362
Query: 280 PFLQIDDYDS 289
DYD
Sbjct: 363 HHHHHHDYDI 372
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 82/411 (19%), Positives = 128/411 (31%), Gaps = 150/411 (36%)
Query: 5 SSPEESDSSEFVEV------DPTGRY---------GRYNEI--LGKGASKTVYRAFDEYE 47
EE S+ E G + GRY+ I LG G TV+ ++D
Sbjct: 2 EQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQG 61
Query: 48 GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 107
VA +K+ + E EI LLK++++ D + N V ++
Sbjct: 62 KKFVA---MKVV--KSAEHYTETALDEIRLLKSVRNS----------DPNDPNREMVVQL 106
Query: 108 FTSGTLR---------------------QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
+ + ++ + + VK +Q+L GL YLH+
Sbjct: 107 LDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-K 165
Query: 147 PPVIHRDLKCDNIFV--------------------------------------------- 161
+IH D+K +NI +
Sbjct: 166 CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPL 225
Query: 162 ---NGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCIL 217
N + +VKI DLG A + K + T ++ + EV YN DI+S
Sbjct: 226 EPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAF 284
Query: 218 EMVTFDYP---------YSECTHPAQIYK--------------------------KVISG 242
E+ T DY + H A I + K I+
Sbjct: 285 ELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344
Query: 243 KKPEALFKV----------EDPEVRQFIEKCLATV-SSRLSARELLTDPFL 282
KP LF+V E F+ L + R +A E L P+L
Sbjct: 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 68/304 (22%), Positives = 105/304 (34%), Gaps = 69/304 (22%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEELERLYCEIHLL 78
+ ++LG GA V A GI VA VK+ E E L E+ ++
Sbjct: 48 EFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKMM 102
Query: 79 KTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------- 129
L H NI+ T + I + E G L Y L+ +R +
Sbjct: 103 TQLGSHENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNY-LRSKREKFSEDEIEYENQKR 159
Query: 130 ----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173
+ Q+ G+ +L + +HRDL N+ V VKI D
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDF 216
Query: 174 GLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYS 227
GLA + G MAPE ++E Y D++S+G+ + E+ + PY
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 228 ECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR-------QFIEKCLATV 267
A YK + +G K E ++ + D R F+ LA
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336
Query: 268 SSRL 271
+
Sbjct: 337 EEAM 340
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 191
+I L YLH R +I+RDLK DN+ ++ +G +K+ D G+ + + GTP
Sbjct: 161 EISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTP 217
Query: 192 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 238
++APE+ E Y VD ++ G+ + EM+ P+ +
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 43/253 (16%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIE-------VAWNQVKLYDFLQSPEELERLYCEIHLL 78
++ + LG GA V A G+ VA VK+ +E E L E+ ++
Sbjct: 49 QFGKTLGAGAFGKVVEA--TAFGLGKEDAVLKVA---VKMLKSTAHADEKEALMSELKIM 103
Query: 79 KTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK-------- 129
L +H NI+ T + +TE G L + L+ + +
Sbjct: 104 SHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNF-LRRKSRVLETDPAFAIANST 160
Query: 130 -------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182
H+ Q+ G+ +L S++ IHRD+ N+ + N KIGD GLA +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGLARDIMND 217
Query: 183 HAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIY 236
G MAPE +++ Y D++S+G+ + E+ + PY ++ Y
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 237 KKVISGK---KPE 246
K V G +P
Sbjct: 278 KLVKDGYQMAQPA 290
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 4e-15
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 14/98 (14%)
Query: 351 LFTCQEDEHLTNFDISIKGKRRED---DGIFLRLRIAD---KEGRIRN---IYFPFDIQT 401
QE+ + ++ +D I L LRI D +G+ ++ I F FD++
Sbjct: 2 AMDPQEE-----TGVRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLER 56
Query: 402 DTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPE 439
D VA EMV + + D +A+ I ++ + +
Sbjct: 57 DVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIKRK 94
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
ILG+G VY+ +G VA VK L + EL+ E+ ++ HRN+++
Sbjct: 37 ILGRGGFGKVYKGRLA-DGTLVA---VKRLKEERTQGGELQFQ-TEVEMISMAVHRNLLR 91
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW------CRQILSGLLYL 142
+ R + V +G++ L R + W GL YL
Sbjct: 92 LRGFCMTPTERLL--VYPYMANGSV-ASCL-RERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 143 HSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAA-RCVGTPEFMAPEV 198
H DP +IHRD+K NI ++ E +GD GLA ++ + +H GT +AP
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP-- 204
Query: 199 YEEEY------NELVDIYSFGMCILEMVT 221
EY +E D++ +G+ +LE++T
Sbjct: 205 ---EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 34/88 (38%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSH-AARCVGTPEF 193
G+ +LH + IHRD+K NI ++ KI D GLA ++ +R VGT +
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 194 MAPEVYEEEYNELVDIYSFGMCILEMVT 221
MAPE E DIYSFG+ +LE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 30 ILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLKHRNIM 87
++G G VY+ +G +VA +K Q EE E EI L +H +++
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVA---LKRRTPESSQGIEEFET---EIETLSFCRHPHLV 98
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW------CRQILSGLLY 141
+ + + + +G L+++ L + W C GL Y
Sbjct: 99 SLIGFCDERNEMIL--IYKYMENGNLKRH-L-YGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAA-RCVGTPEFMAPE 197
LH+ +IHRD+K NI ++ N KI D G++ L ++H + GT ++ PE
Sbjct: 155 LHT--RAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
Query: 198 VYEEEY-NELVDIYSFGMCILEMVT 221
+ + E D+YSFG+ + E++
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 12/125 (9%)
Query: 131 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 190
+ Q+ G+ +L SR IHRDL NI ++ VKI D GLA + K G
Sbjct: 198 YSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254
Query: 191 PEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG-- 242
MAPE +++ Y D++SFG+ + E+ + PY + +++ G
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 243 -KKPE 246
+ P+
Sbjct: 315 MRAPD 319
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 1e-11
Identities = 88/619 (14%), Positives = 182/619 (29%), Gaps = 145/619 (23%)
Query: 1 MNGVSSPEESDSSEFVEV-DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLY 59
+ S EE D + D R L + V + +E I + +
Sbjct: 42 PKSILSKEEID--HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK 99
Query: 60 DFLQSP--------EELERLYCEIHLLKTLKHRNIMKFYT---SWVDTANRNINFVTE-M 107
+ P E+ +RLY + + + + ++ Y + N + + +
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 108 FTSG-------TLRQYRLKHRRVNIRAVKHW-----CR---QILSGLLYLHSR-DPPVIH 151
SG Y+++ + + W C +L L L + DP
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDF--KI-FWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215
Query: 152 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFMAPEVYEEEYNE 205
R NI + + + ++ L + K + C V +
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRL----LKSKPY-ENCLLVLLNVQNA-------------K 257
Query: 206 LVDIYSFGMC-ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264
+ ++ C IL + T ++ A + L EV+ + K L
Sbjct: 258 AWNAFNLS-CKIL-LTTRFKQVTDFL-SAATTTHISLDHHSMTL---TPDEVKSLLLKYL 311
Query: 265 ATVSSRLSARELLTDPFL--QIDDYDSD-LRMIQY--QTDYDEISPLLRQSLYGIYHSNS 319
L L T+P I + D L + D+++ ++ SL
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL-------- 363
Query: 320 SSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISI---KGKRREDDG 376
N L+ P E+++ L H+ +S+ + +
Sbjct: 364 ---------------NVLE--PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 377 I---FLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEI 433
+ + + +K+ + I P I + + + E I D I + DS+
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIP-SIYLELKVKLENEYALHRSIVDHY--NIPKTFDSD- 462
Query: 434 ASLVPEWKRG---------MAMEESPHRSSF---------------CHNCASNGCLPDYI 469
L+P + + E P R + H+ + I
Sbjct: 463 -DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS-TAWNASGSI 520
Query: 470 LSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQV-DGAEQCAPEGADQAASPQSAVVHYA 528
L+ LQ L+ K ++E + + D + + S + ++ A
Sbjct: 521 LNT------LQQLKFYKPYICDNDPKYERLVNAILDFLPKI---EENLICSKYTDLLRIA 571
Query: 529 DIWAQHEGQVLSSQGSRDI 547
E + + + + +
Sbjct: 572 ---LMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 1e-10
Identities = 77/631 (12%), Positives = 161/631 (25%), Gaps = 210/631 (33%)
Query: 60 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 119
+ S + + L + + + KF + N F+ + +
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFV---EEVLRINYKFLMSPI------KTEQR 103
Query: 120 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179
+ R +Y+ RD N NQ +
Sbjct: 104 QPSMMTR-------------MYIEQRDR------------LYNDNQ------------VF 126
Query: 180 RKSHAARCVGTPEFMAPEVYEEEYNEL------------VDIYSFGM------CILEMVT 221
K + +R + Y +L V I G+ + V
Sbjct: 127 AKYNVSR-------------LQPYLKLRQALLELRPAKNVLID--GVLGSGKTWVALDVC 171
Query: 222 FDYPYSECTHPAQIY-KKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSAR-ELLTD 279
Y +C +I+ + + PE + ++ ++K L + ++R + ++
Sbjct: 172 LSYKV-QCKMDFKIFWLNLKNCNSPETVLEM--------LQKLLYQIDPNWTSRSDHSSN 222
Query: 280 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSN--SSSNNGC-----GHYIGYD 332
L+I ++LR + Y+ LL L + ++ ++ N C +
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENC--LL--VLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278
Query: 333 TENGLDYHPHEFQESEIDLFTCQEDEHLTNF----DISIKGKRREDDGIFLRLRIADKEG 388
H + T DE + D + RE
Sbjct: 279 DFLSAATTTHISLDHHSMTLT--PDEVKSLLLKYLDCRPQDLPREVLTTN---------- 326
Query: 389 RIRNIYFPFDIQTDTALSVATEMVSE-LDITDQ----DVTKIAEIIDSEIASLVPEWKRG 443
P LS+ E + + L D + K+ II+S + L P
Sbjct: 327 -------PR------RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA---- 369
Query: 444 MAMEESPHRSSFCHNCASNGCLPDYILSDGSG--AKNLQVLQCSKDGCAAIHGRFEEITY 501
E +R F + + + L ++ +
Sbjct: 370 ----E--YRKMF-DRLS--------VFPPSAHIPTILLSLIWFDVI---------KSDVM 405
Query: 502 QVDGAEQCAPEG-ADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSS 560
V + ++ + + I+ + + K N+
Sbjct: 406 VV--VNKLHKYSLVEKQPKESTISIP-------------------SIYLELKVKLENE-- 442
Query: 561 YGAEEKIINMDSQSKCHERNCFSMNSAMDY-----------GLLDDYENEIRQ---ELRW 606
Y I++ + K + + Y + R + R+
Sbjct: 443 YALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF 502
Query: 607 LKAKYQIQLRELRDQQLGVKYKSSSLTLITD 637
L+ K +R S L +
Sbjct: 503 LEQK-------IRHDSTAWNASGSILNTLQQ 526
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 65/350 (18%), Positives = 111/350 (31%), Gaps = 118/350 (33%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFD-EYEGIEVAW----NQVKLYDFLQSPEE---LERL- 71
+ RY + LG+GA V D + G VA N + + + E LE L
Sbjct: 13 SARY-EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE--AARSEIQVLEHLN 69
Query: 72 -------YCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---R 121
+ + +L+ +H +I V E+ + + +K
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHG--------------HICIVFELL-GLSTYDF-IKENGFL 113
Query: 122 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG--------------- 166
+ ++ QI + +LHS + H DLK +NI +
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 167 ---EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIYSFGMC 215
++K+ D G A + H+ R APEV +++ D++S G C
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRHYR--------APEVILALGWSQPCDVWSIG-C 222
Query: 216 IL-EMVT-------------------------------------FDYPYSECTHPAQIYK 237
IL E F + + + +
Sbjct: 223 ILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282
Query: 238 KVISGKKP-EALFKVEDPEVRQ---FIEKCLA-TVSSRLSARELLTDPFL 282
V KP + +D E + I+K L + R++ RE L PF
Sbjct: 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 54/360 (15%), Positives = 93/360 (25%), Gaps = 130/360 (36%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAW----NQVKLYDFLQSPEE---LERL-- 71
+ +G G V A N K + E L+++
Sbjct: 34 NNAF-LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR--SAKIEADILKKIQN 90
Query: 72 ------YCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RR 122
+ + + ++ + E +L + +
Sbjct: 91 DDINNNNI-VKYHGKFMYYD--------------HMCLIFEPL-GPSLYEI-ITRNNYNG 133
Query: 123 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG---------------- 166
+I +K +C +IL L YL + H DLK +NI ++
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 167 --------EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIY 210
+K+ D G A H + R APEV ++ D++
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--------APEVILNLGWDVSSDMW 243
Query: 211 SFGMCIL-EMVT---------------------------------------------FDY 224
SFG C+L E+ T
Sbjct: 244 SFG-CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 225 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 283
+ E K V + ++ F+ L + R S ELL FL+
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKI--IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 54/351 (15%), Positives = 97/351 (27%), Gaps = 118/351 (33%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIE-VAW----NQVKLYDFLQSPEE---LERL- 71
RY LG+G V D G VA N K + + E L+++
Sbjct: 18 QERY-EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE--AARLEINVLKKIK 74
Query: 72 -------YCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---R 121
+ + + ++ E+ ++ LK +
Sbjct: 75 EKDKENKFLCVLMSDWFNFHG--------------HMCIAFELL-GKNTFEF-LKENNFQ 118
Query: 122 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG--------------- 166
+ V+H Q+ L +LH + H DLK +NI ++
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 167 ---EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIYSFGMC 215
+++ D G A + H R PEV E + + D++S G C
Sbjct: 177 KNTSIRVADFGSATFDHEHHTTIVATRHYR--------PPEVILELGWAQPCDVWSIG-C 227
Query: 216 IL-EMVT--------------------------------------FDYPYSECTHPAQIY 236
IL E + + +
Sbjct: 228 ILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR 287
Query: 237 KKVISGKKPEALFKVEDPEVRQ---FIEKCLA-TVSSRLSARELLTDPFLQ 283
+ K ++ + E Q + + L + R++ E L PF
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 37/201 (18%), Positives = 71/201 (35%), Gaps = 38/201 (18%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
++ + +G G +Y AF + + A + VK+ +E L+ E+ + +
Sbjct: 37 NQW-VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRV 90
Query: 82 KHRNIMKFYTSWVDTANRNI----------------NF-VTEMFTSGT-LRQYRLKHRRV 123
++ +K + I F V E G L++ ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTF 148
Query: 124 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAILR-- 180
V ++L L Y+H + +H D+K N+ + N +V + D GL+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 181 KSHAARC-------VGTPEFM 194
+H GT EF
Sbjct: 207 GNHKQYQENPRKGHNGTIEFT 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 4e-08
Identities = 55/335 (16%), Positives = 94/335 (28%), Gaps = 70/335 (20%)
Query: 10 SDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF----LQSP 65
F PT + R +I G+G V++ ++ VA + +
Sbjct: 8 KGPVPFSHCLPTEKLQRCEKI-GEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQ 64
Query: 66 EELERLYCEIHLLKTL---------KHRNIMKFYTSWV---------------------- 94
+ E + EI + K L + + +
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 95 ------DTANRNINFVTEMFTSGT-LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
+ + V E G L Q R K ++ K Q+ + L +
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLS--SLATAKSILHQLTASLAVAEAS-L 181
Query: 148 PVIHRDLKCDNIFVN----------GNQGEVKIGDLGLAAIL------RKSHAARCVGTP 191
HRDL N+ + N I GL + R V
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD 241
Query: 192 EFMAPEVYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFK 250
M +++ + + DIY +Y PYS + K++ + K
Sbjct: 242 VSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT--K 299
Query: 251 VEDPEVRQFIEKCLATVSSRL---SARELLTDPFL 282
P ++Q K + L SA +LL L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 25/186 (13%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
RY R +G G+ +Y D G EVA + + +L+ E + K +
Sbjct: 9 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMM 61
Query: 82 KH-RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGL 139
+ I + + N+ V E+ +L R+ +++ V Q++S +
Sbjct: 62 QGGVGIPTIRWCGAE-GDYNV-MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 140 LYLHSRDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILRKSHAARCV--------- 188
Y+HS++ IHRD+K DN + V I D GLA R + + +
Sbjct: 119 EYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 189 GTPEFM 194
GT +
Sbjct: 177 GTARYA 182
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 18/161 (11%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
+ R + +G G + + Y VA +K +L+ E K L
Sbjct: 9 PNF-RVGKKIGCGNFGELRLGKNLYTNEYVA---IK---LEPMKSRAPQLHLEYRFYKQL 61
Query: 82 KH-RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGL 139
I + Y + + V E+ +L L R +++ V Q++S +
Sbjct: 62 GSGDGIPQVY--YFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 140 LYLHSRDPPVIHRDLKCDNIFV----NGNQGEVKIGDLGLA 176
Y+HS++ +I+RD+K +N + N Q + I D LA
Sbjct: 119 EYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 26/155 (16%)
Query: 56 VKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS-WVDTANRNINF-VTEMFTSGTL 113
+K Y PE++++ + LK+ + K++ S D ++ F + + F S
Sbjct: 84 LKFYQRAAKPEQIQKW----IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ 139
Query: 114 RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGD 172
+ Y +R + + V +IL L Y+H + +H D+K N+ +N N +V + D
Sbjct: 140 KIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVD 197
Query: 173 LGLAAILR-------------KSHAARCVGTPEFM 194
GLA + H GT EF
Sbjct: 198 YGLAYRYCPEGVHKAYAADPKRCH----DGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 17/71 (23%), Positives = 31/71 (43%), Gaps = 12/71 (16%)
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAILRKSH--------- 183
++L L +LH + +H ++ +NIFV+ +Q +V + G A S
Sbjct: 167 RLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 184 AARCVGTPEFM 194
+ G EF+
Sbjct: 225 RSPHEGDLEFI 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 32/166 (19%), Positives = 64/166 (38%), Gaps = 16/166 (9%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
++ R +G G+ +Y + EVA + + +L E + + L
Sbjct: 7 NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLLYESKIYRIL 59
Query: 82 K-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGL 139
+ I W V ++ +L R+++++ V Q+++ +
Sbjct: 60 QGGTGIPNVR--WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 140 LYLHSRDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILRKSH 183
++HS+ +HRD+K DN + +V I D GLA R +
Sbjct: 117 EFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 26/161 (16%), Positives = 60/161 (37%), Gaps = 18/161 (11%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
Y + +G+G+ ++ + +VA + +L E K L
Sbjct: 10 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLL 62
Query: 82 KH-RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGL 139
I Y + + V ++ +L L R+ +++ V +Q+L+ +
Sbjct: 63 AGCTGIPNVY--YFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARV 119
Query: 140 LYLHSRDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLA 176
+H + +++RD+K DN + + + + D G+
Sbjct: 120 QSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 740 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-14 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 6e-77
Identities = 133/271 (49%), Positives = 181/271 (66%), Gaps = 5/271 (1%)
Query: 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEI 75
V + GR+ +++ +G+G+ KTVY+ D +EVAW +L D + E +R E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAW--CELQDRKLTKSERQRFKEEA 59
Query: 76 HLLKTLKHRNIMKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 133
+LK L+H NI++FY SW T + I VTE+ TSGTL+ Y + + + I+ ++ WCR
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119
Query: 134 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 193
QIL GL +LH+R PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S A +GTPEF
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 179
Query: 194 MAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253
MAPE+YEE+Y+E VD+Y+FGMC+LEM T +YPYSEC + AQIY++V SG KP + KV
Sbjct: 180 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 254 PEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
PEV++ IE C+ R S ++LL F Q
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 5e-57
Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 17/282 (6%)
Query: 7 PEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 66
P+ ++ F + DP + EI G G+ VY A D VA ++ QS E
Sbjct: 2 PDVAEL--FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNE 57
Query: 67 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 126
+ + + E+ L+ L+H N +++ ++ V E + + +
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEV 115
Query: 127 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 186
+ L GL YLHS +IHRD+K NI ++ G VK+GD G A+I+ ++
Sbjct: 116 EIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPAN--S 170
Query: 187 CVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242
VGTP +MAPEV E +Y+ VD++S G+ +E+ P + +Y +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN 229
Query: 243 KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ P R F++ CL R ++ LL F+
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 16/265 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+G G+ + + +G + W ++ + E + L E++LL+ LKH NI++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR----VNIRAVKHWCRQILSGLLYLHS 144
+Y +D N + V E G L K + ++ V Q+ L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 145 R---DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVY 199
R V+HRDLK N+F++G VK+GD GLA IL S A VGTP +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 200 E-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
YNE DI+S G + E+ P+ ++ K+ GK ++ E+ +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRY-SDELNE 244
Query: 259 FIEKCLAT-VSSRLSARELLTDPFL 282
I + L R S E+L +P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-55
Identities = 92/278 (33%), Positives = 136/278 (48%), Gaps = 15/278 (5%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
DP +Y R+ +I G+GAS TVY A D G EVA Q+ L Q + E + EI ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVM 71
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+ K+ NI+ + S++ + V E G+L + ++ + CR+ L
Sbjct: 72 RENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQA 128
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAP 196
L +LHS VIHRD+K DNI + + G VK+ D G A + +S + VGTP +MAP
Sbjct: 129 LEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 197 E-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255
E V + Y VDI+S G+ +EM+ + PY +Y +G +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 256 VRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 292
R F+ +CL V R SA+ELL FL+I S L
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-55
Identities = 79/280 (28%), Positives = 134/280 (47%), Gaps = 22/280 (7%)
Query: 17 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH 76
+++P + LG GA VY+A ++ + A K+ D +S EELE EI
Sbjct: 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAA---AKVID-TKSEEELEDYMVEID 61
Query: 77 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQI 135
+L + H NI+K ++ N+ + E G + L+ R + ++ C+Q
Sbjct: 62 ILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEF 193
L L YLH +IHRDLK NI + G++K+ D G++A ++ R +GTP +
Sbjct: 120 LDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 194 MAPEVY------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 247
MAPEV + Y+ D++S G+ ++EM + P+ E P ++ K+ + P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTL 235
Query: 248 LFKVE-DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 285
+ F++KCL V +R + +LL PF+ +D
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-53
Identities = 63/262 (24%), Positives = 115/262 (43%), Gaps = 15/262 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ LG+GA V A + VA VK+ D ++ + E + EI + K L H N++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
FY E + G L + + + Q+++G++YLH
Sbjct: 68 FY--GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPEVYEEE-- 202
+ HRD+K +N+ ++ +KI D GLA + R+ + GT ++APE+ +
Sbjct: 124 ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 203 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262
+ E VD++S G+ + M+ + P+ + + Q Y K +K D + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 263 CLAT-VSSRLSARELLTDPFLQ 283
L S+R++ ++ D +
Sbjct: 243 ILVENPSARITIPDIKKDRWYN 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-53
Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 11/257 (4%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LGKG VY A ++ +A + L+ +L E+ + L+H NI++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
Y + D + + E GT+ + K + + + + ++ + L Y HS+
Sbjct: 71 LYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--R 126
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELV 207
VIHRD+K +N+ + GE+KI D G + S GT +++ PE+ E ++E V
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT- 266
D++S G+ E + P+ E + YK++ + R I + L
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHN 242
Query: 267 VSSRLSARELLTDPFLQ 283
S R RE+L P++
Sbjct: 243 PSQRPMLREVLEHPWIT 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 68/307 (22%), Positives = 119/307 (38%), Gaps = 51/307 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G V++ + G+ +A KL P ++ E+ +L I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
FY ++ + I+ E G+L Q K R+ + + ++ GL YL +
Sbjct: 69 FYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-HK 125
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELV 207
++HRD+K NI VN GE+K+ D G++ L S A VGT +M+PE + Y+
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 208 DIYSFGMCILEMVTFDYPYSECTH------------------------------------ 231
DI+S G+ ++EM YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 232 -----PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ-I 284
++ +++ P+ V E + F+ KCL + R ++L+ F++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 285 DDYDSDL 291
D + D
Sbjct: 305 DAEEVDF 311
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-49
Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 25/271 (9%)
Query: 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK 79
P G+ + +G G+ TVY+ +VA + + +P++L+ E+ +L+
Sbjct: 6 PDGQI-TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTA--PTPQQLQAFKNEVGVLR 59
Query: 80 TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSG 138
+H NI+ F + VT+ +L + + + + + RQ G
Sbjct: 60 KTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAARCVGTPEFM 194
+ YLH++ +IHRDLK +NIF++ + VKIGD GLA + + + G+ +M
Sbjct: 117 MDYLHAK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 195 APEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250
APEV + Y+ D+Y+FG+ + E++T PYS + QI V G L K
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 251 VED---PEVRQFIEKCLAT-VSSRLSARELL 277
V +++ + +CL R ++L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (438), Expect = 1e-48
Identities = 68/303 (22%), Positives = 124/303 (40%), Gaps = 18/303 (5%)
Query: 16 VEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC 73
VEV Y Y+ E LG GA V+R ++ G + P + +
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKN 75
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWC 132
EI ++ L H ++ + ++ D + + E + G L +++ V ++
Sbjct: 76 EISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAARC-VGT 190
RQ GL ++H ++H D+K +NI + VKI D GLA L + T
Sbjct: 134 RQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 191 PEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-KVISGKKPEAL 248
EF APE+ + E D+++ G+ +++ P++ + K + E
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 249 FKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLL 307
F PE + FI+ L RL+ + L P+L+ S+L + Y++I +
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK--GDHSNLTSRIPSSRYNKIRQKI 309
Query: 308 RQS 310
++
Sbjct: 310 KEK 312
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (423), Expect = 1e-46
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 16/287 (5%)
Query: 16 VEVDPTGRYGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC 73
VE+ Y+ E LG GA V+R + G A V + E +
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRK 72
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 132
EI + L+H ++ + ++ D + + + E + G L + +H +++ +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAARC-VGT 190
RQ+ GL ++H + +H DLK +NI + E+K+ D GL A L + + GT
Sbjct: 131 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 191 PEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-KVISGKKPEAL 248
EF APEV E + D++S G+ +++ P+ + K ++
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248
Query: 249 FKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI 294
F + + FI K L ++R++ + L P+L + I
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 2e-46
Identities = 57/275 (20%), Positives = 113/275 (41%), Gaps = 16/275 (5%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
D Y + ++LG GA V A D+ VA +K + + EI +L
Sbjct: 6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVA---IKCIAKKALEGKEGSMENEIAVL 61
Query: 79 KTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+KH NI+ + ++ + ++ + G L ++ R Q+L
Sbjct: 62 HKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMA 195
+ YLH ++HRDLK +N+ ++ I D GL+ + GTP ++A
Sbjct: 120 VKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 196 PEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVE 252
PEV + Y++ VD +S G+ ++ P+ + + A+++++++ + +
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 253 DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 286
+ FI + R + + L P++ D
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 67/263 (25%), Positives = 123/263 (46%), Gaps = 19/263 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ILG+G+ TV A + E A ++ + ++ + E ++ L H +K
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
Y ++ D + + F +G L +Y K + + + +I+S L YLH
Sbjct: 73 LYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG--KG 128
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPEVY-EEEY 203
+IHRDLK +NI +N + ++I D G A +L +++ A VGT ++++PE+ E+
Sbjct: 129 IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIE 261
+ D+++ G I ++V P+ I++K+I + PE F P+ R +E
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKIIKLEYDFPEKFF----PKARDLVE 242
Query: 262 KCLAT-VSSRLSARELLTDPFLQ 283
K L + RL E+ L+
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 7e-46
Identities = 67/310 (21%), Positives = 128/310 (41%), Gaps = 19/310 (6%)
Query: 24 YGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
Y +Y E LG+G V+R + VK+ + + EI +L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIA 58
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLL 140
+HRNI+ + S+ + + E + + + +N R + + Q+ L
Sbjct: 59 RHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 141 YLHSRDPPVIHRDLKCDNIFV-NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV 198
+LHS + H D++ +NI +KI + G A L+ R PE+ APEV
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 199 YEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPE 255
++ + + D++S G + +++ P+ T QI + +++ + E FK E
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 256 VRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGI 314
F+++ L SR++A E L P+L+ ++I+ L+++ L +
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMV 293
Query: 315 YHSNSSSNNG 324
+ S G
Sbjct: 294 VSAARISCGG 303
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 2e-45
Identities = 64/279 (22%), Positives = 117/279 (41%), Gaps = 25/279 (8%)
Query: 24 YGRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKL-----YDFLQSPEELERLYCEIH 76
Y Y EILG+G S V R + E A + + + + E E E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 77 LLKTLK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQI 135
+L+ + H NI++ ++ N V ++ G L Y + ++ + + R +
Sbjct: 62 ILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 136 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFM 194
L + LH + ++HRDLK +NI ++ + +K+ D G + L R GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 195 APEVYEEE-------YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--P 245
APE+ E Y + VD++S G+ + ++ P+ + + ++SG
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235
Query: 246 EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ V+ + + L R +A E L PF Q
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-44
Identities = 62/278 (22%), Positives = 120/278 (43%), Gaps = 17/278 (6%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVK--LYDFLQSPEELERLYCEIHLLKTL 81
Y+ E LG G V + ++ G++ A +K + E + E+ +LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
+H N++ + + + ++ + E+ G L + + + + +QIL+G+ Y
Sbjct: 71 QHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 142 LHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPE 197
LHS + H DLK +NI + N + +KI D GLA + + + GTPEF+APE
Sbjct: 129 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 198 VYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDP 254
+ E D++S G+ +++ P+ + V + + F
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 255 EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 291
+ FI + L R++ ++ L P+++ D L
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (399), Expect = 7e-44
Identities = 48/274 (17%), Positives = 99/274 (36%), Gaps = 17/274 (6%)
Query: 14 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC 73
EF + + +++G G V + G + +K + ++
Sbjct: 18 EFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 76
Query: 74 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 132
E ++ H N++ V T + + +TE +G+L + R + + +
Sbjct: 77 EASIMGQFDHPNVIHLE--GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 133 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-------HAA 185
R I +G+ YL D +HRDL NI VN N K+ D GL+ L A
Sbjct: 135 RGIAAGMKYLA--DMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 186 RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 244
+ APE + ++ D++S+G+ + E++++ + + +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 245 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 277
+ Q + C + R +++
Sbjct: 252 LPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 56/268 (20%), Positives = 110/268 (41%), Gaps = 21/268 (7%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKT 80
+Y +LG G +VY + + VA V+ R+ E+ LLK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 81 LK--HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
+ +++ W + + + + L + + + + + Q+L
Sbjct: 64 VSSGFSGVIRLL-DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV 198
+ + H+ V+HRD+K +NI ++ N+GE+K+ D G A+L+ + GT + PE
Sbjct: 123 VRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 199 YEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256
+ ++S G+ + +MV D P+ H +I + + ++ E
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQR------VSSEC 231
Query: 257 RQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ I CLA S R + E+ P++Q
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 54/253 (21%), Positives = 102/253 (40%), Gaps = 18/253 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ +GKG V +Y G +VA VK +++ + E ++ L+H N+++
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRD 146
V+ + VTE G+L Y R + + + + + YL
Sbjct: 65 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-EEEYNE 205
+HRDL N+ V+ + K+ D GL + ++ APE E++++
Sbjct: 123 -NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGK-LPVKWTAPEALREKKFST 179
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
D++SFG+ + E+ +F + +V G K +A P V + ++ C
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWH 238
Query: 266 T-VSSRLSARELL 277
+ R S +L
Sbjct: 239 LDAAMRPSFLQLR 251
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 20/284 (7%)
Query: 6 SPEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFL 62
+PE + + V + P+ +NE++G+G VY + + I A VK + +
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRI 66
Query: 63 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 122
E+ + E ++K H N++ + + + V G LR +
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETH 125
Query: 123 -VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181
++ + + Q+ G+ +L +HRDL N ++ VK+ D GLA +
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYD 182
Query: 182 SHAA------RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 234
++MA E + +++ D++SFG+ + E++T P +
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
Query: 235 IYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 277
I ++ G++ + + + KC R S EL+
Sbjct: 243 ITVYLLQGRRLLQPEYC-PDPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (386), Expect = 6e-42
Identities = 61/271 (22%), Positives = 122/271 (45%), Gaps = 17/271 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G+ V+ + G A +K + + +++E E +L + H I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
+ ++ D + I + + G L K +R K + ++ L YLHS
Sbjct: 69 MWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS--KD 124
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELV 207
+I+RDLK +NI ++ N G +KI D G A + C GTP+++APEV + YN+ +
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYTLC-GTPDYIAPEVVSTKPYNKSI 182
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT- 266
D +SFG+ I EM+ P+ + + Y+K+++ + + +V+ + + +
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRD 239
Query: 267 -----VSSRLSARELLTDPFLQIDDYDSDLR 292
+ + ++ P+ + ++ L
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-42
Identities = 63/259 (24%), Positives = 116/259 (44%), Gaps = 15/259 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQ-VKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 87
++LG GA TVY+ EG +V +K SP+ + + E +++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRD 146
+ + + +T++ G L Y +H+ + + + +WC QI G+ YL R
Sbjct: 75 RLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYE-E 201
++HRDL N+ V VKI D GLA +L HA ++MA E
Sbjct: 131 -RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 202 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261
Y D++S+G+ + E++TF + ++I + G++ + +V +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-QPPICTIDVYMIMV 247
Query: 262 KCLAT-VSSRLSARELLTD 279
KC SR REL+ +
Sbjct: 248 KCWMIDADSRPKFRELIIE 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 54/270 (20%), Positives = 104/270 (38%), Gaps = 23/270 (8%)
Query: 28 NEILGKGASKTVYRAF--DEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHR 84
++ LG G TV + + + VA VK L + P + L E ++++ L +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 144
I++ + V EM G L +Y ++R V + + Q+ G+ YL
Sbjct: 69 YIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----RCVGTPEFMAPEVY 199
+HRDL N+ + Q KI D GL+ LR ++ APE
Sbjct: 126 S--NFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 200 E-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
+++ D++SFG+ + E ++ +++ + G++ E+
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYD 241
Query: 259 FIEKCLAT-VSSRLSAREL---LTDPFLQI 284
+ C V +R + L + + +
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 36/286 (12%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEEL-ERLYCEIHLLKTLKHRNIM 87
+ LG+G TVY+A D+ VA ++KL ++ + + EI LL+ L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
++ NI+ V + + + + +K + L GL YLH
Sbjct: 64 GLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVY--EEEY 203
++HRDLK +N+ ++ N G +K+ D GLA + A V T + APE+ Y
Sbjct: 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-------------------------K 238
VD+++ G + E++ + Q+ + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 239 VISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
G +F ++ I+ +R++A + L +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 2e-41
Identities = 63/270 (23%), Positives = 105/270 (38%), Gaps = 16/270 (5%)
Query: 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT 80
+ RY EILG G V+ A D +VA ++ D + P R E
Sbjct: 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAA 63
Query: 81 LKHRNIMKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
L H I+ Y + A V E TLR + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-----AARCVGTPEF 193
L + H +IHRD+K NI ++ VK+ D G+A + S A +GT ++
Sbjct: 124 LNFSHQN--GIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 194 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252
++PE + + D+YS G + E++T + P++ + + Y+ V P +
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 253 -DPEVRQFIEKCLAT-VSSRL-SARELLTD 279
++ + K LA +R +A E+ D
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 51/255 (20%), Positives = 98/255 (38%), Gaps = 18/255 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ +G G V+ + +VA +K + E E ++ L H +++
Sbjct: 11 QEIGSGQFGLVHLGYWL-NKDKVA---IKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDP 147
Y ++ I V E G L Y R + C + G+ YL +
Sbjct: 65 LYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EA 120
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVYE-EEY 203
VIHRDL N V N +K+ D G+ + + + + ++ +PEV+ Y
Sbjct: 121 CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263
+ D++SFG+ + E+ + E +++ + + +G + ++ V Q + C
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQIMNHC 238
Query: 264 LAT-VSSRLSARELL 277
R + LL
Sbjct: 239 WKERPEDRPAFSRLL 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 61/273 (22%), Positives = 120/273 (43%), Gaps = 18/273 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
++LGKG V ++ G A ++ + + + +E+ E +L+ +H +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
++ + + FV E G L + + R + + +I+S L YLHSR
Sbjct: 70 LKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--D 125
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYE-EEYNE 205
V++RD+K +N+ ++ + G +KI D GL A GTPE++APEV E +Y
Sbjct: 126 VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 206 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 265
VD + G+ + EM+ P+ ++++ ++ + + PE + + L
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLK 241
Query: 266 T-VSSRLS-----ARELLTDPFLQIDDYDSDLR 292
RL A+E++ F ++ ++
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (382), Expect = 6e-41
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 15/274 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQV--KLYDFLQSPEELERLYCEIHLLKTLKHRNI 86
I+G+G VY G A + K Q + L+ T I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 146
+ ++ ++F+ ++ G L + +H + ++ + +I+ GL ++H+R
Sbjct: 70 VCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YN 204
V++RDLK NI ++ G V+I DLGLA K VGT +MAPEV ++ Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264
D +S G + +++ P+ + + ++ L PE+R +E L
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 265 AT-VSSRLS-----ARELLTDPFLQIDDYDSDLR 292
V+ RL A+E+ PF + D+
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 278
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 8e-41
Identities = 54/260 (20%), Positives = 106/260 (40%), Gaps = 19/260 (7%)
Query: 29 EILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+G+G V++ E + VA +K S E+ E ++ H +
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHS 144
I+K + + + E+ T G LR + +++ ++ + Q+ + L YL S
Sbjct: 70 IVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE 201
+ +HRD+ N+ V+ VK+GD GL+ + S A++ ++MAPE
Sbjct: 127 K--RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 202 E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260
+ D++ FG+C+ E++ + + ++ +G++ P + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLM 242
Query: 261 EKCLAT-VSSRLSARELLTD 279
KC A S R EL
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-40
Identities = 61/260 (23%), Positives = 107/260 (41%), Gaps = 18/260 (6%)
Query: 29 EILGKGASKTVYRAF---DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
E LG G+ V R + + VA +K D L PE ++ E++ + +L HRN
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-DVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHS 144
+++ Y + + VTE+ G+L KH+ + + + Q+ G+ YL S
Sbjct: 73 LIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 145 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVY 199
+ IHRDL N+ + VKIGD GL L ++ + APE
Sbjct: 130 K--RFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 200 EEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
+ ++ D + FG+ + EM T+ + +QI K+ + + ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 259 FIEKCLAT-VSSRLSARELL 277
+ +C A R + L
Sbjct: 247 VMVQCWAHKPEDRPTFVALR 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 48/267 (17%), Positives = 100/267 (37%), Gaps = 23/267 (8%)
Query: 31 LGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G +V + + I+VA +K+ + E + E ++ L + I++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDP 147
+ V EM G L ++ + R + + V Q+ G+ YL +
Sbjct: 74 LIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPEVYE-E 201
+HRDL N+ + KI D GL+ L + ++ APE
Sbjct: 129 NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 202 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261
+++ D++S+G+ + E +++ + ++ + GK+ E + PE+ +
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMS 246
Query: 262 KCLAT-VSSRLSAREL---LTDPFLQI 284
C R + + + +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-40
Identities = 61/270 (22%), Positives = 120/270 (44%), Gaps = 15/270 (5%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL-KTLKHRNIM 87
++LGKG+ V+ A + A +K D + +++E E +L +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
+ ++ N+ FV E G L + + ++ + +I+ GL +LHS+
Sbjct: 67 HMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVYE-EEYN 204
+++RDLK DNI ++ + G +KI D G+ A GTP+++APE+ ++YN
Sbjct: 124 -IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 264
VD +SFG+ + EM+ P+ +++ + + + E + + K
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLF 238
Query: 265 AT-VSSRLSAR-ELLTDPFLQIDDYDSDLR 292
RL R ++ P + +++ R
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREINWEELER 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 9e-40
Identities = 55/277 (19%), Positives = 112/277 (40%), Gaps = 26/277 (9%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKT 80
Y +++LG G + V + F++ + A +K+ LQ + R E+ +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LKM---LQDCPKARR---EVELHWRA 61
Query: 81 LKHRNIMKFYTSWVD--TANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQIL 136
+ +I++ + + + + V E G L + R + I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILRKSHAARCV-GTPEF 193
+ YLHS + + HRD+K +N+ +K+ D G A ++ TP +
Sbjct: 122 EAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
Query: 194 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKVISGKK--PEA 247
+APEV E+Y++ D++S G+ + ++ P+ A + ++ G+ P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 248 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ EV+ I L T + R++ E + P++
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 53/259 (20%), Positives = 99/259 (38%), Gaps = 20/259 (7%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
+ E LG G V+ + +VA +K Q + E +L+K L+H+
Sbjct: 16 KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQR 69
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLH 143
+++ Y I +TE +G+L + + + + QI G+ ++
Sbjct: 70 LVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAP-EVY 199
R IHRDL+ NI V+ + KI D GLA ++ + ++ AP +
Sbjct: 127 ER--NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259
+ D++SFG+ + E+VT ++ + + G + E+ Q
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQL 242
Query: 260 IEKCLAT-VSSRLSARELL 277
+ C R + L
Sbjct: 243 MRLCWKERPEDRPTFDYLR 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 52/257 (20%), Positives = 98/257 (38%), Gaps = 18/257 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ LG G V +VA +K+ + + E ++ L H +++
Sbjct: 10 KELGTGQFGVVKYGKWR-GQYDVA---IKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
Y R I +TE +G L Y R R + + C+ + + YL S+
Sbjct: 64 LYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYE-EEY 203
+HRDL N VN G VK+ D GL+ + + + PEV ++
Sbjct: 120 QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 263
+ DI++FG+ + E+ + E ++ + + G + + +V + C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYSC 237
Query: 264 LAT-VSSRLSARELLTD 279
R + + LL++
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 64/319 (20%), Positives = 115/319 (36%), Gaps = 50/319 (15%)
Query: 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHL 77
D +Y +G+G V++A G +VA +V + + + EI +
Sbjct: 6 CDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKI 62
Query: 78 LKTLKHRNIMKFYTSWVDTA------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 131
L+ LKH N++ A +I V + + + +K
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122
Query: 132 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---- 187
+ +L+GL Y+H ++HRD+K N+ + + G +K+ D GLA + ++
Sbjct: 123 MQMLLNGLYYIHR--NKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 188 --VGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-KVISG 242
V T + PE+ E +Y +D++ G + EM T T Q+ + G
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 243 KKPEALFK----------------------------VEDPEVRQFIEKCLAT-VSSRLSA 273
++ V DP I+K L + R+ +
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 274 RELLTDPFLQIDDYDSDLR 292
+ L F D SDL+
Sbjct: 300 DDALNHDFFWSDPMPSDLK 318
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-39
Identities = 72/320 (22%), Positives = 119/320 (37%), Gaps = 44/320 (13%)
Query: 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL 78
D RY +G+GA V A+D + VA +K + +R EI +L
Sbjct: 5 DVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKIL 60
Query: 79 KTLKHRNIMKFYTSWVD-TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILS 137
+H NI+ T + + G LK + ++ + ++ QIL
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-----VGTPE 192
GL Y+HS V+HRDLK N+ +N ++KI D GLA + H V T
Sbjct: 121 GLKYIHSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 193 FMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP----- 245
+ APE+ Y + +DI+S G + EM++ + + Q+ + P
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 246 -----------------------EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPF 281
LF D + ++K L R+ + L P+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 282 LQIDDYDSDLRMIQYQTDYD 301
L+ SD + + +D
Sbjct: 298 LEQYYDPSDEPIAEAPFKFD 317
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 55/260 (21%), Positives = 96/260 (36%), Gaps = 22/260 (8%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHR 84
R LG+G V+ VA +K L SPE + E ++K L+H
Sbjct: 20 RLEVKLGQGCFGEVWMGTWN-GTTRVA---IKTLKPGTMSPEAFLQ---EAQVMKKLRHE 72
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYL 142
+++ Y I VTE + G+L + + + + QI SG+ Y+
Sbjct: 73 KLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVY 199
+HRDL+ NI V N K+ D GLA ++ + ++ APE
Sbjct: 130 ERM--NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 200 E-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258
+ D++SFG+ + E+ T ++ +V G + + +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHD 245
Query: 259 FIEKCLAT-VSSRLSARELL 277
+ +C R + L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQ 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 51/273 (18%), Positives = 107/273 (39%), Gaps = 23/273 (8%)
Query: 28 NEILGKGASKTVYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+++G G VY+ + + VA +K + ++ E ++ H
Sbjct: 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYL 142
NI++ + + +TE +G L ++ + ++ + R I +G+ YL
Sbjct: 69 HNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 143 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPE 197
+ +HRDL NI VN N K+ D GL+ +L A + APE
Sbjct: 127 AN--MNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 198 -VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 256
+ ++ D++SFG+ + E++T+ ++ K + G + +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAI 242
Query: 257 RQFIEKCLAT-VSSRLSARELLT--DPFLQIDD 286
Q + +C + R ++++ D ++ D
Sbjct: 243 YQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 56/272 (20%), Positives = 101/272 (37%), Gaps = 27/272 (9%)
Query: 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHR 84
++ +++G+G V +A + +G+ + +K S ++ E+ +L L H
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 85 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAV 128
NI+ + E G L + K ++ + +
Sbjct: 72 NIINLL--GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC- 187
H+ + G+ YL IHRDL NI V N KI D GL+
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMG 186
Query: 188 VGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 246
+MA E + Y D++S+G+ + E+V+ A++Y+K+ G + E
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 247 ALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 277
D EV + +C R S ++L
Sbjct: 247 KPLNC-DDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 4e-38
Identities = 62/271 (22%), Positives = 118/271 (43%), Gaps = 17/271 (6%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+ LG G+ V + G A + + +++E E +L+ + ++K
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 148
S+ D N N+ V E G + + + R + + + QI+ YLHS D
Sbjct: 106 LEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD-- 161
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-EEEYNELV 207
+I+RDLK +N+ ++ G +++ D G A ++ C GTPE +APE+ + YN+ V
Sbjct: 162 LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILSKGYNKAV 219
Query: 208 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT- 266
D ++ G+ I EM P+ P QIY+K++SGK +++ + L
Sbjct: 220 DWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVD 276
Query: 267 -----VSSRLSARELLTDPFLQIDDYDSDLR 292
+ + ++ + D+ + +
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 5e-38
Identities = 57/256 (22%), Positives = 102/256 (39%), Gaps = 18/256 (7%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
LG G VY + + VA +K + E+E E ++K +KH N+++
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRD 146
+TE T G L Y + R + + + QI S + YL +
Sbjct: 78 LLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 134
Query: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAP-EVYEEE 202
IHRDL N V N VK+ D GL+ ++ A ++ AP + +
Sbjct: 135 -NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 203 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262
++ D+++FG+ + E+ T+ +Q+Y+ + + E + +V + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEKVYELMRA 251
Query: 263 CLAT-VSSRLSARELL 277
C S R S E+
Sbjct: 252 CWQWNPSDRPSFAEIH 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 69/316 (21%), Positives = 110/316 (34%), Gaps = 58/316 (18%)
Query: 10 SDSSEFVEVDPT------------GRYGRYNEILGKGASKTVYRAFD-----EYEGIEVA 52
S +E+ VD + ++LG GA V A I+VA
Sbjct: 13 SSDNEYFYVDFREYEYDLKWEFPRENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 53 WNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSG 111
VK+ E E L E+ ++ L H NI+ + + I + E G
Sbjct: 72 ---VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYG 126
Query: 112 TLRQYRLKHRR-----------------------VNIRAVKHWCRQILSGLLYLHSRDPP 148
L Y R + + + Q+ G+ +L +
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--S 184
Query: 149 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAARCVGTPEFMAPE-VYEEEY 203
+HRDL N+ V VKI D GLA + ++MAPE ++E Y
Sbjct: 185 CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 204 NELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 262
D++S+G+ + E+ + PY A YK + +G K + F E+ ++
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA-TEEIYIIMQS 302
Query: 263 CLAT-VSSRLSARELL 277
C A R S L
Sbjct: 303 CWAFDSRKRPSFPNLT 318
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 57/292 (19%), Positives = 108/292 (36%), Gaps = 47/292 (16%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
+++G G+ VY+A G VA +V Q R E+ +++ L H NI++
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 89 ----FYTSWVDTANRNINFVTEMFTSG---TLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
FY+S +N V + R Y + + + VK + Q+ L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVY- 199
+HS + HRD+K N+ ++ + +K+ D G A L + + + + APE+
Sbjct: 138 IHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 200 -EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------- 245
+Y +D++S G + E++ + + Q+ + + P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 246 -------------EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ PE + L ++RL+ E F
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 9e-37
Identities = 70/287 (24%), Positives = 112/287 (39%), Gaps = 39/287 (13%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +G+G VY+A ++ G VA +++L ++ EI LLK L H NI+K
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 89 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDP 147
+ V E + + + +K + Q+L GL + HS
Sbjct: 66 LLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVY--EEEY 203
V+HRDLK N+ +N G +K+ D GLA V T + APE+ + Y
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 204 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------------ 245
+ VDI+S G EMVT + + Q+++ + P
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 246 --------EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ D + R + + L + R+SA+ L PF Q
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 1e-36
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 35/299 (11%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY +G G+ +Y D G EVA +KL + +L+ E + K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVA---IKL---ECVKTKHPQLHIESKIYKMMQ 60
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 142
+ W V E+ + R+ +++ V Q++S + Y+
Sbjct: 61 GGVGIPTI-RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 143 HSRDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILRKSHAARC---------VGTP 191
HS++ IHRD+K DN + V I D GLA R + + GT
Sbjct: 120 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 192 EFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVISGK---KP 245
+ + + E + D+ S G ++ + + Q Y+++ K
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSA---RELLTDPFLQI---DDYDSDLRMIQYQ 297
E L K E ++ C + + R+L + F + DY D M+++
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (343), Expect = 2e-36
Identities = 69/291 (23%), Positives = 113/291 (38%), Gaps = 41/291 (14%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+Y+ E +G+G VY+A + Y G A +++L + EI +LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKH 59
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
NI+K Y + + V E + + + K + Q+L+G+ Y H
Sbjct: 60 SNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEE 201
R V+HRDLK N+ +N GE+KI D GLA + T + AP+V
Sbjct: 118 DR--RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 202 E--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK---------------------- 237
Y+ +DI+S G EMV + + Q+ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 238 ----KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
V E+ K D + K L + R++A++ L + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-36
Identities = 80/320 (25%), Positives = 127/320 (39%), Gaps = 42/320 (13%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
Y + +G GA V A D G +VA ++ QS +R Y E+ LLK ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRH 76
Query: 84 RNIMKFYTSWVDTANRNI--NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
N++ + + +F M GT +KH ++ ++ Q+L GL Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-- 199
+H+ HRDLK N+ VN + E+KI D GLA S V T + APEV
Sbjct: 137 IHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN 192
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV-------------------- 239
Y + VDI+S G + EM+T + H Q+ + +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 240 --------ISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 290
+ K ++ P +EK L R++A E L P+ + D
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312
Query: 291 LRMIQ-YQTDYDEISPLLRQ 309
+Q Y +D++ L +
Sbjct: 313 EPQVQKYDDSFDDVDRTLDE 332
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (341), Expect = 1e-35
Identities = 58/295 (19%), Positives = 110/295 (37%), Gaps = 52/295 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIM 87
LG+G V+ A + +V +K P + +++ EI +L+ L+ NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93
Query: 88 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 147
D +R V E + +Q ++ + ++ + +IL L Y HS
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 148 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAARCVGTPEFMAPEVYEEE--YN 204
++HRD+K N+ ++ ++++ D GLA V + F PE+ + Y+
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 205 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--------------- 249
+D++S G + M+ P+ ++ E L+
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 250 --------------------KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ PE F++K L SRL+ARE + P+
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 72/290 (24%), Positives = 114/290 (39%), Gaps = 50/290 (17%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 88
E +GKG V+R ++ G EVA VK++ + EI+ L+H NI+
Sbjct: 9 ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILG 61
Query: 89 FYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-- 144
F + + V++ G+L Y L V + + SGL +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 145 ----RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPEFM 194
P + HRDLK NI V N G I DLGLA + VGT +M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 195 APEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECTHPA---- 233
APEV ++ E + DIY+ G+ E+ + PY +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 234 QIYKKVISGK-KPEALFKVEDPE----VRQFIEKCLAT-VSSRLSARELL 277
++ K V K +P + + E + + + +C ++RL+A +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 41/292 (14%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
+Y E +G+G TV++A + VA +V+L D EI LLK LKH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 143
+NI++ + ++ + V E + + + ++ VK + Q+L GL + H
Sbjct: 61 KNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 144 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVY-- 199
SR V+HRDLK N+ +N N GE+K+ + GLA + V T + P+V
Sbjct: 119 SR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG----------------- 242
+ Y+ +D++S G E+ P K++
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 243 ----------KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ + R ++ L R+SA E L P+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 72/293 (24%), Positives = 115/293 (39%), Gaps = 38/293 (12%)
Query: 26 RYN--EILGKGASKTVYRAFD-EYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTL 81
+Y +G+GA V++A D + G VA +V++ + P R + L+T
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 82 KHRNIMKFYTSWVDTANRN---INFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILS 137
+H N+++ + + + V E ++ V +K Q+L
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 138 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAP 196
GL +LHS V+HRDLK NI V + G++K+ D GLA I A V T + AP
Sbjct: 128 GLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 197 EV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK------------------ 237
EV + Y VD++S G EM + + Q+ K
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 238 ------KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
S + E D + + KCL + R+SA L+ P+ Q
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 7e-35
Identities = 59/306 (19%), Positives = 105/306 (34%), Gaps = 51/306 (16%)
Query: 14 EFVEVDPT------------GRYGRYNEILGKGASKTVYRA-----FDEYEGIEVAWNQV 56
+V +DPT R + + LG GA V A + VA V
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA---V 58
Query: 57 KLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 115
K+ E E L E+ +L L H NI+ + +TE G L
Sbjct: 59 KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLN 116
Query: 116 YRLKHR------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 157
+ + R +++ + + Q+ G+ +L S++ IHRDL
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174
Query: 158 NIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEEEY-NELVDIYSF 212
NI + KI D GLA ++ ++MAPE D++S+
Sbjct: 175 NILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
Query: 213 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL 271
G+ + E+ + + K+I + E+ ++ C R
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 272 SARELL 277
+ ++++
Sbjct: 294 TFKQIV 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 7e-35
Identities = 60/278 (21%), Positives = 116/278 (41%), Gaps = 24/278 (8%)
Query: 29 EILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 85
++LG GA V+ G A +K +Q + E E +L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 86 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 145
+ T ++ + + G L + + R V+ + +I+ L +LH
Sbjct: 90 FLVTLHYAFQT-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 146 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVY--- 199
+I+RD+K +NI ++ N G V + D GL+ A GT E+MAP++
Sbjct: 149 --GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPY---SECTHPAQIYKKVISGKKPEALFKVEDPEV 256
+ +++ VD +S G+ + E++T P+ E A+I ++++ + P +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 263
Query: 257 RQFIEKCLAT-VSSRLS-----ARELLTDPFLQIDDYD 288
+ I++ L RL A E+ F Q ++D
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (331), Expect = 1e-34
Identities = 38/263 (14%), Positives = 89/263 (33%), Gaps = 29/263 (11%)
Query: 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 81
Y + +G+G+ ++ + +VA +K +L E K L
Sbjct: 5 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLL 57
Query: 82 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
+ + N+ V ++ L R+ +++ V +Q+L+ +
Sbjct: 58 AGCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 142 LHSRDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGLAAILRKSHAARC---------V 188
+H + +++RD+K DN + N + + D G+ R +
Sbjct: 117 IHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 189 GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVISGKKP 245
GT +M+ + E + D+ + G + + + + Q Y+++ K+
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 246 ---EALFKVEDPEVRQFIEKCLA 265
L E +++
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARN 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (331), Expect = 1e-34
Identities = 52/293 (17%), Positives = 97/293 (33%), Gaps = 45/293 (15%)
Query: 20 PTGRYGRYNEILGKGASKTVYRA-----FDEYEGIEVAWNQVKLYDFLQSPEELERLYCE 74
P Y +G+GA V++A VA VK+ S + E
Sbjct: 11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQRE 66
Query: 75 IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKH---- 130
L+ + NI+K + + + E G L ++ + ++ H
Sbjct: 67 AALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 131 --------------------WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170
RQ+ +G+ YL +HRDL N V N VKI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGEN-MVVKI 181
Query: 171 GDLGLAAILRKSHAAR----CVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYP 225
D GL+ + + + +M PE ++ Y D++++G+ + E+ ++
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 226 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 277
++ V G + E+ + C + + R S +
Sbjct: 242 PYYGMAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 51/267 (19%), Positives = 101/267 (37%), Gaps = 24/267 (8%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQV--KLYDFLQSPEELERLYCEIHLLKTLKHRNI 86
LG+G+ VY + + +V K + S E E ++K ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV----------NIRAVKHWCRQIL 136
++ V + + + E+ T G L+ Y R ++ + +I
Sbjct: 86 VRLL--GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 137 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPE 192
G+ YL++ +HRDL N V + VKIGD G+ + ++ R +
Sbjct: 144 DGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 193 FMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251
+M+PE + + D++SFG+ + E+ T + Q+ + V+ G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 260
Query: 252 EDPEVRQFIEKCLAT-VSSRLSARELL 277
+ + + C R S E++
Sbjct: 261 -PDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 59/278 (21%), Positives = 111/278 (39%), Gaps = 33/278 (11%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVAWNQ----VKLYDFLQSPEELERLYCEIHLLKTL-KH 83
+ LG+GA V A + VK+ + ++L L E+ ++K + KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 84 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY----------------RLKHRRVNIRA 127
+NI+ + + + + E + G LR+Y +++ +
Sbjct: 79 KNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 128 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR- 186
+ Q+ G+ YL S+ IHRDL N+ V + +KI D GLA + +
Sbjct: 137 LVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKK 193
Query: 187 ---CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 242
++MAPE + Y D++SFG+ + E+ T +++K + G
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253
Query: 243 KKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTD 279
+ + E+ + C V S R + ++L+ D
Sbjct: 254 HRMDKPSNC-TNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 64/299 (21%), Positives = 107/299 (35%), Gaps = 40/299 (13%)
Query: 7 PEESDSSEFVEVDPTGRYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDF 61
P ++ EF P R + + LG+GA V A VA VK+
Sbjct: 2 PYDASKWEF----PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVA---VKMLKE 53
Query: 62 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 121
+ E L E+ +L + H + + + E G L Y R
Sbjct: 54 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 113
Query: 122 R----------------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 165
+ + + + Q+ G+ +L SR IHRDL NI ++
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK- 170
Query: 166 GEVKIGDLGLAAILRKS----HAARCVGTPEFMA-PEVYEEEYNELVDIYSFGMCILEMV 220
VKI D GLA + K ++MA +++ Y D++SFG+ + E+
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 221 TFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 277
+ PY + +++ G + PE+ Q + C S R + EL+
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-32
Identities = 74/293 (25%), Positives = 113/293 (38%), Gaps = 41/293 (13%)
Query: 26 RYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 83
RY +G GA +V AFD G+ VA ++ QS +R Y E+ LLK +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKH 76
Query: 84 RNIMKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 141
N++ + + + G +K +++ V+ QIL GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 142 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-- 199
+HS D +IHRDLK N+ VN E+KI D GLA T + APE+
Sbjct: 137 IHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGYVA-TRWYRAPEIMLN 192
Query: 200 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK---------------------- 237
YN+ VDI+S G + E++T + H Q+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 238 ------KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 283
+ +F +P +EK L R++A + L +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 9e-29
Identities = 71/317 (22%), Positives = 121/317 (38%), Gaps = 56/317 (17%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY + +G GA V A+D VA ++ Q+ +R Y E+ L+K +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVN 74
Query: 83 HRNIMKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSG 138
H+NI+ + +++ V E+ + + ++ + + Q+L G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 139 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPE 197
+ +LHS IHRDLK NI V + +KI D GLA S V T + APE
Sbjct: 132 IKHLHSAGI--IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 198 -VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV----------------- 239
+ Y E VDI+S G + EMV + + Q K +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 240 ---------------ISGKKPEALF-------KVEDPEVRQFIEKCLAT-VSSRLSAREL 276
P++LF K++ + R + K L + R+S +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 277 LTDPFLQIDDYDSDLRM 293
L P++ + +++
Sbjct: 309 LQHPYINVWYDPAEVEA 325
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (256), Expect = 2e-24
Identities = 69/336 (20%), Positives = 115/336 (34%), Gaps = 73/336 (21%)
Query: 25 GRYN--EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK 82
RY LG G TV+ A D VA V+ E EI LL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVN 67
Query: 83 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--------------RLKHRRVNIRAV 128
+ K + + + ++ +G + +HR + + V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 129 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHA 184
K +Q+L GL Y+H R +IH D+K +N+ + + + +A A H
Sbjct: 128 KQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 185 ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYS---------ECTHPAQ 234
+ T E+ +PEV + DI+S I E++T D+ + + H AQ
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 235 IYK--------------------------KVISGKKPEALFKV----------EDPEVRQ 258
I + + IS K L V E E+
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 259 FIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRM 293
F+ L R A L+ P+L+ ++R+
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.0 bits (168), Expect = 6e-14
Identities = 34/210 (16%), Positives = 67/210 (31%), Gaps = 44/210 (20%)
Query: 29 EILGKGASKTVYRAFDEYEGIEVA--------------WNQVKLYDFLQSPEELERLYCE 74
+++G+G V+ + E + E + D S + E
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 75 IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQ 134
L+ L+ + K Y N + E+ + L + R+++
Sbjct: 65 FRALQKLQGLAVPKVYA-----WEGNA-VLMELIDAKELYRVRVENPD-------EVLDM 111
Query: 135 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM 194
IL + + R ++H DL N+ V+ + I D + + + E +
Sbjct: 112 ILEEVAKFYHR--GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGW------REIL 161
Query: 195 APEV------YEEEYNELVDIYSFGMCILE 218
+V + Y DI S IL+
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 740 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.87 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=438.88 Aligned_cols=266 Identities=49% Similarity=0.920 Sum_probs=244.9
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 34389986358757752028569999998579909999997505557998899999999999983899982146568562
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
+.+.+.|||+++.+.||+|+||+||+|.++.++..||+|.+..... .....+++.+|+++|++|+||||++++++|.+
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCCCCCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8847788778851697008284999999999995999999851227--98999999999999985799985069999840
Q ss_pred C--CCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECC
Q ss_conf 5--88849999933689998999996488899999999999999999987099990303688786587089992899114
Q 004645 96 T--ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 96 ~--~~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DF 173 (740)
. ....+|+||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..++.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEEC
T ss_conf 33458889999957898948999751355469999999999999999999789979968767435116679998898005
Q ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 40443304766433588887882000012684211010135799988537999999998999999981999963446899
Q 004645 174 GLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 174 GlA~~l~~~~~~~~~GTp~YmAPEvl~~~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~s 253 (740)
|+|...........+||+.|||||++.+.|+.++|||||||++|+|++|+.||.+..+..++++.+..+..|..+....+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 76542368766775538130089884789998671100799999998788999876559999999973899865675578
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHCCCCCC
Q ss_conf 589999999961-816999998884495567
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 254 pelr~lI~kCL~-dP~kRpSa~ELL~hpfl~ 283 (740)
+++++||.+||. +|.+|||+.|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 9999999997637975892999996775409
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=414.42 Aligned_cols=262 Identities=33% Similarity=0.499 Sum_probs=227.2
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 34389986358757752028569999998579909999997505557998899999999999983899982146568562
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
...||..+| ++.+.||+|+||+||+|.++.+|..||+|+++..... ..+.+.+|+.+|+.++||||++++++|.+
T Consensus 14 ~~~dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 88 (293)
T d1yhwa1 14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLV 88 (293)
T ss_dssp BSSCTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCCCCCCC-EEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 899951053-8878981285829999999899989999998430172----79999999999986799988058577988
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 58884999993368999899999648889999999999999999998709999030368878658708999289911440
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGl 175 (740)
...+|+||||++||+|.+++.+ +.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 89 --~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~ 162 (293)
T d1yhwa1 89 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 162 (293)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTT
T ss_pred --CCEEEEEEEECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEECCCHH
T ss_conf --9998999970379808988641-59999999999999999999999879--72267768886887-899686425156
Q ss_pred HHHHCCC--CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 4433047--6643358888788200001-268421101013579998853799999999899999998199996344689
Q 004645 176 AAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 176 A~~l~~~--~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~ 252 (740)
|..+... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+..+...+...
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGS
T ss_pred HEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 41321366644444447773682664479988012031372999998048899899799999999985799988885537
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf 9589999999961-81699999888449556778863
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 288 (740)
Q Consensus 253 spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~~~ 288 (740)
++.+++||.+||. +|.+|||+.++|+||||+.....
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~ 279 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL 279 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf 9999999999866996689099999649965778887
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=408.01 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=228.6
Q ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 13438998635875775202856999999857990999999750555799889999999999998389998214656856
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
+...||..+| +..+.||+|+||+||+|+++.+|..||+|+++... .......+.+.+|+.+|++|+|||||+++++|.
T Consensus 8 ~~~~dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp CCCSCHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCCCCHHHC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 5566907856-76279701888099999998999399999984444-358899999999999999778999823899999
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCC
Q ss_conf 25888499999336899989999964888999999999999999999870999903036887865870899928991144
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFG 174 (740)
+ ...+|+||||+.+|+|..++...+++++..++.|++||+.||.|||++| |+||||||+|||++ +.+.+||+|||
T Consensus 86 ~--~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG 160 (309)
T d1u5ra_ 86 R--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFG 160 (309)
T ss_dssp E--TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCT
T ss_pred E--CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCCCEEEEC-CCCCEEEEECC
T ss_conf 8--9988999980699945789973799999999999999999999998689--76667884217987-99978984436
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 04433047664335888878820000----12684211010135799988537999999998999999981999963446
Q 004645 175 LAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 175 lA~~l~~~~~~~~~GTp~YmAPEvl~----~~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~ 250 (740)
+|...... ...+||+.|||||++. +.|+.++|||||||++|+|++|..||.+. +..+....+..+..+.....
T Consensus 161 ~a~~~~~~--~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 161 SASIMAPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp TCBSSSSB--CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCT
T ss_pred CCCCCCCC--CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHCCCCCCCCC
T ss_conf 53346778--7313476636889983467888672145455899999998788999997-99999999982899988878
Q ss_pred CCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 899589999999961-8169999988844955677886
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 251 ~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~~ 287 (740)
..++.+++||.+||. +|.+|||+.++|+||||.....
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCC
T ss_conf 88999999999977379657918999971997537899
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=406.08 Aligned_cols=261 Identities=30% Similarity=0.526 Sum_probs=223.6
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 34389986358757752028569999998579909999997505557998899999999999983899982146568562
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
-+++|...| ++.+.||+|+||+||+|+++.+|..||+|+++.. .....+.+.+|+.+|++|+|||||++++.|.+
T Consensus 6 r~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 80 (288)
T d2jfla1 6 RDLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 80 (288)
T ss_dssp ESSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCCCCCCE-EEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 789910375-9847993077819999999999939999998728----99999999999999986799998849889800
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCC
Q ss_conf 588849999933689998999996-4888999999999999999999870999903036887865870899928991144
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~-~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFG 174 (740)
...+++||||+++|+|..++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 81 --~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG 155 (288)
T d2jfla1 81 --ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFG 155 (288)
T ss_dssp --TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEECCHHHEEEC-CCCCEEEEECH
T ss_conf --99589999627998188999862899999999999999999999999889--88714070031487-89998997161
Q ss_pred HHHHHCCC--CCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-
Q ss_conf 04433047--664335888878820000------126842110101357999885379999999989999999819999-
Q 004645 175 LAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP- 245 (740)
Q Consensus 175 lA~~l~~~--~~~~~~GTp~YmAPEvl~------~~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p- 245 (740)
+|...... .....+||+.|||||++. ..|+.++|||||||++|+|+||+.||.+.. ..+++..+..+..+
T Consensus 156 ~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-~~~~~~~i~~~~~~~ 234 (288)
T d2jfla1 156 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPT 234 (288)
T ss_dssp TCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHHSCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHCCCCCC
T ss_conf 2303577864100102562647999983202578888806657878999999820889999989-999999997079987
Q ss_pred CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 63446899589999999961-8169999988844955677886
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 246 ~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~~ 287 (740)
...+...++++++||.+||+ +|.+|||+.++|+||||+....
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 7765669999999999976699668919999962923188989
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=406.12 Aligned_cols=255 Identities=25% Similarity=0.450 Sum_probs=217.5
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 86358757752028569999998579909999997505557998899999999999983899982146568562588849
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.+| ++.+.||+|+||+||+|.++.+|..||+|+++... .....+++.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 6 d~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 79 (322)
T d1s9ja_ 6 DDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEI 79 (322)
T ss_dssp GGE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEE
T ss_pred CCC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEE
T ss_conf 688-89789712778099999998999699999987540---97899999999999986799999949999998--9999
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHC
Q ss_conf 9999336899989999964888999999999999999999870-999903036887865870899928991144044330
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs-~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~ 180 (740)
|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHH
T ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEC-CCCCEEEEECCCCCCCC
T ss_conf 9999767998689987424999999999999999999999998599--97144577994687-89989995487762567
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH-H-----------------------
Q ss_conf 476643358888788200001-268421101013579998853799999999899-9-----------------------
Q 004645 181 KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-I----------------------- 235 (740)
Q Consensus 181 ~~~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~-i----------------------- 235 (740)
.....+.+||+.|||||++.+ .|+.++||||+||++|+|++|+.||.+...... .
T Consensus 157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 88621113771411946875899894888998999999999888998998878999999887517754577421233322
Q ss_pred -----------------HHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf -----------------999981999963446899589999999961-81699999888449556778
Q 004645 236 -----------------YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 236 -----------------~kki~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~ 285 (740)
...+.....|.......++++++||.+||. +|.+||||.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 11112223541347788766502687667644489999999999868994679089999609864769
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=407.37 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=222.7
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 86358757752028569999998579909999997505557998899999999999983899982146568562588849
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
+.| ++.+.||+|+||+||+|.++.+|..||+|+++.... .+..+++.+|+.+|++++||||+++++++.+ ...+
T Consensus 5 ~dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~ 78 (271)
T d1nvra_ 5 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQ 78 (271)
T ss_dssp TEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred CCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCEE
T ss_conf 460-899897217480999999999997999999845664---1279999999999985799888469654046--7436
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCC
Q ss_conf 99993368999899999648889999999999999999998709999030368878658708999289911440443304
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~ 181 (740)
|+||||+++|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|.....
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEECCCHHHEEECC
T ss_conf 798864589808999753799999999999999999999999759--83575468997887-899879832314224046
Q ss_pred C----CCCCCCCCCCCCCCCCCCC-CC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 7----6643358888788200001-26-8421101013579998853799999999899999998199996344689958
Q 004645 182 S----HAARCVGTPEFMAPEVYEE-EY-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 182 ~----~~~~~~GTp~YmAPEvl~~-~y-s~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spe 255 (740)
. .....+||+.|||||++.+ .| +.++|||||||++|+|+||+.||.........+............+...+++
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHH
T ss_conf 88653111325574742872861899999710161737999999829978888985999999986388878864469999
Q ss_pred HHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 9999999961-8169999988844955677
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 256 lr~lI~kCL~-dP~kRpSa~ELL~hpfl~~ 284 (740)
+++||.+||. +|.+|||+.++|+||||+.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 999999976799668909999961984585
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=397.35 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=224.3
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 98635875775202856999999857990999999750555799889999999999998389998214656856258884
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
-.+| ++.+.||+|+||+||+|.++.+|..||+|++... .....+.+.+|+.+|++|+|||||+++++|.+ ...
T Consensus 25 l~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 97 (350)
T d1koaa2 25 LDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNE 97 (350)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTE
T ss_pred CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 6575-8988984076819999998899989999998452----43169999999999986799799929999998--999
Q ss_pred EEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEEC-CCCCEEEECCCHHHH
Q ss_conf 9999933689998999996-48889999999999999999998709999030368878658708-999289911440443
Q 004645 101 INFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~-~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~-n~G~VKI~DFGlA~~ 178 (740)
+|+||||++||+|.+++.. .+++++..++.|+.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||+|..
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEEEEECHHHEEECCCCCCEEEEEECCHHEE
T ss_conf 99999857998899999762378999999999999999999997569--7600015467364168898699954521044
Q ss_pred HCCCCC-CCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCCH
Q ss_conf 304766-43358888788200001-2684211010135799988537999999998999999981999--9634468995
Q 004645 179 LRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDP 254 (740)
Q Consensus 179 l~~~~~-~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~--p~~~~~~~sp 254 (740)
+..... ....||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. +.......++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred CCCCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCH
T ss_conf 2565432000686242188997589987267655465999999859899899-799999999984788989422358999
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 89999999961-8169999988844955677886
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 255 elr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~~ 287 (740)
++++||.+||. +|.+|||+.++|+||||+....
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 9999999975689667908999862913288988
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=403.42 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=224.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 63587577520285699999985799099999975055579988999999999999838999821465685625888499
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.| ++.+.||+|+||+||+|.++.++..||+|++...... .......+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 7 dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 7 DF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred HE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEE
T ss_conf 76-9988985177858999999899949999998168856-76899999999999985688888859999998--99989
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCCC
Q ss_conf 99933689998999996488899999999999999999987099990303688786587089992899114404433047
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~~ 182 (740)
+||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCC
T ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECCCCCEEC-CCCCEEECCCCEEEECCCC
T ss_conf 99850479858988750489999999999999999999999889--46522023441466-8998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 6643358888788200001-268421101013579998853799999999899999998199996344689958999999
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr~lI~ 261 (740)
.....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+..+ ++...++++++||.
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT--FPDFVTEGARDLIS 236 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHHHHHHHH
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHHH
T ss_conf 52355788763499997589989314404675999998329999888-9999999999718999--98668999999999
Q ss_pred HHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 9961-8169999988844955677
Q 004645 262 KCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 262 kCL~-dP~kRpSa~ELL~hpfl~~ 284 (740)
+||. +|.+|||+.++|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 976479768909999971907078
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=398.39 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=224.7
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 86358757752028569999998579909999997505557998899999999999983899982146568562588849
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
..| ++.+.||+|+||+||+|+++.+|..||+|.++.... +....+.+.+|+.+|++++||||++++++|.+.....+
T Consensus 4 edy-~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred HHC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEE
T ss_conf 337-996798308891999999999997999999874657--97999999999999997789998248999991789989
Q ss_pred EEEEECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCCEEEECCCCCEEEECCC
Q ss_conf 999933689998999996----488899999999999999999987099---9903036887865870899928991144
Q 004645 102 NFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRD---PPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~----~k~l~~~~i~~i~~QIL~gL~yLHs~g---p~IIHrDLKp~NILId~n~G~VKI~DFG 174 (740)
|+||||+++|+|.+++.+ .+.+++..++.|+.||+.||.|||+.+ .+|+||||||+|||++. ++.+||+|||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~-~~~vkl~DFG 159 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFG 159 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT-TSCEEECCHH
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCC-CCCEEEEECC
T ss_conf 999956899938999985154578999999999999999999999971677887885867654257478-8857980010
Q ss_pred HHHHHCCCC--CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 044330476--643358888788200001-26842110101357999885379999999989999999819999634468
Q 004645 175 LAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 175 lA~~l~~~~--~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~ 251 (740)
+|..+.... ....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..++...+..+..+. ++..
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~ 237 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IPYR 237 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTT
T ss_pred CEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCC-CCCC
T ss_conf 003224577755667788232799998399999389887527899998018899899-89999999997189988-9743
Q ss_pred CCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCC
Q ss_conf 99589999999961-81699999888449556
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 282 (740)
Q Consensus 252 ~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl 282 (740)
.++++++||.+||. +|.+|||+.++|+|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 59999999999767995579189999729819
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=396.26 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=222.5
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 86358757752028569999998579909999997505557998899999999999983899982146568562588849
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
++| ++.+.||+|+||+||+|.++.+|..||+|+++.. .......+.+|+.+|++|+||||++++++|.+ +..+
T Consensus 29 d~Y-~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~ 101 (352)
T d1koba_ 29 DYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEM 101 (352)
T ss_dssp GTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEE
T ss_pred CCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEE
T ss_conf 035-9989993177829999999899979999998872----64679999999999986799798919999998--9999
Q ss_pred EEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEEC-CCCCEEEECCCHHHHH
Q ss_conf 9999336899989999964-8889999999999999999998709999030368878658708-9992899114404433
Q 004645 102 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAIL 179 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~-n~G~VKI~DFGlA~~l 179 (740)
|+||||+.||+|.+++... .++++..++.|+.||+.||.|||++| |+||||||+|||++. ..+.+||+|||+|..+
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
T ss_conf 9999828998088889863899899999999999999999999779--26513144553113467884899525630343
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCCHH
Q ss_conf 0476-643358888788200001-2684211010135799988537999999998999999981999--96344689958
Q 004645 180 RKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPE 255 (740)
Q Consensus 180 ~~~~-~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~--p~~~~~~~spe 255 (740)
.... .....||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+...++..+..+.. +...+...+++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCCCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCHH
T ss_conf 788720100476453489997479989763338989999999968899899-7999999999847889893002479999
Q ss_pred HHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 9999999961-816999998884495567788
Q 004645 256 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 256 lr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
+++||.+||. +|.+|||+.++|+||||+...
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 99999997569966891899996097348882
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=398.62 Aligned_cols=257 Identities=21% Similarity=0.389 Sum_probs=224.5
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 98635875775202856999999857990999999750555799889999999999998389998214656856258884
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 100 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~ 100 (740)
..+| ++.+.||+|+||+||+|+++.+|..||+|++..... ......+.+|+.+|++|+||||++++++|.+ +..
T Consensus 8 ~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 81 (307)
T d1a06a_ 8 RDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYES--GGH 81 (307)
T ss_dssp GGTE-EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CCCE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHH---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 6666-998899406583999999999998999999815773---1289999999999986799899919899998--998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEEC--CCCCEEEECCCHHHH
Q ss_conf 999993368999899999648889999999999999999998709999030368878658708--999289911440443
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAI 178 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~--n~G~VKI~DFGlA~~ 178 (740)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. +++.+||+|||+|..
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCE--EEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 8898852689848886530367887899999999999987524130--55687046300110468882499831543587
Q ss_pred HCCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCCH
Q ss_conf 30476-643358888788200001-26842110101357999885379999999989999999819999--634468995
Q 004645 179 LRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDP 254 (740)
Q Consensus 179 l~~~~-~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p--~~~~~~~sp 254 (740)
..... ....+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .....++..+..+..+ .......++
T Consensus 160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred CCCCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf 2589704400328422591887379998078734515999999859799999-899999999861687778766667899
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 89999999961-816999998884495567788
Q 004645 255 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 255 elr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 999999997608975791899986298447997
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.94 Aligned_cols=256 Identities=24% Similarity=0.427 Sum_probs=225.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 63587577520285699999985799099999975055579988999999999999838999821465685625888499
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.| ++.+.||+|+||.||+|+++.+|..||+|+++..... .....+.+.+|+.+|+.++||||++++++|.+ ...+|
T Consensus 6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 6 DF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred HC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCCC
T ss_conf 42-8988983176849999999899989999998156544-97999999999999986799988778764035--64211
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCCC
Q ss_conf 99933689998999996488899999999999999999987099990303688786587089992899114404433047
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~~ 182 (740)
+||||++||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. +|.+||+|||+|......
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~-~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECT-TSCEEECCCTTCBCSCCT
T ss_pred CCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEECC-CCCEEEEECCCCCCCCCC
T ss_conf 10003579860555532567759999999999965211343159--622464777847658-998888205652003567
Q ss_pred --CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf --6643358888788200001-2684211010135799988537999999998999999981999963446899589999
Q 004645 183 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 259 (740)
Q Consensus 183 --~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr~l 259 (740)
.....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+...+++.+..+..+ ++...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIR--FPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHH
T ss_conf 8620551008899666650489888333102230678899878999999-6999999998528998--986689999999
Q ss_pred HHHHHH-CCCCCCC-----HHHHHCCCCCCCCCCC
Q ss_conf 999961-8169999-----9888449556778863
Q 004645 260 IEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 288 (740)
Q Consensus 260 I~kCL~-dP~kRpS-----a~ELL~hpfl~~~~~~ 288 (740)
|.+||+ +|.+|++ +.++++||||+..++.
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 98666389344225652349999729150369999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=394.90 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=218.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCC--CCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 8635875775202856999999857990999999750555--79988999999999999838999821465685625888
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~--~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
..| ++.++||+|+||+||+|+++.+|..||+|++..... ........+...++.+++.++||||++++++|.+ ..
T Consensus 4 ddy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~ 80 (364)
T d1omwa3 4 NDF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD 80 (364)
T ss_dssp TTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred HHC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--CC
T ss_conf 768-510188428890999999999997999999845875426679999999999999850899858899999998--99
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 49999933689998999996488899999999999999999987099990303688786587089992899114404433
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l 179 (740)
.+|+||||+.||+|..++.++..+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCEEEEC-CCCCEEEEEECEEEEC
T ss_conf 88999991489838999873255327899999999999999999779--62204442216785-8896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 047664335888878820000-1-268421101013579998853799999999--899999998199996344689958
Q 004645 180 RKSHAARCVGTPEFMAPEVYE-E-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVEDPE 255 (740)
Q Consensus 180 ~~~~~~~~~GTp~YmAPEvl~-~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~--~~~i~kki~~g~~p~~~~~~~spe 255 (740)
........+||+.|||||++. + .|+.++|||||||++|+|+||+.||.+... ...+.+.+. ..+..++...+++
T Consensus 158 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~ 235 (364)
T d1omwa3 158 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPE 235 (364)
T ss_dssp SSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--SCCCCCCSSSCHH
T ss_pred CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC--CCCCCCCCCCCHH
T ss_conf 78864331134554216876038999844104677899999985999888899899999998604--6888788778999
Q ss_pred HHHHHHHHHH-CCCCCCC-----HHHHHCCCCCCCCCCC
Q ss_conf 9999999961-8169999-----9888449556778863
Q 004645 256 VRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 288 (740)
Q Consensus 256 lr~lI~kCL~-dP~kRpS-----a~ELL~hpfl~~~~~~ 288 (740)
+++||.+||. +|.+||| |.++|+||||+..++.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 999999985669888088743579999749102378987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.43 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=226.3
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 9863587577520285699999985799099999975055579--98899999999999983899982146568562588
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~--s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
..+| ++.+.||+|+||+||+|+++.+|..||+|+++...... .....+.+.+|+.+|++|+|||||+++++|.+ .
T Consensus 9 ~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 85 (293)
T d1jksa_ 9 DDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--K 85 (293)
T ss_dssp GGTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--C
T ss_conf 5677-982798117895999999999998999999875663213406899999999999986799899938899997--9
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCC---CCEEEECCCH
Q ss_conf 8499999336899989999964888999999999999999999870999903036887865870899---9289911440
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGL 175 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~---G~VKI~DFGl 175 (740)
..+|+||||+++|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+. ..+||+|||+
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CEEEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 989999986778643100103564215578999999999987666254--221133301279825898666469643344
Q ss_pred HHHHCCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCC
Q ss_conf 4433047-6643358888788200001-2684211010135799988537999999998999999981999--9634468
Q 004645 176 AAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKV 251 (740)
Q Consensus 176 A~~l~~~-~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~--p~~~~~~ 251 (740)
|...... ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+.+..+..+.. +...+..
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCCCCHHCCC
T ss_conf 2105777631224777743099998189999766522140999999708899889-999999999981688887010478
Q ss_pred CCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 99589999999961-8169999988844955677886
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 252 ~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~~ 287 (740)
.++.+++||.+||. +|.+|||+.++|+||||+..+.
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCH
T ss_conf 8999999999986389668919999961904188870
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.96 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=223.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 63587577520285699999985799099999975055579988999999999999838999821465685625888499
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.| ++.+.||+|+||+||+|.++.+|..||+|+++..... .....+.+.+|+.+|++|+||||++++++|.+ ...+|
T Consensus 9 dy-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 9 DF-KFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CC-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEE
T ss_conf 77-8988985087909999999899979999998657755-77789999999999987688886179999998--99889
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCCC
Q ss_conf 99933689998999996488899999999999999999987099990303688786587089992899114404433047
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~~ 182 (740)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|..+...
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCCCCCCCC-CCCEEEECCCCCCEECCCC
T ss_conf 99970489877776531599999999999999999997621650--88476774123668-8853886032102422567
Q ss_pred ----CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf ----6643358888788200001-26842110101357999885379999999989999999819999634468995899
Q 004645 183 ----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 257 (740)
Q Consensus 183 ----~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr 257 (740)
.....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++.++..+... ++...+++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 238 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYD--FPEKFFPKAR 238 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHH
T ss_conf 764333555677552584400268989666230456999998038899899-5999999999718999--9854799999
Q ss_pred HHHHHHHH-CCCCCCCHHH------HHCCCCCCCCCCC
Q ss_conf 99999961-8169999988------8449556778863
Q 004645 258 QFIEKCLA-TVSSRLSARE------LLTDPFLQIDDYD 288 (740)
Q Consensus 258 ~lI~kCL~-dP~kRpSa~E------LL~hpfl~~~~~~ 288 (740)
+||.+||. +|.+|||+.| +++||||+..++.
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHH
T ss_conf 99999855797689197897377898769764789988
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=393.79 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=224.8
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 86358757752028569999998579909999997505557998899999999999983899982146568562588849
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.+| ++.+.||+|+||+||+|.++.+|..||+|+++.... ......+.+.+|+.+|+.++||||++++++|.+ ...+
T Consensus 41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CCE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC--CCCC
T ss_conf 370-898896117680899999989998999999826774-588999999999999997487727403444432--2222
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCC
Q ss_conf 99993368999899999648889999999999999999998709999030368878658708999289911440443304
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~ 181 (740)
++|+||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|..+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred CCCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHCCCC-CCCCEEEEECEEEEECCC
T ss_conf 322223346622666751589899999999999999899998599--86176799993607-789788610103332256
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf 76643358888788200001-26842110101357999885379999999989999999819999634468995899999
Q 004645 182 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 260 (740)
Q Consensus 182 ~~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr~lI 260 (740)
. ....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+..+ .+...++++++||
T Consensus 194 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLL 269 (350)
T ss_dssp C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHH
T ss_pred C-CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHH
T ss_conf 6-6433676356788997179988533114500789999758899899-5999999998617988--9766899999999
Q ss_pred HHHHH-CCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf 99961-816999-----99888449556778863
Q 004645 261 EKCLA-TVSSRL-----SARELLTDPFLQIDDYD 288 (740)
Q Consensus 261 ~kCL~-dP~kRp-----Sa~ELL~hpfl~~~~~~ 288 (740)
.+||. +|.+|+ ++.++|+||||+..++.
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 9983409986065534549999719051589989
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=389.79 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=224.3
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 63587577520285699999985799099999975055579988999999999999838999821465685625888499
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.| ++.+.||+|+||+||+|.++.+|..||+|+++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 5 dy-~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 5 DF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred HE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE--CCEEE
T ss_conf 70-8888972076808999999899979999998457754-88999999999999986369675330356852--88005
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCCC
Q ss_conf 99933689998999996488899999999999999999987099990303688786587089992899114404433047
Q 004645 103 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 182 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~~ 182 (740)
+||||+.||+|..++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|......
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC
T ss_pred EEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCC--EECCCCCCHHEEEC-CCCCEEEECCCCCEEECCC
T ss_conf 67650378632234322221110079999999987655412476--77055681050386-8998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 6643358888788200001-268421101013579998853799999999899999998199996344689958999999
Q 004645 183 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 261 (740)
Q Consensus 183 ~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr~lI~ 261 (740)
....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++.++..+..+ ++...+++++++|.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR--FPPFFNEDVKDLLS 233 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHH
T ss_pred -CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHHH
T ss_conf -6434576343599998389998043046533368999759899999-6999999999708988--99778999999999
Q ss_pred HHHH-CCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf 9961-816999-----99888449556778863
Q 004645 262 KCLA-TVSSRL-----SARELLTDPFLQIDDYD 288 (740)
Q Consensus 262 kCL~-dP~kRp-----Sa~ELL~hpfl~~~~~~ 288 (740)
+||. +|.+|+ ++.++|+||||+..++.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHH
T ss_conf 995449976664310219999819351467989
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.82 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=223.1
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 89986358757752028569999998579909999997505557998899999999999983899982146568562588
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
+-.+|| ++.+.||+|+||+||+|+++.+|..||+|+++... .....+.+|+.+|+.++||||++++++|.+ .
T Consensus 2 ~~~~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 73 (321)
T d1tkia_ 2 ELYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFES--M 73 (321)
T ss_dssp CCTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--T
T ss_pred CCCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEE--C
T ss_conf 870105-88789831778399999998999699999975786-----659999999999985799798909899988--9
Q ss_pred CEEEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEEC-CCCCEEEECCCHH
Q ss_conf 84999993368999899999648-889999999999999999998709999030368878658708-9992899114404
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLA 176 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k-~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~-n~G~VKI~DFGlA 176 (740)
..+|+||||+.||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++. +...+||+|||++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEEECCCCHH
T ss_conf 9889999538998088998753899999999999999999999998769--97513554443443788518997644111
Q ss_pred HHHCCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCC
Q ss_conf 4330476-643358888788200001-2684211010135799988537999999998999999981999--96344689
Q 004645 177 AILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVE 252 (740)
Q Consensus 177 ~~l~~~~-~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~--p~~~~~~~ 252 (740)
....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+.. +...+...
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEI 230 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred HCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCHHHCCCC
T ss_conf 003467753212233222340210487778401130279999999828999999-8999999999838999880223678
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 9589999999961-81699999888449556778
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 253 spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~ 285 (740)
++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999999999866996689099999639965667
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.96 Aligned_cols=255 Identities=23% Similarity=0.421 Sum_probs=220.0
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCCCEE
Q ss_conf 635875775202856999999857990999999750555799889999999999998-3899982146568562588849
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK-TLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk-~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.| .+.+.||+|+||+||+|.++.+|..||+|+++..... .....+.+..|+.++. .++||||++++++|.+ +..+
T Consensus 3 dy-~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 3 DF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CE-EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCE
T ss_conf 71-8865894087828999999999989999998055533-848999999999999984799968789889704--9831
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCC
Q ss_conf 99993368999899999648889999999999999999998709999030368878658708999289911440443304
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~ 181 (740)
|+||||+++|+|..++....++++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.....
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCC
T ss_pred EEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEEC-CCCCEECCCCCHHHHCCC
T ss_conf 677750379808998640478999999999999999999998689--34034765404444-899630155530232356
Q ss_pred C--CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 7--6643358888788200001-268421101013579998853799999999899999998199996344689958999
Q 004645 182 S--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 182 ~--~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr~ 258 (740)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+..+ +++..++++++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~d 232 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPF--YPRWLEKEAKD 232 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHH
T ss_conf 65334545787776899998279988323201122789898738899999-8999999999718998--97567999999
Q ss_pred HHHHHHH-CCCCCCCHH-HHHCCCCCCCCCC
Q ss_conf 9999961-816999998-8844955677886
Q 004645 259 FIEKCLA-TVSSRLSAR-ELLTDPFLQIDDY 287 (740)
Q Consensus 259 lI~kCL~-dP~kRpSa~-ELL~hpfl~~~~~ 287 (740)
||.+||. +|.+||++. ++++||||+..++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHCCHHCCCCH
T ss_conf 9999654489878388999980901315899
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=376.06 Aligned_cols=256 Identities=24% Similarity=0.411 Sum_probs=222.9
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCC-----HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 8635875775202856999999857990999999750555799-----889999999999998389-9982146568562
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQS-----PEELERLYCEIHLLKTLK-HRNIMKFYTSWVD 95 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s-----~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd 95 (740)
.+| .+.+.||+|+||+||+|+++.+|..||+|+++....... ....+++.+|+.+|++|+ ||||++++++|.+
T Consensus 3 ~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCC-EECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 638-8852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 58884999993368999899999648889999999999999999998709999030368878658708999289911440
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGl 175 (740)
+..+|+||||+++|+|.+++..++++++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGF 156 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred --CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCHH
T ss_conf --7605999976898668999986599999999999999999999998759--94323462548986-899838712403
Q ss_pred HHHHCCCC-CCCCCCCCCCCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--C
Q ss_conf 44330476-643358888788200001-------2684211010135799988537999999998999999981999--9
Q 004645 176 AAILRKSH-AARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--P 245 (740)
Q Consensus 176 A~~l~~~~-~~~~~GTp~YmAPEvl~~-------~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~--p 245 (740)
+..+.... ....+||+.|+|||++.+ .|+.++||||+||++|+|+||+.||.+ .+...+.+.+..+.. +
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred EEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCC-CCHHHHHHHHHHCCCCCC
T ss_conf 1672688721345246788898886053445678899233185656023103228889889-999999999981898889
Q ss_pred CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 63446899589999999961-8169999988844955677
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 246 ~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~ 284 (740)
.......++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 8543468999999999976589668919999973978797
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.73 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=209.9
Q ss_pred EEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCH-HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEEE
Q ss_conf 57752028569999998579909999997505557998-89999999999998389998214656856258884999993
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP-EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 106 (740)
Q Consensus 28 ~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~-~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~lV~E 106 (740)
.++||+|+||+||+|+++.+|..||+|+++........ ....++.+|+.+|++++|||||+++++|.. +..+|+|||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEE
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCEEEHHH
T ss_conf 638512728299999999999699999984202124567999999999999986799998689854225--874022045
Q ss_pred CCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCCCC--C
Q ss_conf 36899989999964888999999999999999999870999903036887865870899928991144044330476--6
Q 004645 107 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--A 184 (740)
Q Consensus 107 y~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~~~--~ 184 (740)
|+.++++..+....+.+++..++.|++||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|....... .
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCC
T ss_pred HHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCCEEEEC-CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 5345077655412667789999999999999998863163--55035776258853-77841146576100057875543
Q ss_pred CCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCC----------------
Q ss_conf 43358888788200001--2684211010135799988537999999998999999981-9999----------------
Q 004645 185 ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP---------------- 245 (740)
Q Consensus 185 ~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~-g~~p---------------- 245 (740)
...+||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+....+++.+.... +..+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred CCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHH
T ss_conf 30204733363999726778880564363042899998596999999999999999985189972545210002134430
Q ss_pred --------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf --------63446899589999999961-816999998884495567788
Q 004645 246 --------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 246 --------~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
.......++++++||.+||+ +|.+||||.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 34789886785656899999999997638945690899996799657899
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.36 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=213.5
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCH--HHHHHHHHHHHHHHHCC--CCCCCEEEEEEEEC
Q ss_conf 986358757752028569999998579909999997505557998--89999999999998389--99821465685625
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSP--EELERLYCEIHLLKTLK--HRNIMKFYTSWVDT 96 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~--~~~~~l~~Ei~iLk~L~--HpNIVkl~~~fvd~ 96 (740)
.++| ++.+.||+|+||+||+|+++.+|..||+|+++........ ....++.+|+.+|++++ ||||++++++|.+
T Consensus 3 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~- 80 (273)
T d1xwsa_ 3 ESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 80 (273)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred CCEE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-
T ss_conf 8837-99679840878399999999999799999985688443345567999999999999743589881279999830-
Q ss_pred CCCEEEEEEECCCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 88849999933689-99899999648889999999999999999998709999030368878658708999289911440
Q 004645 97 ANRNINFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 97 ~~~~i~lV~Ey~~g-GSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGl 175 (740)
...+++||||+.+ +++..++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||+
T Consensus 81 -~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 81 -PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp -SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred -CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf -99689999833686228999861589999999999999999999998779--755667611147744788489775465
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 44330476643358888788200001-2-684211010135799988537999999998999999981999963446899
Q 004645 176 AAILRKSHAARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 253 (740)
Q Consensus 176 A~~l~~~~~~~~~GTp~YmAPEvl~~-~-ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~s 253 (740)
|...........+||+.|||||++.+ . ++.++|||||||++|+|+||+.||.. .. .+..+.. .+....+
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~----~i~~~~~--~~~~~~s 228 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DE----EIIRGQV--FFRQRVS 228 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HH----HHHHCCC--CCSSCCC
T ss_pred CEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCC---CH----HHHHCCC--CCCCCCC
T ss_conf 3532444556656587747999984899788653325540345367568899887---36----7761544--7787799
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 589999999961-81699999888449556778
Q 004645 254 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 254 pelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~ 285 (740)
+++++||.+||. +|.+|||+.++|+||||+..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 999999999760897589399998539866788
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.40 Aligned_cols=255 Identities=20% Similarity=0.323 Sum_probs=208.8
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEEEEEE--CC
Q ss_conf 986358757752028569999998579909999997505557998899999999999983-899982146568562--58
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT-LKHRNIMKFYTSWVD--TA 97 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~fvd--~~ 97 (740)
.++|.-+.++||+|+||+||+|.++.++..||+|+++.. ..+.+|+.++.+ ++||||++++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC---------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
T ss_conf 148798107965454869999998899989999998974---------77999999999866999978298999503468
Q ss_pred CCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEEC--CCCCEEEECC
Q ss_conf 88499999336899989999964--8889999999999999999998709999030368878658708--9992899114
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQGEVKIGDL 173 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~--k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~--n~G~VKI~DF 173 (740)
+..+|+|||||+||+|.+++.+. .++++..++.|+.||+.||.|||+++ |+||||||+|||++. +.+.+||+||
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 978999997789984999998627877579999999999999999999769--864441002201135555663113545
Q ss_pred CHHHHHCCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHCCC--CCC
Q ss_conf 404433047-6643358888788200001-26842110101357999885379999999989---9999998199--996
Q 004645 174 GLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKVISGK--KPE 246 (740)
Q Consensus 174 GlA~~l~~~-~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~---~i~kki~~g~--~p~ 246 (740)
|+|...... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+..... .+...+..+. .|.
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred CEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf 51233368886432267756379277748988888888764516778865889988988778899999998538888898
Q ss_pred CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 3446899589999999961-816999998884495567788
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 247 ~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
..+...++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCCC
T ss_conf 54346999999999997569965790999997098761788
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.14 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=209.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 63587577520285699999985799099999975055579988999999999999838999821465685625888499
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
+| ++.+.||+|+||+||+|.+..+|..||+|+++.... .....+++.+|+.+|++++||||+++++.|.+ ...+|
T Consensus 3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~ 77 (298)
T d1gz8a_ 3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLY 77 (298)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred CC-EECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEE
T ss_conf 97-765177237680999999999997999999802225--75899999999999986799838874453322--43203
Q ss_pred EEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCC
Q ss_conf 99933689998999996-48889999999999999999998709999030368878658708999289911440443304
Q 004645 103 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~-~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~ 181 (740)
+||||+.++.+...... .+.+++..++.++.||+.||.|||+++ ||||||||+|||++. ++.+||+|||+|.....
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINT-EGAIKLADFGLARAFGV 154 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECT-TSCEEECSTTHHHHHCC
T ss_pred EEEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCHHEEECC-CCCCEECCCCCCEECCC
T ss_conf 788623774455544202568888999999999999999865288--992135711401134-67621035786134368
Q ss_pred CC--CCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC-----------
Q ss_conf 76--643358888788200001--268421101013579998853799999999899999998199996-----------
Q 004645 182 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE----------- 246 (740)
Q Consensus 182 ~~--~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~----------- 246 (740)
.. ....+||+.|+|||++.. .++.++||||||+++|+|++|+.||.+.+....+++.+.....+.
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCC
T ss_conf 86410010365215411221366577742210333313427966879989889999999999832898333144422242
Q ss_pred ---------------CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ---------------3446899589999999961-81699999888449556778
Q 004645 247 ---------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 247 ---------------~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~ 285 (740)
......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 1243454322220444166789999999999763995579189999678701469
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.16 Aligned_cols=267 Identities=22% Similarity=0.331 Sum_probs=215.7
Q ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 71343899863587577520285699999985799099999975055579988999999999999838999821465685
Q 004645 14 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 93 (740)
Q Consensus 14 ~~~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 93 (740)
+.+..++.+|| ++.+.||+|+||+||+|++..+|..||+|++..... ......++.+|+.+|+.++||||+++++++
T Consensus 2 ~~~~~~~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~ 78 (318)
T d3blha1 2 ECPFCDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEIC 78 (318)
T ss_dssp CCTTSCBGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCCCCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 89999762798-899997227482999999989997999999842224--637899999999999983599966067654
Q ss_pred EECC------CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCC
Q ss_conf 6258------8849999933689998999996488899999999999999999987099990303688786587089992
Q 004645 94 VDTA------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 167 (740)
Q Consensus 94 vd~~------~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~ 167 (740)
.... ...+++++||+.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 79 ~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~-~~~ 155 (318)
T d3blha1 79 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITR-DGV 155 (318)
T ss_dssp EC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT-TSC
T ss_pred ECCCCCCCCCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC--EEECCCCCHHEEECC-CCC
T ss_conf 02465444457638999853578741012220344330899999999999998852299--885676722203668-996
Q ss_pred EEEECCCHHHHHCCC------CCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 899114404433047------6643358888788200001--26842110101357999885379999999989999999
Q 004645 168 VKIGDLGLAAILRKS------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 239 (740)
Q Consensus 168 VKI~DFGlA~~l~~~------~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki 239 (740)
+||+|||++...... .....+||+.|+|||++.+ .|+.++||||||+++|+|++|+.||.+.. .......+
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~i 234 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALI 234 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHH
T ss_pred EEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCC-HHHHHHHH
T ss_conf 87631350022355444321135660249787428997079998917870067864661744879989989-99999999
Q ss_pred HC--CCCCCCCC----------------------------CCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 81--99996344----------------------------6899589999999961-8169999988844955677886
Q 004645 240 IS--GKKPEALF----------------------------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 287 (740)
Q Consensus 240 ~~--g~~p~~~~----------------------------~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~~ 287 (740)
.. +..+.... ...++.+++||.+||. +|.+|+||.|+|+||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred HHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 9841899825534432034443320133445550334044459989999999987389658909999974950156999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.75 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=209.9
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCC-----EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf 863587577520285699999985799-----099999975055579988999999999999838-99982146568562
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 95 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg-----~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd 95 (740)
.+| ++.++||+|+||+||+|++..++ ..||+|.+.... .......+.+|+.+|.++ +|||||+++++|.+
T Consensus 37 ~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 37 ENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHE-EEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 993-9701983078819999998578855420499999966335---878999999999999971589968687788862
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEC
Q ss_conf 58884999993368999899999648-----------------------8899999999999999999987099990303
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKHR-----------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 152 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~k-----------------------~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHr 152 (740)
...+++||||+++|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEC
T ss_conf --995899997279995999998625777510221000012220012577899999999999999999997399--0505
Q ss_pred CCCCCCEEEECCCCCEEEECCCHHHHHCCCCC----CCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCC
Q ss_conf 68878658708999289911440443304766----4335888878820000-126842110101357999885-37999
Q 004645 153 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPY 226 (740)
Q Consensus 153 DLKp~NILId~n~G~VKI~DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf 226 (740)
||||+|||++.+ +.+||+|||+|+....... ....||+.|||||++. +.|+.++|||||||++|||+| |..||
T Consensus 189 DlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 189 DLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCHHCCCCCCC-CEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCC
T ss_conf 270321443459-8289851422220457786156234357876578388727999963303000399999983899999
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 999998999999981999963446899589999999961-81699999888449
Q 004645 227 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 227 ~~~~~~~~i~kki~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||+.+|++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9989899999998569989-9887678999999999758896689399999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=365.09 Aligned_cols=249 Identities=18% Similarity=0.308 Sum_probs=210.8
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCE---EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 998635875775202856999999857990---99999975055579988999999999999838999821465685625
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGI---EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 96 (740)
Q Consensus 20 p~grY~rl~e~LG~GsfGtVyka~d~~tg~---~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~ 96 (740)
+..+| ++.++||+|+||+||+|.++.++. .||+|.+. ........+.+.+|+.+|++|+|||||++++++..
T Consensus 24 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~---~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~- 98 (299)
T d1jpaa_ 24 DISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK---SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK- 98 (299)
T ss_dssp CGGGE-EEEEEEEECSSSEEEEEEECC---CCEEEEEEECC---SSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred CHHHC-EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEC---CCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-
T ss_conf 80042-78569802788299999995799788999999978---44598999999999999985799888618999962-
Q ss_pred CCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 888499999336899989999964-8889999999999999999998709999030368878658708999289911440
Q 004645 97 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 97 ~~~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGl 175 (740)
...+++||||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 99 -~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 99 -STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGL 174 (299)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC--
T ss_pred -CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCCC
T ss_conf -88779999722798530021045679999999999999999889885279--83576150448988-999199888443
Q ss_pred HHHHCCCCC-------CCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 443304766-------4335888878820000-126842110101357999885-3799999999899999998199996
Q 004645 176 AAILRKSHA-------ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 246 (740)
Q Consensus 176 A~~l~~~~~-------~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~ 246 (740)
|..+..... ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ ....++...+..+..+.
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC
T ss_pred CEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC
T ss_conf 15756777765365025666883003878883699786121445357899998679999999-99999999997378899
Q ss_pred CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 3446899589999999961-81699999888449
Q 004645 247 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 247 ~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
.+...++.+.+++.+||. +|.+|||+.++++.
T Consensus 254 -~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 -PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -974226999999999758797689299999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.95 Aligned_cols=259 Identities=29% Similarity=0.414 Sum_probs=214.5
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-
Q ss_conf 8998635875775202856999999857990999999750555799889999999999998389998214656856258-
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA- 97 (740)
Q Consensus 19 dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~- 97 (740)
+...|| ++.+.||+|+||+||+|.++.+|..||+|+++.. ..+....+++.+|+.+|+.++|||||+++++|....
T Consensus 15 ~~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 15 EVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp CCBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ECCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCC
T ss_conf 447718-9988980177819999999999989999998522--2596999999999999986689875479998635765
Q ss_pred ---CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCC
Q ss_conf ---88499999336899989999964888999999999999999999870999903036887865870899928991144
Q 004645 98 ---NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 98 ---~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFG 174 (740)
...+|+||||+ +.+|..+ .+++++++..++.+++||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~-~~~~kl~Dfg 166 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNE-DCELKILDFG 166 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT-TCCEEECCCT
T ss_pred CCCCCEEEEEEECC-CCCHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCHHHCCC-CCCCCCCCCC
T ss_conf 55541599998405-5218999-87402269999999999999999987378--764566851111210-0122113431
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCC-------
Q ss_conf 044330476643358888788200001--2684211010135799988537999999998999999981-999-------
Q 004645 175 LAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK------- 244 (740)
Q Consensus 175 lA~~l~~~~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~-g~~------- 244 (740)
+|...... ....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+......+...... +..
T Consensus 167 ~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 167 LARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp TCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred CEECCCCC-CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHH
T ss_conf 02206876-31024553335889981787899650103003899999978699888976899999985037884888865
Q ss_pred --------------------CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf --------------------963446899589999999961-816999998884495567788
Q 004645 245 --------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 245 --------------------p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
........++.+++||.+||. +|.+||||.++|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 300034433115786665566775568999999999997729955792999996396237587
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.98 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=204.3
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----CC
Q ss_conf 63587577520285699999985799099999975055579988999999999999838999821465685625----88
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT----AN 98 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~----~~ 98 (740)
+| +..++||+|+||+||+|+++.+|..||+|+++..... ..+|+.+|++|+||||++++++|... ..
T Consensus 21 ~Y-~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CC-EEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH--------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 76-7516982176839999999999979999998816068--------99999999866898987387899744765773
Q ss_pred CEEEEEEECCCCCCHHHH---HHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 849999933689998999---99648889999999999999999998709999030368878658708999289911440
Q 004645 99 RNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 175 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~---l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGl 175 (740)
..+++||||++++.+..+ ......+++..++.|++||+.||.|||++| |+||||||+|||++.+...+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf 189999841688607888863103689999999999999999999998668--764578860378735897116733660
Q ss_pred HHHHCCC-CCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCC-------
Q ss_conf 4433047-6643358888788200001--2684211010135799988537999999998999999981-999-------
Q 004645 176 AAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK------- 244 (740)
Q Consensus 176 A~~l~~~-~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~-g~~------- 244 (740)
+...... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.......++.+.+.. |..
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 54404776532002555556827764046888210002465277855028799898799999999999748981776543
Q ss_pred ----------C--------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf ----------9--------63446899589999999961-8169999988844955677
Q 004645 245 ----------P--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 245 ----------p--------~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~ 284 (740)
+ .......++++++||.+||. +|.+||||.|+|+||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 06210110355445674444315689999999999976589557929999966984524
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=366.83 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=215.5
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 34389986358757752028569999998579909999997505557998899999999999983899982146568562
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
+|+++ .+| ++.+.||+|+||+||+|.++.++..||+|+++... ...+++.+|+.+|++|+|||||+++++|.+
T Consensus 12 wei~~-~~~-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 12 WEMER-TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TBCCG-GGE-EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CEECH-HHE-EEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-----CHHHHHHHHHHHHHHCCCCCEECCCCCEEE
T ss_conf 17457-993-98659820888089999999999699999977761-----039999999999986799988267752745
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECC
Q ss_conf 5888499999336899989999964--88899999999999999999987099990303688786587089992899114
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~~--k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DF 173 (740)
...+++||||+++|+|..++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 85 --~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DF 159 (287)
T d1opja_ 85 --EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADF 159 (287)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCC
T ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCC-CCEEECCC
T ss_conf --785478763146760677753035541579999999999999788898789--3057604576899899-92898324
Q ss_pred CHHHHHCCCCCC---CCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 404433047664---335888878820000-1268421101013579998853799999999899999998199996344
Q 004645 174 GLAAILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249 (740)
Q Consensus 174 GlA~~l~~~~~~---~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~ 249 (740)
|+|......... ...|++.|||||++. +.|+.++||||||+++|||++|..||....+..++++.+..+..+. .+
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~ 238 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RP 238 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CC
T ss_pred CCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-CC
T ss_conf 45465378872210355665466692787279998104302178999999867998877425999999985588888-87
Q ss_pred CCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 6899589999999961-8169999988844
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 250 ~~~spelr~lI~kCL~-dP~kRpSa~ELL~ 278 (740)
...++.+++||.+||. +|.+|||+.++++
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 433099999999975779768939999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=363.61 Aligned_cols=258 Identities=23% Similarity=0.303 Sum_probs=216.4
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--
Q ss_conf 986358757752028569999998579909999997505557998899999999999983899982146568562588--
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN-- 98 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~-- 98 (740)
.+|| ++.+.||+|+||+||+|.+..+|..||+|+++... .......+++.+|+.+|+.++||||+++++++.....
T Consensus 6 ~drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CCEE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC
T ss_conf 6206-98689960899299999999999899999985566-469899999999999998569998873114354326887
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 84999993368999899999648889999999999999999998709999030368878658708999289911440443
Q 004645 99 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~ 178 (740)
..+|+||||+.|++|..++...+++++..++.|+.||+.||.|||+++ |+||||||+|||++. .+.++|+|||.+..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~-~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISA-TNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEET-TSCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCC-CCCCEEEHHHHHHH
T ss_conf 669999977889871011203589999999999999999999998579--527634675566575-43201003444322
Q ss_pred HCCC-----CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-CCCCCC
Q ss_conf 3047-----6643358888788200001-26842110101357999885379999999989999999819999-634468
Q 004645 179 LRKS-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKV 251 (740)
Q Consensus 179 l~~~-----~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p-~~~~~~ 251 (740)
.... .....+||+.|||||++.+ .|+.++||||||+++|+|+||+.||.+....+.+.+.+..+..+ ......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCC
T ss_conf 12354433334642576243699998399999663202652899999769799899699999999984699997100347
Q ss_pred CCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCC
Q ss_conf 99589999999961-816999998884495567
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 283 (740)
Q Consensus 252 ~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~ 283 (740)
.++++++||.+||. +|.+||+..+.|.|+|++
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 899999999998667976777399999999999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.67 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=213.5
Q ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEE
Q ss_conf 13438998635875775202856999999857990999999750555799889999999999998389-99821465685
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSW 93 (740)
Q Consensus 15 ~~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~f 93 (740)
.++.....+| ++.++||+|+||+||+|+++.+|..||+|+++... .+++.+|+.+|+.+. ||||++++++|
T Consensus 28 ~~~~~~~d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~ 99 (328)
T d3bqca1 28 VVEWGNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIV 99 (328)
T ss_dssp CCCCCCGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCCCCCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHHCCCCCCCCEEEEEE
T ss_conf 3678998671-89789831748199999988999799999988899-------999999999998515799876799999
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECC
Q ss_conf 62588849999933689998999996488899999999999999999987099990303688786587089992899114
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DF 173 (740)
.......+++||||+.+++|..+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++.+.+.+||+||
T Consensus 100 ~~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 100 KDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp ECTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCG
T ss_pred EECCCCCEEEEEEECCCCCHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEECCC
T ss_conf 81687712688863179858997---468999999999999999998876433--4434564412377489983664156
Q ss_pred CHHHHHCCC-CCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--C------
Q ss_conf 404433047-6643358888788200001--2684211010135799988537999999998999999981--9------
Q 004645 174 GLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--G------ 242 (740)
Q Consensus 174 GlA~~l~~~-~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~--g------ 242 (740)
|+|...... .....+||+.|+|||++.+ .|+.++||||+|+++|+|++|..||............+.. |
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHH
T ss_conf 54266468874443224864247610268888884523233545558760488999887601899999999878841555
Q ss_pred ------C---------------------CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf ------9---------------------9963446899589999999961-816999998884495567788
Q 004645 243 ------K---------------------KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 243 ------~---------------------~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
. .+.......++++++||.+||. +|.+||||.|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred HHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 554225444743000003334331121155211244899999999998669956890899996493558879
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.79 Aligned_cols=260 Identities=27% Similarity=0.358 Sum_probs=205.2
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCC-CEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEEC
Q ss_conf 986358757752028569999998579-9099999975055579988999999999999838---999821465685625
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYE-GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDT 96 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~t-g~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fvd~ 96 (740)
..+| ++.+.||+|+||+||+|.+..+ +..||+|+++...... .....+.+|+.+|+.| +||||++++++|...
T Consensus 6 ~~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCE-EEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCC--HHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 5897-988899215586999999988899899999980232451--6799999999999987425898802366322146
Q ss_pred ---CCCEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEEC
Q ss_conf ---88849999933689998999996-48889999999999999999998709999030368878658708999289911
Q 004645 97 ---ANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 97 ---~~~~i~lV~Ey~~gGSL~~~l~~-~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~D 172 (740)
....+++++|++.++.+...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECS
T ss_pred CCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEC-CCCCEEECC
T ss_conf 666674699999740587144444303789998999999999999999997588--98357986278985-899754210
Q ss_pred CCHHHHHCCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCC-----
Q ss_conf 4404433047-6643358888788200001-2684211010135799988537999999998999999981-999-----
Q 004645 173 LGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK----- 244 (740)
Q Consensus 173 FGlA~~l~~~-~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~-g~~----- 244 (740)
||++...... .....+||+.|||||++.+ .|+.++||||+||++|+|+||+.||.+.+..+.+.+.+.. +..
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred HHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCC
T ss_conf 00101100234577765485114831001798881110003289999998787998998989999999984079961105
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf ------------------963446899589999999961-816999998884495567788
Q 004645 245 ------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 245 ------------------p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
...+....++.+++||.+||. +|.+||||.|+|+||||+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf 3211110333022345645440445899999999998748966791899996696340752
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.72 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=212.0
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 99863587577520285699999985799099999975055579988999999999999838999821465685625888
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
|.++| ++.+.||+|+||+||+|... ..||+|+++.... +....+.+.+|+.+|++++||||+++++++. ..
T Consensus 6 ~~~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~ 76 (276)
T d1uwha_ 6 PDGQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYST---AP 76 (276)
T ss_dssp CTTCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SS
T ss_pred CCCCE-EEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---CC
T ss_conf 54518-99889830788589999999---9899999973469--9899999999999998479987864567971---55
Q ss_pred EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 499999336899989999964-8889999999999999999998709999030368878658708999289911440443
Q 004645 100 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~ 178 (740)
.+++||||+++|+|.+++... .++++..+..|+.||+.||.|||+++ ||||||||+|||++. ++.+||+|||+|..
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~-~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHE-DLTVKIGDFGLATV 153 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEET-TSSEEECCCCCSCC
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCHHHEEECC-CCCEEECCCCCEEE
T ss_conf 899999658998889998523578999999999999999988875099--951614789979818-99788750022133
Q ss_pred HCCC----CCCCCCCCCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC---C
Q ss_conf 3047----6643358888788200001----268421101013579998853799999999899999998199996---3
Q 004645 179 LRKS----HAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---A 247 (740)
Q Consensus 179 l~~~----~~~~~~GTp~YmAPEvl~~----~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~---~ 247 (740)
.... ......||+.|||||++.+ .|+.++||||||+++|||+||+.||.+......+...+..+..+. .
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHH
T ss_conf 35567763125665574317999995056899995315163599999999788998998969999999965888986000
Q ss_pred CCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 446899589999999961-81699999888449
Q 004645 248 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 248 ~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
.....++.+++|+.+||. +|.+|||+.+++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 365554999999999758897689299999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.76 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=209.2
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC-
Q ss_conf 9986358757752028569999998579909999997505557998899999999999983899982146568562588-
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN- 98 (740)
Q Consensus 20 p~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~- 98 (740)
-+.|| ++.+.||+|+||+||+|.+..+|..||+|+++... .....+++.+|+.+|+.|+||||+++++.+.....
T Consensus 6 i~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 6 VGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCCCE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
T ss_conf 38985-99789940648099999999999499999980310---958999999999999976898988588899505645
Q ss_pred -CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf -8499999336899989999964888999999999999999999870999903036887865870899928991144044
Q 004645 99 -RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 -~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
...+++++++.+|+|.+++.. +++++..++.++.||+.||.|||+++ ||||||||+|||++ +.+.+||+|||++.
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLAR 157 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred CCCEEEEEEEECCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCCCEE
T ss_conf 5414999996259865664405-89999999999999999999999789--86777876437887-99977875457056
Q ss_pred HHCCC-----CCCCCCCCCCCCCCCCCC-C-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-----
Q ss_conf 33047-----664335888878820000-1-26842110101357999885379999999989999999819999-----
Q 004645 178 ILRKS-----HAARCVGTPEFMAPEVYE-E-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP----- 245 (740)
Q Consensus 178 ~l~~~-----~~~~~~GTp~YmAPEvl~-~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p----- 245 (740)
..... .....+||+.|+|||++. + .|+.++||||+|+++|+|++|..||.+.....+....+.....+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 50477764101011026520003878604788874101004670133776697997888889999987652069975664
Q ss_pred -----------------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf -----------------------63446899589999999961-816999998884495567788
Q 004645 246 -----------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 286 (740)
Q Consensus 246 -----------------------~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~~ 286 (740)
.......++++++||.+||. +|.+||||.++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 23433222202446775577877783789999999999997648956790899986198655588
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=361.79 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=211.8
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 86358757752028569999998579909999997505557998899999999999983899982146568562588849
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.|| ++.+.||+|+||+||+|.++ +|..||+|+++.... .....+++.+|+.+|++++||||+++++.|.. ...+
T Consensus 2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 75 (286)
T d1ob3a_ 2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRL 75 (286)
T ss_dssp CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCE
T ss_pred CCC-EECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CCCE
T ss_conf 996-34318722778189999968-999999999812326--85899999999999986799868766012046--7731
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCC
Q ss_conf 99993368999899999648889999999999999999998709999030368878658708999289911440443304
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~ 181 (740)
++++|++.++.+..+....+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||.+.....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINR-EGELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECT-TSCEEECCTTHHHHHCC
T ss_pred EEEEEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCC--EEECCCCCCEEEECC-CCCEEECCCCCCEECCC
T ss_conf 589974004567899860477514456899999999999860574--882678775056868-99787323664301146
Q ss_pred CC--CCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCC-----------
Q ss_conf 76--643358888788200001--2684211010135799988537999999998999999981-9999-----------
Q 004645 182 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP----------- 245 (740)
Q Consensus 182 ~~--~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~-g~~p----------- 245 (740)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.....++.+.... +..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 76541010243110137887178888841002111758999977979989889899999999863899711042123332
Q ss_pred --------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf --------------63446899589999999961-8169999988844955677
Q 004645 246 --------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 246 --------------~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~ 284 (740)
.......++.+++||.+||+ +|.+||||.|+|+||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 214333335676466651258999999999986689668909999856922074
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.86 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=211.7
Q ss_pred CEEEEE-EEECCCCCEEEEEEEEC--CCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 635875-77520285699999985--799099999975055579988999999999999838999821465685625888
Q 004645 23 RYGRYN-EILGKGASKTVYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 23 rY~rl~-e~LG~GsfGtVyka~d~--~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
++..+. +.||+|+||+||+|... .++..||+|+++... .+....+++.+|+.+|++|+|||||++++++.. .
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~ 80 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA---E 80 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred HHCEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC---C
T ss_conf 53700187834587829999998169738599999988010--898999999999999986799898527777505---9
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 49999933689998999996488899999999999999999987099990303688786587089992899114404433
Q 004645 100 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 179 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l 179 (740)
.+++||||+++|+|.+++...+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..+
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKAL 157 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEEC
T ss_pred CEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCHHHCCC-CCCCCCCCCHHHHHHC
T ss_conf 77999974788968999752257899999999999999976687479--55677761131023-5675123413453313
Q ss_pred CCCC-----CCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 0476-----64335888878820000-126842110101357999885-3799999999899999998199996344689
Q 004645 180 RKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 180 ~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~ 252 (740)
.... .....||+.|||||++. +.|+.++||||||+++|||+| |+.||.+ .+..++...+..+..+. .+...
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~ 235 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGC 235 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTC
T ss_pred CCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCC
T ss_conf 43234432244567784203916653799984344303403132896589999999-89999999998289999-98656
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHH---HCCCCCC
Q ss_conf 9589999999961-81699999888---4495567
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSAREL---LTDPFLQ 283 (740)
Q Consensus 253 spelr~lI~kCL~-dP~kRpSa~EL---L~hpfl~ 283 (740)
++++++||.+||. +|.+|||+.++ |+|+|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 79999999997588976890989999985288750
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.19 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=217.9
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 86358757752028569999998579909999997505557998899999999999983899982146568562588849
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i 101 (740)
.|| ++.+.||+|+||+||+|.++.++..||+|+++.... ......++.+|+.+|+.++||||+++++.|.+ ...+
T Consensus 2 ~ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~ 76 (292)
T d1unla_ 2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKL 76 (292)
T ss_dssp CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CCC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCE
T ss_conf 997-862697128681999999999996999999803217--86899999999999985675788821354444--4311
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHCC
Q ss_conf 99993368999899999648889999999999999999998709999030368878658708999289911440443304
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 181 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~~ 181 (740)
+++++++.+++|..++..++.+++..++.++.|++.||+|||+++ |+||||||+|||++. .+.+||+|||.+.....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINR-NGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECT-TCCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEEECCCCCCCCCCC-CCCEEEEECCHHHCCCC
T ss_conf 588630233222112123565403678999999999987743399--860014676121133-78266520460110468
Q ss_pred CC--CCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC--CC-----------
Q ss_conf 76--643358888788200001--26842110101357999885379999999989999999819--99-----------
Q 004645 182 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KK----------- 244 (740)
Q Consensus 182 ~~--~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g--~~----------- 244 (740)
.. .....+++.|+|||++.+ .++.++|||||||++|+|++|..||....+..+...++... ..
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 87510010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred --------------CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf --------------963446899589999999961-8169999988844955677
Q 004645 245 --------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 284 (740)
Q Consensus 245 --------------p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~ 284 (740)
........++.+++||.+||. +|.+||||.|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 2113344454431043306568999999999986499668909999964953407
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.87 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=212.7
Q ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 13438998635875775202856999999857990999999750555799889999999999998389998214656856
Q 004645 15 FVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 15 ~~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
-+|++ ..+| ++.+.||+|+||+||+|.++ ++..||+|+++... ...+.+.+|+.+|++++|||||++++++.
T Consensus 7 ~wei~-~~~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 7 EWEVP-RETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TTBCC-GGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CEECC-HHHE-EEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCEEEEEEEEC
T ss_conf 70038-8993-88679810798289999999-99999999986476-----88899999999998679998857873104
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEEC
Q ss_conf 25888499999336899989999964--8889999999999999999998709999030368878658708999289911
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~--k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~D 172 (740)
...+++||||+++|+|.+++... .++++..+..|+.||+.||.|||+++ |+||||||+||||+ +++.+||+|
T Consensus 79 ---~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~D 152 (272)
T d1qpca_ 79 ---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIAD 152 (272)
T ss_dssp ---SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECC
T ss_pred ---CCCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEE-CCCCEEECC
T ss_conf ---597699999578982888875147898878899999999999999997489--54675642251562-024404234
Q ss_pred CCHHHHHCCCC---CCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 44044330476---64335888878820000-126842110101357999885379999999989999999819999634
Q 004645 173 LGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 173 FGlA~~l~~~~---~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~ 248 (740)
||+|..+.... .....||+.|||||++. +.|+.++||||||+++|||+||..|+.......++...+..+..+. .
T Consensus 153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~ 231 (272)
T d1qpca_ 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-R 231 (272)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-C
T ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-C
T ss_conf 101477358864420356774444582898379998245645257999999968988888889999999997068888-9
Q ss_pred CCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC--CCCCC
Q ss_conf 46899589999999961-8169999988844--95567
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRLSARELLT--DPFLQ 283 (740)
Q Consensus 249 ~~~~spelr~lI~kCL~-dP~kRpSa~ELL~--hpfl~ 283 (740)
+...++++++|+.+||. +|.+|||+.++++ ++||.
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 65571999999999758897689399999998611321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.66 Aligned_cols=249 Identities=20% Similarity=0.346 Sum_probs=209.8
Q ss_pred CEEEEEEE-ECCCCCEEEEEEEECC--CCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 63587577-5202856999999857--99099999975055579988999999999999838999821465685625888
Q 004645 23 RYGRYNEI-LGKGASKTVYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 23 rY~rl~e~-LG~GsfGtVyka~d~~--tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
.+ .+.+. ||+|+||+||+|.++. ++..||+|+++.. ......+++.+|+.+|++|+|||||++++++.. +
T Consensus 9 ~~-~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~ 81 (285)
T d1u59a_ 9 NL-LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---E 81 (285)
T ss_dssp GE-EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred CE-EECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---C
T ss_conf 71-8878487306080999999960897689999998820---397899999999999986799888068656036---8
Q ss_pred EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 499999336899989999964-8889999999999999999998709999030368878658708999289911440443
Q 004645 100 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~ 178 (740)
.+|+||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~-~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVN-RHYAKISDFGLSKA 158 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEE-TTEEEECCCTTCEE
T ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEECC-CCCEEECCCHHHHC
T ss_conf 079999807899689975212569999999999999999878998688--105767646604546-88542033134211
Q ss_pred HCCCC-----CCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 30476-----64335888878820000-126842110101357999885-379999999989999999819999634468
Q 004645 179 LRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 179 l~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~~~~~~ 251 (740)
+.... .....||+.|||||++. +.|+.++||||||+++|||+| |+.||.+.. ..++...+..|..+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~~-~p~~ 236 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRME-CPPE 236 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCCC-CCTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC-HHHHHHHHHCCCCCC-CCCC
T ss_conf 55434321135621137433586887279999541232201789999938999999979-999999998189999-9976
Q ss_pred CCHHHHHHHHHHHH-CCCCCCCHHHH---HCCCCCC
Q ss_conf 99589999999961-81699999888---4495567
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSAREL---LTDPFLQ 283 (740)
Q Consensus 252 ~spelr~lI~kCL~-dP~kRpSa~EL---L~hpfl~ 283 (740)
.++++.+||.+||. +|.+|||+.++ |+|+|+.
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 789999999997577976890999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.47 Aligned_cols=252 Identities=19% Similarity=0.326 Sum_probs=214.3
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCC----EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 343899863587577520285699999985799----0999999750555799889999999999998389998214656
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT 91 (740)
Q Consensus 16 ~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg----~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~ 91 (740)
.|++|.. | .+.++||+|+||+||+|..+.++ ..||+|.++.. ........+.+|+.+|++|+|||||++++
T Consensus 2 ~ei~~~~-~-~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 2 TEIHPSC-V-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp CBCCTTT-E-EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCCHHH-E-EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 8578899-6-86159811779099999996899878799999998844---59689999999999998568987832367
Q ss_pred EEEECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEE
Q ss_conf 85625888499999336899989999964-88899999999999999999987099990303688786587089992899
Q 004645 92 SWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 92 ~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI 170 (740)
++.. ...+++|+||+.+++|..++... +.+++..+..|+.||+.||.|||+++ |+||||||+||||+ .++.+||
T Consensus 77 ~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl 151 (283)
T d1mqba_ 77 VISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKV 151 (283)
T ss_dssp EECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEE
T ss_pred EEEC--CCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCEEEEC-CCCEEEE
T ss_conf 7833--88038999721357402221023454208999999999998541212123--42576564427888-9984998
Q ss_pred ECCCHHHHHCCCC-----CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 1144044330476-----643358888788200001-2684211010135799988537999999998999999981999
Q 004645 171 GDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 244 (740)
Q Consensus 171 ~DFGlA~~l~~~~-----~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~ 244 (740)
+|||+++.+.... .....||+.|||||++.+ .|+.++||||||+++|||+++..|+....+..++++.+..+..
T Consensus 152 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~ 231 (283)
T d1mqba_ 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231 (283)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 45510300357876526742677773434888870499997355634489899999679886556899999999863578
Q ss_pred CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 963446899589999999961-8169999988844
Q 004645 245 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 245 p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~ 278 (740)
+. .+...++.+.++|.+||. +|.+||++.++++
T Consensus 232 ~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 LP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC-CCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99-85045799999999977679768939999999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.53 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=210.2
Q ss_pred ECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 38998635875775202856999999857990999999750555799889999999999998389998214656856258
Q 004645 18 VDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 97 (740)
Q Consensus 18 ~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~ 97 (740)
+||. .| ++.+.||+|+||+||+|.+. ++..||+|+++... ...+.+.+|+.++++++||||+++++++..
T Consensus 2 idp~-~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-- 71 (263)
T d1sm2a_ 2 IDPS-EL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-- 71 (263)
T ss_dssp BCCS-CE-EEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CCHH-HC-EEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCCCCCEECC--
T ss_conf 8969-95-88889820888299999988-99999999987886-----768999999999996689975653524315--
Q ss_pred CCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHH
Q ss_conf 88499999336899989999964-88899999999999999999987099990303688786587089992899114404
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 176 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA 176 (740)
...+++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla 148 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMT 148 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC--
T ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCHHHEEECCC-CCEEECCCCHH
T ss_conf 99337999836999189975201347889999999999999877653164--3104431532666688-77686553210
Q ss_pred HHHCCCCC---CCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 43304766---43358888788200001-268421101013579998853799999999899999998199996344689
Q 004645 177 AILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 177 ~~l~~~~~---~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~ 252 (740)
........ ....||+.|||||++.+ .|+.++||||||+++|||+|+..|+....+..++...+..+..+. .+...
T Consensus 149 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~ 227 (263)
T d1sm2a_ 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLA 227 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTS
T ss_pred EECCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCC
T ss_conf 02368873350430017666785786079998403321059999999878988877899999999998068889-95436
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9589999999961-81699999888449
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 253 spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
++++.+|+.+||+ +|.+|||+.++|++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 7999999999765797689199999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.41 Aligned_cols=261 Identities=30% Similarity=0.412 Sum_probs=211.6
Q ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 71343899863587577520285699999985799099999975055579988999999999999838999821465685
Q 004645 14 EFVEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 93 (740)
Q Consensus 14 ~~~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 93 (740)
.++++ ..|| ++.+.||+|+||+||+|+++.+|..||+|+++.. ..+....+++.+|+.+|+.|+||||++++++|
T Consensus 12 ~~~~~--~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 12 TIWEV--PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp SEEEE--ETTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CCCCC--CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 55458--9871-8888983178839999999999979999998820--02868999999999999866898742599999
Q ss_pred EEC---CCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEE
Q ss_conf 625---88849999933689998999996488899999999999999999987099990303688786587089992899
Q 004645 94 VDT---ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 170 (740)
Q Consensus 94 vd~---~~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI 170 (740)
... .....+++++++.+|+|.+++ ..+++++..++.+++||+.||.|||++| |+||||||+|||++ ..|.+|+
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~-~~~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl 162 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKI 162 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEE
T ss_pred EECCCCCCCCEEEEEEEECCCCHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCC-CCCCCCC
T ss_conf 634645668649999962588623200-2245309999999999999999997388--76516677633455-4322001
Q ss_pred ECCCHHHHHCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC--CCC-
Q ss_conf 1144044330476643358888788200001--26842110101357999885379999999989999999819--999-
Q 004645 171 GDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KKP- 245 (740)
Q Consensus 171 ~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g--~~p- 245 (740)
+|||++...... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .......+... ..+
T Consensus 163 ~dfg~a~~~~~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 163 LDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCC----CCTGG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCH
T ss_pred CCCCHHCCCCCC-CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHCCCCCH
T ss_conf 321000125754-4443454355583553377567855124320589999976889978898-89999999973079975
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf --------------------------63446899589999999961-81699999888449556778
Q 004645 246 --------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 246 --------------------------~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~ 285 (740)
.......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 7732001024454443035578755566267899999999999775883459389998559954879
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.66 Aligned_cols=254 Identities=28% Similarity=0.392 Sum_probs=207.9
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----C
Q ss_conf 863587577520285699999985799099999975055579988999999999999838999821465685625----8
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT----A 97 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~----~ 97 (740)
.|| ++.++||+|+||+||+|.++.+|..||+|+++... .+.....++.+|+.+|++++||||++++++|... .
T Consensus 17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf 775-99889621758599999999999899999988233--697999999999999986489876489989702564345
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 88499999336899989999964888999999999999999999870999903036887865870899928991144044
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
...+|+||||+.++.+..+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++. ++.++++|||++.
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~-~~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS-DCTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECT-TCCEEECCCCC--
T ss_pred CCEEEEEEECCCHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCC-CCCEEEECHHHHH
T ss_conf 7626999841446778765---038999999999999999998865221--124567763211365-4431320102321
Q ss_pred HHCCCCC-CCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC---C----------
Q ss_conf 3304766-43358888788200001-2684211010135799988537999999998999999981---9----------
Q 004645 178 ILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS---G---------- 242 (740)
Q Consensus 178 ~l~~~~~-~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~---g---------- 242 (740)
....... ...+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+......+ .++.. +
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHTTSC
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_conf 146665533221465555813314777787743335662578986598998889778899-9999720589879998765
Q ss_pred ---------CCCC-----------CC-------CCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ---------9996-----------34-------46899589999999961-81699999888449556778
Q 004645 243 ---------KKPE-----------AL-------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 285 (740)
Q Consensus 243 ---------~~p~-----------~~-------~~~~spelr~lI~kCL~-dP~kRpSa~ELL~hpfl~~~ 285 (740)
..+. .. ....++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 66777764175435666421264333543210133379999999999876994579089999669420878
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.24 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=215.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE---CCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECC
Q ss_conf 86358757752028569999998---579909999997505557998899999999999983899-98214656856258
Q 004645 22 GRYGRYNEILGKGASKTVYRAFD---EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSWVDTA 97 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d---~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~fvd~~ 97 (740)
.+| ++.+.||+|+||+||+|++ +.+|..||+|+++...........+.+.+|+.+|++++| |||+++++.+.+
T Consensus 24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred HCE-EEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--
T ss_conf 025-99989832878399999987658879489999983677210168999999999999864679839996200024--
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 88499999336899989999964888999999999999999999870999903036887865870899928991144044
Q 004645 98 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
...+++++||+.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCCCCEEECCC-CCEEEEECCCHH
T ss_conf 8730012312341179999873045437888888999999998851499--8965477320124699-988874132022
Q ss_pred HHCCCC---CCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHCCCCCCCC
Q ss_conf 330476---643358888788200001---26842110101357999885379999999---989999999819999634
Q 004645 178 ILRKSH---AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEAL 248 (740)
Q Consensus 178 ~l~~~~---~~~~~GTp~YmAPEvl~~---~ys~~sDIWSLGiiLyELlTG~~Pf~~~~---~~~~i~kki~~g~~p~~~ 248 (740)
...... .....|++.|+|||++.+ .++.++|||||||++|+|+||+.||.+.. ....+.+.......+ +
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~--~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--Y 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--C
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCC--C
T ss_conf 20344443221222333331068760577688713251777799999976899988887777999999833568998--8
Q ss_pred CCCCCHHHHHHHHHHHH-CCCCCC-----CHHHHHCCCCCCCCCC
Q ss_conf 46899589999999961-816999-----9988844955677886
Q 004645 249 FKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 287 (740)
Q Consensus 249 ~~~~spelr~lI~kCL~-dP~kRp-----Sa~ELL~hpfl~~~~~ 287 (740)
+...++++++||.+||. +|.+|+ +|.|+|+||||+..++
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCH
T ss_conf 654799999999997445898819997450999974972348998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.93 Aligned_cols=246 Identities=25% Similarity=0.422 Sum_probs=207.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCE----EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 635875775202856999999857990----9999997505557998899999999999983899982146568562588
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~----~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
.| ++.++||+|+||+||+|.+..+|. .||+|.++.. .+....+.+.+|+.+|++++|||||++++++.+
T Consensus 10 dy-~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--- 82 (317)
T d1xkka_ 10 EF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 82 (317)
T ss_dssp TE-EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred HC-EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---
T ss_conf 99-78319820899299999995899889899999996513---497999999999999986799888158999961---
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 8499999336899989999964-888999999999999999999870999903036887865870899928991144044
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
...+++++++.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|.
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla~ 159 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAK 159 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHHH
T ss_pred CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCHHHCCEECCC-CCEEEECCCCCE
T ss_conf 9836999842687401011133457999999999999999999998769--5047621203116799-875860255222
Q ss_pred HHCCCCC----CCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 3304766----4335888878820000-126842110101357999885-379999999989999999819999634468
Q 004645 178 ILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKV 251 (740)
Q Consensus 178 ~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~~~~~~ 251 (740)
....... ....||+.|||||++. +.|+.++||||||+++|||+| |..||.+ .+..++...+..|..+. .+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~ 237 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPI 237 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTT
T ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCC
T ss_conf 335444532236510586446708874699983565440799999999779999999-99899999997599899-9855
Q ss_pred CCHHHHHHHHHHHH-CCCCCCCHHHHHCCC
Q ss_conf 99589999999961-816999998884495
Q 004645 252 EDPEVRQFIEKCLA-TVSSRLSARELLTDP 280 (740)
Q Consensus 252 ~spelr~lI~kCL~-dP~kRpSa~ELL~hp 280 (740)
.++.+.+++.+||. +|.+|||+.+++.|.
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 689999999984789934691999999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.76 Aligned_cols=246 Identities=22% Similarity=0.382 Sum_probs=209.7
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCC---EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 863587577520285699999985799---09999997505557998899999999999983899982146568562588
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg---~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
.+| ++.+.||+|+||+||+|.+..++ ..||+|.++. .......+.+.+|+.+|++++||||+++++++. .
T Consensus 7 ~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~ 79 (273)
T d1mp8a_ 7 ERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---E 79 (273)
T ss_dssp GGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT---TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---S
T ss_pred HHE-EEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---C
T ss_conf 996-987799307882999999936996449999999365---668799999999999998689999856988995---3
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 8499999336899989999964-888999999999999999999870999903036887865870899928991144044
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
..+++||||+.+|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. .+.+||+|||+|.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~-~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSS-NDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEE-TTEEEECC-----
T ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCHHHEEECC-CCCEEECCCHHHE
T ss_conf 7479999840698077654224789999999999999987752302267--441410265532067-8967876503421
Q ss_pred HHCCCC---CCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 330476---64335888878820000-126842110101357999885-3799999999899999998199996344689
Q 004645 178 ILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 178 ~l~~~~---~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~ 252 (740)
.+.... .....||+.|+|||++. +.|+.++||||||+++|||+| |.+||.+ .+..+++..+..+..+. .+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~ 234 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNC 234 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTC
T ss_pred ECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCC
T ss_conf 33677623305400583103266751699887452444247899998269999888-99999999998189998-98777
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9589999999961-81699999888449
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 253 spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
++.+++||.+||. +|.+|||+.+++++
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999999999768797689299999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.12 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=209.8
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECC-----CCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEE
Q ss_conf 98635875775202856999999857-----99099999975055579988999999999999838-9998214656856
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWV 94 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~-----tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv 94 (740)
..+| ++.+.||+|+||.||+|.+.. ++..||+|+++.. ......+.+..|..++.++ +|+||+.+++.+.
T Consensus 12 ~~~y-~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHE-EEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEEC
T ss_conf 7997-984498416783999999867775557839999998600---171789999999999886149984997411540
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCC
Q ss_conf 258884999993368999899999648----------------8899999999999999999987099990303688786
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 158 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k----------------~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~N 158 (740)
. .+..+++||||+++|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|
T Consensus 88 ~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~N 164 (299)
T d1ywna1 88 K-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARN 164 (299)
T ss_dssp S-TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred C-CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCC
T ss_conf 4-797579999845899299999853666665322202332146899999999999999999887379--7178677310
Q ss_pred EEEECCCCCEEEECCCHHHHHCCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCH
Q ss_conf 5870899928991144044330476----643358888788200001-268421101013579998853-7999999998
Q 004645 159 IFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHP 232 (740)
Q Consensus 159 ILId~n~G~VKI~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG-~~Pf~~~~~~ 232 (740)
||++ .++.+||+|||+|+...... .....||+.|||||++.+ .|+.++|||||||++|||+|+ ..||.+....
T Consensus 165 ILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 165 ILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EEEC-CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 6577-998289845752001135665222475166721020368646889966322136789999986889999899989
Q ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 999999981999963446899589999999961-81699999888449
Q 004645 233 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 233 ~~i~kki~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
..+...+..+..+. .+...+++++++|.+||. +|.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999996389888-886578999999999767796679199999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.06 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=211.4
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 89986358757752028569999998579909999997505557998899999999999983899982146568562588
Q 004645 19 DPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 19 dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
|| ..| ++.+.||+|+||+||+|..+ ++..||+|+++.... . .+.+.+|+.++++++||||++++++|.+ .
T Consensus 2 ~~-~~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~ 71 (258)
T d1k2pa_ 2 DP-KDL-TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--Q 71 (258)
T ss_dssp CC-CCC-CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--C---HHHHHHHHHHHHTCCCTTBCCEEEEECC--S
T ss_pred CH-HHC-EEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC--C---HHHHHHHHHHHHHCCCCCEEEEEEEEEE--C
T ss_conf 96-997-99689820788399999988-998999999874757--7---8999999999996689860158899850--7
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 8499999336899989999964-888999999999999999999870999903036887865870899928991144044
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
..+++||||+.+|+|..++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSR 148 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCC
T ss_pred CCEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCEEEEEC-CCCCEEECCCHHHE
T ss_conf 8169999704899388864102467768999999999999999875468--43466541358876-99847988614420
Q ss_pred HHCCCCC---CCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 3304766---4335888878820000-126842110101357999885-3799999999899999998199996344689
Q 004645 178 ILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 252 (740)
Q Consensus 178 ~l~~~~~---~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~ 252 (740)
....... ....||+.|+|||++. +.|+.++||||||+++|||+| |+.||.+. +..++...+..+..+. .+...
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~ 226 (258)
T d1k2pa_ 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRLY-RPHLA 226 (258)
T ss_dssp BCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCCC-CCTTC
T ss_pred ECCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCC-CHHHHHHHHHHCCCCC-CCCCC
T ss_conf 235787225246578877578078637998852103364324673975599998899-9999999998079789-96546
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9589999999961-81699999888449
Q 004645 253 DPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 253 spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
++++++||.+||+ +|.+|||+.++|+|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 5999999999766897689399999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.34 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=211.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECCCCEE--EEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCC
Q ss_conf 86358757752028569999998579909--9999975055579988999999999999838-99982146568562588
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEYEGIE--VAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~tg~~--VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fvd~~~ 98 (740)
..| ++.++||+|+||+||+|+++.+|.. ||+|.++.. ...+..+.+.+|+.+|+++ +||||++++++|.+ +
T Consensus 10 ~~~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~ 83 (309)
T d1fvra_ 10 NDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 83 (309)
T ss_dssp GGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred HHC-EEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--C
T ss_conf 996-887798207882899999989996999999997823---3857999999999999862289988367888841--8
Q ss_pred CEEEEEEECCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEE
Q ss_conf 8499999336899989999964----------------888999999999999999999870999903036887865870
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 162 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~----------------k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId 162 (740)
..+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCCCCCCCEEEEC
T ss_conf 7369999802898699998640355555123101234578999999999999999987663089--54555052048986
Q ss_pred CCCCCEEEECCCHHHHHCCCCC-CCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHH
Q ss_conf 8999289911440443304766-4335888878820000-12684211010135799988537-9999999989999999
Q 004645 163 GNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQIYKKV 239 (740)
Q Consensus 163 ~n~G~VKI~DFGlA~~l~~~~~-~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlTG~-~Pf~~~~~~~~i~kki 239 (740)
.+ +.+||+|||++........ ....||+.|+|||.+. +.|+.++||||||+++|||++|. +||.+ .+..+++..+
T Consensus 162 ~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i 239 (309)
T d1fvra_ 162 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 239 (309)
T ss_dssp GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHG
T ss_pred CC-CCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCC-CCHHHHHHHH
T ss_conf 88-763874344322444223455301377555538752699996221531388999998368999999-9999999999
Q ss_pred HCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 81999963446899589999999961-81699999888449
Q 004645 240 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 240 ~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
..+..+. .+...++++++||.+||. +|.+|||+.+++++
T Consensus 240 ~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 8268888-876678999999999767896689499999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=343.55 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=212.6
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 99863587577520285699999985-----7990999999750555799889999999999998389998214656856
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 94 (740)
Q Consensus 20 p~grY~rl~e~LG~GsfGtVyka~d~-----~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 94 (740)
|..+| .+.+.||+|+||+||+|+.+ .++..||+|+++.. ...+..+++.+|+.+|++++||||+++++.|.
T Consensus 11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHC-EEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 98893-886798207883999999888765778829999998821---08579999999999999668997655246660
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEE
Q ss_conf 258884999993368999899999648------------------------88999999999999999999870999903
Q 004645 95 DTANRNINFVTEMFTSGTLRQYRLKHR------------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 150 (740)
Q Consensus 95 d~~~~~i~lV~Ey~~gGSL~~~l~~~k------------------------~l~~~~i~~i~~QIL~gL~yLHs~gp~II 150 (740)
. ....++++||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+
T Consensus 87 ~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 87 V--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred C--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--EE
T ss_conf 5--9803899981589929999985275542100001110012103467889899999999999999855413578--68
Q ss_pred ECCCCCCCEEEECCCCCEEEECCCHHHHHCCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCC-C
Q ss_conf 036887865870899928991144044330476----643358888788200001-2684211010135799988537-9
Q 004645 151 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFD-Y 224 (740)
Q Consensus 151 HrDLKp~NILId~n~G~VKI~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~-~ 224 (740)
||||||+|||++.+ +.+||+|||+|..+.... .....|++.|+|||++.+ .|+.++||||||+++|||+++. .
T Consensus 163 HrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEECCCCEEECCC-CCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 54884011689899-92898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 99999998999999981999963446899589999999961-8169999988844
Q 004645 225 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 225 Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~ 278 (740)
||.+ .+..++...+..+..+. .+...++++.++|.+||. +|.+|||+.++++
T Consensus 242 p~~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999-89999999997399788-87325299999999974889657939999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.67 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=213.5
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 34389986358757752028569999998579909999997505557998899999999999983899982146568562
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 95 (740)
Q Consensus 16 ~e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd 95 (740)
+|+++ .+| ++.+.||+|+||+||+|+++.+ ..||+|+++... .. .+.+.+|+.+|++++|||||++|+++.+
T Consensus 12 ~~i~~-~~~-~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~--~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 12 WEIPR-ESL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT--MS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp SBCCG-GGE-EEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS--SC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EECCH-HHE-EEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCC--CC---HHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 07477-997-9846993079809999999999-999999988044--88---8999999999986666788689999823
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECC
Q ss_conf 588849999933689998999996--488899999999999999999987099990303688786587089992899114
Q 004645 96 TANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 173 (740)
Q Consensus 96 ~~~~~i~lV~Ey~~gGSL~~~l~~--~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DF 173 (740)
..+++||||+.+|+|..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+||
T Consensus 84 ---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~-~~~~kl~Df 157 (285)
T d1fmka3 84 ---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE-NLVCKVADF 157 (285)
T ss_dssp ---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG-GGCEEECCC
T ss_pred ---CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH--EECCCCCCEEEEECC-CCCEEECCC
T ss_conf ---97599999447994354200003553059999999999999999875411--433531230799989-992998442
Q ss_pred CHHHHHCCCC---CCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 4044330476---64335888878820000-1268421101013579998853799999999899999998199996344
Q 004645 174 GLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 249 (740)
Q Consensus 174 GlA~~l~~~~---~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p~~~~ 249 (740)
|+|....... .....||+.|+|||++. +.++.++||||||+++|||+||..||.......++...+..+..+. ..
T Consensus 158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~ 236 (285)
T d1fmka3 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CP 236 (285)
T ss_dssp CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CC
T ss_pred CHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CC
T ss_conf 55542568873352454556654580898379989177413235899999868999998888999999998268999-98
Q ss_pred CCCCHHHHHHHHHHHH-CCCCCCCHHHHHC--CCCCCC
Q ss_conf 6899589999999961-8169999988844--955677
Q 004645 250 KVEDPEVRQFIEKCLA-TVSSRLSARELLT--DPFLQI 284 (740)
Q Consensus 250 ~~~spelr~lI~kCL~-dP~kRpSa~ELL~--hpfl~~ 284 (740)
...++++++||.+||. +|.+||++.+++. ++||..
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 32379999999997566975891999999987666238
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.83 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=213.6
Q ss_pred EECCCCCEEEEEEEECCCCCEEEEEEEECCCC---EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 43899863587577520285699999985799---099999975055579988999999999999838999821465685
Q 004645 17 EVDPTGRYGRYNEILGKGASKTVYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 93 (740)
Q Consensus 17 e~dp~grY~rl~e~LG~GsfGtVyka~d~~tg---~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 93 (740)
.+.+......+.++||+|+||+||+|.+..++ ..||+|.++. ..+....+++.+|+.+|++|+||||+++++++
T Consensus 21 ~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 97 (311)
T d1r0pa_ 21 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 97 (311)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred EECHHHCEECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 768688155266698136880999999977998799999999884---36978999999999999867899986786789
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEEC
Q ss_conf 625888499999336899989999964-8889999999999999999998709999030368878658708999289911
Q 004645 94 VDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 172 (740)
Q Consensus 94 vd~~~~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~D 172 (740)
... +..+++||||+.+|+|.+++... ..++...+..++.|++.||.|||+.+ |+||||||+|||++. .+.+||+|
T Consensus 98 ~~~-~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~-~~~~kL~D 173 (311)
T d1r0pa_ 98 LRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDE-KFTVKVAD 173 (311)
T ss_dssp EET-TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT-TCCEEECS
T ss_pred EEC-CCCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCCCCCHHHEEECC-CCCEEEEC
T ss_conf 806-99438999874067414421013454048999999999887652003367--625776687576779-99889910
Q ss_pred CCHHHHHCCCC------CCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 44044330476------64335888878820000-126842110101357999885379999999989999999819999
Q 004645 173 LGLAAILRKSH------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 245 (740)
Q Consensus 173 FGlA~~l~~~~------~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~kki~~g~~p 245 (740)
||++....... .....||+.|+|||++. +.++.++||||||+++|||+||..||....+..++...+..|..+
T Consensus 174 FG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~ 253 (311)
T d1r0pa_ 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 253 (311)
T ss_dssp SGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC
T ss_pred CCCHHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 65232255665553100256555645567688743799974574661999999997899998889999999999808988
Q ss_pred CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 63446899589999999961-81699999888449
Q 004645 246 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 246 ~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
. .+...++.+.+||.+||. +|.+||++.+++++
T Consensus 254 ~-~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 L-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9-964475999999999768897689399999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.26 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=212.0
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCC-------EEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 99863587577520285699999985799-------099999975055579988999999999999838-9998214656
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEG-------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYT 91 (740)
Q Consensus 20 p~grY~rl~e~LG~GsfGtVyka~d~~tg-------~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L-~HpNIVkl~~ 91 (740)
|..+| .+++.||+|+||.||+|++..++ ..||+|+++.. ........+..|...+.++ +||||+++++
T Consensus 11 ~~~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 11 PRDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp CGGGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHHHE-EEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHHHHCCCCEEEECCC
T ss_conf 58996-97009851678289999985787555667549999998811---286889999999999998139996973465
Q ss_pred EEEECCCCEEEEEEECCCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCC
Q ss_conf 856258884999993368999899999648----------------8899999999999999999987099990303688
Q 004645 92 SWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 155 (740)
Q Consensus 92 ~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k----------------~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLK 155 (740)
+|.+ +..+++||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+|||||
T Consensus 87 ~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiK 162 (299)
T d1fgka_ 87 ACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 162 (299)
T ss_dssp EECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred CCCC--CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEEC
T ss_conf 2201--88689999736999099999860677643222334574346799999999999999998766379--7863022
Q ss_pred CCCEEEECCCCCEEEECCCHHHHHCCCC----CCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 7865870899928991144044330476----64335888878820000-126842110101357999885-37999999
Q 004645 156 CDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSEC 229 (740)
Q Consensus 156 p~NILId~n~G~VKI~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~ 229 (740)
|+|||++ .++.+||+|||++....... .....|++.|+|||++. +.|+.++||||||+++|+|++ |..||.+
T Consensus 163 p~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~- 240 (299)
T d1fgka_ 163 ARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG- 240 (299)
T ss_dssp GGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred CCCEEEC-CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_conf 1022454-78976762211101135555543146678884663266751798882555477588888740179898999-
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 998999999981999963446899589999999961-8169999988844
Q 004645 230 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 230 ~~~~~i~kki~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~ 278 (740)
.+..+++..+..+..+. .+...++.+++||.+||+ +|.+|||+.++|+
T Consensus 241 ~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999999997288889-87435299999999976679767939999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.18 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=206.5
Q ss_pred CCEEEEEEEECCCCCEEEEEEEECC-C--CEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 8635875775202856999999857-9--909999997505557998899999999999983899982146568562588
Q 004645 22 GRYGRYNEILGKGASKTVYRAFDEY-E--GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 98 (740)
Q Consensus 22 grY~rl~e~LG~GsfGtVyka~d~~-t--g~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~ 98 (740)
..| ++.+.||+|+||.||+|.... + ...||+|+++.... ...+..+++.+|+.+|++++||||+++|+++.+
T Consensus 8 ~d~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--- 82 (273)
T d1u46a_ 8 KDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--- 82 (273)
T ss_dssp GGE-EEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHE-EEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---
T ss_conf 891-997898038883999999988999079999999983555-798999999999999986899998789877740---
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 8499999336899989999964-888999999999999999999870999903036887865870899928991144044
Q 004645 99 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 99 ~~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
..+++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~ 159 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMR 159 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCE
T ss_pred CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECHHHHCCCCC-CCEEECCCHHHH
T ss_conf 1001146542386125444212689999999999999999998752178--7520566888156556-543325611555
Q ss_pred HHCCCCC-----CCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 3304766-----43358888788200001-26842110101357999885-37999999998999999981999963446
Q 004645 178 ILRKSHA-----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 250 (740)
Q Consensus 178 ~l~~~~~-----~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~~~~~ 250 (740)
....... ....|++.|+|||++.+ .|+.++||||||+++|||+| |..||.+ .+..++...+...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPE 238 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCT
T ss_pred HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCCCCCC
T ss_conf 3035887526547632573107999983799994215661489999999689999999-699999999984799999854
Q ss_pred CCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 899589999999961-8169999988844
Q 004645 251 VEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 251 ~~spelr~lI~kCL~-dP~kRpSa~ELL~ 278 (740)
..++.++++|.+||. +|.+|||+.++++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 45399999999976889667929999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.40 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=211.2
Q ss_pred EECCCCCEEEEEEEECCCCCEEEEEEEE-----CCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 4389986358757752028569999998-----5799099999975055579988999999999999838-999821465
Q 004645 17 EVDPTGRYGRYNEILGKGASKTVYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFY 90 (740)
Q Consensus 17 e~dp~grY~rl~e~LG~GsfGtVyka~d-----~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L-~HpNIVkl~ 90 (740)
|++ ..+| .+++.||+|+||.||+|.. ..++..||+|+++... .......+.+|+.+++.+ +|||||+++
T Consensus 19 ~~~-~~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 19 EFP-RNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp BCC-GGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCC-HHHE-EEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 377-8996-9854982068829999998066447788699999987424---8779999999999987626999887899
Q ss_pred EEEEECCCCEEEEEEECCCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEC
Q ss_conf 6856258884999993368999899999648------------------8899999999999999999987099990303
Q 004645 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 152 (740)
Q Consensus 91 ~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k------------------~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHr 152 (740)
+++.+ ...+++||||+++|+|.+++.+.. .+++..++.|+.||+.||.|||+++ ++||
T Consensus 94 g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHr 169 (311)
T d1t46a_ 94 GACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHR 169 (311)
T ss_dssp EEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEEEE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEC
T ss_conf 89831--9978999973799879999985356654444453322233458899999999999999999887579--2666
Q ss_pred CCCCCCEEEECCCCCEEEECCCHHHHHCCCCC----CCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCC
Q ss_conf 68878658708999289911440443304766----4335888878820000-126842110101357999885-37999
Q 004645 153 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPY 226 (740)
Q Consensus 153 DLKp~NILId~n~G~VKI~DFGlA~~l~~~~~----~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf 226 (740)
||||+|||++. .+.+||+|||++........ ...+||+.|+|||++. +.++.++||||||+++|||+| |.+||
T Consensus 170 DLKp~NIl~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 170 DLAARNILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp CCSGGGEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCCCCCCCCC-CCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 24102100002-57521023401023367886158620135968767788617999974001025899999985899887
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 999998999999981999963446899589999999961-8169999988844
Q 004645 227 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 227 ~~~~~~~~i~kki~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~ 278 (740)
........+.+.+..+..+. .....++.+.+||.+||. +|.+|||+.++|+
T Consensus 249 ~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 249 PGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 78998999999986689889-85436599999999975779657929999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.63 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=212.4
Q ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 343899863587577520285699999985-----799099999975055579988999999999999838999821465
Q 004645 16 VEVDPTGRYGRYNEILGKGASKTVYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 90 (740)
Q Consensus 16 ~e~dp~grY~rl~e~LG~GsfGtVyka~d~-----~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~ 90 (740)
+|+++ .+| .+.+.||+|+||+||+|.+. .++..||+|+++.. ........+.+|+.++++++||||++++
T Consensus 15 ~ei~~-~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 15 WEVAR-EKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TBCCG-GGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred EEECH-HHE-EEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 04268-991-883598207881899999878644778968999998701---2868999999999999976999884125
Q ss_pred EEEEECCCCEEEEEEECCCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEE
Q ss_conf 685625888499999336899989999964----------8889999999999999999998709999030368878658
Q 004645 91 TSWVDTANRNINFVTEMFTSGTLRQYRLKH----------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 160 (740)
Q Consensus 91 ~~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~----------k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NIL 160 (740)
+.+.. ...+++|+||+.+|+|.+++... ..++...+..++.|++.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiL 165 (308)
T d1p4oa_ 90 GVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCM 165 (308)
T ss_dssp EEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEE
T ss_pred EEEEC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECEECCCCEE
T ss_conf 47842--88106777604899889998750332113444688799999999999999999876479--654328677540
Q ss_pred EECCCCCEEEECCCHHHHHCCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCHHH
Q ss_conf 70899928991144044330476----643358888788200001-2684211010135799988537-99999999899
Q 004645 161 VNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQ 234 (740)
Q Consensus 161 Id~n~G~VKI~DFGlA~~l~~~~----~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~-~Pf~~~~~~~~ 234 (740)
++. ++.+||+|||+|..+.... .....||+.|+|||.+.+ .|+.++||||||+++|||+||. .||.+ .+..+
T Consensus 166 ld~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~ 243 (308)
T d1p4oa_ 166 VAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQ 243 (308)
T ss_dssp ECT-TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHH
T ss_pred ECC-CCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-CCHHH
T ss_conf 359-9649994245420235776303134023163237888873699883334443789999999689999999-89999
Q ss_pred HHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 9999981999963446899589999999961-8169999988844
Q 004645 235 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 278 (740)
Q Consensus 235 i~kki~~g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL~ 278 (740)
++..+..+..+. .....++.+.++|.+||+ +|.+|||+.++++
T Consensus 244 ~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 244 VLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 999998088888-86335399999999975779658939999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.62 Aligned_cols=241 Identities=21% Similarity=0.337 Sum_probs=207.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 63587577520285699999985799099999975055579988999999999999838999821465685625888499
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~~i~ 102 (740)
.| ++.+.||+|+||.||+|.. .|..||+|+++.. ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 8 ~~-~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~ 77 (262)
T d1byga_ 8 EL-KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 77 (262)
T ss_dssp GE-EEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred HE-EEEEEEECCCCEEEEEEEE--CCEEEEEEEECCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEE
T ss_conf 94-8857982079808999999--9909999998857------7799999999999867898985498788723-89289
Q ss_pred EEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEECCCHHHHHC
Q ss_conf 999336899989999964--888999999999999999999870999903036887865870899928991144044330
Q 004645 103 FVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 180 (740)
Q Consensus 103 lV~Ey~~gGSL~~~l~~~--k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~~l~ 180 (740)
+||||+++|+|.+++.+. ..+++..+..|+.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSE-DNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT-TSCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC--EECCCCCHHHHEECC-CCCEEECCCCCCEECC
T ss_conf 9996369998999987457888899999999999985232113376--553666567601468-9977632456003447
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 47664335888878820000-126842110101357999885-3799999999899999998199996344689958999
Q 004645 181 KSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 258 (740)
Q Consensus 181 ~~~~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyELlT-G~~Pf~~~~~~~~i~kki~~g~~p~~~~~~~spelr~ 258 (740)
.. .....+++.|+|||++. +.|+.++||||||+++|||+| |..||.. .+..++...+..+..+. .+...++++++
T Consensus 155 ~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 231 (262)
T d1byga_ 155 ST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYE 231 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHH
T ss_pred CC-CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHH
T ss_conf 87-76556664677817872798885887775799999999789999999-99999999998089999-97657999999
Q ss_pred HHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9999961-81699999888449
Q 004645 259 FIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 259 lI~kCL~-dP~kRpSa~ELL~h 279 (740)
||.+||. +|.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999756697689399999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=327.89 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=198.1
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 99863587577520285699999985799099999975055579988999999999999838999821465685625888
Q 004645 20 PTGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 99 (740)
Q Consensus 20 p~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~~ 99 (740)
..+|| ++.+.||+|+||.||+|++..+|..||+|++...... ..+..|+++++.++|++++..+..+.. ...
T Consensus 5 vg~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~ 76 (299)
T d1ckia_ 5 VGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGA-EGD 76 (299)
T ss_dssp ETTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEE-ETT
T ss_pred ECCEE-EEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC------HHHHHHHHHHHHCCCCCCCCEEEEEEE-CCC
T ss_conf 88889-9968985078809999999889989999997210058------889999999997038996017999995-198
Q ss_pred EEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEEC--CCCCEEEECCCHH
Q ss_conf 49999933689998999996-48889999999999999999998709999030368878658708--9992899114404
Q 004645 100 NINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLA 176 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~-~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~--n~G~VKI~DFGlA 176 (740)
..++||||+ +++|...+.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||++. ....++|+|||+|
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHCCCCCCCCCCEEEEECCCCC
T ss_conf 778999873-87133324430688768999999999999999999799--442667876606433577761565046751
Q ss_pred HHHCCCC---------CCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHC---
Q ss_conf 4330476---------643358888788200001-268421101013579998853799999999899999--9981---
Q 004645 177 AILRKSH---------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVIS--- 241 (740)
Q Consensus 177 ~~l~~~~---------~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~~~i~k--ki~~--- 241 (740)
..+.... ....+||+.|||||++.+ .|+.++||||||+++|+|+||..||........... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred EECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 34255445541000135776787353299999189989832188617789999849876655305779999998523567
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHH---HCCCCC
Q ss_conf 999963446899589999999961-81699999888---449556
Q 004645 242 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAREL---LTDPFL 282 (740)
Q Consensus 242 g~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~EL---L~hpfl 282 (740)
...+.......++++.+|+.+||. +|.+||++.++ |+|+|.
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 898357534788999999999843995579199999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=315.21 Aligned_cols=245 Identities=16% Similarity=0.212 Sum_probs=200.7
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCC
Q ss_conf 986358757752028569999998579909999997505557998899999999999983899-9821465685625888
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSWVDTANR 99 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~fvd~~~~ 99 (740)
.++| ++.+.||+|+||+||+|++..+|..||+|+++.... ...+..|++.++.|.| ++++.++.++.. ..
T Consensus 4 g~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~ 74 (293)
T d1csna_ 4 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GL 74 (293)
T ss_dssp TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TT
T ss_pred CCCE-EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC------CHHHHHHHHHHHHHCCCCCCCEEEEEEEC--CC
T ss_conf 9806-997998417882999999988997999999750258------29999999999996489998779999601--88
Q ss_pred EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEEC----CCCCEEEECCC
Q ss_conf 499999336899989999964-8889999999999999999998709999030368878658708----99928991144
Q 004645 100 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG----NQGEVKIGDLG 174 (740)
Q Consensus 100 ~i~lV~Ey~~gGSL~~~l~~~-k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~----n~G~VKI~DFG 174 (740)
..++||||+ +++|.+++... +.++...+..++.|++.||.|||++| |+||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CCEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEECCCCCCCCCCEEECCCC
T ss_conf 117999964-88879999752031106899999999999999999779--662667713152347543447956872366
Q ss_pred HHHHHCCC---------CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHCC
Q ss_conf 04433047---------6643358888788200001-26842110101357999885379999999--989999999819
Q 004645 175 LAAILRKS---------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISG 242 (740)
Q Consensus 175 lA~~l~~~---------~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~--~~~~i~kki~~g 242 (740)
+|...... .....+||+.|||||++.+ .|+.++||||||+++|+|+||..||.+.. .....++.+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred EEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHC
T ss_conf 05771467665411102467627751026798964888886999898319999998698767885302199999999705
Q ss_pred ---CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHH
Q ss_conf ---99963446899589999999961-816999998884
Q 004645 243 ---KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 277 (740)
Q Consensus 243 ---~~p~~~~~~~spelr~lI~kCL~-dP~kRpSa~ELL 277 (740)
..+..+....++++.+++..|+. +|.+||+...+.
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 679995896579989999999998439930085999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.14 Aligned_cols=247 Identities=26% Similarity=0.319 Sum_probs=189.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--CE
Q ss_conf 6358757752028569999998579909999997505557998899999999999983899982146568562588--84
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--RN 100 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fvd~~~--~~ 100 (740)
+| .+.+.||+|+||+||+|.. +|..||+|+++... ........|+..++.++||||+++++++.+... ..
T Consensus 4 ~~-~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 4 TI-VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GE-EEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred EE-EEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC-----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
T ss_conf 89-9988982078819999999--99899999987200-----4679999999999627998683268899837986048
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC------CCCEEECCCCCCCEEEECCCCCEEEECCC
Q ss_conf 999993368999899999648889999999999999999998709------99903036887865870899928991144
Q 004645 101 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR------DPPVIHRDLKCDNIFVNGNQGEVKIGDLG 174 (740)
Q Consensus 101 i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~------gp~IIHrDLKp~NILId~n~G~VKI~DFG 174 (740)
+++||||+.+|+|..++.+. .+++..+..++.|++.||.|||+. ..+|+||||||+||||+ .++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFG 153 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEEC-CCCCEEEEECC
T ss_conf 99999646698989998658-99989999999999999999887665204689866153173135786-88776887638
Q ss_pred HHHHHCCCC------CCCCCCCCCCCCCCCCCCC-------CCCCCCHHHHHHHHHHHHHCCCCCCCC------------
Q ss_conf 044330476------6433588887882000012-------684211010135799988537999999------------
Q 004645 175 LAAILRKSH------AARCVGTPEFMAPEVYEEE-------YNELVDIYSFGMCILEMVTFDYPYSEC------------ 229 (740)
Q Consensus 175 lA~~l~~~~------~~~~~GTp~YmAPEvl~~~-------ys~~sDIWSLGiiLyELlTG~~Pf~~~------------ 229 (740)
++....... ....+||+.|||||++.+. ++.++||||||+++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 66234677762001355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred --CCHHHHHHHHHCCCCCCCCCCC-----CCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf --9989999999819999634468-----99589999999961-81699999888449
Q 004645 230 --THPAQIYKKVISGKKPEALFKV-----EDPEVRQFIEKCLA-TVSSRLSARELLTD 279 (740)
Q Consensus 230 --~~~~~i~kki~~g~~p~~~~~~-----~spelr~lI~kCL~-dP~kRpSa~ELL~h 279 (740)
.....+...+..+.....+... ....+.+++.+||+ +|.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 6430999999875024688877655776899999999999760698589599999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=316.36 Aligned_cols=256 Identities=26% Similarity=0.353 Sum_probs=197.4
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CCCCCEE
Q ss_conf 98635875775202856999999857990999999750555799889999999999998389-----------9982146
Q 004645 21 TGRYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-----------HRNIMKF 89 (740)
Q Consensus 21 ~grY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~-----------HpNIVkl 89 (740)
.||| ++.++||+|+||+||+|+++.+|..||+|+++. .....+.+.+|+.+++.++ |+||+++
T Consensus 12 ~~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~-----~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 12 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCCE-EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEC-----CCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEE
T ss_conf 7857-998997507781899999999997999999834-----3133689999999999840145555542276764789
Q ss_pred EEEEEECCCCEEEEEEECCCCCCHH-HHHH--HCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEECCCCCCCEEEECCC
Q ss_conf 5685625888499999336899989-9999--64888999999999999999999870-999903036887865870899
Q 004645 90 YTSWVDTANRNINFVTEMFTSGTLR-QYRL--KHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 165 (740)
Q Consensus 90 ~~~fvd~~~~~i~lV~Ey~~gGSL~-~~l~--~~k~l~~~~i~~i~~QIL~gL~yLHs-~gp~IIHrDLKp~NILId~n~ 165 (740)
++++........+++++++..+... .+.. ....+++..++.+++||+.||.|||+ ++ |+||||||+|||++.+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred EEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEECCC
T ss_conf 9876312565202343200035420000012234678689999999999999888764058--64656770570563057
Q ss_pred C-----CEEEECCCHHHHHCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCH------H
Q ss_conf 9-----28991144044330476643358888788200001-2684211010135799988537999999998------9
Q 004645 166 G-----EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP------A 233 (740)
Q Consensus 166 G-----~VKI~DFGlA~~l~~~~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyELlTG~~Pf~~~~~~------~ 233 (740)
. .++++|||.+...... ....+||+.|+|||++.+ .|+.++||||+|+++++|++|+.||...... .
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CCCCCCEEEEEECCCCCCCCCC-CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 6564430567531442123445-422366521057132146677764320123789999987889989875543210268
Q ss_pred HHHHHH-HCCCCCC--------------------------------------CCCCCCCHHHHHHHHHHHH-CCCCCCCH
Q ss_conf 999999-8199996--------------------------------------3446899589999999961-81699999
Q 004645 234 QIYKKV-ISGKKPE--------------------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSA 273 (740)
Q Consensus 234 ~i~kki-~~g~~p~--------------------------------------~~~~~~spelr~lI~kCL~-dP~kRpSa 273 (740)
.+...+ ..|..+. ......++.+++||.+||. +|.+||||
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 99999998379987886245322000132012202432357764442100015674358999999999877994579089
Q ss_pred HHHHCCCCCCCC
Q ss_conf 888449556778
Q 004645 274 RELLTDPFLQID 285 (740)
Q Consensus 274 ~ELL~hpfl~~~ 285 (740)
.|+|+||||+..
T Consensus 323 ~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHHCCCCCCCC
T ss_conf 999669340789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.1e-24 Score=170.43 Aligned_cols=172 Identities=17% Similarity=0.167 Sum_probs=123.2
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCC----C----------CHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 8757752028569999998579909999997505557----9----------9889999999999998389998214656
Q 004645 26 RYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFL----Q----------SPEELERLYCEIHLLKTLKHRNIMKFYT 91 (740)
Q Consensus 26 rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~----~----------s~~~~~~l~~Ei~iLk~L~HpNIVkl~~ 91 (740)
-++++||+|+||+||+|.+. +|..||+|+++..... . ..........|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 22778024856599999979-99999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCCEEEECCCCCEEEE
Q ss_conf 85625888499999336899989999964888999999999999999999870999903036887865870899928991
Q 004645 92 SWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 171 (740)
Q Consensus 92 ~fvd~~~~~i~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp~IIHrDLKp~NILId~n~G~VKI~ 171 (740)
.. . .+++|||+.+..+.. ++...+..++.|++.+|.|||+++ |+||||||+|||++ + +.++|+
T Consensus 82 ~~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~li 144 (191)
T d1zara2 82 WE--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWII 144 (191)
T ss_dssp EE--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEEC
T ss_pred EC--C----CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHEEEE-C-CCEEEE
T ss_conf 62--8----889999504565420-------015789999999999999982688--89836890361142-8-989998
Q ss_pred CCCHHHHHCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 144044330476643358-888788200001268421101013579
Q 004645 172 DLGLAAILRKSHAARCVG-TPEFMAPEVYEEEYNELVDIYSFGMCI 216 (740)
Q Consensus 172 DFGlA~~l~~~~~~~~~G-Tp~YmAPEvl~~~ys~~sDIWSLGiiL 216 (740)
|||+|.....+....... ... .-.+.+...|+..+|+||+.--+
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCCCCCCCCCCHHHHHHHHH-HHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 7788430899870999987799-99999757899844689999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=1.2e-06 Score=57.04 Aligned_cols=141 Identities=16% Similarity=0.042 Sum_probs=85.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCCEE
Q ss_conf 635875775202856999999857990999999750555799889999999999998389-9982146568562588849
Q 004645 23 RYGRYNEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 23 rY~rl~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~~~~i 101 (740)
.| +..+..+.++...||+.. ..+..+.+|........ ....+..|..++..|. +--+.+++... ......
T Consensus 15 ~~-~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~~~ 85 (263)
T d1j7la_ 15 KY-RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWS 85 (263)
T ss_dssp TS-EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEE
T ss_pred CE-EEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCCC----CHHHHHHHHHHHHHHHCCCCCCCEEEEE--ECCCCE
T ss_conf 52-799767899877189999--08986999984887653----2556999999999876069987289997--508964
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCC----------------------------------
Q ss_conf 9999336899989999964888999999999999999999870999----------------------------------
Q 004645 102 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP---------------------------------- 147 (740)
Q Consensus 102 ~lV~Ey~~gGSL~~~l~~~k~l~~~~i~~i~~QIL~gL~yLHs~gp---------------------------------- 147 (740)
++||++++|.++....... .....++.++...|..||+..+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEECCCCCCCCCCCCC-----CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 9999860433435433440-----26999999899999998556842143576446565557789987765555430332
Q ss_pred -----------------------CEEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf -----------------------9030368878658708999289911440443
Q 004645 148 -----------------------PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 148 -----------------------~IIHrDLKp~NILId~n~G~VKI~DFGlA~~ 178 (740)
.++|+|+.|.|||++ +.+.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEEC-CCCEEEEEECHHCCC
T ss_conf 32005799999999844986781789860047642364-996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.42 E-value=1.4e-06 Score=56.59 Aligned_cols=82 Identities=18% Similarity=0.216 Sum_probs=52.2
Q ss_pred EEEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCC---CHHHHHHHHHHHHHHHHC-CC--CCCCEEEEEEEECCCCEE
Q ss_conf 577520285699999985799099999975055579---988999999999999838-99--982146568562588849
Q 004645 28 NEILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQ---SPEELERLYCEIHLLKTL-KH--RNIMKFYTSWVDTANRNI 101 (740)
Q Consensus 28 ~e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~---s~~~~~~l~~Ei~iLk~L-~H--pNIVkl~~~fvd~~~~~i 101 (740)
.+.||.|....||++.+...+..+++|+-...-... -+....+...|...|+.+ .+ ..++++|. .+. ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDT--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EET--TTT
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECC--CCC
T ss_conf 9980798527689999579984899961771303467778887789999999999865057988552899--859--887
Q ss_pred EEEEECCCCCCH
Q ss_conf 999933689998
Q 004645 102 NFVTEMFTSGTL 113 (740)
Q Consensus 102 ~lV~Ey~~gGSL 113 (740)
++|||++.+..+
T Consensus 107 ~lvmE~L~~~~~ 118 (392)
T d2pula1 107 VTVMEDLSHLKI 118 (392)
T ss_dssp EEEECCCTTSEE
T ss_pred EEEEECCCCCCC
T ss_conf 798713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=1.3e-05 Score=50.42 Aligned_cols=141 Identities=14% Similarity=-0.013 Sum_probs=76.0
Q ss_pred EEEEEECCCC-CEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCCCEEE
Q ss_conf 8757752028-569999998579909999997505557998899999999999983899--9821465685625888499
Q 004645 26 RYNEILGKGA-SKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTANRNIN 102 (740)
Q Consensus 26 rl~e~LG~Gs-fGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~fvd~~~~~i~ 102 (740)
++. .+..|. .+.||+.... .+..+.+|...... ...+..|..+++.|.. -.+.+++... ......+
T Consensus 14 ~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~ 82 (255)
T d1nd4a_ 14 DWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDW 82 (255)
T ss_dssp EEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEE
T ss_pred CEE-ECCCCCCCCEEEEEEEC-CCCEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCCCEEEEC--CCCCCEE
T ss_conf 358-76786547758999938-98789999589667-------7689999999999986599988613222--4566159
Q ss_pred EEEECCCCCCHHH--------------HHHHCCCC---------CHHHHHH-----HH---------------HHHHHHH
Q ss_conf 9993368999899--------------99964888---------9999999-----99---------------9999999
Q 004645 103 FVTEMFTSGTLRQ--------------YRLKHRRV---------NIRAVKH-----WC---------------RQILSGL 139 (740)
Q Consensus 103 lV~Ey~~gGSL~~--------------~l~~~k~l---------~~~~i~~-----i~---------------~QIL~gL 139 (740)
+||++++|.++.. .+.+-..+ ....... +. ......+
T Consensus 83 ~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 83 LLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp EEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 99874413554322126899999999999987368854488755412468899999987541101134011213799999
Q ss_pred HHHHHCC-----CCEEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 9987099-----99030368878658708999289911440443
Q 004645 140 LYLHSRD-----PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 178 (740)
Q Consensus 140 ~yLHs~g-----p~IIHrDLKp~NILId~n~G~VKI~DFGlA~~ 178 (740)
..+.... +.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECC-CEEEEEECHHCCC
T ss_conf 999871876579567867888763577379-6589998533265
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.28 E-value=0.0014 Score=37.71 Aligned_cols=75 Identities=19% Similarity=0.130 Sum_probs=47.0
Q ss_pred EEEEEECCCCCEEEEEEEECC-------CCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECC
Q ss_conf 875775202856999999857-------990999999750555799889999999999998389-998214656856258
Q 004645 26 RYNEILGKGASKTVYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTA 97 (740)
Q Consensus 26 rl~e~LG~GsfGtVyka~d~~-------tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fvd~~ 97 (740)
++ +.|+.|-.-.+|++.... ....|.+++.- . .... ....+|..+++.+. +.-..++++++ .
T Consensus 46 ~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g---~--~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~--~- 115 (395)
T d1nw1a_ 46 RI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF---N--PETE-SHLVAESVIFTLLSERHLGPKLYGIF--S- 115 (395)
T ss_dssp EE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC---S--CCCH-HHHHHHHHHHHHHHHTTSSSCEEEEE--T-
T ss_pred EE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC---C--CCHH-HHHHHHHHHHHHHHHCCCCCEEEEEC--C-
T ss_conf 99-991785334348999688775445789817999659---9--6116-58999999999997579998089981--8-
Q ss_pred CCEEEEEEECCCCCCH
Q ss_conf 8849999933689998
Q 004645 98 NRNINFVTEMFTSGTL 113 (740)
Q Consensus 98 ~~~i~lV~Ey~~gGSL 113 (740)
+ ++|+||+.|.+|
T Consensus 116 -~--g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 -G--GRLEEYIPSRPL 128 (395)
T ss_dssp -T--EEEECCCCEEEC
T ss_pred -C--CEEEEEECCCCC
T ss_conf -9--569997345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.87 E-value=0.0027 Score=35.89 Aligned_cols=135 Identities=13% Similarity=0.072 Sum_probs=69.9
Q ss_pred CCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCC--C---EEEEEEEECCCCEEEEEEECC
Q ss_conf 28569999998579909999997505557998899999999999983899982--1---465685625888499999336
Q 004645 34 GASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI--M---KFYTSWVDTANRNINFVTEMF 108 (740)
Q Consensus 34 GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~HpNI--V---kl~~~fvd~~~~~i~lV~Ey~ 108 (740)
+.--.||++... +|..+++|+..-.. .+ .+.+..|...+..|....+ + ..-+..........+.+++++
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~--~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPER--WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTT--SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred CCCCEEEEEECC-CCCEEEEEEECCCC--CC---HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEEC
T ss_conf 612026999838-99979999847877--88---9999999999999985599878752068980566534799998652
Q ss_pred CCCCH-----HHHH---------HH----------------------------CCCCCH---HHHHHHHHHHHHHHHHHH
Q ss_conf 89998-----9999---------96----------------------------488899---999999999999999987
Q 004645 109 TSGTL-----RQYR---------LK----------------------------HRRVNI---RAVKHWCRQILSGLLYLH 143 (740)
Q Consensus 109 ~gGSL-----~~~l---------~~----------------------------~k~l~~---~~i~~i~~QIL~gL~yLH 143 (740)
.|..+ ..+. .. ...++. ......+.+++..+.-+-
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 77688999999999989999998863035786556778978876656899987476998898999999999999999845
Q ss_pred -HC-CCCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf -09-99903036887865870899928991144044
Q 004645 144 -SR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 144 -s~-gp~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
.. ...+||+|+.+.|||++ + + ..++||+-+.
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~-~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWR-D-G-PMFVDLDDAR 219 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-S-EEECCCTTCC
T ss_pred CCCCCCEEECCCCCCCCEEEE-C-C-CEEEECHHCC
T ss_conf 456871202478880428783-8-9-3588652014
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.014 Score=31.42 Aligned_cols=140 Identities=14% Similarity=0.095 Sum_probs=67.7
Q ss_pred EEECCCCCEEEEEEEECCCCEEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----CCCCCEE-EEEEEECCCCEEE
Q ss_conf 775202856999999857990999999750555799889999999999998389-----9982146-5685625888499
Q 004645 29 EILGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-----HRNIMKF-YTSWVDTANRNIN 102 (740)
Q Consensus 29 e~LG~GsfGtVyka~d~~tg~~VAiK~iki~~~~~s~~~~~~l~~Ei~iLk~L~-----HpNIVkl-~~~fvd~~~~~i~ 102 (740)
+.|..|.--+.|+.... .| .+++|++... .....+..|+.++..|. .|..+.. -+.++........
T Consensus 24 ~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~------~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTT-KD-PLILTLYEKR------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ECCCCCCCCCEEEEEEC-CC-CEEEEECCCC------CCHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCC
T ss_conf 23788852673899978-97-2899980789------9988999999998754302555455641048976213412550
Q ss_pred EEEECCCCCCH-----HHH------H---HH---------------------------CCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 99933689998-----999------9---96---------------------------4888999999999999999999
Q 004645 103 FVTEMFTSGTL-----RQY------R---LK---------------------------HRRVNIRAVKHWCRQILSGLLY 141 (740)
Q Consensus 103 lV~Ey~~gGSL-----~~~------l---~~---------------------------~k~l~~~~i~~i~~QIL~gL~y 141 (740)
.++.+..+... ... + .. ............+..+...+..
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHC
T ss_conf 24531146553332046788888998764544432024531011101200245677776531141279999999876420
Q ss_pred HHHCC--CCEEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 87099--9903036887865870899928991144044
Q 004645 142 LHSRD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 177 (740)
Q Consensus 142 LHs~g--p~IIHrDLKp~NILId~n~G~VKI~DFGlA~ 177 (740)
....+ -++||+|+.++||+++++ ...-|+||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCC-CCEEEECCCCCC
T ss_conf 4855454503337863656402045-412674222123
|